

  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-fluoro-4-nitro-, methyl ester
C8H6FNO4
185629-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(methylamino)-4-nitro-, methyl ester
C9H10N2O4
251643-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 1.3336 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 185629-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251643-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1133456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: Methylamine (80 mL of a 2N solution in THF) was added dropwise to
a solution of compound 29-2 (10 g, 50.2 mmol) in 100 mL THF at 0 °C The
mixture was further stirred at 0°C for 20 min., then at room temperature
for 15 h. The volatiles were then evaporated, and the residue was diluted
with EtOAc, and the organic phase was washed with 2 X water, saturated
aqueous NaHCO3, dried (MgSO4), filtered and evaporated to give 10.21 g
(96 % yield) of comound 29-3 as an orange solid. The compound was used as
such for the next reaction.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolylcarbonylaminomethylbenzimidazoles as viral
polymerase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsantrizos, Youla S.; Chabot, Catherine; Beaulieu, Pierre; Brochu,
Christian; Poirier, Martin; Stammers, Timothy A.; Thavonekham, Bounkham;
Rancourt, Jean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005080388 A1 2005-09-01

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyanobenzyl bromide
C8H6BrN
28188-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 Br 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 N 8.0023 3.8501 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 3 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylamino)methyl]benzonitrile
C9H10N2
90389-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 N 0.0000 3.8501 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 28188-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90389-96-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14015198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-[(methylamino)methyl]benzonitrile To a commercially available solution
of methylamine 2M in tetrahydrofuran (200 ml, 400 mmol), 11.2 g (57.1
mmol) of 3-(bromomethyl)benzonitrile dissolved in 112 ml of
tetrahydrofuran were added dropwise. The reaction mixture was stirred at
room temperature for 24 hours. The solvent was removed under reduced
pressure. The obtained residue was diluted with ethyl ether and extracted
with 1 N HCl. The acidic extracts were basified with solid potassium
carbonate and the basic solution extracted with dichloromethane. The
organic phase was dried (MgSO4) and concentrated under reduced pressure.
The title compound was obtained as an oil (7.98g, 96%).
3-[(methylamino)methyl]benzonitrile, yield 7.98g, 96%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-(2-Amino-1-hydroxyethyl)phenol derivatives as agonists of the β2
adrenergic receptor, their preparation, pharmaceutical compositions, and
use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Puig Duran, Carlos; Prat Quinones, Maria; Perez Crespo, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007124898 A1 2007-11-08

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trichloro-1-(1H-pyrrol-2-yl)ethanone
C6H4Cl3NO
35302-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.5637 0.9764 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 Cl 2.1037 3.6437 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.1621 3.8416 0.0 0
M  V30 9 N 5.4080 1.6836 0.0 0
M  V30 10 C 5.6686 4.1618 0.0 0
M  V30 11 C 6.4386 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-pyrrole-2-carboxamide
C6H8N2O
132911-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 N 1.0306 1.6836 0.0 0
M  V30 8 C 0.7700 4.1618 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35302-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132911-42-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25952172
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substrate Controlled Regioselective Bromination of Acylated Pyrroles
Using Tetrabutylammonium Tribromide (TBABr3)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Shuang; Bethel, Travis K.; Kakeshpour, Tayeb; Hubbell, Grace E.;
Jackson, James E.; Tepe, Jetze J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(16), 9250-9255

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31611326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM closed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-Benzo[d]imidazole derivatives as TLR9 inhibitors for the treatment of
fibrosis and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoon, David S.; Regueiro-Ren, Alicia; Mandler, Michael; Posy, Shoshana L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022040260 A1 2022-02-24

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20781904
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted heteroaryl compounds, especially
pyrimidine-2,4-diamines, and methods of use in the treatment of protein
kinase-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xi, Ning; Li, Minxiong; Peng, Ju; Li, Xiaobo; Zhang, Tao; Hu, Haiyang;
Chen, Wuhong; Bai, Changlin; Ke, Donghua; Chen, Peng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019099311 A1 2019-05-23

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diglycolic anhydride
C4H4O4
4480-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0800 0.0 0
M  V30 2 O 5.3349 3.0800 0.0 0
M  V30 3 O 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 O 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(Methylamino)-2-oxoethoxy]acetic acid
C5H9NO4
63449-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 O 4.0012 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4480-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63449-71-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-14496193
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyldiglycolamide (9). To a cold (0 Â°C) 2 M solution of methylamine
in THF (10 mL, 20 mmol) was added commercially available diglycolic
anhydride (2.32 g, 20 mmol). The reaction solution was stirred overnight
at room temperature and concentrated by a rotary-evaporator. The residue
was dried by a vacuum pump without further purification to give 2.82 g
(95.8%) as an oil. 1H NMR (DMSO-d 6): Î´ 12.76 (s, CO2H, 1H), 7.78 (s,
NH, 1H), 4.07 (s, CH2, 2H), 3.93 (s, CH2, 2H), 2.61 (s, CH3, 3H). 13C NMR
(DMSO-d 6): Î´ 171.23, 168.95, 70.08, 67.75, 25.23.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Induced Association of μ Opioid (MOP) and Type 2 Cholecystokinin (CCK2)
Receptors by Novel Bivalent Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Yaguo; Akgun, Eyup; Harikumar, Kaleeckal G.; Hopson, Jessika;
Powers, Michael D.; Lunzer, Mary M.; Miller, Laurence J.; Portoghese,
Philip S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2009), 52(2), 247-258

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-657946
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolines as inhibitors of the fibroblast growth factor
receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bifulco, Neil, Jr.; Dipietro, Lucian V.; Miduturu, Chandrasekhar V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150197519 A1 2015-07-16

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10881687
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted acrylamides as inhibitors of the fibroblast
growth factor receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bifulco, Neil, Jr.; Brooijmans, Natasja; Hodous, Brian L.; Kim, Joseph
L.; Miduturu, Chandrasekhar V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014011900 A2 2014-01-16

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-fluoro-2-nitrobenzene
C6H3BrFNO2
886762-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Br 2.3101 5.3350 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
1150617-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886762-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1150617-53-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3870404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of methylamine in ethanol (8M, 100 mL, 0.8 mol) was added at
0-5 °C to 1-bromo-3-fluoro-2-nitro-benzene (19.8 g, 90 mmol). The mixture
was stirred overnight at room temperature, and then the solvent was
evaporated and the residue was partitioned between water and CH2Cl2. The
organic layer was dried over MgSO4, filtered, and concentrated to provide
crude (3-bromo-2-nitrophenyl)-methyl-amine. Yield 20 g, 96%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent
γ-Secretase Modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bischoff, Francois; Berthelot, Didier; De Cleyn, Michel; MacDonald,
Gregor; Minne, Garrett; Oehlrich, Daniel; Pieters, Serge; Surkyn, Michel;
Trabanco, Andres A.; Tresadern, Gary; Van Brandt, Sven; Velter, Ingrid;
Zaja, Mirko; Borghys, Herman; Masungi, Chantal; Mercken, Marc; Gijsen,
Harrie J. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(21), 9089-9106

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-fluoro-2-nitrobenzene
C6H3BrFNO2
886762-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Br 2.3101 5.3350 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
1150617-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886762-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1150617-53-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5723613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a)Preparation of intermediate 10 A 8 M methylamine sol. in EtOH (100 ml,
0.8 mol) was added to 1-bromo-3-fluoro-2-nitro-benzene (19.8 g, 90 mmol),
cooled on a water bath. The r.m. was stirred at r.t. overnight. Then, the
solvent was evaporated and the residue was partitioned between water and
DCM. The combined organic layers were dried (MgSO4), filtered and
concentrated in vacuo. Yield: 20 g of intermediate 10 (96 %), which was
used as such in the next reaction step. Intermediate 10, yield 20 g, 96
%.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzoxazole, benzimidazole, oxazolopyridine and
imidazopyridine derivatives as γ-secretase modulators and their
preparation and use for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gijsen, Henricus Jacobus Maria; Bischoff, Francois Paul; Zhuang, Wei; Van
Brandt, Sven Franciscus Anna; Surkyn, Michel; Zaja, Mirko; Berthelot,
Didier Jean-Claude; De Cleyn, Michel Anna Jozef; Macdonald, Gregor James;
Oehlrich, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010094647 A1 2010-08-26

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-fluoro-2-nitrobenzene
C6H3BrFNO2
886762-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Br 2.3101 5.3350 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
1150617-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886762-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1150617-53-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15066362
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example A10 a) Preparation of intermediate 17 An 8 M methylamine sol. in
ethanol (100 ml, 0.8 mol) was added to 1-bromo-3-fluoro-2-nitro-benzene
(19.8 g, 90 mmol). The mixture was cooled on a water bath and was stirred
overnight at r.t. Then, the solvent was evaporated and the residue was
partitioned between water and DCM. The combined organic layers were dried
(MgSO4), filtered and concentrated in vacuo. Yield: 20 g of intermediate
17 (96 %), which was used as such in the next step.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel substituted bicyclic heterocyclic compounds as gamma secretase
modulators and their preparation and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gijsen, Henricus Jacobus Maria; Velter, Adriana Ingrid; MacDonald, Gregor
James; Bischoff, Francois Paul; Wu, Tongfei; Van Brandt, Sven Franciscus
Anna; Surkyn, Michel; Zaja, Mirko; Pieters, Serge Maria Aloysius;
Berthelot, Didier Jean-Claude; De Cleyn, Michel Anna Jozef; Oehlrich,
Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010089292 A1 2010-08-12

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitrobenzoic acid
C7H4ClNO4
96-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14174152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for preparation of dabigatran etexilate mesylate and
intermediates thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mathad, Vijayavitthal Thippannachar; Solanki, Pavankumar Vrajlal;
Uppelli, Sekhar Babu; Sarode, Ganesh Gitaram
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015128875 A2 2015-09-03

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43048199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pharmaceutical composition containing canine janus kinase inhibitors for
treating allergic reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Calabrese, Andrew Antony; Stanton, David T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024246837 A1 2024-12-05

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-20731453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Unified Approach to the Chemoselective α-Functionalization of Amides
with Heteroatom Nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goncalves, Carlos R.; Lemmerer, Miran; Teskey, Christopher J.; Adler,
Pauline; Kaiser, Daniel; Maryasin, Boris; Gonzalez, Leticia; Maulide,
Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2019), 141(46), 18437-18443

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzene, 1-bromo-2-chloro-3-fluoro-4-nitro-
C6H2BrClFNO2
1804382-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Cl 5.3901 0.0000 0.0 0
M  V30 6 Br 6.9302 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-2-chloro-N-methyl-6-nitrobenzenamine
C7H6BrClN2O2
2054343-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 5.3900 1.3338 0.0 0
M  V30 7 Br 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 10
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1804382-22-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2054343-83-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36859322
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Aminoimidazole derivatives as PRMT5 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulyk, Svitlana; Smith, Christopher Ronald; Ivetac, Anthony; Lawson, John
David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023081367 A2 2023-05-11

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
3-(4-Methoxyphenyl)propionic acid
C10H12O3
1929-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenepropanamide
C11H15NO2
178382-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 N 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 0.0000 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1929-29-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 178382-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20454279
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 5- to 7-membered benzolactam compounds via strongly
facilitated electrophilic aromtic substitution reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurouchi, Hiroaki; Otani, Yuko; Ohwada, Tomohiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2016), 93(2), 705-713

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lauryl acrylate
C15H28O2
2156-97-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0023 1.5400 0.0 0
M  V30 4 O 4.0012 2.3101 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 13.3372 1.5400 0.0 0
M  V30 13 C 14.6708 2.3101 0.0 0
M  V30 14 C 16.0045 1.5400 0.0 0
M  V30 15 C 17.3382 2.3101 0.0 0
M  V30 16 C 18.6720 1.5400 0.0 0
M  V30 17 C 20.0057 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(Dodecyloxy)-3-oxopropyl]-N-methyl-β-alanine dodecyl ester
C31H61NO4
1123109-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.0057 2.3101 0.0 0
M  V30 2 N 21.3393 1.5400 0.0 0
M  V30 3 C 18.6718 1.5400 0.0 0
M  V30 4 C 22.6730 2.3101 0.0 0
M  V30 5 C 21.3393 0.0000 0.0 0
M  V30 6 C 17.3382 2.3101 0.0 0
M  V30 7 C 24.0067 1.5400 0.0 0
M  V30 8 O 16.0045 1.5400 0.0 0
M  V30 9 O 17.3382 3.8501 0.0 0
M  V30 10 C 25.3405 2.3101 0.0 0
M  V30 11 C 14.6708 2.3101 0.0 0
M  V30 12 O 26.6742 1.5400 0.0 0
M  V30 13 O 25.3405 3.8501 0.0 0
M  V30 14 C 13.3370 1.5400 0.0 0
M  V30 15 C 28.0078 2.3101 0.0 0
M  V30 16 C 12.0033 2.3101 0.0 0
M  V30 17 C 29.3415 1.5400 0.0 0
M  V30 18 C 10.6697 1.5400 0.0 0
M  V30 19 C 30.6753 2.3101 0.0 0
M  V30 20 C 9.3360 2.3101 0.0 0
M  V30 21 C 32.0090 1.5400 0.0 0
M  V30 22 C 8.0022 1.5400 0.0 0
M  V30 23 C 33.3427 2.3101 0.0 0
M  V30 24 C 6.6685 2.3101 0.0 0
M  V30 25 C 34.6765 1.5400 0.0 0
M  V30 26 C 5.3348 1.5400 0.0 0
M  V30 27 C 36.0101 2.3101 0.0 0
M  V30 28 C 4.0012 2.3101 0.0 0
M  V30 29 C 37.3438 1.5400 0.0 0
M  V30 30 C 2.6673 1.5400 0.0 0
M  V30 31 C 38.6775 2.3101 0.0 0
M  V30 32 C 1.3337 2.3101 0.0 0
M  V30 33 C 40.0113 1.5400 0.0 0
M  V30 34 C 0.0000 1.5400 0.0 0
M  V30 35 C 41.3450 2.3101 0.0 0
M  V30 36 C 42.6786 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2156-97-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123109-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22839572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM key step, key intermediate, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, surface activity and antielectrostatic properties of new soft
dichain cationic surfactants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zielinski, Wojciech; Wilk, Kazimiera A.; Para, Grazyna; Jarek, Ewelina;
Ciszewski, Krzysztof; Palus, Jerzy; Warszynski, Piotr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Colloids and Surfaces, A: Physicochemical and Engineering Aspects (2015),
48063-70

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15828646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of new potent anticancer benzothiazole amides and
ureas featuring pyridylamide moiety and possessing dual B-RafV600E and
C-Raf kinase inhibitory activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM El-Damasy, Ashraf Kareem; Lee, Ju-Hyeon; Seo, Seon Hee; Cho, Nam-Chul;
Pae, Ae Nim; Keum, Gyochang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115201-216

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
N-tert-Butoxycarbonyl-D-phenylglycine
C13H17NO4
33125-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.2074 0.0 0 CFG=2
M  V30 2 N 5.3900 2.8738 0.0 0
M  V30 3 C 5.3900 5.5411 0.0 0
M  V30 4 C 6.9300 2.8738 0.0 0
M  V30 5 O 4.6200 6.8749 0.0 0
M  V30 6 O 6.9300 5.5411 0.0 0
M  V30 7 O 7.7000 1.5400 0.0 0
M  V30 8 O 7.7000 4.2074 0.0 0
M  V30 9 C 9.2400 1.5400 0.0 0
M  V30 10 C 9.2400 3.0800 0.0 0
M  V30 11 C 10.7800 1.5400 0.0 0
M  V30 12 C 9.2400 0.0000 0.0 0
M  V30 13 C 3.0800 4.2074 0.0 0
M  V30 14 C 2.3100 2.8738 0.0 0
M  V30 15 C 2.3100 5.5411 0.0 0
M  V30 16 C 0.7700 2.8738 0.0 0
M  V30 17 C 0.7700 5.5411 0.0 0
M  V30 18 C 0.0000 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-2-(methylamino)-2-oxo-1-phenylethyl]carbamate
C14H20N2O3
795310-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=1
M  V30 2 C 5.3900 2.6674 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 N 6.1600 1.3338 0.0 0
M  V30 5 O 3.8500 2.6674 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 O 3.0800 6.6685 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 C 1.5400 6.6685 0.0 0
M  V30 11 C 1.5400 5.1285 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 1.5400 8.2085 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 33125-05-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 795310-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12843967
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methylene-Bridged Bis(imidazoline)-Derived 2-Oxopyrimidinium Salts as
Catalysts for Asymmetric Michael Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheshenev, Andrey E.; Boltukhina, Ekaterina V.; White, Andrew J. P.; Hii,
King Kuok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2013), 52(27), 6988-6991

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
N-tert-Butoxycarbonyl-D-phenylglycine
C13H17NO4
33125-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.2074 0.0 0 CFG=2
M  V30 2 N 5.3900 2.8738 0.0 0
M  V30 3 C 5.3900 5.5411 0.0 0
M  V30 4 C 6.9300 2.8738 0.0 0
M  V30 5 O 4.6200 6.8749 0.0 0
M  V30 6 O 6.9300 5.5411 0.0 0
M  V30 7 O 7.7000 1.5400 0.0 0
M  V30 8 O 7.7000 4.2074 0.0 0
M  V30 9 C 9.2400 1.5400 0.0 0
M  V30 10 C 9.2400 3.0800 0.0 0
M  V30 11 C 10.7800 1.5400 0.0 0
M  V30 12 C 9.2400 0.0000 0.0 0
M  V30 13 C 3.0800 4.2074 0.0 0
M  V30 14 C 2.3100 2.8738 0.0 0
M  V30 15 C 2.3100 5.5411 0.0 0
M  V30 16 C 0.7700 2.8738 0.0 0
M  V30 17 C 0.7700 5.5411 0.0 0
M  V30 18 C 0.0000 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-2-(methylamino)-2-oxo-1-phenylethyl]carbamate
C14H20N2O3
795310-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=1
M  V30 2 C 5.3900 2.6674 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 N 6.1600 1.3338 0.0 0
M  V30 5 O 3.8500 2.6674 0.0 0
M  V30 6 C 3.8500 5.3347 0.0 0
M  V30 7 C 5.3900 0.0000 0.0 0
M  V30 8 O 3.0800 6.6685 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 C 1.5400 6.6685 0.0 0
M  V30 11 C 1.5400 5.1285 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 1.5400 8.2085 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 33125-05-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 795310-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12021664
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Chiral Zwitterionic Phosphorus Heterocycles: Synthesis, Structure,
Properties and Application as Chiral Solvating Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheshenev, Andrey E.; Boltukhina, Ekaterina V.; Grishina, Anastasiya A.;
Cisarova, Ivana; Lyapkalo, Ilya M.; Hii, King Kuok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(25), 8136-8143

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluoronitrobenzene
C6H3F2NO2
446-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N-methyl-2-nitrobenzenamine
C7H7FN2O2
120381-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 F 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 120381-42-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22539019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives and aza-benzimidazole derivatives as janus
kinase 2 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Zhang, Tinghu; Liu, Yao; Weinstock, David; Li,
Loretta Sze-Mun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020097396 A1 2020-05-14

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzaldehyde
C7H5BrO
6630-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzylamine
C8H10BrN
698-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6630-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1976045
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4.5. Synthesis of rac-11. N-Methyl-2-bromobenzylamine (13). To a mixture
of 2-bromobenzaldehyde (1.850 g, 10 mmol) and 3 Å molecular sieves (2 g)
in dry ethanol (4 mL) was added CH3NH2 (4 mL, 33% solution in ethanol, 32
mmol) under argon. The reaction mixture was stirred for 15 h at room
temperature. The resulting mixture was cooled down to 0 °C, and NaBH4
(0.567 g, 15 mmol) was added. The reaction mixture was then stirred at
room temperature for 24 h. Water (10 mL) was added, and the molecular
sieves were filtered off. The filtrate was extracted with ethyl acetate
(3 × 20 mL). The combined organic layers were washed with water and brine
and dried over MgSO4. After removal of the solvent, the crude product was
obtained as a clear pale yellow liquid. Purification by flash column
chromatography on SiO2 (ethyl acetate/n-hexane) afforded the desired
product 13. Clear colorless liquid, yield 1.911 g, 96%. 1H NMR (600 MHz,
CDCl3): δ = 7.56 (dd, J = 8.0 Hz, 0.8 Hz, 1H, Ar-H), 7.39 (dd, J = 7.6
Hz, 1.4 Hz, 1H, Ar-H), 7.32-7.27 (m, 1H, Ar-H), 7.14 (td, J = 7.8 Hz, 1.6
Hz, 1H, Ar-H), 3.85 (s, 2H, NCH2), 2.47 (s, 3H, NCH3), 1.51 (bs, 1H, NH)
ppm; 13C NMR (150 MHz, CDCl3): δ = 139.1, 132.8, 130.3, 128.6, 127.4,
124.0, 55.8 (CH2), 35.9 (CH3) ppm; IR (ATR): ν̃ = 3319 (br), 3059, 2931,
2843, 2791, 1591, 1566, 1487, 1438, 1352, 1199, 1130, 1103, 1024, 823,
744 (s), 655 cm-1.
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Enantioselective Organocatalytic Trifluoromethyl Carbinol
Synthesis-A Caveat on Reaction Times and Product Isolation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duangdee, Nongnaphat; Harnying, Wacharee; Rulli, Giuseppe; Neudoerfl,
Joerg-M.; Groeger, Harald; Berkessel, Albrecht
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2012), 134(27), 11196-11205

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-nitrobenzaldehyde
C7H4BrNO3
84459-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 O 6.9301 2.6675 0.0 0
M  V30 3 Br 4.6201 6.6686 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 2.6675 0.0 0
M  V30 9 C 3.8500 5.3348 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-5-nitrobenzenemethanamine
C8H9BrN2O2
1037082-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 Br 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84459-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037082-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16348303
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and P1' SAR exploration of potent macrocyclic tissue
factor-factor VIIa inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ladziata, Vladimir; Glunz, Peter W.; Zou, Yan; Zhang, Xiaojun; Jiang,
Wen; Jacutin-Porte, Swanee; Cheney, Daniel L.; Wei, Anzhi; Luettgen,
Joseph M.; Harper, Timothy M.; Wong, Pancras C.; Seiffert, Dietmar;
Wexler, Ruth R.; Priestley, E. Scott
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(20), 5051-5057

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-nitrobenzaldehyde
C7H4BrNO3
84459-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 O 6.9301 2.6675 0.0 0
M  V30 3 Br 4.6201 6.6686 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 2.6675 0.0 0
M  V30 9 C 3.8500 5.3348 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-5-nitrobenzenemethanamine
C8H9BrN2O2
1037082-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 Br 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0 VAL=5
M  V30 6 O 2.3100 6.6685 0.0 0
M  V30 7 O 0.0000 5.3347 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84459-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037082-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9193613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 17. To a stirred solution ofIntermediate 17A (17.768 g, 77
mmol) in MeOH (200 mL) was added methylamine (33 wt. % in EtOH) (21.81
mL, 232 mmol) dropwise and stirred for 1 h at 25°C. Then, the reaction
mixture was cooled to 0 °C and sodium borohydride (5.84 g, 154 mmol) was
added portionwise with stirring. The reaction mixture was allowed to
reach rt and stirred overnight. The reaction mixture was concentrated
under reduced pressure, diluted with EtOAc (250 mL), washed with water
(2×100 mL), brine (1×100 mL) and dried (Na2SO4). The solvent was removed
under reduced pressure to give Intermediate 17 (18.134 g, 74.0 mmol, 96 %
yield) as a yellow oil. Compound was pure (>95% by NMR) and utilized in
the subsequent step without any further purification. MS (ESI) m/z 245.1
(M+H)+. 1H-NMR: (500 MHz, CDCl3) δ ppm 2.51 (s, 3 H), 3.90 (s, 2 H), 7.73
(d, J=8.8 Hz, 1 H), 7.99 (dd, J=8.8, 2.7 Hz, 1 H), 8.32 (d, J=2.7 Hz, 1
H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic amino acid derivatives as factor VIIa
inhibitors useful as anticoagulants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wurtz, Nicholas Ronald; Priestley, Eldon Scott; Cheney, Daniel L.; Glunz,
Peter W.; Zhang, Xiaojun; Ladziata, Vladimir; Parkhurst, Brandon;
Mueller, Luciano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008079836 A2 2008-07-03

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
2,5-Dimethyl 2,5-pyridinedicarboxylate
C9H9NO4
881-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 O 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 N 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-[(methylamino)carbonyl]-3-pyridinecarboxylate
C9H10N2O3
173371-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 N 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 N 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 881-86-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 173371-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8730838
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel method for the mild and selective amidation of diesters and the
amidation of monoesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guo, Z.; Dowdy, E. D.; Li, W.-S.; Polniaszek, R.; Delaney, E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2001), 42(10), 1843-1845

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-3-phenyl-2,4(1H,3H)-quinolinedione
C15H10ClNO2
144603-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.8615 0.8629 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 O 6.6685 4.6200 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 N 4.0011 4.6200 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3338 1.5400 0.0 0
M  V30 11 C 1.3338 4.6200 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 6.8513 2.5773 0.0 0
M  V30 15 C 7.3781 4.0245 0.0 0
M  V30 16 C 7.8412 1.3977 0.0 0
M  V30 17 C 8.8947 4.2920 0.0 0
M  V30 18 C 9.3578 1.6652 0.0 0
M  V30 19 C 9.8846 3.1122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-3-phenyl-2,4(1H,3H)-quinolinedione
C16H14N2O2
477950-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.8615 1.1798 0.0 0
M  V30 2 C 4.8716 0.0000 0.0 0
M  V30 3 O 4.0011 0.3169 0.0 0
M  V30 4 O 6.6685 4.9369 0.0 0
M  V30 5 C 5.3347 2.6269 0.0 0
M  V30 6 C 4.0011 1.8569 0.0 0
M  V30 7 C 5.3347 4.1669 0.0 0
M  V30 8 C 2.6674 2.6269 0.0 0
M  V30 9 N 4.0011 4.9369 0.0 0
M  V30 10 C 2.6674 4.1669 0.0 0
M  V30 11 C 1.3338 1.8569 0.0 0
M  V30 12 C 1.3338 4.9369 0.0 0
M  V30 13 C 0.0000 2.6269 0.0 0
M  V30 14 C 0.0000 4.1669 0.0 0
M  V30 15 C 6.8513 2.8943 0.0 0
M  V30 16 C 7.8412 1.7146 0.0 0
M  V30 17 C 7.3781 4.3414 0.0 0
M  V30 18 C 9.3578 1.9820 0.0 0
M  V30 19 C 8.8947 4.6089 0.0 0
M  V30 20 C 9.8846 3.4291 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 3 6
M  V30 4 2 4 7
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 10
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144603-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 477950-03-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16453124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation, no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 1,4-Benzodiazepine-2,5-diones by Base Promoted Ring
Expansion of 3-Aminoquinoline-2,4-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kremen, Filip; Gazvoda, Martin; Kafka, Stanislav; Proisl, Karel;
Srholcova, Anna; Klasek, Antonin; Urankar, Damijana; Kosmrlj, Janez
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(1), 715-722

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-1-methyl-3-phenyl-2,4(1H,3H)-quinolinedione
C16H12ClNO2
144603-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.8615 5.2971 0.0 0
M  V30 2 O 4.0011 6.1600 0.0 0
M  V30 3 O 6.6685 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 N 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 1.3338 4.6200 0.0 0
M  V30 12 C 1.3338 1.5400 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 6.8513 3.5827 0.0 0
M  V30 16 C 7.3781 2.1355 0.0 0
M  V30 17 C 7.8412 4.7623 0.0 0
M  V30 18 C 8.8947 1.8680 0.0 0
M  V30 19 C 9.3578 4.4948 0.0 0
M  V30 20 C 9.8846 3.0478 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 10
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-3-(methylamino)-3-phenyl-2,4(1H,3H)-quinolinedione
C17H16N2O2
477950-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.8615 5.2971 0.0 0
M  V30 2 C 4.8716 6.4769 0.0 0
M  V30 3 O 4.0011 6.1600 0.0 0
M  V30 4 O 6.6685 1.5400 0.0 0
M  V30 5 C 4.0011 0.0000 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 N 4.0011 1.5400 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 1.3338 4.6200 0.0 0
M  V30 13 C 1.3338 1.5400 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 6.8513 3.5827 0.0 0
M  V30 17 C 7.3781 2.1355 0.0 0
M  V30 18 C 7.8412 4.7623 0.0 0
M  V30 19 C 8.8947 1.8680 0.0 0
M  V30 20 C 9.3578 4.4950 0.0 0
M  V30 21 C 9.8846 3.0478 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 2 4 8
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144603-33-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 477950-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16453118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation, no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 1,4-Benzodiazepine-2,5-diones by Base Promoted Ring
Expansion of 3-Aminoquinoline-2,4-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kremen, Filip; Gazvoda, Martin; Kafka, Stanislav; Proisl, Karel;
Srholcova, Anna; Klasek, Antonin; Urankar, Damijana; Kosmrlj, Janez
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(1), 715-722

$RFMT $RIREG SCHEME21 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[(1R)-3-Chloro-1-phenylpropoxy]-4-fluorobenzo[b]thiophene
C17H14ClFOS
476199-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 5.3347 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0 CFG=1
M  V30 3 C 6.1600 2.6674 0.0 0
M  V30 4 C 6.9300 1.3336 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 F 0.0000 5.3347 0.0 0
M  V30 7 C 3.8500 6.6684 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 C 2.3100 6.6684 0.0 0
M  V30 10 S 4.3259 8.1331 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 1.5400 5.3347 0.0 0
M  V30 13 C 1.8341 8.1331 0.0 0
M  V30 14 C 3.0800 9.0383 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 18 C 9.2400 2.6674 0.0 0
M  V30 19 C 10.7801 5.3347 0.0 0
M  V30 20 C 10.7801 2.6674 0.0 0
M  V30 21 C 11.5501 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 2 13 14
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Oxalic acid
C2H2O4
144-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamine, γ-[(4-fluorobenzo[b]thien-7-yl)oxy]-N-methyl-, ethanedioa...
C18H18FNOS.C2H2O4
476200-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 12.0585 0.0 0
M  V30 2 C 6.9301 10.7249 0.0 0 CFG=1
M  V30 3 C 6.1601 9.3912 0.0 0
M  V30 4 C 6.9301 8.0576 0.0 0
M  V30 5 N 6.1601 6.7237 0.0 0
M  V30 6 C 6.9301 5.3901 0.0 0
M  V30 7 F 0.0000 12.0585 0.0 0
M  V30 8 C 3.8501 13.3923 0.0 0
M  V30 9 C 4.6201 12.0585 0.0 0
M  V30 10 C 2.3100 13.3923 0.0 0
M  V30 11 S 4.3259 14.8569 0.0 0
M  V30 12 C 3.8501 10.7249 0.0 0
M  V30 13 C 1.5400 12.0585 0.0 0
M  V30 14 C 1.8342 14.8569 0.0 0
M  V30 15 C 3.0800 15.7621 0.0 0
M  V30 16 C 2.3100 10.7249 0.0 0
M  V30 17 C 8.4701 10.7249 0.0 0
M  V30 18 C 9.2401 9.3912 0.0 0
M  V30 19 C 9.2401 12.0585 0.0 0
M  V30 20 C 10.7801 9.3912 0.0 0
M  V30 21 C 10.7801 12.0585 0.0 0
M  V30 22 C 11.5502 10.7249 0.0 0
M  V30 23 C 6.4419 1.5400 0.0 0
M  V30 24 C 5.1082 2.3101 0.0 0
M  V30 25 O 7.7756 2.3101 0.0 0
M  V30 26 O 6.4419 0.0000 0.0 0
M  V30 27 O 5.1082 3.8501 0.0 0
M  V30 28 O 3.7746 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 16
M  V30 18 2 14 15
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 2 24 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-66-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 144-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476200-45-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4238198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-(heteroaryloxy)propanamines as serotonin and
norepinephrine reuptake inhibitors for treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gallagher, Peter Thaddeus; Rathmell, Richard Edmund; Fagan, Maria Ann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002094262 A1 2002-11-28

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-2-Amino-6-chloropurine-dioxolane
C9H10ClN5O3
145513-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6201 0.0 0
M  V30 2 N 2.6675 0.0000 0.0 0
M  V30 3 C 10.5370 5.4471 0.0 0
M  V30 4 O 11.7831 4.5420 0.0 0
M  V30 5 N 5.1457 4.8805 0.0 0
M  V30 6 C 4.0011 3.8501 0.0 0
M  V30 7 C 4.5192 6.2873 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 N 2.9877 6.1264 0.0 0
M  V30 11 C 1.3338 3.8501 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 13 N 1.3338 2.3100 0.0 0
M  V30 14 C 6.6520 4.5603 0.0 0 CFG=1
M  V30 15 O 7.7966 5.5908 0.0 0
M  V30 16 C 7.2785 3.1534 0.0 0
M  V30 17 C 9.1302 4.8208 0.0 0 CFG=2
M  V30 18 O 8.8100 3.3145 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 17 3 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 14 5 CFG=3
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,4R)-4-[2-Amino-6-(methylamino)-9H-purin-9-yl]-1,3-dioxolane-2-methanol
C10H14N6O3
945983-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 N 4.0012 0.0000 0.0 0
M  V30 4 C 11.8707 5.4471 0.0 0
M  V30 5 O 13.1168 4.5420 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 N 6.4794 4.8805 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 N 5.3348 2.3101 0.0 0
M  V30 10 C 5.8529 6.2873 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 N 4.3213 6.1264 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 N 2.6675 2.3101 0.0 0
M  V30 15 C 7.9857 4.5603 0.0 0 CFG=1
M  V30 16 O 9.1302 5.5908 0.0 0
M  V30 17 C 8.6122 3.1534 0.0 0
M  V30 18 C 10.4639 4.8208 0.0 0 CFG=2
M  V30 19 O 10.1437 3.3145 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 18 4 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 15 7 CFG=3
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 145513-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945983-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5134103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anti-HIV activity of
(-)-β--(2R,4R)-1,3-dioxolane-2,6-diamino purine (DAPD) (amdoxovir) and
(-)-β-D-(2R,4R)-1,3-dioxolane guanosine (DXG) prodrugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Narayanasamy, Janarthanan; Pullagurla, Manik R.; Sharon, Ashoke; Wang,
Jianing; Schinazi, Raymond F.; Chu, Chung K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Antiviral Research (2007), 75(3), 198-209

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine
C7H9Cl2N3S
145783-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 C 8.0023 4.6201 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 Cl 2.6675 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 N 0.0000 1.5400 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 N 4.0012 2.3101 0.0 0
M  V30 10 N 2.6675 4.6201 0.0 0
M  V30 11 C 2.6675 1.5400 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-methyl-2-(propylthio)-4,5-pyrimidinediamine
C8H13ClN4S
2370897-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 4.6201 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 9.3359 3.8500 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 2.6675 0.0000 0.0 0
M  V30 8 N 0.0000 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 N 2.6675 4.6201 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 13 C 2.6675 1.5400 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 145783-15-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2370897-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24215386
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives for prevention and treatment of
Gram-negative bacterial infection, contamination and fouling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lancellotti, Patrizio; Oury, Cecile; Pirotte, Bernard; Musumeci, Lucia;
Jacques, Nicolas; Goffin, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20210290625 A1 2021-09-23

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine
C7H9Cl2N3S
145783-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 C 8.0023 4.6201 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 Cl 2.6675 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.6201 0.0 0
M  V30 7 N 0.0000 1.5400 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 N 4.0012 2.3101 0.0 0
M  V30 10 N 2.6675 4.6201 0.0 0
M  V30 11 C 2.6675 1.5400 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-methyl-2-(propylthio)-4,5-pyrimidinediamine
C8H13ClN4S
2370897-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 4.6201 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 9.3359 3.8500 0.0 0
M  V30 5 N 0.0000 4.6201 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 2.6675 0.0000 0.0 0
M  V30 8 N 0.0000 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 N 2.6675 4.6201 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 13 C 2.6675 1.5400 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 145783-15-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2370897-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21833571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives for use as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lancellotti, Patrizio; Oury, Cecile; Pirotte, Bernard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3527571 A1 2019-08-21

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-chloro-3-nitro-, methyl ester
C8H6ClNO4
14719-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 Cl 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
36242-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14719-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36242-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7946709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Acid Preparation 12.
1-Methyl-2-pyrrolidin-1-yl-1H-benzimidazole-5-carboxylic acid Methyl
3-nitro-4-chlorobenzoate (72.01 g, 0.334 mol) was suspended in freshly
distilled acetonitrile (360 mL) under stirring. Anhydrous sodium acetate
(41.1 g, 0.5 mol) and 30% aqueous solution of methylamine (69 mL, 0.67
mol) were added to this suspension under vigorous stirring. The obtained
mixture was refluxed for 7 hours and then kept overnight with TLC
monitoring (chlorotorm/CCl4,1:2). The yellow precipitate was separated by
filtration and mixed with a solution of K2CO3 (25 g) in water (500 mL).
The mixture was stirred for 30 minutes and filtered. The yellow
precipitate was washed with water to attain pH 7. The filtrate was
concentrated under a reduced pressure to a volume of about 200 mL and
mixed with a solution of K2CO3 (5 g) in water (100 mL). The mixture was
stirred for 30 minutes and filtered. The yellow precipitate was washed
with water to attain pH 7. Two above precipitates were combined and dried
to give methyl 4-methylamino)-3-nitrobenzoate as a yellow powder in
(67.63 g 96%).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of K2CO3 and water in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (hetero)aroyl spiroketones as acetyl-CoA carboxylase
inhibitors for treatment of obesity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Corbett, Jeffrey Wayne; Elliott, Richard Louis; Bell, Andrew Simon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008065508 A1 2008-06-05

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Benzoic acid, 4-chloro-3-nitro-, methyl ester
C8H6ClNO4
14719-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 Cl 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
36242-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 14719-83-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36242-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14943112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl 4-(Methylamino)-3-nitrobenzoate. Methyl 4-chloro-3-nitrobenzoate
(72.01 g, 0.334 mol) was suspended in freshly distilled acetonitrile (360
mL) under stirring. Anhydrous sodium acetate (41.1 g, 0.5 mol) and then a
30% w/w aqueous solution of methylamine (69 mL, 0.67 mol) were added to
this suspension under vigorous stirring. The obtained mixture was
refluxed for 7 h while the course of the reaction was monitored by TLC
(chloroform/CCl4 1:2). The yellow precipitate was separated by filtration
and mixed with a solution of K2CO3 (25 g) in water (500 mL). The mixture
was stirred for 30 min and then filtered. The yellow precipitate was
washed with water to attain pH 7. The filtrate was concentrated under
reduced pressure to a volume of~200 mL and then mixed with a solution of
K2CO3 (5 g) in water (100 mL). The mixture was stirred for 30 min and
then filtered. The yellow precipitate was washed with water to attain pH
7. Two above precipitates were combined and dried to give the title
compound as a yellow powder in 96% (67.63 g) yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole antagonists of the H-3 receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wager, Travis T.; Mente, Scot Richard; Butler, Todd William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007069053 A1 2007-06-21

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Borinic acid, di-2-propenyl-, 1-methylethyl ester
C9H17BO
147315-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 3.0800 4.0011 0.0 0
M  V30 2 O 2.3100 5.3348 0.0 0
M  V30 3 C 4.6201 4.0011 0.0 0
M  V30 4 C 2.3100 2.6675 0.0 0
M  V30 5 C 0.7700 5.3348 0.0 0
M  V30 6 C 5.3901 5.3348 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 0.0000 6.6686 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 C 6.9301 5.3348 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C10H22BNO
3060797-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 4.0012 4.0012 0.0 0 CHG=3 VAL=4
M  V30 2 O 2.6675 3.2311 0.0 0 CHG=-1 VAL=2
M  V30 3 C 5.3348 4.7712 0.0 0 CHG=-1 VAL=4
M  V30 4 C 4.7712 2.6675 0.0 0 CHG=-1 VAL=4
M  V30 5 N 3.2311 5.3348 0.0 0 VAL=4
M  V30 6 C 1.3337 4.0012 0.0 0
M  V30 7 C 6.6687 4.0012 0.0 0
M  V30 8 C 4.0012 1.3338 0.0 0
M  V30 9 C 4.0012 6.6687 0.0 0
M  V30 10 C 0.0000 3.2311 0.0 0
M  V30 11 C 1.3337 5.5412 0.0 0
M  V30 12 C 8.0023 4.7712 0.0 0
M  V30 13 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 2 8 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147315-45-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3060797-86-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42875514
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine adducts of triallylborane as highly reactive allylborating agents
for Cu(I)-catalyzed allylation of chiral sulfinylimines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alexeev, Michael S.; Strelkova, Tatiana V.; Ilyin, Michael M.; Nelyubina,
Yulia V.; Bespalov, Ivan A.; Medvedev, Michael G.; Khrustalev, Victor N.;
Kuznetsov, Nikolai Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2024), 22(23), 4680-4696

$RFMT $RIREG SCHEME26 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Benzenedicarboxaldehyde
C8H6O2
623-27-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trifluoromethanesulfonic acid
CHF3O3S
1493-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 S 3.0800 1.5400 0.0 0 VAL=6
M  V30 3 F 0.7700 2.8736 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 0.7700 0.2064 0.0 0
M  V30 6 O 3.0800 3.0800 0.0 0
M  V30 7 O 3.0800 0.0000 0.0 0
M  V30 8 O 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 6 2 2 7
M  V30 7 1 2 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanesulfonic acid, 1,1,1-trifluoro-, compd. with N1,N4-dimethyl-1,4-benzen...
C10H16N2.2CHF3O3S
1272974-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.9537 0.0 0
M  V30 2 N 1.5400 7.2873 0.0 0
M  V30 3 C 0.0000 7.2873 0.0 0
M  V30 4 C 8.4701 5.9537 0.0 0
M  V30 5 N 9.2401 4.6200 0.0 0
M  V30 6 C 10.7801 4.6200 0.0 0
M  V30 7 C 3.8500 5.9537 0.0 0
M  V30 8 C 4.6201 7.2873 0.0 0
M  V30 9 C 4.6201 4.6200 0.0 0
M  V30 10 C 6.1601 7.2873 0.0 0
M  V30 11 C 6.1601 4.6200 0.0 0
M  V30 12 C 6.9301 5.9537 0.0 0
M  V30 13 C 4.6201 1.5400 0.0 0
M  V30 14 S 6.1601 1.5400 0.0 0 VAL=6
M  V30 15 F 3.8501 2.8736 0.0 0
M  V30 16 F 3.0801 1.5400 0.0 0
M  V30 17 F 3.8501 0.2064 0.0 0
M  V30 18 O 6.1601 3.0800 0.0 0
M  V30 19 O 6.1601 0.0000 0.0 0
M  V30 20 O 7.7001 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 14 19
M  V30 19 1 14 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-27-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1493-13-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1272974-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8206546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM p-Xylylene bis(N-methylammonium) trifluoromethanesulfonate (2a).
Terephthalaldehyde (0.13 g, 1.0 mmol) was dissolved in methanol (5.0 mL),
and a methanolic methylamine solution (2.0 M, 1.5 mL, 3.0 mmol) was added
at 0 °C. After 2 h at 25 °C, the solution was treated with sodium
borohydride (0.19 g, 5.0 mmol) and stirred for an additional 2 h. The
solvent was then evaporated, and the residue partitioned between ethyl
acetate (25 mL) and brine (25 mL). The aqueous layer was extracted with
ethyl acetate (2 × 25 mL), the combined organic layers were dried with
sodium sulfate, and the solvent evaporated. The resulting oil was then
dissolved in methanol (5.0 mL), treated with trifluoromethanesulfonic
acid (0.44 mL, 0.75 g, 5.0 mmol), and the volatiles were evaporated
again. Upon addition of diethyl ether (25 mL), the title product
crystallized as colorless needles, was filtered, and was dried under high
vacuum (0.47 g, 96%). p-Xylylene bis(N-methylammonium)
trifluoromethanesulfonate (2a), yield 0.47 g, 96%. m.p. 265 - 266 °C; 1H
NMR: δ = 7.55 (s, 4 H, 4 × ArH), 4.26 (s, 4 H, 2 × ArCH2), 2.73 (s, 4 H,
2 × CH3). 13C NMR: δ = 132.8 (ArC), 131.2 (ArCH), 120.3 (q, 1JFC = 317.1
Hz, CF3SO3-), 52.5 (ArCH2), 32.8 (H2NCH3) ppm. HRMS (ESI) m/z calcd for
C12H18F6N2O6S2 ([M - CF3SO3]+), 315.098474, found 315.098702.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formation and Stabilization of Silver Nanoparticles with Cucurbit[n]urils
(n = 5-8) and Cucurbituril-Based Pseudorotaxanes in Aqueous Medium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Xiaoyong; Masson, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Langmuir (2011), 27(6), 3051-3058

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-2-azido-3-(3,5-difluoro-4-methoxyphenyl)-2-propenoate
C11H9F2N3O3
1539318-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 C 9.2400 4.0011 0.0 0
M  V30 4 N 6.9300 2.6674 0.0 0
M  V30 5 O 10.0100 5.3347 0.0 0
M  V30 6 O 10.0100 2.6674 0.0 0
M  V30 7 N 7.7000 1.3336 0.0 0 CHG=1 VAL=4
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 N 8.4700 0.0000 0.0 0 CHG=-1
M  V30 10 F 2.3100 8.0021 0.0 0
M  V30 11 F 2.3100 2.6674 0.0 0
M  V30 12 O 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 15 C 4.6200 6.6685 0.0 0
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 10 17
M  V30 11 1 11 18
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-Azido-3-(3,5-difluoro-4-methoxyphenyl)-N-methyl-2-propenamide
C11H10F2N4O2
1539318-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 C 9.2400 4.0011 0.0 0
M  V30 4 N 6.9300 2.6674 0.0 0
M  V30 5 N 10.0100 5.3347 0.0 0
M  V30 6 O 10.0100 2.6674 0.0 0
M  V30 7 N 7.7000 1.3336 0.0 0 CHG=1 VAL=4
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 N 8.4700 0.0000 0.0 0 CHG=-1
M  V30 10 F 2.3100 8.0021 0.0 0
M  V30 11 F 2.3100 2.6674 0.0 0
M  V30 12 O 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 15 C 4.6200 6.6685 0.0 0
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 3.0800 6.6685 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 10 17
M  V30 11 1 11 18
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1539318-37-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1539318-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9881882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of
(Z)-2-azido-3-(3,5-difluoro-4-methoxyphenyl)-N-methylacrylamide (14)4 The
synthesis of compound 14-16 is based on the synthesis of
(Z)-4-(4-hydroxybenzylidene)-1-methyl-2-(trifluoromethyl)-1H-imidazol-5(4H)-one
by Baranov and colleagues.4 A solution of (Z)-methyl
2-azido-3-(3,5-difluoro-4-methoxyphenyl)acrylate 13 (410 mg, 1.49 mmol)
and aqueous methylamine (0.92 ml, 40%) in ethanol (5 ml) was stirred at
room temperature for 24 h. Reaction mixture was evaporated, crude product
dissolved in 15 ml of chloroform, washed with aqueous HCl (5%, 6 ml),
water (2× 5 ml) and dried over sodium sulfate. The solution was
concentrated in vacuo to give product 14. Light yellow solid, yield 384
mg, 96%. 1H NMR (500 MHz, CDCl3) δ 7.23 (d, J=9.5 Hz, 2H), 6.36 (s, 1H),
4.04 (s, 3H), 2.96 (d, J=4.9 Hz, 3H); 13C NMR (125.7 MHz, DMSO-d6) δ
26.25 (CH3), 61.80 (CH3), 113.39 (dd, J= 18.4Hz, 5.8Hz, CH×2), 115.77,
128.84 (t, J= 9.7Hz), 131.15, 135.50 (t, J= 13.7Hz), 154.45 (dd, J=
238.7Hz, 6.8Hz), 163.35.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Plug-and-play fluorophores extend the spectral properties of Spinach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Wenjiao; Strack, Rita L.; Svensen, Nina; Jaffrey, Samie R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2014), 136(4), 1198-1201

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Bis(1,1-dimethylethyl)-2,3-dihydroxybenzaldehyde
C15H22O3
1542562-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.7700 1.3338 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 O 0.0000 5.3347 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 6.9300 5.5411 0.0 0
M  V30 10 C 8.4700 4.0011 0.0 0
M  V30 11 C 6.9300 2.4611 0.0 0
M  V30 12 O 5.3900 6.6685 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 5.3900 4.0011 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 2 5 6
M  V30 6 1 5 14
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 17
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Bis(1,1-dimethylethyl)-3-[(E)-(methylimino)methyl]-1,2-benzenediol
C16H25NO2
2485732-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 4.0012 0.0 0
M  V30 2 N 8.4702 5.3348 0.0 0
M  V30 3 C 10.0102 5.3348 0.0 0
M  V30 4 C 6.1601 1.3338 0.0 0
M  V30 5 C 4.8265 0.5638 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 7.4938 2.1038 0.0 0
M  V30 8 O 6.1601 6.6687 0.0 0
M  V30 9 O 3.0801 6.6687 0.0 0
M  V30 10 C 1.5400 4.0012 0.0 0
M  V30 11 C 0.7700 2.6675 0.0 0
M  V30 12 C 0.0000 4.0012 0.0 0
M  V30 13 C 0.7700 5.3348 0.0 0
M  V30 14 C 6.1601 4.0012 0.0 0
M  V30 15 C 5.3901 2.6675 0.0 0
M  V30 16 C 5.3901 5.3348 0.0 0
M  V30 17 C 3.8501 2.6675 0.0 0
M  V30 18 C 3.8501 5.3348 0.0 0
M  V30 19 C 3.0801 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 15
M  V30 8 1 8 16
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1542562-15-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2485732-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23981194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imine-Based Catechols and o-Benzoquinones: Synthesis, Structure, and
Features of Redox Behavior
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Astaf'eva, Tatiana V.; Arsenyev, Maxim V.; Rumyantcev, Roman V.; Fukin,
Georgy K.; Cherkasov, Vladimir K.; Poddel'sky, Andrey I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2020), 5(35), 22179-22191

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[1-(tert-Butoxycarbonyl)piperidin-4-yl]propanoic acid
C13H23NO4
154775-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 O 2.6673 3.8501 0.0 0
M  V30 3 O 4.0010 6.1601 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 0.5637 3.2864 0.0 0
M  V30 6 C 0.0000 5.3901 0.0 0
M  V30 7 C 2.1037 5.9538 0.0 0
M  V30 8 C 9.3360 1.5400 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 O 13.3370 2.3101 0.0 0
M  V30 12 O 12.0033 0.0000 0.0 0
M  V30 13 N 5.3348 3.8501 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 17 C 8.0022 3.8501 0.0 0
M  V30 18 C 8.0022 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-(methylamino)-3-oxopropyl]-1-piperidinecarboxylate
C14H26N2O3
951223-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 O 2.6673 3.8501 0.0 0
M  V30 3 O 4.0010 6.1601 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 0.5637 3.2864 0.0 0
M  V30 6 C 0.0000 5.3901 0.0 0
M  V30 7 C 2.1037 5.9538 0.0 0
M  V30 8 C 9.3358 1.5400 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 N 13.3370 2.3101 0.0 0
M  V30 12 O 12.0033 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 14 N 5.3348 3.8501 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 6.6685 1.5400 0.0 0
M  V30 18 C 8.0022 3.8501 0.0 0
M  V30 19 C 8.0022 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 154775-43-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951223-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13333947
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A; 4-(2-Methylcarbamoyl-ethyl)-piperidine-1-carboxylic acid
tert-butyl ester. To a stirred solution of
4-(2-carboxy-ethyl)-piperidine-1-carboxylic acid tert-butyl ester (3.0 g,
11.6 mmol) in N,N-dimethylformamide (DMF; 70 mL) was added
1-(3-dimethylpropyl)-3-ethylcarbodiimide hydrochloride (EDC; 3.35 g, 17.4
mmol), 1-hydroxybenzotriazole (HOBt; 2.36 g, 17.4 mmol), and MeNH2 (2 M
in tetrahydrofuran (THF); 8.74 mL, 17.4 mmol). After 18 h, the mixture
was diluted with water (50 mL) and extracted with CHCl3 (2×50 mL). The
organic layer was dried (Na2SO4) and concentrated to obtain the crude
residue, which was purified by FCC (EtOAc/hexanes) to give 3.02 g (96%)
of a yellow oil. MS: mass calcd. for C14H26N2O3, 270.19; m/z found, 271.3
[M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoimidazol-2-yl pyridines as modulators of the
histamine H4 receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Edwards, James P.; Kindrachuk, David E.; Venable, Jennifer D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070232616 A1 2007-10-04

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (3R,4R,5S)-4-(acetylamino)-3-(1-ethylpropoxy)-5-[[[[(phenylmethoxy)carb...
C25H35N3O6S
1588477-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 9.2400 0.0 0
M  V30 2 C 5.3347 10.0100 0.0 0
M  V30 3 C 5.3347 11.5500 0.0 0
M  V30 4 O 4.0011 9.2400 0.0 0
M  V30 5 O 4.0011 7.7000 0.0 0
M  V30 6 C 2.6674 6.9300 0.0 0
M  V30 7 C 1.3336 7.7000 0.0 0
M  V30 8 C 2.6674 5.3900 0.0 0
M  V30 9 C 0.0000 6.9300 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 N 9.3358 7.7000 0.0 0
M  V30 12 C 10.6694 6.9300 0.0 0
M  V30 13 N 12.0031 7.7000 0.0 0
M  V30 14 S 10.6694 5.3900 0.0 0
M  V30 15 C 13.3369 6.9300 0.0 0
M  V30 16 O 14.6705 7.7000 0.0 0
M  V30 17 O 13.3369 5.3900 0.0 0
M  V30 18 C 16.0041 6.9300 0.0 0
M  V30 19 C 6.6684 3.0800 0.0 0
M  V30 20 O 5.3347 2.3100 0.0 0
M  V30 21 O 8.0021 2.3100 0.0 0
M  V30 22 C 5.3347 0.7700 0.0 0
M  V30 23 C 4.0011 0.0000 0.0 0
M  V30 24 C 6.6684 7.7000 0.0 0 CFG=2
M  V30 25 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 26 C 8.0021 6.9300 0.0 0 CFG=1
M  V30 27 C 5.3347 5.3900 0.0 0
M  V30 28 C 8.0021 5.3900 0.0 0
M  V30 29 C 6.6684 4.6200 0.0 0
M  V30 30 C 17.3378 7.7000 0.0 0
M  V30 31 C 18.6716 6.9300 0.0 0
M  V30 32 C 17.3378 9.2400 0.0 0
M  V30 33 C 20.0052 7.7000 0.0 0
M  V30 34 C 18.6716 10.0100 0.0 0
M  V30 35 C 20.0052 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 24 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 25 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 26 11 CFG=1
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 18 30
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 29
M  V30 23 1 20 22
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl (3R,4R,5S)-4-(acetylamino)-3-(1-ethylpropoxy)-5-[[(methylimino)[[(pheny...
C26H38N4O6
1588477-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 7.7002 0.0 0
M  V30 2 C 9.3360 9.2402 0.0 0
M  V30 3 N 10.6697 10.0102 0.0 0
M  V30 4 N 8.0023 10.0102 0.0 0
M  V30 5 C 12.0035 9.2402 0.0 0
M  V30 6 C 8.0023 11.5503 0.0 0
M  V30 7 O 13.3372 10.0102 0.0 0
M  V30 8 O 12.0035 7.7002 0.0 0
M  V30 9 C 14.6708 9.2402 0.0 0
M  V30 10 N 9.3360 4.6201 0.0 0
M  V30 11 C 9.3360 3.0801 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 O 8.0023 2.3101 0.0 0
M  V30 14 O 6.6687 3.0801 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 2.6675 2.3101 0.0 0
M  V30 19 C 4.0012 0.0000 0.0 0
M  V30 20 C 4.0012 7.7002 0.0 0
M  V30 21 O 2.6675 6.9302 0.0 0
M  V30 22 O 4.0012 9.2402 0.0 0
M  V30 23 C 1.3337 7.7002 0.0 0
M  V30 24 C 0.0000 6.9302 0.0 0
M  V30 25 C 8.0023 6.9302 0.0 0 CFG=1
M  V30 26 C 8.0023 5.3901 0.0 0 CFG=1
M  V30 27 C 6.6685 7.7002 0.0 0
M  V30 28 C 6.6687 4.6201 0.0 0 CFG=2
M  V30 29 C 5.3348 6.9302 0.0 0
M  V30 30 C 5.3348 5.3901 0.0 0
M  V30 31 C 16.0045 10.0102 0.0 0
M  V30 32 C 16.0045 11.5503 0.0 0
M  V30 33 C 17.3383 9.2402 0.0 0
M  V30 34 C 17.3383 12.3203 0.0 0
M  V30 35 C 18.6720 10.0102 0.0 0
M  V30 36 C 18.6720 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 25 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 31
M  V30 11 1 10 11
M  V30 12 1 26 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 1 28 14 CFG=3
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 29
M  V30 24 1 21 23
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 30
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 25 26 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1588477-08-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1588477-09-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3490921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of Cbz-Protected N-Substituted Guanidine Compounds 8-15.
General Procedure. Thiourea precursor 7 (253 mg, 0.50 mmol) was dissolved
in CH2Cl2 (8 mL) and treated with the amine of choice (2 equiv, 1.0
mmol), triethylamine (2 equiv, 0.14 mL, 1.0 mmol), and EDCI−HCl (2 equiv,
191 mg, 1.0 mmol) after which the mixture was stirred at room
temperature. After TLC confirmed complete conversion to the substituted
guanidine (typically 2−5 h) CH2Cl2 was removed under reduced pressure and
the residue applied directly to a silica column (typical solvent system
EtOAc/hexane 1:2 to 2:1). Yields of 8−15 ranged from 70% to quantitative.
(3R,4R,5S)-Ethyl
4-Acetamido-5-(2-(benzyloxycarbonyl)-3-methylguanidino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
(8). Yield: 227 mg, 96%. 1H NMR (300 MHz, CDCl3) δ 8.97 (br s, 1H),
7.41−7.23 (m, 5H), 6.79 (s, 1H), 5.85−5.64 (m, 2H), 5.10 (s, 2H),
4.38−4.25 (m, 1H), 4.20 (q, 2H, J = 7.2 Hz), 4.14−3.94 (m, 2H), 3.36 (app
quin, 1H, J = 5.6 Hz), 2.86 (dd, 1H, J = 23.2, 5.3 Hz), 2.76 (d, 3H, J =
5.1 Hz), 2.34 (ddt, 1H, J = 18.0, 9.0, 2.2 Hz), 1.92 (s, 3H), 1.58−1.42
(m, 4H), 1.29 (t, 3H, J = 7.3 Hz), 0.95−0.83 (m, 6H); 13C NMR (75 MHz,
CDCl3) δ 171.8, 166.0, 164.0, 160.8, 137.8, 136.5, 129.7, 128.3, 127.8,
127.6, 82.1, 75.2, 66.5, 61.0, 54.0, 49.7, 31.0, 27.5, 26.3, 25.8, 23.2,
14.2, 9.5, 9.3. HRMS (ESI, M + H) calcd for C26H39N4O6, 503.2864; found,
503.2875.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oseltamivir Analogues Bearing N-Substituted Guanidines as Potent
Neuraminidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mooney, Caitlin A.; Johnson, Stuart A.; 't Hart, Peter; Quarles van
Ufford, Linda; de Haan, Cornelis A. M.; Moret, Ed E.; Martin, Nathaniel
I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2014), 57(7), 3154-3160

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(5-Nitro-2-pyridinyl)-7-azaspiro[3.5]nonane-2-carboxylic acid
C14H17N3O4
1590372-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.7282 1.3337 0.0 0
M  V30 2 O 14.4982 2.6673 0.0 0
M  V30 3 O 14.4982 0.0000 0.0 0
M  V30 4 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 5 O 0.0000 0.0000 0.0 0
M  V30 6 O 0.0000 2.6673 0.0 0
M  V30 7 C 10.0102 1.3337 0.0 0
M  V30 8 C 11.0992 2.4226 0.0 0
M  V30 9 C 11.0992 0.2447 0.0 0
M  V30 10 C 9.2402 0.0000 0.0 0
M  V30 11 C 9.2402 2.6673 0.0 0
M  V30 12 C 12.1881 1.3337 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 7.7002 2.6673 0.0 0
M  V30 15 N 6.9302 1.3337 0.0 0
M  V30 16 C 5.3901 1.3337 0.0 0
M  V30 17 C 4.6201 0.0000 0.0 0
M  V30 18 N 4.6201 2.6673 0.0 0
M  V30 19 C 3.0801 0.0000 0.0 0
M  V30 20 C 3.0801 2.6673 0.0 0
M  V30 21 C 2.3101 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-7-(5-nitro-2-pyridinyl)-7-azaspiro[3.5]nonane-2-carboxamide
C15H20N4O3
1590372-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.7281 1.3337 0.0 0
M  V30 2 N 14.4981 2.6673 0.0 0
M  V30 3 O 14.4981 0.0000 0.0 0
M  V30 4 C 16.0381 2.6673 0.0 0
M  V30 5 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 6 O 0.0000 0.0000 0.0 0
M  V30 7 O 0.0000 2.6673 0.0 0
M  V30 8 C 10.0102 1.3337 0.0 0
M  V30 9 C 11.0991 2.4226 0.0 0
M  V30 10 C 11.0991 0.2447 0.0 0
M  V30 11 C 9.2401 2.6673 0.0 0
M  V30 12 C 9.2401 0.0000 0.0 0
M  V30 13 C 12.1881 1.3337 0.0 0
M  V30 14 C 7.7001 2.6673 0.0 0
M  V30 15 C 7.7001 0.0000 0.0 0
M  V30 16 N 6.9301 1.3337 0.0 0
M  V30 17 C 5.3901 1.3337 0.0 0
M  V30 18 C 4.6201 0.0000 0.0 0
M  V30 19 N 4.6201 2.6673 0.0 0
M  V30 20 C 3.0800 0.0000 0.0 0
M  V30 21 C 3.0800 2.6673 0.0 0
M  V30 22 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1590372-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1590372-74-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1744142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of spirocyclic compounds as DGAT1 inhibitors, compositions
containing same, and medicinal applications thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koul, Summon; Bhuniya, Debnath; Mookhtiar, Kasim; Bhosale, Sandeep;
Kurhade, Suresh; Naik, Keshav; Velayutham, Ravikumar; Salunkhe, Videsh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014054053 A1 2014-04-10

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S)-1-Acetyl-4-(acetyloxy)-L-proline methyl ester
C10H15NO5
159912-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 3.8549 0.0 0
M  V30 2 O 1.5400 5.1886 0.0 0
M  V30 3 O 1.5400 2.5213 0.0 0
M  V30 4 C 0.0000 5.1886 0.0 0
M  V30 5 C 4.2794 1.1444 0.0 0
M  V30 6 C 2.7729 0.8242 0.0 0
M  V30 7 O 5.3098 0.0000 0.0 0
M  V30 8 O 7.4656 5.5302 0.0 0
M  V30 9 C 8.8726 4.9037 0.0 0
M  V30 10 C 10.1185 5.8089 0.0 0
M  V30 11 O 9.0335 3.3722 0.0 0
M  V30 12 C 3.8500 3.8549 0.0 0 CFG=2
M  V30 13 N 4.7552 2.6091 0.0 0
M  V30 14 C 4.7552 5.1008 0.0 0
M  V30 15 C 6.2198 3.0849 0.0 0
M  V30 16 C 6.2198 4.6250 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 8 9
M  V30 9 1 16 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S,4S)-1-Acetyl-4-hydroxy-N-methyl-2-pyrrolidinecarboxamide
C8H14N2O3
213882-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 3.8549 0.0 0
M  V30 2 N 5.9256 5.1886 0.0 0
M  V30 3 O 5.9256 2.5213 0.0 0
M  V30 4 C 7.4656 5.1886 0.0 0
M  V30 5 C 3.1864 1.1444 0.0 0
M  V30 6 C 4.6927 0.8242 0.0 0
M  V30 7 O 2.1559 0.0000 0.0 0
M  V30 8 O 0.0000 5.5302 0.0 0
M  V30 9 C 3.6156 3.8549 0.0 0 CFG=2
M  V30 10 N 2.7104 2.6091 0.0 0
M  V30 11 C 2.7104 5.1008 0.0 0
M  V30 12 C 1.2459 3.0849 0.0 0
M  V30 13 C 1.2459 4.6250 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 13 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159912-51-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 213882-54-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-10864476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Scheme 1. Syntheses of Compounds 1-3a (c) 40%
MeNH2, MeOH, rt Compound 1a Scheme 1. Syntheses of Compounds 1-3a
Compound 6a Yield 96%.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Infrared Probing of 4-Azidoproline Conformations Modulated by Azido
Configurations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyung-Koo; Park, Kwang-Hee; Joo, Cheonik; Kwon, Hyeok-Jun; Jeon,
Jonggu; Jung, Hyeon-Il; Park, Sungnam; Han, Hogyu; Cho, Minhaeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Physical Chemistry B (2012), 116(17), 5097-5110

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(ζS)-5-Iodo-ζ-[[(phenylmethoxy)carbonyl]amino]-1H-imidazole-2-heptanoic acid
C18H22IN3O4
1609191-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 5.3028 0.0 0 CFG=2
M  V30 2 N 9.2402 5.3028 0.0 0
M  V30 3 C 6.9302 6.6365 0.0 0
M  V30 4 C 10.0102 6.6365 0.0 0
M  V30 5 C 5.3901 6.6365 0.0 0
M  V30 6 O 11.5503 6.6365 0.0 0
M  V30 7 O 9.2402 7.9701 0.0 0
M  V30 8 C 4.6201 7.9701 0.0 0
M  V30 9 C 12.3203 7.9701 0.0 0
M  V30 10 C 3.0801 7.9701 0.0 0
M  V30 11 C 2.3101 9.3038 0.0 0
M  V30 12 C 0.7700 9.3038 0.0 0
M  V30 13 O 0.0000 7.9701 0.0 0
M  V30 14 O 0.0000 10.6376 0.0 0
M  V30 15 I 6.5730 0.0000 0.0 0
M  V30 16 C 6.9302 3.9690 0.0 0
M  V30 17 N 7.5565 2.5622 0.0 0
M  V30 18 N 5.3986 3.8080 0.0 0
M  V30 19 C 6.4121 1.5317 0.0 0
M  V30 20 C 5.0784 2.3017 0.0 0
M  V30 21 C 13.8603 7.9701 0.0 0
M  V30 22 C 14.6303 9.3038 0.0 0
M  V30 23 C 14.6303 6.6365 0.0 0
M  V30 24 C 16.1704 9.3038 0.0 0
M  V30 25 C 16.1704 6.6365 0.0 0
M  V30 26 C 16.9404 7.9701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 21
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 15 19
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-(5-iodo-1H-imidazol-2-yl)-7-(methylamino)-7-oxoheptyl]...
C19H25IN4O3
1609191-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 5.3028 0.0 0 CFG=2
M  V30 2 N 7.7002 5.3028 0.0 0
M  V30 3 C 10.0102 6.6365 0.0 0
M  V30 4 C 6.9302 6.6365 0.0 0
M  V30 5 C 11.5503 6.6365 0.0 0
M  V30 6 O 5.3901 6.6365 0.0 0
M  V30 7 O 7.7002 7.9701 0.0 0
M  V30 8 C 12.3203 7.9701 0.0 0
M  V30 9 C 4.6201 7.9701 0.0 0
M  V30 10 C 13.8603 7.9701 0.0 0
M  V30 11 C 14.6303 9.3038 0.0 0
M  V30 12 C 16.1704 9.3038 0.0 0
M  V30 13 N 16.9404 10.6376 0.0 0
M  V30 14 O 16.9404 7.9701 0.0 0
M  V30 15 C 18.4804 10.6376 0.0 0
M  V30 16 I 10.3674 0.0000 0.0 0
M  V30 17 C 10.0102 3.9690 0.0 0
M  V30 18 N 9.3839 2.5622 0.0 0
M  V30 19 N 11.5418 3.8080 0.0 0
M  V30 20 C 10.5283 1.5317 0.0 0
M  V30 21 C 11.8620 2.3017 0.0 0
M  V30 22 C 3.0801 7.9701 0.0 0
M  V30 23 C 2.3101 9.3038 0.0 0
M  V30 24 C 2.3101 6.6365 0.0 0
M  V30 25 C 0.7700 9.3038 0.0 0
M  V30 26 C 0.7700 6.6365 0.0 0
M  V30 27 C 0.0000 7.9701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 22
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 20
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1609191-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1609191-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15595980
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of HBTU and methylamine for every 30 minutes
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Selective Series of Inhibitors of Plasmodium falciparum
HDACs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ontoria, Jesus M.; Paonessa, Giacomo; Ponzi, Simona; Ferrigno, Federica;
Nizi, Emanuela; Biancofiore, Ilaria; Malancona, Savina; Graziani, Rita;
Roberts, David; Willis, Paul; Bresciani, Alberto; Gennari, Nadia;
Cecchetti, Ottavia; Monteagudo, Edith; Orsale, Maria V.; Veneziano,
Maria; Di Marco, Annalise; Cellucci, Antonella; Laufer, Ralph; Altamura,
Sergio; Summa, Vincenzo; Harper, Steven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2016), 7(5), 454-459

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-3-Butyn-1-yl-6-chloro-N4-propyl-1,3,5-triazine-2,4-diamine
C10H14ClN5
1610535-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3358 4.6201 0.0 0
M  V30 2 C 10.6697 3.8501 0.0 0
M  V30 3 C 12.0033 4.6201 0.0 0
M  V30 4 C 13.3370 3.8501 0.0 0
M  V30 5 C 14.6707 3.0801 0.0 0
M  V30 6 N 4.0010 4.6201 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 Cl 6.6685 0.0000 0.0 0
M  V30 11 N 6.6685 4.6201 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 N 8.0022 2.3101 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 3 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-3-Butyn-1-yl-N4-methyl-N6-propyl-1,3,5-triazine-2,4,6-triamine
C11H18N6
1610534-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 6.6685 0.0 0
M  V30 2 C 9.2400 6.6685 0.0 0
M  V30 3 C 10.0100 8.0021 0.0 0
M  V30 4 C 11.5500 8.0021 0.0 0
M  V30 5 C 13.0900 8.0021 0.0 0
M  V30 6 N 3.0800 4.0011 0.0 0
M  V30 7 C 2.3100 5.3347 0.0 0
M  V30 8 C 0.7700 5.3347 0.0 0
M  V30 9 C 0.0000 6.6685 0.0 0
M  V30 10 N 7.7000 1.3336 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 N 5.3900 5.3347 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 N 7.7000 4.0011 0.0 0
M  V30 16 N 5.3900 2.6674 0.0 0
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 3 4 5
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1610535-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1610534-27-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14697632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used, product further converted into HCl salt with 95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazinamine derivatives as oral bioavailable breathing
control modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mannion, James C.; Dax, Scott L.; Golder, Francis John; Macintyre, Duncan
Euan; McLeod, James; Ozola, Vita; Suna, Edgars; Shubin, Kirill; Mencel,
James Joseph; Peng, Sean X.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014078575 A2 2014-05-22

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxylic acid, 5-methyl-, ethyl ester
C12H13NO2
16382-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 O 8.9547 2.3100 0.0 0
M  V30 3 O 7.6211 0.0000 0.0 0
M  V30 4 C 10.2885 1.5400 0.0 0
M  V30 5 C 11.6222 2.3100 0.0 0
M  V30 6 C 0.0000 4.1617 0.0 0
M  V30 7 C 3.8500 2.8281 0.0 0
M  V30 8 C 4.6201 4.1617 0.0 0
M  V30 9 C 4.8805 1.6835 0.0 0
M  V30 10 C 2.3100 2.8281 0.0 0
M  V30 11 N 6.1265 3.8416 0.0 0
M  V30 12 C 3.8500 5.4954 0.0 0
M  V30 13 C 6.2874 2.3100 0.0 0
M  V30 14 C 1.5400 4.1617 0.0 0
M  V30 15 C 2.3100 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-2-carboxamide, N,5-dimethyl-
C11H12N2O
2432066-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6211 1.5400 0.0 0
M  V30 2 N 8.9549 2.3100 0.0 0
M  V30 3 O 7.6211 0.0000 0.0 0
M  V30 4 C 10.2886 1.5400 0.0 0
M  V30 5 C 0.0000 4.1618 0.0 0
M  V30 6 C 4.6201 4.1618 0.0 0
M  V30 7 C 3.8501 2.8281 0.0 0
M  V30 8 N 6.1265 3.8416 0.0 0
M  V30 9 C 3.8501 5.4954 0.0 0
M  V30 10 C 4.8806 1.6836 0.0 0
M  V30 11 C 2.3100 2.8281 0.0 0
M  V30 12 C 6.2875 2.3100 0.0 0
M  V30 13 C 2.3100 5.4954 0.0 0
M  V30 14 C 1.5400 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16382-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2432066-07-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22177342
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu(OAc)2-Promoted Oxidative Cross-Dehydrogenative Coupling Reaction of
α-Acylmethyl Malonates with Indole Derivatives to Access 3-Functionalized
Indoles and Polycyclic Indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Li-Jin; Wang, Kun; Guan, Hong-Rong; Zheng, An-Qi; Yang, Hai-Tao;
Miao, Chun-Bao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(12), 7925-7938

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiophene, 2,3-dihydro-3-methylene-2-[2-[[tris(1-methylethyl)silyl]oxy]ethyl]...
C16H30O3SSi
1646620-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 2.6674 2.6674 0.0 0
M  V30 2 O 4.0011 1.8974 0.0 0
M  V30 3 C 1.3338 3.4374 0.0 0
M  V30 4 C 3.4374 4.0011 0.0 0
M  V30 5 C 1.8974 1.3338 0.0 0
M  V30 6 C 5.3347 2.6674 0.0 0
M  V30 7 C 0.0000 2.6674 0.0 0
M  V30 8 C 1.3338 4.9774 0.0 0
M  V30 9 C 4.9774 4.0011 0.0 0
M  V30 10 C 2.6674 5.3349 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 0.3574 1.3338 0.0 0
M  V30 13 C 6.6685 1.8974 0.0 0
M  V30 14 O 10.6550 1.1359 0.0 0
M  V30 15 O 8.6389 0.7073 0.0 0
M  V30 16 C 7.0187 5.2295 0.0 0
M  V30 17 C 8.0021 2.6674 0.0 0
M  V30 18 S 9.4089 2.0411 0.0 0 VAL=6
M  V30 19 C 8.1631 4.1990 0.0 0
M  V30 20 C 10.4395 3.1855 0.0 0
M  V30 21 C 9.6695 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 13 17
M  V30 14 2 14 18
M  V30 15 2 15 18
M  V30 16 2 16 19
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Thiophenemethanamine, 2,5-dihydro-N-methyl-2-[2-[[tris(1-methylethyl)silyl]...
C17H35NO3SSi
1646620-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 7.9876 5.0989 0.0 0
M  V30 2 O 6.6540 5.8689 0.0 0
M  V30 3 C 9.3213 4.3289 0.0 0
M  V30 4 C 8.7577 6.4327 0.0 0
M  V30 5 C 7.2176 3.7652 0.0 0
M  V30 6 C 5.3203 5.0989 0.0 0
M  V30 7 C 9.3213 2.7888 0.0 0
M  V30 8 C 10.6551 5.0989 0.0 0
M  V30 9 C 7.9876 7.7663 0.0 0
M  V30 10 C 10.2977 6.4327 0.0 0
M  V30 11 C 7.9876 2.4315 0.0 0
M  V30 12 C 5.6776 3.7652 0.0 0
M  V30 13 C 3.9865 5.8689 0.0 0
M  V30 14 C 3.6363 2.5369 0.0 0
M  V30 15 N 3.3161 1.0304 0.0 0
M  V30 16 C 4.4607 0.0000 0.0 0
M  V30 17 O 2.0160 7.0590 0.0 0
M  V30 18 O 0.0000 6.6306 0.0 0
M  V30 19 C 2.6528 5.0989 0.0 0
M  V30 20 C 2.4919 3.5673 0.0 0
M  V30 21 S 1.2460 5.7253 0.0 0 VAL=6
M  V30 22 C 0.9855 3.2471 0.0 0
M  V30 23 C 0.2154 4.5808 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 6 13
M  V30 13 1 13 19
M  V30 14 1 14 15
M  V30 15 1 14 20
M  V30 16 1 15 16
M  V30 17 2 17 21
M  V30 18 2 18 21
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1646620-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1646620-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-10606603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM screw-top sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Zincke aldehyde approach to gelsemine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lam, Jonathan K.; Joseph, Scott B.; Vanderwal, Christopher D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(23), 3165-3168

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-N-[[2-[[[(2S)-1-(methylsulfonyl)-2-pyrrolidinyl]carbonyl]amino]pheny...
C17H25N3O7S2
1648703-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.5089 4.6799 0.0 0
M  V30 2 C 4.1752 3.9098 0.0 0
M  V30 3 O 2.8415 4.6799 0.0 0
M  V30 4 S 8.1763 6.2199 0.0 0 VAL=6
M  V30 5 N 9.5100 5.4499 0.0 0
M  V30 6 O 7.4063 4.8862 0.0 0
M  V30 7 O 8.9464 7.5536 0.0 0
M  V30 8 C 10.8437 6.2199 0.0 0
M  V30 9 C 11.6137 4.8862 0.0 0
M  V30 10 C 12.1775 6.9899 0.0 0
M  V30 11 C 10.0737 7.5536 0.0 0
M  V30 12 O 13.1537 4.8862 0.0 0
M  V30 13 O 10.8437 3.5525 0.0 0
M  V30 14 C 13.9238 3.5525 0.0 0
M  V30 15 S 1.4646 1.9406 0.0 0 VAL=6
M  V30 16 C 0.0000 2.4165 0.0 0
M  V30 17 O 0.9887 0.4759 0.0 0
M  V30 18 O 1.9404 3.4052 0.0 0
M  V30 19 C 5.5089 6.2199 0.0 0
M  V30 20 C 6.8427 6.9899 0.0 0
M  V30 21 C 4.1752 6.9899 0.0 0
M  V30 22 C 6.8427 8.5299 0.0 0
M  V30 23 C 4.1752 8.5299 0.0 0
M  V30 24 C 5.5089 9.3000 0.0 0
M  V30 25 C 4.1752 2.3698 0.0 0 CFG=2
M  V30 26 N 2.9293 1.4646 0.0 0
M  V30 27 C 5.4211 1.4646 0.0 0
M  V30 28 C 3.4052 0.0000 0.0 0
M  V30 29 C 4.9452 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 1 25 2 CFG=3
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 20
M  V30 9 1 5 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 15 18
M  V30 19 1 15 26
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(Methylsulfonyl)-L-prolyl-2-aminobenzenesulfonyl-N,2-dimethylalaninamide
C17H26N4O6S2
1648703-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.5089 4.6799 0.0 0
M  V30 2 C 4.1752 3.9098 0.0 0
M  V30 3 O 2.8415 4.6799 0.0 0
M  V30 4 S 8.1763 6.2199 0.0 0 VAL=6
M  V30 5 N 9.5100 5.4499 0.0 0
M  V30 6 O 7.4063 4.8862 0.0 0
M  V30 7 O 8.9464 7.5536 0.0 0
M  V30 8 C 10.8437 6.2199 0.0 0
M  V30 9 C 11.6137 4.8862 0.0 0
M  V30 10 C 12.1775 6.9899 0.0 0
M  V30 11 C 10.0737 7.5536 0.0 0
M  V30 12 N 13.1537 4.8862 0.0 0
M  V30 13 O 10.8437 3.5525 0.0 0
M  V30 14 C 13.9238 3.5525 0.0 0
M  V30 15 S 1.4646 1.9406 0.0 0 VAL=6
M  V30 16 C 0.0000 2.4165 0.0 0
M  V30 17 O 0.9887 0.4759 0.0 0
M  V30 18 O 1.9404 3.4052 0.0 0
M  V30 19 C 5.5089 6.2199 0.0 0
M  V30 20 C 6.8427 6.9899 0.0 0
M  V30 21 C 4.1752 6.9899 0.0 0
M  V30 22 C 6.8427 8.5299 0.0 0
M  V30 23 C 4.1752 8.5299 0.0 0
M  V30 24 C 5.5089 9.3000 0.0 0
M  V30 25 C 4.1752 2.3698 0.0 0 CFG=2
M  V30 26 N 2.9293 1.4646 0.0 0
M  V30 27 C 5.4211 1.4646 0.0 0
M  V30 28 C 3.4052 0.0000 0.0 0
M  V30 29 C 4.9452 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 2 2 3
M  V30 4 1 25 2 CFG=3
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 20
M  V30 9 1 5 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 15 18
M  V30 19 1 15 26
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1648703-73-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1648703-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8256401
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reversal of H-bonding direction by N-sulfonation in a synthetic
reverse-turn peptide motif
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vijayadas, Kuruppanthara N.; Kotmale, Amol S.; Thorat, Shridhar H.;
Gonnade, Rajesh G.; Nair, Roshna V.; Rajamohanan, Pattuparambil R.;
Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(10), 3064-3069

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-fluoro-3-methyl-5-nitrobenzoic acid
C8H5ClFNO4
173315-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 Cl 1.3336 1.5400 0.0 0
M  V30 5 C 4.0011 0.0000 0.0 0
M  V30 6 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6685 6.1600 0.0 0
M  V30 9 F 6.6685 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 11
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-methyl-4-(methylamino)-5-nitrobenzoic acid
C9H9ClN2O4
1380836-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 2.3100 0.0 0
M  V30 2 C 8.0022 3.0800 0.0 0
M  V30 3 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 O 2.6675 0.0000 0.0 0
M  V30 6 C 6.6686 5.3901 0.0 0
M  V30 7 Cl 4.0011 6.9301 0.0 0
M  V30 8 C 1.3337 5.3901 0.0 0
M  V30 9 O 0.0000 4.6201 0.0 0
M  V30 10 O 1.3337 6.9301 0.0 0
M  V30 11 C 5.3348 3.0800 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 3.0800 0.0 0
M  V30 15 C 4.0011 5.3901 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 173315-56-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380836-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11648129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (b) 2-Chloro-3-methyl-4-methylamino-5-nitro-benzoic acid A mixture of
methylamine (2M THF solution, 8.56 mL, 17 mmol),
2-chloro-3-methyl-4-fluoro- 5-nitro-benzoic acid (1.00 g, 4.2 mmol) and
20 mL THF is stirred over the weekend at rt. Then the mixture is
acidified with 4M aq HCl and concentrated and the residue is washed with
water and dried. Yield 1.0 g (96%). MS m/z: 245 [M+H]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminophenylaminobenzimidazolecarboxamide derivatives for
use as microsomal prostaglandin E2 synthase-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priepke, Henning; Doods, Henri; Heim-Riether, Alexander; Kuelzer,
Raimund; Pfau, Roland; Rudolf, Klaus; Stenkamp, Dirk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012076673 A1 2012-06-14

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,2,2,3,3,4,5,6,7-Decafluoro-2,3-dihydro-1H-indene
C9F10
1736-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.1433 6.4792 0.0 0
M  V30 2 F 4.1592 6.0508 0.0 0
M  V30 3 F 6.2537 5.3348 0.0 0
M  V30 4 F 1.5063 1.4559 0.0 0
M  V30 5 F 0.1274 2.9875 0.0 0
M  V30 6 F 3.1737 0.0000 0.0 0
M  V30 7 F 0.0000 4.1989 0.0 0
M  V30 8 F 1.0304 5.9838 0.0 0
M  V30 9 F 7.7938 2.6673 0.0 0
M  V30 10 F 6.2537 0.0000 0.0 0
M  V30 11 C 3.9437 4.0011 0.0 0
M  V30 12 C 3.1737 2.6673 0.0 0
M  V30 13 C 2.9133 5.1455 0.0 0
M  V30 14 C 5.4837 4.0011 0.0 0
M  V30 15 C 1.6674 2.9875 0.0 0
M  V30 16 C 3.9437 1.3337 0.0 0
M  V30 17 C 1.5063 4.5192 0.0 0
M  V30 18 C 6.2537 2.6673 0.0 0
M  V30 19 C 5.4837 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 13
M  V30 3 1 3 14
M  V30 4 1 4 15
M  V30 5 1 5 15
M  V30 6 1 6 16
M  V30 7 1 7 17
M  V30 8 1 8 17
M  V30 9 1 9 18
M  V30 10 1 10 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 1 16 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,2,2,3,3,4,6,7-Nonafluoro-2,3-dihydro-N-methyl-1H-inden-5-amine
C10H4F9N
132186-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.7160 5.0960 0.0 0
M  V30 2 F 2.6760 5.7329 0.0 0
M  V30 3 F 4.8480 6.1601 0.0 0
M  V30 4 F 2.6760 0.4272 0.0 0
M  V30 5 F 0.7160 1.0642 0.0 0
M  V30 6 F 4.8480 0.0000 0.0 0
M  V30 7 F 0.0000 2.0496 0.0 0
M  V30 8 F 0.0000 4.1105 0.0 0
M  V30 9 N 7.5154 4.6201 0.0 0
M  V30 10 C 8.8490 3.8501 0.0 0
M  V30 11 F 7.5154 1.5400 0.0 0
M  V30 12 C 3.5142 3.8501 0.0 0
M  V30 13 C 3.5142 2.3101 0.0 0
M  V30 14 C 2.0496 4.3260 0.0 0
M  V30 15 C 4.8480 4.6201 0.0 0
M  V30 16 C 2.0496 1.8342 0.0 0
M  V30 17 C 4.8480 1.5400 0.0 0
M  V30 18 C 1.1444 3.0801 0.0 0
M  V30 19 C 6.1817 3.8501 0.0 0
M  V30 20 C 6.1817 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 1 5 16
M  V30 6 1 6 17
M  V30 7 1 7 18
M  V30 8 1 8 18
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 11 20
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1736-47-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132186-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9444896
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylnitramines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Platonov, V. E.; Haas, A.; Schelvis, M.; Lieb, M.; Dvornikova, K. V.;
Osina, O. I.; Gatilov, Y. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 109(2), 131-139

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
cis-3-[4-[6-Fluoro-1-(phenylsulfonyl)-1H-indol-3-yl]-1H-pyrazol-1-yl]cyclobut...
C22H18FN3O4S
1771758-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.0551 0.0 0 VAL=6
M  V30 2 O 3.2311 4.7213 0.0 0
M  V30 3 O 4.7711 7.3888 0.0 0
M  V30 4 F 3.9107 0.0000 0.0 0
M  V30 5 C 15.4873 9.4598 0.0 0
M  V30 6 O 15.1672 10.9660 0.0 0
M  V30 7 O 16.9520 8.9837 0.0 0
M  V30 8 C 5.4958 3.7534 0.0 0
M  V30 9 C 7.0021 3.4333 0.0 0
M  V30 10 N 5.3347 5.2851 0.0 0
M  V30 11 C 4.4652 2.6091 0.0 0
M  V30 12 C 7.7721 4.7671 0.0 0
M  V30 13 C 7.4779 1.9687 0.0 0
M  V30 14 C 6.7417 5.9114 0.0 0
M  V30 15 C 4.9411 1.1444 0.0 0
M  V30 16 C 6.4475 0.8242 0.0 0
M  V30 17 C 9.3036 4.9280 0.0 0
M  V30 18 C 10.0736 6.2616 0.0 0
M  V30 19 C 10.3342 3.7835 0.0 0
M  V30 20 N 11.5800 5.9415 0.0 0
M  V30 21 N 11.7410 4.4099 0.0 0
M  V30 22 C 2.6674 6.8251 0.0 0
M  V30 23 C 2.6674 8.3651 0.0 0
M  V30 24 C 1.3336 6.0551 0.0 0
M  V30 25 C 1.3336 9.1351 0.0 0
M  V30 26 C 0.0000 6.8251 0.0 0
M  V30 27 C 0.0000 8.3651 0.0 0
M  V30 28 C 12.7244 6.9719 0.0 0 CFG=1
M  V30 29 C 14.2622 6.8913 0.0 0
M  V30 30 C 12.8049 8.5099 0.0 0
M  V30 31 C 14.3429 8.4292 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 22
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 31 5 CFG=1
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 28 20 CFG=1
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 28 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
cis-3-[4-[6-Fluoro-1-(phenylsulfonyl)-1H-indol-3-yl]-1H-pyrazol-1-yl]-N-methy...
C23H21FN4O3S
1771759-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.0552 0.0 0 VAL=6
M  V30 2 O 4.7711 7.3888 0.0 0
M  V30 3 O 3.2311 4.7214 0.0 0
M  V30 4 F 3.9107 0.0000 0.0 0
M  V30 5 C 15.4876 9.4598 0.0 0
M  V30 6 N 16.9521 8.9838 0.0 0
M  V30 7 O 15.1673 10.9661 0.0 0
M  V30 8 C 18.0967 10.0144 0.0 0
M  V30 9 C 5.4958 3.7535 0.0 0
M  V30 10 C 7.0021 3.4333 0.0 0
M  V30 11 N 5.3349 5.2852 0.0 0
M  V30 12 C 4.4653 2.6091 0.0 0
M  V30 13 C 7.7721 4.7671 0.0 0
M  V30 14 C 7.4780 1.9688 0.0 0
M  V30 15 C 6.7417 5.9115 0.0 0
M  V30 16 C 4.9413 1.1444 0.0 0
M  V30 17 C 6.4476 0.8242 0.0 0
M  V30 18 C 9.3037 4.9280 0.0 0
M  V30 19 C 10.0737 6.2617 0.0 0
M  V30 20 C 10.3343 3.7835 0.0 0
M  V30 21 N 11.5801 5.9415 0.0 0
M  V30 22 N 11.7411 4.4100 0.0 0
M  V30 23 C 2.6675 6.8252 0.0 0
M  V30 24 C 2.6675 8.3652 0.0 0
M  V30 25 C 1.3338 6.0552 0.0 0
M  V30 26 C 1.3338 9.1352 0.0 0
M  V30 27 C 0.0000 6.8252 0.0 0
M  V30 28 C 0.0000 8.3652 0.0 0
M  V30 29 C 12.7245 6.9719 0.0 0 CFG=2
M  V30 30 C 12.8052 8.5100 0.0 0
M  V30 31 C 14.2625 6.8914 0.0 0
M  V30 32 C 14.3431 8.4293 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 23
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 32 5 CFG=1
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 13 18
M  V30 19 1 14 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 29 21 CFG=1
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 29 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1771758-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1771759-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18626261
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolylpyrazole derivatives for use as tryptophan
2,3-dioxygenase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crosignani, Stefano; Cauwenberghs, Sandra; Deroose, Frederik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150133422 A1 2015-05-14

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
cis-3-[4-[6-Fluoro-1-(phenylsulfonyl)-1H-indol-3-yl]-1H-pyrazol-1-yl]cyclobut...
C22H18FN3O4S
1771758-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.0551 0.0 0 VAL=6
M  V30 2 O 3.2311 4.7213 0.0 0
M  V30 3 O 4.7711 7.3888 0.0 0
M  V30 4 F 3.9107 0.0000 0.0 0
M  V30 5 C 15.4873 9.4598 0.0 0
M  V30 6 O 15.1672 10.9660 0.0 0
M  V30 7 O 16.9520 8.9837 0.0 0
M  V30 8 C 5.4958 3.7534 0.0 0
M  V30 9 C 7.0021 3.4333 0.0 0
M  V30 10 N 5.3347 5.2851 0.0 0
M  V30 11 C 4.4652 2.6091 0.0 0
M  V30 12 C 7.7721 4.7671 0.0 0
M  V30 13 C 7.4779 1.9687 0.0 0
M  V30 14 C 6.7417 5.9114 0.0 0
M  V30 15 C 4.9411 1.1444 0.0 0
M  V30 16 C 6.4475 0.8242 0.0 0
M  V30 17 C 9.3036 4.9280 0.0 0
M  V30 18 C 10.0736 6.2616 0.0 0
M  V30 19 C 10.3342 3.7835 0.0 0
M  V30 20 N 11.5800 5.9415 0.0 0
M  V30 21 N 11.7410 4.4099 0.0 0
M  V30 22 C 2.6674 6.8251 0.0 0
M  V30 23 C 2.6674 8.3651 0.0 0
M  V30 24 C 1.3336 6.0551 0.0 0
M  V30 25 C 1.3336 9.1351 0.0 0
M  V30 26 C 0.0000 6.8251 0.0 0
M  V30 27 C 0.0000 8.3651 0.0 0
M  V30 28 C 12.7244 6.9719 0.0 0 CFG=1
M  V30 29 C 14.2622 6.8913 0.0 0
M  V30 30 C 12.8049 8.5099 0.0 0
M  V30 31 C 14.3429 8.4292 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 22
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 31 5 CFG=1
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 28 20 CFG=1
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 28 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
cis-3-[4-[6-Fluoro-1-(phenylsulfonyl)-1H-indol-3-yl]-1H-pyrazol-1-yl]-N-methy...
C23H21FN4O3S
1771759-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 6.0552 0.0 0 VAL=6
M  V30 2 O 4.7711 7.3888 0.0 0
M  V30 3 O 3.2311 4.7214 0.0 0
M  V30 4 F 3.9107 0.0000 0.0 0
M  V30 5 C 15.4876 9.4598 0.0 0
M  V30 6 N 16.9521 8.9838 0.0 0
M  V30 7 O 15.1673 10.9661 0.0 0
M  V30 8 C 18.0967 10.0144 0.0 0
M  V30 9 C 5.4958 3.7535 0.0 0
M  V30 10 C 7.0021 3.4333 0.0 0
M  V30 11 N 5.3349 5.2852 0.0 0
M  V30 12 C 4.4653 2.6091 0.0 0
M  V30 13 C 7.7721 4.7671 0.0 0
M  V30 14 C 7.4780 1.9688 0.0 0
M  V30 15 C 6.7417 5.9115 0.0 0
M  V30 16 C 4.9413 1.1444 0.0 0
M  V30 17 C 6.4476 0.8242 0.0 0
M  V30 18 C 9.3037 4.9280 0.0 0
M  V30 19 C 10.0737 6.2617 0.0 0
M  V30 20 C 10.3343 3.7835 0.0 0
M  V30 21 N 11.5801 5.9415 0.0 0
M  V30 22 N 11.7411 4.4100 0.0 0
M  V30 23 C 2.6675 6.8252 0.0 0
M  V30 24 C 2.6675 8.3652 0.0 0
M  V30 25 C 1.3338 6.0552 0.0 0
M  V30 26 C 1.3338 9.1352 0.0 0
M  V30 27 C 0.0000 6.8252 0.0 0
M  V30 28 C 0.0000 8.3652 0.0 0
M  V30 29 C 12.7245 6.9719 0.0 0 CFG=2
M  V30 30 C 12.8052 8.5100 0.0 0
M  V30 31 C 14.2625 6.8914 0.0 0
M  V30 32 C 14.3431 8.4293 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 23
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 32 5 CFG=1
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 13 18
M  V30 19 1 14 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 29 21 CFG=1
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 29 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1771758-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1771759-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2239436
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolylpyrazole derivatives for use as tryptophan
2,3-dioxygenase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crosignani, Stefano; Cauwenberghs, Sandra; Deroose, Frederik; Driessens,
Gregory
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015067782 A1 2015-05-14

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,5S,6R)-2-Oxobicyclo[3.1.0]hexane-6-carboxylic acid
C7H8O3
177317-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5245 1.5400 0.0 0
M  V30 2 O 5.5245 0.0000 0.0 0
M  V30 3 O 6.8583 2.3100 0.0 0
M  V30 4 O 0.0000 1.5998 0.0 0
M  V30 5 C 2.6508 2.3100 0.0 0 CFG=2
M  V30 6 C 3.4208 3.6437 0.0 0 CFG=1
M  V30 7 C 4.1908 2.3100 0.0 0 CFG=1
M  V30 8 C 1.1445 2.6302 0.0 0
M  V30 9 C 2.3904 4.7882 0.0 0
M  V30 10 C 0.9834 4.1617 0.0 0
M  V30 11 H 2.4899 0.7785 0.0 0
M  V30 12 H 4.6667 4.5489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 2 4 8
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 11 CFG=3
M  V30 9 1 6 7
M  V30 10 1 6 9
M  V30 11 1 6 12 CFG=3
M  V30 12 1 8 10
M  V30 13 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 5 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,5S,6R)-N-Methyl-2-oxobicyclo[3.1.0]hexane-6-carboxamide
C8H11NO2
936232-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5245 1.5400 0.0 0
M  V30 2 N 6.8583 2.3100 0.0 0
M  V30 3 O 5.5245 0.0000 0.0 0
M  V30 4 C 8.1920 1.5400 0.0 0
M  V30 5 O 0.0000 1.5998 0.0 0
M  V30 6 C 2.6508 2.3100 0.0 0 CFG=1
M  V30 7 C 4.1908 2.3100 0.0 0 CFG=1
M  V30 8 C 3.4208 3.6437 0.0 0 CFG=1
M  V30 9 C 1.1445 2.6302 0.0 0
M  V30 10 C 2.3904 4.7882 0.0 0
M  V30 11 C 0.9835 4.1617 0.0 0
M  V30 12 H 2.4899 0.7785 0.0 0
M  V30 13 H 4.6667 4.5489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 9
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 12 CFG=3
M  V30 10 1 7 8
M  V30 11 1 8 10
M  V30 12 1 8 13 CFG=3
M  V30 13 1 9 11
M  V30 14 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 177317-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 936232-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14100251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scalable synthesis of
(+)-2-amino-3-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid as a
potent and selective group II metabotropic glutamate receptor agonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sakagami, Kazunari; Kumagai, Toshihito; Taguchi, Takeo; Nakazato, Atsuro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2007), 55(1), 37-43

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 6-amino-5-bromo-, methyl ester
C7H7BrN2O2
178876-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 N 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-5-bromo-N-methyl-2-pyridinecarboxamide
C7H8BrN3O
875051-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 N 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 178876-82-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875051-80-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-162348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and Optimization of Selective Nav1.8 Modulator Series That
Demonstrate Efficacy in Preclinical Models of Pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bagal, Sharan K.; Bungay, Peter J.; Denton, Stephen M.; Gibson, Karl R.;
Glossop, Melanie S.; Hay, Tanya L.; Kemp, Mark I.; Lane, Charlotte A. L.;
Lewis, Mark L.; Maw, Graham N.; Million, William A.; Payne, C. Elizabeth;
Poinsard, Cedric; Rawson, David J.; Stammen, Blanda L.; Stevens, Edward
B.; Thompson, Lisa R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2015), 6(6), 650-654

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 6-amino-5-bromo-, methyl ester
C7H7BrN2O2
178876-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 N 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-5-bromo-N-methyl-2-pyridinecarboxamide
C7H8BrN3O
875051-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 N 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 178876-82-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875051-80-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9699496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 4 6-Amino-5-bromo-pvridine-2-carboxvlic acid methylamide
Methylamine (2M, in tetrahydrofuran, 36.8ml, 73.64mmol) was added to a
suspension of the product of preparation 2 (1.7Og, 7.36mmol) in methanol
(1OmL) and the mixture was stirred for 18 hours at room temperature. The
reaction mixture was then concentrated in vacuo and the residue was
purified by column chromatography on silica gel, eluting with ethyl
acetate: heptane, 75:25, to afford the title compound as a solid in 96%
yield, 1.63g. 1H NMR (400MHz, CD3OD) δ : 2.90(s, 3H), 7.20(d, 1 H),
7.82(d, 1 H) LRMS: m/z APCI 231 [M+H]+ Microanalysis: C7H8BrN3O requires:
C 36.55; H 3.50 N 18.26; found C 36.50; H 3.47, N 18.12
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridine derivatives, particularly 6-amino-5-phenylpyridine-2-carboxylic
acid amides, with activity as sodium channel modulators, useful for the
treatment of pain, and their preparation, pharmaceutical compositions,
and use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lane, Charlotte Alice Louise; Maw, Graham Nigel; Rawson, David James;
Thompson, Lisa Rosemary
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006011050 A2 2006-02-02

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,4-difluoro-5-nitrobenzoate
C9H7F2NO4
179011-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 5.3900 0.0 0
M  V30 2 O 6.6684 4.6200 0.0 0
M  V30 3 O 5.3347 6.9300 0.0 0
M  V30 4 C 8.0021 5.3900 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 F 2.6674 6.9300 0.0 0
M  V30 7 N 2.6674 0.7700 0.0 0 VAL=5
M  V30 8 O 1.3336 0.0000 0.0 0
M  V30 9 O 4.0011 0.0000 0.0 0
M  V30 10 F 0.0000 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 3.0800 0.0 0
M  V30 13 C 2.6674 5.3900 0.0 0
M  V30 14 C 2.6674 2.3100 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 1.3336 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-fluoro-4-(methylamino)-5-nitro-, ethyl ester
C10H11FN2O4
1219119-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.3900 0.0 0
M  V30 2 O 8.0021 4.6200 0.0 0
M  V30 3 O 6.6684 6.9300 0.0 0
M  V30 4 C 9.3358 5.3900 0.0 0
M  V30 5 C 10.6694 4.6200 0.0 0
M  V30 6 F 4.0011 6.9300 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 8 O 5.3347 0.0000 0.0 0
M  V30 9 O 2.6673 0.0000 0.0 0
M  V30 10 N 1.3336 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 5.3347 3.0800 0.0 0
M  V30 14 C 4.0011 5.3900 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 C 2.6673 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 179011-37-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1219119-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15054107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (a) Ethyl 2-fluoro-4-(methylamino)-5-nitrobenzoate. A 2M solution of
MeNH2 in THF (21.6 mL; 43.3 mmol) is added dropwise to a solution of
ethyl 2,4-difluoro-5-nitrobenzoate (5.0 g; 21.6 mmol) in THF (70 mL) at
-5°C. The mixture is left overnight at rt whereafter an additional
portion of 2M MeNH2 in THF (10.0 mL; 2 M; 21.6 mmol) is added at 0°C.
After 3 h at rt, water is added and the mixture is concentrated. The
resulting precipitate is filtered off and dried to give the subtitle
compound. Yield: 5.0 g (96%).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, incremental addition of MeNH2 in THF
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylaminobenzoimidazolecarboxamide derivatives for use as
mPGES-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priepke, Henning; Doods, Henri; Kuelzer, Raimund; Pfau, Roland; Stenkamp,
Dirk; Pelcman, Benjamin; Roenn, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012022793 A1 2012-02-23

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,4-difluoro-5-nitrobenzoate
C9H7F2NO4
179011-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 5.3900 0.0 0
M  V30 2 O 6.6684 4.6200 0.0 0
M  V30 3 O 5.3347 6.9300 0.0 0
M  V30 4 C 8.0021 5.3900 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 F 2.6674 6.9300 0.0 0
M  V30 7 N 2.6674 0.7700 0.0 0 VAL=5
M  V30 8 O 1.3336 0.0000 0.0 0
M  V30 9 O 4.0011 0.0000 0.0 0
M  V30 10 F 0.0000 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 3.0800 0.0 0
M  V30 13 C 2.6674 5.3900 0.0 0
M  V30 14 C 2.6674 2.3100 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 1.3336 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-fluoro-4-(methylamino)-5-nitro-, ethyl ester
C10H11FN2O4
1219119-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.3900 0.0 0
M  V30 2 O 8.0021 4.6200 0.0 0
M  V30 3 O 6.6684 6.9300 0.0 0
M  V30 4 C 9.3358 5.3900 0.0 0
M  V30 5 C 10.6694 4.6200 0.0 0
M  V30 6 F 4.0011 6.9300 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 8 O 5.3347 0.0000 0.0 0
M  V30 9 O 2.6673 0.0000 0.0 0
M  V30 10 N 1.3336 2.3100 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 5.3347 3.0800 0.0 0
M  V30 14 C 4.0011 5.3900 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 C 2.6673 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 179011-37-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1219119-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-42983
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (e) Ethyl 2-fluoro-4-(methylamino)-5-nitrobenzoate. A solution of MeNH2
in THF (21.6 mL; 2 M; 43.3 mmol) was added dropwise to a solution of
ethyl 2,4-difluoro-5-nitrobenzoate (5.0 g; 21.6 mmol) in THF (70 mL) at
-5 °C. The mixture was left over night at rt whereafter an additional
portion of MeNH2 in THF (10.0 mL; 2 M; 21.6 mmol) was added at 0 °C.
After 3 h at rt, water was added and the mixture was concentrated. The
resulting precipitate was filtered off and dried to give the sub-title
compound. Yield: 5.0 g, 96%.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, incremental addition of methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3H-imidazo[4,5-c]pyridine-6-carboxamides as
anti-inflammatory agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pfau, Roland; Arndt, Kirsten; Doods, Henri; Klinder, Klaus; Kuelzer,
Raimund; Lubriks, Dimitrijs; Mack, Juergen; Pelcman, Benjamin; Priepke,
Henning; Roenn, Robert; Stenkamp, Dirk; Suna, Edgars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010100249 A1 2010-09-10

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylsulfony...
C28H34Cl2N4O8S
1802932-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7001 9.3357 0.0 0
M  V30 2 Cl 2.3100 8.0021 0.0 0
M  V30 3 Cl 6.9301 10.6695 0.0 0
M  V30 4 C 9.2401 6.6684 0.0 0
M  V30 5 C 10.0101 8.0021 0.0 0
M  V30 6 O 11.5501 8.0021 0.0 0
M  V30 7 O 0.7700 10.6695 0.0 0
M  V30 8 C 0.0000 12.0032 0.0 0
M  V30 9 O 5.3901 13.3369 0.0 0
M  V30 10 C 4.6201 14.6705 0.0 0
M  V30 11 S 7.7001 1.3337 0.0 0 VAL=6
M  V30 12 C 8.4701 0.0000 0.0 0
M  V30 13 O 6.3664 0.5636 0.0 0
M  V30 14 O 9.0337 2.1037 0.0 0
M  V30 15 C 16.1702 10.6695 0.0 0
M  V30 16 O 16.9402 12.0032 0.0 0
M  V30 17 O 16.9402 9.3357 0.0 0
M  V30 18 C 18.4802 12.0032 0.0 0
M  V30 19 C 18.4802 10.4632 0.0 0
M  V30 20 C 20.0202 12.0032 0.0 0
M  V30 21 C 18.4802 13.5432 0.0 0
M  V30 22 C 5.3901 8.0021 0.0 0
M  V30 23 C 4.6201 6.6684 0.0 0
M  V30 24 C 6.9301 8.0021 0.0 0
M  V30 25 C 5.3901 5.3348 0.0 0
M  V30 26 N 7.7001 6.6684 0.0 0
M  V30 27 C 6.9301 5.3348 0.0 0
M  V30 28 C 4.6201 4.0010 0.0 0
M  V30 29 N 7.7001 4.0010 0.0 0
M  V30 30 N 5.3901 2.6673 0.0 0
M  V30 31 C 6.9301 2.6673 0.0 0
M  V30 32 C 4.6201 9.3357 0.0 0
M  V30 33 C 3.0800 9.3357 0.0 0
M  V30 34 C 5.3901 10.6695 0.0 0
M  V30 35 C 2.3100 10.6695 0.0 0
M  V30 36 C 4.6201 12.0032 0.0 0
M  V30 37 C 3.0800 12.0032 0.0 0
M  V30 38 C 12.3201 9.3357 0.0 0
M  V30 39 C 13.8602 9.3357 0.0 0
M  V30 40 C 11.5501 10.6695 0.0 0
M  V30 41 N 14.6302 10.6695 0.0 0
M  V30 42 C 12.3201 12.0032 0.0 0
M  V30 43 C 13.8602 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 33
M  V30 3 1 3 34
M  V30 4 1 4 5
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 1 6 38
M  V30 8 1 7 8
M  V30 9 1 7 35
M  V30 10 1 9 10
M  V30 11 1 9 36
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 11 31
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 41
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 22 32
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 25 28
M  V30 30 1 26 27
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 1 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[2-[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-...
C28H35Cl2N5O6
1802932-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 8.4702 0.0 0
M  V30 2 Cl 4.0012 4.6201 0.0 0
M  V30 3 Cl 6.6685 9.2402 0.0 0
M  V30 4 C 10.6697 6.9302 0.0 0
M  V30 5 C 12.0033 6.1601 0.0 0
M  V30 6 O 13.3370 6.9302 0.0 0
M  V30 7 O 1.3337 6.1601 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 O 4.0012 10.7802 0.0 0
M  V30 10 C 2.6673 11.5503 0.0 0
M  V30 11 N 12.0033 1.5400 0.0 0
M  V30 12 C 12.0033 0.0000 0.0 0
M  V30 13 C 18.6718 6.9302 0.0 0
M  V30 14 O 20.0057 6.1601 0.0 0
M  V30 15 O 18.6718 8.4702 0.0 0
M  V30 16 C 21.3393 6.9302 0.0 0
M  V30 17 C 20.5693 8.2638 0.0 0
M  V30 18 C 22.6730 7.7002 0.0 0
M  V30 19 C 22.1093 5.5965 0.0 0
M  V30 20 C 6.6685 6.1601 0.0 0
M  V30 21 C 8.0022 6.9302 0.0 0
M  V30 22 C 6.6685 4.6201 0.0 0
M  V30 23 N 9.3360 6.1601 0.0 0
M  V30 24 C 8.0022 3.8501 0.0 0
M  V30 25 C 9.3360 4.6201 0.0 0
M  V30 26 C 8.0022 2.3101 0.0 0
M  V30 27 N 10.6697 3.8501 0.0 0
M  V30 28 N 9.3360 1.5400 0.0 0
M  V30 29 C 10.6697 2.3101 0.0 0
M  V30 30 C 5.3348 6.9302 0.0 0
M  V30 31 C 4.0012 6.1601 0.0 0
M  V30 32 C 5.3348 8.4702 0.0 0
M  V30 33 C 2.6673 6.9302 0.0 0
M  V30 34 C 4.0012 9.2402 0.0 0
M  V30 35 C 2.6673 8.4702 0.0 0
M  V30 36 C 14.6708 6.1601 0.0 0
M  V30 37 C 16.0045 6.9302 0.0 0
M  V30 38 C 14.6708 4.6201 0.0 0
M  V30 39 N 17.3382 6.1601 0.0 0
M  V30 40 C 16.0045 3.8501 0.0 0
M  V30 41 C 17.3382 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 1 2 31
M  V30 3 1 3 32
M  V30 4 1 4 5
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 6 36
M  V30 8 1 7 8
M  V30 9 1 7 33
M  V30 10 1 9 10
M  V30 11 1 9 34
M  V30 12 1 11 12
M  V30 13 1 11 29
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 39
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 30
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1802932-97-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802932-98-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18250488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinolone derivatives as fibroblast growth factor receptor
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verner, Erik; Brameld, Kenneth Albert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015120049 A1 2015-08-13

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dimethyl (2R,3R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxane-2,3-dicarbo...
C12H20O8
181586-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.9498 7.1952 0.0 0
M  V30 2 C 1.6823 8.7118 0.0 0
M  V30 3 C 3.6643 8.1851 0.0 0
M  V30 4 O 1.4471 4.3448 0.0 0
M  V30 5 C 0.0000 4.8716 0.0 0
M  V30 6 C 1.4471 6.3246 0.0 0
M  V30 7 C 7.2469 5.3347 0.0 0
M  V30 8 O 8.0169 6.6684 0.0 0
M  V30 9 O 8.0169 4.0011 0.0 0
M  V30 10 C 9.5569 6.6684 0.0 0
M  V30 11 C 5.7069 2.6674 0.0 0
M  V30 12 O 4.9369 1.3336 0.0 0
M  V30 13 O 7.2469 2.6674 0.0 0
M  V30 14 C 5.7069 0.0000 0.0 0
M  V30 15 C 3.3969 6.6684 0.0 0 CFG=2
M  V30 16 C 2.6269 5.3347 0.0 0 CFG=2
M  V30 17 O 4.9369 6.6684 0.0 0
M  V30 18 O 3.3969 4.0011 0.0 0
M  V30 19 C 5.7069 5.3347 0.0 0 CFG=1
M  V30 20 C 4.9369 4.0011 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 15 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 16 4 CFG=1
M  V30 6 1 16 6 CFG=3
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 19 7 CFG=1
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 20 11 CFG=3
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,3R,5R,6R)-5,6-Dimethoxy-N2,N3,5,6-tetramethyl-1,4-dioxane-2,3-dicarboxamide
C12H22N2O6
925425-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.9498 7.1952 0.0 0
M  V30 2 C 1.6823 8.7118 0.0 0
M  V30 3 C 3.6643 8.1851 0.0 0
M  V30 4 O 1.4471 4.3448 0.0 0
M  V30 5 C 0.0000 4.8716 0.0 0
M  V30 6 C 1.4471 6.3246 0.0 0
M  V30 7 C 7.2469 5.3347 0.0 0
M  V30 8 N 8.0169 6.6684 0.0 0
M  V30 9 O 8.0169 4.0011 0.0 0
M  V30 10 C 9.5569 6.6684 0.0 0
M  V30 11 C 5.7069 2.6674 0.0 0
M  V30 12 N 4.9369 1.3336 0.0 0
M  V30 13 O 7.2469 2.6674 0.0 0
M  V30 14 C 5.7069 0.0000 0.0 0
M  V30 15 C 3.3969 6.6684 0.0 0 CFG=2
M  V30 16 C 2.6269 5.3347 0.0 0 CFG=2
M  V30 17 O 4.9369 6.6684 0.0 0
M  V30 18 O 3.3969 4.0011 0.0 0
M  V30 19 C 5.7069 5.3347 0.0 0 CFG=1
M  V30 20 C 4.9369 4.0011 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 15 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 16 4 CFG=1
M  V30 6 1 16 6 CFG=3
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 19 7 CFG=1
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 20 11 CFG=3
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 181586-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 925425-42-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1257083
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new chiral amines with a cyclic 1,2-diacetal skeleton
derived from (2R,3R)-(+)-tartaric acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barros, M. Teresa; Phillips, Ana Maria Faisca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2006), 11(2-3), 177-196

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(9-phenyl-9H-purin-6-yl)carbamate
C16H17N5O2
1821369-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.6648 3.0801 0.0 0
M  V30 2 C 10.9985 2.3101 0.0 0
M  V30 3 O 12.3321 3.0801 0.0 0
M  V30 4 O 10.9985 0.7700 0.0 0
M  V30 5 C 13.6660 2.3101 0.0 0
M  V30 6 C 14.4360 3.6437 0.0 0
M  V30 7 C 14.9996 1.5400 0.0 0
M  V30 8 C 12.8959 0.9762 0.0 0
M  V30 9 C 5.6636 2.3101 0.0 0
M  V30 10 C 6.9973 3.0801 0.0 0
M  V30 11 N 4.5192 3.3405 0.0 0
M  V30 12 N 5.6636 0.7700 0.0 0
M  V30 13 C 8.3311 2.3101 0.0 0
M  V30 14 N 6.6771 4.5864 0.0 0
M  V30 15 C 5.1456 4.7473 0.0 0
M  V30 16 C 6.9973 0.0000 0.0 0
M  V30 17 N 8.3311 0.7700 0.0 0
M  V30 18 C 3.0128 3.0203 0.0 0
M  V30 19 C 2.5369 1.5556 0.0 0
M  V30 20 C 1.9823 4.1647 0.0 0
M  V30 21 C 1.0304 1.2354 0.0 0
M  V30 22 C 0.4759 3.8445 0.0 0
M  V30 23 C 0.0000 2.3800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 18
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-(9-phenyl-9H-purin-6-yl)urea
C13H12N6O
1821369-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.6648 3.0801 0.0 0
M  V30 2 C 10.9985 2.3101 0.0 0
M  V30 3 N 12.3321 3.0801 0.0 0
M  V30 4 O 10.9985 0.7700 0.0 0
M  V30 5 C 13.6660 2.3101 0.0 0
M  V30 6 C 5.6636 2.3101 0.0 0
M  V30 7 C 6.9973 3.0801 0.0 0
M  V30 8 N 4.5192 3.3405 0.0 0
M  V30 9 N 5.6636 0.7700 0.0 0
M  V30 10 C 8.3311 2.3101 0.0 0
M  V30 11 N 6.6771 4.5864 0.0 0
M  V30 12 C 5.1456 4.7473 0.0 0
M  V30 13 C 6.9973 0.0000 0.0 0
M  V30 14 N 8.3311 0.7700 0.0 0
M  V30 15 C 3.0128 3.0203 0.0 0
M  V30 16 C 2.5369 1.5556 0.0 0
M  V30 17 C 1.9823 4.1647 0.0 0
M  V30 18 C 1.0306 1.2354 0.0 0
M  V30 19 C 0.4759 3.8445 0.0 0
M  V30 20 C 0.0000 2.3800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 15
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 12
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1821369-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1821369-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7139478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used, pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient one-pot conversion of Boc-protected adenines to N6-ureas
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Machicao, Paulo A.; Peterson, Matt A.; Schols, Dominique
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(47), 6574-6576

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[9-[4-(1-methylpropyl)phenyl]-9H-purin-6-yl]carbamate
C20H25N5O2
1821369-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0801 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 2.6675 3.0801 0.0 0
M  V30 4 O 4.0012 0.7700 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 2.1037 0.9762 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 0.5637 3.6437 0.0 0
M  V30 9 C 16.5059 2.0596 0.0 0
M  V30 10 C 17.5364 3.2042 0.0 0
M  V30 11 C 16.9818 0.5951 0.0 0
M  V30 12 C 19.0428 2.8840 0.0 0
M  V30 13 C 8.0023 3.0801 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 N 8.3225 4.5864 0.0 0
M  V30 17 N 10.4804 3.3405 0.0 0
M  V30 18 N 9.3360 0.7700 0.0 0
M  V30 19 N 6.6685 0.7700 0.0 0
M  V30 20 C 9.8541 4.7473 0.0 0
M  V30 21 C 8.0023 0.0000 0.0 0
M  V30 22 C 11.9869 3.0203 0.0 0
M  V30 23 C 13.0173 4.1647 0.0 0
M  V30 24 C 12.4627 1.5556 0.0 0
M  V30 25 C 14.5237 3.8445 0.0 0
M  V30 26 C 13.9690 1.2354 0.0 0
M  V30 27 C 14.9996 2.3800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 27
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 17 22
M  V30 22 1 18 21
M  V30 23 2 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-[9-[4-(1-methylpropyl)phenyl]-9H-purin-6-yl]urea
C17H20N6O
1821369-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 13.4489 2.5368 0.0 0
M  V30 2 C 14.5934 1.5063 0.0 0
M  V30 3 N 16.0581 1.9823 0.0 0
M  V30 4 O 14.2732 0.0000 0.0 0
M  V30 5 C 17.2025 0.9517 0.0 0
M  V30 6 C 2.3100 3.8614 0.0 0
M  V30 7 C 1.5400 5.1950 0.0 0
M  V30 8 C 1.5400 2.5278 0.0 0
M  V30 9 C 0.0000 5.1950 0.0 0
M  V30 10 C 10.8398 3.0914 0.0 0
M  V30 11 C 9.3752 2.6155 0.0 0
M  V30 12 C 11.9843 2.0610 0.0 0
M  V30 13 N 10.8398 4.6314 0.0 0
M  V30 14 N 8.4700 3.8614 0.0 0
M  V30 15 N 9.0551 1.1091 0.0 0
M  V30 16 N 11.6641 0.5546 0.0 0
M  V30 17 C 9.3752 5.1073 0.0 0
M  V30 18 C 10.1994 0.0787 0.0 0
M  V30 19 C 6.9300 3.8614 0.0 0
M  V30 20 C 6.1600 2.5278 0.0 0
M  V30 21 C 6.1600 5.1950 0.0 0
M  V30 22 C 4.6200 2.5278 0.0 0
M  V30 23 C 4.6200 5.1950 0.0 0
M  V30 24 C 3.8500 3.8614 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 17
M  V30 18 1 14 19
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1821369-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1821369-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15327909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used, pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient one-pot conversion of Boc-protected adenines to N6-ureas
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Machicao, Paulo A.; Peterson, Matt A.; Schols, Dominique
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(47), 6574-6576

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-2H-...
C20H18N2O6
1850385-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 7.7000 2.6674 0.0 0
M  V30 3 C 10.0100 4.0011 0.0 0
M  V30 4 C 11.5500 4.0011 0.0 0
M  V30 5 O 12.3200 2.6674 0.0 0
M  V30 6 O 12.3200 5.3347 0.0 0
M  V30 7 C 13.8600 2.6674 0.0 0
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 N 7.7000 5.3347 0.0 0
M  V30 10 C 6.9300 6.6684 0.0 0
M  V30 11 C 9.2400 5.3347 0.0 0
M  V30 12 C 7.7000 8.0021 0.0 0
M  V30 13 C 5.3900 6.6684 0.0 0
M  V30 14 C 10.0100 6.6684 0.0 0
M  V30 15 O 9.2400 8.0021 0.0 0
M  V30 16 C 6.9300 9.3358 0.0 0
M  V30 17 C 4.6200 8.0021 0.0 0
M  V30 18 C 5.3900 9.3358 0.0 0
M  V30 19 C 5.3900 4.0011 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 4.6200 5.3347 0.0 0
M  V30 22 C 3.0800 2.6674 0.0 0
M  V30 23 C 3.0800 5.3347 0.0 0
M  V30 24 C 2.3100 4.0011 0.0 0
M  V30 25 N 2.3100 1.3336 0.0 0
M  V30 26 O 0.7700 4.0011 0.0 0
M  V30 27 C 0.7700 1.3336 0.0 0
M  V30 28 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 19
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 2 8 27
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 2 23 24
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(3,4-Dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-N-methyl-2...
C20H19N3O5
1850385-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 7.7000 2.6674 0.0 0
M  V30 3 C 10.0100 4.0011 0.0 0
M  V30 4 C 11.5500 4.0011 0.0 0
M  V30 5 N 12.3200 2.6674 0.0 0
M  V30 6 O 12.3200 5.3347 0.0 0
M  V30 7 C 13.8600 2.6674 0.0 0
M  V30 8 O 0.0000 0.0000 0.0 0
M  V30 9 N 7.7000 5.3347 0.0 0
M  V30 10 C 6.9300 6.6684 0.0 0
M  V30 11 C 9.2400 5.3347 0.0 0
M  V30 12 C 7.7000 8.0021 0.0 0
M  V30 13 C 5.3900 6.6684 0.0 0
M  V30 14 C 10.0100 6.6684 0.0 0
M  V30 15 O 9.2400 8.0021 0.0 0
M  V30 16 C 6.9300 9.3358 0.0 0
M  V30 17 C 4.6200 8.0021 0.0 0
M  V30 18 C 5.3900 9.3358 0.0 0
M  V30 19 C 5.3900 4.0011 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 4.6200 5.3347 0.0 0
M  V30 22 C 3.0800 2.6674 0.0 0
M  V30 23 C 3.0800 5.3347 0.0 0
M  V30 24 C 2.3100 4.0011 0.0 0
M  V30 25 N 2.3100 1.3336 0.0 0
M  V30 26 O 0.7700 4.0011 0.0 0
M  V30 27 C 0.7700 1.3336 0.0 0
M  V30 28 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 19
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 2 8 27
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 22 25
M  V30 27 2 23 24
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1850385-76-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1850385-53-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9505743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoxazinone amides as mineralocorticoid receptor
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM O'Mahony, Gavin; Kossenjans, Michael; Edman, Karl; Kajanus, Johan;
Hogner, Karl Anders; Cornwall, Philip; Turner, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150376170 A1 2015-12-31

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
(2-Iodophenyl)acetic acid
C8H7IO2
18698-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 I 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methylbenzeneacetamide
C9H10INO
86811-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 O 5.3347 3.8500 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 I 1.3336 0.0000 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18698-96-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86811-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12670004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A regioselective synthesis of 3-benzazepinones via intramolecular
hydroamidation of acetylenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Ying; Stephenson, Gregory A.; Mitchell, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2006), 47(23), 3811-3814

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
(4-Chlorophenyl)acetic acid
C8H7ClO2
1878-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 O 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 Cl 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzeneacetamide
C9H10ClNO
60336-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Cl 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1878-66-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60336-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15462035
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM slow addition of thionyl chloride with temperature control (stage 1),
slow inverse addition stage 2, exothermic reaction stage 2, scalable
(multigram scale)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinolin-3-ones via cyclization of phenyl
acetamides using Eaton's reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Qiang; Ulysse, Luckner G.; McLaws, Mark D.; Keefe, Daniel K.;
Guzzo, Peter R.; Haney, Brian P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Syntheses (2012), 8944-54

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-2-(dimethoxymethyl)-α-oxobenzeneacetate
C12H13ClO5
1882034-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 O 1.3336 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 C 1.3336 0.0000 0.0 0
M  V30 5 C 4.0011 0.0000 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 O 5.3347 2.3100 0.0 0
M  V30 9 O 8.0021 3.8500 0.0 0
M  V30 10 O 6.6684 6.1600 0.0 0
M  V30 11 C 9.3358 4.6200 0.0 0
M  V30 12 Cl 0.0000 6.9300 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 14 C 4.0011 4.6200 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 4.0011 6.1600 0.0 0
M  V30 17 C 1.3336 6.1600 0.0 0
M  V30 18 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-(dimethoxymethyl)-N-methyl-α-oxobenzeneacetamide
C12H14ClNO4
1882034-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 O 4.0011 1.5400 0.0 0
M  V30 3 O 1.3336 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 6.6684 4.6200 0.0 0
M  V30 8 O 5.3347 2.3100 0.0 0
M  V30 9 N 8.0021 3.8500 0.0 0
M  V30 10 O 6.6684 6.1600 0.0 0
M  V30 11 C 9.3358 4.6200 0.0 0
M  V30 12 Cl 0.0000 6.9300 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 14 C 4.0011 4.6200 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 4.0011 6.1600 0.0 0
M  V30 17 C 1.3336 6.1600 0.0 0
M  V30 18 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1882034-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1882034-72-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1649458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Convenient Synthesis of
1-Alkoxy-2-alkyl-1,2-dihydroisoquinoline-3,4-diones Utilizing the
Reaction of 2-(Dialkoxymethyl)phenyllithiums with Dimethyl Oxalate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobayashi, Kazuhiro; Honda, Yuuya; Kuroda, Minami
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2016), 99(2), 125-129

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-O,α-dimethyl-L-tyrosine methyl ester
C13H19NO4
19728-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 4.0012 0.0 0
M  V30 2 C 7.7002 5.3348 0.0 0 CFG=1
M  V30 3 C 9.0338 4.5648 0.0 0
M  V30 4 C 8.4702 6.6687 0.0 0
M  V30 5 N 6.3663 6.1048 0.0 0
M  V30 6 O 10.3675 5.3348 0.0 0
M  V30 7 O 9.0338 3.0248 0.0 0
M  V30 8 C 11.7012 4.5648 0.0 0
M  V30 9 O 2.3101 1.3338 0.0 0
M  V30 10 C 3.0801 0.0000 0.0 0
M  V30 11 O 0.7700 4.0012 0.0 0
M  V30 12 C 0.0000 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 3.0801 2.6675 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5 CFG=3
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzenepropanamide, α-amino-3,4-dimethoxy-N,α-dimethyl-, (S)-
C13H20N2O3
120346-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 4.0012 0.0 0
M  V30 2 C 7.7002 5.3348 0.0 0 CFG=1
M  V30 3 C 9.0338 4.5648 0.0 0
M  V30 4 C 6.3663 6.1048 0.0 0
M  V30 5 N 8.4702 6.6687 0.0 0
M  V30 6 N 10.3675 5.3348 0.0 0
M  V30 7 O 9.0338 3.0248 0.0 0
M  V30 8 C 11.7012 4.5648 0.0 0
M  V30 9 O 2.3101 1.3338 0.0 0
M  V30 10 C 3.0801 0.0000 0.0 0
M  V30 11 O 0.7700 4.0012 0.0 0
M  V30 12 C 0.0000 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 3.0801 2.6675 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=3
M  V30 2 1 1 13
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19728-71-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 120346-38-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12716438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (MeNH2-MeOH solution)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mechanistic Insights into Enantioselective C-H Photooxygenation of
Aldehydes via Enamine Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Walaszek, Dominika J.; Rybicka-Jasinska, Katarzyna; Smolen, Sabina;
Karczewski, Maksymilian; Gryko, Dorota
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(9), 2061-2070

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 1-[(2S,3S)-3,4-dihydro-3-[(methylsulfonyl)oxy]-2-[2-[(methylsulfony...
C17H21NO8S2
2001554-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3472 8.2319 0.0 0
M  V30 2 C 1.3748 9.7718 0.0 0
M  V30 3 O 0.0000 7.4860 0.0 0
M  V30 4 O 6.5970 2.1668 0.0 0
M  V30 5 S 5.4040 1.1932 0.0 0 VAL=6
M  V30 6 C 6.3776 0.0000 0.0 0
M  V30 7 O 4.2108 0.2196 0.0 0
M  V30 8 O 4.4302 2.3864 0.0 0
M  V30 9 C 8.9474 3.7891 0.0 0
M  V30 10 C 10.2813 4.5591 0.0 0
M  V30 11 O 11.6149 3.7891 0.0 0
M  V30 12 S 12.9486 4.5591 0.0 0 VAL=6
M  V30 13 C 13.7186 3.2254 0.0 0
M  V30 14 O 14.2823 5.3291 0.0 0
M  V30 15 O 12.1786 5.8928 0.0 0
M  V30 16 C 5.0847 6.8730 0.0 0
M  V30 17 C 4.3039 5.5561 0.0 0
M  V30 18 C 4.0876 8.0413 0.0 0
M  V30 19 C 6.5953 7.1371 0.0 0
M  V30 20 C 4.8724 4.1162 0.0 0
M  V30 21 C 2.7996 5.9043 0.0 0
M  V30 22 N 2.6669 7.4382 0.0 0
M  V30 23 C 4.6110 9.4918 0.0 0
M  V30 24 O 7.7376 6.0930 0.0 0
M  V30 25 C 7.1182 8.5885 0.0 0
M  V30 26 C 6.3505 3.6870 0.0 0 CFG=2
M  V30 27 C 6.1263 9.7661 0.0 0
M  V30 28 C 7.6138 4.5591 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 4 5
M  V30 5 1 26 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 10
M  V30 10 1 28 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 12 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 2 18 23
M  V30 23 1 19 24
M  V30 24 1 19 25
M  V30 25 1 20 26
M  V30 26 1 21 22
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,6aS)-3,3a,4,5,6,6a-Hexahydro-4-methyl-1H-pyrrolo[2′,3′:6,7]oxepino[4,3,2...
C14H16N2O
298204-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.7406 3.9914 0.0 0
M  V30 2 C 3.0031 2.4704 0.0 0
M  V30 3 C 4.4094 1.8653 0.0 0
M  V30 4 C 2.5469 3.9346 0.0 0
M  V30 5 C 1.9726 1.3314 0.0 0
M  V30 6 C 5.7643 2.6139 0.0 0
M  V30 7 C 4.2574 0.3288 0.0 0
M  V30 8 O 3.4357 5.2016 0.0 0
M  V30 9 C 1.0406 4.2665 0.0 0
M  V30 10 N 2.7533 0.0000 0.0 0
M  V30 11 C 0.4669 1.6640 0.0 0
M  V30 12 C 6.0000 4.1350 0.0 0 CFG=1
M  V30 13 C 4.9695 5.2795 0.0 0 CFG=1
M  V30 14 C 0.0000 3.1313 0.0 0
M  V30 15 N 7.4068 4.7615 0.0 0
M  V30 16 C 5.7395 6.6132 0.0 0
M  V30 17 C 7.2458 6.2930 0.0 0
M  V30 18 H 7.2234 3.1996 0.0 0
M  V30 19 H 4.1658 6.5932 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 7 10
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 2 11 14
M  V30 16 1 12 13
M  V30 17 1 12 15
M  V30 18 1 12 18 CFG=1
M  V30 19 1 13 16
M  V30 20 1 13 19 CFG=3
M  V30 21 1 15 17
M  V30 22 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2001554-99-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 298204-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16325807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, overall yield 9% over 10 steps from 3-nitro-phenol
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A concise gram-scale synthesis of ht-13-A via a rhodium-catalyzed
intramolecular C-H activation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tao, Pengyu; Chen, Zhuang; Jia, Yanxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2016), 52(75),
11300-11303

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 1-[(2S,3R)-3,4-dihydro-3-[(methylsulfonyl)oxy]-2-[2-[(methylsulfony...
C17H21NO8S2
2001555-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3472 8.2319 0.0 0
M  V30 2 C 1.3748 9.7718 0.0 0
M  V30 3 O 0.0000 7.4860 0.0 0
M  V30 4 O 6.5970 2.1668 0.0 0
M  V30 5 S 5.4040 1.1932 0.0 0 VAL=6
M  V30 6 C 6.3776 0.0000 0.0 0
M  V30 7 O 4.2108 0.2196 0.0 0
M  V30 8 O 4.4302 2.3864 0.0 0
M  V30 9 C 8.9474 3.7891 0.0 0
M  V30 10 C 10.2813 4.5591 0.0 0
M  V30 11 O 11.6149 3.7891 0.0 0
M  V30 12 S 12.9486 4.5591 0.0 0 VAL=6
M  V30 13 C 13.7186 3.2254 0.0 0
M  V30 14 O 14.2823 5.3291 0.0 0
M  V30 15 O 12.1786 5.8928 0.0 0
M  V30 16 C 5.0847 6.8730 0.0 0
M  V30 17 C 4.3039 5.5561 0.0 0
M  V30 18 C 4.0876 8.0413 0.0 0
M  V30 19 C 6.5953 7.1371 0.0 0
M  V30 20 C 4.8724 4.1162 0.0 0
M  V30 21 C 2.7996 5.9043 0.0 0
M  V30 22 N 2.6669 7.4382 0.0 0
M  V30 23 C 4.6110 9.4918 0.0 0
M  V30 24 O 7.7376 6.0930 0.0 0
M  V30 25 C 7.1182 8.5885 0.0 0
M  V30 26 C 6.3505 3.6870 0.0 0 CFG=1
M  V30 27 C 6.1263 9.7661 0.0 0
M  V30 28 C 7.6138 4.5591 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 4 5
M  V30 5 1 26 4 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 10
M  V30 10 1 28 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 12 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 2 18 23
M  V30 23 1 19 24
M  V30 24 1 19 25
M  V30 25 1 20 26
M  V30 26 1 21 22
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aS,6aS)-3,3a,4,5,6,6a-Hexahydro-4-methyl-1H-pyrrolo[2′,3′:6,7]oxepino[4,3,2...
C14H16N2O
2001555-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.7406 3.9914 0.0 0
M  V30 2 C 3.0031 2.4704 0.0 0
M  V30 3 C 4.4094 1.8653 0.0 0
M  V30 4 C 2.5469 3.9346 0.0 0
M  V30 5 C 1.9726 1.3314 0.0 0
M  V30 6 C 5.7643 2.6139 0.0 0
M  V30 7 C 4.2574 0.3288 0.0 0
M  V30 8 O 3.4357 5.2016 0.0 0
M  V30 9 C 1.0406 4.2665 0.0 0
M  V30 10 N 2.7533 0.0000 0.0 0
M  V30 11 C 0.4669 1.6640 0.0 0
M  V30 12 C 6.0000 4.1350 0.0 0 CFG=2
M  V30 13 C 4.9695 5.2795 0.0 0 CFG=1
M  V30 14 C 0.0000 3.1313 0.0 0
M  V30 15 N 7.4068 4.7615 0.0 0
M  V30 16 C 5.7395 6.6132 0.0 0
M  V30 17 C 7.2458 6.2930 0.0 0
M  V30 18 H 7.2234 3.1996 0.0 0
M  V30 19 H 4.1658 6.5932 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 7 10
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 2 11 14
M  V30 16 1 12 13
M  V30 17 1 12 15
M  V30 18 1 12 18 CFG=3
M  V30 19 1 13 16
M  V30 20 1 13 19 CFG=3
M  V30 21 1 15 17
M  V30 22 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2001555-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2001555-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16325817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, overall yield 14% over 10 steps from 3-nitro-phenol
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A concise gram-scale synthesis of ht-13-A via a rhodium-catalyzed
intramolecular C-H activation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tao, Pengyu; Chen, Zhuang; Jia, Yanxing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2016), 52(75),
11300-11303

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-methyl-β-oxobenzenepropanoate
C11H12O3
200404-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 8.0022 3.0800 0.0 0
M  V30 5 O 9.3359 2.3100 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 C 10.6695 3.0800 0.0 0
M  V30 8 C 0.0000 3.0800 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6673 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(methylamino)-3-(3-methylphenyl)-2-propenoate
C12H15NO2
2304416-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 N 4.0011 6.1600 0.0 0
M  V30 4 C 6.6684 4.6200 0.0 0
M  V30 5 C 2.6674 6.9300 0.0 0
M  V30 6 O 8.0021 3.8500 0.0 0
M  V30 7 O 6.6684 6.1600 0.0 0
M  V30 8 C 9.3358 4.6200 0.0 0
M  V30 9 C 1.3336 0.0000 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 1.3336 1.5400 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 200404-35-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946810
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iron(1+), dicarbonyl(η5-2,4-cyclopentadien-1-yl)(2-isocyano-1,3-dimethylbenze...
C16H14FeNO2.ClO4
2115726-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5094 6.2590 0.0 0 CHG=-1 VAL=4
M  V30 2 N 4.2801 6.2590 0.0 0 CHG=1 VAL=4
M  V30 3 C 0.8429 6.2590 0.0 0
M  V30 4 O 0.0722 6.2590 0.0 0 VAL=3
M  V30 5 C 2.1761 5.4883 0.0 0
M  V30 6 O 2.9468 5.4883 0.0 0 VAL=3
M  V30 7 C 4.2801 4.6518 0.0 0
M  V30 8 C 5.6707 7.0615 0.0 0
M  V30 9 Fe 2.1761 7.0297 0.0 0 CHG=2 VAL=8
M  V30 10 C 2.1761 11.1484 0.0 0 CHG=-1 VAL=4
M  V30 11 C 1.3758 9.0891 0.0 0 VAL=5
M  V30 12 C 2.9765 9.0891 0.0 0 VAL=5
M  V30 13 C 4.3502 9.8895 0.0 0 VAL=5
M  V30 14 C 0.0000 9.8895 0.0 0 VAL=5
M  V30 15 C 4.9468 5.8726 0.0 0
M  V30 16 C 4.9468 5.0382 0.0 0
M  V30 17 C 5.6707 6.2909 0.0 0
M  V30 18 C 5.6707 4.6200 0.0 0
M  V30 19 C 6.3947 5.8726 0.0 0
M  V30 20 C 6.3947 5.0382 0.0 0
M  V30 21 Cl 3.1973 1.5400 0.0 0 VAL=7
M  V30 22 O 1.6573 1.5400 0.0 0
M  V30 23 O 4.7373 1.5400 0.0 0
M  V30 24 O 3.1973 0.0000 0.0 0
M  V30 25 O 3.1973 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 3 3 4
M  V30 5 1 3 9
M  V30 6 3 5 6
M  V30 7 1 5 9
M  V30 8 1 7 16
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 13
M  V30 16 1 10 14
M  V30 17 1 11 12
M  V30 18 2 11 14
M  V30 19 2 12 13
M  V30 20 2 15 16
M  V30 21 1 15 17
M  V30 22 1 16 18
M  V30 23 2 17 19
M  V30 24 2 18 20
M  V30 25 1 19 20
M  V30 26 2 21 22
M  V30 27 2 21 23
M  V30 28 2 21 24
M  V30 29 1 21 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H19FeN2O2.ClO4
2115726-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5832 7.8345 0.0 0 CHG=-2 VAL=4
M  V30 2 N 3.5832 6.2945 0.0 0
M  V30 3 N 4.2643 8.2271 0.0 0
M  V30 4 C 5.0148 7.7954 0.0 0
M  V30 5 C 0.8589 7.8345 0.0 0
M  V30 6 O 0.0737 7.8345 0.0 0 VAL=3
M  V30 7 C 2.2211 7.0471 0.0 0
M  V30 8 O 3.0084 7.0471 0.0 0 VAL=3
M  V30 9 C 3.5832 4.6547 0.0 0
M  V30 10 C 5.0061 7.1144 0.0 0
M  V30 11 Fe 2.2211 8.6218 0.0 0 CHG=4 VAL=9
M  V30 12 C 2.2211 12.8297 0.0 0 CHG=-1 VAL=4
M  V30 13 C 1.4034 10.7258 0.0 0 VAL=5
M  V30 14 C 3.0410 10.7258 0.0 0 VAL=5
M  V30 15 C 4.4421 11.5435 0.0 0 VAL=5
M  V30 16 C 0.0000 11.5435 0.0 0 VAL=5
M  V30 17 C 4.2643 5.9019 0.0 0
M  V30 18 C 4.2643 5.0473 0.0 0
M  V30 19 C 5.0061 6.3270 0.0 0
M  V30 20 C 5.0061 4.6200 0.0 0
M  V30 21 C 5.7435 5.9019 0.0 0
M  V30 22 C 5.7435 5.0473 0.0 0
M  V30 23 Cl 2.8718 1.5400 0.0 0 VAL=7
M  V30 24 O 1.3318 1.5400 0.0 0
M  V30 25 O 4.4118 1.5400 0.0 0
M  V30 26 O 2.8718 0.0000 0.0 0
M  V30 27 O 2.8718 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 11 CFG=2
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 3 5 6
M  V30 7 1 5 11
M  V30 8 3 7 8
M  V30 9 1 7 11
M  V30 10 1 9 18
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 15
M  V30 18 1 12 16
M  V30 19 1 13 14
M  V30 20 2 13 16
M  V30 21 2 14 15
M  V30 22 2 17 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 2 19 21
M  V30 26 2 20 22
M  V30 27 1 21 22
M  V30 28 2 23 24
M  V30 29 2 23 25
M  V30 30 2 23 26
M  V30 31 1 23 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2115726-91-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2115726-98-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29256705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM time dependent product
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Half-sandwich iron(II) complexes with protic acyclic diaminocarbene
ligands: synthesis, deprotonation and metalation reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ruiz, Javier; Garcia, Lucia; Vivanco, Marilin; Sol, Daniel;
Garcia-Granda, Santiago
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2017), 46(31), 10387-10398

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,9,12,15,18,21,24,27-Nonaoxaoctacosan-1-ol, 1-(4-methylbenzenesulfonate)
C26H46O12S
211859-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 2 O 4.4139 4.5648 0.0 0
M  V30 3 O 1.7464 6.1048 0.0 0
M  V30 4 O 3.8501 6.6687 0.0 0
M  V30 5 C 5.7476 5.3348 0.0 0
M  V30 6 C 7.0812 4.5648 0.0 0
M  V30 7 O 8.4149 5.3348 0.0 0
M  V30 8 C 9.7487 4.5648 0.0 0
M  V30 9 C 11.0824 5.3348 0.0 0
M  V30 10 O 12.4161 4.5648 0.0 0
M  V30 11 C 13.7497 5.3348 0.0 0
M  V30 12 C 15.0836 4.5648 0.0 0
M  V30 13 O 16.4172 5.3348 0.0 0
M  V30 14 C 17.7509 4.5648 0.0 0
M  V30 15 C 19.0846 5.3348 0.0 0
M  V30 16 O 20.4184 4.5648 0.0 0
M  V30 17 C 21.7521 5.3348 0.0 0
M  V30 18 C 23.0857 4.5648 0.0 0
M  V30 19 O 24.4194 5.3348 0.0 0
M  V30 20 C 25.7532 4.5648 0.0 0
M  V30 21 C 27.0869 5.3348 0.0 0
M  V30 22 O 28.4206 4.5648 0.0 0
M  V30 23 C 29.7542 5.3348 0.0 0
M  V30 24 C 31.0880 4.5648 0.0 0
M  V30 25 O 32.4217 5.3348 0.0 0
M  V30 26 C 33.7554 4.5648 0.0 0
M  V30 27 C 35.0890 5.3348 0.0 0
M  V30 28 O 36.4229 4.5648 0.0 0
M  V30 29 C 37.7565 5.3348 0.0 0
M  V30 30 C 39.0902 4.5648 0.0 0
M  V30 31 O 40.4239 5.3348 0.0 0
M  V30 32 C 41.7577 4.5648 0.0 0
M  V30 33 C 0.0000 0.0000 0.0 0
M  V30 34 C 2.3101 4.0012 0.0 0
M  V30 35 C 3.0801 2.6675 0.0 0
M  V30 36 C 0.7700 4.0012 0.0 0
M  V30 37 C 2.3101 1.3338 0.0 0
M  V30 38 C 0.0000 2.6675 0.0 0
M  V30 39 C 0.7700 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 34
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 33 39
M  V30 34 2 34 35
M  V30 35 1 34 36
M  V30 36 1 35 37
M  V30 37 2 36 38
M  V30 38 2 37 39
M  V30 39 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,6,9,12,15,18,21,24,27-nonaoxaoctacosan-1-amine
C20H43NO9
936499-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.6720 0.7700 0.0 0
M  V30 2 C 20.0057 0.0000 0.0 0
M  V30 3 O 17.3383 0.0000 0.0 0
M  V30 4 O 21.3393 0.7700 0.0 0
M  V30 5 C 16.0045 0.7700 0.0 0
M  V30 6 C 22.6731 0.0000 0.0 0
M  V30 7 C 14.6708 0.0000 0.0 0
M  V30 8 C 24.0068 0.7700 0.0 0
M  V30 9 O 13.3372 0.7700 0.0 0
M  V30 10 O 25.3405 0.0000 0.0 0
M  V30 11 C 12.0035 0.0000 0.0 0
M  V30 12 C 26.6742 0.7700 0.0 0
M  V30 13 C 10.6697 0.7700 0.0 0
M  V30 14 C 28.0080 0.0000 0.0 0
M  V30 15 O 9.3360 0.0000 0.0 0
M  V30 16 O 29.3416 0.7700 0.0 0
M  V30 17 C 8.0023 0.7700 0.0 0
M  V30 18 C 30.6753 0.0000 0.0 0
M  V30 19 C 6.6687 0.0000 0.0 0
M  V30 20 C 32.0090 0.7700 0.0 0
M  V30 21 O 5.3348 0.7700 0.0 0
M  V30 22 O 33.3428 0.0000 0.0 0
M  V30 23 C 4.0012 0.0000 0.0 0
M  V30 24 C 34.6765 0.7700 0.0 0
M  V30 25 C 2.6675 0.7700 0.0 0
M  V30 26 C 36.0101 0.0000 0.0 0
M  V30 27 N 1.3338 0.0000 0.0 0
M  V30 28 O 37.3438 0.7700 0.0 0
M  V30 29 C 0.0000 0.7700 0.0 0
M  V30 30 C 38.6776 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 211859-75-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 936499-80-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4693301
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gold(I)-isocyanide and gold(I)-carbene complexes as substrates for the
laser decoration of gold onto ceramic surfaces
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heathcote, Robert; Howell, James A. S.; Jennings, Nicola; Cartlidge,
David; Cobden, Lisa; Coles, Simon; Hursthouse, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2007), (13), 1309-1315

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-(fluorosulfonyl)benzoic acid
C7H4ClFO4S
21346-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 Cl 6.6687 0.0000 0.0 0
M  V30 5 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 6 F 0.0000 3.8501 0.0 0
M  V30 7 O 2.1037 4.4137 0.0 0
M  V30 8 O 0.5637 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-[(methylamino)sulfonyl]benzoic acid
C8H8ClNO4S
68901-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 Cl 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21346-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68901-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15480213
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) 2-Chloro-5-methylsulfamoyl-benzoic acid To 41.9 mmol
2-chloro-5-(fluorosulfonyl)sulfanylbenzoic acid in 100 ml dioxane was
added dropwise 420 mmol methylamine solution (41% aqueous) and the
mixture was stirred at RT for 2 h. An excess of 2 M aqueous hydrochloric
acid was then added to the reaction mixture and the resulting mixture was
then concentrated in vacuo. The residue was treated with water and
extracted 3 times with ethyl acetate. The combined organic phases were
dried over sodium sulfate. Evaporation under reduced pressure yielded the
title compound as a white crystalline solid (yield 96%).
2-Chloro-5-methylsulfamoyl-benzoic acid, yield (96%). MS (m/e): 248.1
([M-H]-, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-(alkylsulfanyl)phenyl piperazinyl ketones as inhibitors
of glycine transporters for the treatment of schizophrenia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jolidon, Synese; Narquizian, Robert; Norcross, Roger David; Pinard,
Emmanuel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060149062 A1 2006-07-06

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
(2R,3R)-1-[[(1,1-Dimethylethoxy)carbonyl]amino]-2,3-diphenylcyclopropanecarbo...
C21H23NO4
214492-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9883 5.4270 0.0 0
M  V30 2 C 8.1680 6.4170 0.0 0
M  V30 3 O 9.6151 5.8903 0.0 0
M  V30 4 O 7.9006 7.9336 0.0 0
M  V30 5 C 10.7950 6.8801 0.0 0
M  V30 6 C 11.7847 5.7004 0.0 0
M  V30 7 C 11.9746 7.8700 0.0 0
M  V30 8 C 9.8050 8.0599 0.0 0
M  V30 9 C 5.8085 7.4704 0.0 0
M  V30 10 O 7.2557 7.9970 0.0 0
M  V30 11 O 4.6289 8.4603 0.0 0
M  V30 12 C 5.5412 5.9537 0.0 0 CFG=1
M  V30 13 C 4.7712 4.6201 0.0 0 CFG=1
M  V30 14 C 4.0011 5.9537 0.0 0 CFG=1
M  V30 15 C 4.7712 3.0800 0.0 0
M  V30 16 C 3.4375 2.3100 0.0 0
M  V30 17 C 6.1048 2.3100 0.0 0
M  V30 18 C 3.4375 0.7700 0.0 0
M  V30 19 C 6.1048 0.7700 0.0 0
M  V30 20 C 4.7712 0.0000 0.0 0
M  V30 21 C 2.6675 6.7237 0.0 0
M  V30 22 C 2.6675 8.2638 0.0 0
M  V30 23 C 1.3337 5.9537 0.0 0
M  V30 24 C 1.3337 9.0338 0.0 0
M  V30 25 C 0.0000 6.7237 0.0 0
M  V30 26 C 0.0000 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 12 9 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 15 1 13 15 CFG=1
M  V30 16 1 14 21 CFG=3
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(2R,3R)-1-[(methylamino)carbonyl]-2,3-diphenylcyclopropyl]-, ...
C22H26N2O3
876727-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9883 5.4270 0.0 0
M  V30 2 C 8.1680 6.4170 0.0 0
M  V30 3 O 9.6151 5.8903 0.0 0
M  V30 4 O 7.9006 7.9336 0.0 0
M  V30 5 C 10.7950 6.8801 0.0 0
M  V30 6 C 11.7847 5.7004 0.0 0
M  V30 7 C 11.9746 7.8700 0.0 0
M  V30 8 C 9.8050 8.0599 0.0 0
M  V30 9 C 5.8085 7.4704 0.0 0
M  V30 10 N 4.6289 8.4603 0.0 0
M  V30 11 O 7.2557 7.9970 0.0 0
M  V30 12 C 4.8962 9.9769 0.0 0
M  V30 13 C 5.5412 5.9537 0.0 0 CFG=2
M  V30 14 C 4.0011 5.9537 0.0 0 CFG=1
M  V30 15 C 4.7712 4.6201 0.0 0 CFG=1
M  V30 16 C 2.6675 6.7237 0.0 0
M  V30 17 C 2.6675 8.2638 0.0 0
M  V30 18 C 1.3337 5.9537 0.0 0
M  V30 19 C 1.3337 9.0338 0.0 0
M  V30 20 C 0.0000 6.7237 0.0 0
M  V30 21 C 0.0000 8.2638 0.0 0
M  V30 22 C 4.7712 3.0800 0.0 0
M  V30 23 C 6.1048 2.3100 0.0 0
M  V30 24 C 3.4375 2.3100 0.0 0
M  V30 25 C 6.1048 0.7700 0.0 0
M  V30 26 C 3.4375 0.7700 0.0 0
M  V30 27 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 13 9 CFG=1
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 16 1 14 16 CFG=3
M  V30 17 1 15 22 CFG=1
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 214492-28-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876727-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6024671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):NOTES
$DATUM no exptl. detail, reactant assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preferred 3D-structure of peptides rich in a severely conformationally
restricted cyclopropane analog of phenylalanine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crisma, Marco; De Borggraeve, Wim M.; Peggion, Cristina; Formaggio,
Fernando; Royo, Soledad; Jimenez, Ana I.; Cativiela, Carlos; Toniolo,
Claudio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2005), 12(1), 251-260

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichlorophenyl 4-[(1,2,3,4-tetrahydro-6-methoxy-1-oxo-2-naphthalenyl)m...
C24H18Cl3NO4
2173247-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2402 6.6685 0.0 0
M  V30 2 O 16.1704 5.3348 0.0 0
M  V30 3 C 16.9404 6.6685 0.0 0
M  V30 4 C 7.7002 4.0012 0.0 0
M  V30 5 C 4.6201 4.0012 0.0 0
M  V30 6 O 3.0801 4.0012 0.0 0
M  V30 7 O 5.3901 5.3348 0.0 0
M  V30 8 Cl 4.6201 6.6685 0.0 0
M  V30 9 Cl 0.0000 4.0012 0.0 0
M  V30 10 Cl 0.0000 9.3360 0.0 0
M  V30 11 C 12.3203 4.0012 0.0 0
M  V30 12 C 11.5503 5.3348 0.0 0
M  V30 13 C 13.8603 4.0012 0.0 0
M  V30 14 C 11.5503 2.6675 0.0 0
M  V30 15 C 10.0102 5.3348 0.0 0
M  V30 16 C 12.3203 6.6685 0.0 0
M  V30 17 C 14.6303 5.3348 0.0 0
M  V30 18 C 10.0102 2.6675 0.0 0
M  V30 19 C 9.2402 4.0012 0.0 0
M  V30 20 C 13.8603 6.6685 0.0 0
M  V30 21 C 6.9302 2.6675 0.0 0
M  V30 22 C 5.3901 2.6675 0.0 0
M  V30 23 C 7.7002 1.3337 0.0 0
M  V30 24 C 4.6201 1.3337 0.0 0
M  V30 25 C 6.9302 0.0000 0.0 0
M  V30 26 N 5.3901 0.0000 0.0 0
M  V30 27 C 2.3101 5.3348 0.0 0
M  V30 28 C 3.0801 6.6685 0.0 0
M  V30 29 C 0.7700 5.3348 0.0 0
M  V30 30 C 2.3101 8.0023 0.0 0
M  V30 31 C 0.0000 6.6685 0.0 0
M  V30 32 C 0.7700 8.0023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 4 19
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 6 27
M  V30 10 1 8 28
M  V30 11 1 9 29
M  V30 12 1 10 32
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 2 17 20
M  V30 23 1 18 19
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[(1,2,3,4-tetrahydro-6-methoxy-1-oxo-2-naphthalenyl)methyl]-3-pyri...
C19H20N2O3
2173247-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 6.6685 0.0 0
M  V30 2 O 13.8600 5.3347 0.0 0
M  V30 3 C 14.6300 6.6685 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 N 0.7700 4.0011 0.0 0
M  V30 7 O 3.0800 5.3347 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 C 10.0100 4.0011 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0
M  V30 11 C 11.5500 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 7.7000 5.3347 0.0 0
M  V30 14 C 10.0100 6.6685 0.0 0
M  V30 15 C 12.3200 5.3347 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 C 11.5500 6.6685 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 21 C 5.3900 1.3338 0.0 0
M  V30 22 C 2.3100 1.3338 0.0 0
M  V30 23 C 4.6200 0.0000 0.0 0
M  V30 24 N 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 4 17
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 20
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 17
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2173247-02-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173247-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18422802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel donepezil-like N-benzylpyridinium salt derivatives as AChE
inhibitors and their corresponding dihydropyridine "bio-oxidizable"
prodrugs: Synthesis, biological evaluation and structure-activity
relationship
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Azzouz, Rabah; Peauger, Ludovic; Gembus, Vincent; Tintas,
Mihaela-Liliana; Sopkova-de Oliveira Santos, Jana; Papamicael, Cyril;
Levacher, Vincent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 145165-190

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[(2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-3-methoxy-3-oxopropyl]th...
C23H25NO6S
2176461-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0869 7.5409 0.0 0
M  V30 4 N 7.0869 9.0810 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 8.4207 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4207 11.3910 0.0 0
M  V30 9 S 11.0881 9.8510 0.0 0
M  V30 10 O 7.0869 12.1610 0.0 0
M  V30 11 O 9.7544 12.1610 0.0 0
M  V30 12 C 12.4218 9.0810 0.0 0
M  V30 13 C 7.0869 13.7011 0.0 0
M  V30 14 C 13.7556 9.8510 0.0 0
M  V30 15 C 15.0892 9.0810 0.0 0
M  V30 16 C 16.4229 9.8510 0.0 0
M  V30 17 O 16.4229 11.3910 0.0 0
M  V30 18 O 17.7566 9.0810 0.0 0
M  V30 19 C 4.4196 4.4609 0.0 0
M  V30 20 C 3.0126 5.0873 0.0 0
M  V30 21 C 4.2587 2.9293 0.0 0
M  V30 22 C 1.9822 3.9428 0.0 0
M  V30 23 C 2.5367 6.5519 0.0 0
M  V30 24 C 2.7522 2.6091 0.0 0
M  V30 25 C 5.2891 1.7849 0.0 0
M  V30 26 C 0.4759 4.2630 0.0 0
M  V30 27 C 1.0304 6.8721 0.0 0
M  V30 28 C 2.2763 1.1444 0.0 0
M  V30 29 C 4.8132 0.3202 0.0 0
M  V30 30 C 0.0000 5.7277 0.0 0
M  V30 31 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 2 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-[4-(methylamino)-4-oxobutyl]-L-cysteine
C23H26N2O5S
2176461-31-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 5.7533 6.7708 0.0 0
M  V30 3 C 7.0869 7.5408 0.0 0
M  V30 4 N 7.0869 9.0808 0.0 0
M  V30 5 O 8.4207 6.7708 0.0 0
M  V30 6 C 8.4207 9.8508 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0808 0.0 0
M  V30 8 C 8.4207 11.3908 0.0 0
M  V30 9 S 11.0880 9.8508 0.0 0
M  V30 10 O 7.0869 12.1608 0.0 0
M  V30 11 O 9.7544 12.1608 0.0 0
M  V30 12 C 12.4216 9.0808 0.0 0
M  V30 13 C 13.7554 9.8508 0.0 0
M  V30 14 C 15.0891 9.0808 0.0 0
M  V30 15 C 16.4227 9.8508 0.0 0
M  V30 16 N 17.7564 9.0808 0.0 0
M  V30 17 O 16.4227 11.3908 0.0 0
M  V30 18 C 19.0901 9.8508 0.0 0
M  V30 19 C 4.4196 4.4608 0.0 0
M  V30 20 C 3.0127 5.0872 0.0 0
M  V30 21 C 4.2587 2.9292 0.0 0
M  V30 22 C 1.9823 3.9427 0.0 0
M  V30 23 C 2.5368 6.5518 0.0 0
M  V30 24 C 2.7523 2.6091 0.0 0
M  V30 25 C 5.2891 1.7849 0.0 0
M  V30 26 C 0.4760 4.2629 0.0 0
M  V30 27 C 1.0306 6.8719 0.0 0
M  V30 28 C 2.2764 1.1444 0.0 0
M  V30 29 C 4.8133 0.3202 0.0 0
M  V30 30 C 0.0000 5.7276 0.0 0
M  V30 31 C 3.3068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 2 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2176461-63-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2176461-31-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-19455363
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The mimics of Nε-acyl-lysine derived from cysteine as sirtuin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Chun; Wang, Fang; Chen, Xiaoxue; Zou, Yefang; Zhu, Hong; Zhao,
Qingjie; Shen, Jingshan; Li, Yan; Li, Yongjun; He, Bin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2018), 28(14), 2375-2378

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
rel-Methyl (3aR,8aS)-3a-(1,1-dimethyl-2-propen-1-yl)-2,3,3a,8a-tetrahydro-2-o...
C17H19NO4
221230-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.5411 0.0 0
M  V30 2 C 1.3337 3.7711 0.0 0
M  V30 3 C 1.3337 5.3111 0.0 0
M  V30 4 C 2.6673 6.0811 0.0 0
M  V30 5 C 0.0000 4.5411 0.0 0
M  V30 6 C 7.9857 3.7115 0.0 0
M  V30 7 O 9.0161 4.8559 0.0 0
M  V30 8 O 8.4616 2.2468 0.0 0
M  V30 9 C 10.5224 4.5357 0.0 0
M  V30 10 O 2.7129 0.0000 0.0 0
M  V30 11 C 4.0010 3.7711 0.0 0 CFG=2
M  V30 12 C 5.3348 3.0011 0.0 0 CFG=2
M  V30 13 C 4.3213 5.2775 0.0 0
M  V30 14 C 2.8566 2.7406 0.0 0
M  V30 15 N 6.4792 4.0317 0.0 0
M  V30 16 O 5.0147 1.4948 0.0 0
M  V30 17 C 5.8529 5.4385 0.0 0
M  V30 18 C 3.4161 6.5234 0.0 0
M  V30 19 C 3.4829 1.3338 0.0 0
M  V30 20 C 6.4792 6.8454 0.0 0
M  V30 21 C 4.0424 7.9302 0.0 0
M  V30 22 C 5.5740 8.0913 0.0 0
M  V30 23 H 6.6685 2.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 11 1 CFG=3
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 10 19
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 23 CFG=3
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aS)-3a-(1,1-Dimethyl-2-propen-1-yl)-3,3a,8,8a-tetrahydro-1-methylpy...
C16H20N2O
440327-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5278 5.0204 0.0 0
M  V30 2 C 5.8616 5.7904 0.0 0
M  V30 3 C 4.5278 6.5604 0.0 0
M  V30 4 C 3.1941 5.7904 0.0 0
M  V30 5 C 5.8616 7.3304 0.0 0
M  V30 6 C 6.4683 0.0000 0.0 0
M  V30 7 O 8.4377 2.7104 0.0 0
M  V30 8 C 4.5278 3.4804 0.0 0 CFG=2
M  V30 9 C 4.5278 1.9404 0.0 0 CFG=2
M  V30 10 C 3.0632 3.9564 0.0 0
M  V30 11 C 5.9925 3.9564 0.0 0
M  V30 12 N 3.0632 1.4645 0.0 0
M  V30 13 N 5.9925 1.4645 0.0 0
M  V30 14 C 2.1580 2.7104 0.0 0
M  V30 15 C 2.4367 5.3632 0.0 0
M  V30 16 C 6.8977 2.7104 0.0 0
M  V30 17 C 0.6265 2.8715 0.0 0
M  V30 18 C 0.9052 5.5241 0.0 0
M  V30 19 C 0.0000 4.2783 0.0 0
M  V30 20 H 4.5278 0.4004 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 8 1 CFG=1
M  V30 5 2 2 5
M  V30 6 1 6 13
M  V30 7 2 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 12 14
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 221230-13-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 440327-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-261073
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First total syntheses of dihydroflustramine C and flustramine E,
alkaloids from the marine bryozoan Flustra foliacea
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Suarez-Castillo, Oscar R.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(8), 1479-1484

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(1E)-2-butoxyethenyl]-3-quinolinecarboxylate
C18H21NO3
2234893-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 O 9.2400 2.6674 0.0 0
M  V30 4 C 10.7800 2.6674 0.0 0
M  V30 5 C 11.5500 1.3336 0.0 0
M  V30 6 C 13.0900 1.3336 0.0 0
M  V30 7 C 13.8600 0.0000 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 O 2.3100 4.0011 0.0 0
M  V30 10 O 4.6200 2.6674 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 6.1600 8.0021 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0
M  V30 18 C 3.8500 6.6684 0.0 0
M  V30 19 N 4.6200 8.0021 0.0 0
M  V30 20 C 6.9300 9.3358 0.0 0
M  V30 21 C 9.2400 8.0021 0.0 0
M  V30 22 C 8.4700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 2 18 19
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylbenzo[c][2,7]naphthyridin-4(3H)-one
C13H10N2O
2234894-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7002 0.0000 0.0 0
M  V30 2 C 9.2402 2.6673 0.0 0
M  V30 3 C 4.6201 2.6673 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 5.3901 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 6.9302 1.3337 0.0 0
M  V30 11 C 6.9302 4.0010 0.0 0
M  V30 12 N 3.0801 0.0000 0.0 0
M  V30 13 C 0.7700 1.3337 0.0 0
M  V30 14 C 0.7700 4.0010 0.0 0
M  V30 15 N 7.7002 2.6673 0.0 0
M  V30 16 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 2 9 12
M  V30 15 1 10 15
M  V30 16 1 11 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2234893-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2234894-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19489593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Confirmation of the Revised Structure of Samoquasine A and a Proposed
Structural Revision of Cherimoline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dhoro, Francis; Parkin-Gibbs, Jesse; McIldowie, Matthew; Skelton, Brian
W.; Piggott, Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Natural Products (2018), 81(7), 1658-1665

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(4-chlorophenyl)-2,4,5,6-tetrahydro-5-methyl-4,6-dioxopyrrolo[3,4-c]p...
C16H13ClN2O4
2242709-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.1942 2.4898 0.0 0
M  V30 2 C 9.3038 5.1590 0.0 0
M  V30 3 O 9.9301 6.5659 0.0 0
M  V30 4 O 10.2089 3.9131 0.0 0
M  V30 5 C 11.4617 6.7269 0.0 0
M  V30 6 C 12.0880 8.1338 0.0 0
M  V30 7 O 8.4968 1.3628 0.0 0
M  V30 8 C 5.4360 0.0000 0.0 0
M  V30 9 Cl 0.0000 8.5962 0.0 0
M  V30 10 C 5.4958 3.9845 0.0 0
M  V30 11 C 7.0021 3.6644 0.0 0
M  V30 12 C 5.3348 5.5161 0.0 0
M  V30 13 C 4.7257 2.6509 0.0 0
M  V30 14 C 7.7721 4.9980 0.0 0
M  V30 15 C 7.1632 2.1328 0.0 0
M  V30 16 N 6.7417 6.1426 0.0 0
M  V30 17 N 5.7562 1.5063 0.0 0
M  V30 18 C 4.0010 6.2861 0.0 0
M  V30 19 C 4.0010 7.8261 0.0 0
M  V30 20 C 2.6673 5.5161 0.0 0
M  V30 21 C 2.6673 8.5962 0.0 0
M  V30 22 C 1.3337 6.2861 0.0 0
M  V30 23 C 1.3337 7.8261 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 15
M  V30 8 1 8 17
M  V30 9 1 9 23
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 18
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-N2,N3,N4-trimethyl-1H-pyrrole-2,3,4-tricarboxamide
C16H17ClN4O3
2242709-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 2.6091 0.0 0
M  V30 2 N 4.8087 1.4647 0.0 0
M  V30 3 O 7.3455 2.2889 0.0 0
M  V30 4 C 5.2845 0.0000 0.0 0
M  V30 5 C 2.6528 3.6444 0.0 0
M  V30 6 N 1.2459 4.2707 0.0 0
M  V30 7 O 2.8137 2.1129 0.0 0
M  V30 8 C 0.0000 3.3657 0.0 0
M  V30 9 C 2.6528 6.9949 0.0 0
M  V30 10 N 2.8137 8.5264 0.0 0
M  V30 11 O 1.2459 6.3684 0.0 0
M  V30 12 C 1.5679 9.4316 0.0 0
M  V30 13 Cl 12.4285 5.3196 0.0 0
M  V30 14 C 6.2684 5.3196 0.0 0
M  V30 15 C 5.3632 4.0738 0.0 0
M  V30 16 N 5.3632 6.5655 0.0 0
M  V30 17 C 3.8987 4.5496 0.0 0
M  V30 18 C 3.8987 6.0897 0.0 0
M  V30 19 C 7.8085 5.3196 0.0 0
M  V30 20 C 8.5785 6.6533 0.0 0
M  V30 21 C 8.5785 3.9860 0.0 0
M  V30 22 C 10.1185 6.6533 0.0 0
M  V30 23 C 10.1185 3.9860 0.0 0
M  V30 24 C 10.8885 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 1 13 24
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242709-25-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242709-36-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-19137700
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile access to highly functionalized pyrrole
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Meng; Zhao, Wenting; Zhao, Hongyi; Lin, Ziyun; Zhang, Dongfeng;
Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2018), 14884-890

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-1-(phenylmethyl)tryptophan phenylmethyl ester
C30H32N2O4
2248079-93-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7239 9.3358 0.0 0
M  V30 2 C 5.9539 8.0021 0.0 0
M  V30 3 C 6.7239 6.6685 0.0 0
M  V30 4 N 4.4139 8.0021 0.0 0
M  V30 5 O 5.9539 5.3348 0.0 0
M  V30 6 O 8.2639 6.6685 0.0 0
M  V30 7 C 3.6439 9.3358 0.0 0
M  V30 8 C 6.7239 4.0010 0.0 0
M  V30 9 O 2.1038 9.3358 0.0 0
M  V30 10 O 4.4139 10.6696 0.0 0
M  V30 11 C 1.3338 10.6696 0.0 0
M  V30 12 C 2.6675 11.4396 0.0 0
M  V30 13 C 0.5638 12.0033 0.0 0
M  V30 14 C 0.0000 9.8996 0.0 0
M  V30 15 C 11.8796 7.6607 0.0 0
M  V30 16 C 9.1691 10.5818 0.0 0
M  V30 17 C 8.2639 9.3358 0.0 0
M  V30 18 C 10.6337 10.1058 0.0 0
M  V30 19 C 8.8488 12.0881 0.0 0
M  V30 20 C 9.1691 8.0899 0.0 0
M  V30 21 N 10.6337 8.5658 0.0 0
M  V30 22 C 11.7783 11.1364 0.0 0
M  V30 23 C 9.9934 13.1185 0.0 0
M  V30 24 C 11.4579 12.6427 0.0 0
M  V30 25 C 13.2866 8.2870 0.0 0
M  V30 26 C 13.4475 9.8186 0.0 0
M  V30 27 C 14.5324 7.3818 0.0 0
M  V30 28 C 14.8543 10.4451 0.0 0
M  V30 29 C 15.9393 8.0081 0.0 0
M  V30 30 C 16.1003 9.5398 0.0 0
M  V30 31 C 5.9539 2.6673 0.0 0
M  V30 32 C 6.7239 1.3337 0.0 0
M  V30 33 C 4.4139 2.6673 0.0 0
M  V30 34 C 5.9539 0.0000 0.0 0
M  V30 35 C 3.6439 1.3337 0.0 0
M  V30 36 C 4.4139 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 31
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 21
M  V30 17 1 15 25
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C24H29N3O3
2248079-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3763 5.3347 0.0 0
M  V30 2 C 10.1463 4.0011 0.0 0
M  V30 3 N 11.6863 4.0011 0.0 0
M  V30 4 C 9.3763 2.6674 0.0 0
M  V30 5 C 12.4563 5.3347 0.0 0
M  V30 6 N 10.1463 1.3336 0.0 0
M  V30 7 O 7.8363 2.6674 0.0 0
M  V30 8 O 13.9963 5.3347 0.0 0
M  V30 9 O 11.6863 6.6684 0.0 0
M  V30 10 C 9.3763 0.0000 0.0 0
M  V30 11 C 14.7663 6.6684 0.0 0
M  V30 12 C 16.1001 5.8984 0.0 0
M  V30 13 C 15.5363 8.0022 0.0 0
M  V30 14 C 13.4327 7.4384 0.0 0
M  V30 15 C 4.2207 3.6595 0.0 0
M  V30 16 C 6.9312 6.5806 0.0 0
M  V30 17 C 5.4666 6.1047 0.0 0
M  V30 18 C 7.8363 5.3347 0.0 0
M  V30 19 C 7.2514 8.0870 0.0 0
M  V30 20 N 5.4666 4.5647 0.0 0
M  V30 21 C 4.3220 7.1351 0.0 0
M  V30 22 C 6.9312 4.0889 0.0 0
M  V30 23 C 6.1069 9.1174 0.0 0
M  V30 24 C 4.6423 8.6416 0.0 0
M  V30 25 C 2.8137 4.2860 0.0 0
M  V30 26 C 1.5679 3.3808 0.0 0
M  V30 27 C 2.6528 5.8175 0.0 0
M  V30 28 C 0.1611 4.0071 0.0 0
M  V30 29 C 1.2460 6.4438 0.0 0
M  V30 30 C 0.0000 5.5386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 20
M  V30 16 1 15 25
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2248079-93-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2248079-94-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19706580
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric α-arylation of amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leonard, Daniel J.; Ward, John W.; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature (London, United Kingdom) (2018), 562(7725), 105-109

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl-6-formyl-N,N-bis(1-methylethyl)benzamide
C16H23NO2
227201-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4757 3.3503 0.0 0
M  V30 2 N 5.7373 4.2336 0.0 0
M  V30 3 O 4.6100 1.8161 0.0 0
M  V30 4 C 5.6030 5.7678 0.0 0
M  V30 5 C 7.1330 3.5827 0.0 0
M  V30 6 C 4.2073 6.4186 0.0 0
M  V30 7 C 6.8645 6.6510 0.0 0
M  V30 8 C 7.2673 2.0485 0.0 0
M  V30 9 C 8.3945 4.4660 0.0 0
M  V30 10 C 3.0800 6.6685 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 3.0800 1.3336 0.0 0
M  V30 13 O 2.3100 0.0000 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 C 0.7700 5.3347 0.0 0
M  V30 18 C 0.7700 2.6674 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 2 12 13
M  V30 13 1 12 16
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl-N,N-bis(1-methylethyl)-6-[(methylimino)methyl]benzamide
C17H26N2O
227201-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6519 3.9189 0.0 0
M  V30 2 N 3.7686 2.6573 0.0 0
M  V30 3 O 6.1861 3.7846 0.0 0
M  V30 4 C 2.2344 2.7916 0.0 0
M  V30 5 C 4.4194 1.2616 0.0 0
M  V30 6 C 1.5836 4.1873 0.0 0
M  V30 7 C 1.3512 1.5300 0.0 0
M  V30 8 C 5.9535 1.1273 0.0 0
M  V30 9 C 3.5362 0.0000 0.0 0
M  V30 10 C 6.6684 5.3146 0.0 0
M  V30 11 N 8.0022 6.0846 0.0 0
M  V30 12 C 9.3359 5.3146 0.0 0
M  V30 13 C 1.3337 5.3146 0.0 0
M  V30 14 C 0.0000 6.0846 0.0 0
M  V30 15 C 4.0011 5.3146 0.0 0
M  V30 16 C 5.3348 6.0846 0.0 0
M  V30 17 C 2.6675 6.0846 0.0 0
M  V30 18 C 5.3348 7.6246 0.0 0
M  V30 19 C 2.6675 7.6246 0.0 0
M  V30 20 C 4.0011 8.3946 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 2 10 11 CFG=2
M  V30 11 1 10 16
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 17
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 227201-73-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 227201-62-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8673239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereoselective synthesis of atropisomers containing two non-biaryl
stereogenic axes: stereochemical relay through stereogenic centers in
dihydrostilbene-2,2'-dicarboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Clayden, Jonathan; Westlund, Neil; Frampton, Christopher S.; Helliwell,
Madeleine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2006), 4(3), 455-461

$RFMT $RIREG SCHEME67 STEP1
$RXN



  5  1
$MOL
Quinoline
C9H7N
91-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 N 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenyl isothiocyanate
C8H7NOS
2284-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 C 8.0023 0.7700 0.0 0
M  V30 3 S 9.3360 1.5400 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-5-carboxaldehyde, 6-amino-2-(1-methylethenyl)-
C12H12N2O
2991873-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3912 5.2891 0.0 0
M  V30 2 C 8.3912 6.8291 0.0 0
M  V30 3 C 9.7250 4.5191 0.0 0
M  V30 4 C 0.7700 2.6673 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 N 2.3100 0.0000 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 5.6507 5.1455 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 N 6.8966 2.9875 0.0 0
M  V30 12 C 4.6201 1.3337 0.0 0
M  V30 13 C 7.0575 4.5191 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 2 4 5
M  V30 5 1 4 14
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
15cH-Indolizino[3,2-f]quino[1,2-c]quinazoline-13,14-dicarboxylic acid, 6-[(4-...
C36H31N5O5
2991872-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5128 7.4720 0.0 0
M  V30 2 O 5.2719 8.9930 0.0 0
M  V30 3 O 6.9505 6.9200 0.0 0
M  V30 4 C 3.8342 9.5448 0.0 0
M  V30 5 C 10.4080 2.3100 0.0 0
M  V30 6 N 10.4080 0.7700 0.0 0
M  V30 7 C 11.7416 0.0000 0.0 0
M  V30 8 C 1.6004 2.7651 0.0 0
M  V30 9 C 2.1580 8.0706 0.0 0
M  V30 10 O 0.6265 8.2316 0.0 0
M  V30 11 O 3.0632 9.3166 0.0 0
M  V30 12 C 0.0000 9.6384 0.0 0
M  V30 13 N 11.7416 7.7000 0.0 0
M  V30 14 O 17.0764 4.6200 0.0 0
M  V30 15 C 18.4102 5.3900 0.0 0
M  V30 16 C 6.4069 4.6200 0.0 0
M  V30 17 C 7.7407 5.3900 0.0 0
M  V30 18 N 4.9423 5.0959 0.0 0
M  V30 19 C 6.4069 3.0800 0.0 0
M  V30 20 C 7.7407 6.9300 0.0 0
M  V30 21 C 9.0743 4.6200 0.0 0
M  V30 22 C 4.0371 3.8500 0.0 0
M  V30 23 C 4.3159 6.5028 0.0 0
M  V30 24 C 4.9423 2.6042 0.0 0
M  V30 25 C 7.7407 2.3100 0.0 0
M  V30 26 N 9.0743 7.7000 0.0 0
M  V30 27 C 6.4069 7.7000 0.0 0
M  V30 28 C 9.0743 3.0800 0.0 0
M  V30 29 N 10.4080 5.3900 0.0 0
M  V30 30 C 2.5056 4.0110 0.0 0
M  V30 31 C 2.7843 6.6638 0.0 0
M  V30 32 C 10.4080 6.9300 0.0 0
M  V30 33 C 9.0743 9.2400 0.0 0
M  V30 34 C 6.4069 9.2400 0.0 0
M  V30 35 C 1.8791 5.4179 0.0 0
M  V30 36 C 7.7407 10.0101 0.0 0
M  V30 37 C 10.4080 10.0101 0.0 0
M  V30 38 C 7.7407 11.5501 0.0 0
M  V30 39 C 10.4080 11.5501 0.0 0
M  V30 40 C 9.0743 12.3201 0.0 0
M  V30 41 C 13.0754 6.9300 0.0 0
M  V30 42 C 13.0754 5.3900 0.0 0
M  V30 43 C 14.4091 7.7000 0.0 0
M  V30 44 C 14.4091 4.6200 0.0 0
M  V30 45 C 15.7427 6.9300 0.0 0
M  V30 46 C 15.7427 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 23
M  V30 4 1 2 4
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 8 30
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 31
M  V30 12 1 10 12
M  V30 13 1 13 32
M  V30 14 1 13 41
M  V30 15 1 14 15
M  V30 16 1 14 46
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 19 25
M  V30 26 1 20 26
M  V30 27 1 20 27
M  V30 28 1 21 28
M  V30 29 1 21 29
M  V30 30 2 22 24
M  V30 31 1 22 30
M  V30 32 2 23 31
M  V30 33 2 25 28
M  V30 34 1 26 32
M  V30 35 1 26 33
M  V30 36 2 27 34
M  V30 37 2 29 32
M  V30 38 2 30 35
M  V30 39 1 31 35
M  V30 40 1 33 36
M  V30 41 2 33 37
M  V30 42 1 34 36
M  V30 43 2 36 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 2 39 40
M  V30 47 2 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 91-22-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2284-20-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2991873-09-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2991872-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37936684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, recyclable and reusable catalyst used, catalyst prepared
and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green synthesis of new quinolinoquinazoline derivatives via one-pot
multicomponent reactions using ZnO/TiO2@MWCNTs as a new nanocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hasani, Leila; Ezzatzadeh, Elham; Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2023), 60(12), 2023-2035

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
(3S)-1-(5-Bromo-6-fluoro-2-pyridinyl)-3-pyrrolidinecarboxylic acid
C10H10BrFN2O2
2344750-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 1.5315 0.0 0
M  V30 2 O 11.1826 2.1580 0.0 0
M  V30 3 O 9.6147 0.0000 0.0 0
M  V30 4 F 1.5400 5.8742 0.0 0
M  V30 5 Br 0.0000 3.2068 0.0 0
M  V30 6 N 6.1600 3.2068 0.0 0
M  V30 7 C 7.0652 1.9609 0.0 0
M  V30 8 C 7.0652 4.4526 0.0 0
M  V30 9 C 8.5298 2.4368 0.0 0 CFG=1
M  V30 10 C 8.5298 3.9768 0.0 0
M  V30 11 C 4.6200 3.2068 0.0 0
M  V30 12 N 3.8500 4.5406 0.0 0
M  V30 13 C 3.8500 1.8731 0.0 0
M  V30 14 C 2.3100 4.5406 0.0 0
M  V30 15 C 2.3100 1.8731 0.0 0
M  V30 16 C 1.5400 3.2068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=3
M  V30 4 1 4 14
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-1-(5-Bromo-6-fluoro-2-pyridinyl)-N-methyl-3-pyrrolidinecarboxamide
C11H13BrFN3O
2344750-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.7757 4.3427 0.0 0
M  V30 2 N 11.1826 3.7162 0.0 0
M  V30 3 O 9.6147 5.8742 0.0 0
M  V30 4 C 12.4285 4.6214 0.0 0
M  V30 5 F 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6674 0.0 0
M  V30 7 N 6.1600 2.6674 0.0 0
M  V30 8 C 7.0652 3.9133 0.0 0
M  V30 9 C 7.0652 1.4216 0.0 0
M  V30 10 C 8.5298 3.4375 0.0 0 CFG=1
M  V30 11 C 8.5298 1.8974 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 N 3.8500 1.3336 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2344750-22-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2344750-24-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21576705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines having activity against the
respiratory syncytial virus (RSV)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lancois, David Francis Alain; Guillemont, Jerome Emile Georges;
Raboisson, Pierre Jean-Marie Bernard; Roymans, Dirk Andre Emmy; Rigaux,
Peter; Michaut, Antoine Benjamin; Mercey, Guillaume Jean Maurice
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019106004 A1 2019-06-06

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1,2,3,4-Tetrahydro-1-methyl-6-nitro-2-oxo-8-quinolinyl)oxy]hexanal
C16H20N2O5
2369632-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 5.3901 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 C 8.0022 5.3901 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 O 13.3370 5.3901 0.0 0
M  V30 9 C 4.0010 7.7002 0.0 0
M  V30 10 O 1.3337 9.2402 0.0 0
M  V30 11 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 12 O 4.0010 0.0000 0.0 0
M  V30 13 O 1.3337 0.0000 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 N 2.6673 6.9302 0.0 0
M  V30 18 C 1.3337 3.0801 0.0 0
M  V30 19 C 0.0000 5.3901 0.0 0
M  V30 20 C 4.0010 3.0801 0.0 0
M  V30 21 C 1.3337 7.7002 0.0 0
M  V30 22 C 2.6673 2.3101 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 9 17
M  V30 10 2 10 21
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 22
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-1-methyl-8-[[1-methyl-5-(methylamino)pentyl]oxy]-6-nitro-2(1H)-qu...
C17H25N3O4
2390553-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 5.3901 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 C 8.0022 5.3901 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 C 9.3358 4.6201 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 N 13.3370 5.3901 0.0 0
M  V30 9 C 14.6707 4.6201 0.0 0
M  V30 10 C 4.0010 7.7002 0.0 0
M  V30 11 O 1.3337 9.2402 0.0 0
M  V30 12 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 13 O 4.0010 0.0000 0.0 0
M  V30 14 O 1.3337 0.0000 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 C 4.0010 4.6201 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 N 2.6673 6.9302 0.0 0
M  V30 19 C 4.0010 3.0801 0.0 0
M  V30 20 C 1.3337 3.0801 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 22 C 1.3337 7.7002 0.0 0
M  V30 23 C 2.6673 2.3101 0.0 0
M  V30 24 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 18
M  V30 11 2 11 22
M  V30 12 2 12 13
M  V30 13 2 12 14
M  V30 14 1 12 23
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 2 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 2 19 23
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2369632-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2390553-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25032597
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based
Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic
Macrocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Balazs, Amber Y. S.; Carbajo, Rodrigo J.; Davies, Nichola L.; Dong, Yu;
Hird, Alexander W.; Johannes, Jeffrey W.; Lamb, Michelle L.; McCoull,
William; Raubo, Piotr; Robb, Graeme R.; Packer, Martin J.; Chiarparin,
Elisabetta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(21), 9418-9437

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylethyl 5-hydroxy-4-[4-(1-methylethyl)phenyl]-6-oxo-6H-1,2-oxazine-3-ca...
C17H19NO5
2388985-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 O 8.4700 5.3347 0.0 0
M  V30 3 O 6.1600 6.6684 0.0 0
M  V30 4 C 9.2400 6.6684 0.0 0
M  V30 5 C 10.7800 6.6684 0.0 0
M  V30 6 C 8.4700 8.0021 0.0 0
M  V30 7 O 2.3100 2.6673 0.0 0
M  V30 8 O 3.8500 0.0000 0.0 0
M  V30 9 C 1.5400 9.3358 0.0 0
M  V30 10 C 2.3100 10.6694 0.0 0
M  V30 11 C 0.0000 9.3358 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 3.8500 2.6673 0.0 0
M  V30 15 N 6.9300 2.6673 0.0 0
M  V30 16 C 4.6200 1.3336 0.0 0
M  V30 17 O 6.1600 1.3336 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 4.6200 6.6684 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 3.8500 8.0021 0.0 0
M  V30 22 C 1.5400 6.6684 0.0 0
M  V30 23 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 14
M  V30 8 2 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 23
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 18
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylethyl 5-[(methylamino)carbonyl]-4-[4-(1-methylethyl)phenyl]-3-isoxazo...
C18H22N2O4
2388986-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2494 7.2317 0.0 0
M  V30 2 O 1.7849 7.7075 0.0 0
M  V30 3 O 4.3939 8.2621 0.0 0
M  V30 4 C 1.4647 9.2138 0.0 0
M  V30 5 C 0.0000 9.6897 0.0 0
M  V30 6 C 2.6091 10.2444 0.0 0
M  V30 7 C 5.9600 2.5368 0.0 0
M  V30 8 N 5.6398 1.0306 0.0 0
M  V30 9 O 7.4246 3.0127 0.0 0
M  V30 10 C 6.7842 0.0000 0.0 0
M  V30 11 C 10.3112 8.1789 0.0 0
M  V30 12 C 10.3112 9.7189 0.0 0
M  V30 13 C 11.6449 7.4089 0.0 0
M  V30 14 C 4.9765 5.0989 0.0 0
M  V30 15 C 3.5696 5.7253 0.0 0
M  V30 16 C 4.8154 3.5674 0.0 0
M  V30 17 N 2.5392 4.5809 0.0 0
M  V30 18 O 3.3092 3.2471 0.0 0
M  V30 19 C 6.3102 5.8689 0.0 0
M  V30 20 C 7.6438 5.0989 0.0 0
M  V30 21 C 6.3102 7.4089 0.0 0
M  V30 22 C 8.9776 5.8689 0.0 0
M  V30 23 C 7.6438 8.1789 0.0 0
M  V30 24 C 8.9776 7.4089 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 24
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 19
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2388985-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2388986-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20733389
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitroacetic Esters in the Regioselective Synthesis of
Isoxazole-3,5-dicarboxylic Acid Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smirnov, Alexander Yu; Zaitseva, Elvira R.; Belozerova, Olga A.;
Alekseyev, Roman S.; Baleeva, Nadezhda S.; Zagudaylova, Marina B.;
Mikhaylov, Andrey A.; Baranov, Mikhail S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2019), 84(23), 15417-15428

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 7-(4-formylphenoxy)heptanoate
C15H20O4
2421119-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0035 3.0801 0.0 0
M  V30 6 C 13.3372 2.3101 0.0 0
M  V30 7 C 14.6708 3.0801 0.0 0
M  V30 8 C 16.0045 2.3101 0.0 0
M  V30 9 O 17.3383 3.0801 0.0 0
M  V30 10 O 16.0045 0.7700 0.0 0
M  V30 11 C 18.6720 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 O 0.0000 0.7700 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 2.6675 2.3101 0.0 0
M  V30 19 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 7-[4-[(methylamino)methyl]phenoxy]heptanoate
C16H25NO3
2454243-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 C 12.0033 2.3101 0.0 0
M  V30 5 C 13.3372 3.0801 0.0 0
M  V30 6 C 14.6708 2.3101 0.0 0
M  V30 7 C 16.0045 3.0801 0.0 0
M  V30 8 C 17.3382 2.3101 0.0 0
M  V30 9 O 18.6720 3.0801 0.0 0
M  V30 10 O 17.3382 0.7700 0.0 0
M  V30 11 C 20.0057 2.3101 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 N 1.3337 0.7700 0.0 0
M  V30 14 C 0.0000 0.0000 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 C 4.0012 2.3101 0.0 0
M  V30 20 C 4.0012 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 20
M  V30 14 1 13 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2421119-08-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454243-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357536
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME72 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C48H48FeN8O8
2422968-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  65 76 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3892 14.3711 0.0 0
M  V30 2 C 4.6192 15.7048 0.0 0
M  V30 3 C 5.3892 17.0385 0.0 0
M  V30 4 O 2.2788 9.0543 0.0 0
M  V30 5 C 0.7392 9.0896 0.0 0
M  V30 6 C 0.0000 10.4407 0.0 0
M  V30 7 O 15.3298 8.6319 0.0 0
M  V30 8 C 16.8698 8.6319 0.0 0
M  V30 9 C 17.6399 7.2982 0.0 0
M  V30 10 O 12.2497 3.2971 0.0 0
M  V30 11 C 13.0198 1.9634 0.0 0
M  V30 12 C 12.2497 0.6297 0.0 0
M  V30 13 O 8.5449 2.2788 0.0 0
M  V30 14 C 8.5096 0.7392 0.0 0
M  V30 15 C 7.1585 0.0000 0.0 0
M  V30 16 O 3.2281 5.3892 0.0 0
M  V30 17 C 1.8944 4.6192 0.0 0
M  V30 18 C 0.5607 5.3892 0.0 0
M  V30 19 O 14.3195 12.2805 0.0 0
M  V30 20 C 15.6352 13.0810 0.0 0
M  V30 21 C 16.9863 12.3418 0.0 0
M  V30 22 O 8.9673 15.3298 0.0 0
M  V30 23 C 8.9673 16.8698 0.0 0
M  V30 24 C 10.3010 17.6399 0.0 0
M  V30 25 Fe 8.7996 8.7996 0.0 0 CHG=2 VAL=4
M  V30 26 N 7.1977 9.7245 0.0 0 CHG=-1 VAL=3
M  V30 27 N 10.4015 7.8748 0.0 0 CHG=-1 VAL=3
M  V30 28 N 7.8748 7.1977 0.0 0 VAL=4
M  V30 29 N 9.7245 10.4015 0.0 0 VAL=4
M  V30 30 C 6.8160 11.1622 0.0 0
M  V30 31 C 5.7617 9.3361 0.0 0
M  V30 32 C 11.8375 8.2631 0.0 0
M  V30 33 C 10.7833 6.4370 0.0 0
M  V30 34 C 8.2631 5.7617 0.0 0
M  V30 35 C 6.4370 6.8160 0.0 0
M  V30 36 C 11.1622 10.7833 0.0 0
M  V30 37 C 9.3361 11.8375 0.0 0
M  V30 38 C 5.3893 11.7036 0.0 0
M  V30 39 N 7.9363 12.0215 0.0 0
M  V30 40 C 4.5794 10.3010 0.0 0
M  V30 41 N 5.5778 7.9364 0.0 0
M  V30 42 C 13.0198 7.2982 0.0 0
M  V30 43 N 12.0215 9.6629 0.0 0
M  V30 44 C 12.2497 5.9646 0.0 0
M  V30 45 N 9.6629 5.5778 0.0 0
M  V30 46 C 7.2982 4.5794 0.0 0
M  V30 47 C 5.8956 5.3893 0.0 0
M  V30 48 C 11.7036 12.2100 0.0 0
M  V30 49 C 10.3010 13.0198 0.0 0
M  V30 50 C 4.6192 13.0375 0.0 0
M  V30 51 C 3.0793 10.3700 0.0 0
M  V30 52 C 14.5598 7.2982 0.0 0
M  V30 53 C 13.0198 4.6307 0.0 0
M  V30 54 C 7.2292 3.0793 0.0 0
M  V30 55 C 4.5619 4.6192 0.0 0
M  V30 56 C 12.9685 13.0198 0.0 0
M  V30 57 C 10.3010 14.5598 0.0 0
M  V30 58 C 3.0793 13.0375 0.0 0
M  V30 59 C 2.3091 11.7036 0.0 0
M  V30 60 C 15.3298 5.9646 0.0 0
M  V30 61 C 14.5598 4.6307 0.0 0
M  V30 62 C 5.8956 2.3091 0.0 0
M  V30 63 C 4.5619 3.0791 0.0 0
M  V30 64 C 12.9685 14.5598 0.0 0
M  V30 65 C 11.6348 15.3298 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 50
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 51
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 52
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 53
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 54
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 55
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 56
M  V30 21 1 20 21
M  V30 22 1 22 23
M  V30 23 1 22 57
M  V30 24 1 23 24
M  V30 25 1 25 26
M  V30 26 1 25 27
M  V30 27 1 25 28
M  V30 28 1 25 29
M  V30 29 1 26 30
M  V30 30 1 26 31
M  V30 31 1 27 32
M  V30 32 1 27 33
M  V30 33 1 28 34
M  V30 34 2 28 35
M  V30 35 1 29 36
M  V30 36 2 29 37
M  V30 37 1 30 38
M  V30 38 2 30 39
M  V30 39 1 31 40
M  V30 40 2 31 41
M  V30 41 2 32 42
M  V30 42 1 32 43
M  V30 43 2 33 44
M  V30 44 1 33 45
M  V30 45 2 34 45
M  V30 46 1 34 46
M  V30 47 1 35 41
M  V30 48 1 35 47
M  V30 49 2 36 43
M  V30 50 1 36 48
M  V30 51 1 37 39
M  V30 52 1 37 49
M  V30 53 1 38 40
M  V30 54 2 38 50
M  V30 55 2 40 51
M  V30 56 1 42 44
M  V30 57 1 42 52
M  V30 58 1 44 53
M  V30 59 1 46 47
M  V30 60 2 46 54
M  V30 61 2 47 55
M  V30 62 1 48 49
M  V30 63 2 48 56
M  V30 64 2 49 57
M  V30 65 1 50 58
M  V30 66 1 51 59
M  V30 67 2 52 60
M  V30 68 2 53 61
M  V30 69 1 54 62
M  V30 70 1 55 63
M  V30 71 1 56 64
M  V30 72 1 57 65
M  V30 73 2 58 59
M  V30 74 1 60 61
M  V30 75 2 62 63
M  V30 76 2 64 65
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dichloromethane
CH2Cl2
75-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 Cl 0.0000 0.7700 0.0 0
M  V30 3 Cl 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C50H58FeN10O8.2CH2Cl2
2642218-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  72 82 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5041 2.3100 0.0 0 VAL=4
M  V30 2 C 6.1362 3.1004 0.0 0
M  V30 3 N 1.1518 16.8473 0.0 0 VAL=4
M  V30 4 C 0.0000 16.1795 0.0 0
M  V30 5 O 10.2529 18.5120 0.0 0
M  V30 6 C 11.2691 17.9281 0.0 0
M  V30 7 C 12.2821 18.5120 0.0 0
M  V30 8 O 5.1361 18.5539 0.0 0
M  V30 9 C 4.1231 17.9700 0.0 0
M  V30 10 C 3.1101 18.5539 0.0 0
M  V30 11 O 10.2206 7.2461 0.0 0
M  V30 12 C 11.2336 6.6622 0.0 0
M  V30 13 C 12.2467 7.2461 0.0 0
M  V30 14 O 5.1039 7.2042 0.0 0
M  V30 15 C 4.0908 6.6202 0.0 0
M  V30 16 C 3.0778 7.2042 0.0 0
M  V30 17 O 2.0486 9.5916 0.0 0
M  V30 18 C 1.0356 9.0044 0.0 0
M  V30 19 C 0.0226 9.5916 0.0 0
M  V30 20 O 2.0938 15.0245 0.0 0
M  V30 21 C 1.0808 15.6084 0.0 0
M  V30 22 C 0.0678 15.0245 0.0 0
M  V30 23 O 13.1177 9.6819 0.0 0
M  V30 24 C 12.1047 9.0979 0.0 0
M  V30 25 C 11.0917 9.6819 0.0 0
M  V30 26 O 13.0726 15.1148 0.0 0
M  V30 27 C 12.0595 15.6988 0.0 0
M  V30 28 C 11.0465 15.1148 0.0 0
M  V30 29 Fe 7.6396 12.3048 0.0 0 CHG=2 VAL=6
M  V30 30 N 7.5977 14.1921 0.0 0 CHG=-1 VAL=3
M  V30 31 N 7.6364 10.3820 0.0 0 CHG=-1 VAL=3
M  V30 32 N 5.7426 12.2725 0.0 0 VAL=4
M  V30 33 N 9.4850 12.3048 0.0 0 VAL=4
M  V30 34 C 8.6882 15.2826 0.0 0
M  V30 35 C 6.5556 15.2987 0.0 0
M  V30 36 C 8.6946 9.3786 0.0 0
M  V30 37 C 6.5395 9.2915 0.0 0
M  V30 38 C 4.6490 11.1788 0.0 0
M  V30 39 C 4.6651 13.4081 0.0 0
M  V30 40 C 10.5852 11.2692 0.0 0
M  V30 41 C 10.5755 13.3920 0.0 0
M  V30 42 C 8.4462 16.5989 0.0 0
M  V30 43 N 10.1787 14.8825 0.0 0
M  V30 44 C 6.9073 16.6182 0.0 0
M  V30 45 N 5.0684 14.9051 0.0 0
M  V30 46 C 8.4139 7.9914 0.0 0
M  V30 47 N 10.1883 9.7819 0.0 0
M  V30 48 C 6.8718 7.9688 0.0 0
M  V30 49 N 5.0522 9.6916 0.0 0
M  V30 50 C 3.4004 11.5176 0.0 0
M  V30 51 C 3.4230 13.0597 0.0 0
M  V30 52 C 11.7660 11.6079 0.0 0
M  V30 53 C 11.7434 13.1501 0.0 0
M  V30 54 C 9.2398 17.9281 0.0 0
M  V30 55 C 6.1491 17.9700 0.0 0
M  V30 56 C 9.2076 6.6622 0.0 0
M  V30 57 C 6.1169 6.6202 0.0 0
M  V30 58 C 2.0486 10.7627 0.0 0
M  V30 59 C 2.0938 13.8534 0.0 0
M  V30 60 C 13.1177 10.8530 0.0 0
M  V30 61 C 13.0726 13.9437 0.0 0
M  V30 62 C 8.4914 19.2766 0.0 0
M  V30 63 C 6.9428 19.2992 0.0 0
M  V30 64 C 8.4526 5.3104 0.0 0
M  V30 65 C 6.9105 5.2878 0.0 0
M  V30 66 C 0.7194 11.5563 0.0 0
M  V30 67 C 0.7420 13.1017 0.0 0
M  V30 68 C 14.4437 11.6466 0.0 0
M  V30 69 C 14.4243 13.1888 0.0 0
M  V30 70 C 7.2219 0.0000 0.0 0
M  V30 71 Cl 5.8882 0.7700 0.0 0
M  V30 72 Cl 8.5555 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 29
M  V30 3 1 3 4
M  V30 4 1 3 29
M  V30 5 1 5 6
M  V30 6 1 5 54
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 55
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 56
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 57
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 58
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 1 20 59
M  V30 22 1 21 22
M  V30 23 1 23 24
M  V30 24 1 23 60
M  V30 25 1 24 25
M  V30 26 1 26 27
M  V30 27 1 26 61
M  V30 28 1 27 28
M  V30 29 1 29 30
M  V30 30 1 29 31
M  V30 31 1 29 32
M  V30 32 1 29 33
M  V30 33 1 30 34
M  V30 34 1 30 35
M  V30 35 1 31 36
M  V30 36 1 31 37
M  V30 37 1 32 38
M  V30 38 2 32 39
M  V30 39 1 33 40
M  V30 40 2 33 41
M  V30 41 1 34 42
M  V30 42 2 34 43
M  V30 43 1 35 44
M  V30 44 2 35 45
M  V30 45 2 36 46
M  V30 46 1 36 47
M  V30 47 2 37 48
M  V30 48 1 37 49
M  V30 49 2 38 49
M  V30 50 1 38 50
M  V30 51 1 39 45
M  V30 52 1 39 51
M  V30 53 2 40 47
M  V30 54 1 40 52
M  V30 55 1 41 43
M  V30 56 1 41 53
M  V30 57 1 42 44
M  V30 58 2 42 54
M  V30 59 2 44 55
M  V30 60 1 46 48
M  V30 61 1 46 56
M  V30 62 1 48 57
M  V30 63 1 50 51
M  V30 64 2 50 58
M  V30 65 2 51 59
M  V30 66 1 52 53
M  V30 67 2 52 60
M  V30 68 2 53 61
M  V30 69 1 54 62
M  V30 70 1 55 63
M  V30 71 2 56 64
M  V30 72 2 57 65
M  V30 73 1 58 66
M  V30 74 1 59 67
M  V30 75 1 60 68
M  V30 76 1 61 69
M  V30 77 2 62 63
M  V30 78 1 64 65
M  V30 79 2 66 67
M  V30 80 2 68 69
M  V30 81 1 70 71
M  V30 82 1 70 72
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2422968-92-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2642218-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-23774984
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM glove box used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multiple N-H and C-H Hydrogen Atom Abstractions Through
Coordination-Induced Bond Weakening at Fe-Amine Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zongheng; Johnson, Samantha I.; Wu, Guang; Menard, Gabriel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2021), 60(11), 8242-8251

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C27H33N3O4
2431983-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.2308 0.0 0
M  V30 2 C 6.6685 6.7708 0.0 0 CFG=2
M  V30 3 C 5.3347 7.5408 0.0 0
M  V30 4 N 8.0021 7.5408 0.0 0
M  V30 5 N 5.3347 9.0808 0.0 0
M  V30 6 O 4.0011 6.7708 0.0 0
M  V30 7 C 9.3358 6.7708 0.0 0
M  V30 8 C 4.0011 9.8508 0.0 0 CFG=1
M  V30 9 C 10.6696 7.5408 0.0 0
M  V30 10 O 9.3358 5.2308 0.0 0
M  V30 11 C 4.0011 11.3908 0.0 0
M  V30 12 C 2.6674 9.0808 0.0 0
M  V30 13 C 12.0032 6.7708 0.0 0
M  V30 14 O 5.3349 12.1608 0.0 0
M  V30 15 O 2.6674 12.1608 0.0 0
M  V30 16 C 1.3338 9.8508 0.0 0
M  V30 17 C 5.3349 13.7008 0.0 0
M  V30 18 C 0.0000 9.0808 0.0 0
M  V30 19 C 1.3338 11.3908 0.0 0
M  V30 20 C 5.3347 4.4608 0.0 0
M  V30 21 C 5.1738 2.9292 0.0 0
M  V30 22 C 3.9279 5.0872 0.0 0
M  V30 23 C 3.6675 2.6091 0.0 0
M  V30 24 C 6.2044 1.7849 0.0 0
M  V30 25 N 2.8975 3.9427 0.0 0
M  V30 26 C 3.1917 1.1444 0.0 0
M  V30 27 C 5.7283 0.3202 0.0 0
M  V30 28 C 4.2221 0.0000 0.0 0
M  V30 29 C 13.3369 7.5408 0.0 0
M  V30 30 C 13.3369 9.0808 0.0 0
M  V30 31 C 14.6705 6.7708 0.0 0
M  V30 32 C 14.6705 9.8508 0.0 0
M  V30 33 C 16.0043 7.5408 0.0 0
M  V30 34 C 16.0043 9.0808 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 29
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C27H34N4O3
2431983-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.2308 0.0 0
M  V30 2 C 6.6685 6.7708 0.0 0 CFG=2
M  V30 3 C 5.3347 7.5408 0.0 0
M  V30 4 N 8.0021 7.5408 0.0 0
M  V30 5 N 5.3347 9.0808 0.0 0
M  V30 6 O 4.0011 6.7708 0.0 0
M  V30 7 C 9.3358 6.7708 0.0 0
M  V30 8 C 4.0011 9.8508 0.0 0 CFG=1
M  V30 9 C 10.6696 7.5408 0.0 0
M  V30 10 O 9.3358 5.2308 0.0 0
M  V30 11 C 4.0011 11.3908 0.0 0
M  V30 12 C 2.6674 9.0808 0.0 0
M  V30 13 C 12.0032 6.7708 0.0 0
M  V30 14 N 5.3349 12.1608 0.0 0
M  V30 15 O 2.6674 12.1608 0.0 0
M  V30 16 C 1.3338 9.8508 0.0 0
M  V30 17 C 5.3349 13.7008 0.0 0
M  V30 18 C 0.0000 9.0808 0.0 0
M  V30 19 C 1.3338 11.3908 0.0 0
M  V30 20 C 5.3347 4.4608 0.0 0
M  V30 21 C 5.1738 2.9292 0.0 0
M  V30 22 C 3.9279 5.0872 0.0 0
M  V30 23 C 3.6675 2.6091 0.0 0
M  V30 24 C 6.2044 1.7849 0.0 0
M  V30 25 N 2.8975 3.9427 0.0 0
M  V30 26 C 3.1917 1.1444 0.0 0
M  V30 27 C 5.7283 0.3202 0.0 0
M  V30 28 C 4.2221 0.0000 0.0 0
M  V30 29 C 13.3369 7.5408 0.0 0
M  V30 30 C 14.6705 6.7708 0.0 0
M  V30 31 C 13.3369 9.0808 0.0 0
M  V30 32 C 16.0043 7.5408 0.0 0
M  V30 33 C 14.6705 9.8508 0.0 0
M  V30 34 C 16.0043 9.0808 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 2 1 CFG=1
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12 CFG=1
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 29
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2431983-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2431983-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23162381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 925-93-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The new dipeptide TSPOa ligands: design, synthesis and
structure-anxiolytic activity relationship
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gudasheva, Tatiana A.; Deeva, Olga A.; Pantileev, Andrey S.; Mokrov,
Grigory V.; Rybina, Inna V.; Yarkova, Milada A.; Seredenin, Sergei B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2020), 25(21), 5132

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[2-fluoro-3-(2-methyl-5-oxazolyl)phenyl]-7-[(1-methyl-1H-pyrazol-3-y...
C23H19FN6O3
2434720-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 10.6376 0.0 0
M  V30 2 O 0.7700 10.6376 0.0 0
M  V30 3 O 3.0800 11.9712 0.0 0
M  V30 4 C 0.0000 11.9712 0.0 0
M  V30 5 N 5.3901 5.3028 0.0 0
M  V30 6 F 9.7248 8.2819 0.0 0
M  V30 7 C 4.2629 0.0000 0.0 0
M  V30 8 C 16.3612 9.4648 0.0 0
M  V30 9 C 4.6201 9.3037 0.0 0
M  V30 10 C 5.3901 7.9701 0.0 0
M  V30 11 C 3.0800 9.3037 0.0 0
M  V30 12 C 5.6505 10.4483 0.0 0
M  V30 13 C 4.6201 6.6364 0.0 0
M  V30 14 N 6.8965 8.2902 0.0 0
M  V30 15 C 2.3100 7.9701 0.0 0
M  V30 16 C 7.0575 9.8220 0.0 0
M  V30 17 N 3.0800 6.6364 0.0 0
M  V30 18 C 8.3911 10.5920 0.0 0
M  V30 19 C 9.7248 9.8220 0.0 0
M  V30 20 C 8.3911 12.1320 0.0 0
M  V30 21 C 11.0586 10.5920 0.0 0
M  V30 22 C 9.7248 12.9020 0.0 0
M  V30 23 C 11.0586 12.1320 0.0 0
M  V30 24 C 4.6201 3.9689 0.0 0
M  V30 25 C 3.0885 3.8080 0.0 0
M  V30 26 N 5.2464 2.5621 0.0 0
M  V30 27 C 2.7683 2.3017 0.0 0
M  V30 28 N 4.1020 1.5317 0.0 0
M  V30 29 C 12.3923 9.8220 0.0 0
M  V30 30 C 12.5532 8.2902 0.0 0
M  V30 31 O 13.7991 10.4483 0.0 0
M  V30 32 N 14.0596 7.9701 0.0 0
M  V30 33 C 14.8296 9.3037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 5 24
M  V30 7 1 6 19
M  V30 8 1 7 28
M  V30 9 1 8 33
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 21 29
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-Fluoro-3-(2-methyl-5-oxazolyl)phenyl]-N-methyl-7-[(1-methyl-1H-pyrazol-3...
C23H20FN7O2
2434715-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 10.6376 0.0 0
M  V30 2 N 0.7700 10.6376 0.0 0
M  V30 3 O 3.0800 11.9712 0.0 0
M  V30 4 C 0.0000 11.9712 0.0 0
M  V30 5 N 5.3901 5.3028 0.0 0
M  V30 6 F 9.7248 8.2819 0.0 0
M  V30 7 C 4.2629 0.0000 0.0 0
M  V30 8 C 16.3612 9.4648 0.0 0
M  V30 9 C 4.6201 9.3037 0.0 0
M  V30 10 C 5.3901 7.9701 0.0 0
M  V30 11 C 3.0800 9.3037 0.0 0
M  V30 12 C 5.6505 10.4483 0.0 0
M  V30 13 C 4.6201 6.6364 0.0 0
M  V30 14 N 6.8965 8.2902 0.0 0
M  V30 15 C 2.3100 7.9701 0.0 0
M  V30 16 C 7.0575 9.8220 0.0 0
M  V30 17 N 3.0800 6.6364 0.0 0
M  V30 18 C 8.3911 10.5920 0.0 0
M  V30 19 C 9.7248 9.8220 0.0 0
M  V30 20 C 8.3911 12.1320 0.0 0
M  V30 21 C 11.0586 10.5920 0.0 0
M  V30 22 C 9.7248 12.9020 0.0 0
M  V30 23 C 11.0586 12.1320 0.0 0
M  V30 24 C 4.6201 3.9689 0.0 0
M  V30 25 C 3.0885 3.8080 0.0 0
M  V30 26 N 5.2464 2.5621 0.0 0
M  V30 27 C 2.7683 2.3017 0.0 0
M  V30 28 N 4.1020 1.5317 0.0 0
M  V30 29 C 12.3923 9.8220 0.0 0
M  V30 30 C 12.5532 8.2902 0.0 0
M  V30 31 O 13.7991 10.4483 0.0 0
M  V30 32 N 14.0596 7.9701 0.0 0
M  V30 33 C 14.8296 9.3037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 5 24
M  V30 7 1 6 19
M  V30 8 1 7 28
M  V30 9 1 8 33
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 21 29
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2434720-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2434715-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22479505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azaindzoles as TYK2 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greenwood, Jeremy Robert; Masse, Craig E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020112937 A1 2020-06-04

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[trans-3-[3-[(methylsulfonyl)oxy]propoxy]cyclobutyl]-, 1,1-d...
C13H25NO6S
2434850-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.5637 0.0 0
M  V30 2 C 4.0012 1.3337 0.0 0
M  V30 3 O 2.6673 0.5637 0.0 0
M  V30 4 O 4.0012 2.8737 0.0 0
M  V30 5 C 1.3337 1.3337 0.0 0
M  V30 6 C 0.5637 0.0000 0.0 0
M  V30 7 C 0.0000 2.1037 0.0 0
M  V30 8 C 2.1037 2.6675 0.0 0
M  V30 9 O 9.8884 3.1928 0.0 0
M  V30 10 C 11.2221 2.4228 0.0 0
M  V30 11 C 12.5557 3.1928 0.0 0
M  V30 12 C 13.8894 2.4228 0.0 0
M  V30 13 O 15.2232 3.1928 0.0 0
M  V30 14 S 16.5569 2.4228 0.0 0 VAL=6
M  V30 15 C 17.3269 3.7564 0.0 0
M  V30 16 O 17.8906 1.6528 0.0 0
M  V30 17 O 15.7869 1.0890 0.0 0
M  V30 18 C 6.6685 1.3337 0.0 0 CFG=1
M  V30 19 C 7.0671 2.8213 0.0 0
M  V30 20 C 8.1560 0.9351 0.0 0
M  V30 21 C 8.5546 2.4228 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 21 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 14 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 18 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[trans-3-[3-(methylamino)propoxy]cyclobutyl]-, 1,1-dimethyle...
C13H26N2O3
2434850-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.5638 0.0 0
M  V30 2 C 4.0012 1.3338 0.0 0
M  V30 3 O 2.6673 0.5638 0.0 0
M  V30 4 O 4.0012 2.8739 0.0 0
M  V30 5 C 1.3337 1.3338 0.0 0
M  V30 6 C 2.1037 2.6675 0.0 0
M  V30 7 C 0.0000 2.1038 0.0 0
M  V30 8 C 0.5637 0.0000 0.0 0
M  V30 9 O 9.8884 3.1928 0.0 0
M  V30 10 C 11.2221 2.4228 0.0 0
M  V30 11 C 12.5557 3.1928 0.0 0
M  V30 12 C 13.8896 2.4228 0.0 0
M  V30 13 N 15.2232 3.1928 0.0 0
M  V30 14 C 16.5569 2.4228 0.0 0
M  V30 15 C 6.6685 1.3338 0.0 0 CFG=1
M  V30 16 C 7.0671 2.8213 0.0 0
M  V30 17 C 8.1560 0.9351 0.0 0
M  V30 18 C 8.5547 2.4228 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 18 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2434850-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2434850-01-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23737809
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020264499 A1 2020-12-30

$RFMT $RIREG SCHEME76 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Acetyl-6-bromonorleucine ethyl ester
C10H18BrNO3
757233-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0
M  V30 4 N 5.3900 2.6674 0.0 0
M  V30 5 O 2.3100 5.3347 0.0 0
M  V30 6 O 2.3100 2.6674 0.0 0
M  V30 7 C 6.9300 5.3347 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 C 0.7700 5.3347 0.0 0
M  V30 10 C 7.7000 6.6685 0.0 0
M  V30 11 C 3.0800 1.3336 0.0 0
M  V30 12 O 5.3900 0.0000 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 Br 10.0100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-Acetyl-N6-[(1,1-dimethylethoxy)carbonyl]-N6-methyllysine ethyl ester
C16H30N2O5
1238313-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 N 5.3900 2.6674 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 O 2.3100 5.3347 0.0 0
M  V30 7 O 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 C 7.7000 6.6684 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 O 3.0800 1.3336 0.0 0
M  V30 13 C 9.2400 6.6684 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 N 10.0100 8.0021 0.0 0
M  V30 16 C 11.5500 8.0021 0.0 0
M  V30 17 C 9.2400 9.3358 0.0 0
M  V30 18 O 12.3200 9.3358 0.0 0
M  V30 19 O 12.3200 6.6684 0.0 0
M  V30 20 C 13.8600 9.3358 0.0 0
M  V30 21 C 13.8600 7.7958 0.0 0
M  V30 22 C 15.4000 9.3358 0.0 0
M  V30 23 C 13.8600 10.8758 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 18 20
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 757233-09-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1238313-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17605492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient preparation of Nε-methyl-L-lysine derivatives and its
application to the synthesis of histone tail peptides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chi, Hongfang; Islam, Shahidul Md.; Nsiama, Tienabe K.; Kato, Tamaki;
Nishino, Norikazu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Amino Acids (2014), 46(5), 1305-1311

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[4-(4-formylphenyl)butoxy]benzeneacetate
C20H22O4
2454237-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 0.0000 0.0 0
M  V30 2 C 10.6697 0.7700 0.0 0
M  V30 3 C 12.0033 0.0000 0.0 0
M  V30 4 C 13.3372 0.7700 0.0 0
M  V30 5 C 14.6708 0.0000 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 20.0057 3.0801 0.0 0
M  V30 12 O 21.3393 2.3101 0.0 0
M  V30 13 C 8.0022 0.7700 0.0 0
M  V30 14 C 6.6685 0.0000 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 16.0045 0.7700 0.0 0
M  V30 20 C 16.0045 2.3101 0.0 0
M  V30 21 C 17.3382 0.0000 0.0 0
M  V30 22 C 17.3382 3.0801 0.0 0
M  V30 23 C 18.6720 0.7700 0.0 0
M  V30 24 C 18.6720 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[4-[4-[(methylamino)methyl]phenyl]butoxy]benzeneacetate
C21H27NO3
2454237-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 0.0000 0.0 0
M  V30 2 C 10.6697 0.7700 0.0 0
M  V30 3 C 12.0033 0.0000 0.0 0
M  V30 4 C 13.3370 0.7700 0.0 0
M  V30 5 C 14.6708 0.0000 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 20.0057 3.0801 0.0 0
M  V30 12 N 21.3393 2.3101 0.0 0
M  V30 13 C 22.6730 3.0801 0.0 0
M  V30 14 C 8.0022 0.7700 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 6.6685 0.0000 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 16.0045 0.7700 0.0 0
M  V30 21 C 17.3382 0.0000 0.0 0
M  V30 22 C 16.0045 2.3101 0.0 0
M  V30 23 C 18.6718 0.7700 0.0 0
M  V30 24 C 17.3382 3.0801 0.0 0
M  V30 25 C 18.6718 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454237-95-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454237-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(4-formylphenoxy)propoxy]benzenepropanoate
C20H22O5
2454238-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.3382 1.5400 0.0 0
M  V30 2 C 18.6718 2.3101 0.0 0
M  V30 3 C 20.0057 1.5400 0.0 0
M  V30 4 O 21.3393 2.3101 0.0 0
M  V30 5 O 20.0057 0.0000 0.0 0
M  V30 6 C 22.6730 1.5400 0.0 0
M  V30 7 O 12.0033 4.6201 0.0 0
M  V30 8 C 10.6697 3.8501 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 O 6.6685 4.6201 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 O 0.0000 2.3101 0.0 0
M  V30 14 C 16.0045 2.3101 0.0 0
M  V30 15 C 16.0045 3.8501 0.0 0
M  V30 16 C 14.6708 1.5400 0.0 0
M  V30 17 C 14.6708 4.6201 0.0 0
M  V30 18 C 13.3370 2.3101 0.0 0
M  V30 19 C 13.3370 3.8501 0.0 0
M  V30 20 C 5.3348 3.8501 0.0 0
M  V30 21 C 5.3348 2.3101 0.0 0
M  V30 22 C 4.0012 4.6201 0.0 0
M  V30 23 C 4.0012 1.5400 0.0 0
M  V30 24 C 2.6673 3.8501 0.0 0
M  V30 25 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 20
M  V30 13 2 12 13
M  V30 14 1 12 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[4-[(methylamino)methyl]phenoxy]propoxy]benzenepropanoate
C21H27NO4
2454238-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.6697 4.6201 0.0 0
M  V30 2 C 12.0033 3.8501 0.0 0
M  V30 3 C 13.3370 4.6201 0.0 0
M  V30 4 C 14.6708 3.8501 0.0 0
M  V30 5 O 16.0045 4.6201 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 O 1.3337 2.3101 0.0 0
M  V30 10 O 2.6673 0.0000 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 21.3393 1.5400 0.0 0
M  V30 13 N 22.6730 2.3101 0.0 0
M  V30 14 C 24.0067 1.5400 0.0 0
M  V30 15 C 9.3358 3.8501 0.0 0
M  V30 16 C 9.3358 2.3101 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 8.0022 1.5400 0.0 0
M  V30 19 C 6.6685 3.8501 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 17.3382 3.8501 0.0 0
M  V30 22 C 17.3382 2.3101 0.0 0
M  V30 23 C 18.6718 4.6201 0.0 0
M  V30 24 C 18.6718 1.5400 0.0 0
M  V30 25 C 20.0057 3.8501 0.0 0
M  V30 26 C 20.0057 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454238-04-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454238-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357567
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(2-formylphenoxy)propoxy]benzoate
C18H18O5
2454240-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 O 9.2400 6.6684 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 C 15.4000 6.6685 0.0 0
M  V30 9 O 16.1700 8.0021 0.0 0
M  V30 10 O 16.1700 5.3347 0.0 0
M  V30 11 C 17.7100 8.0021 0.0 0
M  V30 12 C 3.8500 2.6674 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 4.6200 1.3336 0.0 0
M  V30 15 C 1.5400 1.3336 0.0 0
M  V30 16 C 3.8500 0.0000 0.0 0
M  V30 17 C 2.3100 0.0000 0.0 0
M  V30 18 C 10.7800 6.6685 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 11.5500 8.0021 0.0 0
M  V30 21 C 13.0900 5.3347 0.0 0
M  V30 22 C 13.0900 8.0021 0.0 0
M  V30 23 C 13.8600 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 18
M  V30 7 2 6 7
M  V30 8 1 6 13
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 23
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[2-[(methylamino)methyl]phenoxy]propoxy]benzoate
C19H23NO4
2454235-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 10.0100 6.6685 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 C 16.1700 6.6684 0.0 0
M  V30 10 O 16.9400 8.0021 0.0 0
M  V30 11 O 16.9400 5.3347 0.0 0
M  V30 12 C 18.4800 8.0021 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 5.3900 1.3336 0.0 0
M  V30 16 C 2.3100 1.3336 0.0 0
M  V30 17 C 4.6200 0.0000 0.0 0
M  V30 18 C 3.0800 0.0000 0.0 0
M  V30 19 C 11.5500 6.6685 0.0 0
M  V30 20 C 12.3200 8.0021 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 22 C 13.8600 8.0021 0.0 0
M  V30 23 C 13.8600 5.3347 0.0 0
M  V30 24 C 14.6300 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 14
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 10 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454240-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454235-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[[4-(4-formylphenyl)-1-oxobutyl]amino]benzeneacetate
C20H21NO4
2454240-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 0.0000 0.0 0
M  V30 2 C 10.6697 0.7700 0.0 0
M  V30 3 C 12.0033 0.0000 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 C 13.3372 0.7700 0.0 0
M  V30 6 C 14.6708 0.0000 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 O 1.3337 3.0801 0.0 0
M  V30 10 O 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 20.0057 3.0801 0.0 0
M  V30 13 O 21.3393 2.3101 0.0 0
M  V30 14 C 8.0022 0.7700 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 6.6685 0.0000 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 16.0045 0.7700 0.0 0
M  V30 21 C 17.3382 0.0000 0.0 0
M  V30 22 C 16.0045 2.3101 0.0 0
M  V30 23 C 18.6720 0.7700 0.0 0
M  V30 24 C 17.3382 3.0801 0.0 0
M  V30 25 C 18.6720 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[[4-[4-[(methylamino)methyl]phenyl]-1-oxobutyl]amino]benzeneacetate
C21H26N2O3
2454240-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 0.0000 0.0 0
M  V30 2 C 10.6697 0.7700 0.0 0
M  V30 3 C 12.0033 0.0000 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 C 13.3370 0.7700 0.0 0
M  V30 6 C 14.6708 0.0000 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 O 1.3337 3.0801 0.0 0
M  V30 10 O 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 20.0057 3.0801 0.0 0
M  V30 13 N 21.3393 2.3101 0.0 0
M  V30 14 C 22.6730 3.0801 0.0 0
M  V30 15 C 8.0022 0.7700 0.0 0
M  V30 16 C 8.0022 2.3101 0.0 0
M  V30 17 C 6.6685 0.0000 0.0 0
M  V30 18 C 6.6685 3.0801 0.0 0
M  V30 19 C 5.3348 0.7700 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 16.0045 0.7700 0.0 0
M  V30 22 C 17.3382 0.0000 0.0 0
M  V30 23 C 16.0045 2.3101 0.0 0
M  V30 24 C 18.6718 0.7700 0.0 0
M  V30 25 C 17.3382 3.0801 0.0 0
M  V30 26 C 18.6718 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454240-76-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454240-90-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(2-formylphenoxy)propoxy]benzeneacetate
C19H20O5
2454240-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 C 1.3337 0.7700 0.0 0
M  V30 7 O 0.0000 0.0000 0.0 0
M  V30 8 C 14.6708 5.3901 0.0 0
M  V30 9 C 16.0045 4.6201 0.0 0
M  V30 10 O 17.3383 5.3901 0.0 0
M  V30 11 O 16.0045 3.0801 0.0 0
M  V30 12 C 18.6720 4.6201 0.0 0
M  V30 13 C 2.6675 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 12.0035 2.3101 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 13.3372 3.0801 0.0 0
M  V30 23 C 12.0035 5.3901 0.0 0
M  V30 24 C 13.3372 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 19
M  V30 7 2 6 7
M  V30 8 1 6 14
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[2-[(methylamino)methyl]phenoxy]propoxy]benzeneacetate
C20H25NO4
2454242-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 10.0100 6.6684 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 C 16.1700 6.6684 0.0 0
M  V30 10 C 16.9400 8.0021 0.0 0
M  V30 11 O 18.4800 8.0021 0.0 0
M  V30 12 O 16.1700 9.3358 0.0 0
M  V30 13 C 19.2500 9.3358 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 3.0800 2.6674 0.0 0
M  V30 16 C 5.3900 1.3336 0.0 0
M  V30 17 C 2.3100 1.3336 0.0 0
M  V30 18 C 4.6200 0.0000 0.0 0
M  V30 19 C 3.0800 0.0000 0.0 0
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 22 C 12.3200 8.0021 0.0 0
M  V30 23 C 13.8600 5.3347 0.0 0
M  V30 24 C 13.8600 8.0021 0.0 0
M  V30 25 C 14.6300 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454240-89-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454242-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357558
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(3-formylphenoxy)propoxy]benzeneacetate
C19H20O5
2454241-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 12.0033 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 17.3382 0.0000 0.0 0
M  V30 9 C 18.6720 0.7700 0.0 0
M  V30 10 O 20.0057 0.0000 0.0 0
M  V30 11 O 18.6720 2.3101 0.0 0
M  V30 12 C 21.3393 0.7700 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 C 13.3372 2.3101 0.0 0
M  V30 20 C 14.6708 3.0801 0.0 0
M  V30 21 C 13.3372 0.7700 0.0 0
M  V30 22 C 16.0045 2.3101 0.0 0
M  V30 23 C 14.6708 0.0000 0.0 0
M  V30 24 C 16.0045 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 19
M  V30 7 2 6 7
M  V30 8 1 6 16
M  V30 9 1 8 9
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[3-[(methylamino)methyl]phenoxy]propoxy]benzeneacetate
C20H25NO4
2502096-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 14.6708 3.0801 0.0 0
M  V30 2 C 13.3370 2.3101 0.0 0
M  V30 3 C 12.0033 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 C 20.0057 3.0801 0.0 0
M  V30 7 N 21.3393 2.3101 0.0 0
M  V30 8 C 22.6730 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 O 1.3337 0.0000 0.0 0
M  V30 12 O 2.6673 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 16.0045 2.3101 0.0 0
M  V30 15 C 17.3382 3.0801 0.0 0
M  V30 16 C 16.0045 0.7700 0.0 0
M  V30 17 C 18.6718 2.3101 0.0 0
M  V30 18 C 17.3382 0.0000 0.0 0
M  V30 19 C 18.6718 0.7700 0.0 0
M  V30 20 C 8.0022 2.3101 0.0 0
M  V30 21 C 8.0022 0.7700 0.0 0
M  V30 22 C 6.6685 3.0801 0.0 0
M  V30 23 C 6.6685 0.0000 0.0 0
M  V30 24 C 5.3348 2.3101 0.0 0
M  V30 25 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 17
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454241-68-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2502096-02-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357575
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(4-formylphenyl)propoxy]benzeneacetate
C19H20O4
2454242-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.0045 5.3901 0.0 0
M  V30 2 C 17.3382 4.6201 0.0 0
M  V30 3 O 18.6720 5.3901 0.0 0
M  V30 4 O 17.3382 3.0801 0.0 0
M  V30 5 C 20.0057 4.6201 0.0 0
M  V30 6 O 10.6697 2.3101 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 C 6.6685 3.0801 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 14.6708 4.6201 0.0 0
M  V30 13 C 14.6708 3.0801 0.0 0
M  V30 14 C 13.3372 5.3901 0.0 0
M  V30 15 C 13.3372 2.3101 0.0 0
M  V30 16 C 12.0033 4.6201 0.0 0
M  V30 17 C 12.0033 3.0801 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 4.0012 3.0801 0.0 0
M  V30 20 C 5.3348 0.7700 0.0 0
M  V30 21 C 2.6675 2.3101 0.0 0
M  V30 22 C 4.0012 0.0000 0.0 0
M  V30 23 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 18
M  V30 11 2 10 11
M  V30 12 1 10 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[4-[(methylamino)methyl]phenyl]propoxy]benzeneacetate
C20H25NO3
2502096-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 2.3101 0.0 0
M  V30 2 C 10.6697 3.0801 0.0 0
M  V30 3 C 12.0033 2.3101 0.0 0
M  V30 4 C 13.3372 3.0801 0.0 0
M  V30 5 C 4.0012 5.3901 0.0 0
M  V30 6 C 2.6673 4.6201 0.0 0
M  V30 7 O 1.3337 5.3901 0.0 0
M  V30 8 O 2.6673 3.0801 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 18.6720 0.0000 0.0 0
M  V30 11 N 20.0057 0.7700 0.0 0
M  V30 12 C 21.3393 0.0000 0.0 0
M  V30 13 C 8.0022 3.0801 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 5.3348 3.0801 0.0 0
M  V30 17 C 6.6685 5.3901 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 14.6708 2.3101 0.0 0
M  V30 20 C 14.6708 0.7700 0.0 0
M  V30 21 C 16.0045 3.0801 0.0 0
M  V30 22 C 16.0045 0.0000 0.0 0
M  V30 23 C 17.3382 2.3101 0.0 0
M  V30 24 C 17.3382 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454242-47-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2502096-06-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(4-formylphenoxy)propoxy]benzeneacetate
C19H20O5
2454243-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 0.0000 0.0 0
M  V30 2 C 10.6697 0.7700 0.0 0
M  V30 3 C 12.0033 0.0000 0.0 0
M  V30 4 C 13.3372 0.7700 0.0 0
M  V30 5 O 14.6708 0.0000 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 20.0057 3.0801 0.0 0
M  V30 12 O 21.3393 2.3101 0.0 0
M  V30 13 C 8.0022 0.7700 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 6.6685 0.0000 0.0 0
M  V30 16 C 6.6685 3.0801 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 16.0045 0.7700 0.0 0
M  V30 20 C 17.3382 0.0000 0.0 0
M  V30 21 C 16.0045 2.3101 0.0 0
M  V30 22 C 18.6720 0.7700 0.0 0
M  V30 23 C 17.3382 3.0801 0.0 0
M  V30 24 C 18.6720 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[4-[(methylamino)methyl]phenoxy]propoxy]benzeneacetate
C20H25NO4
2454241-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 0.0000 0.0 0
M  V30 2 C 10.6697 0.7700 0.0 0
M  V30 3 C 12.0033 0.0000 0.0 0
M  V30 4 C 13.3370 0.7700 0.0 0
M  V30 5 O 14.6708 0.0000 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 20.0057 3.0801 0.0 0
M  V30 12 N 21.3393 2.3101 0.0 0
M  V30 13 C 22.6730 3.0801 0.0 0
M  V30 14 C 8.0022 0.7700 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 6.6685 0.0000 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 16.0045 0.7700 0.0 0
M  V30 21 C 17.3382 0.0000 0.0 0
M  V30 22 C 16.0045 2.3101 0.0 0
M  V30 23 C 18.6718 0.7700 0.0 0
M  V30 24 C 17.3382 3.0801 0.0 0
M  V30 25 C 18.6718 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2454243-79-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454241-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357565
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-[(difluoromethyl)sulfonyl]-2-nitrobenzene
C7H4ClF2NO4S
2488-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 2.3101 0.0 0 VAL=6
M  V30 2 C 8.0023 1.5400 0.0 0
M  V30 3 O 5.8985 0.9764 0.0 0
M  V30 4 O 7.4385 3.6437 0.0 0
M  V30 5 F 9.3360 2.3101 0.0 0
M  V30 6 F 8.0023 0.0000 0.0 0
M  V30 7 N 1.3337 2.3101 0.0 0 VAL=5
M  V30 8 O 1.3337 0.7700 0.0 0
M  V30 9 O 0.0000 3.0801 0.0 0
M  V30 10 Cl 1.3337 5.3901 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Difluoromethyl)sulfonyl]-N-methyl-2-nitrobenzenamine
C8H8F2N2O4S
638204-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 2.3101 0.0 0 VAL=6
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 1.8975 3.6437 0.0 0
M  V30 4 O 3.4375 0.9764 0.0 0
M  V30 5 F 1.3337 0.0000 0.0 0
M  V30 6 F 0.0000 2.3101 0.0 0
M  V30 7 N 5.3348 6.9302 0.0 0 VAL=5
M  V30 8 O 4.0012 7.7002 0.0 0
M  V30 9 O 6.6685 7.7002 0.0 0
M  V30 10 N 8.0023 5.3901 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 5.3348 5.3901 0.0 0
M  V30 16 C 6.6685 3.0801 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2488-54-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 638204-53-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4226697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives containing fluoro-, difluoro- and
trifluoromethylsulfonyl groups as new compounds with biological activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizerski, A.; Gajadhur, A.; Zalecki, S.; Ochal, Z.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Environmental Research (2002), 11(1 & 2), 63-75

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(6-Formylimidazo[1,2-a]pyridin-2-yl)methyl]-1-(tetrahydro-2H-pyran-2-yl)-1...
C22H21N5O3
2499661-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6646 3.9555 0.0 0
M  V30 2 N 10.9983 3.1855 0.0 0
M  V30 3 O 9.6646 5.4955 0.0 0
M  V30 4 C 12.3319 3.9555 0.0 0
M  V30 5 C 19.9530 1.3338 0.0 0
M  V30 6 O 20.7230 0.0000 0.0 0
M  V30 7 C 5.6635 3.1855 0.0 0
M  V30 8 C 6.9972 3.9555 0.0 0
M  V30 9 N 4.5190 4.2159 0.0 0
M  V30 10 C 5.6635 1.6455 0.0 0
M  V30 11 C 8.3308 3.1855 0.0 0
M  V30 12 C 6.6770 5.4618 0.0 0
M  V30 13 N 5.1455 5.6229 0.0 0
M  V30 14 C 6.9972 0.8755 0.0 0
M  V30 15 C 8.3308 1.6455 0.0 0
M  V30 16 C 3.0127 3.8958 0.0 0
M  V30 17 C 2.5369 2.4312 0.0 0
M  V30 18 O 1.9823 5.0403 0.0 0
M  V30 19 C 1.0304 2.1109 0.0 0
M  V30 20 C 0.4759 4.7200 0.0 0
M  V30 21 C 0.0000 3.2554 0.0 0
M  V30 22 C 13.6656 3.1855 0.0 0
M  V30 23 C 15.0725 3.8118 0.0 0
M  V30 24 N 13.8267 1.6540 0.0 0
M  V30 25 N 16.1030 2.6675 0.0 0
M  V30 26 C 15.3330 1.3338 0.0 0
M  V30 27 C 17.6430 2.6675 0.0 0
M  V30 28 C 16.1030 0.0000 0.0 0
M  V30 29 C 18.4130 1.3338 0.0 0
M  V30 30 C 17.6430 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 22
M  V30 6 2 5 6
M  V30 7 1 5 29
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 16
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 13
M  V30 18 2 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[6-[(Methylamino)methyl]imidazo[1,2-a]pyridin-2-yl]methyl]-1-(tetrahydro-2...
C23H26N6O2
2499661-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6646 1.6674 0.0 0
M  V30 2 N 10.9982 2.4374 0.0 0
M  V30 3 O 9.6646 0.1274 0.0 0
M  V30 4 C 12.3319 1.6674 0.0 0
M  V30 5 C 19.9529 4.2891 0.0 0
M  V30 6 N 20.7229 5.6228 0.0 0
M  V30 7 C 22.2629 5.6228 0.0 0
M  V30 8 C 5.6635 2.4374 0.0 0
M  V30 9 C 6.9971 1.6674 0.0 0
M  V30 10 N 4.5190 1.4069 0.0 0
M  V30 11 C 5.6635 3.9774 0.0 0
M  V30 12 C 8.3308 2.4374 0.0 0
M  V30 13 C 6.6770 0.1611 0.0 0
M  V30 14 N 5.1454 0.0000 0.0 0
M  V30 15 C 6.9971 4.7474 0.0 0
M  V30 16 C 8.3308 3.9774 0.0 0
M  V30 17 C 3.0127 1.7271 0.0 0
M  V30 18 C 2.5368 3.1917 0.0 0
M  V30 19 O 1.9823 0.5826 0.0 0
M  V30 20 C 1.0304 3.5120 0.0 0
M  V30 21 C 0.4759 0.9029 0.0 0
M  V30 22 C 0.0000 2.3674 0.0 0
M  V30 23 C 13.6655 2.4374 0.0 0
M  V30 24 N 13.8266 3.9689 0.0 0
M  V30 25 C 15.0724 1.8110 0.0 0
M  V30 26 C 15.3329 4.2891 0.0 0
M  V30 27 N 16.1029 2.9554 0.0 0
M  V30 28 C 16.1029 5.6228 0.0 0
M  V30 29 C 17.6429 2.9554 0.0 0
M  V30 30 C 17.6429 5.6228 0.0 0
M  V30 31 C 18.4129 4.2891 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 31
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 10 17
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 2 13 14
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2499661-15-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2499661-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-23234416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (sodium triacetoxyborohydride and methanamine)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridines and related derivatives as MeTTL3
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blackaby, Wesley Peter; Hardick, David James; Thomas, Elizabeth Jane;
Brookfield, Frederick Arthur; Bubert, Christian; Shepherd, Jon; Ridgill,
Mark Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020201773 A1 2020-10-08

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(3-formylphenoxy)propoxy]benzenepropanoate
C20H22O5
2502095-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 C 17.3382 1.5400 0.0 0
M  V30 9 C 18.6718 2.3101 0.0 0
M  V30 10 C 20.0057 1.5400 0.0 0
M  V30 11 O 21.3393 2.3101 0.0 0
M  V30 12 O 20.0057 0.0000 0.0 0
M  V30 13 C 22.6730 1.5400 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 4.0012 1.5400 0.0 0
M  V30 19 C 2.6673 2.3101 0.0 0
M  V30 20 C 13.3370 3.8501 0.0 0
M  V30 21 C 14.6708 4.6201 0.0 0
M  V30 22 C 13.3370 2.3101 0.0 0
M  V30 23 C 16.0045 3.8501 0.0 0
M  V30 24 C 14.6708 1.5400 0.0 0
M  V30 25 C 16.0045 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 20
M  V30 7 2 6 7
M  V30 8 1 6 17
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[3-[(methylamino)methyl]phenoxy]propoxy]benzenepropanoate
C21H27NO4
2502096-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 16.0045 4.6201 0.0 0
M  V30 2 C 14.6708 3.8501 0.0 0
M  V30 3 C 13.3370 4.6201 0.0 0
M  V30 4 C 12.0033 3.8501 0.0 0
M  V30 5 O 10.6697 4.6201 0.0 0
M  V30 6 C 21.3393 4.6201 0.0 0
M  V30 7 N 22.6730 3.8501 0.0 0
M  V30 8 C 24.0067 4.6201 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 O 1.3337 2.3101 0.0 0
M  V30 13 O 2.6673 0.0000 0.0 0
M  V30 14 C 0.0000 1.5400 0.0 0
M  V30 15 C 17.3382 3.8501 0.0 0
M  V30 16 C 18.6718 4.6201 0.0 0
M  V30 17 C 17.3382 2.3101 0.0 0
M  V30 18 C 20.0057 3.8501 0.0 0
M  V30 19 C 18.6718 1.5400 0.0 0
M  V30 20 C 20.0057 2.3101 0.0 0
M  V30 21 C 9.3358 3.8501 0.0 0
M  V30 22 C 9.3358 2.3101 0.0 0
M  V30 23 C 8.0022 4.6201 0.0 0
M  V30 24 C 8.0022 1.5400 0.0 0
M  V30 25 C 6.6685 3.8501 0.0 0
M  V30 26 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2502095-98-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2502096-03-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(2-formylphenoxy)propoxy]benzenepropanoate
C20H22O5
2502095-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 O 9.2400 6.6684 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 C 15.4000 6.6684 0.0 0
M  V30 9 C 16.1700 8.0021 0.0 0
M  V30 10 C 17.7100 8.0021 0.0 0
M  V30 11 O 18.4800 9.3358 0.0 0
M  V30 12 O 18.4800 6.6684 0.0 0
M  V30 13 C 20.0200 9.3358 0.0 0
M  V30 14 C 3.8500 2.6674 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 4.6200 1.3336 0.0 0
M  V30 17 C 1.5400 1.3336 0.0 0
M  V30 18 C 3.8500 0.0000 0.0 0
M  V30 19 C 2.3100 0.0000 0.0 0
M  V30 20 C 10.7800 6.6684 0.0 0
M  V30 21 C 11.5500 8.0021 0.0 0
M  V30 22 C 11.5500 5.3347 0.0 0
M  V30 23 C 13.0900 8.0021 0.0 0
M  V30 24 C 13.0900 5.3347 0.0 0
M  V30 25 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 20
M  V30 7 2 6 7
M  V30 8 1 6 15
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[2-[(methylamino)methyl]phenoxy]propoxy]benzenepropanoate
C21H27NO4
2454243-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 10.0100 6.6684 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 C 16.1700 6.6684 0.0 0
M  V30 10 C 16.9400 8.0021 0.0 0
M  V30 11 C 18.4800 8.0021 0.0 0
M  V30 12 O 19.2500 9.3358 0.0 0
M  V30 13 O 19.2500 6.6684 0.0 0
M  V30 14 C 20.7900 9.3358 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 17 C 5.3900 1.3336 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 4.6200 0.0000 0.0 0
M  V30 20 C 3.0800 0.0000 0.0 0
M  V30 21 C 11.5500 6.6684 0.0 0
M  V30 22 C 12.3200 5.3347 0.0 0
M  V30 23 C 12.3200 8.0021 0.0 0
M  V30 24 C 13.8600 5.3347 0.0 0
M  V30 25 C 13.8600 8.0021 0.0 0
M  V30 26 C 14.6300 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2502095-99-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454243-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357555
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-[(1E)-2-phenylethenyl][1,2,4]triazolo[4,3-a]quinoxaline
C17H11ClN4
2529934-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 5.3302 0.0 0
M  V30 2 C 7.6823 6.4748 0.0 0
M  V30 3 Cl 0.0000 5.3900 0.0 0
M  V30 4 N 4.0011 4.6200 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 2.6674 5.3900 0.0 0
M  V30 7 C 5.1454 5.6504 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 N 2.9876 6.8963 0.0 0
M  V30 11 C 1.3338 4.6200 0.0 0
M  V30 12 N 4.5191 7.0574 0.0 0
M  V30 13 N 1.3338 3.0800 0.0 0
M  V30 14 C 2.6674 0.7700 0.0 0
M  V30 15 C 5.3347 0.7700 0.0 0
M  V30 16 C 4.0011 0.0000 0.0 0
M  V30 17 C 9.1887 6.1546 0.0 0
M  V30 18 C 9.6646 4.6899 0.0 0
M  V30 19 C 10.2191 7.2990 0.0 0
M  V30 20 C 11.1709 4.3698 0.0 0
M  V30 21 C 11.7256 6.9788 0.0 0
M  V30 22 C 12.2014 5.5141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 17
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 2 6 10
M  V30 11 1 6 11
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 1 10 12
M  V30 17 2 11 13
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-[(1E)-2-phenylethenyl][1,2,4]triazolo[4,3-a]quinoxalin-4-amine
C18H15N5
2529934-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9856 5.3303 0.0 0
M  V30 2 C 9.0160 6.4748 0.0 0
M  V30 3 N 1.3336 5.3900 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 N 5.3348 4.6200 0.0 0
M  V30 6 C 5.3348 3.0800 0.0 0
M  V30 7 C 4.0011 5.3900 0.0 0
M  V30 8 C 6.4793 5.6505 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 6.6684 2.3100 0.0 0
M  V30 11 C 2.6675 4.6200 0.0 0
M  V30 12 N 4.3213 6.8963 0.0 0
M  V30 13 N 5.8528 7.0574 0.0 0
M  V30 14 N 2.6675 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 6.6684 0.7700 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 10.5224 6.1547 0.0 0
M  V30 19 C 11.5529 7.2990 0.0 0
M  V30 20 C 10.9983 4.6899 0.0 0
M  V30 21 C 13.0593 6.9789 0.0 0
M  V30 22 C 12.5047 4.3698 0.0 0
M  V30 23 C 13.5352 5.5142 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 2 11 14
M  V30 18 1 12 13
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2529934-45-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529934-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22845069
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole
derivatives as potent antiproliferative agents via a hybrid pharmacophore
approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaneko, Daiki; Ninomiya, Masayuki; Yoshikawa, Rina; Ono, Yukari;
Sonawane, Amol D.; Tanaka, Kaori; Nishina, Atsuyoshi; Koketsu, Mamoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 104104293

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(Dimethylamino)-3-quinolinyl]-2,2,2-trifluoroethanone
C13H11F3N2O
260444-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.7700 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 O 6.6685 0.7700 0.0 0
M  V30 7 F 7.2323 4.4137 0.0 0
M  V30 8 F 9.3360 3.8501 0.0 0
M  V30 9 F 8.7723 1.7464 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 N 4.0012 5.3901 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 0.0000 3.0801 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trifluoro-1-[4-(methylamino)-3-quinolinyl]ethanone
C12H9F3N2O
260444-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 O 6.6685 0.7700 0.0 0
M  V30 6 F 8.7723 1.7464 0.0 0
M  V30 7 F 9.3360 3.8501 0.0 0
M  V30 8 F 7.2323 4.4137 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 N 4.0012 5.3901 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 260444-63-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 260444-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-21384079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple syntheses of 3-trifluoroacetyl-4-quinolylamines, sulfides, and
ethers starting from N,N-dimethyl-4-quinolylamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okada, Etsuji; Hatakenaka, Mizuki; Sakaemura, Takushi; Shimomura,
Naofumi; Ashida, Takuro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2012), 86(2), 1177-1185

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(Dimethylamino)-3-quinolinyl]-2,2,2-trifluoroethanone
C13H11F3N2O
260444-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.7700 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 O 6.6685 0.7700 0.0 0
M  V30 7 F 7.2323 4.4137 0.0 0
M  V30 8 F 9.3360 3.8501 0.0 0
M  V30 9 F 8.7723 1.7464 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 N 4.0012 5.3901 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 0.0000 3.0801 0.0 0
M  V30 18 C 5.3348 4.6201 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trifluoro-1-[4-(methylamino)-3-quinolinyl]ethanone
C12H9F3N2O
260444-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 O 6.6685 0.7700 0.0 0
M  V30 6 F 8.7723 1.7464 0.0 0
M  V30 7 F 9.3360 3.8501 0.0 0
M  V30 8 F 7.2323 4.4137 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 N 4.0012 5.3901 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 260444-63-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 260444-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-2586536
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A simple synthetic method for 3-trifluoroacetylated 4-aminoquinolines
from 4-dimethylaminoquinoline by novel trifluoroacetylation and N-N
exchange reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okada, Etsuji; Sakaemura, Takushi; Shimomura, Naofumi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry Letters (2000), (1), 50-51

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2-Bromoethoxy)-5-nitro-1-(phenylmethyl)-1H-indazole
C16H14BrN3O3
2611186-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7471 2.7843 0.0 0
M  V30 2 C 4.3402 2.1578 0.0 0
M  V30 3 C 4.1793 0.6263 0.0 0
M  V30 4 Br 2.7723 0.0000 0.0 0
M  V30 5 C 4.6200 8.0868 0.0 0
M  V30 6 N 11.3155 5.1645 0.0 0 VAL=5
M  V30 7 O 11.6356 3.6581 0.0 0
M  V30 8 O 12.4598 6.1950 0.0 0
M  V30 9 C 7.2417 5.0859 0.0 0
M  V30 10 C 6.9215 6.5921 0.0 0
M  V30 11 C 5.9081 4.3159 0.0 0
M  V30 12 C 8.7064 4.6100 0.0 0
M  V30 13 N 5.3900 6.7532 0.0 0
M  V30 14 C 8.0659 7.6227 0.0 0
M  V30 15 N 4.7635 5.3463 0.0 0
M  V30 16 C 9.8508 5.6404 0.0 0
M  V30 17 C 9.5306 7.1468 0.0 0
M  V30 18 C 3.0800 8.0868 0.0 0
M  V30 19 C 2.3100 6.7532 0.0 0
M  V30 20 C 2.3100 9.4205 0.0 0
M  V30 21 C 0.7700 6.7532 0.0 0
M  V30 22 C 0.7700 9.4205 0.0 0
M  V30 23 C 0.0000 8.0868 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 13
M  V30 6 1 5 18
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[[5-nitro-1-(phenylmethyl)-1H-indazol-3-yl]oxy]ethanamine
C17H18N4O3
2611186-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7471 4.3159 0.0 0
M  V30 2 C 4.3402 3.6895 0.0 0
M  V30 3 C 4.1793 2.1580 0.0 0
M  V30 4 N 2.7723 1.5315 0.0 0
M  V30 5 C 2.6114 0.0000 0.0 0
M  V30 6 C 4.6200 9.6185 0.0 0
M  V30 7 N 11.3155 6.6962 0.0 0 VAL=5
M  V30 8 O 12.4598 7.7266 0.0 0
M  V30 9 O 11.6356 5.1898 0.0 0
M  V30 10 C 7.2417 6.6175 0.0 0
M  V30 11 C 6.9215 8.1238 0.0 0
M  V30 12 C 5.9081 5.8475 0.0 0
M  V30 13 C 8.7064 6.1415 0.0 0
M  V30 14 N 5.3900 8.2847 0.0 0
M  V30 15 C 8.0659 9.1542 0.0 0
M  V30 16 N 4.7635 6.8779 0.0 0
M  V30 17 C 9.8508 7.1721 0.0 0
M  V30 18 C 9.5306 8.6784 0.0 0
M  V30 19 C 3.0800 9.6185 0.0 0
M  V30 20 C 2.3100 8.2847 0.0 0
M  V30 21 C 2.3100 10.9522 0.0 0
M  V30 22 C 0.7700 8.2847 0.0 0
M  V30 23 C 0.7700 10.9522 0.0 0
M  V30 24 C 0.0000 9.6185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 6 19
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2611186-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2611186-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23312217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Promising hit compounds against resistant trichomoniasis: Synthesis and
antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ibanez-Escribano, Alexandra; Reviriego, Felipe; Vela, Nerea;
Fonseca-Berzal, Cristina; Nogal-Ruiz, Juan Jose; Aran, Vicente J.;
Escario, Jose Antonio; Gomez-Barrio, Alicia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 37127843

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
3-(2-Methoxyphenyl)-4-phenyl-1H-pyrrole-2-carboxylic acid
C18H15NO3
2639232-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4874 1.4647 0.0 0
M  V30 2 O 2.0114 0.0000 0.0 0
M  V30 3 O 1.4568 2.6091 0.0 0
M  V30 4 O 1.5400 3.1916 0.0 0
M  V30 5 C 0.0000 3.1916 0.0 0
M  V30 6 C 4.6200 3.1916 0.0 0
M  V30 7 C 6.1517 3.0307 0.0 0
M  V30 8 C 3.9937 1.7849 0.0 0
M  V30 9 C 6.4718 1.5243 0.0 0
M  V30 10 N 5.1381 0.7543 0.0 0
M  V30 11 C 3.8500 4.5253 0.0 0
M  V30 12 C 2.3100 4.5253 0.0 0
M  V30 13 C 4.6200 5.8591 0.0 0
M  V30 14 C 1.5400 5.8591 0.0 0
M  V30 15 C 3.8500 7.1927 0.0 0
M  V30 16 C 2.3100 7.1927 0.0 0
M  V30 17 C 7.1821 4.1751 0.0 0
M  V30 18 C 8.6884 3.8549 0.0 0
M  V30 19 C 6.7062 5.6398 0.0 0
M  V30 20 C 9.7189 4.9995 0.0 0
M  V30 21 C 7.7367 6.7842 0.0 0
M  V30 22 C 9.2429 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2-Methoxyphenyl)-N-methyl-4-phenyl-1H-pyrrole-2-carboxamide
C19H18N2O2
2639232-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 5.0493 0.0 0
M  V30 2 N 1.4646 6.0799 0.0 0
M  V30 3 O 2.2890 3.5430 0.0 0
M  V30 4 C 0.0000 5.6040 0.0 0
M  V30 5 O 2.6522 3.0801 0.0 0
M  V30 6 C 1.3186 2.3101 0.0 0
M  V30 7 C 5.3196 4.6201 0.0 0
M  V30 8 C 6.5656 5.5253 0.0 0
M  V30 9 C 4.0737 5.5253 0.0 0
M  V30 10 C 6.0896 6.9899 0.0 0
M  V30 11 N 4.5496 6.9899 0.0 0
M  V30 12 C 5.3196 3.0801 0.0 0
M  V30 13 C 3.9859 2.3101 0.0 0
M  V30 14 C 6.6534 2.3101 0.0 0
M  V30 15 C 3.9859 0.7700 0.0 0
M  V30 16 C 6.6534 0.7700 0.0 0
M  V30 17 C 5.3196 0.0000 0.0 0
M  V30 18 C 8.0302 5.0493 0.0 0
M  V30 19 C 8.3504 3.5430 0.0 0
M  V30 20 C 9.1748 6.0799 0.0 0
M  V30 21 C 9.8151 3.0671 0.0 0
M  V30 22 C 10.6393 5.6040 0.0 0
M  V30 23 C 10.9595 4.0976 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 8 18
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2639232-59-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2639232-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23382621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antiproliferative properties of
3,4-diarylpyrrole-2-carboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Silyanova, E. A.; Samet, A. V.; Semenova, M. N.; Semenov, V. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2021), 70(3), 498-509

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
6-Chloro-N2-[2-(1H-indol-3-yl)ethyl]-1,3,5-triazine-2,4-diamine
C13H13ClN6
2639880-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.6201 0.0 0
M  V30 2 C 7.0871 3.8501 0.0 0
M  V30 3 N 8.4207 4.6201 0.0 0
M  V30 4 Cl 13.7555 4.6201 0.0 0
M  V30 5 N 11.0882 0.0000 0.0 0
M  V30 6 C 3.0128 4.4766 0.0 0
M  V30 7 C 4.4196 3.8501 0.0 0
M  V30 8 C 1.9823 3.3320 0.0 0
M  V30 9 C 2.5369 5.9411 0.0 0
M  V30 10 C 4.2586 2.3185 0.0 0
M  V30 11 N 2.7523 1.9983 0.0 0
M  V30 12 C 0.4759 3.6523 0.0 0
M  V30 13 C 1.0304 6.2614 0.0 0
M  V30 14 C 0.0000 5.1169 0.0 0
M  V30 15 C 9.7544 3.8501 0.0 0
M  V30 16 N 11.0882 4.6201 0.0 0
M  V30 17 N 9.7544 2.3100 0.0 0
M  V30 18 C 12.4219 3.8501 0.0 0
M  V30 19 C 11.0882 1.5400 0.0 0
M  V30 20 N 12.4219 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 15
M  V30 5 1 4 18
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[2-(1H-Indol-3-yl)ethyl]-N4-methyl-1,3,5-triazine-2,4,6-triamine
C14H17N7
2639880-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 4.6201 0.0 0
M  V30 2 C 7.0871 3.8501 0.0 0
M  V30 3 N 8.4208 4.6201 0.0 0
M  V30 4 N 13.7556 4.6201 0.0 0
M  V30 5 C 15.0892 3.8501 0.0 0
M  V30 6 N 11.0881 0.0000 0.0 0
M  V30 7 C 3.0128 4.4766 0.0 0
M  V30 8 C 4.4196 3.8501 0.0 0
M  V30 9 C 1.9822 3.3320 0.0 0
M  V30 10 C 2.5369 5.9411 0.0 0
M  V30 11 C 4.2587 2.3185 0.0 0
M  V30 12 N 2.7522 1.9983 0.0 0
M  V30 13 C 0.4759 3.6523 0.0 0
M  V30 14 C 1.0304 6.2615 0.0 0
M  V30 15 C 0.0000 5.1169 0.0 0
M  V30 16 C 9.7544 3.8501 0.0 0
M  V30 17 N 11.0881 4.6201 0.0 0
M  V30 18 N 9.7544 2.3101 0.0 0
M  V30 19 C 12.4219 3.8501 0.0 0
M  V30 20 C 11.0881 1.5400 0.0 0
M  V30 21 N 12.4219 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2639880-39-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2639880-40-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31083490
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aminotriazines with indole motif as novel, 5-HT7 receptor ligands with
atypical binding mode
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulaga, Damian; Jaskowska, Jolanta; Satala, Grzegorz; Latacz, Gniewomir;
Sliwa, Pawel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 104104254

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-2-(4-bromobenzoyl)-1,2-dihydro-3H-naphtho[2,1-b]pyran-3-one
C20H12Br2O3
2640123-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3347 0.0 0
M  V30 2 O 0.0000 5.3347 0.0 0
M  V30 3 O 0.0000 8.0021 0.0 0
M  V30 4 Br 10.7800 8.0021 0.0 0
M  V30 5 Br 4.6200 0.0000 0.0 0
M  V30 6 C 4.6200 8.0021 0.0 0
M  V30 7 C 6.1600 8.0021 0.0 0
M  V30 8 C 3.8500 9.3358 0.0 0
M  V30 9 C 3.8500 6.6684 0.0 0
M  V30 10 C 6.9300 9.3358 0.0 0
M  V30 11 C 6.9300 6.6684 0.0 0
M  V30 12 O 2.3100 9.3358 0.0 0
M  V30 13 C 4.6200 10.6694 0.0 0
M  V30 14 C 2.3100 6.6684 0.0 0
M  V30 15 C 6.1600 10.6694 0.0 0
M  V30 16 C 8.4700 9.3358 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0
M  V30 18 C 1.5400 8.0021 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 1.5400 2.6673 0.0 0
M  V30 22 C 3.8500 4.0011 0.0 0
M  V30 23 C 2.3100 1.3336 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 3.8500 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 2 3 18
M  V30 5 1 4 19
M  V30 6 1 5 25
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 1 10 16
M  V30 17 2 11 17
M  V30 18 1 12 18
M  V30 19 1 13 15
M  V30 20 1 14 18
M  V30 21 2 16 19
M  V30 22 1 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-α-(4-bromobenzoyl)-2-hydroxy-N-methyl-1-naphthalenepropanamide
C21H17Br2NO3
2640123-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8444 4.0011 0.0 0
M  V30 2 C 8.3844 4.0011 0.0 0
M  V30 3 C 9.1544 5.3347 0.0 0
M  V30 4 C 9.1544 2.6673 0.0 0
M  V30 5 O 8.3844 6.6684 0.0 0
M  V30 6 N 8.3844 1.3336 0.0 0
M  V30 7 O 10.6944 2.6673 0.0 0
M  V30 8 C 9.1544 0.0000 0.0 0
M  V30 9 O 7.1128 7.0694 0.0 0
M  V30 10 Br 0.0000 2.2811 0.0 0
M  V30 11 Br 15.3144 5.3347 0.0 0
M  V30 12 C 4.1871 4.2335 0.0 0
M  V30 13 C 5.5828 4.8843 0.0 0
M  V30 14 C 2.9257 5.1168 0.0 0
M  V30 15 C 4.0530 2.6993 0.0 0
M  V30 16 C 5.7171 6.4184 0.0 0
M  V30 17 C 3.0598 6.6510 0.0 0
M  V30 18 C 1.5300 4.4660 0.0 0
M  V30 19 C 2.6573 2.0485 0.0 0
M  V30 20 C 4.4555 7.3018 0.0 0
M  V30 21 C 1.3957 2.9319 0.0 0
M  V30 22 C 10.6944 5.3347 0.0 0
M  V30 23 C 11.4644 6.6684 0.0 0
M  V30 24 C 11.4644 4.0011 0.0 0
M  V30 25 C 13.0044 6.6684 0.0 0
M  V30 26 C 13.0044 4.0011 0.0 0
M  V30 27 C 13.7744 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 6 8
M  V30 10 1 9 16
M  V30 11 1 10 21
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2640123-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2640123-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23589225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56-34-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of selective SIRT2 inhibitors as therapeutic agents in B-Cell
lymphoma and other malignancies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chowdhury, Sarwat; Sripathy, Smitha; Webster, Alyssa; Park, Angela; Lao,
Uyen; Hsu, Joanne H.; Loe, Taylor; Bedalov, Antonio; Simon, Julian A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2020), 25(3), 455

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
N-Methyl-N-[(phenylmethoxy)carbonyl]-L-norleucyl-L-norleucine
C21H32N2O5
264887-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 4.6200 0.0 0 CFG=2
M  V30 2 C 10.6694 5.3900 0.0 0
M  V30 3 N 8.0021 5.3900 0.0 0
M  V30 4 C 9.3358 3.0800 0.0 0
M  V30 5 N 10.6694 6.9300 0.0 0
M  V30 6 O 12.0032 4.6200 0.0 0
M  V30 7 C 6.6685 4.6200 0.0 0
M  V30 8 C 8.0021 6.9300 0.0 0
M  V30 9 C 10.6694 2.3100 0.0 0
M  V30 10 C 12.0032 7.7000 0.0 0 CFG=2
M  V30 11 O 5.3347 5.3900 0.0 0
M  V30 12 O 6.6685 3.0800 0.0 0
M  V30 13 C 10.6694 0.7700 0.0 0
M  V30 14 C 13.3369 6.9300 0.0 0
M  V30 15 C 12.0032 9.2400 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 12.0032 0.0000 0.0 0
M  V30 18 C 14.6705 7.7000 0.0 0
M  V30 19 O 13.3369 10.0100 0.0 0
M  V30 20 O 10.6694 10.0100 0.0 0
M  V30 21 C 16.0041 6.9300 0.0 0
M  V30 22 C 17.3379 7.7000 0.0 0
M  V30 23 C 2.6674 5.3900 0.0 0
M  V30 24 C 2.6674 6.9300 0.0 0
M  V30 25 C 1.3338 4.6200 0.0 0
M  V30 26 C 1.3338 7.7000 0.0 0
M  V30 27 C 0.0000 5.3900 0.0 0
M  V30 28 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 9 13
M  V30 13 1 10 14 CFG=3
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 1 16 23
M  V30 21 1 18 21
M  V30 22 1 21 22
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 2 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-[(phenylmethoxy)carbonyl]-L-norleucyl-N-methyl-L-norleucinamide
C22H35N3O4
264887-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 4.6200 0.0 0 CFG=2
M  V30 2 C 6.6685 5.3900 0.0 0
M  V30 3 N 9.3358 5.3900 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 N 6.6685 6.9300 0.0 0
M  V30 6 O 5.3347 4.6200 0.0 0
M  V30 7 C 10.6694 4.6200 0.0 0
M  V30 8 C 9.3358 6.9300 0.0 0
M  V30 9 C 6.6685 2.3100 0.0 0
M  V30 10 C 5.3347 7.7000 0.0 0 CFG=2
M  V30 11 O 12.0032 5.3900 0.0 0
M  V30 12 O 10.6694 3.0800 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 14 C 4.0011 6.9300 0.0 0
M  V30 15 C 5.3347 9.2400 0.0 0
M  V30 16 C 13.3369 4.6200 0.0 0
M  V30 17 C 5.3347 0.0000 0.0 0
M  V30 18 C 2.6674 7.7000 0.0 0
M  V30 19 N 4.0011 10.0100 0.0 0
M  V30 20 O 6.6685 10.0100 0.0 0
M  V30 21 C 1.3338 6.9300 0.0 0
M  V30 22 C 4.0011 11.5500 0.0 0
M  V30 23 C 0.0000 7.7000 0.0 0
M  V30 24 C 14.6705 5.3900 0.0 0
M  V30 25 C 14.6705 6.9300 0.0 0
M  V30 26 C 16.0041 4.6200 0.0 0
M  V30 27 C 16.0041 7.7000 0.0 0
M  V30 28 C 17.3379 5.3900 0.0 0
M  V30 29 C 17.3379 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 9 13
M  V30 13 1 10 14 CFG=1
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 1 16 24
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 21 23
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 264887-70-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 264887-71-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16901178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 100-74-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of Tripeptidyl Peptidase II. 2. Generation of the First Novel
Lead Inhibitor of Cholecystokinin-8-Inactivating Peptidase: A Strategy
for the Design of Peptidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ganellin, C. Robin; Bishop, Paul B.; Bambal, Ramesh B.; Chan, Suzanne M.
T.; Law, James K.; Marabout, Benoit; Luthra, Pratibha Mehta; Moore,
Andrew N. J.; Peschard, Olivier; Bourgeat, Pierre; Rose, Christiane;
Vargas, Froylan; Schwartz, Jean-Charles
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(4), 664-674

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H20ClN3O3
2673372-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3349 0.0 0
M  V30 2 N 6.7239 4.5649 0.0 0
M  V30 3 C 6.1601 6.6686 0.0 0
M  V30 4 C 4.0564 6.1049 0.0 0
M  V30 5 C 8.0575 5.3349 0.0 0
M  V30 6 O 9.3912 4.5649 0.0 0
M  V30 7 O 8.0575 6.8749 0.0 0
M  V30 8 C 10.7248 5.3349 0.0 0
M  V30 9 C 9.9548 6.6686 0.0 0
M  V30 10 C 12.0586 6.1049 0.0 0
M  V30 11 C 11.4948 4.0011 0.0 0
M  V30 12 O 2.3100 0.0000 0.0 0
M  V30 13 Cl 0.0000 6.6686 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 4.6201 4.0011 0.0 0
M  V30 16 C 2.3100 2.6675 0.0 0
M  V30 17 C 2.3100 5.3349 0.0 0
M  V30 18 C 5.3901 2.6675 0.0 0
M  V30 19 C 3.0800 1.3338 0.0 0
M  V30 20 C 0.7700 2.6675 0.0 0
M  V30 21 C 0.7700 5.3349 0.0 0
M  V30 22 N 4.6201 1.3338 0.0 0
M  V30 23 N 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 19
M  V30 13 1 13 21
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H23ClN4O2
2673372-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 6.6687 0.0 0
M  V30 2 N 6.7239 5.8986 0.0 0
M  V30 3 C 6.1601 8.0023 0.0 0
M  V30 4 C 4.0564 7.4387 0.0 0
M  V30 5 C 8.0576 6.6687 0.0 0
M  V30 6 O 9.3913 5.8986 0.0 0
M  V30 7 O 8.0576 8.2087 0.0 0
M  V30 8 C 10.7249 6.6687 0.0 0
M  V30 9 C 9.9549 8.0023 0.0 0
M  V30 10 C 12.0588 7.4387 0.0 0
M  V30 11 C 11.4950 5.3348 0.0 0
M  V30 12 N 2.3101 1.3338 0.0 0
M  V30 13 C 3.0801 0.0000 0.0 0
M  V30 14 Cl 0.0000 8.0023 0.0 0
M  V30 15 C 3.0801 5.3348 0.0 0
M  V30 16 C 2.3101 4.0012 0.0 0
M  V30 17 C 4.6201 5.3348 0.0 0
M  V30 18 C 2.3101 6.6687 0.0 0
M  V30 19 C 3.0801 2.6675 0.0 0
M  V30 20 C 0.7700 4.0012 0.0 0
M  V30 21 C 5.3901 4.0012 0.0 0
M  V30 22 C 0.7700 6.6687 0.0 0
M  V30 23 N 4.6201 2.6675 0.0 0
M  V30 24 N 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 1 14 22
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 2 20 24
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2673372-07-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2673372-08-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24267677
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrogen-containing heteroarylamines as MAP4K1 inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brubaker, Jason D.; Miduturu, Chandrasekhar V.; Burke, Michael J.;
Dineen, Thomas A.; Kim, Joseph L.; Close, Joshua T.; Perola, Emanuele
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021146370 A1 2021-07-22

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[[4-(4-formylphenyl)-1-oxobutyl]amino]benzoate
C19H19NO4
2704605-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 N 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 12.0033 3.8501 0.0 0
M  V30 10 C 13.3372 4.6201 0.0 0
M  V30 11 C 18.6720 1.5400 0.0 0
M  V30 12 O 20.0057 2.3101 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 4.0012 3.8501 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 6.6685 3.8501 0.0 0
M  V30 19 C 14.6708 3.8501 0.0 0
M  V30 20 C 14.6708 2.3101 0.0 0
M  V30 21 C 16.0045 4.6201 0.0 0
M  V30 22 C 16.0045 1.5400 0.0 0
M  V30 23 C 17.3382 3.8501 0.0 0
M  V30 24 C 17.3382 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 19
M  V30 12 2 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[[4-[4-[(methylamino)methyl]phenyl]-1-oxobutyl]amino]benzoate
C20H24N2O3
2454238-33-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 4.6201 0.0 0
M  V30 2 C 9.3360 3.8501 0.0 0
M  V30 3 C 10.6697 4.6201 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 C 12.0033 3.8501 0.0 0
M  V30 6 C 13.3372 4.6201 0.0 0
M  V30 7 C 2.6673 1.5400 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 O 2.6673 0.0000 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 18.6720 1.5400 0.0 0
M  V30 12 N 20.0057 2.3101 0.0 0
M  V30 13 C 21.3393 1.5400 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 C 4.0012 3.8501 0.0 0
M  V30 19 C 4.0012 2.3101 0.0 0
M  V30 20 C 14.6708 3.8501 0.0 0
M  V30 21 C 14.6708 2.3101 0.0 0
M  V30 22 C 16.0045 4.6201 0.0 0
M  V30 23 C 16.0045 1.5400 0.0 0
M  V30 24 C 17.3382 3.8501 0.0 0
M  V30 25 C 17.3382 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 20
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 19
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2704605-77-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454238-33-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-(10-bromodecyl)phosphonate
C14H30BrO3P
272785-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4137 3.8501 0.0 0
M  V30 3 O 1.7462 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7474 3.0801 0.0 0
M  V30 7 C 1.7462 0.7700 0.0 0
M  V30 8 C 0.7700 4.4137 0.0 0
M  V30 9 C 7.0811 3.8501 0.0 0
M  V30 10 C 0.4126 0.0000 0.0 0
M  V30 11 C 0.0000 5.7474 0.0 0
M  V30 12 C 8.4149 3.0801 0.0 0
M  V30 13 C 9.7486 3.8501 0.0 0
M  V30 14 C 11.0822 3.0801 0.0 0
M  V30 15 C 12.4159 3.8501 0.0 0
M  V30 16 C 13.7497 3.0801 0.0 0
M  V30 17 C 15.0834 3.8501 0.0 0
M  V30 18 C 16.4171 3.0801 0.0 0
M  V30 19 Br 17.7507 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[10-(methylamino)decyl]phosphonate
C15H34NO3P
1101178-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4139 3.8501 0.0 0
M  V30 3 O 1.7464 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7476 3.0801 0.0 0
M  V30 7 C 1.7464 0.7700 0.0 0
M  V30 8 C 0.7700 4.4137 0.0 0
M  V30 9 C 7.0812 3.8501 0.0 0
M  V30 10 C 0.4127 0.0000 0.0 0
M  V30 11 C 0.0000 5.7474 0.0 0
M  V30 12 C 8.4149 3.0801 0.0 0
M  V30 13 C 9.7487 3.8501 0.0 0
M  V30 14 C 11.0824 3.0801 0.0 0
M  V30 15 C 12.4161 3.8501 0.0 0
M  V30 16 C 13.7499 3.0801 0.0 0
M  V30 17 C 15.0836 3.8501 0.0 0
M  V30 18 C 16.4172 3.0801 0.0 0
M  V30 19 N 17.7509 3.8501 0.0 0
M  V30 20 C 19.0847 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 272785-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1101178-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7175035
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrolytically stable acidic monomers used in two steps self-etch
adhesives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Derbanne, Mathieu A.; Besse, Vincent; Le Goff, Stephane; Sadoun, Michael;
Pham, Thi-Nhan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Degradation and Stability (2013), 98(9), 1688-1698

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-(10-bromodecyl)phosphonate
C14H30BrO3P
272785-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4137 3.8501 0.0 0
M  V30 3 O 1.7462 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7474 3.0801 0.0 0
M  V30 7 C 1.7462 0.7700 0.0 0
M  V30 8 C 0.7700 4.4137 0.0 0
M  V30 9 C 7.0811 3.8501 0.0 0
M  V30 10 C 0.4126 0.0000 0.0 0
M  V30 11 C 0.0000 5.7474 0.0 0
M  V30 12 C 8.4149 3.0801 0.0 0
M  V30 13 C 9.7486 3.8501 0.0 0
M  V30 14 C 11.0822 3.0801 0.0 0
M  V30 15 C 12.4159 3.8501 0.0 0
M  V30 16 C 13.7497 3.0801 0.0 0
M  V30 17 C 15.0834 3.8501 0.0 0
M  V30 18 C 16.4171 3.0801 0.0 0
M  V30 19 Br 17.7507 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[10-(methylamino)decyl]phosphonate
C15H34NO3P
1101178-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.0801 3.0801 0.0 0 VAL=5
M  V30 2 C 4.4139 3.8501 0.0 0
M  V30 3 O 1.7464 2.3101 0.0 0
M  V30 4 O 2.3101 4.4137 0.0 0
M  V30 5 O 3.8501 1.7462 0.0 0
M  V30 6 C 5.7476 3.0801 0.0 0
M  V30 7 C 1.7464 0.7700 0.0 0
M  V30 8 C 0.7700 4.4137 0.0 0
M  V30 9 C 7.0812 3.8501 0.0 0
M  V30 10 C 0.4127 0.0000 0.0 0
M  V30 11 C 0.0000 5.7474 0.0 0
M  V30 12 C 8.4149 3.0801 0.0 0
M  V30 13 C 9.7487 3.8501 0.0 0
M  V30 14 C 11.0824 3.0801 0.0 0
M  V30 15 C 12.4161 3.8501 0.0 0
M  V30 16 C 13.7499 3.0801 0.0 0
M  V30 17 C 15.0836 3.8501 0.0 0
M  V30 18 C 16.4172 3.0801 0.0 0
M  V30 19 N 17.7509 3.8501 0.0 0
M  V30 20 C 19.0847 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 1 14 15
M  V30 15 1 15 16
M  V30 16 1 16 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 272785-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1101178-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10437367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, photopolymerization and adhesive properties of new
hydrolytically stable phosphonic acids for dental applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catel, Yohann; Degrange, Michel; Le Pluart, Loic; Madec, Pierre-Jean;
Pham, Thi-Nhan; Picton, Luc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Polymer Science, Part A: Polymer Chemistry (2008), 46(21),
7074-7090

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) (2S)-7-[(4-fluorophenyl)methyl]-2,3-dihydro-2-methyl-1H...
C21H23FN2O5
2750613-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.9302 0.0 0
M  V30 2 O 2.6673 7.7002 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 C 1.3337 6.9302 0.0 0
M  V30 5 C 0.5637 8.2638 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 2.1037 5.5965 0.0 0
M  V30 8 C 4.0012 10.0102 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0
M  V30 10 C 10.6697 4.6201 0.0 0
M  V30 11 O 10.6697 3.0801 0.0 0
M  V30 12 O 12.0033 5.3901 0.0 0
M  V30 13 F 2.6673 0.0000 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 C 8.0022 7.7002 0.0 0
M  V30 16 N 5.3348 7.7002 0.0 0
M  V30 17 C 6.6685 5.3901 0.0 0
M  V30 18 N 9.3360 6.9302 0.0 0
M  V30 19 O 8.0022 9.2402 0.0 0
M  V30 20 C 5.3348 9.2402 0.0 0 CFG=1
M  V30 21 C 8.0022 4.6201 0.0 0
M  V30 22 C 9.3360 5.3901 0.0 0
M  V30 23 C 6.6685 10.0102 0.0 0
M  V30 24 C 6.6685 2.3101 0.0 0
M  V30 25 C 6.6685 0.7700 0.0 0
M  V30 26 C 5.3348 3.0801 0.0 0
M  V30 27 C 5.3348 0.0000 0.0 0
M  V30 28 C 4.0012 2.3101 0.0 0
M  V30 29 C 4.0012 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 20 8 CFG=1
M  V30 9 1 9 21
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 22
M  V30 14 1 13 29
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 23
M  V30 25 2 21 22
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-7-[(4-fluorophenyl)methyl]-2,3-dihydro-2-methyl-6-[(me...
C22H26FN3O4
2750616-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 6.9302 0.0 0
M  V30 2 O 2.6673 7.7002 0.0 0
M  V30 3 O 4.0010 5.3901 0.0 0
M  V30 4 C 1.3337 6.9302 0.0 0
M  V30 5 C 2.1037 5.5965 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 0.5637 8.2638 0.0 0
M  V30 8 C 4.0010 10.0102 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0
M  V30 10 C 10.6697 4.6201 0.0 0
M  V30 11 N 12.0033 5.3901 0.0 0
M  V30 12 O 10.6697 3.0801 0.0 0
M  V30 13 C 13.3370 4.6201 0.0 0
M  V30 14 F 2.6673 0.0000 0.0 0
M  V30 15 C 6.6685 6.9302 0.0 0
M  V30 16 C 8.0022 7.7002 0.0 0
M  V30 17 N 5.3348 7.7002 0.0 0
M  V30 18 C 6.6685 5.3901 0.0 0
M  V30 19 N 9.3360 6.9302 0.0 0
M  V30 20 O 8.0022 9.2402 0.0 0
M  V30 21 C 5.3348 9.2402 0.0 0 CFG=1
M  V30 22 C 8.0022 4.6201 0.0 0
M  V30 23 C 9.3360 5.3901 0.0 0
M  V30 24 C 6.6685 10.0102 0.0 0
M  V30 25 C 6.6685 2.3101 0.0 0
M  V30 26 C 5.3348 3.0801 0.0 0
M  V30 27 C 6.6685 0.7700 0.0 0
M  V30 28 C 4.0010 2.3101 0.0 0
M  V30 29 C 5.3348 0.0000 0.0 0
M  V30 30 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 21 8 CFG=1
M  V30 9 1 9 22
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 23
M  V30 14 1 11 13
M  V30 15 1 14 30
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 24
M  V30 26 2 22 23
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2750613-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2750616-62-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27661488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrido[2,3-b][1,4]oxazines and tetrahydropyrido[2,3-b][1,4]oxazepines as
IAP antagonists and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Jing; Song, Fengtao; Wang, Zhiwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021244608 A1 2021-12-09

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3,5-Dichloro-4-[[3-(1-methylethyl)-4-(phenylmethoxy)phenyl]methyl]phenoxy]...
C25H21Cl3F2O3
2756022-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 7.7002 0.0 0
M  V30 2 C 4.0012 7.7002 0.0 0
M  V30 3 C 4.0012 9.2402 0.0 0
M  V30 4 C 2.6675 6.9302 0.0 0
M  V30 5 Cl 12.0035 9.2402 0.0 0
M  V30 6 Cl 9.3360 4.6201 0.0 0
M  V30 7 O 4.0012 4.6201 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 O 14.6708 4.6201 0.0 0
M  V30 10 C 16.0045 5.3901 0.0 0
M  V30 11 C 17.3383 4.6201 0.0 0
M  V30 12 F 15.2345 6.7238 0.0 0
M  V30 13 F 16.7745 6.7238 0.0 0
M  V30 14 Cl 18.6720 5.3901 0.0 0
M  V30 15 O 17.3383 3.0801 0.0 0
M  V30 16 C 8.0023 6.9302 0.0 0
M  V30 17 C 6.6685 7.7002 0.0 0
M  V30 18 C 8.0023 5.3901 0.0 0
M  V30 19 C 5.3348 6.9302 0.0 0
M  V30 20 C 6.6685 4.6201 0.0 0
M  V30 21 C 5.3348 5.3901 0.0 0
M  V30 22 C 10.6697 6.9302 0.0 0
M  V30 23 C 12.0035 7.7002 0.0 0
M  V30 24 C 10.6697 5.3901 0.0 0
M  V30 25 C 13.3372 6.9302 0.0 0
M  V30 26 C 12.0035 4.6201 0.0 0
M  V30 27 C 13.3372 5.3901 0.0 0
M  V30 28 C 2.6675 2.3101 0.0 0
M  V30 29 C 2.6675 0.7700 0.0 0
M  V30 30 C 1.3337 3.0801 0.0 0
M  V30 31 C 1.3337 0.0000 0.0 0
M  V30 32 C 0.0000 2.3101 0.0 0
M  V30 33 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 19
M  V30 6 1 5 23
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 28
M  V30 11 1 9 10
M  V30 12 1 9 27
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 2 11 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3,5-Dichloro-4-[[3-(1-methylethyl)-4-(phenylmethoxy)phenyl]methyl]phenoxy]...
C26H25Cl2F2NO3
2756022-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 4.0011 0.0 0
M  V30 2 C 13.0900 1.3336 0.0 0
M  V30 3 C 14.6300 1.3336 0.0 0
M  V30 4 C 12.3200 0.0000 0.0 0
M  V30 5 Cl 5.3900 4.0011 0.0 0
M  V30 6 Cl 10.0100 6.6684 0.0 0
M  V30 7 O 14.6300 4.0011 0.0 0
M  V30 8 C 15.4000 5.3347 0.0 0
M  V30 9 O 5.3900 9.3358 0.0 0
M  V30 10 C 3.8500 9.3358 0.0 0
M  V30 11 C 2.3100 9.3358 0.0 0
M  V30 12 F 3.8500 10.8758 0.0 0
M  V30 13 F 3.8500 7.7958 0.0 0
M  V30 14 N 1.5400 10.6694 0.0 0
M  V30 15 O 1.5400 8.0021 0.0 0
M  V30 16 C 0.0000 10.6694 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.7800 2.6674 0.0 0
M  V30 19 C 10.7800 5.3347 0.0 0
M  V30 20 C 12.3200 2.6674 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 22 C 13.0900 4.0011 0.0 0
M  V30 23 C 7.7000 5.3347 0.0 0
M  V30 24 C 6.1600 5.3347 0.0 0
M  V30 25 C 8.4700 6.6684 0.0 0
M  V30 26 C 5.3900 6.6684 0.0 0
M  V30 27 C 7.7000 8.0021 0.0 0
M  V30 28 C 6.1600 8.0021 0.0 0
M  V30 29 C 16.9400 5.3347 0.0 0
M  V30 30 C 17.7100 4.0011 0.0 0
M  V30 31 C 17.7100 6.6684 0.0 0
M  V30 32 C 19.2500 4.0011 0.0 0
M  V30 33 C 19.2500 6.6684 0.0 0
M  V30 34 C 20.0200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 20
M  V30 6 1 5 24
M  V30 7 1 6 25
M  V30 8 1 7 8
M  V30 9 1 7 22
M  V30 10 1 8 29
M  V30 11 1 9 10
M  V30 12 1 9 28
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 2 11 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2756022-04-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2756022-05-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31075013
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzylphenols as thyromimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Von Geldern, Thomas; Backes, Bradley; Stearns, Brian Andrew; Baccei, Jill
Melissa; Harris, Jason Randall
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021257851 A1 2021-12-23

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-(Methoxycarbonyl)-2-nitrophenyl]methyl 1H-imidazole-1-carboxylate
C13H11N3O6
2762599-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9317 4.0011 0.0 0
M  V30 2 O 4.1617 5.3347 0.0 0
M  V30 3 C 2.6217 5.3347 0.0 0
M  V30 4 O 1.8517 4.0011 0.0 0
M  V30 5 N 6.4717 1.3336 0.0 0 VAL=5
M  V30 6 O 7.2417 0.0000 0.0 0
M  V30 7 O 4.9317 1.3336 0.0 0
M  V30 8 C 9.5517 6.6684 0.0 0
M  V30 9 O 11.0917 6.6684 0.0 0
M  V30 10 O 8.7817 8.0021 0.0 0
M  V30 11 C 11.8617 8.0021 0.0 0
M  V30 12 C 6.4717 4.0011 0.0 0
M  V30 13 C 7.2417 2.6673 0.0 0
M  V30 14 C 7.2417 5.3347 0.0 0
M  V30 15 C 8.7817 2.6673 0.0 0
M  V30 16 C 8.7817 5.3347 0.0 0
M  V30 17 C 9.5517 4.0011 0.0 0
M  V30 18 N 1.8517 6.6684 0.0 0
M  V30 19 C 2.4782 8.0753 0.0 0
M  V30 20 C 0.3202 6.8294 0.0 0
M  V30 21 C 1.3336 9.1057 0.0 0
M  V30 22 N 0.0000 8.3357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 18
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 16
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[[[(methylamino)carbonyl]oxy]methyl]-4-nitrobenzoate
C11H12N2O6
2762599-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 O 7.7000 5.3347 0.0 0
M  V30 3 C 9.2400 5.3347 0.0 0
M  V30 4 N 10.0100 6.6685 0.0 0
M  V30 5 O 10.0100 4.0011 0.0 0
M  V30 6 C 11.5500 6.6685 0.0 0
M  V30 7 N 5.3900 1.3336 0.0 0 VAL=5
M  V30 8 O 6.9300 1.3336 0.0 0
M  V30 9 O 4.6200 0.0000 0.0 0
M  V30 10 C 2.3100 6.6685 0.0 0
M  V30 11 O 0.7700 6.6685 0.0 0
M  V30 12 O 3.0800 8.0021 0.0 0
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 3.0800 2.6674 0.0 0
M  V30 18 C 3.0800 5.3347 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2762599-54-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2762599-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34999568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoactivatable Fluorescent Dyes with Hydrophilic Caging Groups and
Their Use in Multicolor Nanoscopy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Butkevich, Alexey N.; Weber, Michael; Cereceda Delgado, Angel R.;
Ostersehlt, Lynn M.; D'Este, Elisa; Hell, Stefan W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2021), 143(44), 18388-18393

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
1′-[(2,4-Dichlorophenyl)methyl]-1,2-dihydro-2-oxospiro[3H-indole-3,4′-piperid...
C20H18Cl2N2O3
2762762-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.8824 8.3955 0.0 0
M  V30 2 C 1.4647 5.2443 0.0 0
M  V30 3 O 1.7849 3.7380 0.0 0
M  V30 4 O 0.0000 5.7202 0.0 0
M  V30 5 C 9.0598 2.6673 0.0 0
M  V30 6 Cl 10.5998 0.0000 0.0 0
M  V30 7 Cl 15.2198 2.6673 0.0 0
M  V30 8 C 6.7498 6.6684 0.0 0
M  V30 9 C 5.2181 6.8294 0.0 0
M  V30 10 C 7.3761 8.0753 0.0 0
M  V30 11 C 8.2898 6.6684 0.0 0
M  V30 12 C 5.9798 5.3347 0.0 0
M  V30 13 C 4.8980 8.3357 0.0 0
M  V30 14 C 4.0738 5.7989 0.0 0
M  V30 15 N 6.2318 9.1057 0.0 0
M  V30 16 C 9.0598 5.3347 0.0 0
M  V30 17 C 6.7498 4.0011 0.0 0
M  V30 18 C 3.4334 8.8116 0.0 0
M  V30 19 C 2.6091 6.2747 0.0 0
M  V30 20 N 8.2898 4.0011 0.0 0
M  V30 21 C 2.2889 7.7812 0.0 0
M  V30 22 C 10.5998 2.6673 0.0 0
M  V30 23 C 11.3698 1.3336 0.0 0
M  V30 24 C 11.3698 4.0011 0.0 0
M  V30 25 C 12.9098 1.3336 0.0 0
M  V30 26 C 12.9098 4.0011 0.0 0
M  V30 27 C 13.6798 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 5 20
M  V30 6 1 5 22
M  V30 7 1 6 23
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,4′-piperidine]-5-carboxamide, 1′-[(2,4-dichlorophenyl)methy...
C21H21Cl2N3O2
3024591-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3373 8.3955 0.0 0
M  V30 2 C 13.7550 5.2443 0.0 0
M  V30 3 N 15.2197 5.7202 0.0 0
M  V30 4 O 13.4348 3.7380 0.0 0
M  V30 5 C 16.3640 4.6898 0.0 0
M  V30 6 C 6.1600 2.6673 0.0 0
M  V30 7 Cl 4.6200 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 8.4700 6.6684 0.0 0
M  V30 10 C 10.0015 6.8294 0.0 0
M  V30 11 C 7.8435 8.0753 0.0 0
M  V30 12 C 6.9300 6.6684 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 10.3217 8.3357 0.0 0
M  V30 15 C 11.1459 5.7989 0.0 0
M  V30 16 N 8.9881 9.1057 0.0 0
M  V30 17 C 6.1600 5.3347 0.0 0
M  V30 18 C 8.4700 4.0011 0.0 0
M  V30 19 C 11.7864 8.8116 0.0 0
M  V30 20 C 12.6106 6.2747 0.0 0
M  V30 21 N 6.9300 4.0011 0.0 0
M  V30 22 C 12.9308 7.7812 0.0 0
M  V30 23 C 4.6200 2.6673 0.0 0
M  V30 24 C 3.8500 1.3336 0.0 0
M  V30 25 C 3.8500 4.0011 0.0 0
M  V30 26 C 2.3100 1.3336 0.0 0
M  V30 27 C 2.3100 4.0011 0.0 0
M  V30 28 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 6 21
M  V30 7 1 6 23
M  V30 8 1 7 24
M  V30 9 1 8 28
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 14 16
M  V30 20 2 14 19
M  V30 21 1 15 20
M  V30 22 1 17 21
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2762762-17-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3024591-21-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41673333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 123333-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed reaction vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and Characterization of a Blood-Brain Barrier Penetrant
Inositol Hexakisphosphate Kinase (IP6K) Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heitmann, Tyler; Liao, Gangling; Ernst, Glen; Poslusney, Michael; van
Kralingen, Thomas; Li, Ye; Masi, Megan; DePasquale, Michael; Buchler,
Ingrid; Wei, Huijun; Carr, Gregory V.; Shlevkov, Evgeny; Lu, Mengsi;
Jessen, Henning; Barrow, James C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(16), 13639-13665

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
1′-[(2,4-Dichlorophenyl)methyl]-1,2-dihydro-2-oxospiro[3H-indole-3,4′-piperid...
C20H18Cl2N2O3
2762762-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.8824 8.3955 0.0 0
M  V30 2 C 1.4647 5.2443 0.0 0
M  V30 3 O 1.7849 3.7380 0.0 0
M  V30 4 O 0.0000 5.7202 0.0 0
M  V30 5 C 9.0598 2.6673 0.0 0
M  V30 6 Cl 10.5998 0.0000 0.0 0
M  V30 7 Cl 15.2198 2.6673 0.0 0
M  V30 8 C 6.7498 6.6684 0.0 0
M  V30 9 C 5.2181 6.8294 0.0 0
M  V30 10 C 7.3761 8.0753 0.0 0
M  V30 11 C 8.2898 6.6684 0.0 0
M  V30 12 C 5.9798 5.3347 0.0 0
M  V30 13 C 4.8980 8.3357 0.0 0
M  V30 14 C 4.0738 5.7989 0.0 0
M  V30 15 N 6.2318 9.1057 0.0 0
M  V30 16 C 9.0598 5.3347 0.0 0
M  V30 17 C 6.7498 4.0011 0.0 0
M  V30 18 C 3.4334 8.8116 0.0 0
M  V30 19 C 2.6091 6.2747 0.0 0
M  V30 20 N 8.2898 4.0011 0.0 0
M  V30 21 C 2.2889 7.7812 0.0 0
M  V30 22 C 10.5998 2.6673 0.0 0
M  V30 23 C 11.3698 1.3336 0.0 0
M  V30 24 C 11.3698 4.0011 0.0 0
M  V30 25 C 12.9098 1.3336 0.0 0
M  V30 26 C 12.9098 4.0011 0.0 0
M  V30 27 C 13.6798 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 1 5 20
M  V30 6 1 5 22
M  V30 7 1 6 23
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,4′-piperidine]-5-carboxamide, 1′-[(2,4-dichlorophenyl)methy...
C21H21Cl2N3O2
3024591-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3373 8.3955 0.0 0
M  V30 2 C 13.7550 5.2443 0.0 0
M  V30 3 N 15.2197 5.7202 0.0 0
M  V30 4 O 13.4348 3.7380 0.0 0
M  V30 5 C 16.3640 4.6898 0.0 0
M  V30 6 C 6.1600 2.6673 0.0 0
M  V30 7 Cl 4.6200 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 8.4700 6.6684 0.0 0
M  V30 10 C 10.0015 6.8294 0.0 0
M  V30 11 C 7.8435 8.0753 0.0 0
M  V30 12 C 6.9300 6.6684 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 10.3217 8.3357 0.0 0
M  V30 15 C 11.1459 5.7989 0.0 0
M  V30 16 N 8.9881 9.1057 0.0 0
M  V30 17 C 6.1600 5.3347 0.0 0
M  V30 18 C 8.4700 4.0011 0.0 0
M  V30 19 C 11.7864 8.8116 0.0 0
M  V30 20 C 12.6106 6.2747 0.0 0
M  V30 21 N 6.9300 4.0011 0.0 0
M  V30 22 C 12.9308 7.7812 0.0 0
M  V30 23 C 4.6200 2.6673 0.0 0
M  V30 24 C 3.8500 1.3336 0.0 0
M  V30 25 C 3.8500 4.0011 0.0 0
M  V30 26 C 2.3100 1.3336 0.0 0
M  V30 27 C 2.3100 4.0011 0.0 0
M  V30 28 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 6 21
M  V30 7 1 6 23
M  V30 8 1 7 24
M  V30 9 1 8 28
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 14 16
M  V30 20 2 14 19
M  V30 21 1 15 20
M  V30 22 1 17 21
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2762762-17-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3024591-21-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38745386
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 80029-43-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Non-acid inhibitor of inositol hexakisphosphate kinase IP6K compound and
method for treating disease, condition or disorder
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barrow, James; Heitmann, Tyler
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023244657 A1 2023-12-21

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H21BrO3
2764776-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 9.2400 2.6674 0.0 0
M  V30 4 C 6.9300 1.3338 0.0 0
M  V30 5 O 7.7000 5.3349 0.0 0
M  V30 6 C 10.0100 4.0011 0.0 0
M  V30 7 C 5.5964 2.1038 0.0 0
M  V30 8 C 6.1600 0.0000 0.0 0
M  V30 9 C 8.2636 0.5638 0.0 0
M  V30 10 O 9.2400 5.3349 0.0 0
M  V30 11 O 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 Br 16.1700 4.0011 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 4.6200 5.3349 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 3.0800 5.3349 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 21 C 12.3200 5.3349 0.0 0
M  V30 22 C 12.3200 2.6674 0.0 0
M  V30 23 C 13.8600 5.3349 0.0 0
M  V30 24 C 13.8600 2.6674 0.0 0
M  V30 25 C 14.6300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 14
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 2 6 10
M  V30 11 1 6 20
M  V30 12 1 11 12
M  V30 13 1 11 19
M  V30 14 1 13 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Bromophenyl)-3-(1,1-dimethylethyl)-2-(4-methoxyphenyl)-1-methyl-1H-pyrrole
C22H24BrNO
2764777-17-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9242 1.4645 0.0 0
M  V30 2 C 5.8938 0.3202 0.0 0
M  V30 3 C 7.4000 0.0000 0.0 0
M  V30 4 C 8.4305 1.1444 0.0 0
M  V30 5 C 6.9242 6.8857 0.0 0
M  V30 6 O 13.5136 4.1751 0.0 0
M  V30 7 C 14.2836 5.5088 0.0 0
M  V30 8 Br 0.0000 8.5658 0.0 0
M  V30 9 C 7.3535 4.1751 0.0 0
M  V30 10 C 6.4483 2.9292 0.0 0
M  V30 11 N 6.4483 5.4210 0.0 0
M  V30 12 C 4.9836 3.4051 0.0 0
M  V30 13 C 4.9836 4.9451 0.0 0
M  V30 14 C 8.8935 4.1751 0.0 0
M  V30 15 C 9.6635 5.5088 0.0 0
M  V30 16 C 9.6635 2.8415 0.0 0
M  V30 17 C 11.2036 5.5088 0.0 0
M  V30 18 C 11.2036 2.8415 0.0 0
M  V30 19 C 11.9736 4.1751 0.0 0
M  V30 20 C 3.7378 5.8503 0.0 0
M  V30 21 C 2.3310 5.2239 0.0 0
M  V30 22 C 3.8987 7.3819 0.0 0
M  V30 23 C 1.0849 6.1291 0.0 0
M  V30 24 C 2.6528 8.2871 0.0 0
M  V30 25 C 1.2460 7.6608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 8 25
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 13 20
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2764776-97-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2764777-17-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31588957
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convergent Synthesis of 1,4-Dicarbonyl Z-Alkenes through Three-Component
Coupling of Alkynes, α-Diazo Sulfonium Triflate, and Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xuyong; Tong, Wen-Yan; Huang, Bing; Cao, Si; Li, Yunlong; Jiao,
Jingchao; Huang, Hang; Yi, Qiu; Qu, Shuanglin; Wang, Xi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2022), 144(11), 4952-4965

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-1-[(1,1-dimethylethoxy)carbonyl]-1H-indole-2-acetic acid
C15H16BrNO4
2766180-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5603 3.4886 0.0 0
M  V30 2 O 3.0958 3.0128 0.0 0
M  V30 3 O 5.7049 2.4582 0.0 0
M  V30 4 C 2.7756 1.5063 0.0 0
M  V30 5 C 4.2819 1.1861 0.0 0
M  V30 6 C 2.4554 0.0000 0.0 0
M  V30 7 C 1.2691 1.8265 0.0 0
M  V30 8 C 7.6211 4.8514 0.0 0
M  V30 9 C 8.9550 5.6214 0.0 0
M  V30 10 O 8.9550 7.1614 0.0 0
M  V30 11 O 10.2886 4.8514 0.0 0
M  V30 12 Br 0.0000 7.4731 0.0 0
M  V30 13 C 3.8501 6.1395 0.0 0
M  V30 14 N 4.8807 4.9949 0.0 0
M  V30 15 C 4.6201 7.4731 0.0 0
M  V30 16 C 2.3100 6.1395 0.0 0
M  V30 17 C 6.2875 5.6214 0.0 0
M  V30 18 C 6.1265 7.1530 0.0 0
M  V30 19 C 3.8501 8.8068 0.0 0
M  V30 20 C 1.5400 7.4731 0.0 0
M  V30 21 C 2.3100 8.8068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 20
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 2 17 18
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 6-bromo-2-[2-(methylamino)-2-oxoethyl]-1H-indole-1-carboxylate
C16H19BrN2O3
2766180-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5603 3.4886 0.0 0
M  V30 2 O 3.0958 3.0128 0.0 0
M  V30 3 O 5.7049 2.4582 0.0 0
M  V30 4 C 2.7756 1.5063 0.0 0
M  V30 5 C 1.2691 1.8265 0.0 0
M  V30 6 C 2.4553 0.0000 0.0 0
M  V30 7 C 4.2819 1.1861 0.0 0
M  V30 8 C 7.6212 4.8514 0.0 0
M  V30 9 C 8.9548 5.6214 0.0 0
M  V30 10 N 10.2887 4.8514 0.0 0
M  V30 11 O 8.9548 7.1615 0.0 0
M  V30 12 C 11.6223 5.6214 0.0 0
M  V30 13 Br 0.0000 7.4732 0.0 0
M  V30 14 C 3.8501 6.1395 0.0 0
M  V30 15 N 4.8805 4.9949 0.0 0
M  V30 16 C 4.6201 7.4732 0.0 0
M  V30 17 C 2.3101 6.1395 0.0 0
M  V30 18 C 6.2875 5.6214 0.0 0
M  V30 19 C 6.1266 7.1530 0.0 0
M  V30 20 C 3.8501 8.8068 0.0 0
M  V30 21 C 1.5400 7.4732 0.0 0
M  V30 22 C 2.3101 8.8068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 21
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 2 18 19
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2766180-36-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2766180-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31969684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of heterocyclic substituted pyrimidine anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Borjesson, Ulf; Perry, Matthew William Dampier; Grebner, Christoph;
Michaelides, Iacovos Neal; Hayhow, Thomas George Christopher; Kettle,
Jason Grant; Collie, Gavin William; Storer, Robert Ian; Bagal, Sharanjeet
Kaur; Fallan, Charlene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022069520 A1 2022-04-07

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αS)-α-[[(E)-(2-benzothiazolylimino)hydroxymethyl]amino]benzeneacetate
C17H15N3O3S
2770660-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.7001 6.6686 0.0 0
M  V30 2 C 6.9301 5.3348 0.0 0
M  V30 3 N 5.3901 5.3348 0.0 0
M  V30 4 O 7.7001 4.0011 0.0 0
M  V30 5 C 4.6201 4.0011 0.0 0 CFG=1
M  V30 6 C 5.3901 2.6675 0.0 0
M  V30 7 O 4.6201 1.3338 0.0 0
M  V30 8 O 6.9301 2.6675 0.0 0
M  V30 9 C 5.3901 0.0000 0.0 0
M  V30 10 C 11.6099 5.8986 0.0 0
M  V30 11 C 11.6099 7.4386 0.0 0
M  V30 12 N 10.1452 5.4226 0.0 0
M  V30 13 C 12.9435 5.1286 0.0 0
M  V30 14 S 10.1452 7.9145 0.0 0
M  V30 15 C 12.9435 8.2086 0.0 0
M  V30 16 C 9.2401 6.6686 0.0 0
M  V30 17 C 14.2772 5.8986 0.0 0
M  V30 18 C 14.2772 7.4386 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 2.3100 2.6675 0.0 0
M  V30 21 C 2.3100 5.3348 0.0 0
M  V30 22 C 0.7700 2.6675 0.0 0
M  V30 23 C 0.7700 5.3348 0.0 0
M  V30 24 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3 CFG=1
M  V30 4 2 2 4
M  V30 5 1 5 3 CFG=3
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C17H16N4O2S
2770660-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 7.7001 6.6686 0.0 0
M  V30 2 C 6.9301 5.3348 0.0 0
M  V30 3 N 5.3901 5.3348 0.0 0
M  V30 4 O 7.7001 4.0011 0.0 0
M  V30 5 C 4.6201 4.0011 0.0 0 CFG=1
M  V30 6 C 5.3901 2.6675 0.0 0
M  V30 7 N 4.6201 1.3338 0.0 0
M  V30 8 O 6.9301 2.6675 0.0 0
M  V30 9 C 5.3901 0.0000 0.0 0
M  V30 10 C 11.6099 5.8986 0.0 0
M  V30 11 C 11.6099 7.4386 0.0 0
M  V30 12 N 10.1452 5.4226 0.0 0
M  V30 13 C 12.9435 5.1286 0.0 0
M  V30 14 S 10.1452 7.9145 0.0 0
M  V30 15 C 12.9435 8.2086 0.0 0
M  V30 16 C 9.2401 6.6686 0.0 0
M  V30 17 C 14.2772 5.8986 0.0 0
M  V30 18 C 14.2772 7.4386 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 2.3100 2.6675 0.0 0
M  V30 21 C 2.3100 5.3348 0.0 0
M  V30 22 C 0.7700 2.6675 0.0 0
M  V30 23 C 0.7700 5.3348 0.0 0
M  V30 24 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3 CFG=1
M  V30 4 2 2 4
M  V30 5 1 5 3 CFG=3
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2770660-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2770660-92-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32438670
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isothioureas, ureas, and their N-methyl amides from 2-aminobenzothiazole
and chiral amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Padilla-Martinez, Itzia I.; Gonzalez-Encarnacion, Jose Miguel;
Garcia-Baez, Efren V.; Cruz, Alejandro; Ramos-Organillo, Angel Andres
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2019), 24(18), 3391

$RFMT $RIREG SCHEME106 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-5-nitrobenzaldehyde
C7H4FNO3
27996-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 O 6.9301 2.6675 0.0 0
M  V30 3 F 4.6201 6.6686 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 2.6675 0.0 0
M  V30 9 C 3.8500 5.3348 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl chloroformate
C8H7ClO2
501-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 Cl 6.6685 0.0000 0.0 0
M  V30 5 O 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(2-fluoro-5-nitrophenyl)methyl]-N-methylcarbamate
C16H15FN2O4
1508298-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6675 0.0 0
M  V30 2 N 6.9301 4.0011 0.0 0
M  V30 3 C 8.4701 4.0011 0.0 0
M  V30 4 C 6.1601 5.3348 0.0 0
M  V30 5 O 9.2401 5.3348 0.0 0
M  V30 6 O 9.2401 2.6675 0.0 0
M  V30 7 C 10.7801 5.3348 0.0 0
M  V30 8 F 4.6201 0.0000 0.0 0
M  V30 9 N 1.5400 5.3348 0.0 0 VAL=5
M  V30 10 O 0.0000 5.3348 0.0 0
M  V30 11 O 2.3100 6.6684 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 3.8500 4.0011 0.0 0
M  V30 14 C 3.8500 1.3337 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 1.3337 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 18 C 11.5501 6.6684 0.0 0
M  V30 19 C 13.0901 6.6684 0.0 0
M  V30 20 C 10.7801 8.0022 0.0 0
M  V30 21 C 13.8602 8.0022 0.0 0
M  V30 22 C 11.5501 9.3359 0.0 0
M  V30 23 C 13.0901 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 18
M  V30 9 1 8 14
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 15
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27996-87-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 501-53-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1508298-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6676662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic compounds as factor VIIa inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojun; Glunz, Peter W.; Priestley, Eldon Scott; Johnson, James
A.; Wurtz, Nicholas Ronald; Ladziata, Vladimir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013184734 A1 2013-12-12

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Ethyl (5aS,9aR)-6,7,8,9-tetrahydro-4-methoxy-7-oxo-9a(5aH)-dibenzofuranacetate
C17H20O5
2824972-34-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2404 5.6252 0.0 0
M  V30 2 C 7.7050 5.1492 0.0 0
M  V30 3 O 8.8495 6.1797 0.0 0
M  V30 4 O 8.0251 3.6429 0.0 0
M  V30 5 C 10.3140 5.7039 0.0 0
M  V30 6 C 11.4586 6.7343 0.0 0
M  V30 7 O 0.7700 7.3930 0.0 0
M  V30 8 C 0.0000 8.7266 0.0 0
M  V30 9 O 5.5788 0.0000 0.0 0
M  V30 10 C 5.0959 4.5946 0.0 0 CFG=1
M  V30 11 C 4.6200 6.0593 0.0 0
M  V30 12 C 3.8500 3.6894 0.0 0 CFG=2
M  V30 13 C 6.5028 3.9683 0.0 0
M  V30 14 C 3.0800 6.0593 0.0 0
M  V30 15 C 5.3900 7.3930 0.0 0
M  V30 16 O 2.6042 4.5946 0.0 0
M  V30 17 C 4.0110 2.1579 0.0 0
M  V30 18 C 6.6638 2.4368 0.0 0
M  V30 19 C 2.3100 7.3930 0.0 0
M  V30 20 C 4.6200 8.7266 0.0 0
M  V30 21 C 5.4179 1.5315 0.0 0
M  V30 22 C 3.0800 8.7266 0.0 0
M  V30 23 H 2.5164 2.9194 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 2 9 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 1 12 23 CFG=1
M  V30 18 1 13 18
M  V30 19 1 14 16
M  V30 20 2 14 19
M  V30 21 1 15 20
M  V30 22 1 17 21
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5aS,9aR)-6,7,8,9-Tetrahydro-4-methoxy-N-methyl-7-oxo-9a(5aH)-dibenzofuranace...
C16H19NO4
2824972-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.4886 5.2023 0.0 0
M  V30 2 C 1.9823 5.5225 0.0 0
M  V30 3 N 1.5064 6.9872 0.0 0
M  V30 4 O 0.9517 4.3781 0.0 0
M  V30 5 C 0.0000 7.3073 0.0 0
M  V30 6 O 9.1101 3.9982 0.0 0
M  V30 7 C 10.4437 4.7682 0.0 0
M  V30 8 O 1.2489 0.0000 0.0 0
M  V30 9 C 3.9644 3.7378 0.0 0 CFG=1
M  V30 10 C 5.1090 4.7682 0.0 0
M  V30 11 C 4.5909 2.3308 0.0 0 CFG=2
M  V30 12 C 2.4329 3.8987 0.0 0
M  V30 13 C 6.4426 3.9982 0.0 0
M  V30 14 C 5.1090 6.3082 0.0 0
M  V30 15 O 6.1225 2.4917 0.0 0
M  V30 16 C 3.6857 1.0849 0.0 0
M  V30 17 C 1.5277 2.6528 0.0 0
M  V30 18 C 7.7763 4.7682 0.0 0
M  V30 19 C 6.4426 7.0782 0.0 0
M  V30 20 C 2.1542 1.2459 0.0 0
M  V30 21 C 7.7763 6.3082 0.0 0
M  V30 22 H 5.3609 0.9972 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 2 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 22 CFG=3
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 16 20
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 2 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2824972-34-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2824972-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34206101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Total Syntheses of (-)-Lycoramine, (-)-Lycoraminone,
(-)-Narwedine, and (-)-Galanthamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Majumder, Satyajit; Yadav, Abhinay; Pal, Souvik; Khatua, Arindam; Bisai,
Alakesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2022), 87(12), 7786-7797

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazo[1,2-a]pyrazine-2-carboxylic acid, 8-[[[1-[(1,1-dimethylethoxy)carbony...
C25H32N6O4
2827006-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1392 7.7002 0.0 0
M  V30 2 C 10.4730 6.9302 0.0 0
M  V30 3 C 3.8501 10.7012 0.0 0
M  V30 4 O 2.3101 10.7012 0.0 0
M  V30 5 O 4.6201 12.0351 0.0 0
M  V30 6 C 1.5400 12.0351 0.0 0
M  V30 7 C 0.0000 12.0351 0.0 0
M  V30 8 C 15.8078 10.0102 0.0 0
M  V30 9 O 17.1415 9.2402 0.0 0
M  V30 10 O 15.8078 11.5503 0.0 0
M  V30 11 C 18.4752 10.0102 0.0 0
M  V30 12 C 17.7052 11.3440 0.0 0
M  V30 13 C 19.8088 10.7802 0.0 0
M  V30 14 C 19.2452 8.6765 0.0 0
M  V30 15 C 6.4718 7.7002 0.0 0
M  V30 16 N 5.1382 6.9302 0.0 0
M  V30 17 C 7.8055 6.9302 0.0 0
M  V30 18 N 6.1517 9.2066 0.0 0
M  V30 19 C 5.1382 5.3901 0.0 0
M  V30 20 C 3.9936 7.9607 0.0 0
M  V30 21 N 7.8055 5.3901 0.0 0
M  V30 22 C 4.6201 9.3676 0.0 0
M  V30 23 C 6.4718 4.6201 0.0 0
M  V30 24 C 6.4718 3.0801 0.0 0
M  V30 25 C 5.1382 2.3101 0.0 0
M  V30 26 C 7.8055 2.3101 0.0 0
M  V30 27 C 5.1382 0.7700 0.0 0
M  V30 28 C 7.8055 0.7700 0.0 0
M  V30 29 N 6.4718 0.0000 0.0 0
M  V30 30 C 11.8067 7.7002 0.0 0
M  V30 31 C 13.1403 6.9302 0.0 0
M  V30 32 C 11.8067 9.2402 0.0 0
M  V30 33 C 14.4740 7.7002 0.0 0
M  V30 34 C 13.1403 10.0102 0.0 0
M  V30 35 N 14.4740 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 30
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 35
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[[2-[(methylamino)carbonyl]-6-(4-pyridinyl)imidazo[1,2-a...
C24H31N7O3
2827006-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 7.7002 0.0 0
M  V30 2 C 8.9330 6.9302 0.0 0
M  V30 3 C 2.3101 10.7012 0.0 0
M  V30 4 N 0.7700 10.7012 0.0 0
M  V30 5 O 3.0801 12.0351 0.0 0
M  V30 6 C 0.0000 12.0351 0.0 0
M  V30 7 C 14.2678 10.0102 0.0 0
M  V30 8 O 15.6015 9.2402 0.0 0
M  V30 9 O 14.2678 11.5503 0.0 0
M  V30 10 C 16.9351 10.0102 0.0 0
M  V30 11 C 17.7052 8.6765 0.0 0
M  V30 12 C 18.2688 10.7802 0.0 0
M  V30 13 C 16.1651 11.3440 0.0 0
M  V30 14 C 4.9318 7.7002 0.0 0
M  V30 15 N 3.5981 6.9302 0.0 0
M  V30 16 C 6.2655 6.9302 0.0 0
M  V30 17 N 4.6116 9.2066 0.0 0
M  V30 18 C 3.5981 5.3901 0.0 0
M  V30 19 C 2.4536 7.9607 0.0 0
M  V30 20 N 6.2655 5.3901 0.0 0
M  V30 21 C 3.0801 9.3676 0.0 0
M  V30 22 C 4.9318 4.6201 0.0 0
M  V30 23 C 4.9318 3.0801 0.0 0
M  V30 24 C 6.2655 2.3101 0.0 0
M  V30 25 C 3.5981 2.3101 0.0 0
M  V30 26 C 6.2655 0.7700 0.0 0
M  V30 27 C 3.5981 0.7700 0.0 0
M  V30 28 N 4.9318 0.0000 0.0 0
M  V30 29 C 10.2666 7.7002 0.0 0
M  V30 30 C 10.2666 9.2402 0.0 0
M  V30 31 C 11.6003 6.9302 0.0 0
M  V30 32 C 11.6003 10.0102 0.0 0
M  V30 33 C 12.9340 7.7002 0.0 0
M  V30 34 N 12.9340 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 29
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 21
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 34
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2827006-91-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2827006-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35352392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazo[1,2-a]pyrazines as inhibitors of haspin and therapeutic uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastor Fernandez, Joaquin; Martinez Gonzalez, Sonia; Blanco-Aparicio,
Carmen; Gonzalez Cantalapiedra, Esther; Garcia Garcia, Ana Belen; Pastor
Fernandez, Miryam; Hernandez Higueras, Ana Isabel; Albarran Santino,
Maria Isabel; Cebria Gomez, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4049726 A1 2022-08-31

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanepropanoic acid, 4-methyl-2-oxo-6-(2-propyn-1-yl)-, methyl ester, (...
C14H20O3
2832167-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 5.3347 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 C 3.0800 5.3347 0.0 0
M  V30 6 C 2.3100 6.6685 0.0 0
M  V30 7 O 0.7700 6.6685 0.0 0
M  V30 8 O 3.0800 8.0021 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 O 3.0800 2.6674 0.0 0
M  V30 11 C 7.7000 0.0000 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 13 C 5.3900 4.0011 0.0 0 CFG=3
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 6.9300 1.3336 0.0 0 CFG=1
M  V30 17 C 5.3900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 3 2 3
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 10 15
M  V30 11 1 16 11 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5S,7R)-3,4,5,6,7,8-Hexahydro-1,7-dimethyl-5-(2-propyn-1-yl)-2(1H)-quinolinone
C14H19NO
2832167-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 C 8.4700 5.3349 0.0 0
M  V30 4 C 10.0100 5.3349 0.0 0
M  V30 5 O 0.0000 4.0011 0.0 0
M  V30 6 C 6.9300 0.0000 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 6.1600 1.3338 0.0 0 CFG=2
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 11 2 CFG=3
M  V30 4 3 3 4
M  V30 5 2 5 13
M  V30 6 1 14 6 CFG=1
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2832167-84-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2832167-91-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34971259
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Collective Total Syntheses of Five Lycopodium Alkaloids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM He, Feifei; Feng, Shangbiao; Zhao, Yulong; Shi, Hongliang; Duan,
Xiaoguang; Li, Huilin; Xie, Xingang; She, Xuegong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2022), 61(32), e202205439

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-8-(1,1-dimethylethyl)-8,9-dihydro-4-(trifluoromethyl)pyrido[1,2-a]be...
C16H16ClF3N2O
2848561-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 2.1037 5.9537 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 0.5636 3.2864 0.0 0
M  V30 5 Cl 4.0011 0.0000 0.0 0
M  V30 6 O 6.1318 8.9401 0.0 0
M  V30 7 C 10.4477 5.8045 0.0 0
M  V30 8 C 11.3529 7.0504 0.0 0
M  V30 9 C 11.9792 5.6434 0.0 0
M  V30 10 C 11.0740 4.3975 0.0 0
M  V30 11 N 5.3348 3.8501 0.0 0
M  V30 12 C 6.4792 4.8805 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 15 C 5.8529 6.2874 0.0 0
M  V30 16 C 8.0109 4.7196 0.0 0
M  V30 17 N 4.3213 6.1264 0.0 0
M  V30 18 C 2.6675 3.8501 0.0 0
M  V30 19 C 4.0011 1.5400 0.0 0
M  V30 20 C 6.7581 7.5333 0.0 0
M  V30 21 C 8.9161 5.9654 0.0 0
M  V30 22 C 2.6675 2.3100 0.0 0
M  V30 23 C 8.2896 7.3722 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 18
M  V30 5 1 5 19
M  V30 6 2 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 21
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 13 18
M  V30 18 2 14 19
M  V30 19 1 15 17
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 18 22
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-Chloro-8-(1,1-dimethylethyl)-8,9-dihydro-4-(trifluoromethyl)pyrido[1,2-a...
C17H19ClF3N3
2848561-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.7270 9.1138 0.0 0
M  V30 2 C 6.4970 10.4474 0.0 0
M  V30 3 C 10.3470 6.4465 0.0 0
M  V30 4 C 11.1170 7.7801 0.0 0
M  V30 5 C 11.8870 6.4465 0.0 0
M  V30 6 C 11.1170 5.1127 0.0 0
M  V30 7 C 1.4070 4.3159 0.0 0
M  V30 8 F 2.0333 5.7227 0.0 0
M  V30 9 F 0.0000 4.9422 0.0 0
M  V30 10 F 0.7805 2.9089 0.0 0
M  V30 11 Cl 4.5426 0.0000 0.0 0
M  V30 12 C 6.4970 5.1127 0.0 0
M  V30 13 N 5.4666 3.9683 0.0 0
M  V30 14 C 5.7270 6.4465 0.0 0
M  V30 15 C 8.0370 5.1127 0.0 0
M  V30 16 C 4.0596 4.5946 0.0 0
M  V30 17 C 5.6275 2.4368 0.0 0
M  V30 18 C 6.4970 7.7801 0.0 0
M  V30 19 N 4.2205 6.1262 0.0 0
M  V30 20 C 8.8070 6.4465 0.0 0
M  V30 21 C 2.8137 3.6894 0.0 0
M  V30 22 C 4.3816 1.5315 0.0 0
M  V30 23 C 8.0370 7.7801 0.0 0
M  V30 24 C 2.9747 2.1579 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 18 CFG=2
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 21
M  V30 11 1 11 22
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 2 16 19
M  V30 21 1 16 21
M  V30 22 2 17 22
M  V30 23 1 18 23
M  V30 24 1 20 23
M  V30 25 2 21 24
M  V30 26 1 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2848561-34-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2848561-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34732032
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7775-14-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted tetracyclic carboxylic acids, analogues
thereof, for the treatment and prevention of HBV and HDV infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Shuai; Cole, Andrew G.; Dorsey, Bruce D.; Gao, Min; Gotchev,
Dimitar B.; Harasym, Troy; Sofia, Michael J.; Tang, Sunny Ho-Kwong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022214937 A1 2022-10-13

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-2-(5,6,7-trifluoro-1H-indol-3-yl)-5-quinolinecarboxylic acid
C18H8F4N2O2
2851434-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 12.9765 6.7324 0.0 0
M  V30 2 F 11.8673 1.5142 0.0 0
M  V30 3 F 13.9284 3.8031 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 O 4.0012 0.0000 0.0 0
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 F 0.0000 2.3101 0.0 0
M  V30 8 C 9.4091 4.7636 0.0 0
M  V30 9 C 8.0023 5.3901 0.0 0
M  V30 10 C 10.4397 5.9082 0.0 0
M  V30 11 C 9.8850 3.2991 0.0 0
M  V30 12 C 8.1633 6.9217 0.0 0
M  V30 13 N 9.6697 7.2419 0.0 0
M  V30 14 C 11.9460 5.5880 0.0 0
M  V30 15 C 11.3915 2.9789 0.0 0
M  V30 16 C 12.4219 4.1233 0.0 0
M  V30 17 C 6.6687 4.6201 0.0 0
M  V30 18 N 5.3348 5.3901 0.0 0
M  V30 19 C 6.6687 3.0801 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 5.3348 2.3101 0.0 0
M  V30 22 C 4.0012 3.0801 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 1.3338 4.6201 0.0 0
M  V30 26 C 1.3338 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 15
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 24
M  V30 7 1 7 26
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 17
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-N-methyl-2-(5,6,7-trifluoro-1H-indol-3-yl)-5-quinolinecarboxamide
C19H11F4N3O
1817721-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 3.9644 0.0 0
M  V30 2 F 3.5696 0.0000 0.0 0
M  V30 3 F 0.6403 0.9517 0.0 0
M  V30 4 C 11.9089 3.9554 0.0 0
M  V30 5 N 13.4489 3.9554 0.0 0
M  V30 6 O 11.1389 2.6216 0.0 0
M  V30 7 C 14.2189 2.6216 0.0 0
M  V30 8 F 13.4489 6.6226 0.0 0
M  V30 9 C 4.0736 4.0431 0.0 0
M  V30 10 C 4.9788 5.2890 0.0 0
M  V30 11 C 2.6091 4.5190 0.0 0
M  V30 12 C 4.3938 2.5367 0.0 0
M  V30 13 C 4.0736 6.5349 0.0 0
M  V30 14 N 2.6091 6.0590 0.0 0
M  V30 15 C 1.4645 3.4886 0.0 0
M  V30 16 C 3.2494 1.5063 0.0 0
M  V30 17 C 1.7847 1.9821 0.0 0
M  V30 18 C 6.5189 5.2890 0.0 0
M  V30 19 N 7.2889 6.6226 0.0 0
M  V30 20 C 7.2889 3.9554 0.0 0
M  V30 21 C 8.8289 6.6226 0.0 0
M  V30 22 C 8.8289 3.9554 0.0 0
M  V30 23 C 9.5989 5.2890 0.0 0
M  V30 24 C 9.5989 7.9563 0.0 0
M  V30 25 C 11.1389 5.2890 0.0 0
M  V30 26 C 11.1389 7.9563 0.0 0
M  V30 27 C 11.9089 6.6226 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 16
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 25
M  V30 7 1 5 7
M  V30 8 1 8 27
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 18
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 22 23
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2851434-95-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1817721-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34816550
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tri-substituted indole binding function 3 (bf3) compounds and methods for
their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tcherkasov, Artem; Lack, Nathan; Leblanc, Eric J.; Rennie, Paul S.; Ban,
Fuqiang; Andre, Christophe; Chen, Gang; Mohan, Sankar; Young, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022219541 A1 2022-10-20

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 5-[[1-[(1,1-dimethylethoxy)carbonyl]-3-azetidinyl]...
C15H21N3O4
2868276-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5547 4.6201 0.0 0
M  V30 2 C 4.0012 1.9911 0.0 0
M  V30 3 O 2.6673 2.7611 0.0 0
M  V30 4 O 4.0012 0.4511 0.0 0
M  V30 5 C 1.3337 1.9911 0.0 0
M  V30 6 C 0.5637 3.3248 0.0 0
M  V30 7 C 0.0000 1.2211 0.0 0
M  V30 8 C 2.1037 0.6574 0.0 0
M  V30 9 C 13.8896 1.5400 0.0 0
M  V30 10 O 15.2232 2.3101 0.0 0
M  V30 11 O 13.8896 0.0000 0.0 0
M  V30 12 C 16.5569 1.5400 0.0 0
M  V30 13 C 7.2209 3.8501 0.0 0
M  V30 14 C 6.8224 2.3626 0.0 0
M  V30 15 C 5.7334 4.2486 0.0 0
M  V30 16 N 5.3348 2.7611 0.0 0
M  V30 17 C 9.8884 3.8501 0.0 0
M  V30 18 C 11.2221 4.6201 0.0 0
M  V30 19 C 9.8884 2.3101 0.0 0
M  V30 20 C 12.5557 3.8501 0.0 0
M  V30 21 N 11.2221 1.5400 0.0 0
M  V30 22 C 12.5557 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 22
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[[6-[(methylamino)carbonyl]-3-pyridinyl]amino]-1-azetidin...
C15H22N4O3
2868276-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5547 4.6201 0.0 0
M  V30 2 C 4.0012 1.9911 0.0 0
M  V30 3 O 2.6673 2.7611 0.0 0
M  V30 4 O 4.0012 0.4511 0.0 0
M  V30 5 C 1.3337 1.9911 0.0 0
M  V30 6 C 0.5637 3.3248 0.0 0
M  V30 7 C 0.0000 1.2211 0.0 0
M  V30 8 C 2.1037 0.6574 0.0 0
M  V30 9 C 13.8896 1.5400 0.0 0
M  V30 10 N 15.2232 2.3101 0.0 0
M  V30 11 O 13.8896 0.0000 0.0 0
M  V30 12 C 16.5569 1.5400 0.0 0
M  V30 13 C 7.2209 3.8501 0.0 0
M  V30 14 C 6.8224 2.3626 0.0 0
M  V30 15 C 5.7334 4.2486 0.0 0
M  V30 16 N 5.3348 2.7611 0.0 0
M  V30 17 C 9.8884 3.8501 0.0 0
M  V30 18 C 9.8884 2.3101 0.0 0
M  V30 19 C 11.2221 4.6201 0.0 0
M  V30 20 C 11.2221 1.5400 0.0 0
M  V30 21 N 12.5557 3.8501 0.0 0
M  V30 22 C 12.5557 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 22
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-78-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-77-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34894134
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro biological evaluation of
3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective
inhibitors and PARP-1 DNA trappers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Junkang; Quan, Xu; Liu, Ying; Li, Jiani; Zhang, Xiaoyu; Li, Zhiyu;
Zhang, Xiaomeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 78129046

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2-deoxy-4-thio-β-L-erythro-pentofuranosyl)-9H-purine
C10H11ClN4O2S
287724-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 10.6980 2.3587 0.0 0
M  V30 2 C 0.1609 1.5316 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 0.8575 4.8088 0.0 0
M  V30 5 N 5.5524 2.0983 0.0 0
M  V30 6 C 6.6968 3.1287 0.0 0
M  V30 7 C 6.1788 0.6913 0.0 0
M  V30 8 C 8.0307 2.3587 0.0 0
M  V30 9 N 6.6968 4.6688 0.0 0
M  V30 10 N 7.7103 0.8524 0.0 0
M  V30 11 C 9.3643 3.1287 0.0 0
M  V30 12 C 8.0307 5.4388 0.0 0
M  V30 13 N 9.3643 4.6688 0.0 0
M  V30 14 C 4.0460 2.4185 0.0 0 CFG=2
M  V30 15 S 2.9016 1.3880 0.0 0
M  V30 16 C 3.4196 3.8253 0.0 0
M  V30 17 C 1.5679 2.1580 0.0 0 CFG=1
M  V30 18 C 1.8881 3.6644 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=1
M  V30 4 1 18 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-(2-Deoxy-4-thio-β-L-erythro-pentofuranosyl)-N-methyl-9H-purin-6-amine
C11H15N5O2S
287724-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.6980 2.3587 0.0 0
M  V30 2 C 12.0317 3.1287 0.0 0
M  V30 3 C 0.1609 1.5316 0.0 0
M  V30 4 O 0.0000 0.0000 0.0 0
M  V30 5 O 0.8575 4.8088 0.0 0
M  V30 6 N 5.5524 2.0983 0.0 0
M  V30 7 C 6.6968 3.1287 0.0 0
M  V30 8 C 6.1788 0.6913 0.0 0
M  V30 9 C 8.0305 2.3587 0.0 0
M  V30 10 N 6.6968 4.6688 0.0 0
M  V30 11 N 7.7103 0.8524 0.0 0
M  V30 12 C 9.3643 3.1287 0.0 0
M  V30 13 C 8.0305 5.4388 0.0 0
M  V30 14 N 9.3643 4.6688 0.0 0
M  V30 15 C 4.0460 2.4185 0.0 0 CFG=2
M  V30 16 S 2.9016 1.3880 0.0 0
M  V30 17 C 3.4196 3.8253 0.0 0
M  V30 18 C 1.5679 2.1580 0.0 0 CFG=1
M  V30 19 C 1.8881 3.6644 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=1
M  V30 5 1 19 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 15 6 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 287724-97-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 287724-98-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4806478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly efficient synthesis of L-β-2'-deoxy-4'-thio-1'-purine
nucleosides as potential antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Hea Ok; Jeong, Lak Shin; Lee, Sun Nan; Yoo, Soo Jeong; Moon, Hyung
Ryong; Kim, Kil Soo; Chun, Moon Woo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Perkin 1 (2000), (9), 1327-1329

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′-(1,1-Dimethylethyl) 6-methyl 2-fluoro-3′,6′-dihydro[3,4′-bipyridine]-1′,6(...
C17H21FN2O4
2891600-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 O 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 5.5410 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 2.4610 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 C 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[3,4′-Bipyridine]-1′(2′H)-carboxylic acid, 2-fluoro-3′,6′-dihydro-6-[(methyla...
C17H22FN3O3
2920174-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 10.0102 0.0000 0.0 0
M  V30 2 C 14.6303 2.6673 0.0 0
M  V30 3 N 15.4003 4.0010 0.0 0
M  V30 4 O 15.4003 1.3337 0.0 0
M  V30 5 C 16.9404 4.0010 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 O 3.0801 4.0010 0.0 0
M  V30 8 O 3.0801 1.3337 0.0 0
M  V30 9 C 1.5400 4.0010 0.0 0
M  V30 10 C 1.5400 2.4610 0.0 0
M  V30 11 C 0.0000 4.0010 0.0 0
M  V30 12 C 1.5400 5.5410 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 15 C 10.7802 4.0010 0.0 0
M  V30 16 N 12.3203 1.3337 0.0 0
M  V30 17 C 12.3203 4.0010 0.0 0
M  V30 18 C 13.0903 2.6673 0.0 0
M  V30 19 C 8.4702 2.6673 0.0 0
M  V30 20 C 7.7002 1.3337 0.0 0
M  V30 21 C 7.7002 4.0010 0.0 0
M  V30 22 C 6.1601 1.3337 0.0 0
M  V30 23 C 6.1601 4.0010 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 24
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2891600-71-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2920174-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37652349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Piperazine derivatives as PARP1 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffman, Robert L.; Va, Porino Jinjo; Pinchman, Joseph Robert; Trzoss,
Lynnie; Dong, Qing; Kaldor, Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023146960 A1 2023-08-03

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 4-(4-fluorophenyl)-3-(methylthio)-4-oxo-, methyl ester, (2E)-
C12H11FO3S
2922561-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 S 5.3900 1.3338 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 O 0.7700 4.0011 0.0 0
M  V30 9 O 3.0800 5.3349 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 F 11.5500 4.0011 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Pyrrol-2-one, 5-(4-fluorophenyl)-1,5-dihydro-5-hydroxy-1-methyl-4-(methylt...
C12H12FNO2S
2922561-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8253 5.1959 0.0 0
M  V30 2 S 1.5316 5.3915 0.0 0
M  V30 3 C 0.0000 5.5524 0.0 0
M  V30 4 C 5.1591 1.3628 0.0 0
M  V30 5 O 2.0983 0.0000 0.0 0
M  V30 6 F 9.8245 3.6644 0.0 0
M  V30 7 C 3.6644 3.6644 0.0 0
M  V30 8 C 2.1580 3.9845 0.0 0
M  V30 9 N 3.8253 2.1328 0.0 0
M  V30 10 C 1.3880 2.6509 0.0 0
M  V30 11 C 2.4185 1.5065 0.0 0
M  V30 12 C 5.2044 3.6644 0.0 0
M  V30 13 C 5.9744 4.9980 0.0 0
M  V30 14 C 5.9744 2.3307 0.0 0
M  V30 15 C 7.5144 4.9980 0.0 0
M  V30 16 C 7.5144 2.3307 0.0 0
M  V30 17 C 8.2845 3.6644 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 8
M  V30 4 1 4 9
M  V30 5 2 5 11
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2922561-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2922561-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36150634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM I2-DMSO Promoted Deaminative Coupling Reactions of Glycine Esters: Access
to 5-(Methylthio)pyridazin-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhat, Showkat Ahmad; Bhat, Mohammad Yaqoob; Rather, Suhail Ahmad; Jameel,
Salman; Bhat, Khursheed Ahmad; Ahmed, Qazi Naveed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2023), 25(14), 2382-2387

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Pyrano[2,3-b]pyridin-4-one, 3-bromo-5,7-dimethyl-2-phenyl-
C16H12BrNO2
2943939-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 C 8.0022 0.0000 0.0 0
M  V30 3 Br 2.6673 1.5400 0.0 0
M  V30 4 C 10.6695 4.6201 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 C 6.6684 3.8500 0.0 0
M  V30 7 C 5.3348 1.5400 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 O 5.3348 4.6201 0.0 0
M  V30 10 N 8.0022 4.6201 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 9.3359 2.3100 0.0 0
M  V30 13 C 4.0011 3.8500 0.0 0
M  V30 14 C 9.3359 3.8500 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 2.6673 6.1601 0.0 0
M  V30 17 C 1.3337 3.8500 0.0 0
M  V30 18 C 1.3337 6.9301 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 20 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 11
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furo[2,3-b]pyridin-3(2H)-one, 4,6-dimethyl-2-[(methylamino)phenylmethylene]-,...
C17H16N2O2
2943939-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0009 0.0 0
M  V30 2 N 2.3100 5.3347 0.0 0
M  V30 3 C 0.7700 5.3347 0.0 0
M  V30 4 O 5.0494 6.7115 0.0 0
M  V30 5 C 8.3235 7.0809 0.0 0
M  V30 6 C 10.9910 2.4609 0.0 0
M  V30 7 C 4.6200 4.0009 0.0 0
M  V30 8 C 5.5252 5.2469 0.0 0
M  V30 9 O 5.5252 2.7551 0.0 0
M  V30 10 C 6.9899 4.7709 0.0 0
M  V30 11 C 6.9899 3.2309 0.0 0
M  V30 12 C 8.3235 5.5409 0.0 0
M  V30 13 N 8.3235 2.4609 0.0 0
M  V30 14 C 9.6572 4.7709 0.0 0
M  V30 15 C 9.6572 3.2309 0.0 0
M  V30 16 C 2.3100 2.6673 0.0 0
M  V30 17 C 3.0800 1.3336 0.0 0
M  V30 18 C 0.7700 2.6673 0.0 0
M  V30 19 C 2.3100 0.0000 0.0 0
M  V30 20 C 0.0000 1.3336 0.0 0
M  V30 21 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 2 4 8
M  V30 6 1 5 12
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2943939-94-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2943939-98-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36892440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Accessing 7-Azaaurones of Controllable E and Z Configurations from
8-Azaflavones via a Rearrangement-Acylation-Photoisomerization Sequence
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saulnier, Steve; Mehiaoui, Nawel; Leleu, Stephane; Jean, Ludovic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(20), e202301218

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Pyrano[2,3-b]pyridin-4-one, 3-bromo-2,5,7-triphenyl-
C26H16BrNO2
2943939-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 3.0800 0.0 0
M  V30 2 Br 10.6695 4.6201 0.0 0
M  V30 3 C 6.6684 5.3901 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 C 6.6684 6.9301 0.0 0
M  V30 6 C 8.0021 4.6201 0.0 0
M  V30 7 C 4.0010 5.3901 0.0 0
M  V30 8 N 5.3348 7.7001 0.0 0
M  V30 9 O 8.0021 7.7001 0.0 0
M  V30 10 C 9.3359 5.3901 0.0 0
M  V30 11 C 4.0010 6.9301 0.0 0
M  V30 12 C 9.3359 6.9301 0.0 0
M  V30 13 C 5.3348 3.0800 0.0 0
M  V30 14 C 4.0010 2.3100 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 16 C 4.0010 0.7700 0.0 0
M  V30 17 C 6.6684 0.7700 0.0 0
M  V30 18 C 5.3348 0.0000 0.0 0
M  V30 19 C 2.6673 7.7001 0.0 0
M  V30 20 C 2.6673 9.2401 0.0 0
M  V30 21 C 1.3337 6.9301 0.0 0
M  V30 22 C 1.3337 10.0101 0.0 0
M  V30 23 C 0.0000 7.7001 0.0 0
M  V30 24 C 0.0000 9.2401 0.0 0
M  V30 25 C 10.6695 7.7001 0.0 0
M  V30 26 C 10.6695 9.2401 0.0 0
M  V30 27 C 12.0032 6.9301 0.0 0
M  V30 28 C 12.0032 10.0101 0.0 0
M  V30 29 C 13.3369 7.7001 0.0 0
M  V30 30 C 13.3369 9.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 13
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 2 10 12
M  V30 15 1 11 19
M  V30 16 1 12 25
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furo[2,3-b]pyridin-3(2H)-one, 2-[(methylamino)phenylmethylene]-4,6-diphenyl-,...
C27H20N2O2
2943940-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0494 3.4495 0.0 0
M  V30 2 C 3.0800 6.1600 0.0 0
M  V30 3 N 2.3100 4.8262 0.0 0
M  V30 4 C 0.7700 4.8262 0.0 0
M  V30 5 C 6.9899 5.3900 0.0 0
M  V30 6 C 6.9899 6.9300 0.0 0
M  V30 7 C 8.3236 4.6200 0.0 0
M  V30 8 C 5.5252 4.9140 0.0 0
M  V30 9 O 5.5252 7.4059 0.0 0
M  V30 10 N 8.3236 7.7000 0.0 0
M  V30 11 C 9.6572 5.3900 0.0 0
M  V30 12 C 4.6200 6.1600 0.0 0
M  V30 13 C 9.6572 6.9300 0.0 0
M  V30 14 C 8.3236 3.0800 0.0 0
M  V30 15 C 9.6572 2.3100 0.0 0
M  V30 16 C 6.9899 2.3100 0.0 0
M  V30 17 C 9.6572 0.7700 0.0 0
M  V30 18 C 6.9899 0.7700 0.0 0
M  V30 19 C 8.3236 0.0000 0.0 0
M  V30 20 C 10.9909 7.7000 0.0 0
M  V30 21 C 12.3247 6.9300 0.0 0
M  V30 22 C 10.9909 9.2400 0.0 0
M  V30 23 C 13.6583 7.7000 0.0 0
M  V30 24 C 12.3247 10.0101 0.0 0
M  V30 25 C 13.6583 9.2400 0.0 0
M  V30 26 C 2.3100 7.4937 0.0 0
M  V30 27 C 3.0800 8.8273 0.0 0
M  V30 28 C 0.7700 7.4937 0.0 0
M  V30 29 C 2.3100 10.1610 0.0 0
M  V30 30 C 0.0000 8.8273 0.0 0
M  V30 31 C 0.7700 10.1610 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 2 2 12
M  V30 4 1 2 26
M  V30 5 1 3 4
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 7 14
M  V30 13 1 8 12
M  V30 14 1 9 12
M  V30 15 1 10 13
M  V30 16 2 11 13
M  V30 17 1 13 20
M  V30 18 2 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2943939-97-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2943940-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36892443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Accessing 7-Azaaurones of Controllable E and Z Configurations from
8-Azaflavones via a Rearrangement-Acylation-Photoisomerization Sequence
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saulnier, Steve; Mehiaoui, Nawel; Leleu, Stephane; Jean, Ludovic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(20), e202301218

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H20D3N3O4
2947391-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3338 0.0 0
M  V30 2 C 0.7700 4.0011 0.0 0
M  V30 3 O 0.0000 2.6674 0.0 0
M  V30 4 O 0.0000 5.3349 0.0 0
M  V30 5 C 11.5500 4.0011 0.0 0
M  V30 6 O 12.3200 5.3349 0.0 0
M  V30 7 O 12.3200 2.6674 0.0 0
M  V30 8 C 13.8600 5.3349 0.0 0
M  V30 9 C 13.8600 6.8749 0.0 0
M  V30 10 C 15.4000 5.3349 0.0 0
M  V30 11 C 13.8600 3.7949 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 4.6200 5.3349 0.0 0
M  V30 15 N 3.0800 2.6674 0.0 0
M  V30 16 C 3.0800 5.3349 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 N 6.9300 4.0011 0.0 0
M  V30 19 C 7.7000 5.3349 0.0 0
M  V30 20 C 7.7000 2.6674 0.0 0
M  V30 21 C 9.2400 5.3349 0.0 0
M  V30 22 C 9.2400 2.6674 0.0 0
M  V30 23 N 10.0100 4.0011 0.0 0
M  V30 24 H 4.6200 0.0000 0.0 0 MASS=2
M  V30 25 H 6.1600 0.0000 0.0 0 MASS=2
M  V30 26 H 6.9300 1.3338 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 24
M  V30 3 1 1 25
M  V30 4 1 1 26
M  V30 5 1 2 3
M  V30 6 2 2 4
M  V30 7 1 2 17
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 5 23
M  V30 11 1 6 8
M  V30 12 1 8 9
M  V30 13 1 8 10
M  V30 14 1 8 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 12 18
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C17H23D3N4O3
3053822-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 1.3338 0.0 0
M  V30 2 C 14.6300 4.0011 0.0 0
M  V30 3 N 15.4000 5.3349 0.0 0
M  V30 4 O 15.4000 2.6674 0.0 0
M  V30 5 C 16.9400 5.3349 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 O 3.0800 5.3349 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 C 1.5400 5.3349 0.0 0
M  V30 10 C 1.5400 6.8749 0.0 0
M  V30 11 C 0.0000 5.3347 0.0 0
M  V30 12 C 1.5400 3.7949 0.0 0
M  V30 13 C 10.0100 4.0011 0.0 0
M  V30 14 C 10.7800 2.6674 0.0 0
M  V30 15 C 10.7800 5.3349 0.0 0
M  V30 16 N 12.3200 2.6674 0.0 0
M  V30 17 C 12.3200 5.3349 0.0 0
M  V30 18 C 13.0900 4.0011 0.0 0
M  V30 19 N 8.4700 4.0011 0.0 0
M  V30 20 C 7.7000 5.3349 0.0 0
M  V30 21 C 7.7000 2.6674 0.0 0
M  V30 22 C 6.1600 5.3349 0.0 0
M  V30 23 C 6.1600 2.6674 0.0 0
M  V30 24 N 5.3900 4.0011 0.0 0
M  V30 25 H 10.7800 0.0000 0.0 0 MASS=2
M  V30 26 H 9.2400 0.0000 0.0 0 MASS=2
M  V30 27 H 8.4700 1.3338 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 25
M  V30 3 1 1 26
M  V30 4 1 1 27
M  V30 5 1 2 3
M  V30 6 2 2 4
M  V30 7 1 2 18
M  V30 8 1 3 5
M  V30 9 1 6 7
M  V30 10 2 6 8
M  V30 11 1 6 24
M  V30 12 1 7 9
M  V30 13 1 9 10
M  V30 14 1 9 11
M  V30 15 1 9 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 13 19
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2947391-21-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3053822-00-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42578835
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives and methods of use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178127 A1 2024-08-29

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Quinazolinecarboxylic acid, 6-[(3R)-3-[[(1,1-dimethylethoxy)carbonyl]methyl...
C32H40N6O6
2952906-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.0811 9.3359 0.0 0
M  V30 2 C 5.3110 10.6695 0.0 0
M  V30 3 O 6.0811 12.0032 0.0 0
M  V30 4 C 5.3110 13.3368 0.0 0
M  V30 5 C 3.0010 9.3359 0.0 0
M  V30 6 C 10.7011 4.0010 0.0 0
M  V30 7 O 9.9311 2.6673 0.0 0
M  V30 8 O 12.2411 4.0010 0.0 0
M  V30 9 C 10.7011 1.3337 0.0 0
M  V30 10 C 9.9311 0.0000 0.0 0
M  V30 11 C 0.0000 4.0467 0.0 0
M  V30 12 N 18.1669 9.6773 0.0 0
M  V30 13 C 19.5737 9.0510 0.0 0
M  V30 14 C 18.0059 11.2088 0.0 0
M  V30 15 O 20.8196 9.9562 0.0 0
M  V30 16 O 19.7347 7.5194 0.0 0
M  V30 17 C 22.2266 9.3297 0.0 0
M  V30 18 C 21.6001 7.9229 0.0 0
M  V30 19 C 23.6334 8.7034 0.0 0
M  V30 20 C 22.8529 10.7367 0.0 0
M  V30 21 C 6.0811 6.6684 0.0 0
M  V30 22 C 5.3110 8.0021 0.0 0
M  V30 23 C 5.3110 5.3348 0.0 0
M  V30 24 C 3.7710 8.0021 0.0 0
M  V30 25 C 3.7710 5.3348 0.0 0
M  V30 26 C 3.0010 6.6684 0.0 0
M  V30 27 C 2.7406 4.1902 0.0 0
M  V30 28 N 1.4946 6.3482 0.0 0
M  V30 29 N 1.3337 4.8167 0.0 0
M  V30 30 C 7.6211 6.6684 0.0 0
M  V30 31 N 8.3911 8.0021 0.0 0
M  V30 32 N 8.3911 5.3348 0.0 0
M  V30 33 C 9.9311 8.0021 0.0 0
M  V30 34 C 9.9311 5.3348 0.0 0
M  V30 35 C 10.7011 6.6684 0.0 0
M  V30 36 C 10.7011 9.3359 0.0 0
M  V30 37 C 12.2411 6.6684 0.0 0
M  V30 38 C 12.2411 9.3359 0.0 0
M  V30 39 C 13.0111 8.0021 0.0 0
M  V30 40 N 14.5511 8.0021 0.0 0
M  V30 41 C 15.4564 9.2479 0.0 0
M  V30 42 C 15.4564 6.7562 0.0 0
M  V30 43 C 16.9209 8.7721 0.0 0 CFG=2
M  V30 44 C 16.9209 7.2321 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 24
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 34
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 29
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 43 12 CFG=3
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 1 21 30
M  V30 24 2 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 33 36
M  V30 38 1 34 35
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 1 39 40
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 43)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(3R)-1-[2-[6-(methoxymethoxy)-2,7-dimethyl-2H-indazol-5-yl]...
C31H39N7O5
2952906-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.0811 8.0022 0.0 0
M  V30 2 C 5.3111 9.3360 0.0 0
M  V30 3 O 6.0811 10.6697 0.0 0
M  V30 4 C 5.3111 12.0033 0.0 0
M  V30 5 C 3.0011 8.0022 0.0 0
M  V30 6 C 10.7012 2.6673 0.0 0
M  V30 7 N 9.9312 1.3337 0.0 0
M  V30 8 O 12.2413 2.6673 0.0 0
M  V30 9 C 10.7012 0.0000 0.0 0
M  V30 10 C 0.0000 2.7131 0.0 0
M  V30 11 N 18.1672 8.3437 0.0 0
M  V30 12 C 19.5740 7.7174 0.0 0
M  V30 13 C 18.0061 9.8753 0.0 0
M  V30 14 O 20.8199 8.6225 0.0 0
M  V30 15 O 19.7349 6.1857 0.0 0
M  V30 16 C 22.2268 7.9962 0.0 0
M  V30 17 C 22.8532 9.4031 0.0 0
M  V30 18 C 23.6337 7.3698 0.0 0
M  V30 19 C 21.6004 6.5893 0.0 0
M  V30 20 C 6.0811 5.3348 0.0 0
M  V30 21 C 5.3111 6.6685 0.0 0
M  V30 22 C 5.3111 4.0012 0.0 0
M  V30 23 C 3.7711 6.6685 0.0 0
M  V30 24 C 3.7711 4.0012 0.0 0
M  V30 25 C 3.0011 5.3348 0.0 0
M  V30 26 C 2.7406 2.8566 0.0 0
M  V30 27 N 1.4946 5.0147 0.0 0
M  V30 28 N 1.3337 3.4831 0.0 0
M  V30 29 C 7.6212 5.3348 0.0 0
M  V30 30 N 8.3912 6.6685 0.0 0
M  V30 31 N 8.3912 4.0012 0.0 0
M  V30 32 C 9.9312 6.6685 0.0 0
M  V30 33 C 9.9312 4.0012 0.0 0
M  V30 34 C 10.7012 5.3348 0.0 0
M  V30 35 C 10.7012 8.0022 0.0 0
M  V30 36 C 12.2413 5.3348 0.0 0
M  V30 37 C 12.2413 8.0022 0.0 0
M  V30 38 C 13.0113 6.6685 0.0 0
M  V30 39 N 14.5513 6.6685 0.0 0
M  V30 40 C 15.4565 7.9144 0.0 0
M  V30 41 C 15.4565 5.4226 0.0 0
M  V30 42 C 16.9211 7.4385 0.0 0 CFG=2
M  V30 43 C 16.9211 5.8985 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 23
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 33
M  V30 9 1 7 9
M  V30 10 1 10 28
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 42 11 CFG=3
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 14 16
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 20 21
M  V30 21 2 20 22
M  V30 22 1 20 29
M  V30 23 2 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 32 35
M  V30 37 1 33 34
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 1 38 39
M  V30 43 1 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2952906-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2952906-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37546210
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-(Indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and
related compounds as modulators for splicing nucleic acids and for the
treatment of proliferative diseases and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reynolds, Dominic; Seiler, Michael W.; Agrawal, Anant A.; Vaillancourt,
Frederic; Smith, Peter; Prajapati, Sudeep; Hopper, Allen T.; Vyskocil,
Stepan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023133217 A1 2023-07-13

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzenedicarboxaldehyde, 4-[[1-(2-methylphenyl)-1H-1,2,3-triazol-4-yl]met...
C18H15N3O3
3036994-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.0849 4.8519 0.0 0
M  V30 2 C 7.8085 5.3347 0.0 0
M  V30 3 O 8.5785 4.0011 0.0 0
M  V30 4 C 10.1185 1.3336 0.0 0
M  V30 5 O 10.8885 0.0000 0.0 0
M  V30 6 C 14.7385 4.0011 0.0 0
M  V30 7 O 15.5085 5.3347 0.0 0
M  V30 8 N 3.8987 6.1047 0.0 0
M  V30 9 C 5.3632 6.5806 0.0 0
M  V30 10 N 3.8987 4.5647 0.0 0
M  V30 11 C 6.2684 5.3347 0.0 0
M  V30 12 N 5.3632 4.0889 0.0 0
M  V30 13 C 2.6528 7.0100 0.0 0
M  V30 14 C 1.2459 6.3836 0.0 0
M  V30 15 C 2.8137 8.5415 0.0 0
M  V30 16 C 0.0000 7.2887 0.0 0
M  V30 17 C 1.5679 9.4467 0.0 0
M  V30 18 C 0.1609 8.8204 0.0 0
M  V30 19 C 10.1185 4.0011 0.0 0
M  V30 20 C 10.8885 2.6674 0.0 0
M  V30 21 C 10.8885 5.3347 0.0 0
M  V30 22 C 12.4285 2.6674 0.0 0
M  V30 23 C 12.4285 5.3347 0.0 0
M  V30 24 C 13.1985 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 19
M  V30 5 2 4 5
M  V30 6 1 4 20
M  V30 7 2 6 7
M  V30 8 1 6 24
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 13
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H21N5O
3036994-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.0849 6.1856 0.0 0
M  V30 2 C 7.8085 6.6684 0.0 0
M  V30 3 O 8.5785 5.3347 0.0 0
M  V30 4 C 10.1185 2.6673 0.0 0
M  V30 5 N 10.8885 1.3336 0.0 0
M  V30 6 C 10.1185 0.0000 0.0 0
M  V30 7 C 14.7385 5.3347 0.0 0
M  V30 8 N 15.5085 6.6684 0.0 0
M  V30 9 C 17.0485 6.6684 0.0 0
M  V30 10 N 3.8987 7.4384 0.0 0
M  V30 11 C 5.3632 7.9143 0.0 0
M  V30 12 N 3.8987 5.8984 0.0 0
M  V30 13 C 6.2684 6.6684 0.0 0
M  V30 14 N 5.3632 5.4225 0.0 0
M  V30 15 C 2.6528 8.3436 0.0 0
M  V30 16 C 1.2459 7.7173 0.0 0
M  V30 17 C 2.8137 9.8751 0.0 0
M  V30 18 C 0.0000 8.6225 0.0 0
M  V30 19 C 1.5679 10.7804 0.0 0
M  V30 20 C 0.1609 10.1540 0.0 0
M  V30 21 C 10.1185 5.3347 0.0 0
M  V30 22 C 10.8885 4.0011 0.0 0
M  V30 23 C 10.8885 6.6684 0.0 0
M  V30 24 C 12.4285 4.0011 0.0 0
M  V30 25 C 12.4285 6.6684 0.0 0
M  V30 26 C 13.1985 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 21
M  V30 5 2 4 5
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 26
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036994-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036994-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40195540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and molecular docking studies of novel Schiff
bases bearing 1-(o-tolyl)-4-(phenoxymethyl)-(1H)1,2,3-triazole
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keskin, Selbi; Vural, Derya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Chemistry and Technology (Kilis, Turkey) (2023),
7(2), 171-179

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H26N2O7S
3052324-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5932 6.0559 0.0 0
M  V30 2 N 6.0665 4.6088 0.0 0
M  V30 3 C 4.5499 4.3414 0.0 0
M  V30 4 O 3.5600 5.5211 0.0 0
M  V30 5 O 12.1109 4.0134 0.0 0
M  V30 6 C 13.4445 4.7834 0.0 0
M  V30 7 O 14.7781 4.0134 0.0 0
M  V30 8 O 13.4445 6.3234 0.0 0
M  V30 9 O 1.5167 3.8066 0.0 0
M  V30 10 C 0.0000 3.5391 0.0 0
M  V30 11 N 20.1129 7.0934 0.0 0 VAL=5
M  V30 12 O 20.1129 8.6334 0.0 0
M  V30 13 O 21.4467 6.3234 0.0 0
M  V30 14 C 8.1098 6.3234 0.0 0 CFG=1
M  V30 15 C 8.1098 4.7834 0.0 0
M  V30 16 C 9.4434 7.0934 0.0 0
M  V30 17 C 9.4434 4.0134 0.0 0
M  V30 18 C 10.7772 6.3234 0.0 0
M  V30 19 C 10.7772 4.7834 0.0 0 CFG=1
M  V30 20 C 7.5831 7.7705 0.0 0
M  V30 21 C 8.4443 9.0472 0.0 0
M  V30 22 C 6.1027 8.1950 0.0 0
M  V30 23 C 7.4961 10.2607 0.0 0
M  V30 24 S 6.0490 9.7340 0.0 0
M  V30 25 C 4.0231 2.8943 0.0 0
M  V30 26 C 2.5065 2.6268 0.0 0
M  V30 27 C 5.0130 1.7145 0.0 0
M  V30 28 C 1.9798 1.1796 0.0 0
M  V30 29 C 4.4863 0.2673 0.0 0
M  V30 30 C 2.9697 0.0000 0.0 0
M  V30 31 C 16.1119 4.7834 0.0 0
M  V30 32 C 16.1119 6.3234 0.0 0
M  V30 33 C 17.4456 4.0134 0.0 0
M  V30 34 C 17.4456 7.0934 0.0 0
M  V30 35 C 18.7792 4.7834 0.0 0
M  V30 36 C 18.7792 6.3234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 1 19 5 CFG=3
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 31
M  V30 11 1 9 10
M  V30 12 1 9 26
M  V30 13 2 11 12
M  V30 14 2 11 13
M  V30 15 1 11 36
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20 CFG=3
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-methoxy-N-[[trans-4-[[(methylamino)carbonyl]oxy]-1-(3-thienyl)cy...
C21H26N2O4S
3052324-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.9841 0.0 0
M  V30 2 N 6.1600 5.3178 0.0 0
M  V30 3 C 4.6200 5.3178 0.0 0
M  V30 4 O 3.8500 3.9841 0.0 0
M  V30 5 O 12.0092 6.9539 0.0 0
M  V30 6 C 13.4562 6.4270 0.0 0
M  V30 7 N 14.6360 7.4169 0.0 0
M  V30 8 O 13.7237 4.9104 0.0 0
M  V30 9 C 16.0831 6.8903 0.0 0
M  V30 10 O 1.5400 5.3178 0.0 0
M  V30 11 C 0.0000 5.3178 0.0 0
M  V30 12 C 8.4700 3.9841 0.0 0 CFG=1
M  V30 13 C 8.2027 5.5007 0.0 0
M  V30 14 C 9.9171 3.4575 0.0 0
M  V30 15 C 9.3823 6.4906 0.0 0
M  V30 16 C 11.0969 4.4474 0.0 0
M  V30 17 C 10.8294 5.9640 0.0 0 CFG=1
M  V30 18 C 8.2027 2.4675 0.0 0
M  V30 19 C 9.2723 1.3597 0.0 0
M  V30 20 C 6.8185 1.7924 0.0 0
M  V30 21 C 8.5495 0.0000 0.0 0
M  V30 22 S 7.0327 0.2673 0.0 0
M  V30 23 C 3.8500 6.6514 0.0 0
M  V30 24 C 2.3100 6.6514 0.0 0
M  V30 25 C 4.6200 7.9852 0.0 0
M  V30 26 C 1.5400 7.9852 0.0 0
M  V30 27 C 3.8500 9.3188 0.0 0
M  V30 28 C 2.3100 9.3188 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 1 17 5 CFG=1
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=1
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052324-19-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052324-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37330992
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM overall yield 47% over two steps
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Immunosuppressive effects of new thiophene-based KV1.3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gubic, Spela; Montalbano, Alberto; Sala, Cesare; Becchetti, Andrea;
Hendrickx, Louise Antonia; Van Theemsche, Kenny M.; Pinheiro-Junior,
Ernesto Lopes; Altadonna, Ginevra Chioccioli; Peigneur, Steve; Ilas,
Janez; Labro, Alain J.; Pardo, Luis A.; Tytgat, Jan; Tomasic, Tihomir;
Arcangeli, Annarosa; Peterlin Masic, Lucija
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 259115561

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H26N2O7S
3052324-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5932 6.0559 0.0 0
M  V30 2 N 6.0665 4.6088 0.0 0
M  V30 3 C 4.5499 4.3414 0.0 0
M  V30 4 O 3.5600 5.5211 0.0 0
M  V30 5 O 12.1109 4.0134 0.0 0
M  V30 6 C 13.4445 4.7834 0.0 0
M  V30 7 O 14.7781 4.0134 0.0 0
M  V30 8 O 13.4445 6.3234 0.0 0
M  V30 9 O 1.5167 3.8066 0.0 0
M  V30 10 C 0.0000 3.5391 0.0 0
M  V30 11 N 20.1129 7.0934 0.0 0 VAL=5
M  V30 12 O 20.1129 8.6334 0.0 0
M  V30 13 O 21.4467 6.3234 0.0 0
M  V30 14 C 8.1098 6.3234 0.0 0 CFG=2
M  V30 15 C 8.1098 4.7834 0.0 0
M  V30 16 C 9.4434 7.0934 0.0 0
M  V30 17 C 9.4434 4.0134 0.0 0
M  V30 18 C 10.7772 6.3234 0.0 0
M  V30 19 C 10.7772 4.7834 0.0 0 CFG=1
M  V30 20 C 7.5831 7.7705 0.0 0
M  V30 21 C 8.4443 9.0472 0.0 0
M  V30 22 C 6.1027 8.1950 0.0 0
M  V30 23 C 7.4961 10.2607 0.0 0
M  V30 24 S 6.0490 9.7340 0.0 0
M  V30 25 C 4.0231 2.8943 0.0 0
M  V30 26 C 2.5065 2.6268 0.0 0
M  V30 27 C 5.0130 1.7145 0.0 0
M  V30 28 C 1.9798 1.1796 0.0 0
M  V30 29 C 4.4863 0.2673 0.0 0
M  V30 30 C 2.9697 0.0000 0.0 0
M  V30 31 C 16.1119 4.7834 0.0 0
M  V30 32 C 16.1119 6.3234 0.0 0
M  V30 33 C 17.4456 4.0134 0.0 0
M  V30 34 C 17.4456 7.0934 0.0 0
M  V30 35 C 18.7792 4.7834 0.0 0
M  V30 36 C 18.7792 6.3234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 1 19 5 CFG=3
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 31
M  V30 11 1 9 10
M  V30 12 1 9 26
M  V30 13 2 11 12
M  V30 14 2 11 13
M  V30 15 1 11 36
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20 CFG=1
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-methoxy-N-[[cis-4-[[(methylamino)carbonyl]oxy]-1-(3-thienyl)cycl...
C21H26N2O4S
3052324-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.9841 0.0 0
M  V30 2 N 6.1600 5.3178 0.0 0
M  V30 3 C 4.6200 5.3178 0.0 0
M  V30 4 O 3.8500 3.9841 0.0 0
M  V30 5 O 12.0092 6.9539 0.0 0
M  V30 6 C 13.4562 6.4270 0.0 0
M  V30 7 N 14.6360 7.4169 0.0 0
M  V30 8 O 13.7237 4.9104 0.0 0
M  V30 9 C 16.0831 6.8903 0.0 0
M  V30 10 O 1.5400 5.3178 0.0 0
M  V30 11 C 0.0000 5.3178 0.0 0
M  V30 12 C 8.4700 3.9841 0.0 0 CFG=2
M  V30 13 C 8.2027 5.5007 0.0 0
M  V30 14 C 9.9171 3.4575 0.0 0
M  V30 15 C 9.3823 6.4906 0.0 0
M  V30 16 C 11.0969 4.4474 0.0 0
M  V30 17 C 10.8294 5.9640 0.0 0 CFG=1
M  V30 18 C 8.2027 2.4675 0.0 0
M  V30 19 C 9.2723 1.3597 0.0 0
M  V30 20 C 6.8185 1.7924 0.0 0
M  V30 21 C 8.5495 0.0000 0.0 0
M  V30 22 S 7.0327 0.2673 0.0 0
M  V30 23 C 3.8500 6.6514 0.0 0
M  V30 24 C 2.3100 6.6514 0.0 0
M  V30 25 C 4.6200 7.9852 0.0 0
M  V30 26 C 1.5400 7.9852 0.0 0
M  V30 27 C 3.8500 9.3188 0.0 0
M  V30 28 C 2.3100 9.3188 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 1 17 5 CFG=1
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=3
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3052324-20-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052324-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37331004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM overall yield 42% over two steps
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Immunosuppressive effects of new thiophene-based KV1.3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gubic, Spela; Montalbano, Alberto; Sala, Cesare; Becchetti, Andrea;
Hendrickx, Louise Antonia; Van Theemsche, Kenny M.; Pinheiro-Junior,
Ernesto Lopes; Altadonna, Ginevra Chioccioli; Peigneur, Steve; Ilas,
Janez; Labro, Alain J.; Pardo, Luis A.; Tytgat, Jan; Tomasic, Tihomir;
Arcangeli, Annarosa; Peterlin Masic, Lucija
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 259115561

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 5-[[1-[(1,1-dimethylethoxy)carbonyl]-3-azetidinyl]...
C16H23N3O4
3053596-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 C 11.2221 4.1690 0.0 0
M  V30 4 O 12.5557 3.3990 0.0 0
M  V30 5 O 11.2221 5.7091 0.0 0
M  V30 6 C 13.8896 4.1690 0.0 0
M  V30 7 C 13.1195 5.5027 0.0 0
M  V30 8 C 15.2232 4.9390 0.0 0
M  V30 9 C 14.6596 2.8354 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 O 1.3337 6.1601 0.0 0
M  V30 13 O 0.0000 3.8501 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 C 9.4898 1.9115 0.0 0
M  V30 16 C 8.4009 3.7976 0.0 0
M  V30 17 N 9.8884 3.3990 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 19 C 4.0012 1.5400 0.0 0
M  V30 20 C 5.3348 3.8501 0.0 0
M  V30 21 N 2.6675 2.3101 0.0 0
M  V30 22 C 4.0012 4.6201 0.0 0
M  V30 23 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 23
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Azetidinecarboxylic acid, 3-[methyl[2-methyl-6-[(methylamino)carbonyl]-3-py...
C17H26N4O3
3053596-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5547 1.5400 0.0 0
M  V30 2 C 8.5547 0.0000 0.0 0
M  V30 3 C 4.0012 4.1690 0.0 0
M  V30 4 O 2.6673 3.3990 0.0 0
M  V30 5 O 4.0012 5.7091 0.0 0
M  V30 6 C 1.3337 4.1690 0.0 0
M  V30 7 C 0.5637 2.8354 0.0 0
M  V30 8 C 0.0000 4.9390 0.0 0
M  V30 9 C 2.1037 5.5027 0.0 0
M  V30 10 C 11.2221 0.0000 0.0 0
M  V30 11 C 13.8896 4.6201 0.0 0
M  V30 12 N 15.2232 3.8501 0.0 0
M  V30 13 O 13.8896 6.1601 0.0 0
M  V30 14 C 16.5569 4.6201 0.0 0
M  V30 15 C 7.2209 2.3101 0.0 0
M  V30 16 C 6.8224 3.7976 0.0 0
M  V30 17 C 5.7334 1.9115 0.0 0
M  V30 18 N 5.3348 3.3990 0.0 0
M  V30 19 C 9.8884 2.3101 0.0 0
M  V30 20 C 11.2221 1.5400 0.0 0
M  V30 21 C 9.8884 3.8501 0.0 0
M  V30 22 N 12.5557 2.3101 0.0 0
M  V30 23 C 11.2221 4.6201 0.0 0
M  V30 24 C 12.5557 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 1 19
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 18
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 20
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 24
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3053596-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3053596-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42575096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives as PARP1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178125 A1 2024-08-29

$RFMT $RIREG SCHEME124 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethyl 2,6-bis(3-chlorophenyl)-1-methyl-4-oxo-3,5-piperidinedicarboxylate
C22H21Cl2NO5
306994-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 O 1.3337 5.3901 0.0 0
M  V30 3 O 2.6673 3.0801 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 8.0022 4.6201 0.0 0
M  V30 6 O 2.6673 7.7002 0.0 0
M  V30 7 C 5.3348 9.2402 0.0 0
M  V30 8 O 4.0012 10.0102 0.0 0
M  V30 9 O 6.6685 10.0102 0.0 0
M  V30 10 C 4.0012 11.5503 0.0 0
M  V30 11 Cl 8.0022 0.0000 0.0 0
M  V30 12 Cl 12.0033 6.9302 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 N 6.6685 5.3901 0.0 0
M  V30 16 C 4.0012 6.9302 0.0 0
M  V30 17 C 6.6685 6.9302 0.0 0
M  V30 18 C 5.3348 7.7002 0.0 0
M  V30 19 C 5.3348 3.0801 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 4.0012 2.3101 0.0 0
M  V30 22 C 6.6685 0.7700 0.0 0
M  V30 23 C 4.0012 0.7700 0.0 0
M  V30 24 C 5.3348 0.0000 0.0 0
M  V30 25 C 8.0022 7.7002 0.0 0
M  V30 26 C 9.3360 6.9302 0.0 0
M  V30 27 C 8.0022 9.2402 0.0 0
M  V30 28 C 10.6697 7.7002 0.0 0
M  V30 29 C 9.3360 10.0102 0.0 0
M  V30 30 C 10.6697 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 2 6 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 1 8 10
M  V30 11 1 11 22
M  V30 12 1 12 28
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 17 25
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Diazabicyclo[3.3.1]nonane-1,5-dicarboxylic acid, 2,4-bis(3-chlorophenyl)-...
C25H26Cl2N2O5
145160-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1807 6.1651 0.0 0
M  V30 2 O 10.2683 7.2554 0.0 0
M  V30 3 O 9.5813 4.6781 0.0 0
M  V30 4 C 11.7564 6.8587 0.0 0
M  V30 5 O 5.5497 6.3388 0.0 0
M  V30 6 C 4.8296 3.6513 0.0 0
M  V30 7 C 2.3182 8.0038 0.0 0
M  V30 8 O 1.9215 9.4919 0.0 0
M  V30 9 O 1.2278 6.9163 0.0 0
M  V30 10 C 0.4344 9.8923 0.0 0
M  V30 11 C 6.6684 10.5139 0.0 0
M  V30 12 Cl 6.7581 0.0000 0.0 0
M  V30 13 Cl 1.3338 1.4535 0.0 0
M  V30 14 C 7.6928 6.5618 0.0 0 CFG=2
M  V30 15 C 6.7581 5.3347 0.0 0 CFG=2
M  V30 16 C 5.9483 7.8263 0.0 0
M  V30 17 C 7.4941 8.0818 0.0 0
M  V30 18 N 5.2281 5.1388 0.0 0
M  V30 19 C 3.8052 7.6034 0.0 0 CFG=2
M  V30 20 N 6.2698 9.0264 0.0 0
M  V30 21 C 4.0011 6.0735 0.0 0 CFG=2
M  V30 22 C 4.7372 8.8205 0.0 0
M  V30 23 C 7.5281 4.0011 0.0 0
M  V30 24 C 6.7581 2.6674 0.0 0
M  V30 25 C 9.0681 4.0011 0.0 0
M  V30 26 C 7.5281 1.3336 0.0 0
M  V30 27 C 9.8381 2.6674 0.0 0
M  V30 28 C 9.0681 1.3336 0.0 0
M  V30 29 C 2.6674 5.3035 0.0 0
M  V30 30 C 2.6674 3.7635 0.0 0
M  V30 31 C 1.3338 6.0735 0.0 0
M  V30 32 C 1.3338 2.9935 0.0 0
M  V30 33 C 0.0000 5.3035 0.0 0
M  V30 34 C 0.0000 3.7635 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 5 16
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 8 10
M  V30 11 1 11 20
M  V30 12 1 12 26
M  V30 13 1 13 32
M  V30 14 1 14 15
M  V30 15 1 14 16 CFG=1
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 23 CFG=3
M  V30 19 1 19 16 CFG=1
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 20 22
M  V30 25 1 21 29 CFG=3
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 14 15 19 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 306994-49-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 145160-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-6164007
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Synthesis of
2,4-Diaryl-Substituted
1,5-Dialkyl-3,7-dimethyl-3,7-diaza-9-oxobicyclo-[3.3.1]nonane-1,5-dicarboxylates
11-19 (modified after procedures in ref 19). Exactly 0.0025 mol of the
piperidin-4-one was dissolved in 20 mL of methanol by refluxing. To this
solution, was added 0.6 mL of a 35% aqueous solution of HCHO, followed by
0.4 mL of a 40% aqueous solution of methylamine. The mixture was refluxed
for 7-8 min, and afterward it was allowed to stand for 3 h at ambient
temperature. Three different workup procedures were possible. First, the
obtained precipitate was filtered and washed with a mixture of
ethanol/diethyl ether. When no precipitate appeared within 24 h, the
solvent was removed in vacuo at 40-50 °C, and the remaining oil was
dissolved in a small amount of ethanol and diethyl ether. Crystals
usually appeared within 2 days. When no crystals were obtained during
this time, the solvent was removed again, and the remaining oil was
treated with diethyl ether. The raw product can be recrystallized from
ethanol. The perchlorates and oxalates of HZ2 were formed according to
known procedures.20 Entry: 11a Entry: 14b 1.22g; Yield: 96% molecular
formula: C25H26N2O5Cl2, 505.4 mp: 219-220°C elemental analyses calc:
59.51%C, 5.20%H, 5.56%N found: 59.34%C, 5.20%H, 5.55%N
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Opioid Receptor Affinity of a Series of
2,4-Diaryl-Substituted 3,7-Diazabicyclononanones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Siener, Tom; Cambareri, Antonella; Kuhl, Ulrich; Englberger, Werner;
Haurand, Michael; Koegel, Babette; Holzgrabe, Ulrike
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(20), 3746-3751

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitro-2-(1-pyrrolidinyl)benzaldehyde
C11H12N2O3
30742-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 1.3338 0.0 0
M  V30 2 O 4.6798 0.0000 0.0 0
M  V30 3 N 8.5298 4.0011 0.0 0 VAL=5
M  V30 4 O 9.2998 2.6674 0.0 0
M  V30 5 O 9.2998 5.3349 0.0 0
M  V30 6 C 3.9098 4.0011 0.0 0
M  V30 7 C 4.6798 2.6674 0.0 0
M  V30 8 C 4.6798 5.3349 0.0 0
M  V30 9 C 6.2198 2.6674 0.0 0
M  V30 10 C 6.2198 5.3349 0.0 0
M  V30 11 C 6.9898 4.0011 0.0 0
M  V30 12 N 2.3698 4.0011 0.0 0
M  V30 13 C 1.4645 2.7552 0.0 0
M  V30 14 C 1.4645 5.2469 0.0 0
M  V30 15 C 0.0000 3.2311 0.0 0
M  V30 16 C 0.0000 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-nitro-2-(1-pyrrolidinyl)benzenemethanamine
C12H17N3O2
1799563-27-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.6674 0.0 0
M  V30 2 N 4.6798 1.3338 0.0 0
M  V30 3 C 3.9098 0.0000 0.0 0
M  V30 4 N 8.5298 5.3347 0.0 0 VAL=5
M  V30 5 O 9.2998 6.6685 0.0 0
M  V30 6 O 9.2998 4.0011 0.0 0
M  V30 7 C 3.9098 5.3347 0.0 0
M  V30 8 C 4.6798 4.0011 0.0 0
M  V30 9 C 4.6798 6.6685 0.0 0
M  V30 10 C 6.2198 4.0011 0.0 0
M  V30 11 C 6.2198 6.6685 0.0 0
M  V30 12 C 6.9898 5.3347 0.0 0
M  V30 13 N 2.3698 5.3347 0.0 0
M  V30 14 C 1.4645 4.0889 0.0 0
M  V30 15 C 1.4645 6.5807 0.0 0
M  V30 16 C 0.0000 4.5647 0.0 0
M  V30 17 C 0.0000 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 30742-59-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1799563-27-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12316066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harrison, Timothy; Trevitt, Graham; Hewitt, Peter Robin; O'Dowd, Colin
Roderick; Burkamp, Frank; Wilkinson, Andrew John; Shepherd, Steven D.;
Miel, Hugues
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015092431 A1 2015-06-25

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Trifluoro-2-nitrobenzene
C6H2F3NO2
315-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 F 2.3100 5.3349 0.0 0
M  V30 6 F 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Difluoro-N-methyl-2-nitrobenzenamine
C7H6F2N2O2
872367-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 F 2.3101 6.6687 0.0 0
M  V30 7 F 6.9302 4.0012 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 315-14-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 872367-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5355495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinoindole derivatives as gyrase inhibitors for use
as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bensen, Daniel; Borchardt, Allen; Chen, Zhiyong; Finn, John M.; Lam,
Thanh To; Lee, Suk Joong; Li, Xiaoming; Tari, Leslie William; Teng, Min;
Trzoss, Michael; Zhang, Junhu; Jung, Michael E.; Lightstone, Felice C.;
Wong, Sergio E.; Nguyen, Toan B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014043272 A1 2014-03-20

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Trifluoro-2-nitrobenzene
C6H2F3NO2
315-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 F 2.3100 5.3349 0.0 0
M  V30 6 F 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Difluoro-N-methyl-2-nitrobenzenamine
C7H6F2N2O2
872367-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 F 2.3101 6.6687 0.0 0
M  V30 7 F 6.9302 4.0012 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 315-14-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 872367-64-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10195274
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3,5-difluoro-N-methyl-2-nitroaniline (C2): 1,3,5-Trifluoro-2-nitrobenzene
(35.16 g, 0.2 mol) was dissolved in 100 ml of THF and cooled in an
ice-water bath. To this solution was added drop-wise the 40% aqueous
solution of methylamine (23.25g, 0.3 mol) over ∼20 minutes through an
additional funnel. The reaction mixture was stirred for 1 hour. It was
then diluted with hexane (50 ml), and the solvents were partitioned into
two layers. The aqueous solution was removed, and the organic layer was
washed with water (20 ml). The solution was concentrated by gentle rotary
evaporation at room temperature and further dried under high vacuum.
Yield: (36g, 96%), orange solid. 1H NMR (CDCl3, 300 MHz): δ = 6.97-6.88
(m, 2H), 3.27 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidoindole derivatives as gyrase inhibitors and their preparation and
use as antibacterials
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bensen, Daniel; Finn, John; Lee, Suk Joong; Chen, Zhiyong; Lam, Thanh To;
Li, Xiaoming; Trzoss, Michael; Jung, Michael; Nguyen, Toan B.;
Lightstone, Felice; Tari, Leslie William; Zhang, Junhu; Aristoff, Paul;
Phillipson, Douglas W.; Wong, Sergio E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012125746 A1 2012-09-20

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,12,13-Tetrabromoperylo[3,4-cd:9,10-c'd′]dipyran-1,3,8,10-tetrone
C24H4Br4O6
321945-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.0010 2.3100 0.0 0
M  V30 2 Br 8.0021 9.2401 0.0 0
M  V30 3 O 2.6673 10.7801 0.0 0
M  V30 4 O 0.0000 6.1601 0.0 0
M  V30 5 Br 5.3348 1.5400 0.0 0
M  V30 6 Br 9.3357 8.4701 0.0 0
M  V30 7 O 13.3369 4.6201 0.0 0
M  V30 8 O 10.6695 0.0000 0.0 0
M  V30 9 C 5.3348 6.1601 0.0 0
M  V30 10 C 4.0010 6.9301 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 6.6684 6.9301 0.0 0
M  V30 13 C 4.0010 8.4701 0.0 0
M  V30 14 C 2.6673 6.1601 0.0 0
M  V30 15 C 6.6684 3.8500 0.0 0
M  V30 16 C 4.0010 3.8500 0.0 0
M  V30 17 C 8.0021 6.1601 0.0 0
M  V30 18 C 6.6684 8.4701 0.0 0
M  V30 19 C 2.6673 9.2401 0.0 0
M  V30 20 C 5.3348 9.2401 0.0 0
M  V30 21 C 1.3337 6.9301 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 23 C 8.0021 4.6201 0.0 0
M  V30 24 C 6.6684 2.3100 0.0 0
M  V30 25 C 9.3359 6.9301 0.0 0
M  V30 26 O 1.3337 8.4701 0.0 0
M  V30 27 C 9.3359 3.8500 0.0 0
M  V30 28 C 8.0021 1.5400 0.0 0
M  V30 29 C 10.6695 6.1601 0.0 0
M  V30 30 C 10.6695 4.6201 0.0 0
M  V30 31 C 9.3359 2.3100 0.0 0
M  V30 32 C 12.0032 3.8500 0.0 0
M  V30 33 C 10.6695 1.5400 0.0 0
M  V30 34 O 12.0032 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 18
M  V30 3 2 3 19
M  V30 4 2 4 21
M  V30 5 1 5 24
M  V30 6 1 6 25
M  V30 7 2 7 32
M  V30 8 2 8 33
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 2 13 20
M  V30 20 1 14 21
M  V30 21 2 14 22
M  V30 22 1 15 23
M  V30 23 2 15 24
M  V30 24 1 16 22
M  V30 25 1 17 23
M  V30 26 2 17 25
M  V30 27 1 18 20
M  V30 28 1 19 26
M  V30 29 1 21 26
M  V30 30 2 23 27
M  V30 31 1 24 28
M  V30 32 1 25 29
M  V30 33 1 27 30
M  V30 34 1 27 31
M  V30 35 2 28 31
M  V30 36 2 29 30
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H10Br4N2O4
2377419-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.9300 8.0021 0.0 0
M  V30 2 Br 6.9300 0.0000 0.0 0
M  V30 3 O 1.5400 1.3338 0.0 0
M  V30 4 O 1.5400 6.6685 0.0 0
M  V30 5 Br 8.4700 8.0021 0.0 0
M  V30 6 Br 8.4700 0.0000 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 O 13.8600 1.3336 0.0 0
M  V30 9 O 13.8600 6.6684 0.0 0
M  V30 10 C 15.4000 4.0011 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 3.8500 2.6674 0.0 0
M  V30 16 C 3.8500 5.3347 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 6.1600 6.6685 0.0 0
M  V30 19 C 8.4700 2.6674 0.0 0
M  V30 20 C 6.1600 1.3336 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 4.6200 1.3338 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 4.6200 6.6685 0.0 0
M  V30 25 C 9.2400 4.0011 0.0 0
M  V30 26 C 9.2400 6.6685 0.0 0
M  V30 27 C 9.2400 1.3336 0.0 0
M  V30 28 N 1.5400 4.0011 0.0 0
M  V30 29 C 10.7800 4.0011 0.0 0
M  V30 30 C 10.7800 6.6684 0.0 0
M  V30 31 C 10.7800 1.3336 0.0 0
M  V30 32 C 11.5500 2.6674 0.0 0
M  V30 33 C 11.5500 5.3347 0.0 0
M  V30 34 C 13.0900 2.6674 0.0 0
M  V30 35 C 13.0900 5.3347 0.0 0
M  V30 36 N 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 20
M  V30 3 2 3 21
M  V30 4 2 4 23
M  V30 5 1 5 26
M  V30 6 1 6 27
M  V30 7 1 7 28
M  V30 8 2 8 34
M  V30 9 2 9 35
M  V30 10 1 10 36
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 2 14 20
M  V30 20 1 15 21
M  V30 21 2 15 22
M  V30 22 1 16 23
M  V30 23 2 16 24
M  V30 24 1 17 25
M  V30 25 2 17 26
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 2 19 27
M  V30 29 1 20 22
M  V30 30 1 21 28
M  V30 31 1 23 28
M  V30 32 2 25 29
M  V30 33 1 26 30
M  V30 34 1 27 31
M  V30 35 1 29 32
M  V30 36 1 29 33
M  V30 37 2 30 33
M  V30 38 2 31 32
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321945-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2377419-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-20826005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 79-09-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Relation between molecular packing and singlet fission in thin films of
brominated perylenediimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Felter, Kevin M.; Dubey, Rajeev K.; Grozema, Ferdinand C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Physics (2019), 151(9), 094301/1-094301/10

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6,8-Tetrachloropyrimido[5,4-d]pyrimidine
C6Cl4N4
32980-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6200 6.6685 0.0 0
M  V30 2 Cl 3.8500 0.0000 0.0 0
M  V30 3 Cl 8.4700 2.6674 0.0 0
M  V30 4 Cl 0.0000 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 N 6.1600 4.0011 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 N 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 N 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 N 6.1600 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N4,N8-dimethylpyrimido[5,4-d]pyrimidine-4,8-diamine
C8H8Cl2N6
500860-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.8501 0.0 0
M  V30 2 C 0.0000 4.6201 0.0 0
M  V30 3 N 8.0023 4.6201 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 Cl 5.3348 0.0000 0.0 0
M  V30 6 Cl 4.0012 8.4702 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 N 4.0012 2.3101 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 N 5.3348 6.1601 0.0 0
M  V30 13 N 2.6675 6.1601 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 N 6.6685 2.3101 0.0 0
M  V30 16 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 14
M  V30 6 1 6 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32980-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500860-54-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18357932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimido[5,4-d]pyrimidine derivatives as novel breathing
control modulating compounds for preventing and/or treating respiratory
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dax, Scott L.; Mencel, James Joseph; Ozola, Vita; Suna, Edgars; Shubin,
Kirill
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017003822 A1 2017-01-05

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6,8-Tetrachloropyrimido[5,4-d]pyrimidine
C6Cl4N4
32980-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6200 6.6685 0.0 0
M  V30 2 Cl 3.8500 0.0000 0.0 0
M  V30 3 Cl 8.4700 2.6674 0.0 0
M  V30 4 Cl 0.0000 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 N 6.1600 4.0011 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 N 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 N 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 N 6.1600 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N4,N8-dimethylpyrimido[5,4-d]pyrimidine-4,8-diamine
C8H8Cl2N6
500860-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.8501 0.0 0
M  V30 2 C 0.0000 4.6201 0.0 0
M  V30 3 N 8.0023 4.6201 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 Cl 5.3348 0.0000 0.0 0
M  V30 6 Cl 4.0012 8.4702 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 N 4.0012 2.3101 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0
M  V30 12 N 5.3348 6.1601 0.0 0
M  V30 13 N 2.6675 6.1601 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 N 6.6685 2.3101 0.0 0
M  V30 16 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 14
M  V30 6 1 6 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32980-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500860-54-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6440275
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimido[5,4-d]pyrimidine derivatives as novel breathing control
modulating compounds for preventing and/or treating respiratory diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dax, Scott; Mencel, James Joseph; Ozola, Vita; Shubin, Kirill; Martjuga,
Marina; Suna, Edgars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014151462 A1 2014-09-25

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-methylbenzofuran
C9H7BrO
33118-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.4294 0.0000 0.0 0
M  V30 2 Br 6.3710 1.1704 0.0 0
M  V30 3 C 2.3699 1.9404 0.0 0
M  V30 4 C 2.3699 3.4804 0.0 0
M  V30 5 C 0.9052 1.4645 0.0 0
M  V30 6 C 3.7036 1.1704 0.0 0
M  V30 7 C 3.7036 4.2504 0.0 0
M  V30 8 O 0.9052 3.9564 0.0 0
M  V30 9 C 0.0000 2.7104 0.0 0
M  V30 10 C 5.0372 1.9404 0.0 0
M  V30 11 C 5.0372 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-5-benzofuranamine
C10H11NO
2460316-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.4294 0.0000 0.0 0
M  V30 2 N 6.3709 1.1704 0.0 0
M  V30 3 C 7.7047 1.9404 0.0 0
M  V30 4 C 2.3699 1.9404 0.0 0
M  V30 5 C 2.3699 3.4804 0.0 0
M  V30 6 C 3.7036 1.1704 0.0 0
M  V30 7 C 0.9052 1.4645 0.0 0
M  V30 8 C 3.7036 4.2504 0.0 0
M  V30 9 O 0.9052 3.9564 0.0 0
M  V30 10 C 5.0372 1.9404 0.0 0
M  V30 11 C 0.0000 2.7104 0.0 0
M  V30 12 C 5.0372 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33118-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2460316-30-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22913320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1447963-75-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of acetamide derivatives as DNA polymerase theta (Polθ)
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beck, Hilary Plake; Dillon, Michael; Jones, Brian; Martinez, Luisruben
P.; Pei, Zhonghua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020160134 A1 2020-08-06

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
rel-Methyl (3aR,8aS)-6-bromo-3a-(1,1-dimethyl-2-propen-1-yl)-2,3,3a,8a-tetrah...
C17H18BrNO4
331716-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.9569 0.0 0
M  V30 2 C 1.3337 5.7269 0.0 0
M  V30 3 C 1.3337 4.1869 0.0 0
M  V30 4 C 2.6673 3.4169 0.0 0
M  V30 5 C 0.0000 4.9569 0.0 0
M  V30 6 C 7.9857 5.7867 0.0 0
M  V30 7 O 9.0161 4.6423 0.0 0
M  V30 8 O 8.4616 7.2514 0.0 0
M  V30 9 C 10.5224 4.9625 0.0 0
M  V30 10 O 2.7129 9.4980 0.0 0
M  V30 11 Br 6.2005 0.0000 0.0 0
M  V30 12 C 4.0010 5.7269 0.0 0 CFG=1
M  V30 13 C 4.3213 4.2206 0.0 0
M  V30 14 C 5.3348 6.4969 0.0 0 CFG=2
M  V30 15 C 2.8566 6.7575 0.0 0
M  V30 16 C 5.8529 4.0597 0.0 0
M  V30 17 C 3.4161 2.9747 0.0 0
M  V30 18 N 6.4792 5.4665 0.0 0
M  V30 19 O 5.0147 8.0034 0.0 0
M  V30 20 C 3.4829 8.1643 0.0 0
M  V30 21 C 6.4792 2.6527 0.0 0
M  V30 22 C 4.0424 1.5678 0.0 0
M  V30 23 C 5.5740 1.4068 0.0 0
M  V30 24 H 6.6685 7.2670 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 12 1 CFG=1
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 2 10 20
M  V30 11 1 11 23
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 14 24 CFG=1
M  V30 20 1 15 20
M  V30 21 1 16 18
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 1 19 20
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,8aS)-6-Bromo-3a-(1,1-dimethyl-2-propen-1-yl)-3,3a,8,8a-tetrahydro-1-...
C16H19BrN2O
440327-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 5.0204 0.0 0
M  V30 2 C 2.5761 5.7904 0.0 0
M  V30 3 C 3.9098 6.5604 0.0 0
M  V30 4 C 5.2434 5.7904 0.0 0
M  V30 5 C 2.5761 7.3304 0.0 0
M  V30 6 C 1.9692 0.0000 0.0 0
M  V30 7 O 0.0000 2.7104 0.0 0
M  V30 8 Br 9.9691 4.4392 0.0 0
M  V30 9 C 3.9098 3.4804 0.0 0 CFG=1
M  V30 10 C 5.3745 3.9564 0.0 0
M  V30 11 C 3.9098 1.9404 0.0 0 CFG=2
M  V30 12 C 2.4452 3.9564 0.0 0
M  V30 13 C 6.2797 2.7104 0.0 0
M  V30 14 C 6.0008 5.3632 0.0 0
M  V30 15 N 5.3745 1.4645 0.0 0
M  V30 16 N 2.4452 1.4645 0.0 0
M  V30 17 C 1.5400 2.7104 0.0 0
M  V30 18 C 7.8112 2.8715 0.0 0
M  V30 19 C 7.5323 5.5242 0.0 0
M  V30 20 C 8.4375 4.2783 0.0 0
M  V30 21 H 3.9098 0.4004 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 9 1 CFG=3
M  V30 5 2 2 5
M  V30 6 1 6 16
M  V30 7 2 7 17
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 21 CFG=3
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 16 17
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 331716-90-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 440327-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-11565145
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First total syntheses of dihydroflustramine C and flustramine E,
alkaloids from the marine bryozoan Flustra foliacea
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morales-Rios, Martha S.; Suarez-Castillo, Oscar R.; Joseph-Nathan, Pedro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(8), 1479-1484

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyclopenten-1-ylphenylmethanone
C12H12O
33524-58-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 5.3348 2.3100 0.0 0
M  V30 4 C 5.4957 3.8416 0.0 0
M  V30 5 C 6.7417 1.6837 0.0 0
M  V30 6 C 7.0021 4.1617 0.0 0
M  V30 7 C 7.7722 2.8281 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-3-Cyclopenten-1-yl-N-methylbenzenemethanamine
C13H17N
2645364-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 4.0012 0.7700 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 2.6675 3.0801 0.0 0
M  V30 5 C 2.6675 4.6201 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 C 1.3337 5.3901 0.0 0
M  V30 8 C 0.0000 3.0801 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 6.7418 2.4537 0.0 0
M  V30 12 C 5.4958 4.6116 0.0 0
M  V30 13 C 7.7722 3.5981 0.0 0
M  V30 14 C 7.0022 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 2 3
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33524-58-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2645364-53-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-23808008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disproof of the Proposed Structures of Bradyoxetin, a Putative
Bradyrhizobium japonicum Signaling Molecule, and HMCP, a Putative
Ralstonia solanacearum Quorum-Sensing Molecule
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yajima, Arata; Katsuta, Ryo; Shimura, Mikaho; Yoshihara, Ayaka; Saito,
Tatsuo; Ishigami, Ken; Kai, Kenji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Natural Products (2021), 84(2), 495-502

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-naphthaldehyde
C12H10O2
3453-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 9.3360 0.0000 0.0 0
M  V30 4 C 10.6697 0.7700 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.0023 0.7700 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-6-methoxy-N-methyl-2-naphthalenemethanamine
C13H17NO
1782348-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 C 12.0033 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 6.6685 0.0000 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 15
M  V30 16 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3453-33-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1782348-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-22887098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly enantioselective copper-catalyzed propargylic amination to access
N-tethered 1,6-enynes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Si-Jia; Huang, Jian; He, Jin-Yu; Zhang, Rui-Jin; Qian, Hao-Dong; Dai,
Xue-Lin; Kong, Han-Han; Xu, Hao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(63), 38478-38483

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-naphthaldehyde
C12H10O2
3453-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 9.3360 0.0000 0.0 0
M  V30 4 C 10.6697 0.7700 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.0023 0.7700 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(6-Methoxy-2-naphthalenyl)methylene]methanamine
C13H13NO
479631-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 C 12.0033 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 6.6685 0.0000 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3453-33-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 479631-36-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3072340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-arylamido(methyl)-naphthalen-2-yloxy-acetic acid
derivatives as inhibitors of plasminogen activator inhibitor type-1
(PAI-1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Commons, Thomas Joseph; Croce, Susan Christman; Woodworth, Richard Page;
Trybulski, Eugene John; Elokdah, Hassan Mahmoud; Crandall, David Leroy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003000649 A1 2003-01-03

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(2-methoxyethyl)-3-nitrobenzamide
C10H11ClN2O4
349396-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 12.0033 3.0801 0.0 0
M  V30 7 C 13.3370 2.3101 0.0 0
M  V30 8 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 4.6201 0.0 0
M  V30 11 Cl 1.3337 0.0000 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0010 3.0801 0.0 0
M  V30 14 C 5.3348 0.7700 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 4.0010 0.0000 0.0 0
M  V30 17 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methoxyethyl)-4-(methylamino)-3-nitrobenzamide
C11H15N3O4
1387203-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3337 6.1601 0.0 0
M  V30 3 O 0.0000 3.8501 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 6.6685 4.6201 0.0 0
M  V30 7 N 8.0022 3.8501 0.0 0
M  V30 8 O 6.6685 6.1601 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 11 O 12.0033 4.6201 0.0 0
M  V30 12 C 13.3370 3.8501 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 4.0010 1.5400 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349396-62-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1387203-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22734033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoimidazoles and related heterocycles as HMOX-1
inducers for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Biddle, Margaret; Kluge, Arthur; Sasmal, Sanjita; Lagu, Bharat; Wu,
Xinyuan; Ogiyama, Takashi; Bell, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US10766888 B1 2020-09-08

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-4-iodo-2-nitrobenzene
C6H3FINO2
364-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 I 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-N-methyl-2-nitrobenzenamine
C7H7IN2O2
1260791-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 I 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-75-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1260791-09-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25873453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaryl compounds as inhibitors of fibroblast growth factor receptor
kinases and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaldor, Stephen W.; Tyhonas, John; Murphy, Eric A.; Kanouni, Toufike;
Arnold, Lee D.; Kania, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021247971 A1 2021-12-09

$RFMT $RIREG SCHEME136 STEP1
$RXN



  3  1
$MOL
Ethyl 5-(phenylmethoxy)-1H-indole-2-carboxylate
C18H17NO3
37033-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.0113 1.5400 0.0 0
M  V30 2 O 14.3450 2.3101 0.0 0
M  V30 3 O 13.0113 0.0000 0.0 0
M  V30 4 C 15.6788 1.5400 0.0 0
M  V30 5 C 17.0124 2.3101 0.0 0
M  V30 6 O 5.3901 4.1618 0.0 0
M  V30 7 C 4.6201 5.4955 0.0 0
M  V30 8 C 9.2402 2.8281 0.0 0
M  V30 9 C 10.0102 4.1618 0.0 0
M  V30 10 C 10.2706 1.6836 0.0 0
M  V30 11 C 7.7002 2.8281 0.0 0
M  V30 12 N 11.5167 3.8416 0.0 0
M  V30 13 C 9.2402 5.4955 0.0 0
M  V30 14 C 11.6776 2.3101 0.0 0
M  V30 15 C 6.9302 4.1618 0.0 0
M  V30 16 C 7.7002 5.4955 0.0 0
M  V30 17 C 3.0801 5.4955 0.0 0
M  V30 18 C 2.3101 6.8291 0.0 0
M  V30 19 C 2.3101 4.1618 0.0 0
M  V30 20 C 0.7700 6.8291 0.0 0
M  V30 21 C 0.7700 4.1618 0.0 0
M  V30 22 C 0.0000 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl iodide
CH3I
74-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 I 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-5-(phenylmethoxy)-1H-indole-2-carboxamide
C18H18N2O2
133845-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2763 0.0000 0.0 0
M  V30 2 C 13.2457 2.7104 0.0 0
M  V30 3 N 14.0157 4.0442 0.0 0
M  V30 4 O 14.0157 1.3768 0.0 0
M  V30 5 C 15.5557 4.0442 0.0 0
M  V30 6 O 5.3348 4.2505 0.0 0
M  V30 7 C 4.0011 3.4804 0.0 0
M  V30 8 C 9.3359 1.9404 0.0 0
M  V30 9 C 9.3359 3.4804 0.0 0
M  V30 10 N 10.8005 1.4646 0.0 0
M  V30 11 C 8.0021 1.1704 0.0 0
M  V30 12 C 10.8005 3.9565 0.0 0
M  V30 13 C 8.0021 4.2505 0.0 0
M  V30 14 C 11.7057 2.7104 0.0 0
M  V30 15 C 6.6684 1.9404 0.0 0
M  V30 16 C 6.6684 3.4804 0.0 0
M  V30 17 C 2.6673 4.2505 0.0 0
M  V30 18 C 1.3337 3.4804 0.0 0
M  V30 19 C 2.6673 5.7905 0.0 0
M  V30 20 C 0.0000 4.2505 0.0 0
M  V30 21 C 1.3337 6.5605 0.0 0
M  V30 22 C 0.0000 5.7905 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 37033-95-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-88-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 133845-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8746467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 1. Preparation of
1-methyl-2-(methylaminomethyl)indole. a)
N,1-Dimethylindole-2-carboxamide. To a stirred solution of ethyl
indole-2-carboxylate (25.0 g, 132.1 mmole) in dry DMF (100 mL) at 5 °C
was added 60% NaH (6.9 g, 171.7 mmole). After 10 min, methyl iodide (56.2
g, 396.3 mmole) was added and the reaction slurry was allowed to warm RT
and stirred for 12 hr. The reaction contents were poured into H2O (200
mL) and extracted with EtOAc (2 × 150 mL). The combined organic phases
were washed sequentially with H20 and brine, then were dried over Na2SO4.
Concentration under reduced pressure gave a yellow oil. This oil was
suspended in a 40% methylaminefH2O solution (100 mL) containing THF (50
mL) and stirred vigorously at RT for 24 hr. The reaction solution was
concentrated under vacuum to remove the THF and then poured into H2O (400
mL). The precipitate was filtered, washed with H2O and dried under vacuum
at RT. Preparation of 5-benzyloxy-1-methyl-2-(methylaminomethyl)indole.
a) 5-Benzyloxy-N,1-dimethylindole-2-carboxamide. According to the
procedure of Preparation 1 (a), except substituting ethyl
5-(benzyloxy)indole carboxylate (40.8 g, 132.0 mmole) for the ethyl
indole-2-carboxylate, the title compound (37.4 g, 96%) was prepared as a
white solid. MS (ES) m/e 295 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carboxamides as Fab I
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000063187 A1 2000-10-26

$RFMT $RIREG SCHEME137 STEP1
$RXN



  3  1
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Fluorophenyl)amino]-1-methyl-1H-pyrrole-2,5-dione
C11H9FN2O2
1613024-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3028 1.3628 0.0 0
M  V30 2 O 2.2420 0.0000 0.0 0
M  V30 3 C 0.0000 2.4898 0.0 0
M  V30 4 O 1.6752 5.3914 0.0 0
M  V30 5 F 10.6376 4.4428 0.0 0
M  V30 6 C 3.9690 2.1328 0.0 0
M  V30 7 C 2.5622 1.5063 0.0 0
M  V30 8 C 3.8080 3.6644 0.0 0
M  V30 9 N 1.5317 2.6509 0.0 0
M  V30 10 C 2.3017 3.9845 0.0 0
M  V30 11 C 6.6365 2.1328 0.0 0
M  V30 12 C 7.9701 1.3628 0.0 0
M  V30 13 C 6.6365 3.6728 0.0 0
M  V30 14 C 9.3038 2.1328 0.0 0
M  V30 15 C 7.9701 4.4428 0.0 0
M  V30 16 C 9.3038 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 2 4 10
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613024-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-6148383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused pyrrolo[3,4-d]tetrahydropyrimidine derivatives by
proline-catalyzed multicomponent reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhi-Peng; Wang, Hai-Bo; Wang, Yu-Qin; Zhu, Qiu-Hua; Xie, Yang; Liu,
Shu-Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(29), 4379-4385

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-3,7-Dimethyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-...
C24H21ClN2O7
379234-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3348 0.0 0
M  V30 2 C 1.5400 4.0011 0.0 0
M  V30 3 O 1.5400 6.6684 0.0 0
M  V30 4 Cl 0.0000 4.0011 0.0 0
M  V30 5 C 3.8501 2.6673 0.0 0
M  V30 6 O 4.6201 1.3337 0.0 0
M  V30 7 O 2.3100 2.6673 0.0 0
M  V30 8 C 3.8501 0.0000 0.0 0
M  V30 9 C 12.6571 7.5341 0.0 0
M  V30 10 O 13.9030 6.6289 0.0 0
M  V30 11 O 12.8181 9.0656 0.0 0
M  V30 12 C 15.3100 7.2553 0.0 0
M  V30 13 C 4.6201 6.6684 0.0 0 CFG=1
M  V30 14 C 6.1601 6.6684 0.0 0
M  V30 15 N 3.8501 5.3348 0.0 0
M  V30 16 C 6.9301 5.3348 0.0 0
M  V30 17 N 7.1907 7.8128 0.0 0
M  V30 18 C 4.6201 4.0011 0.0 0 CFG=1
M  V30 19 C 8.4365 5.6550 0.0 0
M  V30 20 C 6.1601 4.0011 0.0 0
M  V30 21 C 8.5975 7.1865 0.0 0
M  V30 22 C 9.6824 4.7497 0.0 0
M  V30 23 C 10.0043 7.8128 0.0 0
M  V30 24 C 11.0892 5.3761 0.0 0
M  V30 25 C 11.2503 6.9078 0.0 0
M  V30 26 C 3.8501 8.0021 0.0 0
M  V30 27 C 4.6201 9.3359 0.0 0
M  V30 28 C 2.3100 8.0021 0.0 0
M  V30 29 C 3.8501 10.6696 0.0 0
M  V30 30 C 1.5400 9.3359 0.0 0
M  V30 31 C 2.3100 10.6696 0.0 0
M  V30 32 O 4.3259 12.1341 0.0 0
M  V30 33 O 1.8342 12.1341 0.0 0
M  V30 34 C 3.0800 13.0394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 18 5 CFG=3
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 25
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 26 CFG=3
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 19 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 29 32
M  V30 35 2 30 31
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-Methyl (6R,12aR)-6-(1,3-benzodioxol-5-yl)-1,2,3,4,6,7,12,12a-octahydro-2-...
C24H21N3O6
379234-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 4.7474 0.0 0
M  V30 2 O 2.6673 10.9074 0.0 0
M  V30 3 C 0.0000 9.3674 0.0 0
M  V30 4 C 12.7277 9.5562 0.0 0
M  V30 5 O 13.3542 10.9630 0.0 0
M  V30 6 O 13.6329 8.3103 0.0 0
M  V30 7 C 14.8857 11.1241 0.0 0
M  V30 8 C 5.3347 6.2874 0.0 0 CFG=1
M  V30 9 C 6.6684 7.0574 0.0 0
M  V30 10 N 4.0011 7.0574 0.0 0
M  V30 11 C 6.6684 8.5974 0.0 0
M  V30 12 N 8.1331 6.5815 0.0 0
M  V30 13 C 4.0011 8.5974 0.0 0 CFG=1
M  V30 14 C 2.6673 6.2874 0.0 0
M  V30 15 C 8.1331 9.0733 0.0 0
M  V30 16 C 5.3347 9.3674 0.0 0
M  V30 17 C 9.0383 7.8274 0.0 0
M  V30 18 C 2.6673 9.3674 0.0 0
M  V30 19 C 1.3336 7.0574 0.0 0
M  V30 20 C 8.7594 10.4802 0.0 0
M  V30 21 C 10.5698 7.9883 0.0 0
M  V30 22 N 1.3336 8.5974 0.0 0
M  V30 23 C 10.2909 10.6411 0.0 0
M  V30 24 C 11.1962 9.3953 0.0 0
M  V30 25 C 5.3347 4.7474 0.0 0
M  V30 26 C 6.6684 3.9774 0.0 0
M  V30 27 C 4.0011 3.9774 0.0 0
M  V30 28 C 6.6684 2.4374 0.0 0
M  V30 29 C 4.0011 2.4374 0.0 0
M  V30 30 C 5.3347 1.6674 0.0 0
M  V30 31 O 7.8129 1.4070 0.0 0
M  V30 32 O 5.6549 0.1611 0.0 0
M  V30 33 C 7.1864 0.0000 0.0 0
M  V30 34 H 4.0011 10.1374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 18
M  V30 3 1 3 22
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 24
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 25 CFG=1
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 13 18
M  V30 20 1 13 34 CFG=3
M  V30 21 1 14 19
M  V30 22 1 15 17
M  V30 23 2 15 20
M  V30 24 2 17 21
M  V30 25 1 18 22
M  V30 26 1 19 22
M  V30 27 1 20 23
M  V30 28 1 21 24
M  V30 29 2 23 24
M  V30 30 1 25 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 28 31
M  V30 36 2 29 30
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 379234-95-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 379234-97-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3190130
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 5 Preparation of (+-,
cis)-6-Benzo[1,3]dioxo5-y2-methy1,4-dioxo-1,2,3,6,7,12,12 a
octahydropyrazino [1',2':1,6]pyrido[3,4-b] indole-9-carboxylic acid
methyl ester A mixture of Intermediate 23 (132 mg, 0.27 mmol) and
methylamine (6.2 mL, 12.4 mmol, 2 M solution in THF) in methylene
chloride (18 mL) was refluxed under a nitrogen blanket for 4 hours. The
resulting solution was concentrated under reduced pressure to yield a
yellow solid, which was stirred in methanol (4 mL) for 1 hour. The solid
was isolated by filtration under reduced pressure, washed with methanol (
5 x 1 mL) , and dried in a vacuum oven at 70°C for 17 hours to provide
Example 5. Yield 117 mg, 96%; off-white solid. mp 294-295°C; TLC Rf
(5:1:0.5 methylene chloride/ethyl acetate/methanol) =0.65; 1H NMR (300
MHz, CDCl3): δ 8.25 (bs, 1H) , 8.03 (s, 1H) , 7.84 (d, J = 8.7 Hz, 1H) ,
7.60 (d, J = 8.7 Hz, 1H) , 6.86 (dd, J = 8.0, 1.7 Hz, 1H) , 6.73 (d, J =
I.7 Hz 7 1H), 6.69 (d, J = 8.0 Hz, 1H), 6.20 (s, 1H), 5.88 (s, 1H) , 5.86
(s, 1H) , 4.30 (dd,J = 11.6, 4.5 Hz, 1H) , 4.11 (dd, J = 17.6, 1.3 Hz,
1H) , 4.00-3.88 (m, 4H), 3.78 (dd, J = 16.1, 4.5 Hz, 1H), 3.27-3.16 (m,
1H) , 3.05 (s, 3H) ppm; CI MS m/z 448 [C24H21N3O6+H]+, Anal. Calcd. for
C24H21N3O6: C, 64.42; H, 4.73; N, 9.39. Found: C, 64.12; H, 4.61; N,
9.12. HPLC analysis (Aquasil C18 Column, 100 X 4.6mm, Retention Time=10.3
minutes; 45:55/0.03 acetonitrile : water/TFA; flow=0.50 mL/min; detector
@ 254 nm; temperature ambient) showed one peak, with a purity of 99.7%.
The stereochemistry of Example 5 was confirmed to be the cis isomer by a
series of NOE difference experiments: a positive NOE enhancement from the
C12a proton at 4.30 ppm to the C6 proton at 6.20 ppm; a positive NOE
enhancement from the C6 proton at 6.20 ppm to the C12a proton at 4.30
ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclic guanosine monophosphate specific phosphodiesterase
inhibiting heterocyclylpyrazinopyridoindolediones for treatment of
cardiovascular disorders and erectile disfunction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Orme, Mark W.; Sawyer, Jason Scott; Daugan, Alain Claud-Marie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001094345 A2 2001-12-13

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Di-tert-butylsalicylaldehyde
C15H22O2
37942-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 C 0.0000 4.6201 0.0 0
M  V30 3 C 0.0000 6.1601 0.0 0
M  V30 4 C 1.3337 6.9302 0.0 0
M  V30 5 O 1.3337 2.3101 0.0 0
M  V30 6 C 6.6687 5.3901 0.0 0
M  V30 7 C 5.8986 6.7238 0.0 0
M  V30 8 C 8.0023 6.1601 0.0 0
M  V30 9 C 7.4387 4.0564 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 O 5.3348 0.0000 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 4.0012 2.3101 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 16
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Bis(1,1-dimethylethyl)-6-[(methylimino)methyl]phenol
C16H25NO
143569-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 6.1600 0.0 0
M  V30 2 C 0.0000 5.3900 0.0 0
M  V30 3 C 0.0000 6.9300 0.0 0
M  V30 4 C 1.3336 7.7000 0.0 0
M  V30 5 O 4.0011 7.7000 0.0 0
M  V30 6 C 6.6684 6.1600 0.0 0
M  V30 7 N 8.0021 5.3900 0.0 0
M  V30 8 C 9.3358 6.1600 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.4611 1.5400 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.5411 1.5400 0.0 0
M  V30 13 C 2.6674 5.3900 0.0 0
M  V30 14 C 4.0011 6.1600 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 5.3347 5.3900 0.0 0
M  V30 17 C 4.0011 3.0800 0.0 0
M  V30 18 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 14
M  V30 6 2 6 7 CFG=2
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37942-07-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 143569-55-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2869224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM ethanol/solvent also used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, spectroscopic and redox properties of a novel series of
copper(II) complexes of N-alkyl-3,5- But2-salicylaldimines. Generation of
the directly coordinated Cu(II)-phenoxyl radical complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kasumov, Veli T.; Koeksal, Fevzi; Sezer, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2005), 24(10), 1203-1211

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloronicotinic acid
C6H3Cl2NO2
38496-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 N 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2-(methylamino)-3-pyridinecarboxylic acid
C7H7ClN2O2
1339167-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38496-18-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1339167-38-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4608903
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. 6-Chloro-2-(methylamino)nicotinic acid, shown below, was prepared
as follows. To a steel autoclave was added 2,6-dichloronicotinic acid
(tech.) (30 g, 156.2 mmoles), tetrahydrofuran (30 mL) and monomethylamine
(68.2 mL. 33 wt% in ethanol, 500 mmol). The reaction vessel was heated at
100 °C for 4 h. The reaction mixture was cooled and the solution
transferred from the autoclave to a 500 mL flask and concentrated under
vacuum to give a green solid. The solid was dissolved in 300 mL MeOH and
1.2 L EtOAc, poured into a separatory funnel and washed with 1N HCl (2 x
300 mL) and brine. The organic solution was then concentrated to dryness
to yield 6-chloro-2-(methylamino)nicotinic acid. Off-white solid, yield
29 g, 96 %. 1H NMR (400 MHz, DMSO-d6) δ ppm 13.14 (br. s., 1 H), 8.17 (d,
J=2.7 Hz, 1 H), 8.00 (d, J=8.0 Hz, 1 H), 7.57 (br. s., 1 H), 6.58 (d,
J=8.0 Hz, 1 H), 2.89 (d, J=4.1 Hz, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, steel autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolospiroketone acetyl-CoA carboxylase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Didiuk, Mary Theresa; Dow, Robert Lee; Griffith, David Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012042433 A1 2012-04-05

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-methoxy-3-nitropyridine
C6H5ClN2O3
38533-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 Cl 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-N-methyl-3-nitro-2-pyridinamine
C7H9N3O3
94166-58-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 N 4.0011 4.6200 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38533-61-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 94166-58-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8077547
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (154a) 6-Amino-5-nitro-nicotinic acid
6-Chloro-5-nitro-nicotinic acid (3.00 g, 14.8 mmol) in 100 mL conc.
ammonia was stirred for 16 h. The mixture was concentrated, the residue
mixed with 50 mL water, acidified with hydrochloric acid and stirred for
10 min. The precipitate was filtered off and washed with water. The solid
was dried and taken up in refluxing THF. The mixture was filtered and
concentrated. Yield: 1.90 g (70%) (377a)
6-Methoxy-N-methyl-3-nitropyridin-2-amine Prepared analogously to example
154a from 2-chloro-6-methoxy-3-nitropyridine and 2 N methylamine
(solution in THF) in THF Yield: 96% mass spectrum: (M+H)+ = 184
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3H-imidazo[4,5-b]pyridine-6-carboxamides as therapeutic
inhibitors of enzymes belonging to the MAPEG family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pfau, Roland; Arndt, Kirsten; Doods, Henri; Hauel, Norbert; Klinder,
Klaus; Kuelzer, Raimund
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010034799 A1 2010-04-01

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 8-(4-formylphenoxy)octanoate
C16H22O4
386212-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 1.5400 0.0 0
M  V30 6 C 13.3372 2.3101 0.0 0
M  V30 7 C 14.6708 1.5400 0.0 0
M  V30 8 C 16.0045 2.3101 0.0 0
M  V30 9 C 17.3382 1.5400 0.0 0
M  V30 10 O 18.6720 2.3101 0.0 0
M  V30 11 O 17.3382 0.0000 0.0 0
M  V30 12 C 20.0057 1.5400 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 O 0.0000 3.8501 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 4.0012 1.5400 0.0 0
M  V30 17 C 5.3348 3.8501 0.0 0
M  V30 18 C 2.6675 2.3101 0.0 0
M  V30 19 C 4.0012 4.6201 0.0 0
M  V30 20 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 8-[4-[(methylamino)methyl]phenoxy]octanoate
C17H27NO3
2454235-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 1.5400 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 1.5400 0.0 0
M  V30 4 C 12.0033 2.3101 0.0 0
M  V30 5 C 13.3372 1.5400 0.0 0
M  V30 6 C 14.6708 2.3101 0.0 0
M  V30 7 C 16.0045 1.5400 0.0 0
M  V30 8 C 17.3382 2.3101 0.0 0
M  V30 9 C 18.6720 1.5400 0.0 0
M  V30 10 O 20.0057 2.3101 0.0 0
M  V30 11 O 18.6720 0.0000 0.0 0
M  V30 12 C 21.3393 1.5400 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 N 1.3337 3.8501 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 6.6685 3.8501 0.0 0
M  V30 18 C 5.3348 1.5400 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 20 C 4.0012 2.3101 0.0 0
M  V30 21 C 4.0012 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 21
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 386212-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454235-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357550
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
2-Fluorobenzoyl chloride
C7H4ClFO
393-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methan-d3-amine
CH2D3N
5581-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3337 0.0 0
M  V30 2 N 0.7700 0.0000 0.0 0
M  V30 3 H 0.0000 1.3337 0.0 0 MASS=2
M  V30 4 H 0.7700 2.6673 0.0 0 MASS=2
M  V30 5 H 3.0800 1.3337 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C8H5D3FNO
2029176-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 F 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6675 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6675 0.0 0
M  V30 12 H 7.7001 2.6675 0.0 0 MASS=2
M  V30 13 H 8.4701 4.0011 0.0 0 MASS=2
M  V30 14 H 7.7001 5.3349 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 12
M  V30 6 1 4 13
M  V30 7 1 4 14
M  V30 8 1 5 7
M  V30 9 2 6 7
M  V30 10 1 6 8
M  V30 11 1 7 9
M  V30 12 2 8 10
M  V30 13 2 9 11
M  V30 14 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 393-52-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5581-55-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2029176-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-16292235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Site-Selective Silylation of Aliphatic C-H Bonds Mediated by
[1,5]-Hydrogen Transfer: Synthesis of α-Sila Benzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2016), 18(21), 5536-5539

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzoyl chloride
C7H4ClFO
393-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methylbenzamide
C8H8FNO
52833-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 F 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 393-52-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52833-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-16292198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Site-Selective Silylation of Aliphatic C-H Bonds Mediated by
[1,5]-Hydrogen Transfer: Synthesis of α-Sila Benzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2016), 18(21), 5536-5539

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenemethanesulfonyl chloride
C7H6ClNO4S
4025-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 4.6201 0.0 0
M  V30 2 S 1.3337 3.8501 0.0 0 VAL=6
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 O 2.1037 2.5164 0.0 0
M  V30 5 O 0.5637 5.1838 0.0 0
M  V30 6 N 8.0023 1.5400 0.0 0 VAL=5
M  V30 7 O 9.3360 2.3101 0.0 0
M  V30 8 O 8.0023 0.0000 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenemethanesulfonamide
C8H10N2O4S
85952-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 S 8.0023 3.8501 0.0 0 VAL=6
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 7.2323 2.5164 0.0 0
M  V30 5 O 8.7723 5.1838 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4025-75-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85952-29-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-9716563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved process for the preparation of
4-(N-methylaminosulfonylmethyl)aniline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babu, Mereyalahari; Athar, Taimur
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN186425 B 2001-09-01

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4,6-dichloro-3-pyridinecarboxylate
C8H7Cl2NO2
40296-46-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 C 9.3358 2.3100 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 Cl 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 N 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-chloro-4-(methylamino)-3-pyridinecarboxylate
C9H11ClN2O2
449811-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 O 6.6684 3.0800 0.0 0
M  V30 3 O 5.3347 0.7700 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 9.3358 3.0800 0.0 0
M  V30 6 N 2.6674 0.7700 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 Cl 0.0000 5.3900 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 1.3336 3.0800 0.0 0
M  V30 13 N 2.6674 5.3900 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40296-46-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 449811-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15631613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 1,6-naphthyridin-2(1H)-ones as potential anticancer agents
targeting Hsp90
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Montoir, David; Barille-Nion, Sophie; Tonnerre, Alain; Juin, Philippe;
Duflos, Muriel; Bazin, Marc-Antoine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 11917-33

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4,6-dichloro-3-pyridinecarboxylate
C8H7Cl2NO2
40296-46-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 C 9.3358 2.3100 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 Cl 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 N 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-chloro-4-(methylamino)-3-pyridinecarboxylate
C9H11ClN2O2
449811-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 O 6.6684 3.0800 0.0 0
M  V30 3 O 5.3347 0.7700 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 9.3358 3.0800 0.0 0
M  V30 6 N 2.6674 0.7700 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 Cl 0.0000 5.3900 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 1.3336 3.0800 0.0 0
M  V30 13 N 2.6674 5.3900 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40296-46-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 449811-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2890109
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Differential Functionalization of 1,6-Naphthyridin-2(1H)-ones through
Sequential One-Pot Suzuki-Miyaura Cross-Couplings
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Montoir, David; Tonnerre, Alain; Duflos, Muriel; Bazin, Marc-Antoine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2014), 2014(7), 1487-1495

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-nitrobenzoic acid
C7H4FNO4
403-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6200 0.0 0
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 3-fluoro-N-methyl-4-nitro-
C8H7FN2O3
658700-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-21-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 658700-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10062180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 3-fluoro-4-nitrobenzoic acid (4.0 g, 21.6 mmol) and EDC
(1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride) (4.36 g,
28.1 mmol) in methylene chloride (100 mL) was added methylamine (11.3 mL
of a 2 M solution in MeOH, 22.7 mmol) and the solution was stirred at
room temperature overnight. The solution was washed with 1 N HCl, dried
over MgSO4 and concentrated to a solid. The solid was triturated with
butyl chloride and collected by filtration to give the
N-methyl-3-fluoro-4-nitrobenzamide. Yield 3.81 g, 96%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzimidazoles as interleukin-2 tyrosine
kinase (Itk) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cywin, Charles; Pullen, Steven S.; Roth, Gregory Paul; Snow, Roger John;
Fleck, Roman Wolfgang; Takahashi, Hidenori; Winters, Michael; Qiao, Lei;
Nemoto, Peter Allen; Moriarity, Kevin J.; Wang, Ji; Bentzien, Joerg;
Cook, Brian; Lo, Ho-yin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004014905 A1 2004-02-19

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-propoxybenzaldehyde
C11H14O3
41828-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 C 6.9300 0.0000 0.0 0
M  V30 4 C 8.4700 0.0000 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 O 6.9300 5.3349 0.0 0
M  V30 7 O 1.5400 1.3338 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxy-2-propoxybenzyl)-N-methylamine
C12H19NO2
709649-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 5.3901 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 5.3901 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 5.3348 6.9302 0.0 0
M  V30 14 C 2.6675 6.9302 0.0 0
M  V30 15 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41828-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-53-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-74251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine b)
(3-Methoxy-2-propoxy-benzyl)methylamine [0828] According to the procedure
of Preparation 67, except substituting 3-methoxy-2-propoxy-benzaldehyde
for 1-propyl-naphthalene-2-carbaldehyde, the title compound (13.2 g, 96%)
was prepared as a light yellow oil. MS (ESI) m/e 210 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-propoxybenzaldehyde
C11H14O3
41828-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 C 6.9300 0.0000 0.0 0
M  V30 4 C 8.4700 0.0000 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 O 6.9300 5.3349 0.0 0
M  V30 7 O 1.5400 1.3338 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxy-2-propoxybenzyl)-N-methylamine
C12H19NO2
709649-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 5.3901 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 5.3901 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 5.3348 6.9302 0.0 0
M  V30 14 C 2.6675 6.9302 0.0 0
M  V30 15 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41828-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-53-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7168389
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-propoxybenzaldehyde
C11H14O3
41828-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 C 6.9300 0.0000 0.0 0
M  V30 4 C 8.4700 0.0000 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 O 6.9300 5.3349 0.0 0
M  V30 7 O 1.5400 1.3338 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxy-2-propoxybenzyl)-N-methylamine
C12H19NO2
709649-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 5.3901 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 5.3901 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 5.3348 6.9302 0.0 0
M  V30 14 C 2.6675 6.9302 0.0 0
M  V30 15 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41828-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-53-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3856438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. b) (3-Methoxy-2-propoxy-benzyl)methylamine
According to the procedure of Preparation 1, except substituting
3-methoxy-2-propoxy-benzaldehyde for 1-propyl-naphthalene-2-carbaldehyde,
the title compound (13.2 g, 96%) was prepared as a light yellow oil. MS
(ESI) m/e 210 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxybenzoyl chloride
C9H9ClO2
42926-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0011 0.0 0
M  V30 2 Cl 0.0000 4.0011 0.0 0
M  V30 3 O 2.3100 5.3349 0.0 0
M  V30 4 O 4.6200 4.0011 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 2-ethoxy-N-methyl-
C10H13NO2
21276-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3349 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 N 0.7700 4.0011 0.0 0
M  V30 6 O 3.0800 5.3349 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42926-52-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21276-34-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20231792
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalyzed para-selective formation of quaternary carbon centers
by alkylation of benzamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Chen, Changpeng; Cong, Xuefeng; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2018), 9(1), 1-8

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Octafluorotoluene
C7F8
434-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 F 6.1600 4.2074 0.0 0
M  V30 3 F 7.7000 2.6674 0.0 0
M  V30 4 F 6.1600 1.1274 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 F 4.6200 5.3349 0.0 0
M  V30 7 F 1.5400 0.0000 0.0 0
M  V30 8 F 1.5400 5.3349 0.0 0
M  V30 9 F 0.0000 2.6674 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.8500 1.3338 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,6-Tetrafluoro-N-methyl-4-(trifluoromethyl)benzenamine
C8H4F7N
28012-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6674 0.0 0
M  V30 2 F 1.5400 1.1274 0.0 0
M  V30 3 F 0.0000 2.6674 0.0 0
M  V30 4 F 1.5400 4.2074 0.0 0
M  V30 5 F 3.0800 5.3349 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 F 6.1600 5.3349 0.0 0
M  V30 8 F 6.1600 0.0000 0.0 0
M  V30 9 N 7.7000 2.6674 0.0 0
M  V30 10 C 8.4700 4.0011 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 3.8500 1.3338 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 5.3900 1.3338 0.0 0
M  V30 16 C 6.1600 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 12
M  V30 6 1 6 13
M  V30 7 1 7 14
M  V30 8 1 8 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434-64-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 28012-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7646798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylnitramines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Platonov, V. E.; Haas, A.; Schelvis, M.; Lieb, M.; Dvornikova, K. V.;
Osina, O. I.; Gatilov, Y. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 109(2), 131-139

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-2-methylbenzenesulfonyl chloride
C7H6ClFO2S
445-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 2 Cl 0.0000 0.5637 0.0 0
M  V30 3 O 0.5638 2.6673 0.0 0
M  V30 4 O 2.1038 0.0000 0.0 0
M  V30 5 C 1.3338 4.4137 0.0 0
M  V30 6 F 6.6687 1.3337 0.0 0
M  V30 7 C 2.6675 2.1037 0.0 0
M  V30 8 C 2.6675 3.6437 0.0 0
M  V30 9 C 4.0012 1.3337 0.0 0
M  V30 10 C 4.0012 4.4137 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N,2-dimethylbenzenesulfonamide
C8H10FNO2S
870562-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 F 0.0000 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 445-05-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870562-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-4219115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 49. 5-Fluoro-2,N-dimethyl-benzenesulJonamide. To a solution
of 5-fluoro-2-methyl-benzenesulfonyl chloride (4.18 g, 20 romol) in
acetone (20 mL) was added a 40% aqueous solution of methylamine (4.5 mL,
60 mmol) under nitrogen and the mixture stirred for 5 min. Acetone was
removed in vacuo and the aqueous residue extracted with CH2Cl2. The
CH2Cl2 extract was dried (Na2SO4), filtered, concentrated and the residue
purified by column chromatography (SiO2, 10% ether in CH2Cl2) to provide
3.9 g (19.2mmol, Yield 96%) of the title compound as a white solid. 1H
NMR (500 MHz, CDCl3) δ ppm: 2.59 (3H, s), 2.67 (3H, d, J=5.5 Hz), 4.41
(1H, brs), 7.13-7.20 (1H, m), 7.29 (1H, dd, J=8.2, 5.5 Hz), 7.69 (1H,
J=8.6, 2.1 Hz); LC/MS m/z 204 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic heterocycles, particularly
4-oxopyrimido[2,1-c][1,4]oxazine-2-carboxamide and
4-oxopyrimido[2,1-c][1,4]oxazepine-2-carboxamide derivatives, as HIV
integrase inhibitors, their preparation, pharmaceutical compositions, and
use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Banville, Jacques; Beaulieu, Francis; Connolly,
Timothy P.; Krystal, Mark R.; Matiskella, John D.; Ouellet, Carl;
Plamondon, Serge; Remillard, Roger; Sorenson, Margaret E.; Ueda,
Yasutsugu; Walker, Michael A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007064316 A1 2007-06-07

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-2-methylbenzenesulfonyl chloride
C7H6ClFO2S
445-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 2 Cl 0.0000 0.5637 0.0 0
M  V30 3 O 0.5638 2.6673 0.0 0
M  V30 4 O 2.1038 0.0000 0.0 0
M  V30 5 C 1.3338 4.4137 0.0 0
M  V30 6 F 6.6687 1.3337 0.0 0
M  V30 7 C 2.6675 2.1037 0.0 0
M  V30 8 C 2.6675 3.6437 0.0 0
M  V30 9 C 4.0012 1.3337 0.0 0
M  V30 10 C 4.0012 4.4137 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N,2-dimethylbenzenesulfonamide
C8H10FNO2S
870562-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 F 0.0000 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 445-05-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870562-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-4146251
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 13: 5-Fluoro-2,N-dimethyl-benzenesulfonamide. To a solution
of 5-fluoro-2-methyl-benzenesulfonyl chloride (4.18 g, 20 mmol) in
acetone (20 mL) was added a 40% aqueous solution of methylamine (4.5 mL,
60 mmol) under nitrogen and the mixture stirred for 5 min. Acetone was
removed in vacuo and the aqueous residue extracted with CH2Cl2. The
CH2Cl2 extract was dried (Na2SO4), filtered, concentrated and the residue
purified by column chromatography (SiO2, 10% ether in CH2Cl2) to provide
3.9 g (19.2 mmol, Yield 96%) of the title compound as a white solid. 1H
NMR (500 MHz, CDCl3) δ ppm: 2.59 (3H, s), 2.67 (3H, d,J=5.5 Hz), 4.41
(1H, brs), 7.13-7.20 (1H, m), 7.29 (1H, dd,J=8.2, 5.5 Hz), 7.69
(1H,J=8.6, 2.1 Hz); LC/MS m/z 204 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives as HIV integrase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, Narasimhulu B.; Ueda, Yasutsugu; Connolly, Timothy P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007064619 A1 2007-06-07

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-2-methylbenzenesulfonyl chloride
C7H6ClFO2S
445-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 2 Cl 0.0000 0.5637 0.0 0
M  V30 3 O 0.5638 2.6673 0.0 0
M  V30 4 O 2.1038 0.0000 0.0 0
M  V30 5 C 1.3338 4.4137 0.0 0
M  V30 6 F 6.6687 1.3337 0.0 0
M  V30 7 C 2.6675 2.1037 0.0 0
M  V30 8 C 2.6675 3.6437 0.0 0
M  V30 9 C 4.0012 1.3337 0.0 0
M  V30 10 C 4.0012 4.4137 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N,2-dimethylbenzenesulfonamide
C8H10FNO2S
870562-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 F 0.0000 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 445-05-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870562-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-6726839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Fluoro-2,N-dimethyl-benzenesulfonamide. To a solution of
5-fluoro-2-methyl-benzenesulfonyl chloride (4.18 g, 20 mmol) in acetone
(20 mL) was added a 40% aqueous solution of methylamine (4.5 mL, 60 mmol)
under nitrogen and the mixture stirred for 5 min. Acetone was removed in
vaeuo and the aqueous residue extracted with CH2Cl2. The CH2Cl2 extract
was dried Na2SO4), filtered, concentrated and the residue purified by
column chromatography (SiO2, 10% ether in CH2Cl2) to provide 3.9 g (19.2
mmol, Yield 96%) of the titie compound as a white solid. 1H NMR (500 MHz,
CDCl3) δ ppm: 2.59 (3H, s), 2.67 (3H, d, J=5.5 Hz), 4.41 (1H, brs),
7.13-7.20 (1H, m), 7.29 (1H, dd, J=8.2, 5.5 Hz), 7.69 (1H, J=8.6, 2.1
Hz); LC/MS m/z 204 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic pyrimidinone compounds as HIV integrase inhibitors, their
preparation, pharmaceutical compositions, and use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Ueda, Yasutsugu; Matiskella, John D.; Walker,
Michael A.; Banville, Jacques; Beaulieu, Francis; Ouellet, Carl;
Plamondon, Serge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070111984 A1 2007-05-17

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-2-methylbenzenesulfonyl chloride
C7H6ClFO2S
445-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 2 Cl 0.0000 0.5637 0.0 0
M  V30 3 O 0.5638 2.6673 0.0 0
M  V30 4 O 2.1038 0.0000 0.0 0
M  V30 5 C 1.3338 4.4137 0.0 0
M  V30 6 F 6.6687 1.3337 0.0 0
M  V30 7 C 2.6675 2.1037 0.0 0
M  V30 8 C 2.6675 3.6437 0.0 0
M  V30 9 C 4.0012 1.3337 0.0 0
M  V30 10 C 4.0012 4.4137 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N,2-dimethylbenzenesulfonamide
C8H10FNO2S
870562-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 F 0.0000 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 445-05-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870562-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-8147812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Fluoro-2,N-dimethyl-benzenesulfonamide. To a solution of
5-fluoro-2-methyl-benzenesulfonyl chloride (4.18 g, 20 mmol) in acetone
(20 mL) was added a 40% aqueous solution of methylamine (4.5 mL, 60 mmol)
under nitrogen and the mixture stirred for 5 min. Acetone was removed in
vacuo and the aqueous residue extracted with CH2Cl2. The CH2Cl2 extract
was dried (Na2SO4), filtered, concentrated and the residue purified by
column chromatography (SiO2, 10% ether in CH2Cl2) to provide 3.9 g (19.2
mmol, Yield 96%) of the title compound as a white solid. 1H NMR (500 MHz,
CDCl3) δ ppm: 2.59 (3H, s), 2.67 (3H, d, J=5.5 Hz), 4.41 (1H, brs),
7.13-7.20 (1H, m), 7.29 (1H, dd, J=8.2, 5.5 Hz), 7.69 (1H, J=8.6, 2.1
Hz); LC/MS m/z 204 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic heterocycles, particularly
pyrimido[2,1-c][1,4]oxazine-2-carboxamides, as HIV integrase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Banville, Jacques; Beaulieu, Francis; Connolly,
Timothy P.; Krystal, Mark R.; Matiskella, John D.; Ouellet, Carl;
Plamondon, Serge; Remillard, Roger; Sorenson, Margaret E.; Ueda,
Yasutsugu; Walker, Michael A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050267105 A1 2005-12-01

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-nitropyridine
C5H3BrN2O2
4487-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-nitro-2-pyridinamine
C6H7N3O2
4093-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 N 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4487-59-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4093-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8020420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A. N-Methyl-5-nitropyridin-2-amine. A solution of 2-bromo-5-nitropyridine
(1.2 g, 5.9 mmol) in methylamine (aqueous solution, 10 mL) was stirred at
room temperature for 5 h. Brine was added, and the precipitate was
collected and washed with water to give N-methyl-5-nitropyridin-2-amine
(870 mg, 96 % yield) as a solid. N-Methyl-5-nitropyridin-2-amine, yield
870 mg, 96 %
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aminotriazolopyridines as kinase inhibitors and their preparation,
pharmaceutical compositions and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bahmanyar, Sogole; Bates, R.J.; Blease, Kate; Calabrese, Andrew Antony;
Daniel, Thomas Oran; Delgado, Mercedes; Elsner, Jan; Erdman, Paul; Fahr,
Bruce; Ferguson, Gregory; Lee, Branden; Nadolny, Lisa; Packard, Garrick;
Papa, Patrick; Plantevin-Krenitsky, Veronique; Riggs, Jennifer; Rohane,
Patricia; Sankar, Sabita; Sapienza, John; Satoh, Yoshitaka; Sloan,
Victor; Stevens, Randall; Tehrani, Lida; Tikhe, Jayashree; Torres,
Eduardo; Wallace, Andrew; Whitefield, Brandon Wade; Zhao, Jingjing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010027500 A1 2010-03-11

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzaldehyde
C7H5FO
456-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methylbenzenemethanamine
C8H10FN
90389-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 F 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 456-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90389-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3307619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of Methylamine (15.3 mL, 40% aq. solution, 177 mmol) was
added to a stirred solution of 3-fluorobenzaldehyde (20.0 g, 161 mmol) in
MeOH (150 mL) at room temperature. After stirring for 6 h, the reaction
was cooled to 0°C and then NaBH4 (6.10 g, 161 mmol) was added
portionwise. The cooling bath was removed and the reaction was warmed to
room temperature and stirred for 16.5 h. The reaction was quenched with
HP, and cautiously acidified with 2 N HCl, and then extracted (3×) with
CH2Cl2. The aq. phase was then basified using 6 N NaOH and then extracted
(4×) with CH2Cl2. The latter organic extracts were combined, dried over
Na2SO4, filtered, and concentrated in vacuo to afford the product (21.51
g, 96%), as aclear oil. 1H NMR (300 MHz, CDCl3) δ 7.32 (td, J = 7.5, 1.7
Hz, 1H), 7.28-7.19 (m, 1H), 7.14-6.98 (m, 2H), 3.80 (s, 2H), 2.45 (s,
3H), 1.47 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-phenyl substituted tetrahydroisoquinolines and their use
to block reuptake of norepinephrine, dopamine, and serotonin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molino, Bruce F.; Berkowitz, Barry; Cohen, Marlene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060111393 A1 2006-05-25

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzaldehyde
C7H5FO
456-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methylbenzenemethanamine
C8H10FN
90389-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 F 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 456-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90389-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9383476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: Methylamine (15.3 mL, 40% aq. solution, 177 mmol) was added to a
stirred solution of 3-fluorobenzaldehyde (20.0 g, 161 mmol) in MeOH (150
mL) at room temperature. After stirring for 6 h, the reaction was cooled
to 0°C and then NaBH4 (6.10 g, 161 mmol) was added portionwise. The
cooling bath was removed and the reaction was warmed to room temperature
and stirred for 16.5 h. The reaction was quenched with H2O, and
cautiously acidified with 2 N HCl, and then extracted (3×) with CH2Cl2.
The aq. phase was then basified using 6 N NaOH and then extracted (4×)
with CH2Cl2. The latter organic extracts were combined, dried over
Na2SO4, filtered, and concentrated in vacuo to afford the product.
Intermediate compound, Yield: (21.51 g. 96%), clear oil. 1H NMR (300 MHz,
CDCl3) δ 7.32 (td, J= 7.5, 1.7 Hz, 1H), 7.28-7.19 (m, 1H), 7.14-6.98 (m,
2H). 3.80 (s, 2H), 2.45 (s. 3H), 1.47 (br s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-Phenyltetrahydroisoquinolines and use thereof to block reuptake of
norepinephrine, dopamine and serotonin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beck, James P.; Smith, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001032624 A1 2001-05-10

$RFMT $RIREG SCHEME154 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Curcumin
C21H20O6
458-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 C 10.6695 1.5400 0.0 0
M  V30 7 C 12.0034 2.3100 0.0 0
M  V30 8 O 10.6695 0.0000 0.0 0
M  V30 9 C 13.3370 1.5400 0.0 0
M  V30 10 O 0.0000 1.5400 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 O 0.0000 4.6201 0.0 0
M  V30 13 O 18.6718 1.5400 0.0 0
M  V30 14 C 18.6718 0.0000 0.0 0
M  V30 15 O 18.6718 4.6201 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 2.6675 1.5400 0.0 0
M  V30 18 C 4.0011 3.8500 0.0 0
M  V30 19 C 1.3337 2.3100 0.0 0
M  V30 20 C 2.6675 4.6201 0.0 0
M  V30 21 C 1.3337 3.8500 0.0 0
M  V30 22 C 14.6707 2.3100 0.0 0
M  V30 23 C 16.0043 1.5400 0.0 0
M  V30 24 C 14.6707 3.8500 0.0 0
M  V30 25 C 17.3381 2.3100 0.0 0
M  V30 26 C 16.0043 4.6201 0.0 0
M  V30 27 C 17.3381 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 1 10 19
M  V30 13 1 12 21
M  V30 14 1 13 14
M  V30 15 1 13 25
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl propiolate
C5H6O2
623-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 3 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C33H38N2O8
3047659-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 7.7000 0.0 0
M  V30 2 O 4.0011 9.2400 0.0 0
M  V30 3 O 2.6674 6.9300 0.0 0
M  V30 4 C 2.6674 10.0100 0.0 0
M  V30 5 C 2.6674 11.5500 0.0 0
M  V30 6 C 9.3358 4.6200 0.0 0
M  V30 7 O 2.6674 0.7700 0.0 0
M  V30 8 C 1.3336 0.0000 0.0 0
M  V30 9 C 9.3358 7.7000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 12.0031 3.0800 0.0 0
M  V30 12 C 14.6705 7.7000 0.0 0
M  V30 13 O 16.0041 6.9300 0.0 0
M  V30 14 O 14.6705 9.2400 0.0 0
M  V30 15 C 17.3379 7.7000 0.0 0
M  V30 16 C 18.6716 6.9300 0.0 0
M  V30 17 O 14.6705 12.3200 0.0 0
M  V30 18 C 14.6705 13.8600 0.0 0
M  V30 19 O 12.0031 13.8600 0.0 0
M  V30 20 C 5.3347 5.3900 0.0 0
M  V30 21 C 5.3347 6.9300 0.0 0
M  V30 22 C 6.6684 4.6200 0.0 0
M  V30 23 C 6.6684 7.7000 0.0 0
M  V30 24 C 8.0021 5.3900 0.0 0
M  V30 25 N 8.0021 6.9300 0.0 0
M  V30 26 C 4.0011 4.6200 0.0 0
M  V30 27 C 4.0011 3.0800 0.0 0
M  V30 28 C 2.6674 5.3900 0.0 0
M  V30 29 C 2.6674 2.3100 0.0 0
M  V30 30 C 1.3336 4.6200 0.0 0
M  V30 31 C 1.3336 3.0800 0.0 0
M  V30 32 C 10.6694 5.3900 0.0 0
M  V30 33 C 10.6694 6.9300 0.0 0
M  V30 34 N 12.0032 4.6200 0.0 0
M  V30 35 C 12.0031 7.7000 0.0 0
M  V30 36 C 13.3369 5.3900 0.0 0
M  V30 37 C 13.3369 6.9300 0.0 0
M  V30 38 C 12.0032 9.2400 0.0 0
M  V30 39 C 13.3369 10.0100 0.0 0
M  V30 40 C 10.6694 10.0100 0.0 0
M  V30 41 C 13.3369 11.5500 0.0 0
M  V30 42 C 10.6694 11.5500 0.0 0
M  V30 43 C 12.0031 12.3200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 24
M  V30 7 1 6 32
M  V30 8 1 7 8
M  V30 9 1 7 29
M  V30 10 1 9 25
M  V30 11 1 10 31
M  V30 12 1 11 34
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 37
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 41
M  V30 20 1 19 43
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 26
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 1 35 38
M  V30 40 2 36 37
M  V30 41 2 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 2 40 42
M  V30 45 2 41 43
M  V30 46 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 458-37-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 623-47-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3047659-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40794655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14219-31-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-coated magnetite-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, silica-coated magnetic nanoparticles
functionalized copper catalyst used in stage 2, reusable catalyst in
stage 2, solid-supported catalyst in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One pot multicomponent reaction of curcumin: Green synthesis of novel
1,4-dihydropyridine-2,3-dicarboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Motamed, Nasim Khoshlahjeh; Larijani, Kambiz; Pournamdari, Elham;
Saeidian, Hamid; Hargalani, Fariba Zamani
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2024), 61(8), 1306-1313

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[2-(2-amino-5-chlorophenyl)-2-(2-fluorophenyl)ethyl]thio]acetate
C17H17ClFNO2S
488828-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 S 8.0022 4.6201 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 O 12.0033 5.3901 0.0 0
M  V30 7 O 10.6697 3.0801 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 5.3348 7.7002 0.0 0
M  V30 10 F 2.6673 3.0801 0.0 0
M  V30 11 Cl 0.0000 4.6201 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 4.0010 6.9302 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 7.7002 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 4.0010 0.7700 0.0 0
M  V30 22 C 6.6685 0.7700 0.0 0
M  V30 23 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 13
M  V30 11 1 10 19
M  V30 12 1 11 16
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-(2-Amino-5-chlorophenyl)-2-(2-fluorophenyl)ethyl]thio]-N-methylacetamide
C17H18ClFN2OS
581059-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 S 8.0022 4.6201 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 N 12.0033 5.3901 0.0 0
M  V30 7 O 10.6697 3.0801 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 5.3348 7.7002 0.0 0
M  V30 10 F 2.6673 3.0801 0.0 0
M  V30 11 Cl 0.0000 4.6201 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 4.0010 6.9302 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 7.7002 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 4.0010 0.7700 0.0 0
M  V30 22 C 6.6685 0.7700 0.0 0
M  V30 23 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 13
M  V30 11 1 10 19
M  V30 12 1 11 16
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 488828-91-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 581059-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14009495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzene derivatives for inhibiting insulin secretion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pei, Yazhong; James, Ian W.; Ghosh, Soumitra S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003066035 A2 2003-08-14

$RFMT $RIREG SCHEME156 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diphenylacetylene
C14H10
501-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 7.7002 1.3337 0.0 0
M  V30 10 C 8.4702 0.0000 0.0 0
M  V30 11 C 8.4702 2.6673 0.0 0
M  V30 12 C 10.0102 0.0000 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethoxybenzaldehyde
C9H10O3
613-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 O 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isoquinolinium, 6,8-dimethoxy-2-methyl-3,4-diphenyl-, tetrafluoroborate(1-) (...
C24H22NO2.BF4
1356496-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.9301 0.0 0
M  V30 2 O 8.0022 5.3900 0.0 0
M  V30 3 C 9.3360 4.6200 0.0 0
M  V30 4 O 10.6697 10.0101 0.0 0
M  V30 5 C 12.0033 9.2401 0.0 0
M  V30 6 C 5.3348 10.0101 0.0 0
M  V30 7 C 6.6685 9.2401 0.0 0
M  V30 8 C 4.0012 9.2401 0.0 0
M  V30 9 C 6.6685 7.7001 0.0 0
M  V30 10 C 8.0022 10.0101 0.0 0
M  V30 11 N 4.0012 7.7001 0.0 0 CHG=1 VAL=4
M  V30 12 C 8.0022 6.9301 0.0 0
M  V30 13 C 5.3348 6.9301 0.0 0
M  V30 14 C 9.3360 9.2401 0.0 0
M  V30 15 C 9.3360 7.7001 0.0 0
M  V30 16 C 5.3348 11.5502 0.0 0
M  V30 17 C 6.6685 12.3202 0.0 0
M  V30 18 C 4.0012 12.3202 0.0 0
M  V30 19 C 6.6685 13.8602 0.0 0
M  V30 20 C 4.0012 13.8602 0.0 0
M  V30 21 C 5.3348 14.6302 0.0 0
M  V30 22 C 2.6673 10.0101 0.0 0
M  V30 23 C 2.6673 11.5502 0.0 0
M  V30 24 C 1.3337 9.2401 0.0 0
M  V30 25 C 1.3337 12.3202 0.0 0
M  V30 26 C 0.0000 10.0101 0.0 0
M  V30 27 C 0.0000 11.5502 0.0 0
M  V30 28 B 6.0017 1.5400 0.0 0 CHG=3 VAL=4
M  V30 29 F 4.4617 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 30 F 7.5417 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 31 F 6.0017 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 32 F 6.0017 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 22
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 2 10 14
M  V30 16 2 11 13
M  V30 17 2 12 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 1 28 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 501-65-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 613-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1356496-51-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27273368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 12354-85-7
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 14104-20-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-85-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-Pot Synthesis of Isoquinolinium Salts by Rhodium-Catalyzed C-H Bond
Activation: Application to the Total Synthesis of Oxychelerythrine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayakumar, Jayachandran; Parthasarathy, Kanniyappan; Cheng, Chien-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(1), 197-200

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dixanthogen
C6H10O2S4
502-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 S 5.3348 2.3101 0.0 0
M  V30 3 O 2.6673 2.3101 0.0 0
M  V30 4 S 4.0012 0.0000 0.0 0
M  V30 5 S 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0022 2.3101 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 O 9.3360 1.5400 0.0 0
M  V30 10 S 8.0022 3.8501 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-Ethyl N-methylcarbamothioate
C4H9NOS
817-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0
M  V30 4 S 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 502-55-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 817-73-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-13563181
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 638-38-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method 3: Synthesis of N-alkyl and N,N-dialkyl O-ethyl thiocarbamates
using manganese(II) acetate/oxygen system In a 250 cm3 three-necked flask
equipped with magnetic mixer, dropping funnel, condenser, thermometer,
and oxygen bubbling device 100 cm3 water and 18.5 g (0.075 mol) 98%
diethyl dixanthogenate were placed. During 1 h, 11.4 cm3 (0.15 mol) of
40% methylamine solution was added dropwise with vigorous stirring,
causing the temperature to increase to 30 °C. At this point, 15.2 g (0.15
mol) triethylamine and 30.0 mg (1.2 x 10-4 mol) manganese(II) acetate
tetrahydrate were added, and oxygen bubbling was started immediately. The
reaction mixture was maintained at constant temperature of 50 °C while
providing an oxygen pressure of 2 x 105 Pa for 1.0 h, after which the
reaction was complete. In the course of the reaction sulfur particles
precipitated in a quantity less than expected for the reaction yield.
Some elemental sulfur was probably oxidized to sulfur oxides. The
reaction mixture was filtered on a Büchner funnel, separating sulfur from
an aqueous emulsion phase of N-methyl O-ethyl thiocarbamate. The product
was isolated from the aqueous phase by two ethereal extractions, the
organic phase was dried with sodium sulfate, and ether was removed by
distillation at atmospheric pressure. Pure product was obtained by
fractional vacuum distillation at 105 °C/2 kPa. 18.7 g N-methyl O-ethyl
thiocarbamate (yield 95.8%, GC purity 98.7%)
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, optimized on oxidant and catalyst for yield and an
environmentally friendly process, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A synthesis of N-alkyl and N,N-dialkyl O-ethyl thiocarbamates from
diethyl dixanthogenate using different oxidants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Milosavljevic, Milutin M.; Sovrlic, Milica; Marinkovic, Aleksandar D.;
Milenkovic, Dragan D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2010), 141(7), 749-755

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3(2H)-Pyridazinone, 6-(4-fluoro-3-methylphenyl)-2-(2-methylpropyl)-4-[[(methy...
C17H21FN2O4S
503825-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 6.6684 0.0 0
M  V30 2 O 9.2400 5.3347 0.0 0
M  V30 3 S 10.7800 5.3347 0.0 0 VAL=6
M  V30 4 C 10.7800 6.8747 0.0 0
M  V30 5 O 12.3200 5.3347 0.0 0
M  V30 6 O 10.7800 3.7947 0.0 0
M  V30 7 C 3.8500 9.3358 0.0 0
M  V30 8 C 2.3100 9.3358 0.0 0
M  V30 9 C 1.5400 10.6694 0.0 0
M  V30 10 C 1.5400 8.0021 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 12 O 6.9300 9.3358 0.0 0
M  V30 13 F 1.5400 0.0000 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 6.1600 5.3347 0.0 0
M  V30 16 N 3.8500 6.6684 0.0 0
M  V30 17 C 6.9300 6.6684 0.0 0
M  V30 18 N 4.6200 8.0021 0.0 0
M  V30 19 C 6.1600 8.0021 0.0 0
M  V30 20 C 3.8500 4.0011 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 4.6200 2.6673 0.0 0
M  V30 23 C 1.5400 2.6673 0.0 0
M  V30 24 C 3.8500 1.3336 0.0 0
M  V30 25 C 2.3100 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 23
M  V30 12 2 12 19
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Fluoro-3-methylphenyl)-4-[(methylamino)methyl]-2-(2-methylpropyl)-3(2H)-...
C17H22FN3O
503823-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 6.6684 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.7800 5.3347 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 C 3.8500 9.3358 0.0 0
M  V30 6 N 2.3100 9.3358 0.0 0
M  V30 7 C 1.5400 10.6694 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 O 6.9300 9.3358 0.0 0
M  V30 10 F 1.5400 0.0000 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 N 6.1600 5.3347 0.0 0
M  V30 13 C 3.8500 6.6684 0.0 0
M  V30 14 N 6.9300 6.6684 0.0 0
M  V30 15 C 4.6200 8.0021 0.0 0
M  V30 16 C 6.1600 8.0021 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 4.6200 2.6673 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 21 C 3.8500 1.3336 0.0 0
M  V30 22 C 2.3100 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 8 20
M  V30 9 2 9 16
M  V30 10 1 10 22
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 503825-31-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 503823-51-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11560629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 4) Preparation of
2-cyclopropylmethyl-6-(3-fluoro-4-methoxyphenyl)-4-methylaminomethyl-2H-pyridazin-3-one
A solution of
2-cyclopropylmethyl-6-(3-fluoro-4-methoxyphenyl)-4-methanesulfonyloxymethyl-2H-pyridazin-3-one
(160 mg, 0.42 mmol) in 30% methylamine/ethanol (5 mL) was stirred at
80°C. for 4 hours in a sealed tube. The solvent was distilled off under
reduced pressure, and the residue was purified by preparative thin-layer
chromatography on silica gel [developing solvent: chloroform/methanol
(10/1)]. Preparation of
6-(4-fluoro-3-methylphenyl)-2-isobutyl-4-methylaminomethyl-2H-pyridazin-3-one
Following the procedure of Example 9 (4),
6-(4-fluoro-3-methylphenyl)-2-isobutyl-4-methanesulfonyloxy
methyl-2H-pyridazin-3-one was reacted. The title compound as a pale
yellow oil (yield: 96.2%). 1H NMR (400 MHz, CDCl3) δ: 0.98 (6H, d, J=6.8
Hz), 1.65 (1H, br), 2.29-2.42 (1H, m), 2.34 (3H, d, J=1.7 Hz), 2.51 (3H,
s), 3.77 (2H, d, J=1.2 Hz), 4.07 (2H, d, J=7.3 Hz), 7.07 (1H, dd, J=8.8,
8.8 Hz), 7.54-7.63 (2H, m), 7.64 (1H, t, J=1.2 Hz). IR (Neat) cm-1: 3306,
1653, 1605, 1507. Mass m/z: 303 (M+).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, product further converted to HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of water-soluble phenylpyridazine derivatives as IL-β
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kyotani, Yoshinori; Koshi, Tomoyuki; Shigyo, Hiromichi; Yoshizaki, Hideo;
Kitamura, Takahiro; Takemura, Shunji; Yasuoka, Kyoko; Totsuka, Junko;
Sato, Seiichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040002497 A1 2004-01-01

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Maleopimaric acid
C24H32O5
510-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9546 6.6394 0.0 0
M  V30 2 O 7.9837 0.5676 0.0 0
M  V30 3 C 0.8758 3.9498 0.0 0
M  V30 4 C 0.0000 5.2166 0.0 0
M  V30 5 C 0.2165 2.5581 0.0 0
M  V30 6 O 2.5478 0.3514 0.0 0
M  V30 7 C 11.4818 3.4453 0.0 0
M  V30 8 O 11.7493 1.9287 0.0 0
M  V30 9 O 12.6616 4.4352 0.0 0
M  V30 10 C 9.7673 2.4554 0.0 0
M  V30 11 C 5.4146 3.9720 0.0 0 CFG=2
M  V30 12 C 6.1846 5.3058 0.0 0 CFG=2
M  V30 13 C 5.9462 2.4063 0.0 0 CFG=2
M  V30 14 C 3.5565 4.4220 0.0 0
M  V30 15 C 6.1846 2.6383 0.0 0
M  V30 16 C 7.7246 5.3058 0.0 0 CFG=2
M  V30 17 C 4.7672 5.1524 0.0 0
M  V30 18 C 4.5501 2.3345 0.0 0 CFG=2
M  V30 19 C 6.4966 0.9679 0.0 0
M  V30 20 C 2.4107 4.0748 0.0 0
M  V30 21 C 7.7246 2.6383 0.0 0
M  V30 22 C 8.4946 3.9720 0.0 0 CFG=2
M  V30 23 C 8.4946 6.6394 0.0 0
M  V30 24 C 4.0399 3.8589 0.0 0 CFG=1
M  V30 25 C 4.0082 0.8401 0.0 0
M  V30 26 O 5.2988 0.0000 0.0 0
M  V30 27 C 10.0346 3.9720 0.0 0 CFG=2
M  V30 28 C 10.0346 6.6394 0.0 0
M  V30 29 C 10.8046 5.3058 0.0 0
M  V30 30 H 6.1018 6.8435 0.0 0
M  V30 31 H 8.2469 2.1987 0.0 0
M  V30 32 H 2.3115 1.7645 0.0 0
M  V30 33 H 9.2646 2.6383 0.0 0
M  V30 34 H 2.1588 2.5182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 2 2 19
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 20
M  V30 6 2 6 25
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 27 7 CFG=1
M  V30 10 1 27 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15 CFG=3
M  V30 15 1 12 16
M  V30 16 1 12 17 CFG=3
M  V30 17 1 12 30 CFG=1
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 13 31 CFG=1
M  V30 21 2 14 20
M  V30 22 1 15 21
M  V30 23 1 16 22
M  V30 24 1 16 23
M  V30 25 1 17 24
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 1 18 32 CFG=1
M  V30 29 1 19 26
M  V30 30 1 20 24
M  V30 31 1 21 22
M  V30 32 1 22 27
M  V30 33 1 22 33 CFG=1
M  V30 34 1 23 28
M  V30 35 1 24 34 CFG=1
M  V30 36 1 25 26
M  V30 37 1 27 29
M  V30 38 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 11 12 13 16 18 22 24 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
17,19-Dinoratis-15-ene-4,13,14-tricarboxylic acid, 16-(1-methylethyl)-, cycli...
C24H32O5.CH5N
766516-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9546 8.1794 0.0 0
M  V30 2 O 7.9837 2.1076 0.0 0
M  V30 3 C 0.8758 5.4898 0.0 0
M  V30 4 C 0.0000 6.7566 0.0 0
M  V30 5 C 0.2165 4.0981 0.0 0
M  V30 6 O 2.5478 1.8914 0.0 0
M  V30 7 C 11.4818 4.9853 0.0 0
M  V30 8 O 11.7493 3.4687 0.0 0
M  V30 9 O 12.6616 5.9752 0.0 0
M  V30 10 C 9.7673 3.9954 0.0 0
M  V30 11 C 5.4146 5.5120 0.0 0 CFG=2
M  V30 12 C 6.1846 6.8458 0.0 0 CFG=2
M  V30 13 C 5.9462 3.9463 0.0 0 CFG=2
M  V30 14 C 3.5565 5.9620 0.0 0
M  V30 15 C 6.1846 4.1783 0.0 0
M  V30 16 C 7.7246 6.8458 0.0 0 CFG=2
M  V30 17 C 4.7672 6.6924 0.0 0
M  V30 18 C 4.5501 3.8745 0.0 0 CFG=2
M  V30 19 C 6.4966 2.5079 0.0 0
M  V30 20 C 2.4107 5.6148 0.0 0
M  V30 21 C 7.7246 4.1783 0.0 0
M  V30 22 C 8.4946 5.5120 0.0 0 CFG=2
M  V30 23 C 8.4946 8.1794 0.0 0
M  V30 24 C 4.0399 5.3989 0.0 0 CFG=1
M  V30 25 C 4.0082 2.3801 0.0 0
M  V30 26 O 5.2988 1.5400 0.0 0
M  V30 27 C 10.0346 5.5120 0.0 0 CFG=2
M  V30 28 C 10.0346 8.1794 0.0 0
M  V30 29 C 10.8046 6.8458 0.0 0
M  V30 30 H 6.1018 8.3835 0.0 0
M  V30 31 H 8.2469 3.7387 0.0 0
M  V30 32 H 2.3115 3.3045 0.0 0
M  V30 33 H 9.2646 4.1783 0.0 0
M  V30 34 H 2.1588 4.0582 0.0 0
M  V30 35 C 5.5608 0.0000 0.0 0
M  V30 36 N 7.1008 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 2 2 19
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 20
M  V30 6 2 6 25
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 27 7 CFG=1
M  V30 10 1 27 10 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15 CFG=3
M  V30 15 1 12 16
M  V30 16 1 12 17 CFG=3
M  V30 17 1 12 30 CFG=1
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 13 31 CFG=1
M  V30 21 2 14 20
M  V30 22 1 15 21
M  V30 23 1 16 22
M  V30 24 1 16 23
M  V30 25 1 17 24
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 1 18 32 CFG=1
M  V30 29 1 19 26
M  V30 30 1 20 24
M  V30 31 1 21 22
M  V30 32 1 22 27
M  V30 33 1 22 33 CFG=1
M  V30 34 1 23 28
M  V30 35 1 24 34 CFG=1
M  V30 36 1 25 26
M  V30 37 1 27 29
M  V30 38 1 28 29
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 11 12 13 16 18 22 24 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 510-39-4
$DTYPE RXN:RCT(2):AMD
$DATUM salts
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 766516-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25903388
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Nitrogen- and phosphorus-containing carboxylic
acid salts IIIa-IIIt, IVa-IVi, Va-Vi, VIa-VIi, and VIIa-VIIi (general
procedure). Compound II, 0.05 mol, was added to a solution of 0.005 mol
of acid Ia-Ic in 20 ml of absolute chloroform (or 0.0025 mol of acid Id
or If in 20 ml of absolute methanol). When compound II had dissolved
completely, the solvent was removed, and the residue subjected to a
vacuum at a temperature not higher than 40-50°C. Salts IIIa-IIIt,
IVa-IVi, Va-Vi, VIa-VIi, and VIIa-VIIi were obtained as homogeneous
brittle porous materials. The reaction was complete within 10-15 min at
20-23°C. The yields of salts IIIa-IIIt, IVa- IVi, Va-Vi, and VIIa-VIIi
were 89-96%. Compound IIIa, yield 96%. mp (decomp.): 67 °C; Formula:
C25H37NO5; Mcalc: 431.6; Elemental analysis - Found: C 69.74%, H 8.77%, N
3.16%; Calculated: C 69.58%, H 8.64%, N 3.25%; 1H NMR δ, ppm: 0.56 s (3H,
C12Me), 0.96 d (6H, Me2C), 1.11 s (3H, C1Me), 0.80-3.15 m [18H, 6CH, CH2,
(CH2)2 and (CH2)3], 2.52 s (3H, MeN), 5.48 s (1H, C=CH), 8.55-9.05 br.s
(3H, NH3); IR spectrum, ν , cm-1: 3045 (=CH); 2985, 2935, 2869 (CHAlk);
1824, 1779, 1704 (C=O); 1640 (C=C); 1466 (CH2); 1231, 1087, 947, 923
(C-O); UV spectrum, λ max, nm (ε): 204 (6000).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functionalyzed nitrogen- and phosphorus-containing salts of
cycloalkanecarboxylic and carboranecarboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dikusar, E. A.; Kozlov, N. G.; Zvereva, T. D.; Murashko, V. L.;
Yuvchenko, A. P.; Bey, M. P.; Ol'khovik, V. K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of General Chemistry (2005), 75(1), 58-68

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(2-Chloroethoxy)ethoxy]ethanol
C6H13ClO3
5197-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 O 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 C 9.3360 0.0000 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 Cl 0.0000 0.7700 0.0 0
M  V30 10 O 12.0033 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[2-(Methylamino)ethoxy]ethoxy]ethanol
C7H17NO3
282551-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 O 8.0022 0.7700 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 5 C 9.3360 0.0000 0.0 0
M  V30 6 C 2.6673 0.7700 0.0 0
M  V30 7 C 10.6697 0.7700 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 N 12.0033 0.0000 0.0 0
M  V30 10 O 0.0000 0.7700 0.0 0
M  V30 11 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5197-62-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 282551-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17175296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Recyclable Chiral Bifunctional Thioureas Derived from [60]Fullerene and
Their Use as Highly Efficient Organocatalysts for the Asymmetric
Nitro-Michael Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andres, Jose M.; Gonzalez, Miguel; Maestro, Alicia; Naharro, Daniel;
Pedrosa, Rafael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2017), 2017(19), 2683-2691

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[4-(Acetyloxy)phenyl]methylene]-2-methyl-5(4H)-oxazolone
C13H11NO4
52507-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3320 5.3026 0.0 0
M  V30 2 O 0.0000 4.9524 0.0 0
M  V30 3 C 2.2049 0.0000 0.0 0
M  V30 4 O 9.4922 5.3026 0.0 0
M  V30 5 C 10.2622 6.6363 0.0 0
M  V30 6 C 9.4922 7.9700 0.0 0
M  V30 7 O 11.8022 6.6363 0.0 0
M  V30 8 C 2.5620 3.9690 0.0 0
M  V30 9 N 3.1885 2.5620 0.0 0
M  V30 10 C 1.0304 3.8079 0.0 0
M  V30 11 C 2.0439 1.5316 0.0 0
M  V30 12 O 0.7103 2.3016 0.0 0
M  V30 13 C 4.8721 5.3026 0.0 0
M  V30 14 C 5.6421 6.6363 0.0 0
M  V30 15 C 5.6421 3.9690 0.0 0
M  V30 16 C 7.1821 6.6363 0.0 0
M  V30 17 C 7.1821 3.9690 0.0 0
M  V30 18 C 7.9521 5.3026 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8 CFG=2
M  V30 2 1 1 13
M  V30 3 2 2 10
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Acetylamino)-3-(4-hydroxyphenyl)-N-methyl-2-propenamide
C12H14N2O3
1384247-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 N 2.3100 4.0011 0.0 0
M  V30 5 N 3.8500 1.3338 0.0 0
M  V30 6 O 6.1600 2.6674 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 2.3100 6.6685 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 O 10.7800 5.3347 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 8.4700 6.6685 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52507-17-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1384247-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5584402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of 4-arylidene-5-imidazolinones as synthetic analogs of
fluorescent protein chromophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Cheng-Yu; Chen, Yun-Chung; Lin, Hao-Chun; Jhong, Yuandong; Chang,
Chih-Wei; Tsai, Ching-Hua; Kao, Chai-Lin; Chien, Tun-Cheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(29), 5898-5907

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic acid, compd. with 1,1′,6,6′,7,7′-hexahydroxy-3,3′-dimethyl-5,5′-bis(1-...
C30H30O8.C2H4O2
5453-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.8600 7.8511 0.0 0
M  V30 2 C 13.0900 6.5173 0.0 0
M  V30 3 C 15.4000 7.8511 0.0 0
M  V30 4 C 10.7800 13.1858 0.0 0
M  V30 5 O 11.5500 14.5195 0.0 0
M  V30 6 O 8.4700 11.8522 0.0 0
M  V30 7 O 15.4000 10.5184 0.0 0
M  V30 8 C 8.4700 6.5173 0.0 0
M  V30 9 O 13.8600 13.1858 0.0 0
M  V30 10 O 6.9300 6.5173 0.0 0
M  V30 11 C 6.9300 11.8522 0.0 0
M  V30 12 C 4.6200 5.1837 0.0 0
M  V30 13 O 3.8500 3.8501 0.0 0
M  V30 14 C 1.5400 10.5184 0.0 0
M  V30 15 C 2.3100 11.8522 0.0 0
M  V30 16 C 0.0000 10.5184 0.0 0
M  V30 17 O 1.5400 5.1837 0.0 0
M  V30 18 O 0.0000 7.8511 0.0 0
M  V30 19 C 11.5500 9.1848 0.0 0
M  V30 20 C 10.7800 10.5184 0.0 0
M  V30 21 C 13.0900 9.1848 0.0 0
M  V30 22 C 10.7800 7.8511 0.0 0
M  V30 23 C 11.5500 11.8522 0.0 0
M  V30 24 C 9.2400 10.5184 0.0 0
M  V30 25 C 13.8600 10.5184 0.0 0
M  V30 26 C 9.2400 7.8511 0.0 0
M  V30 27 C 13.0900 11.8522 0.0 0
M  V30 28 C 8.4700 9.1848 0.0 0
M  V30 29 C 6.9300 9.1848 0.0 0
M  V30 30 C 6.1600 7.8511 0.0 0
M  V30 31 C 6.1600 10.5184 0.0 0
M  V30 32 C 4.6200 7.8511 0.0 0
M  V30 33 C 4.6200 10.5184 0.0 0
M  V30 34 C 3.8500 9.1848 0.0 0
M  V30 35 C 3.8500 6.5173 0.0 0
M  V30 36 C 2.3100 9.1848 0.0 0
M  V30 37 C 2.3100 6.5173 0.0 0
M  V30 38 C 1.5400 7.8511 0.0 0
M  V30 39 C 7.7000 1.5400 0.0 0
M  V30 40 C 6.3663 2.3101 0.0 0
M  V30 41 O 9.0337 2.3101 0.0 0
M  V30 42 O 7.7000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 2 4 5
M  V30 5 1 4 23
M  V30 6 1 6 24
M  V30 7 1 7 25
M  V30 8 1 8 26
M  V30 9 1 9 27
M  V30 10 1 10 30
M  V30 11 1 11 31
M  V30 12 2 12 13
M  V30 13 1 12 35
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 36
M  V30 17 1 17 37
M  V30 18 1 18 38
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 2 21 25
M  V30 25 2 22 26
M  V30 26 2 23 27
M  V30 27 2 24 28
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 28 29
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 32 35
M  V30 37 1 33 34
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 42 1 39 40
M  V30 43 1 39 41
M  V30 44 2 39 42
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′,6,6′-Tetrahydroxy-3,3′-dimethyl-8,8′-bis[(methylamino)methylene]-5,5′-bi...
C32H36N2O6
195379-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.8600 5.3347 0.0 0
M  V30 2 C 15.4000 5.3347 0.0 0
M  V30 3 C 13.0900 4.0009 0.0 0
M  V30 4 C 10.7800 10.6694 0.0 0
M  V30 5 N 11.5500 12.0031 0.0 0
M  V30 6 C 10.7800 13.3367 0.0 0
M  V30 7 O 8.4700 9.3358 0.0 0
M  V30 8 O 15.4000 8.0020 0.0 0
M  V30 9 C 8.4700 4.0009 0.0 0
M  V30 10 O 13.8600 10.6694 0.0 0
M  V30 11 O 6.9300 4.0009 0.0 0
M  V30 12 C 6.9300 9.3358 0.0 0
M  V30 13 C 4.6200 2.6673 0.0 0
M  V30 14 N 3.8500 1.3336 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 16 C 1.5400 8.0020 0.0 0
M  V30 17 C 0.0000 8.0020 0.0 0
M  V30 18 C 2.3100 9.3358 0.0 0
M  V30 19 O 1.5400 2.6673 0.0 0
M  V30 20 O 0.0000 5.3347 0.0 0
M  V30 21 C 11.5500 6.6684 0.0 0
M  V30 22 C 10.7800 8.0020 0.0 0
M  V30 23 C 13.0900 6.6684 0.0 0
M  V30 24 C 10.7800 5.3347 0.0 0
M  V30 25 C 11.5500 9.3358 0.0 0
M  V30 26 C 9.2400 8.0020 0.0 0
M  V30 27 C 13.8600 8.0020 0.0 0
M  V30 28 C 9.2400 5.3347 0.0 0
M  V30 29 C 13.0900 9.3358 0.0 0
M  V30 30 C 8.4700 6.6684 0.0 0
M  V30 31 C 6.9300 6.6684 0.0 0
M  V30 32 C 6.1600 5.3347 0.0 0
M  V30 33 C 6.1600 8.0020 0.0 0
M  V30 34 C 4.6200 5.3347 0.0 0
M  V30 35 C 4.6200 8.0020 0.0 0
M  V30 36 C 3.8500 6.6684 0.0 0
M  V30 37 C 3.8500 4.0009 0.0 0
M  V30 38 C 2.3100 6.6684 0.0 0
M  V30 39 C 2.3100 4.0009 0.0 0
M  V30 40 C 1.5400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 23
M  V30 4 1 4 5
M  V30 5 2 4 25 CFG=2
M  V30 6 1 5 6
M  V30 7 1 7 26
M  V30 8 1 8 27
M  V30 9 1 9 28
M  V30 10 2 10 29
M  V30 11 1 11 32
M  V30 12 1 12 33
M  V30 13 1 13 14
M  V30 14 2 13 37 CFG=2
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 38
M  V30 19 2 19 39
M  V30 20 1 20 40
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 2 21 24
M  V30 24 1 22 25
M  V30 25 2 22 26
M  V30 26 2 23 27
M  V30 27 1 24 28
M  V30 28 1 25 29
M  V30 29 1 26 30
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 1 30 31
M  V30 33 1 31 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 34 37
M  V30 39 2 35 36
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5453-04-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195379-67-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2157235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antiviral, insecticidal, and fungicidal activities of
gossypol derivatives containing alkylimine, oxime or hydrazine moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Ling; Li, Zheng; Wang, Kailiang; Liu, Yuxiu; Li, Yongqiang; Wang,
Qingmin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(3), 474-483

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-iodo-3-methyl-, methyl ester
C9H9IO2
5471-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 I 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-N,3-dimethylbenzamide
C9H10INO
1259323-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 I 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5471-81-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1259323-74-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18597796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Epoxides as Alkylating Reagents for the Catellani Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Hong-Gang; Wu, Chenggui; Chen, Han; Chen, Ruiming; Qian, Guangyin;
Geng, Zhi; Wei, Qiang; Xia, Yuanyuan; Zhang, Jingyang; Zhang, Yuming;
Zhou, Qianghui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2018), 57(13), 3444-3448

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenemethanamine
C8H10N2O2
19499-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19499-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7042889
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxidation of secondary amines by molecular oxygen and cyclohexanone
monooxygenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Colonna, Stefano; Pironti, Vincenza; Carrea, Giacomo; Pasta, Piero;
Zambianchi, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(3), 569-575

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-3-(phenylmethyl)-2,4(1H,3H)-quinolinedione
C16H12ClNO2
58013-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5698 1.6775 0.0 0
M  V30 2 Cl 6.5698 3.6573 0.0 0
M  V30 3 O 5.3900 5.3349 0.0 0
M  V30 4 O 5.3900 0.0000 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 N 3.0800 1.3338 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 0.7700 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.0169 2.2042 0.0 0
M  V30 16 C 8.2843 3.7208 0.0 0
M  V30 17 C 9.1966 1.2143 0.0 0
M  V30 18 C 9.7314 4.2476 0.0 0
M  V30 19 C 10.6437 1.7411 0.0 0
M  V30 20 C 10.9112 3.2577 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 15
M  V30 3 1 2 5
M  V30 4 2 3 6
M  V30 5 2 4 7
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 10
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-3-(phenylmethyl)-2,4(1H,3H)-quinolinedione
C17H16N2O2
477949-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5698 3.6573 0.0 0
M  V30 2 N 6.5698 1.6775 0.0 0
M  V30 3 C 6.3023 0.1609 0.0 0
M  V30 4 O 5.3900 5.3349 0.0 0
M  V30 5 O 5.3900 0.0000 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 N 3.0800 1.3338 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 8.0169 3.1307 0.0 0
M  V30 17 C 9.1966 4.1206 0.0 0
M  V30 18 C 8.2843 1.6141 0.0 0
M  V30 19 C 10.6437 3.5937 0.0 0
M  V30 20 C 9.7314 1.0872 0.0 0
M  V30 21 C 10.9112 2.0772 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 6
M  V30 5 2 4 7
M  V30 6 2 5 8
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58013-72-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 477949-98-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16453128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation, no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 1,4-Benzodiazepine-2,5-diones by Base Promoted Ring
Expansion of 3-Aminoquinoline-2,4-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kremen, Filip; Gazvoda, Martin; Kafka, Stanislav; Proisl, Karel;
Srholcova, Anna; Klasek, Antonin; Urankar, Damijana; Kosmrlj, Janez
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(1), 715-722

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[2-(2-amino-5-bromophenyl)-2-(2-fluorophenyl)ethyl]thio]acetate
C17H17BrFNO2S
581059-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 S 8.0022 4.6201 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 O 12.0033 5.3901 0.0 0
M  V30 7 O 10.6697 3.0801 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 5.3348 7.7002 0.0 0
M  V30 10 F 2.6673 3.0801 0.0 0
M  V30 11 Br 0.0000 4.6201 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 4.0010 6.9302 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 7.7002 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 4.0010 0.7700 0.0 0
M  V30 22 C 6.6685 0.7700 0.0 0
M  V30 23 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 13
M  V30 11 1 10 19
M  V30 12 1 11 16
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-(2-Amino-5-bromophenyl)-2-(2-fluorophenyl)ethyl]thio]-N-methylacetamide
C17H18BrFN2OS
581059-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 S 8.0022 4.6201 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 N 12.0033 5.3901 0.0 0
M  V30 7 O 10.6697 3.0801 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 5.3348 7.7002 0.0 0
M  V30 10 F 2.6673 3.0801 0.0 0
M  V30 11 Br 0.0000 4.6201 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 4.0010 6.9302 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 2.6673 7.7002 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 4.0010 0.7700 0.0 0
M  V30 22 C 6.6685 0.7700 0.0 0
M  V30 23 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 13
M  V30 11 1 10 19
M  V30 12 1 11 16
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 581059-11-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 581059-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-614019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzene derivatives for inhibiting insulin secretion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pei, Yazhong; James, Ian W.; Ghosh, Soumitra S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003066035 A2 2003-08-14

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[2-(2-amino-5-chlorophenyl)-2-phenylethyl]thio]acetate
C17H18ClNO2S
581059-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 S 8.0022 4.6201 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 O 12.0033 5.3901 0.0 0
M  V30 7 O 10.6697 3.0801 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 5.3348 7.7002 0.0 0
M  V30 10 Cl 0.0000 4.6201 0.0 0
M  V30 11 C 4.0010 5.3901 0.0 0
M  V30 12 C 4.0010 6.9302 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 2.6673 7.7002 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 4.0010 0.7700 0.0 0
M  V30 22 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 12
M  V30 11 1 10 15
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-(2-Amino-5-chlorophenyl)-2-phenylethyl]thio]-N-methylacetamide
C17H19ClN2OS
581059-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 S 8.0022 4.6201 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 10.6697 4.6201 0.0 0
M  V30 6 N 12.0033 5.3901 0.0 0
M  V30 7 O 10.6697 3.0801 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 N 5.3348 7.7002 0.0 0
M  V30 10 Cl 0.0000 4.6201 0.0 0
M  V30 11 C 4.0010 5.3901 0.0 0
M  V30 12 C 4.0010 6.9302 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 2.6673 7.7002 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 1.3337 6.9302 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 4.0010 2.3101 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 4.0010 0.7700 0.0 0
M  V30 22 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 9 12
M  V30 11 1 10 15
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 581059-13-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 581059-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2752559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzene derivatives for inhibiting insulin secretion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pei, Yazhong; James, Ian W.; Ghosh, Soumitra S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003066035 A2 2003-08-14

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-3-nitrobenzonitrile
C7H2Cl2N2O2
5866-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 3.0800 0.0 0
M  V30 2 N 0.0000 3.8500 0.0 0
M  V30 3 Cl 4.0011 4.6200 0.0 0
M  V30 4 Cl 1.3336 0.0000 0.0 0
M  V30 5 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2-(methylamino)-3-nitrobenzonitrile
C8H6ClN3O2
333458-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 1.3337 2.3100 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 6.6686 2.3100 0.0 0 VAL=5
M  V30 6 O 6.6686 0.7700 0.0 0
M  V30 7 O 8.0022 3.0800 0.0 0
M  V30 8 Cl 1.3337 5.3901 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6675 3.0800 0.0 0
M  V30 11 C 5.3348 3.0800 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 4.0011 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 3 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5866-98-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333458-39-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9148209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1 To a 1L two-neck round bottom flask was added
2,6-dichloro-3-nitro-benzonitrile (11.1g, 51.1 mmol) followed by ethyl
acetate (102 mL). The flask was equipped with an internal thermometer and
magnetic stir bar and cooled to 5°C by immersion into an ice bath.
Methylamine was added dropwise to the cooled reaction mixture as a 40%
aqueous solution (8.9 mL, 115 mmol) with vigorous stirring. The reaction
mixture was stirred for an additional 3 hours with cooling, after which
more methylamine (1.8 mL, 23 mmol) was added. The reaction vessel was
removed from the ice bath and stirred for an additional 1.5 hours. To the
reaction mixture was added water (30 mL) followed immediately by hexane
(45 mL) and the resulting slurry was stirred for 15 minutes. The solid
was recovered by filtration and washed with water followed by methanol to
provide 6-chloro-2-methylamino-3-nitro-benzonitrile (10.49 g, 96%) as a
bright yellow solid, which was used directly without further
purification. 6-chloro-2-methylamino-3-nitro-benzonitrile, yield 10.49 g,
96% 1H NMR (400 MHz, DMSO-d6) δ 8.55 - 8.53 (m, 1H), 8.28 (d, 1H, J= 9.0
Hz), 6.95 (d, 1H, J= 9.0 Hz), 3.30 (d, 1H, J= 5.5 Hz).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylaminoimidazoisoquinolinones as inhibitors of Bruton's
tyrosine kinase (Btk) for treatment of B-cell proliferative disorders.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jankowski, Orion D.; Palmer, James T.; Honigberg, Lee
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007087068 A2 2007-08-02

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1-isocyanato-4-methoxybenzene
C8H6ClNO2
59741-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 2.6675 0.0 0
M  V30 2 C 0.7700 4.0011 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 Cl 3.0800 0.0000 0.0 0
M  V30 5 O 7.7001 2.6675 0.0 0
M  V30 6 C 8.4701 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Chloro-4-methoxyphenyl)-N′-methylurea
C9H11ClN2O2
488706-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 2.6674 0.0 0
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0
M  V30 4 O 3.0800 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6200 0.0000 0.0 0
M  V30 7 O 9.2400 2.6674 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 6.9300 1.3338 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 59741-05-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 488706-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-14479721
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-(2,4-Dichlorophenyl)-N'-methyl-urea (7). A
cooled (0 °C) solution of methylamine in EtOH (50 mL, 400 mmol, 8.0 M)
was dissolved in anhydrous THF (300 mL) and was treated with
2,4-dichlorophenyl isocyanate (25.0 g, 133 mmol). The cooling bath was
removed, and the mixture was warmed to 65 °C for 20 min. The reaction
mixture was then cooled to 0 °C. The solid was collected on a Buchner
funnel, washed with cold ether and dried under vacuum to afford
N-(2,4-dichlorophenyl)-N'-methyl-urea (21.7 g, 74% yield) as a colorless
solid. Yield 74-96%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione
derivatives as corticotropin-releasing factor1 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartz, Richard A.; Nanda, Kausik K.; Ingalls, Charles L.; Ahuja, Vijay
T.; Molski, Thaddeus F.; Zhang, Ge; Wong, Harvey; Peng, Yong; Kelley,
Michelle; Lodge, Nicholas J.; Zaczek, Robert; Gilligan, Paul J.; Trainor,
George L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(19), 4741-4754

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylglyoxylic acid
C8H6O3
611-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 O 6.9302 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.7700 1.3337 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-α-oxobenzeneacetamide
C9H9NO2
83490-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 611-73-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83490-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19555565
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free and One-Pot Procedure for Fast Formation of α-Ketoamides
Using α-Oxocarboxylic Acids and Amines at Room Temperature
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Fuyan; Liu, Yaxu; Chen, Yiping; Sun, Zhongliang; Wang, Bo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2017), 2(17), 4638-4641

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
3-Iodobenzoic acid
C7H5IO2
618-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 I 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-N-methylbenzamide
C8H8INO
90434-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 I 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 618-51-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90434-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1368473
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and redistribution reactions of asymmetric σ-arylplatinum(II)
complexes containing 4,7-phenanthroline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gallasch, David P.; Woodhouse, Susan L.; Rendina, Louis M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2004), 689(7), 1288-1294

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-3,3-dimethyl-1H-dibenzo[b,d]pyran-1,6(2H)-dione
C15H14O3
6315-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.6687 0.0 0
M  V30 2 O 2.3101 0.0000 0.0 0
M  V30 3 C 8.8798 3.0112 0.0 0
M  V30 4 C 8.8798 4.9911 0.0 0
M  V30 5 C 3.0801 4.0012 0.0 0
M  V30 6 C 4.6201 4.0012 0.0 0
M  V30 7 C 2.3101 2.6675 0.0 0
M  V30 8 C 2.3101 5.3348 0.0 0
M  V30 9 C 5.3901 2.6675 0.0 0
M  V30 10 C 5.3901 5.3348 0.0 0
M  V30 11 C 3.0801 1.3338 0.0 0
M  V30 12 C 0.7700 2.6675 0.0 0
M  V30 13 C 0.7700 5.3348 0.0 0
M  V30 14 O 4.6201 1.3338 0.0 0
M  V30 15 C 6.9302 2.6675 0.0 0
M  V30 16 C 6.9302 5.3348 0.0 0
M  V30 17 C 0.0000 4.0012 0.0 0
M  V30 18 C 7.7002 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 11
M  V30 3 1 3 18
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 14
M  V30 17 1 12 17
M  V30 18 2 13 17
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-3,3,5-trimethyl-1,6(2H,5H)-phenanthridinedione
C16H17NO2
2759106-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.6687 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 O 2.3101 0.0000 0.0 0
M  V30 4 C 8.8798 3.0112 0.0 0
M  V30 5 C 8.8798 4.9911 0.0 0
M  V30 6 C 4.6201 4.0012 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 5.3901 2.6675 0.0 0
M  V30 9 C 5.3901 5.3348 0.0 0
M  V30 10 C 2.3101 2.6675 0.0 0
M  V30 11 C 2.3101 5.3348 0.0 0
M  V30 12 N 4.6201 1.3338 0.0 0
M  V30 13 C 6.9302 2.6675 0.0 0
M  V30 14 C 6.9302 5.3348 0.0 0
M  V30 15 C 3.0801 1.3338 0.0 0
M  V30 16 C 0.7700 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 7.7002 4.0012 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 12
M  V30 3 2 3 15
M  V30 4 1 4 18
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 1 12 15
M  V30 18 1 13 18
M  V30 19 1 14 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6315-06-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2759106-07-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31118240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rh(III)-catalyzed C-H annulation of sulfoxonium ylides with iodonium
ylides towards isocoumarins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yin, Chuanliu; Li, Lianghao; Yu, Chuanming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2022), 20(5), 1112-1116

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichlorobenzaldehyde
C7H4Cl2O
6334-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2,3-Dichlorophenyl)methylene]methanamine
C8H7Cl2N
1289570-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 Cl 2.6674 0.0000 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6334-18-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289570-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9955270
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of intermediate
[1-(4-chloro-phenyl)-meth-(E)-ylidene]-methyl-amine A mixture of
2,3-dichloro-benzoaldehyde (Aldrich, 3.50 g, 20.0 mmol) and methyl amine
(2.0 Min THF, Aldrich, 15 mL, 15.0 mmol) in CH2Cl2 (20 mL) was stirred at
rt overnight. The reaction mixture was concentrated and the residue was
dried under reduced pressure to afford
[[1-(4-chloro-2-fluoro-phenyl)-meth-(E)-ylidene]-methyl-amine (3.62 g,
96.3%) as colorless oil which was used in the next step without further
purification.
[1-(4-chloro-2-fluoro-phenyl)-meth-(E)-ylidene]-methyl-amine, yield
(3.62, 96.3%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel N-substituted-pyrrolidines as inhibitors of MDM2-p53 interactions
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bartkovitz, David Joseph; Chu, Xin-Jie; Liu, Jin-Jun; Morgan Ross, Tina;
Zhang, Zhuming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110086854 A1 2011-04-14

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-chloro-3-methoxy-5-nitro-, methyl ester
C9H8ClNO5
63603-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 6.9301 0.0 0
M  V30 4 Cl 1.3337 2.3100 0.0 0
M  V30 5 O 4.0011 0.7700 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 C 6.6684 5.3901 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 O 6.6684 6.9301 0.0 0
M  V30 10 C 9.3359 5.3901 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 2.6675 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-methoxy-4-(methylamino)-5-nitro-, methyl ester
C10H12N2O5
1549812-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 2.3100 0.0 0
M  V30 2 C 1.3336 0.7700 0.0 0
M  V30 3 N 1.3336 5.3900 0.0 0 VAL=5
M  V30 4 O 1.3336 6.9300 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 4.0011 0.7700 0.0 0
M  V30 7 C 5.3347 0.0000 0.0 0
M  V30 8 C 6.6684 5.3900 0.0 0
M  V30 9 O 8.0021 4.6200 0.0 0
M  V30 10 O 6.6684 6.9300 0.0 0
M  V30 11 C 9.3358 5.3900 0.0 0
M  V30 12 C 2.6674 3.0800 0.0 0
M  V30 13 C 2.6674 4.6200 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 4.0011 5.3900 0.0 0
M  V30 16 C 5.3347 3.0800 0.0 0
M  V30 17 C 5.3347 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63603-09-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1549812-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20554696
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as inhibitors of PAD4 and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beaumont, Edward Jean; Devraj, Rajesh; Kerry, Philip Stephen; Kumaravel,
Gnanasambandam; Loke, Pui Leng; Meniconi, Mirco; Palfrey, Jordan John;
North, Carl; Lecci, Cristina; Tye, Heather
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018022897 A1 2018-02-01

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-chloro-3-methoxy-5-nitro-, methyl ester
C9H8ClNO5
63603-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 6.9301 0.0 0
M  V30 4 Cl 1.3337 2.3100 0.0 0
M  V30 5 O 4.0011 0.7700 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 C 6.6684 5.3901 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 O 6.6684 6.9301 0.0 0
M  V30 10 C 9.3359 5.3901 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 2.6675 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-methoxy-4-(methylamino)-5-nitro-, methyl ester
C10H12N2O5
1549812-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 2.3100 0.0 0
M  V30 2 C 1.3336 0.7700 0.0 0
M  V30 3 N 1.3336 5.3900 0.0 0 VAL=5
M  V30 4 O 1.3336 6.9300 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 4.0011 0.7700 0.0 0
M  V30 7 C 5.3347 0.0000 0.0 0
M  V30 8 C 6.6684 5.3900 0.0 0
M  V30 9 O 8.0021 4.6200 0.0 0
M  V30 10 O 6.6684 6.9300 0.0 0
M  V30 11 C 9.3358 5.3900 0.0 0
M  V30 12 C 2.6674 3.0800 0.0 0
M  V30 13 C 2.6674 4.6200 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 4.0011 5.3900 0.0 0
M  V30 16 C 5.3347 3.0800 0.0 0
M  V30 17 C 5.3347 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63603-09-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1549812-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18791915
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazole compounds as peptidylarginine deiminase 4
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Devraj, Rajesh; Kumaravel, Gnanasambandam; Atton, Holly; Beaumont,
Edward; Gadouleau, Elise; Gleave, Laura; Kerry, Philip Stephen; Lecci,
Cristina; Meniconi, Mirco; Monck, Nat; Palfrey, Jordan; Papadopoulos,
Kostas; Tye, Heather; Woods, Philip A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017147102 A1 2017-08-31

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Iodo-4-nitrobenzene
C6H4INO2
636-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitroaniline
C7H8N2O2
100-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 636-98-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11054334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-4-nitroaniline (Table 2-24) The reaction of
4-nitroiodobenzene (2.491 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (5 mol%), produced 1.466 g (96.4 %) product. 1H NMR
(300 MHz, d 6-DMSO) δ (ppm): 2.78–2.90(d, J = 4.5 Hz , 3H), 6.60(s, 2H),
7.26(s, 1H), 7.97–7.99(d, J = 7.5 Hz, 2H); 13C NMR (75 MHz, d 6-DMSO) δ
(ppm): 29.7, 110.9, 126.7, 136.0, 155.8.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,8-Dibromoimidazo[1,2-a]pyrazine
C6H3Br2N3
63744-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.7036 0.0000 0.0 0
M  V30 2 Br 6.3710 4.6200 0.0 0
M  V30 3 N 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 3.7036 4.6200 0.0 0
M  V30 6 C 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
PAB 13
C7H7BrN4
117718-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Br 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 N 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 N 2.1579 6.1264 0.0 0
M  V30 8 C 1.1444 2.3101 0.0 0
M  V30 9 C 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 C 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63744-22-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 117718-85-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10779470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 8-bromo-6-methylaminoimidazo [1, 2-a] pyrazine A mixture of 100 mg (0.36
mmol) of 6.8-dibromoimidazo [1,2-a] pyrazine in 5 ml of a 25% aqueous
methylamine solution was stirred for 12 h. After the removal of solvent,
the residue was purified by chromatography (silica column eluted with
ether) to provide 78 mg (yield: 96%) of 8-bromo-6-methylaminoimidazo
[1,2-a] pyrazine. ESI-MS (M+H+): 227.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinonyl PDK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lind, Kenneth Egnard; Cao, Kathy; Lin, Edward Yin-Shiang; Nguyen, Thinh
Ba; Tangonan, Bradley T.; Erlanson, Daniel A.; Guckian, Kevin; Simmons,
Robert Lowell; Lee, Wen-Cherng; Sun, Lihong; Hansen, Stig; Pathan,
Nuzhat; Zhang, Lei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008005457 A2 2008-01-10

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-2-(Acetylamino)-N-[2-(4-hydroxyphenyl)ethyl]-2-butenamide
C14H18N2O3
646072-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 5.3347 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 5.3900 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 N 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 O 0.0000 5.3347 0.0 0
M  V30 13 O 13.8600 5.3347 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 10.0100 6.6685 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 18 C 11.5500 6.6685 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-[[[2-(4-Hydroxyphenyl)ethyl]amino]carbonyl]-2-(methylamino)propyl]benzamide
C20H25N3O3
646071-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 3.8500 0.0 0
M  V30 2 N 4.0011 4.6200 0.0 0
M  V30 3 C 6.6685 4.6200 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 C 4.0011 6.1600 0.0 0
M  V30 6 N 8.0021 3.8500 0.0 0
M  V30 7 O 6.6685 6.1600 0.0 0
M  V30 8 N 4.0011 1.5400 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 O 5.3349 6.9300 0.0 0
M  V30 11 C 9.3358 4.6200 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 C 10.6696 3.8500 0.0 0
M  V30 14 O 16.0043 6.9300 0.0 0
M  V30 15 C 2.6674 6.9300 0.0 0
M  V30 16 C 1.3338 6.1600 0.0 0
M  V30 17 C 2.6674 8.4700 0.0 0
M  V30 18 C 0.0000 6.9300 0.0 0
M  V30 19 C 1.3338 9.2400 0.0 0
M  V30 20 C 0.0000 8.4700 0.0 0
M  V30 21 C 12.0032 4.6200 0.0 0
M  V30 22 C 12.0032 6.1600 0.0 0
M  V30 23 C 13.3369 3.8500 0.0 0
M  V30 24 C 13.3369 6.9300 0.0 0
M  V30 25 C 14.6705 4.6200 0.0 0
M  V30 26 C 14.6705 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 2 5 10
M  V30 10 1 5 15
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 11 13
M  V30 14 1 13 21
M  V30 15 1 14 26
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 646072-01-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 646071-88-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10457631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-{1-[2-(4-Hydroxyphenyl)ethylcarbamoyl]-2-methylaminopropyl }benzamide
(2t). To a suspension of 1d (0.10 g, 0.31 mmol) in MeOH (3 mL) was added
methylamine (2.15 mL, 40 wt % in H2O, 15.5 mmol). The resulting solution
was stirred at room temperature for 48 h and concentrated to yield 2t as
a green solid (0.108 g, 96%): 1H NMR (300 MHz CDCl3) δ 8.01 (1H, t, J =
4.0 Hz), 7.86-7.79 (2H, m), 7.64 (1H, d, J = 5.9 Hz), 7.51-7.39 (4H, m),
7.03 (2H, d, J = 8.4 Hz), 6.73 (2H, d, J = 8.4 Hz), 4.52 (1H, dd, J =
3.1, 5.7 Hz), 3.54-3.47 (2H, m), 3.27 (1H, dd, J = 6.6, 3.30 Hz), 2.74
(2H, t, J = 6.8 Hz), 2.47 (3H, s), 1.11 (0.9H, d, J = 6.6 Hz), 0.96 (2.1
H, d, J = 6.6 Hz); LCMS calcd for C20H26N3O3 (M + H) 356 20, found
356.14. Anal. Calcd for C20H25N3O3•0.5H2O: C, 65.91; H, 7.19; N, 11.53.
Found: C, 65.99; H, 7.26; N, 11.50.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, Michael addn. reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Michael addition of amines and thiols to dehydroalanine amides: a
remarkable rate acceleration in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Sorenson, Margaret E.; Connolly, Timothy P.; Ueda,
Yasutsugu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2003), 68(26), 10098-10102

$RFMT $RIREG SCHEME178 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibutyltin dichloride
C8H18Cl2Sn
683-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Sn 5.3348 1.3337 0.0 0
M  V30 2 C 4.0012 0.5637 0.0 0
M  V30 3 C 6.6685 2.1037 0.0 0
M  V30 4 Cl 4.5648 2.6673 0.0 0
M  V30 5 Cl 6.1048 0.0000 0.0 0
M  V30 6 C 2.6673 1.3337 0.0 0
M  V30 7 C 8.0023 1.3337 0.0 0
M  V30 8 C 1.3337 0.5637 0.0 0
M  V30 9 C 9.3360 2.1037 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 C 10.6697 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H26N2S4Sn
1448221-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3791 0.9091 0.0 0 CHG=-1 VAL=4
M  V30 2 C 5.9709 0.0000 0.0 0
M  V30 3 C 7.0165 0.6027 0.0 0
M  V30 4 C 8.0622 0.0000 0.0 0
M  V30 5 C 4.3791 5.7411 0.0 0 CHG=-1 VAL=4
M  V30 6 C 5.5912 6.4404 0.0 0
M  V30 7 C 6.6369 5.8377 0.0 0
M  V30 8 C 7.6826 6.4404 0.0 0
M  V30 9 N 1.1522 3.9262 0.0 0
M  V30 10 C 0.0000 3.2635 0.0 0
M  V30 11 N 7.6060 3.9262 0.0 0
M  V30 12 C 8.7548 3.2635 0.0 0
M  V30 13 Sn 4.3791 3.3234 0.0 0 CHG=4 VAL=6
M  V30 14 S 3.2868 2.2345 0.0 0 CHG=-1 VAL=2
M  V30 15 S 5.4680 2.2345 0.0 0 CHG=-1 VAL=2
M  V30 16 S 5.4680 4.4124 0.0 0 VAL=3
M  V30 17 S 3.2868 4.4124 0.0 0 VAL=3
M  V30 18 C 2.1979 3.3234 0.0 0
M  V30 19 C 6.5603 3.3234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 11 12
M  V30 12 1 11 19
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 19
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 683-18-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448221-76-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-12676056
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, properties and spectroscopic characterization of some
diorganotin(IV) dithiocarbamates complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jain, Disha; Chaturvedi, Alok; Upadhyay, Rajesh Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research Journal of Pharmaceutical, Biological and Chemical Sciences
(2012), 3(3), 1311-1318

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1-Methylethoxy)-2-(4-pyridinyl)-3-benzofurancarboxylic acid
C17H15NO4
691857-24-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 1.1444 0.0 0
M  V30 2 O 6.0798 0.0000 0.0 0
M  V30 3 O 3.5429 0.8242 0.0 0
M  V30 4 O 10.9909 2.3149 0.0 0
M  V30 5 C 12.3247 3.0849 0.0 0
M  V30 6 C 12.3247 4.6250 0.0 0
M  V30 7 C 13.6583 2.3149 0.0 0
M  V30 8 C 6.9899 3.0849 0.0 0
M  V30 9 C 5.5252 2.6091 0.0 0
M  V30 10 C 6.9899 4.6250 0.0 0
M  V30 11 C 8.3236 2.3149 0.0 0
M  V30 12 C 4.6200 3.8549 0.0 0
M  V30 13 O 5.5252 5.1008 0.0 0
M  V30 14 C 8.3236 5.3950 0.0 0
M  V30 15 C 9.6572 3.0849 0.0 0
M  V30 16 C 9.6572 4.6250 0.0 0
M  V30 17 C 3.0800 3.8549 0.0 0
M  V30 18 C 2.3100 2.5213 0.0 0
M  V30 19 C 2.3100 5.1886 0.0 0
M  V30 20 C 0.7700 2.5213 0.0 0
M  V30 21 C 0.7700 5.1886 0.0 0
M  V30 22 N 0.0000 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 12 17
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-(1-methylethoxy)-2-(4-pyridinyl)-3-benzofurancarboxamide
C18H18N2O3
691852-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 2.6091 0.0 0
M  V30 2 N 6.0798 1.4645 0.0 0
M  V30 3 O 3.5429 2.2889 0.0 0
M  V30 4 C 5.6039 0.0000 0.0 0
M  V30 5 O 10.9908 3.7795 0.0 0
M  V30 6 C 12.3246 4.5495 0.0 0
M  V30 7 C 12.3246 6.0895 0.0 0
M  V30 8 C 13.6583 3.7795 0.0 0
M  V30 9 C 6.9899 4.5495 0.0 0
M  V30 10 C 5.5252 4.0736 0.0 0
M  V30 11 C 6.9899 6.0895 0.0 0
M  V30 12 C 8.3235 3.7795 0.0 0
M  V30 13 C 4.6200 5.3195 0.0 0
M  V30 14 O 5.5252 6.5655 0.0 0
M  V30 15 C 8.3235 6.8595 0.0 0
M  V30 16 C 9.6572 4.5495 0.0 0
M  V30 17 C 9.6572 6.0895 0.0 0
M  V30 18 C 3.0800 5.3195 0.0 0
M  V30 19 C 2.3100 6.6533 0.0 0
M  V30 20 C 2.3100 3.9858 0.0 0
M  V30 21 C 0.7700 6.6533 0.0 0
M  V30 22 C 0.7700 3.9858 0.0 0
M  V30 23 N 0.0000 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 13 18
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 691857-24-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 691852-42-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5708243
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuran compounds for treatment and prophylaxis of
hepatitis C viral infections and associated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burns, Christopher J.; Del Vecchio, Alfred M.; Bailey, Thomas R.;
Kulkarni, Bheemashankar A.; Faitg, Thomas H.; Sherk, Susan R.;
Blackledge, Charles W.; Rys, David J.; Lessen, Thomas A.; Swestock, John;
Deng, Yijun; Nitz, Theodore J.; Reinhardt, Jason A.; Feng, Hao; Saha,
Ashis K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004041201 A2 2004-05-21

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
3-Fluoro-2-methylbenzoic acid
C8H7FO2
699-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N,2-dimethylbenzamide
C9H10FNO
634924-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 F 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 699-90-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 634924-03-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13711716
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isochromanone-based urotensin-II receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lehmann, Fredrik; Currier, Erika A.; Olsson, Roger; Hacksell, Uli;
Luthman, Kristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2005), 13(8), 3057-3068

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
3-Fluoro-2-methylbenzoic acid
C8H7FO2
699-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N,2-dimethylbenzamide
C9H10FNO
634924-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 C 2.6674 4.6200 0.0 0
M  V30 6 F 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3336 2.3100 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 699-90-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 634924-03-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5804646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isochromanones as urotensin II receptor modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andersson, Carl-Magnus; Kary, May-Britt; Lehmann, Per Fredrik; Luthman,
Ingridkristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003104216 A1 2003-12-18

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-fluoro-1-nitrobenzene
C6H3ClFNO2
700-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 700-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30636405
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolecarboxamides as inhibitors of fibroblast growth factor receptor
kinases and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaldor, Stephen W.; Tyhonas, John; Murphy, Eric A.; Kanouni, Toufike;
Arnold, Lee D.; Kania, Robert; Cox, Jason M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021247969 A1 2021-12-09

$RFMT $RIREG SCHEME182 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenacyl bromide
C8H7BrO
70-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-methyl-4-phenyl-2-thiazolidinethione
C10H11NOS2
19975-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.4590 3.6896 0.0 0
M  V30 2 C 6.7527 3.8852 0.0 0
M  V30 3 S 8.4279 0.9836 0.0 0
M  V30 4 C 4.6201 2.1580 0.0 0
M  V30 5 N 6.1264 2.4782 0.0 0
M  V30 6 C 4.4590 0.6265 0.0 0
M  V30 7 C 6.8964 1.1445 0.0 0
M  V30 8 S 5.8659 0.0000 0.0 0
M  V30 9 C 3.0800 2.1580 0.0 0
M  V30 10 C 2.3100 0.8244 0.0 0
M  V30 11 C 2.3100 3.4917 0.0 0
M  V30 12 C 0.7700 0.8244 0.0 0
M  V30 13 C 0.7700 3.4917 0.0 0
M  V30 14 C 0.0000 2.1580 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 7
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 70-11-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19975-60-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6713302
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-08-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM dropwise addition of CS2/MeOH (stage 1) and bromoacetophenone/MeOH (stage
2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Evaluation of 2(3H)-Thiazole Thiones as Tyrosinase
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Emami, Saeed; Hosseinimehr, Seyed Jalal; Shahrbandi, Kami; Enayati, Ahmad
Ali; Esmaeeli, Zahra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Archiv der Pharmazie (Weinheim, Germany) (2012), 345(8), 629-637

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Gulonic acid, 3,5:4,6-bis-O-(phenylmethylene)-, methyl ester
C21H22O7
70373-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9675 3.4963 0.0 0 CFG=2
M  V30 2 C 6.7879 2.5066 0.0 0
M  V30 3 O 9.4147 2.9696 0.0 0
M  V30 4 O 7.0554 0.9899 0.0 0
M  V30 5 O 5.3407 3.0333 0.0 0
M  V30 6 C 5.8755 0.0000 0.0 0
M  V30 7 C 6.9302 6.3468 0.0 0 CFG=2
M  V30 8 C 7.7002 5.0131 0.0 0 CFG=1
M  V30 9 C 7.7002 7.6805 0.0 0 CFG=2
M  V30 10 O 5.3901 6.3468 0.0 0
M  V30 11 O 9.2402 5.0131 0.0 0
M  V30 12 O 9.2402 7.6805 0.0 0
M  V30 13 C 6.9302 9.0141 0.0 0
M  V30 14 C 4.6201 7.6805 0.0 0 CFG=3
M  V30 15 C 10.0102 6.3468 0.0 0 CFG=3
M  V30 16 O 5.3901 9.0141 0.0 0
M  V30 17 C 3.0801 7.6805 0.0 0
M  V30 18 C 2.3101 9.0141 0.0 0
M  V30 19 C 2.3101 6.3468 0.0 0
M  V30 20 C 0.7700 9.0141 0.0 0
M  V30 21 C 0.7700 6.3468 0.0 0
M  V30 22 C 0.0000 7.6805 0.0 0
M  V30 23 C 11.5503 6.3468 0.0 0
M  V30 24 C 12.3203 7.6805 0.0 0
M  V30 25 C 12.3203 5.0131 0.0 0
M  V30 26 C 13.8603 7.6805 0.0 0
M  V30 27 C 13.8603 5.0131 0.0 0
M  V30 28 C 14.6303 6.3468 0.0 0
M  V30 29 H 6.1601 5.0131 0.0 0
M  V30 30 H 6.2530 4.4863 0.0 0
M  V30 31 H 8.4702 9.0141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 29 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 30 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 23
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Gulonamide, N-methyl-3,5:4,6-bis-O-(phenylmethylene)-
C21H23NO6
2376620-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9675 3.4963 0.0 0 CFG=2
M  V30 2 C 6.7879 2.5066 0.0 0
M  V30 3 O 9.4147 2.9696 0.0 0
M  V30 4 N 7.0554 0.9899 0.0 0
M  V30 5 O 5.3407 3.0333 0.0 0
M  V30 6 C 5.8755 0.0000 0.0 0
M  V30 7 C 6.9302 6.3468 0.0 0 CFG=2
M  V30 8 C 7.7002 5.0131 0.0 0 CFG=1
M  V30 9 C 7.7002 7.6805 0.0 0 CFG=2
M  V30 10 O 5.3901 6.3468 0.0 0
M  V30 11 O 9.2402 5.0131 0.0 0
M  V30 12 O 9.2402 7.6805 0.0 0
M  V30 13 C 6.9302 9.0141 0.0 0
M  V30 14 C 4.6201 7.6805 0.0 0 CFG=3
M  V30 15 C 10.0102 6.3468 0.0 0 CFG=3
M  V30 16 O 5.3901 9.0141 0.0 0
M  V30 17 C 3.0801 7.6805 0.0 0
M  V30 18 C 2.3101 9.0141 0.0 0
M  V30 19 C 2.3101 6.3468 0.0 0
M  V30 20 C 0.7700 9.0141 0.0 0
M  V30 21 C 0.7700 6.3468 0.0 0
M  V30 22 C 0.0000 7.6805 0.0 0
M  V30 23 C 11.5503 6.3468 0.0 0
M  V30 24 C 12.3203 5.0131 0.0 0
M  V30 25 C 12.3203 7.6805 0.0 0
M  V30 26 C 13.8603 5.0131 0.0 0
M  V30 27 C 13.8603 7.6805 0.0 0
M  V30 28 C 14.6303 6.3468 0.0 0
M  V30 29 H 6.1601 5.0131 0.0 0
M  V30 30 H 6.2530 4.4863 0.0 0
M  V30 31 H 8.4702 9.0141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 29 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 30 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 23
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70373-42-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-09-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21780024
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer composition comprising gulonic acid diacetal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Budde, Felix; Muller, Thierry; Hauck, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019179774 A1 2019-09-26

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Gulonic acid, 3,5:4,6-bis-O-(phenylmethylene)-, methyl ester
C21H22O7
70373-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9675 3.4963 0.0 0 CFG=2
M  V30 2 C 6.7879 2.5066 0.0 0
M  V30 3 O 9.4147 2.9696 0.0 0
M  V30 4 O 7.0554 0.9899 0.0 0
M  V30 5 O 5.3407 3.0333 0.0 0
M  V30 6 C 5.8755 0.0000 0.0 0
M  V30 7 C 6.9302 6.3468 0.0 0 CFG=2
M  V30 8 C 7.7002 5.0131 0.0 0 CFG=1
M  V30 9 C 7.7002 7.6805 0.0 0 CFG=2
M  V30 10 O 5.3901 6.3468 0.0 0
M  V30 11 O 9.2402 5.0131 0.0 0
M  V30 12 O 9.2402 7.6805 0.0 0
M  V30 13 C 6.9302 9.0141 0.0 0
M  V30 14 C 4.6201 7.6805 0.0 0 CFG=3
M  V30 15 C 10.0102 6.3468 0.0 0 CFG=3
M  V30 16 O 5.3901 9.0141 0.0 0
M  V30 17 C 3.0801 7.6805 0.0 0
M  V30 18 C 2.3101 9.0141 0.0 0
M  V30 19 C 2.3101 6.3468 0.0 0
M  V30 20 C 0.7700 9.0141 0.0 0
M  V30 21 C 0.7700 6.3468 0.0 0
M  V30 22 C 0.0000 7.6805 0.0 0
M  V30 23 C 11.5503 6.3468 0.0 0
M  V30 24 C 12.3203 7.6805 0.0 0
M  V30 25 C 12.3203 5.0131 0.0 0
M  V30 26 C 13.8603 7.6805 0.0 0
M  V30 27 C 13.8603 5.0131 0.0 0
M  V30 28 C 14.6303 6.3468 0.0 0
M  V30 29 H 6.1601 5.0131 0.0 0
M  V30 30 H 6.2530 4.4863 0.0 0
M  V30 31 H 8.4702 9.0141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 29 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 30 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 23
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Gulonamide, N-methyl-3,5:4,6-bis-O-(phenylmethylene)-
C21H23NO6
2376620-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9675 3.4963 0.0 0 CFG=2
M  V30 2 C 6.7879 2.5066 0.0 0
M  V30 3 O 9.4147 2.9696 0.0 0
M  V30 4 N 7.0554 0.9899 0.0 0
M  V30 5 O 5.3407 3.0333 0.0 0
M  V30 6 C 5.8755 0.0000 0.0 0
M  V30 7 C 6.9302 6.3468 0.0 0 CFG=2
M  V30 8 C 7.7002 5.0131 0.0 0 CFG=1
M  V30 9 C 7.7002 7.6805 0.0 0 CFG=2
M  V30 10 O 5.3901 6.3468 0.0 0
M  V30 11 O 9.2402 5.0131 0.0 0
M  V30 12 O 9.2402 7.6805 0.0 0
M  V30 13 C 6.9302 9.0141 0.0 0
M  V30 14 C 4.6201 7.6805 0.0 0 CFG=3
M  V30 15 C 10.0102 6.3468 0.0 0 CFG=3
M  V30 16 O 5.3901 9.0141 0.0 0
M  V30 17 C 3.0801 7.6805 0.0 0
M  V30 18 C 2.3101 9.0141 0.0 0
M  V30 19 C 2.3101 6.3468 0.0 0
M  V30 20 C 0.7700 9.0141 0.0 0
M  V30 21 C 0.7700 6.3468 0.0 0
M  V30 22 C 0.0000 7.6805 0.0 0
M  V30 23 C 11.5503 6.3468 0.0 0
M  V30 24 C 12.3203 5.0131 0.0 0
M  V30 25 C 12.3203 7.6805 0.0 0
M  V30 26 C 13.8603 5.0131 0.0 0
M  V30 27 C 13.8603 7.6805 0.0 0
M  V30 28 C 14.6303 6.3468 0.0 0
M  V30 29 H 6.1601 5.0131 0.0 0
M  V30 30 H 6.2530 4.4863 0.0 0
M  V30 31 H 8.4702 9.0141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 29 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 30 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 23
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70373-42-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-09-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21725662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nucleating agents diacetal derivatives and their use as
clarifier
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Budde, Felix; Muller, Thierry; Hauck, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019179773 A1 2019-09-26

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Gulonic acid, 3,5:4,6-bis-O-(phenylmethylene)-, methyl ester
C21H22O7
70373-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9675 3.4963 0.0 0 CFG=2
M  V30 2 C 6.7879 2.5066 0.0 0
M  V30 3 O 9.4147 2.9696 0.0 0
M  V30 4 O 7.0554 0.9899 0.0 0
M  V30 5 O 5.3407 3.0333 0.0 0
M  V30 6 C 5.8755 0.0000 0.0 0
M  V30 7 C 6.9302 6.3468 0.0 0 CFG=2
M  V30 8 C 7.7002 5.0131 0.0 0 CFG=1
M  V30 9 C 7.7002 7.6805 0.0 0 CFG=2
M  V30 10 O 5.3901 6.3468 0.0 0
M  V30 11 O 9.2402 5.0131 0.0 0
M  V30 12 O 9.2402 7.6805 0.0 0
M  V30 13 C 6.9302 9.0141 0.0 0
M  V30 14 C 4.6201 7.6805 0.0 0 CFG=3
M  V30 15 C 10.0102 6.3468 0.0 0 CFG=3
M  V30 16 O 5.3901 9.0141 0.0 0
M  V30 17 C 3.0801 7.6805 0.0 0
M  V30 18 C 2.3101 9.0141 0.0 0
M  V30 19 C 2.3101 6.3468 0.0 0
M  V30 20 C 0.7700 9.0141 0.0 0
M  V30 21 C 0.7700 6.3468 0.0 0
M  V30 22 C 0.0000 7.6805 0.0 0
M  V30 23 C 11.5503 6.3468 0.0 0
M  V30 24 C 12.3203 7.6805 0.0 0
M  V30 25 C 12.3203 5.0131 0.0 0
M  V30 26 C 13.8603 7.6805 0.0 0
M  V30 27 C 13.8603 5.0131 0.0 0
M  V30 28 C 14.6303 6.3468 0.0 0
M  V30 29 H 6.1601 5.0131 0.0 0
M  V30 30 H 6.2530 4.4863 0.0 0
M  V30 31 H 8.4702 9.0141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 29 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 30 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 23
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Gulonamide, N-methyl-3,5:4,6-bis-O-(phenylmethylene)-
C21H23NO6
2376620-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9675 3.4963 0.0 0 CFG=2
M  V30 2 C 6.7879 2.5066 0.0 0
M  V30 3 O 9.4147 2.9696 0.0 0
M  V30 4 N 7.0554 0.9899 0.0 0
M  V30 5 O 5.3407 3.0333 0.0 0
M  V30 6 C 5.8755 0.0000 0.0 0
M  V30 7 C 6.9302 6.3468 0.0 0 CFG=2
M  V30 8 C 7.7002 5.0131 0.0 0 CFG=1
M  V30 9 C 7.7002 7.6805 0.0 0 CFG=2
M  V30 10 O 5.3901 6.3468 0.0 0
M  V30 11 O 9.2402 5.0131 0.0 0
M  V30 12 O 9.2402 7.6805 0.0 0
M  V30 13 C 6.9302 9.0141 0.0 0
M  V30 14 C 4.6201 7.6805 0.0 0 CFG=3
M  V30 15 C 10.0102 6.3468 0.0 0 CFG=3
M  V30 16 O 5.3901 9.0141 0.0 0
M  V30 17 C 3.0801 7.6805 0.0 0
M  V30 18 C 2.3101 9.0141 0.0 0
M  V30 19 C 2.3101 6.3468 0.0 0
M  V30 20 C 0.7700 9.0141 0.0 0
M  V30 21 C 0.7700 6.3468 0.0 0
M  V30 22 C 0.0000 7.6805 0.0 0
M  V30 23 C 11.5503 6.3468 0.0 0
M  V30 24 C 12.3203 5.0131 0.0 0
M  V30 25 C 12.3203 7.6805 0.0 0
M  V30 26 C 13.8603 5.0131 0.0 0
M  V30 27 C 13.8603 7.6805 0.0 0
M  V30 28 C 14.6303 6.3468 0.0 0
M  V30 29 H 6.1601 5.0131 0.0 0
M  V30 30 H 6.2530 4.4863 0.0 0
M  V30 31 H 8.4702 9.0141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 29 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 30 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 23
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70373-42-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-09-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21831743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nuclating agents diacetal derivatives and their use as
clarifier
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hauck, Stefan; Budde, Felix; Muller, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3543244 A1 2019-09-25

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Gulonic acid, 3,5:4,6-bis-O-(phenylmethylene)-, methyl ester
C21H22O7
70373-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9675 3.4963 0.0 0 CFG=2
M  V30 2 C 6.7879 2.5066 0.0 0
M  V30 3 O 9.4147 2.9696 0.0 0
M  V30 4 O 7.0554 0.9899 0.0 0
M  V30 5 O 5.3407 3.0333 0.0 0
M  V30 6 C 5.8755 0.0000 0.0 0
M  V30 7 C 6.9302 6.3468 0.0 0 CFG=2
M  V30 8 C 7.7002 5.0131 0.0 0 CFG=1
M  V30 9 C 7.7002 7.6805 0.0 0 CFG=2
M  V30 10 O 5.3901 6.3468 0.0 0
M  V30 11 O 9.2402 5.0131 0.0 0
M  V30 12 O 9.2402 7.6805 0.0 0
M  V30 13 C 6.9302 9.0141 0.0 0
M  V30 14 C 4.6201 7.6805 0.0 0 CFG=3
M  V30 15 C 10.0102 6.3468 0.0 0 CFG=3
M  V30 16 O 5.3901 9.0141 0.0 0
M  V30 17 C 3.0801 7.6805 0.0 0
M  V30 18 C 2.3101 9.0141 0.0 0
M  V30 19 C 2.3101 6.3468 0.0 0
M  V30 20 C 0.7700 9.0141 0.0 0
M  V30 21 C 0.7700 6.3468 0.0 0
M  V30 22 C 0.0000 7.6805 0.0 0
M  V30 23 C 11.5503 6.3468 0.0 0
M  V30 24 C 12.3203 7.6805 0.0 0
M  V30 25 C 12.3203 5.0131 0.0 0
M  V30 26 C 13.8603 7.6805 0.0 0
M  V30 27 C 13.8603 5.0131 0.0 0
M  V30 28 C 14.6303 6.3468 0.0 0
M  V30 29 H 6.1601 5.0131 0.0 0
M  V30 30 H 6.2530 4.4863 0.0 0
M  V30 31 H 8.4702 9.0141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 29 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 30 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 23
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Gulonamide, N-methyl-3,5:4,6-bis-O-(phenylmethylene)-
C21H23NO6
2376620-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.9675 3.4963 0.0 0 CFG=2
M  V30 2 C 6.7879 2.5066 0.0 0
M  V30 3 O 9.4147 2.9696 0.0 0
M  V30 4 N 7.0554 0.9899 0.0 0
M  V30 5 O 5.3407 3.0333 0.0 0
M  V30 6 C 5.8755 0.0000 0.0 0
M  V30 7 C 6.9302 6.3468 0.0 0 CFG=2
M  V30 8 C 7.7002 5.0131 0.0 0 CFG=1
M  V30 9 C 7.7002 7.6805 0.0 0 CFG=2
M  V30 10 O 5.3901 6.3468 0.0 0
M  V30 11 O 9.2402 5.0131 0.0 0
M  V30 12 O 9.2402 7.6805 0.0 0
M  V30 13 C 6.9302 9.0141 0.0 0
M  V30 14 C 4.6201 7.6805 0.0 0 CFG=3
M  V30 15 C 10.0102 6.3468 0.0 0 CFG=3
M  V30 16 O 5.3901 9.0141 0.0 0
M  V30 17 C 3.0801 7.6805 0.0 0
M  V30 18 C 2.3101 9.0141 0.0 0
M  V30 19 C 2.3101 6.3468 0.0 0
M  V30 20 C 0.7700 9.0141 0.0 0
M  V30 21 C 0.7700 6.3468 0.0 0
M  V30 22 C 0.0000 7.6805 0.0 0
M  V30 23 C 11.5503 6.3468 0.0 0
M  V30 24 C 12.3203 5.0131 0.0 0
M  V30 25 C 12.3203 7.6805 0.0 0
M  V30 26 C 13.8603 5.0131 0.0 0
M  V30 27 C 13.8603 7.6805 0.0 0
M  V30 28 C 14.6303 6.3468 0.0 0
M  V30 29 H 6.1601 5.0131 0.0 0
M  V30 30 H 6.2530 4.4863 0.0 0
M  V30 31 H 8.4702 9.0141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 29 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 30 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 31 CFG=1
M  V30 16 1 10 14
M  V30 17 1 11 15
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 14 16
M  V30 21 1 14 17
M  V30 22 1 15 23
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 7 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70373-42-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-09-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21938136
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer composition comprising gulonic acid diacetal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hauck, Stefan; Budde, Felix; Muller, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3543286 A1 2019-09-25

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[5-[2-[[3-(9-Anthracenyl)propyl]methylamino]ethoxy]-1H-indol-1-yl](2′-fluoro[...
C41H35FN2O2
705961-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 N 9.2400 6.6684 0.0 0
M  V30 5 C 10.0100 8.0021 0.0 0
M  V30 6 C 10.0100 5.3347 0.0 0
M  V30 7 C 11.5500 8.0021 0.0 0
M  V30 8 O 12.3200 9.3358 0.0 0
M  V30 9 C 19.5908 8.6255 0.0 0
M  V30 10 O 19.2706 7.1191 0.0 0
M  V30 11 F 26.2735 7.9923 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 4.6200 1.3336 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 3.0800 4.0011 0.0 0
M  V30 17 C 3.0800 1.3336 0.0 0
M  V30 18 C 5.3900 0.0000 0.0 0
M  V30 19 C 7.7000 1.3336 0.0 0
M  V30 20 C 2.3100 2.6674 0.0 0
M  V30 21 C 2.3100 5.3347 0.0 0
M  V30 22 C 6.9300 0.0000 0.0 0
M  V30 23 C 0.7700 2.6674 0.0 0
M  V30 24 C 0.7700 5.3347 0.0 0
M  V30 25 C 0.0000 4.0011 0.0 0
M  V30 26 C 13.8600 9.3358 0.0 0
M  V30 27 C 14.6300 10.6694 0.0 0
M  V30 28 C 14.6300 8.0021 0.0 0
M  V30 29 C 16.1700 10.6694 0.0 0
M  V30 30 C 16.1700 8.0021 0.0 0
M  V30 31 C 16.9400 9.3358 0.0 0
M  V30 32 C 17.2004 11.8140 0.0 0
M  V30 33 N 18.4463 9.6560 0.0 0
M  V30 34 C 18.6074 11.1875 0.0 0
M  V30 35 C 21.0553 9.1014 0.0 0
M  V30 36 C 21.3755 10.6077 0.0 0
M  V30 37 C 22.1999 8.0710 0.0 0
M  V30 38 C 22.8402 11.0835 0.0 0
M  V30 39 C 23.6644 8.5468 0.0 0
M  V30 40 C 23.9846 10.0531 0.0 0
M  V30 41 C 25.4493 10.5290 0.0 0
M  V30 42 C 26.5936 9.4986 0.0 0
M  V30 43 C 25.7694 12.0354 0.0 0
M  V30 44 C 28.0583 9.9744 0.0 0
M  V30 45 C 27.2341 12.5113 0.0 0
M  V30 46 C 28.3785 11.4809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 26
M  V30 10 2 9 10
M  V30 11 1 9 33
M  V30 12 1 9 35
M  V30 13 1 11 42
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 2 17 20
M  V30 24 2 18 22
M  V30 25 1 19 22
M  V30 26 1 20 23
M  V30 27 2 21 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 29 32
M  V30 36 2 30 31
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 1 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 46 1 40 41
M  V30 47 2 41 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 2 43 45
M  V30 51 2 44 46
M  V30 52 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Fluoro-N-methyl[1,1′-biphenyl]-4-carboxamide
C14H12FNO
705961-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.0801 0.0000 0.0 0
M  V30 2 C 9.2402 2.6673 0.0 0
M  V30 3 N 10.0102 4.0010 0.0 0
M  V30 4 O 10.0102 1.3337 0.0 0
M  V30 5 C 11.5503 4.0010 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 12 C 4.6201 2.6673 0.0 0
M  V30 13 C 5.3901 4.0010 0.0 0
M  V30 14 C 5.3901 1.3337 0.0 0
M  V30 15 C 6.9302 4.0010 0.0 0
M  V30 16 C 6.9302 1.3337 0.0 0
M  V30 17 C 7.7002 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705961-73-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 705961-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-12068215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel phase-switching protecting group for multi-step parallel solution
phase synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Xin; Abell, Chris; Congreve, Miles S.; Warrington, Brian H.; Ladlow,
Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(7), 989-998

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-chloro-3-pyridineacetate
C8H8ClNO2
717106-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Cl 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 N 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-3-pyridineacetamide
C8H9ClN2O
433336-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Cl 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 N 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 717106-69-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 433336-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3433559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of insecticidal, acaricidal and nematocidal pyridine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benko, Zoltan Laszlo; Deamicis, Carl Vincent; Demeter, David Anthony;
Markley, Lowell Dean; Samaritoni, Jack Geno; Schmidt, Carrie Lynn Rau;
Zhu, Yuamning; Erickson, W. Randal; Anzeveno, Peter Biagio; Pechacek,
James Todd; Watson, Gerald Bryan; Deboer, Gerrit Jan; Sheets, Joel Jay;
Zabik, Susan Erhardt; Yerkes, Carla Nanette; Schobert, Christian Thomas;
Dripps, James Edwin; Dintenfass, Leonard Paul; Karr, Laura Lee; Neese,
Paul Allen; Huang, Jim Xinpei; Gifford, James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004057960 A2 2004-07-15

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
4,6-Dichloronicotinic acid
C6H3Cl2NO2
73027-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-N-methyl-3-pyridinecarboxamide
C7H6Cl2N2O
1609530-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 Cl 3.8501 0.0000 0.0 0
M  V30 6 Cl 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 N 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 73027-79-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1609530-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24390845
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl and heteroaryl-carboxamide substituted heteroaryl compounds as TYK2
inhibitors and preparation thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Puig Duran, Carlos; Gomez Castillo, Elena; Caturla Javaloyes, Juan
Francisco; Pages Santacana, Lluis Miquel; Erra Sola, Montserrat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021204626 A1 2021-10-14

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2′-methoxy[1,1′-biphenyl]-2-acetate
C16H16O3
736143-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 O 9.2400 5.3347 0.0 0
M  V30 4 O 9.2400 2.6674 0.0 0
M  V30 5 C 10.7800 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 6.1600 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 6.9300 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.1600 0.0000 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 1.5400 5.3347 0.0 0
M  V30 18 C 3.8500 6.6685 0.0 0
M  V30 19 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Methoxy-N-methyl[1,1′-biphenyl]-2-acetamide
C16H17NO2
197841-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 N 9.2400 5.3347 0.0 0
M  V30 4 O 9.2400 2.6674 0.0 0
M  V30 5 C 10.7800 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 6.1600 2.6674 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 6.9300 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.1600 0.0000 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 1.5400 5.3347 0.0 0
M  V30 18 C 3.8500 6.6685 0.0 0
M  V30 19 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 736143-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 197841-04-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5075466
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The palladium(0) Suzuki cross-coupling reaction as the key step in the
synthesis of aporphinoids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suau, R.; Rico, R.; Najera, F.; Ortiz-Lopez, F. J.; Lopez-Romero, J. M.;
Moreno-Manas, M.; Roglans, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(27), 5725-5735

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,3,4,5,6-Pentafluorophenyl)-3-phenyl-1,2,4-oxadiazole
C14H5F5N2O
740817-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.6675 6.1601 0.0 0
M  V30 2 F 5.3348 1.5400 0.0 0
M  V30 3 F 0.0000 4.6200 0.0 0
M  V30 4 F 2.6675 0.0000 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6675 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 12 C 5.3348 4.6200 0.0 0
M  V30 13 N 6.7417 3.9936 0.0 0
M  V30 14 O 5.4959 6.1516 0.0 0
M  V30 15 C 7.7721 5.1381 0.0 0
M  V30 16 N 7.0021 6.4718 0.0 0
M  V30 17 C 9.3037 4.9772 0.0 0
M  V30 18 C 10.2089 6.2230 0.0 0
M  V30 19 C 9.9302 3.5702 0.0 0
M  V30 20 C 11.7405 6.0621 0.0 0
M  V30 21 C 11.4617 3.4093 0.0 0
M  V30 22 C 12.3669 4.6552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,6-Tetrafluoro-N-methyl-4-(3-phenyl-1,2,4-oxadiazol-5-yl)benzenamine
C15H9F4N3O
910645-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.0011 6.1601 0.0 0
M  V30 2 F 6.6684 1.5400 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 F 4.0011 0.0000 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 5.3348 3.8501 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 6.6684 4.6201 0.0 0
M  V30 14 N 8.0754 3.9936 0.0 0
M  V30 15 O 6.8295 6.1516 0.0 0
M  V30 16 C 9.1058 5.1381 0.0 0
M  V30 17 N 8.3358 6.4718 0.0 0
M  V30 18 C 10.6374 4.9772 0.0 0
M  V30 19 C 11.5426 6.2231 0.0 0
M  V30 20 C 11.2639 3.5702 0.0 0
M  V30 21 C 13.0742 6.0621 0.0 0
M  V30 22 C 12.7954 3.4093 0.0 0
M  V30 23 C 13.7007 4.6552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 740817-54-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 910645-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7153189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fluorinated indazoles through ANRORC-like rearrangement of
1,2,4-oxadiazoles with hydrazine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palumbo Piccionello, Antonio; Pace, Andrea; Pibiri, Ivana; Buscemi,
Silvestre; Vivona, Nicolo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(37), 8792-8797

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (4aR,10bS)-3,4,6,10b-tetrahydro-2-[[(methylsulfonyl)oxy]methyl]-10...
C23H26O6S
748138-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 2.6673 1.5400 0.0 0
M  V30 3 O 5.3348 1.5400 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 C 8.0021 6.1601 0.0 0
M  V30 6 O 9.3359 5.3901 0.0 0
M  V30 7 S 10.6696 6.1601 0.0 0 VAL=6
M  V30 8 C 11.4396 4.8264 0.0 0
M  V30 9 O 12.0032 6.9301 0.0 0
M  V30 10 O 9.8996 7.4939 0.0 0
M  V30 11 C 4.0011 5.3901 0.0 0 CFG=2
M  V30 12 C 4.0011 3.8501 0.0 0 CFG=2
M  V30 13 C 2.6673 6.1601 0.0 0
M  V30 14 O 5.3348 6.1601 0.0 0
M  V30 15 C 2.6673 3.0800 0.0 0
M  V30 16 C 5.3348 3.0800 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 2.6673 7.7001 0.0 0
M  V30 19 C 6.6685 5.3901 0.0 0 CFG=3
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 21 C 6.6685 3.8501 0.0 0
M  V30 22 C 0.0000 6.1601 0.0 0
M  V30 23 C 1.3337 8.4701 0.0 0
M  V30 24 C 0.0000 7.7001 0.0 0
M  V30 25 C 4.6519 6.7858 0.0 0
M  V30 26 C 3.7686 8.0474 0.0 0
M  V30 27 C 6.1861 6.9201 0.0 0
M  V30 28 C 4.4194 9.4431 0.0 0
M  V30 29 C 6.8369 8.3158 0.0 0
M  V30 30 C 5.9536 9.5774 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 25 CFG=3
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 1 17 20
M  V30 23 2 17 22
M  V30 24 1 18 23
M  V30 25 1 19 21
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-Methyl (4aR,10bS)-3,4,6,10b-tetrahydro-2-[(methylamino)methyl]-10b-phenyl...
C23H27NO3
748138-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 2.6673 1.5400 0.0 0
M  V30 3 O 5.3348 1.5400 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 C 8.0022 6.1600 0.0 0
M  V30 6 N 9.3359 5.3900 0.0 0
M  V30 7 C 10.6695 6.1600 0.0 0
M  V30 8 C 4.0011 5.3900 0.0 0 CFG=2
M  V30 9 C 4.0011 3.8500 0.0 0 CFG=2
M  V30 10 C 2.6673 6.1600 0.0 0
M  V30 11 O 5.3348 6.1600 0.0 0
M  V30 12 C 2.6673 3.0800 0.0 0
M  V30 13 C 5.3348 3.0800 0.0 0
M  V30 14 C 1.3336 5.3900 0.0 0
M  V30 15 C 2.6673 7.7001 0.0 0
M  V30 16 C 6.6684 5.3900 0.0 0 CFG=3
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 6.6684 3.8500 0.0 0
M  V30 19 C 0.0000 6.1600 0.0 0
M  V30 20 C 1.3336 8.4701 0.0 0
M  V30 21 C 0.0000 7.7001 0.0 0
M  V30 22 C 4.6519 6.7858 0.0 0
M  V30 23 C 3.7686 8.0473 0.0 0
M  V30 24 C 6.1861 6.9200 0.0 0
M  V30 25 C 4.4194 9.4430 0.0 0
M  V30 26 C 6.8369 8.3158 0.0 0
M  V30 27 C 5.9535 9.5773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 22 CFG=3
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 14 17
M  V30 20 2 14 19
M  V30 21 1 15 20
M  V30 22 1 16 18
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 748138-73-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 748138-75-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6723621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Incorporation of diarylbutylamine pharmacophore into indeno- or
naphtho[1,2-b]pyran ring systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maertens, Faye; Toppet, Suzanne; Compernolle, Frans; Hoornaert, Georges
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2004), (12), 2707-2714

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1-isocyanato-4-(1-methylethyl)benzene
C10H10ClNO
756481-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 Cl 4.0012 6.1601 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-Chloro-4-(1-methylethyl)phenyl]-N′-methylurea
C11H15ClN2O
756481-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 N 9.3360 4.6201 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 Cl 4.0012 6.1601 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 756481-35-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 756481-34-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-1083830
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-(2,4-Dichlorophenyl)-N'-methyl-urea (7). A
cooled (0 °C) solution of methylamine in EtOH (50 mL, 400 mmol, 8.0 M)
was dissolved in anhydrous THF (300 mL) and was treated with
2,4-dichlorophenyl isocyanate (25.0 g, 133 mmol). The cooling bath was
removed, and the mixture was warmed to 65 °C for 20 min. The reaction
mixture was then cooled to 0 °C. The solid was collected on a Buchner
funnel, washed with cold ether and dried under vacuum to afford
N-(2,4-dichlorophenyl)-N'-methyl-urea (21.7 g, 74% yield) as a colorless
solid. Yield 74-96%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of
1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione
derivatives as corticotropin-releasing factor1 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartz, Richard A.; Nanda, Kausik K.; Ingalls, Charles L.; Ahuja, Vijay
T.; Molski, Thaddeus F.; Zhang, Ge; Wong, Harvey; Peng, Yong; Kelley,
Michelle; Lodge, Nicholas J.; Zaczek, Robert; Gilligan, Paul J.; Trainor,
George L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(19), 4741-4754

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
3-[5-Bromo-4-[(2,4-difluorophenyl)methoxy]-2-methyl-6-oxo-1(6H)-pyrimidinyl]-...
C20H15BrF2N2O4
773103-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 1.3336 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0
M  V30 3 C 4.6200 6.6685 0.0 0
M  V30 4 Br 9.2400 1.3336 0.0 0
M  V30 5 C 1.5400 1.3336 0.0 0
M  V30 6 O 0.0000 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 10.7800 4.0011 0.0 0
M  V30 9 C 11.5500 5.3347 0.0 0
M  V30 10 F 13.0900 8.0021 0.0 0
M  V30 11 F 17.7100 5.3347 0.0 0
M  V30 12 N 6.1600 4.0011 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 N 8.4700 5.3347 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 3.8500 5.3347 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 2.3100 5.3347 0.0 0
M  V30 23 C 1.5400 4.0011 0.0 0
M  V30 24 C 13.0900 5.3347 0.0 0
M  V30 25 C 13.8600 6.6685 0.0 0
M  V30 26 C 13.8600 4.0011 0.0 0
M  V30 27 C 15.4000 6.6685 0.0 0
M  V30 28 C 15.4000 4.0011 0.0 0
M  V30 29 C 16.1700 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 20
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 24
M  V30 11 1 10 25
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[5-Bromo-4-[(2,4-difluorophenyl)methoxy]-2-methyl-6-oxo-1(6H)-pyrimidinyl]-...
C21H18BrF2N3O3
773103-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0032 5.3900 0.0 0
M  V30 2 C 9.3358 0.7700 0.0 0
M  V30 3 C 10.6694 0.0000 0.0 0
M  V30 4 Br 9.3358 6.9300 0.0 0
M  V30 5 C 16.0041 3.0800 0.0 0
M  V30 6 N 17.3379 2.3100 0.0 0
M  V30 7 O 16.0041 4.6200 0.0 0
M  V30 8 C 18.6716 3.0800 0.0 0
M  V30 9 O 6.6684 5.3900 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 F 2.6674 3.0800 0.0 0
M  V30 12 F 0.0000 7.7000 0.0 0
M  V30 13 N 10.6694 3.0800 0.0 0
M  V30 14 C 10.6694 4.6200 0.0 0
M  V30 15 C 9.3358 2.3100 0.0 0
M  V30 16 C 9.3358 5.3900 0.0 0
M  V30 17 N 8.0021 3.0800 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 12.0032 2.3100 0.0 0
M  V30 20 C 13.3369 3.0800 0.0 0
M  V30 21 C 12.0032 0.7700 0.0 0
M  V30 22 C 14.6705 2.3100 0.0 0
M  V30 23 C 13.3369 0.0000 0.0 0
M  V30 24 C 14.6705 0.7700 0.0 0
M  V30 25 C 4.0011 5.3900 0.0 0
M  V30 26 C 2.6674 4.6200 0.0 0
M  V30 27 C 4.0011 6.9300 0.0 0
M  V30 28 C 1.3336 5.3900 0.0 0
M  V30 29 C 2.6674 7.7000 0.0 0
M  V30 30 C 1.3336 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 15
M  V30 3 1 3 21
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 25
M  V30 12 1 11 26
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 773103-94-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 773103-16-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-124860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6: Preparation of Title Compound. Preparation of
3-[5-Bromo-4-[(2,4-difluorobenzyl)oxy]-2-methyl-6-oxopyrimidin-1(6H)-yl]-N,4-dimethylbenzamide.
To a solution of
3-[5-bromo-4-[(2,4-difluorobenzyl)oxy]-2-methyl-6-oxopyrimidin-1(6H)-yl]-4-methylbenzoic
acid (0.16 g, 0.00034 mol, obtained from Step 5) at 0° C. is added
isobutylchloroformate (0.063 g, 0.00046 mol) followed by the addition of
N-methylmorpholine (0.064 g, 0.00064 mol). The resulting reaction mixture
is stirred for 5 minutes under an argon atmosphere. The ice bath is then
removed, the reaction mixture is stirred at room temperature for 20
minutes, then the reaction mixture is recooled to 0° C., and
N-methylamine (0.5 mL of 2.0 M soln in THF) is added. The resulting
mixture is stirred at room temperature for 10 min, concentrated in vacuo,
and the residue is purified by reverse-phase HPLC using 10-90%
CH3CN/Water gradient (40 min) at a flow rate of 80 mL/min. The
appropriate fractions are combined, concentrated to a small volume (~20
mL), cooled, 5% NaHCO3 solution (10 mL) is added and then the combined
fractions are extracted with dichloromethane (3×20 mL). The combined
organic extracts are dried (Na2SO4), filtered, and concentrated to
dryness to afford the title compound (0.16 g, 96%) as a white amorphous
substance. 1H NMR (CD3OD/400 MHz) δ 7.87 (dd 1H, J=8.0 Hz), 7.64 (d, 1H,
J=1.6 Hz), 7.61 (m, 1H), 7.53 (d, 1H, J=8.0 Hz), 7.01 (m, 2H), 5.55 (m,
2H), 2.89 (s, 3H), 2.16 (s, 3H), and 2.12 (s, 3H); ES-HRMS m/z 478.0586
(M+H calcd for C21H19N2O4F2 requires 478.0572). 19F NMR(CD3OD/400 MHz)
-111.84(m) and -115.91 (m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinones for treating diseases and conditions caused
or exacerbated by unregulated p38 MAP Kinase and/or TNF activity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Durley, Richard C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070167621 A1 2007-07-19

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
3-[5-Bromo-4-[(2,4-difluorophenyl)methoxy]-2-methyl-6-oxo-1(6H)-pyrimidinyl]-...
C20H15BrF2N2O4
773103-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 1.3336 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0
M  V30 3 C 4.6200 6.6685 0.0 0
M  V30 4 Br 9.2400 1.3336 0.0 0
M  V30 5 C 1.5400 1.3336 0.0 0
M  V30 6 O 0.0000 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 10.7800 4.0011 0.0 0
M  V30 9 C 11.5500 5.3347 0.0 0
M  V30 10 F 13.0900 8.0021 0.0 0
M  V30 11 F 17.7100 5.3347 0.0 0
M  V30 12 N 6.1600 4.0011 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 N 8.4700 5.3347 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 3.8500 5.3347 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 2.3100 5.3347 0.0 0
M  V30 23 C 1.5400 4.0011 0.0 0
M  V30 24 C 13.0900 5.3347 0.0 0
M  V30 25 C 13.8600 6.6685 0.0 0
M  V30 26 C 13.8600 4.0011 0.0 0
M  V30 27 C 15.4000 6.6685 0.0 0
M  V30 28 C 15.4000 4.0011 0.0 0
M  V30 29 C 16.1700 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 20
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 24
M  V30 11 1 10 25
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[5-Bromo-4-[(2,4-difluorophenyl)methoxy]-2-methyl-6-oxo-1(6H)-pyrimidinyl]-...
C21H18BrF2N3O3
773103-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0032 5.3900 0.0 0
M  V30 2 C 9.3358 0.7700 0.0 0
M  V30 3 C 10.6694 0.0000 0.0 0
M  V30 4 Br 9.3358 6.9300 0.0 0
M  V30 5 C 16.0041 3.0800 0.0 0
M  V30 6 N 17.3379 2.3100 0.0 0
M  V30 7 O 16.0041 4.6200 0.0 0
M  V30 8 C 18.6716 3.0800 0.0 0
M  V30 9 O 6.6684 5.3900 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 F 2.6674 3.0800 0.0 0
M  V30 12 F 0.0000 7.7000 0.0 0
M  V30 13 N 10.6694 3.0800 0.0 0
M  V30 14 C 10.6694 4.6200 0.0 0
M  V30 15 C 9.3358 2.3100 0.0 0
M  V30 16 C 9.3358 5.3900 0.0 0
M  V30 17 N 8.0021 3.0800 0.0 0
M  V30 18 C 8.0021 4.6200 0.0 0
M  V30 19 C 12.0032 2.3100 0.0 0
M  V30 20 C 13.3369 3.0800 0.0 0
M  V30 21 C 12.0032 0.7700 0.0 0
M  V30 22 C 14.6705 2.3100 0.0 0
M  V30 23 C 13.3369 0.0000 0.0 0
M  V30 24 C 14.6705 0.7700 0.0 0
M  V30 25 C 4.0011 5.3900 0.0 0
M  V30 26 C 2.6674 4.6200 0.0 0
M  V30 27 C 4.0011 6.9300 0.0 0
M  V30 28 C 1.3336 5.3900 0.0 0
M  V30 29 C 2.6674 7.7000 0.0 0
M  V30 30 C 1.3336 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 15
M  V30 3 1 3 21
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 22
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 18
M  V30 11 1 10 25
M  V30 12 1 11 26
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 773103-94-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 773103-16-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14376287
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6: Preparation of title compound. To a solution of
3-[5-bromo-4-[(2,4-difluorobenzyl)oxy]-2-methyl-6-oxopyrimidin-1(6H)-yl]-4-methylbenzoic
acid (0.16 g, 0.00034 mol, obtained from Step 5) at 0 °C is added
isobutylchloroformate (0.063 g, 0.00046 mol) followed by the addition of
N-methylmorpholine (0.064 g, 0.00064 mol). The resulting reaction mixture
is stirred for 5 minutes under an argon atmosphere. The ice bath is then
removed, the reaction mixture is stirred at room temperature for 20
minutes, then the reaction mixture is recooled to 0 °C, and N-methylamine
(0.5 mL of 2.0 M soln in THF) is added. The resulting mixture is stirred
at room temperature for 10 min, concentrated in vacuo, and the residue is
purified by reverse-phase HPLC using 10-90% CH3CN/Water gradient (40 min)
at a flow rate of 80 mL/min. The appropriate fractions (MH+, m/z = 478 )
are combined, concentrated to a small volume (~ 20 mL), cooled, 5% NaHCO3
solution (10 mL) is added and then the combined fractions are extracted
with dichloromethane (3 x 20 mL). The combined organic extracts are dried
(Na2SO4) , filtered, and concentrated to dryness to afford the title
compound.
3-[5-Bromo-4-[(2,4-difluorobenzyl)oxy]-2-methyl-6-oxopyrimidin-1(6H)-yl]-N,4-dimethylbenzamide,
yield 0.16 g, 96%, white amorphous substance. 1H NMR (CD3OD/ 400 MHz) δ
7.87 (dd 1H, J = 8.0 Hz), 7.64 (d, 1H, J = 1.6 Hz), 7.61 (m, 1H) , 7.53.
(d, 1H, J = 8.0 Hz), 7.01 (m, 2H), 5.55 (m, 2H), 2.89 (s, 3H), 2.16 (s,
3H), and 2.12 (s, 3H); ES-HRMS m/z 478.0586 (M+H calcd for C21H19N2O4F2
requires 478.0572). 19F NMR (CD3OD/ 400 MHz) -111.84(m) and -115.91 (m) .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrimidinones with ability to inhibit p38 MAP
kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Durley, Richard; Devadas, Balekudru; Madsen, Heather; Hickory, Brian;
Palmquist, Katherine; Selness, Shaun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004087677 A2 2004-10-14

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-N-(2,2,6,6-tetramethyl-4-piperidinyl)-1,3,5-triazin-2-amine
C12H19Cl2N5
78717-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5177 4.6200 0.0 0
M  V30 2 C 0.0000 3.5825 0.0 0
M  V30 3 C 0.9899 5.2970 0.0 0
M  V30 4 C 3.8401 0.3602 0.0 0
M  V30 5 C 1.8605 0.3602 0.0 0
M  V30 6 Cl 10.8524 4.6200 0.0 0
M  V30 7 Cl 8.1849 0.0000 0.0 0
M  V30 8 C 4.1840 3.8500 0.0 0
M  V30 9 C 2.8502 4.6200 0.0 0
M  V30 10 C 4.1840 2.3100 0.0 0
M  V30 11 C 1.5166 3.8500 0.0 0
M  V30 12 C 2.8502 1.5400 0.0 0
M  V30 13 N 1.5166 2.3100 0.0 0
M  V30 14 C 6.8513 3.8500 0.0 0
M  V30 15 N 8.1849 4.6200 0.0 0
M  V30 16 N 6.8513 2.3100 0.0 0
M  V30 17 C 9.5187 3.8500 0.0 0
M  V30 18 C 8.1849 1.5400 0.0 0
M  V30 19 N 9.5187 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 11
M  V30 4 1 3 11
M  V30 5 1 4 12
M  V30 6 1 5 12
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-methyl-N4-(2,2,6,6-tetramethyl-4-piperidinyl)-1,3,5-triazine-2,4-...
C13H23ClN6
1863139-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5177 4.6200 0.0 0
M  V30 2 C 0.0000 3.5825 0.0 0
M  V30 3 C 0.9899 5.2970 0.0 0
M  V30 4 C 3.8401 0.3602 0.0 0
M  V30 5 C 1.8603 0.3602 0.0 0
M  V30 6 N 10.8524 4.6200 0.0 0
M  V30 7 C 12.1860 3.8500 0.0 0
M  V30 8 Cl 8.1849 0.0000 0.0 0
M  V30 9 C 4.1840 3.8500 0.0 0
M  V30 10 C 2.8502 4.6200 0.0 0
M  V30 11 C 4.1840 2.3100 0.0 0
M  V30 12 C 1.5166 3.8500 0.0 0
M  V30 13 C 2.8502 1.5400 0.0 0
M  V30 14 N 1.5166 2.3100 0.0 0
M  V30 15 C 6.8513 3.8500 0.0 0
M  V30 16 N 8.1849 4.6200 0.0 0
M  V30 17 N 6.8513 2.3100 0.0 0
M  V30 18 C 9.5187 3.8500 0.0 0
M  V30 19 C 8.1849 1.5400 0.0 0
M  V30 20 N 9.5187 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 12
M  V30 4 1 3 12
M  V30 5 1 4 13
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 78717-59-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1863139-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8067599
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of some symmetrically substituted stilbene-triazine derivatives
containing tetramethylenepiperidine fragments and their application to
make self-whitening polyacrylonitrile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miladinova, Polya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Coloration Technology (2015), 131(4), 272-278

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,4a,8a-Tetrahydro-1-[(4-methoxyphenyl)methyl]-3-methyl-3-[3-[(methylsulfon...
C22H29NO5S
792122-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0009 0.0 0
M  V30 2 O 6.1600 6.6684 0.0 0
M  V30 3 C 9.9171 5.8614 0.0 0
M  V30 4 C 10.1845 7.3780 0.0 0
M  V30 5 C 11.6316 7.9047 0.0 0
M  V30 6 O 11.8990 9.4213 0.0 0
M  V30 7 S 13.3461 9.9479 0.0 0 VAL=6
M  V30 8 C 12.8194 11.3951 0.0 0
M  V30 9 O 14.7932 10.4748 0.0 0
M  V30 10 O 13.8729 8.5010 0.0 0
M  V30 11 C 8.2025 6.8513 0.0 0
M  V30 12 O 1.5400 9.3356 0.0 0
M  V30 13 C 0.0000 9.3356 0.0 0
M  V30 14 N 6.1600 4.0009 0.0 0
M  V30 15 C 6.9300 2.6673 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 8.4700 2.6673 0.0 0
M  V30 18 C 6.1600 1.3336 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 9.2400 4.0009 0.0 0
M  V30 21 C 9.2400 1.3336 0.0 0
M  V30 22 C 6.9300 0.0000 0.0 0
M  V30 23 C 8.4700 0.0000 0.0 0
M  V30 24 C 3.8500 5.3347 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 26 C 4.6200 6.6684 0.0 0
M  V30 27 C 1.5400 6.6684 0.0 0
M  V30 28 C 3.8500 8.0020 0.0 0
M  V30 29 C 2.3100 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 24
M  V30 3 2 2 16
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 1 12 29
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 20
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,4a,8a-Tetrahydro-1-[(4-methoxyphenyl)methyl]-3-methyl-3-[3-(methylamino)p...
C22H30N2O2
792122-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 6.1600 6.6684 0.0 0
M  V30 3 C 9.9171 5.8614 0.0 0
M  V30 4 C 10.1846 7.3780 0.0 0
M  V30 5 C 11.6316 7.9048 0.0 0
M  V30 6 N 11.8991 9.4214 0.0 0
M  V30 7 C 13.3463 9.9481 0.0 0
M  V30 8 C 8.2027 6.8513 0.0 0
M  V30 9 O 1.5400 9.3358 0.0 0
M  V30 10 C 0.0000 9.3358 0.0 0
M  V30 11 N 6.1600 4.0011 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 8.4700 2.6674 0.0 0
M  V30 15 C 6.1600 1.3336 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 9.2400 1.3336 0.0 0
M  V30 19 C 6.9300 0.0000 0.0 0
M  V30 20 C 8.4700 0.0000 0.0 0
M  V30 21 C 3.8500 5.3347 0.0 0
M  V30 22 C 4.6200 6.6684 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 3.8500 8.0021 0.0 0
M  V30 25 C 1.5400 6.6684 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 2 2 13
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 17
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 792122-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 792122-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3006470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM crude mesylate (22 g, 99%) was dissolved in ethanol (500 mL) and aqueous
40% methylamine (200 mL) and heated at 65°C under nitrogen for 2 h. The
reaction mixture was cooled, concentrated and then extracted with ethyl
acetate (300 mL). The organic layer was washed with water, brine, dried
over MgSO4 and concentrated to give the crude product (17.8 g, 96%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as selective norepinephrine
reuptake inhibitors for treating hot flashes, impulse control disorders
and personality change due to a general medical condition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Albert John; Hemrick-Luecke, Susan; Sumner, Calvin Russell;
Wallace, Owen Brendan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005060949 A2 2005-07-07

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,4a,8a-Tetrahydro-1-[(4-methoxyphenyl)methyl]-3-methyl-3-[3-[(methylsulfon...
C22H29NO5S
792122-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0009 0.0 0
M  V30 2 O 6.1600 6.6684 0.0 0
M  V30 3 C 9.9171 5.8614 0.0 0
M  V30 4 C 10.1845 7.3780 0.0 0
M  V30 5 C 11.6316 7.9047 0.0 0
M  V30 6 O 11.8990 9.4213 0.0 0
M  V30 7 S 13.3461 9.9479 0.0 0 VAL=6
M  V30 8 C 12.8194 11.3951 0.0 0
M  V30 9 O 14.7932 10.4748 0.0 0
M  V30 10 O 13.8729 8.5010 0.0 0
M  V30 11 C 8.2025 6.8513 0.0 0
M  V30 12 O 1.5400 9.3356 0.0 0
M  V30 13 C 0.0000 9.3356 0.0 0
M  V30 14 N 6.1600 4.0009 0.0 0
M  V30 15 C 6.9300 2.6673 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 8.4700 2.6673 0.0 0
M  V30 18 C 6.1600 1.3336 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 9.2400 4.0009 0.0 0
M  V30 21 C 9.2400 1.3336 0.0 0
M  V30 22 C 6.9300 0.0000 0.0 0
M  V30 23 C 8.4700 0.0000 0.0 0
M  V30 24 C 3.8500 5.3347 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 26 C 4.6200 6.6684 0.0 0
M  V30 27 C 1.5400 6.6684 0.0 0
M  V30 28 C 3.8500 8.0020 0.0 0
M  V30 29 C 2.3100 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 24
M  V30 3 2 2 16
M  V30 4 1 3 4
M  V30 5 1 3 19
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 1 12 29
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 20
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,4a,8a-Tetrahydro-1-[(4-methoxyphenyl)methyl]-3-methyl-3-[3-(methylamino)p...
C22H30N2O2
792122-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 6.1600 6.6684 0.0 0
M  V30 3 C 9.9171 5.8614 0.0 0
M  V30 4 C 10.1846 7.3780 0.0 0
M  V30 5 C 11.6316 7.9048 0.0 0
M  V30 6 N 11.8991 9.4214 0.0 0
M  V30 7 C 13.3463 9.9481 0.0 0
M  V30 8 C 8.2027 6.8513 0.0 0
M  V30 9 O 1.5400 9.3358 0.0 0
M  V30 10 C 0.0000 9.3358 0.0 0
M  V30 11 N 6.1600 4.0011 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 8.4700 2.6674 0.0 0
M  V30 15 C 6.1600 1.3336 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 9.2400 1.3336 0.0 0
M  V30 19 C 6.9300 0.0000 0.0 0
M  V30 20 C 8.4700 0.0000 0.0 0
M  V30 21 C 3.8500 5.3347 0.0 0
M  V30 22 C 4.6200 6.6684 0.0 0
M  V30 23 C 2.3100 5.3347 0.0 0
M  V30 24 C 3.8500 8.0021 0.0 0
M  V30 25 C 1.5400 6.6684 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 2 2 13
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 17
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 792122-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 792122-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2615076
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-(4-Methoxy-benzyl)-3-methyl-3-(3-methylamino-propyl)-3,4,4a,8atetrahydro-
1H-quinoln-2-one (18b) To a soln of (17b) (18 g, 53 mmol) and
triethylamine (11.1 mL, 79 mmol) in anhydrous THF (450 mL) at 0°C under
nitrogen was added dropwise a soln of methanesulfonyl chloride (4.52 mL,
58 mmol) in THF (50 mL). The reaction mixture was warmed to rt and
stirred for 3 h. The reaction mixture was poured into ethyl acetate and
water and extracted. The organic layer was separated, dried over MgSO4
and concentrated. The crude mesylate (22 g, 99%) was dissolved in ethanol
(500 mL) and aqueous 40% methylamine (200 mL) and heated at 65°C under
nitrogen for 2 h. The reaction mixture was cooled, concentrated and then
extracted with ethyl acetate (300 mL). The organic layer was washed with
water, brine, dried over MgSO4 and concentrated to give the crude
product. Yield (17.8 g, 96%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinolone derivatives useful as selective norepinephrine reuptake
inhibitors, and their preparation, pharmaceutical compositions, and use
in the treatment of nervous system disorders.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Camp, Nicholas Paul; Penariol, Roberta; Beadle, Christopher David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004096773 A1 2004-11-11

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Sertraline
C17H17Cl2N
79617-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0 CFG=2
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0 CFG=1
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15 CFG=1
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79617-96-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3310884
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-21-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 2: PROCESS FOR THE PREPARATION OF
N-[4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)-NAPTHALENYLIDENE]METHANAMINE
(Schiff’s Base). To a slurry of Tetralone ( 10 g) in ethyleneglycol (100
ml) was added aqueous monomethylamine ( 40 % w/v, 20 ml). The resultant
reaction mixture was heated to 60°C for 4 hrs. The reaction mixture was
cooled to 30°C. The slurry was filtered, and the solid was washed with
ethyleneglycol (10 ml) and dried under reduced pressure at 50°C to 55°C
for 6 hrs. resulting in 10 g (96 %) of Schiff s base of 85% purity.
Purity: 85%.
$DTYPE RXN:VAR(1):NOTES
$DATUM Optimized on solvent, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved process for the preparation of sertraline via catalytic
hydrogenation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kintali, Ramana Venkata; Fischer, Erik; Nair, Raji; Barve, Pravin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007124920 A1 2007-11-08

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-fluoro-4-iodopyridine
C5H2ClFIN
796851-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6674 0.0000 0.0 0
M  V30 2 I 0.0000 1.5400 0.0 0
M  V30 3 F 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 1.3338 3.8500 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-iodo-N-methyl-2-pyridinamine
C6H6ClIN2
2245085-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 I 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 796851-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2245085-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23529444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-Imidazo[4,5-b]pyrazine derivatives as SHP2 inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ciammaichella, Alina; Ferrigno, Federica; Ontoria Ontoria, Jesus Maria;
Petrocchi, Alessia; Ponzi, Simona; Rossetti, Ilaria; Sferrazza, Alessio;
Torrente, Esther
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021028362 A1 2021-02-18

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-fluoro-4-iodopyridine
C5H2ClFIN
796851-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6674 0.0000 0.0 0
M  V30 2 I 0.0000 1.5400 0.0 0
M  V30 3 F 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 1.3338 3.8500 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-iodo-N-methyl-2-pyridinamine
C6H6ClIN2
2245085-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 Cl 2.6675 0.0000 0.0 0
M  V30 4 I 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 796851-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2245085-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-24230641
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-Imidazo[4,5-b]pyrazine derivatives as SHP2 inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ciammaichella, Alina; Ferrigno, Federica; Ontoria Ontoria, Jesus Maria;
Petrocchi, Alessia; Ponzi, Simona; Rossetti, Ilaria; Sferrazza, Alessio;
Torrente, Esther
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3772513 A1 2021-02-10

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Diethoxymethyl)benzaldehyde
C12H16O3
81172-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 O 2.6673 4.6200 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 C 1.3336 3.8500 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 C 9.3358 6.9300 0.0 0
M  V30 9 O 10.6694 6.1600 0.0 0
M  V30 10 C 5.3347 4.6200 0.0 0
M  V30 11 C 6.6684 3.8500 0.0 0
M  V30 12 C 5.3347 6.1600 0.0 0
M  V30 13 C 8.0021 4.6200 0.0 0
M  V30 14 C 6.6684 6.9300 0.0 0
M  V30 15 C 8.0021 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Diethoxymethyl)-N-methylbenzenemethanamine
C13H21NO2
214424-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 O 2.6673 4.6201 0.0 0
M  V30 3 O 4.0012 2.3101 0.0 0
M  V30 4 C 1.3337 3.8501 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 C 9.3360 6.9302 0.0 0
M  V30 9 N 10.6697 6.1601 0.0 0
M  V30 10 C 12.0033 6.9302 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 8.0022 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81172-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 214424-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3106476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 1-[4-(Diethoxymethyl)phenyl]-N-methyl-methanamine, 2M methylamine
in MeOH (288.1 mL, 576.2 mmol) was diluted with methanol (1.000 L) and
stirred at 20 °C. 4-(Diethoxymethyl)benzaldehyde (100 g, 480.2 mmol) was
added dropwise over 1 minute and the reaction stirred at ambient
temperature for 1.25 hours. Sodium borohydride (29.07 g, 30.76 mL, 768.3
mmol) was added portionwise over 20 minutes while maintaining the
temperature between 20 and 30 °C with an ice-water bath. The reaction
solution was stirred at ambient temperature overnight then quenched by
the dropwise addition of NaOH (960.4 mL of 1.0 M, 960.4 mmol) over 20
minutes. The reaction was stirred for 30 minutes and concentrated in
vacuo to remove MeOH. The reaction was partitioned with MTBE (1.200 L)
and the phases separated. The organic phase was washed with water (300.0
mL), dried (Na2SO4), and concentrated in vacuo. yellow oil (102.9 g, 96%
Yield). 1H NMR (400 MHz, CDCl3) δ 1.25 (t, 6H), 2.46 (s, 3H), 3.45 -3.65
(m, 4H), 3.75 (s, 2H), 5.51 (s, 1H), 7.32 (d, 2H) and 7.44 (d, 2H) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aminopyrazine-isoxazole derivatives useful as inhibitors
of ATR kinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Charrier, Jean-Damien; Studley, John; Pierard, Francoise Yvonne Theodora
Marie; Durrant, Steven John; Littler, Benjamin Joseph; Hughes, Robert
Michael; Siesel, David Andrew; Angell, Paul; Urbina, Armando; Shi, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013049726 A2 2013-04-04

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
(αS)-α-Phenyl-1-piperidineethanol
C13H19NO
83829-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0 CFG=2
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 7.7002 4.0010 0.0 0
M  V30 6 C 7.7002 1.3337 0.0 0
M  V30 7 C 9.2402 4.0010 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 10.0102 2.6673 0.0 0
M  V30 10 N 3.0801 1.3337 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 10
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-N-Methyl-α-phenyl-1-piperidineethanamine
C14H22N2
129380-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0 CFG=2
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 N 5.3900 1.3338 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 N 6.9300 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 C 7.7000 5.3349 0.0 0
M  V30 14 C 9.2400 2.6674 0.0 0
M  V30 15 C 9.2400 5.3349 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 3 4
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 83829-03-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 129380-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-9126367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of chiral non-racemic 1,2-diamines from O-acetyl mandelic acid:
application in enantioselective deprotonation of epoxides and diethylzinc
addition to aldehydes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saravanan, P.; Bisai, Alakesh; Baktharaman, S.; Chandrasekhar, M.; Singh,
Vinod K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(23), 4693-4706

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-2-(bromomethyl)quinoline
C10H7Br2N
847861-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.6686 1.5400 0.0 0
M  V30 3 Br 8.0022 2.3100 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 N 4.0011 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-2-quinolinemethanamine
C11H11BrN2
847861-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 N 4.0012 1.5400 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847861-97-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847861-98-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2409219
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (c) (8-Bromo-quinolin-2-ylmethyl)-methylamine (4) To a solution of (3) (1
g, 3.32 mmol) in tetrahydrofuran (5 mL) was added methylamine (10.5 mL,
40% aqueous solution). The solution was stirred for 30 min and then
extracted with EtOAc (30 mL). The organic phase was washed with deionized
water (2 x 20 mL), dried over anhydrous magnesium sulfate and
concentrated to give a red oily product, which was purified by column
chromatography (methanol/dichloromethane 1:99) to yield a yellow solid
(0.8 g, 96%). (8-Bromo-quinolin-2-ylmethyl)-methylamine (4), yield (0.8
g, 96%) 1H NMR (400 MHz CDCl3) δ 8.09 (1H, d, J = 8.4 Hz), 8.02 (1H, d, J
= 7.2 Hz), 7.77 (1H, d, J = 8 Hz), 7.49 (1H, d, J = 8.4 Hz), 7.36 (1H, t,
J = 8.0 Hz), 4.12 (2H, s), 2.58 (3H, s); FABMS, m/z 251/253 (M+H/M+2+H);
Anal. Calculated for C11H11BrN2: C, 52.61; H, 4.42; N, 11.16. Found: C,
52.17; H, 4.46; N, 11.10.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aptamer inhibition of thrombus formation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Binghe; Li, Minyong; Ni, Nanting; Liu, Yidan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010019847 A2 2010-02-18

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-2-(bromomethyl)quinoline
C10H7Br2N
847861-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.6686 1.5400 0.0 0
M  V30 3 Br 8.0022 2.3100 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 N 4.0011 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-2-quinolinemethanamine
C11H11BrN2
847861-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 N 4.0012 1.5400 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 847861-97-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847861-98-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9977153
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of boronic-acid-labeled thymidine triphosphate for
incorporation into DNA
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Na; Yan, Jun; Huang, Zhen; Altier, Craig; Li, Minyong; Carrasco,
Nicolas; Suyemoto, Mitsu; Johnston, Lynette; Wang, Siming; Wang, Qian;
Fang, Hao; Caton-Williams, Julianne; Wang, Binghe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleic Acids Research (2007), 35(4), 1222-1229

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-bromo-4-fluoro-5-nitro-, methyl ester
C8H5BrFNO4
85953-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 8.4700 2.6674 0.0 0
M  V30 5 Br 4.6200 6.6685 0.0 0
M  V30 6 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 O 0.0000 1.3338 0.0 0
M  V30 9 F 0.0000 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-bromo-4-(methylamino)-5-nitrobenzoate
C9H9BrN2O4
2573308-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 Br 4.0012 6.9302 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 O 8.0023 4.6201 0.0 0
M  V30 9 O 6.6685 6.9302 0.0 0
M  V30 10 C 9.3360 5.3901 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85953-31-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2573308-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23736825
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020264499 A1 2020-12-30

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
6-[4-(1-Methylethyl)phenoxy]-3-pyridinecarboxylic acid
C15H15NO3
862088-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 4.6201 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 C 0.0000 2.3100 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 12.0032 1.5400 0.0 0
M  V30 6 O 13.3369 2.3100 0.0 0
M  V30 7 O 12.0032 0.0000 0.0 0
M  V30 8 C 5.3348 3.8500 0.0 0
M  V30 9 C 4.0010 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 N 9.3359 4.6201 0.0 0
M  V30 17 C 9.3359 1.5400 0.0 0
M  V30 18 C 10.6695 3.8500 0.0 0
M  V30 19 C 10.6695 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-[4-(1-methylethyl)phenoxy]-3-pyridinecarboxamide
C16H18N2O2
2243098-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 1.5400 0.0 0
M  V30 2 N 13.3370 2.3101 0.0 0
M  V30 3 O 12.0033 0.0000 0.0 0
M  V30 4 C 14.6707 1.5400 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 11 C 9.3358 1.5400 0.0 0
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 N 8.0022 2.3101 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 20
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 862088-75-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243098-36-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20465392
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of di(hetero)aryl ether acid derivatives as Notch augmenting
compounds for treatment of cancer, immune disease, and other disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reinmueller, Viktoria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018154118 A2 2018-08-30

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl (3R)-8-cyclopropyl-2,3-dihydro-7-(1-naphthalenylmethyl)-5-oxo-5H-thi...
C24H21NO5S
868367-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 1.3338 0.0 0
M  V30 3 O 7.7000 0.0000 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 12.6607 3.2908 0.0 0
M  V30 6 O 14.1253 3.7667 0.0 0
M  V30 7 O 12.3405 1.7844 0.0 0
M  V30 8 C 15.2697 2.7363 0.0 0
M  V30 9 O 10.0100 1.3338 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 C 9.2400 5.3347 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 N 10.0100 4.0011 0.0 0
M  V30 14 S 10.2704 6.4792 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 11.5163 4.3212 0.0 0 CFG=2
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 11.6772 5.8528 0.0 0
M  V30 19 C 6.9300 6.6685 0.0 0
M  V30 20 C 6.9300 8.2085 0.0 0
M  V30 21 C 5.5962 7.4385 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 3.0800 5.3347 0.0 0
M  V30 24 C 5.3900 6.6685 0.0 0
M  V30 25 C 2.3100 6.6685 0.0 0
M  V30 26 C 2.3100 4.0011 0.0 0
M  V30 27 C 4.6200 8.0022 0.0 0
M  V30 28 C 3.0800 8.0022 0.0 0
M  V30 29 C 0.7700 6.6685 0.0 0
M  V30 30 C 0.7700 4.0011 0.0 0
M  V30 31 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 16 5 CFG=1
M  V30 9 1 6 8
M  V30 10 2 9 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 19
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 23 26
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 1 25 29
M  V30 32 2 26 30
M  V30 33 2 27 28
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (3R)-8-cyclopropyl-2,3-dihydro-6-[(methylamino)carbonyl]-7-(1-naphthal...
C25H24N2O4S
916314-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 N 7.7000 1.3336 0.0 0
M  V30 4 O 5.3900 2.6674 0.0 0
M  V30 5 C 6.9300 0.0000 0.0 0
M  V30 6 C 12.6607 4.6245 0.0 0
M  V30 7 O 14.1253 5.1003 0.0 0
M  V30 8 O 12.3405 3.1182 0.0 0
M  V30 9 C 15.2697 4.0699 0.0 0
M  V30 10 O 10.0100 2.6674 0.0 0
M  V30 11 C 7.7000 6.6685 0.0 0
M  V30 12 C 9.2400 6.6685 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 N 10.0100 5.3347 0.0 0
M  V30 15 S 10.2704 7.8129 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 11.5163 5.6549 0.0 0 CFG=2
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 11.6772 7.1866 0.0 0
M  V30 20 C 6.9300 8.0021 0.0 0
M  V30 21 C 6.9300 9.5422 0.0 0
M  V30 22 C 5.5962 8.7721 0.0 0
M  V30 23 C 4.6200 6.6685 0.0 0
M  V30 24 C 3.0800 6.6685 0.0 0
M  V30 25 C 5.3900 8.0021 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 27 C 2.3100 5.3347 0.0 0
M  V30 28 C 4.6200 9.3358 0.0 0
M  V30 29 C 3.0800 9.3358 0.0 0
M  V30 30 C 0.7700 8.0021 0.0 0
M  V30 31 C 0.7700 5.3347 0.0 0
M  V30 32 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 17 6 CFG=1
M  V30 10 1 7 9
M  V30 11 2 10 18
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 20
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 1 26 29
M  V30 32 1 26 30
M  V30 33 2 27 31
M  V30 34 2 28 29
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 868367-27-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916314-98-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12492735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM inert, 84% overall yield in 3 steps from
8-cyclopropyl-2,3-dihydro-7-(1-naphthalenylmethyl)-5-pyridone methyl
ester derivative
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of peptidomimetics based on substituted
bicyclic 2-pyridones-Targeting virulence of uropathogenic E. coli
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aaberg, Veronica; Sellstedt, Magnus; Hedenstroem, Mattias; Pinkner,
Jerome S.; Hultgren, Scott J.; Almqvist, Fredrik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(22), 7563-7581

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-L-tryptophan methyl ester
C12H13ClN2O2
870481-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.3076 1.6412 0.0 0
M  V30 2 C 7.6414 2.4112 0.0 0 CFG=2
M  V30 3 C 8.9751 1.6412 0.0 0
M  V30 4 N 7.6414 3.9512 0.0 0
M  V30 5 O 10.3087 2.4112 0.0 0
M  V30 6 O 8.9751 0.1012 0.0 0
M  V30 7 C 11.6423 1.6412 0.0 0
M  V30 8 Cl 0.0000 3.7536 0.0 0
M  V30 9 C 3.5672 1.7848 0.0 0
M  V30 10 C 2.5367 2.9292 0.0 0
M  V30 11 C 4.9740 2.4112 0.0 0
M  V30 12 C 3.0914 0.3202 0.0 0
M  V30 13 N 3.3067 4.2630 0.0 0
M  V30 14 C 1.0304 2.6091 0.0 0
M  V30 15 C 4.8131 3.9428 0.0 0
M  V30 16 C 1.5850 0.0000 0.0 0
M  V30 17 C 0.5546 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N-methyl-1H-indole-3-propanamide
C12H15N3O
53708-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 2.6218 0.0 0
M  V30 2 C 7.0869 1.8518 0.0 0 CFG=2
M  V30 3 C 8.4206 2.6218 0.0 0
M  V30 4 N 7.0869 0.3118 0.0 0
M  V30 5 N 9.7544 1.8518 0.0 0
M  V30 6 O 8.4206 4.1618 0.0 0
M  V30 7 C 11.0880 2.6218 0.0 0
M  V30 8 C 3.0127 2.4782 0.0 0
M  V30 9 C 4.4196 1.8518 0.0 0
M  V30 10 C 1.9823 1.3338 0.0 0
M  V30 11 C 2.5368 3.9429 0.0 0
M  V30 12 C 4.2586 0.3202 0.0 0
M  V30 13 N 2.7523 0.0000 0.0 0
M  V30 14 C 0.4759 1.6540 0.0 0
M  V30 15 C 1.0304 4.2630 0.0 0
M  V30 16 C 0.0000 3.1185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 870481-80-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53708-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-113-CAS-8059577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationship study of novel necroptosis inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Teng, Xin; Degterev, Alexei; Jagtap, Prakash; Xing, Xuechao; Choi,
Sungwoon; Denu, Regine; Yuan, Junying; Cuny, Gregory D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(22), 5039-5044

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-Chloro-5-(trifluoromethyl)phenyl]ethanone
C9H6ClF3O
886497-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 0.5637 3.2864 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 2.1037 5.9538 0.0 0
M  V30 5 C 6.6687 4.6201 0.0 0
M  V30 6 C 6.6687 6.1601 0.0 0
M  V30 7 O 8.0023 3.8501 0.0 0
M  V30 8 Cl 4.0012 0.0000 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N,α-dimethyl-5-(trifluoromethyl)benzenemethanamine
C10H11ClF3N
1076229-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 C 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 F 2.1037 5.9538 0.0 0
M  V30 7 F 0.0000 5.3901 0.0 0
M  V30 8 F 0.5637 3.2864 0.0 0
M  V30 9 Cl 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886497-11-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1076229-86-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12262835
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (step 3) To a solution of the compound (12.0 g) obtained in step 2 in
MeOH (23 mL) was added 38% methylamine (14.9 mL/MeOH solution), and the
mixture was stirred at room temperature for 2 days. The reaction mixture
was cooled to 0°C, NaBH4 (2.10 g) was added, and the mixture was stirred
at room temperature for 2 hr. Water was added to the reaction mixture,
and the mixture was concentrated under reduced pressure. A 2N aqueous
sodium hydroxide solution was poured onto the residue, and the resultant
product was extracted with ethyl acetate. The organic layer was washed
with water and saturated brine and dried, and the solvent was evaporated
under reduced pressure to give crude 1-[3-chloro-5-(trifluoromethyl)
phenyl]-N-methylethanamine (12.26 g, 96%) as a colorless oil. 1H-NMR (300
MHz, CDCl3) : δ 1.34 (3H, d, J=6.6 Hz), 2.30 (3H, s), 3.69 (1H, q, J=6.6
Hz), 7.46-7.48 (2H, m), 7.50 (1H, s)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperidine derivatives as tachykinin receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shirai, Junya; Morimoto, Shinji; Sugiyama, Hideyuki; Sakauchi, Nobuki;
Yoshikawa, Takeshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008133344 A2 2008-11-06

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
2-Iodobenzoic acid
C7H5IO2
88-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 I 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methylbenzamide
C8H8INO
58084-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 I 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 88-67-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58084-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3883957
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 7. Synthesis of 2-iodo-N-methyl-benzamide (Method 8). Thionyl
chloride (29.4 mL, 404 mmol) is added to a solution of (2-iodo-benzoic
acid (50.0 g, 202 mmol) in dry toluene (600 mL). The mixture is heated to
reflux for 4 hours and the solvent is removed in vacuo. The remanence is
redissolved in dry toluene (600 mL) and cooled to 0°C. 40% methylamine
(aq., 94.1 mL, 1.21 mol) is added dropwise at 0-5°C. during 30 minutes.
The mixture is then stirred at ambient temperature for 16 hours, poured
onto water (300 mL) and extracted with ethyl acetate (3×300 mL) The
combined organic fractions are washed successively with saturated sodium
bicarbonate solution (250 mL) and brine (250 mL), dried (MgSO4) and
concentrated in vacuo. This gives 50.8 g (96%) of crystalline
2-iodo-N-methyl-benzamide.
$DTYPE RXN:VAR(1):NOTES
$DATUM analogs similarly prepared
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzo[b]furan and benzo[b]thiophene derivatives as
serotonin, noradrenalin and/or dopamine reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kehler, Jan; Juhl, Karsten; Norgaard, Morten Bang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060287386 A1 2006-12-21

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-[[2-[(1,3-benzodioxol-5-ylmethyl)[(1,1-dimethylethoxy)carbonyl]amino]...
C28H36N6O6
888314-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4720 6.6685 0.0 0
M  V30 2 N 7.2420 8.0022 0.0 0
M  V30 3 C 7.2420 5.3348 0.0 0
M  V30 4 C 8.7820 8.0022 0.0 0
M  V30 5 C 6.4720 4.0010 0.0 0
M  V30 6 C 9.5521 9.3358 0.0 0
M  V30 7 O 7.2420 2.6673 0.0 0
M  V30 8 O 4.9320 4.0010 0.0 0
M  V30 9 N 11.0921 9.3358 0.0 0
M  V30 10 C 6.4720 1.3337 0.0 0
M  V30 11 C 11.8621 8.0022 0.0 0
M  V30 12 C 11.8621 10.6697 0.0 0
M  V30 13 C 7.2420 0.0000 0.0 0
M  V30 14 O 11.0921 12.0033 0.0 0
M  V30 15 O 13.4021 10.6697 0.0 0
M  V30 16 C 11.8621 13.3370 0.0 0
M  V30 17 C 13.1958 12.5670 0.0 0
M  V30 18 C 12.6321 14.6707 0.0 0
M  V30 19 C 10.5284 14.1070 0.0 0
M  V30 20 C 1.8519 4.0010 0.0 0
M  V30 21 C 4.9320 6.6685 0.0 0
M  V30 22 N 4.1619 8.0022 0.0 0
M  V30 23 C 4.1619 5.3348 0.0 0
M  V30 24 C 2.6219 8.0022 0.0 0
M  V30 25 C 2.6219 5.3348 0.0 0
M  V30 26 N 1.8519 6.6685 0.0 0
M  V30 27 N 1.8519 9.3358 0.0 0
M  V30 28 C 0.3203 9.4969 0.0 0
M  V30 29 C 2.4782 10.7428 0.0 0
M  V30 30 C 0.0000 11.0032 0.0 0
M  V30 31 N 1.3338 11.7733 0.0 0
M  V30 32 C 13.4021 8.0022 0.0 0
M  V30 33 C 14.1722 6.6685 0.0 0
M  V30 34 C 14.1722 9.3358 0.0 0
M  V30 35 C 15.7122 6.6685 0.0 0
M  V30 36 C 15.7122 9.3358 0.0 0
M  V30 37 C 16.4822 8.0022 0.0 0
M  V30 38 O 16.7426 5.5239 0.0 0
M  V30 39 O 17.9885 7.6820 0.0 0
M  V30 40 C 18.1496 6.1504 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 32
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 25
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 24 27
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 32 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 36
M  V30 38 1 35 37
M  V30 39 1 35 38
M  V30 40 2 36 37
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, (1,3-benzodioxol-5-ylmethyl)[2-[[1-[2-(1H-imidazol-1-yl)-6-met...
C27H35N7O5
888314-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4720 5.3348 0.0 0
M  V30 2 N 7.2420 6.6685 0.0 0
M  V30 3 C 7.2420 4.0010 0.0 0
M  V30 4 C 8.7820 6.6685 0.0 0
M  V30 5 C 6.4720 2.6673 0.0 0
M  V30 6 C 9.5521 8.0022 0.0 0
M  V30 7 N 7.2420 1.3337 0.0 0
M  V30 8 O 4.9320 2.6673 0.0 0
M  V30 9 N 11.0921 8.0022 0.0 0
M  V30 10 C 6.4720 0.0000 0.0 0
M  V30 11 C 11.8621 6.6685 0.0 0
M  V30 12 C 11.8621 9.3360 0.0 0
M  V30 13 O 11.0921 10.6697 0.0 0
M  V30 14 O 13.4021 9.3360 0.0 0
M  V30 15 C 11.8621 12.0033 0.0 0
M  V30 16 C 10.5284 12.7733 0.0 0
M  V30 17 C 12.6321 13.3370 0.0 0
M  V30 18 C 13.1958 11.2333 0.0 0
M  V30 19 C 1.8519 2.6673 0.0 0
M  V30 20 C 4.9320 5.3348 0.0 0
M  V30 21 N 4.1619 6.6685 0.0 0
M  V30 22 C 4.1619 4.0010 0.0 0
M  V30 23 C 2.6219 6.6685 0.0 0
M  V30 24 C 2.6219 4.0010 0.0 0
M  V30 25 N 1.8519 5.3348 0.0 0
M  V30 26 N 1.8519 8.0022 0.0 0
M  V30 27 C 2.4782 9.4091 0.0 0
M  V30 28 C 0.3203 8.1633 0.0 0
M  V30 29 C 1.3338 10.4396 0.0 0
M  V30 30 N 0.0000 9.6696 0.0 0
M  V30 31 C 13.4021 6.6685 0.0 0
M  V30 32 C 14.1722 5.3348 0.0 0
M  V30 33 C 14.1722 8.0022 0.0 0
M  V30 34 C 15.7122 5.3348 0.0 0
M  V30 35 C 15.7122 8.0022 0.0 0
M  V30 36 C 16.4822 6.6685 0.0 0
M  V30 37 O 16.7426 4.1903 0.0 0
M  V30 38 O 17.9885 6.3483 0.0 0
M  V30 39 C 18.1496 4.8168 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 11 31
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 19 24
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 23 26
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 1 31 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 1 34 37
M  V30 39 2 35 36
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888314-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888314-65-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6274650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of compound 136a:
Benzo[1,3]dioxol-5-ylmethyl-{2-[1-(2-imidazol-1-yl-6-methyl-pyrimidin-4-yl)-2-methylcarbamoyl-ethylamino]-ethyl}-carbamic
acid tert-butyl ester. Methylamine (800 μL, 40 wt % aqueous) was added to
a solution of
3-[2-(benzo[1,3]dioxol-5-ylmethyltert-butoxycarbonyl-amino)-ethylamino]-3-(2-imidazol-1-yl-
6-methyl-pyrimidin-4-yl)-propionic acid ethyl ester (15 mg, 0.027 mmol)
in THF (0.8 mL). The reaction mixture stirred at room temperature for 16
h then was concentrated under reduced pressure. The residue was purified
using column chromatography (DCM to 9:1 DCM/MeOH) to afford 14 mg (96%)
of
benzo[1,3]dioxol-5-ylmethyl-{2-[1-(2-imidazol-1-yl-6-methyl-pyrimidin-4-yl)-2-methylcarbamoyl-ethylamino]-ethyl}-carbamic
acid tert-butyl ester as a clear oil.
Benzo[1,3]dioxol-5-ylmethyl-{2-[1-(2-imidazol-1-yl-6-methyl-pyrimidin-4-yl)-2-methylcarbamoyl-ethylamino]-ethyl}-carbamic
acid tert-butyl ester. yield 14 mg (96%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic inhibitors of inducible nitric oxide synthase
dimerization for therapeutic use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gahman, Timothy C.; Lang, Hengyuan; Herbert, Mark R.; Thayer, Angelina
M.; Hassig, Christian A.; Noble, Stewart A.; Cousins, Russell D.; Zhuang,
Hui; Santos, Christopher R.; Chen, Xiaohong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060116515 A1 2006-06-01

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-γ-methylenebenzenebutanal
C11H11FO
889656-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 C 8.4702 1.3337 0.0 0
M  V30 5 C 9.2402 0.0000 0.0 0
M  V30 6 O 10.7802 0.0000 0.0 0
M  V30 7 F 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 3.8501 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methyl-δ-methylenebenzenebutanamine
C12H16FN
889656-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 N 10.6697 1.5400 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 F 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 889656-12-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 889656-05-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4964954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Methyl-(4-phenylpent-4-enyl)-amine. To a
solution of 4-Phenylpent-4-enal (1.30 g, 8.11 mmol) in MeOH (16 mL) was
added methylamine (2.0 M in MeOH, 8.1 mL, 16.2 mmol) at room temperature.
The resulting mixture was stirred for 2 h. The reaction mixture was then
cooled to 0 °C. Sodium borohydride (154 mg, 4.06 mmol) was added to the
reaction mixture and stirred at 0 °C for 30 min. The reaction was
quenched by addition of water. The organic layer was extracted with
dichloromethane and dried over potassium carbonate. Silica gel
(Chromatorex NH-DU3050 aminopropyl-capped silica, purchased from FUJI
SYLYSISA Co. Ltd., Japan) chromatography (50% EtOAc/hexane) gave the
title compound as a pale yellow oil. (1.02 g, 5.82 mmol)
[3-(4-Fluorophenyl)-but-3-enyl]-methylamine. The procedure for
methyl-(4-phenylpent-4-enyl)-amine was followed with
4-(4-fluorophenyl)-pent-4-enal (3.00 g, 16.8 mmol). The title compound
was obtained as a pale yellow oil (3.11 g, 16.1 mmol, 96%). 1H NMR (400
MHz, CDCl3, TMS) δ 1.11 (br, 1H), 1.59-1.66 (m, 2H), 2.41 (s, 3H), 2.52
(t, 2H, J = 7.3 Hz), 2.58 (t, 2H, J = 7.3 Hz), 5.06 (s, 1H), 5.22 (s,
1H), 7.00 (t, 2H, J = 8.8 Hz), 7.37 (t, 2H, J = 8.8 Hz); 13C{1H} NMR (100
MHz, CDCl3) δ 28.3, 33.2, 36.5, 51.7, 112.3, 115.1 (d, J = 21.1 Hz),
127.7 (d, J = 7.8 Hz), 137.2 (d, J = 3.4 Hz), 147.2, 162.2 (d, J = 241.2
Hz); MS, m/e : 193 [M+], 178 [M+ - Me], 135 [FC6H4C(=CH2)CH2+], 121
[FC6H4C(=CH2)CH2 +], 57 [CH2CH2NHMe+ – H].
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhodium-Catalyzed Intramolecular, Anti-Markovnikov Hydroamination.
Synthesis of 3-Arylpiperidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Takemiya, Akihiro; Hartwig, John F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2006), 128(18), 6042-6043

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-propoxybenzaldehyde
C10H11ClO2
894851-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 O 0.0000 4.0011 0.0 0
M  V30 7 Cl 6.1600 1.3338 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-2-propoxybenzenemethanamine
C11H16ClNO
894851-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3349 0.0 0
M  V30 4 C 9.2400 5.3349 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 N 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 Cl 6.9300 1.3338 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 8 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3247008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) (3-Chloro-2-propoxybenzyl)methylamine [1288] A solution of methylamine
(8.5 mL of a 2.0 M solution in MeOH, 17 mmol) was added to
3-chloro-2-propoxybenzaldehyde (0.425 g, 2.14 mmol) and the mixture was
stirred for 72 h. The solution was concentrated under reduced pressure.
The resulting clear oil was dissolved in EtOH (8.5 mL) and treated with
NaBH4 (0.080 g, 2.1 mmol). After stirring for 18 h, the reaction mixture
was concentrated under reduced pressure and then dissolved in 1 N NaOH
(10 mL). The mixture was extracted with Et2O (3×50 mL). The combined
organics were washed with brine (2×100 mL), dried (Na2SO4) and
concentrated to yield the title compound (0.441 g, 96%) as a light yellow
oil. 1H NMR (300 MHz, DMSO-d6) δ 7.37-7.31 (m, 2H), 7.08 (t, J=7.7 Hz,
1H), 3.85 (t, J=6.4 Hz, 2H), 3.67 (s, 2H), 2.26 (s, 3H), 2.04 (br s, 1H),
1.82-1.70 (m, 2H), 1.02 (t, J=7.3 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-2-propoxybenzaldehyde
C10H11ClO2
894851-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 O 0.0000 4.0011 0.0 0
M  V30 7 Cl 6.1600 1.3338 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 1.5400 1.3338 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-2-propoxybenzenemethanamine
C11H16ClNO
894851-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 4.0011 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3349 0.0 0
M  V30 4 C 9.2400 5.3349 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 N 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 Cl 6.9300 1.3338 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 8 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8986843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) (3-Chloro-2-propoxybenzyl)methylamine A solution of methylamine (8.5
mL of a 2.0 M solution in MeOH, 17 mmol) was added to
3-chloro-2-propoxybenzaldehyde (0.425 g, 2.14 mmol) and the mixture was
stirred for 72 h. The solution was concentrated under reduced pressure.
The resulting clear oil was dissolved in EtOH (8.5 mL) and treated with
NaBH4 (0.080 g, 2.1 mmol). After stirring for 18 h, the reaction mixture
was concentrated under reduced pressure and then dissolved in 1 N NaOH
(10 mL). The mixture was extracted with Et2O (3×50 mL). The combined
organics were washed with brine (2×100 mL), dried (Na2SO4) and
concentrated to yield the title compound (0.441 g, 96%) as a light yellow
oil: 1H NMR (300 MHz, DMSO-d6 ) δ 7.37-7.31 (m, 2H), 7.08 (t, J = 7.7 Hz,
1H), 3.85 (t, J = 6.4 Hz, 2H), 3.67 (s, 2H), 2.26 (s, 3H), 2.04 (br s,
1H), 1.82-1.70 (m, 2H), 1.02 (t, J = 7.3 Hz, 3H). C11H16ClNO Exact Mass:
213.09.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl)-2-propoxybenzaldehyde
C14H20O2
894852-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 0.7700 5.3349 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 6.1600 1.3338 0.0 0
M  V30 10 O 6.9300 0.0000 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 1.5400 1.3338 0.0 0
M  V30 15 C 3.8500 0.0000 0.0 0
M  V30 16 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 13
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl)-N-methyl-2-propoxybenzenemethanamine
C15H25NO
894852-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 3.8501 0.0 0
M  V30 8 C 0.0000 5.3901 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 N 8.0023 5.3901 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 C 2.6675 6.9302 0.0 0
M  V30 16 C 5.3348 6.9302 0.0 0
M  V30 17 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894852-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894852-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3250581
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) (3-tert-Butyl-2-propoxy-benzyl)-methyl-amine [1419]
3-tert-Butyl-2-propoxy-benzaldehyde (1.15 g, 5.21 mmol) was dissolved in
anhydrous methanol (25 ml). Methylamine (2.00 ml of 33% solution in
ethanol, 16.1 mmol) was added and the reaction was stirred for 3 h. The
solution was concentrated to a yellow oil and then dissolved in anhydrous
methanol (25 ml). Sodium borohydride (198 mg, 5.23 mmol) was added and
the mixture was stirred overnight at room temperature. Water (10 ml) was
added and the solution was concentrated. Sodium hydroxide (30 ml, 1N) was
added and the aqueous layer was extracted with ethyl acetate (3×50 ml).
Combined organic layers were dried over MgSO4, filtered and concentrated
to afford (3-tert-butyl-2-propoxy-benzyl)-methyl-amine (1.18 g, 96%) as a
clear oil. 1H NMR (400 MHz, DMSO-d6) δ 7.28 (d, J=8.0 Hz, 1H), 7.15 (d,
J=8.0 Hz, 1H), 6.97 (y J=8.0, y1H), 3.79 (t, J=4.0 Hz, 2H), 3.61 (s, 2H),
2.28 (s, 3H), 1.80-1.75 (m, 2H), 1.33 (s, 9H), 1.03 (t, J=8.0 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl)-2-propoxybenzaldehyde
C14H20O2
894852-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 0.7700 5.3349 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 6.1600 1.3338 0.0 0
M  V30 10 O 6.9300 0.0000 0.0 0
M  V30 11 C 3.8500 2.6674 0.0 0
M  V30 12 C 2.3100 2.6674 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 1.5400 1.3338 0.0 0
M  V30 15 C 3.8500 0.0000 0.0 0
M  V30 16 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 13
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethylethyl)-N-methyl-2-propoxybenzenemethanamine
C15H25NO
894852-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 3.8501 0.0 0
M  V30 8 C 0.0000 5.3901 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 N 8.0023 5.3901 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 C 2.6675 6.9302 0.0 0
M  V30 16 C 5.3348 6.9302 0.0 0
M  V30 17 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894852-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894852-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5987788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) (3-tert-Butyl-2-propoxy-benzyl)-methyl-amine
3-tert-Butyl-2-propoxy-benzaldehyde (1.15 g, 5.21 mmol) was dissolved in
anhydrous methanol (25 ml). Methylamine (2.00 ml of 33% solution in
ethanol, 16.1 mmol) was added and the reaction was stirred for 3 h. The
solution was concentrated to a yellow oil and then dissolved in anhydrous
methanol (25 ml). Sodium borohydride (198 mg, 5.23 mmol) was added and
the mixture was stirred overnight at room temperature. Water (10 ml) was
added and the solution was concentrated. Sodium hydroxide (30 ml, 1N) was
added and the aqueous layer was extracted with ethyl acetate (3×50 ml).
Combined organic layers were dried over MgSO4, filtered and concentrated
to afford (3-tert-butyl-2-propoxy-benzyl)-methyl-amine (1.18 g, 96%) as a
clear oil: 1H NMR (400 MHz, DMSO-d 6) δ 7.28 (d, J = 8.0 Hz, 1H), 7.15
(d, J = 8.0 Hz, 1H), 6.97 (y J = 8.0, 1H), 3.79 (t, J = 4.0 Hz, 2H), 3.61
(s, 2H), 2.28 (s, 3H), 1.80-1.75 (m, 2H), 1.33 (s, 9H), 1.03 (t, J = 8.0
Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dimethyl-1H-indole-5-carboxaldehyde
C11H11NO
894853-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.2907 0.0 0
M  V30 2 C 0.0000 4.0012 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 3.8501 5.3348 0.0 0
M  V30 6 C 4.6201 4.0012 0.0 0
M  V30 7 C 2.3101 5.3348 0.0 0
M  V30 8 N 4.8805 6.4792 0.0 0
M  V30 9 C 3.8501 2.6673 0.0 0
M  V30 10 C 6.1264 4.3213 0.0 0
M  V30 11 C 1.5400 4.0012 0.0 0
M  V30 12 C 6.2873 5.8529 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3,6-Trimethyl-1H-indole-5-methanamine
C12H16N2
894853-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7270 0.0000 0.0 0
M  V30 2 C 6.2873 3.9845 0.0 0
M  V30 3 N 7.0574 2.6509 0.0 0
M  V30 4 C 8.5974 2.6509 0.0 0
M  V30 5 C 4.7473 6.6520 0.0 0
M  V30 6 C 2.4373 2.6509 0.0 0
M  V30 7 C 1.6672 3.9845 0.0 0
M  V30 8 C 3.9773 2.6509 0.0 0
M  V30 9 C 1.4068 1.5065 0.0 0
M  V30 10 C 2.4373 5.3184 0.0 0
M  V30 11 N 0.1609 3.6644 0.0 0
M  V30 12 C 4.7473 3.9845 0.0 0
M  V30 13 C 0.0000 2.1328 0.0 0
M  V30 14 C 3.9773 5.3184 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894853-38-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894853-39-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4180692
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM e) 3,6-dimethyl-1H-indol-5-yl)-N-methylmethanamine [1513]Methylamine (2.4
mL, 19 mmol, 33% in EtOH) was added to a MeOH (10 mL) solution of
3,6-dimethyl-1H-indole-5-carbaldehyde(810 mg, 4.7 mmol). The mixture was
stirred for 5 h at 21° C. The mixture was cooled to 0° C. and NaBH4 (180
mg, 4.7 mmol) was added slowly. The mixture was stirred at 21° C. for 16
h, water (1 mL) was added then it was evaporated to a paste. This was
diluted with CH2Cl2, washed with water, dried over K2CO3 and evaporated
to afford the title compound (848 mg 96%). (300 MHz, CDCl3) 7.77 (s, br,
1H), 7.47 (s, br, 1H), 7.26 (is, 1H), 6.87 (s, 1H), 3.83 (s, 2H), 2.54
(s, 3H), 2.45 (s, 3H), 2.31 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dimethyl-1H-indole-5-carboxaldehyde
C11H11NO
894853-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.2907 0.0 0
M  V30 2 C 0.0000 4.0012 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 3.8501 5.3348 0.0 0
M  V30 6 C 4.6201 4.0012 0.0 0
M  V30 7 C 2.3101 5.3348 0.0 0
M  V30 8 N 4.8805 6.4792 0.0 0
M  V30 9 C 3.8501 2.6673 0.0 0
M  V30 10 C 6.1264 4.3213 0.0 0
M  V30 11 C 1.5400 4.0012 0.0 0
M  V30 12 C 6.2873 5.8529 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3,6-Trimethyl-1H-indole-5-methanamine
C12H16N2
894853-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.7270 0.0000 0.0 0
M  V30 2 C 6.2873 3.9845 0.0 0
M  V30 3 N 7.0574 2.6509 0.0 0
M  V30 4 C 8.5974 2.6509 0.0 0
M  V30 5 C 4.7473 6.6520 0.0 0
M  V30 6 C 2.4373 2.6509 0.0 0
M  V30 7 C 1.6672 3.9845 0.0 0
M  V30 8 C 3.9773 2.6509 0.0 0
M  V30 9 C 1.4068 1.5065 0.0 0
M  V30 10 C 2.4373 5.3184 0.0 0
M  V30 11 N 0.1609 3.6644 0.0 0
M  V30 12 C 4.7473 3.9845 0.0 0
M  V30 13 C 0.0000 2.1328 0.0 0
M  V30 14 C 3.9773 5.3184 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894853-38-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894853-39-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13481025
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM e) 3,6-dimethyl-1H-indol-5-yl)-N-methylmethanamine Methylamine (2.4 mL,
19 mmol, 33% in EtOH) was added to a MeOH (10 mL) solution of
3,6-dimethyl-1H-indole-5-carbaldehyde (810 mg, 4.7 mmol). The mixture was
stirred for 5 h at 21° C. The mixture was cooled to 0° C and NaBH4 (180
mg, 4.7 mmol) was added slowly. The mixture was stirred at 21° C for 16
h, water (1 mL) was added then it was evaporated to a paste. This was
diluted with CH2Cl2, washed with water, dried over K2CO3 and evaporated
to afford the title compound (848 mg 96%). (300 MHz, CDCl3) δ 7.77 (s,
br, 1H), 7.47 (s, br, 1H), 7.26 (1s, 1H), 6.87 (s, 1H), 3.83 (s, 2H),
2.54 (s, 3H), 2.45 (s, 3H), 2.31 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3-nitrobenzonitrile
C7H3BrN2O2
89642-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 Br 1.3337 4.6201 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 N 8.0022 0.7700 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 3 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 4-(methylamino)-3-nitro-
C8H7N3O2
64910-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 0.7700 1.3338 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89642-49-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64910-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6570516
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Flavin-catalyzed oxidation of amines and sulfides with molecular oxygen:
biomimetic green oxidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Imada, Yasushi; Iida, Hiroki; Ono, Satoshi; Masui, Yoshiyuki; Murahashi,
Shun-Ichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - An Asian Journal (2006), 1(1-2), 136-147

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allitinib
C24H18ClFN4O2
897383-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0033 5.3901 0.0 0
M  V30 2 N 17.3382 6.9302 0.0 0
M  V30 3 C 18.6720 7.7002 0.0 0
M  V30 4 C 20.0057 6.9302 0.0 0
M  V30 5 O 18.6720 9.2402 0.0 0
M  V30 6 C 21.3393 7.7002 0.0 0
M  V30 7 Cl 9.3360 0.7700 0.0 0
M  V30 8 O 6.6685 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 F 0.0000 3.0801 0.0 0
M  V30 11 C 13.3372 7.7002 0.0 0
M  V30 12 C 12.0033 6.9302 0.0 0
M  V30 13 C 13.3372 9.2402 0.0 0
M  V30 14 C 14.6708 6.9302 0.0 0
M  V30 15 N 10.6697 7.7002 0.0 0
M  V30 16 C 14.6708 10.0102 0.0 0
M  V30 17 N 12.0033 10.0102 0.0 0
M  V30 18 C 16.0045 7.7002 0.0 0
M  V30 19 C 10.6697 9.2402 0.0 0
M  V30 20 C 16.0045 9.2402 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 10.6697 3.0801 0.0 0
M  V30 23 C 9.3360 5.3901 0.0 0
M  V30 24 C 9.3360 2.3101 0.0 0
M  V30 25 C 8.0022 4.6201 0.0 0
M  V30 26 C 8.0022 3.0801 0.0 0
M  V30 27 C 4.0012 2.3101 0.0 0
M  V30 28 C 2.6673 3.0801 0.0 0
M  V30 29 C 4.0012 0.7700 0.0 0
M  V30 30 C 1.3337 2.3101 0.0 0
M  V30 31 C 2.6673 0.0000 0.0 0
M  V30 32 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 4 6
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 8 26
M  V30 11 1 9 27
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-3-(m...
C25H23ClFN5O2
897383-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 12.0033 5.3901 0.0 0
M  V30 2 N 17.3382 6.9302 0.0 0
M  V30 3 C 18.6718 7.7002 0.0 0
M  V30 4 C 20.0057 6.9302 0.0 0
M  V30 5 O 18.6718 9.2402 0.0 0
M  V30 6 C 21.3393 7.7002 0.0 0
M  V30 7 N 22.6730 6.9302 0.0 0
M  V30 8 C 24.0067 7.7002 0.0 0
M  V30 9 Cl 9.3358 0.7700 0.0 0
M  V30 10 O 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 F 0.0000 3.0801 0.0 0
M  V30 13 C 13.3370 7.7002 0.0 0
M  V30 14 C 12.0033 6.9302 0.0 0
M  V30 15 C 13.3370 9.2402 0.0 0
M  V30 16 C 14.6708 6.9302 0.0 0
M  V30 17 N 10.6697 7.7002 0.0 0
M  V30 18 C 14.6708 10.0102 0.0 0
M  V30 19 N 12.0033 10.0102 0.0 0
M  V30 20 C 16.0045 7.7002 0.0 0
M  V30 21 C 10.6697 9.2402 0.0 0
M  V30 22 C 16.0045 9.2402 0.0 0
M  V30 23 C 10.6697 4.6201 0.0 0
M  V30 24 C 10.6697 3.0801 0.0 0
M  V30 25 C 9.3358 5.3901 0.0 0
M  V30 26 C 9.3358 2.3101 0.0 0
M  V30 27 C 8.0022 4.6201 0.0 0
M  V30 28 C 8.0022 3.0801 0.0 0
M  V30 29 C 4.0010 2.3101 0.0 0
M  V30 30 C 2.6673 3.0801 0.0 0
M  V30 31 C 4.0010 0.7700 0.0 0
M  V30 32 C 1.3337 2.3101 0.0 0
M  V30 33 C 2.6673 0.0000 0.0 0
M  V30 34 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 28
M  V30 13 1 11 29
M  V30 14 1 12 32
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 897383-62-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 897383-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2052610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (141-2) Preparation of
N-{4-[3-chloro-4-(3-iluoro-benzyloxy)-phenylamino]-quinazolin-6-yl}-3-dimethylamino-propionamide
(142-1) Preparation of
N-{4-[3-chloro-4-(3-fluoro-benzyloxy)-phenylamino]-quinazolin-6-yl}-3-methylamino-propionamide
The procedure of (141-2) of Example 141 was repeated except for using
methylamine instead of dimethylamine to obtain the title compound (0.41
g, 96%). 1H-NMR (CD3OD, 300MHz): δ 8.56 (d, 1H), 8.35 (s, 1H), 7.78 (d,
1H), 7.66 (m, 2H), 7.49 (dd, 1H), 7.32 (m, 1H), 7.16 (m, 2H), 7.08 (d,
1H), 6.96 (t, 1H), 5.13 (s, 2H), 2.85 (t, 2H), 2.57 (t, 2H), 2.34 (s,
3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline derivatives as inhibitors of epidermal growth
factor receptor and growth of cancer cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ham, Young Jin; Gong, Ji Hyeon; Cha, Mi Young; Kim, Jong Woo; Kim, Maeng
Sup; Kim, Eun Young; Song, Ji Yeon; Kim, Chang In; Kim, Se Young; Lee,
Gwan Sun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006071017 A1 2006-07-06

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-(2,5-Furandiyldimethylidyne)bis[methanamine]
C8H10N2O
92259-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.6218 0.0 0
M  V30 2 N 1.3337 1.8517 0.0 0
M  V30 3 C 0.0000 2.6218 0.0 0
M  V30 4 C 7.9701 1.4946 0.0 0
M  V30 5 N 8.8754 0.2487 0.0 0
M  V30 6 C 10.4069 0.4096 0.0 0
M  V30 7 C 4.0012 1.8517 0.0 0
M  V30 8 O 5.4080 2.4782 0.0 0
M  V30 9 C 4.1621 0.3202 0.0 0
M  V30 10 C 6.4386 1.3337 0.0 0
M  V30 11 C 5.6686 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N5-Dimethyl-2,5-furandimethanamine
C8H14N2O
92349-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.6218 0.0 0
M  V30 2 N 1.3337 1.8517 0.0 0
M  V30 3 C 0.0000 2.6218 0.0 0
M  V30 4 C 7.9701 1.4946 0.0 0
M  V30 5 N 8.8754 0.2487 0.0 0
M  V30 6 C 10.4069 0.4096 0.0 0
M  V30 7 C 4.0012 1.8517 0.0 0
M  V30 8 O 5.4080 2.4782 0.0 0
M  V30 9 C 4.1621 0.3202 0.0 0
M  V30 10 C 6.4386 1.3337 0.0 0
M  V30 11 C 5.6686 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 92259-17-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 92349-60-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24485219
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-18-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-44-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study (optimized on catalyst), conversion = 100%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient approach to synthesizing 2,5-bis(N-methyl-aminomethyl)furan
from 5-hydroxymethylfurfural via 2,5-bis(N-methyl-iminomethyl)furan using
a two-step reaction in one pot
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Jie; Jia, Wenlong; Sun, Yong; Yang, Shuliang; Tang, Xing; Zeng,
Xianhai; Lin, Lu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2021), 23(15), 5656-5664

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl glycidyl ether
C4H8O2
930-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 2.1037 0.0 0
M  V30 2 O 4.2074 1.3337 0.0 0
M  V30 3 C 5.5410 2.1037 0.0 0
M  V30 4 C 1.5400 1.3337 0.0 0
M  V30 5 C 0.7700 0.0000 0.0 0
M  V30 6 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methoxy-3-(methylamino)-2-propanol
C5H13NO2
60755-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 N 6.6687 1.5400 0.0 0
M  V30 6 O 1.3337 1.5400 0.0 0
M  V30 7 C 8.0023 2.3101 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 930-37-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60755-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-6272288
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: A mixture of glycidyl methyl ether and aq. methylamine (1.5 eq)
was heated at 55 °C for 2 hr. Removal of volatile components.
Intermediate A which was used directly in next step.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dimethylphosphorylphenylaminopyrimidine derivatives for
treatment of EGFR-driven cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Xiaotian; Wang, Yihan; Shakespeare, William C.; Huang, Wei-Sheng;
Dalgarno, David C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013169401 A1 2013-11-14

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,9,12,15,18,21,24,27,30,33-Undecaoxatetratriacontan-1-ol, 1-(4-methylbenze...
C30H54O14S
936499-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 2 O 4.4137 4.5648 0.0 0
M  V30 3 O 1.7462 6.1048 0.0 0
M  V30 4 O 3.8501 6.6687 0.0 0
M  V30 5 C 5.7474 5.3348 0.0 0
M  V30 6 C 7.0811 4.5648 0.0 0
M  V30 7 O 8.4149 5.3348 0.0 0
M  V30 8 C 9.7486 4.5648 0.0 0
M  V30 9 C 11.0822 5.3348 0.0 0
M  V30 10 O 12.4159 4.5648 0.0 0
M  V30 11 C 13.7497 5.3348 0.0 0
M  V30 12 C 15.0834 4.5648 0.0 0
M  V30 13 O 16.4171 5.3348 0.0 0
M  V30 14 C 17.7507 4.5648 0.0 0
M  V30 15 C 19.0846 5.3348 0.0 0
M  V30 16 O 20.4182 4.5648 0.0 0
M  V30 17 C 21.7519 5.3348 0.0 0
M  V30 18 C 23.0856 4.5648 0.0 0
M  V30 19 O 24.4194 5.3348 0.0 0
M  V30 20 C 25.7531 4.5648 0.0 0
M  V30 21 C 27.0867 5.3348 0.0 0
M  V30 22 O 28.4204 4.5648 0.0 0
M  V30 23 C 29.7542 5.3348 0.0 0
M  V30 24 C 31.0879 4.5648 0.0 0
M  V30 25 O 32.4216 5.3348 0.0 0
M  V30 26 C 33.7552 4.5648 0.0 0
M  V30 27 C 35.0890 5.3348 0.0 0
M  V30 28 O 36.4227 4.5648 0.0 0
M  V30 29 C 37.7564 5.3348 0.0 0
M  V30 30 C 39.0901 4.5648 0.0 0
M  V30 31 O 40.4239 5.3348 0.0 0
M  V30 32 C 41.7575 4.5648 0.0 0
M  V30 33 C 43.0912 5.3348 0.0 0
M  V30 34 O 44.4249 4.5648 0.0 0
M  V30 35 C 45.7587 5.3348 0.0 0
M  V30 36 C 47.0924 4.5648 0.0 0
M  V30 37 O 48.4260 5.3348 0.0 0
M  V30 38 C 49.7597 4.5648 0.0 0
M  V30 39 C 0.0000 0.0000 0.0 0
M  V30 40 C 2.3100 4.0012 0.0 0
M  V30 41 C 3.0801 2.6675 0.0 0
M  V30 42 C 0.7700 4.0012 0.0 0
M  V30 43 C 2.3100 1.3338 0.0 0
M  V30 44 C 0.0000 2.6675 0.0 0
M  V30 45 C 0.7700 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 40
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 39 45
M  V30 40 2 40 41
M  V30 41 1 40 42
M  V30 42 1 41 43
M  V30 43 2 42 44
M  V30 44 2 43 45
M  V30 45 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,6,9,12,15,18,21,24,27,30,33-undecaoxatetratriacontan-1-amine
C24H51NO11
936499-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 22.6730 0.0000 0.0 0
M  V30 2 C 24.0067 0.7700 0.0 0
M  V30 3 O 21.3393 0.7700 0.0 0
M  V30 4 O 25.3403 0.0000 0.0 0
M  V30 5 C 20.0055 0.0000 0.0 0
M  V30 6 C 26.6742 0.7700 0.0 0
M  V30 7 C 18.6718 0.7700 0.0 0
M  V30 8 C 28.0078 0.0000 0.0 0
M  V30 9 O 17.3382 0.0000 0.0 0
M  V30 10 O 29.3415 0.7700 0.0 0
M  V30 11 C 16.0045 0.7700 0.0 0
M  V30 12 C 30.6752 0.0000 0.0 0
M  V30 13 C 14.6707 0.0000 0.0 0
M  V30 14 C 32.0090 0.7700 0.0 0
M  V30 15 O 13.3370 0.7700 0.0 0
M  V30 16 O 33.3427 0.0000 0.0 0
M  V30 17 C 12.0033 0.0000 0.0 0
M  V30 18 C 34.6763 0.7700 0.0 0
M  V30 19 C 10.6697 0.7700 0.0 0
M  V30 20 C 36.0100 0.0000 0.0 0
M  V30 21 O 9.3358 0.0000 0.0 0
M  V30 22 O 37.3438 0.7700 0.0 0
M  V30 23 C 8.0022 0.7700 0.0 0
M  V30 24 C 38.6775 0.0000 0.0 0
M  V30 25 C 6.6685 0.0000 0.0 0
M  V30 26 C 40.0112 0.7700 0.0 0
M  V30 27 O 5.3348 0.7700 0.0 0
M  V30 28 O 41.3448 0.0000 0.0 0
M  V30 29 C 4.0010 0.0000 0.0 0
M  V30 30 C 42.6786 0.7700 0.0 0
M  V30 31 C 2.6673 0.7700 0.0 0
M  V30 32 C 44.0123 0.0000 0.0 0
M  V30 33 N 1.3337 0.0000 0.0 0
M  V30 34 O 45.3460 0.7700 0.0 0
M  V30 35 C 0.0000 0.7700 0.0 0
M  V30 36 C 46.6797 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 936499-78-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 936499-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14122578
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gold(I)-isocyanide and gold(I)-carbene complexes as substrates for the
laser decoration of gold onto ceramic surfaces
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heathcote, Robert; Howell, James A. S.; Jennings, Nicola; Cartlidge,
David; Cobden, Lisa; Coles, Simon; Hursthouse, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2007), (13), 1309-1315

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(3-formylphenoxy)propoxy]benzoate
C18H18O5
937601-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3372 4.6201 0.0 0
M  V30 2 C 12.0033 3.8501 0.0 0
M  V30 3 C 10.6697 4.6201 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 18.6720 4.6201 0.0 0
M  V30 7 O 20.0057 3.8501 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 O 1.3337 2.3101 0.0 0
M  V30 10 O 2.6675 0.0000 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 14.6708 3.8501 0.0 0
M  V30 13 C 16.0045 4.6201 0.0 0
M  V30 14 C 14.6708 2.3101 0.0 0
M  V30 15 C 17.3382 3.8501 0.0 0
M  V30 16 C 16.0045 1.5400 0.0 0
M  V30 17 C 17.3382 2.3101 0.0 0
M  V30 18 C 6.6685 3.8501 0.0 0
M  V30 19 C 6.6685 2.3101 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 5.3348 1.5400 0.0 0
M  V30 22 C 4.0012 3.8501 0.0 0
M  V30 23 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 18
M  V30 7 2 6 7
M  V30 8 1 6 15
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 23
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[3-[(methylamino)methyl]phenoxy]propoxy]benzoate
C19H23NO4
2454238-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 13.3372 4.6201 0.0 0
M  V30 2 C 12.0033 3.8501 0.0 0
M  V30 3 C 10.6697 4.6201 0.0 0
M  V30 4 C 9.3360 3.8501 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 C 18.6720 4.6201 0.0 0
M  V30 7 N 20.0057 3.8501 0.0 0
M  V30 8 C 21.3393 4.6201 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 O 2.6673 0.0000 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 14.6708 3.8501 0.0 0
M  V30 14 C 16.0045 4.6201 0.0 0
M  V30 15 C 14.6708 2.3101 0.0 0
M  V30 16 C 17.3382 3.8501 0.0 0
M  V30 17 C 16.0045 1.5400 0.0 0
M  V30 18 C 17.3382 2.3101 0.0 0
M  V30 19 C 6.6685 3.8501 0.0 0
M  V30 20 C 6.6685 2.3101 0.0 0
M  V30 21 C 5.3348 4.6201 0.0 0
M  V30 22 C 5.3348 1.5400 0.0 0
M  V30 23 C 4.0012 3.8501 0.0 0
M  V30 24 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 10 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 937601-98-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454238-02-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-(4-formylphenoxy)propoxy]benzoate
C18H18O5
937602-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 4.6201 0.0 0
M  V30 2 C 9.3360 3.8501 0.0 0
M  V30 3 C 10.6697 4.6201 0.0 0
M  V30 4 C 12.0033 3.8501 0.0 0
M  V30 5 O 13.3372 4.6201 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 O 1.3337 2.3101 0.0 0
M  V30 8 O 2.6675 0.0000 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 18.6720 1.5400 0.0 0
M  V30 11 O 20.0057 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 1.5400 0.0 0
M  V30 16 C 4.0012 3.8501 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 14.6708 3.8501 0.0 0
M  V30 19 C 16.0045 4.6201 0.0 0
M  V30 20 C 14.6708 2.3101 0.0 0
M  V30 21 C 17.3382 3.8501 0.0 0
M  V30 22 C 16.0045 1.5400 0.0 0
M  V30 23 C 17.3382 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 17
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[3-[4-[(methylamino)methyl]phenoxy]propoxy]benzoate
C19H23NO4
2454240-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 4.6201 0.0 0
M  V30 2 C 9.3360 3.8501 0.0 0
M  V30 3 C 10.6697 4.6201 0.0 0
M  V30 4 C 12.0033 3.8501 0.0 0
M  V30 5 O 13.3372 4.6201 0.0 0
M  V30 6 C 2.6673 1.5400 0.0 0
M  V30 7 O 1.3337 2.3101 0.0 0
M  V30 8 O 2.6673 0.0000 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 18.6720 1.5400 0.0 0
M  V30 11 N 20.0057 2.3101 0.0 0
M  V30 12 C 21.3393 1.5400 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 5.3348 1.5400 0.0 0
M  V30 17 C 4.0012 3.8501 0.0 0
M  V30 18 C 4.0012 2.3101 0.0 0
M  V30 19 C 14.6708 3.8501 0.0 0
M  V30 20 C 16.0045 4.6201 0.0 0
M  V30 21 C 14.6708 2.3101 0.0 0
M  V30 22 C 17.3382 3.8501 0.0 0
M  V30 23 C 16.0045 1.5400 0.0 0
M  V30 24 C 17.3382 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 18
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 937602-00-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454240-16-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357551
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
(2E)-3-(4-Methylphenyl)-2-propenoic acid
C10H10O2
940-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, N-methyl-3-(4-methylphenyl)-, (E)-
C11H13NO
125506-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 8.4702 1.3337 0.0 0
M  V30 4 N 9.2402 0.0000 0.0 0
M  V30 5 O 9.2402 2.6673 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 3.8501 4.0010 0.0 0
M  V30 11 C 2.3101 1.3337 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 940-61-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 125506-94-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13765156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem superelectrophilic hydroarylation of C=C bond and carbonyl
reduction in cinnamides: synthetic route to 3,3-diarylpropylamines,
valuable pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zakusilo, Dmitry N.; Ryabukhin, Dmitry S.; Boyarskaya, Irina A.;
Yuzikhin, Oleg S.; Vasilyev, Aleksander V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2015), 71(1), 102-108

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
3-[(4-Methyl-2-nitrophenyl)thio]benzoic acid
C14H11NO4S
943616-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3347 2.3100 0.0 0
M  V30 2 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 0.0000 5.3900 0.0 0
M  V30 6 C 10.6694 2.3100 0.0 0
M  V30 7 O 12.0031 3.0800 0.0 0
M  V30 8 O 10.6694 0.7700 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 1.3336 3.0800 0.0 0
M  V30 13 C 2.6673 5.3900 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 6.6684 3.0800 0.0 0
M  V30 16 C 8.0020 2.3100 0.0 0
M  V30 17 C 6.6684 4.6200 0.0 0
M  V30 18 C 9.3358 3.0800 0.0 0
M  V30 19 C 8.0020 5.3900 0.0 0
M  V30 20 C 9.3358 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 18
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-[(4-methyl-2-nitrophenyl)thio]benzamide
C15H14N2O3S
943616-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 2.3101 0.0 0
M  V30 2 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 4.0010 0.0000 0.0 0
M  V30 5 C 0.0000 5.3901 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 N 12.0033 3.0801 0.0 0
M  V30 8 O 10.6697 0.7700 0.0 0
M  V30 9 C 13.3370 2.3101 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 6.6685 3.0801 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 6.6685 4.6201 0.0 0
M  V30 19 C 9.3360 3.0801 0.0 0
M  V30 20 C 8.0022 5.3901 0.0 0
M  V30 21 C 9.3360 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 943616-72-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943616-77-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11183816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: Example 1g.
(7-Methyl-[1,8]naphthyridin-4-yl)-(5-methyl-2-phenylsulfanyl-phenyl)-amine.
A stirred solution of the product from Example 1 d (65 mg, 0.36 mmol) and
the product from Example 1f (77 mg, 0.36 mmol) in 3 mL of EtOH was heated
at 80 °C for 7 h. Concentrated under vacuum. Recrystallized from THF with
a few drops of MeOH. Filtration gave the title compound as the
hydrochloride salt.
N-Methyl-3-(4-methyl-2-nitro-phenylsulfanyl)-benzamide. (0.25g, 96 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,6- and 1,8-naphthyridines as antiviral compounds for
treatment of HCV infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rockway, Todd W.; Betebenner, David A.; Krueger, Allan C.; Iwasaki,
Nobuhiko; Cooper, Curt S.; Anderson, David D.; Kempf, Dale J.; Madigan,
Darold L.; Motter, Christopher E.; Shanley, Jason P.; Tufano, Michael D.;
Wagner, Rolf; Zhang, Rong; Molla, Akhteruzzaman; Mo, Hongmei;
Pilot-Matias, Tami; Masse, Sherie V. L.; Carrick, Robert J.; He, Weping;
Lu, Liangjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007076035 A2 2007-07-05

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-(trifluoromethyl)benzaldehyde
C9H7F3O2
945003-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 1.3336 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 C 1.5400 4.0009 0.0 0
M  V30 4 F 1.5400 5.5409 0.0 0
M  V30 5 F 0.0000 4.0009 0.0 0
M  V30 6 F 1.5400 2.4609 0.0 0
M  V30 7 C 7.7000 4.0009 0.0 0
M  V30 8 O 8.4700 5.3347 0.0 0
M  V30 9 C 3.8500 2.6673 0.0 0
M  V30 10 C 3.0800 4.0009 0.0 0
M  V30 11 C 5.3900 2.6673 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 6.1600 4.0009 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 10
M  V30 7 2 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-4-(trifluoromethyl)benzenemethanamine
C10H12F3NO
1779915-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 1.3336 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 C 1.5400 4.0009 0.0 0
M  V30 4 F 1.5400 5.5409 0.0 0
M  V30 5 F 0.0000 4.0009 0.0 0
M  V30 6 F 1.5400 2.4609 0.0 0
M  V30 7 C 7.7000 4.0009 0.0 0
M  V30 8 N 8.4700 5.3347 0.0 0
M  V30 9 C 10.0100 5.3347 0.0 0
M  V30 10 C 3.8500 2.6673 0.0 0
M  V30 11 C 3.0800 4.0009 0.0 0
M  V30 12 C 5.3900 2.6673 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 6.1600 4.0009 0.0 0
M  V30 15 C 5.3900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945003-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1779915-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[1-(2-Furanylcarbonyl)-3-oxo-3-(4-pyridinyl)propyl]benzoic acid
C20H15NO5
945375-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.1618 0.0 0
M  V30 2 C 5.3348 2.6218 0.0 0
M  V30 3 C 4.0012 4.9318 0.0 0
M  V30 4 O 6.6685 1.8517 0.0 0
M  V30 5 C 4.0012 6.4718 0.0 0
M  V30 6 O 5.3348 7.2419 0.0 0
M  V30 7 C 10.6697 7.2419 0.0 0
M  V30 8 O 10.6697 8.7819 0.0 0
M  V30 9 O 12.0033 6.4718 0.0 0
M  V30 10 C 6.6685 4.9318 0.0 0
M  V30 11 C 8.0022 4.1618 0.0 0
M  V30 12 C 6.6685 6.4718 0.0 0
M  V30 13 C 9.3360 4.9318 0.0 0
M  V30 14 C 8.0022 7.2419 0.0 0
M  V30 15 C 9.3360 6.4718 0.0 0
M  V30 16 C 4.0012 1.8517 0.0 0
M  V30 17 C 2.5942 2.4782 0.0 0
M  V30 18 O 3.8401 0.3202 0.0 0
M  V30 19 C 1.5638 1.3337 0.0 0
M  V30 20 C 2.3338 0.0000 0.0 0
M  V30 21 C 2.6673 7.2419 0.0 0
M  V30 22 C 2.6673 8.7819 0.0 0
M  V30 23 C 1.3337 6.4718 0.0 0
M  V30 24 C 1.3337 9.5519 0.0 0
M  V30 25 C 0.0000 7.2419 0.0 0
M  V30 26 N 0.0000 8.7819 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 1 5 21
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 15
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-(2-Furanyl)-1-methyl-5-(4-pyridinyl)-1H-pyrrol-3-yl]benzoic acid
C21H16N2O3
945375-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9623 7.8788 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 C 6.8295 6.1518 0.0 0
M  V30 7 C 8.0754 3.9937 0.0 0
M  V30 8 N 8.3358 6.4719 0.0 0
M  V30 9 C 9.1058 5.1383 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 3.8501 0.0 0
M  V30 15 C 2.6675 2.3100 0.0 0
M  V30 16 C 5.6850 7.1822 0.0 0
M  V30 17 C 5.8461 8.7138 0.0 0
M  V30 18 O 4.1787 6.8620 0.0 0
M  V30 19 C 4.4391 9.3402 0.0 0
M  V30 20 C 3.4087 8.1957 0.0 0
M  V30 21 C 10.6374 4.9772 0.0 0
M  V30 22 C 11.2639 3.5704 0.0 0
M  V30 23 C 11.5426 6.2231 0.0 0
M  V30 24 C 12.7954 3.4093 0.0 0
M  V30 25 C 13.0742 6.0621 0.0 0
M  V30 26 N 13.7007 4.6553 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 1 9 21
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945375-45-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945375-32-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-919874
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A solution of this material (2.35 mmol) in
EtOH (10 mL) was treated with primary amine (11.8 mmol) and-in the case
of amines other than methylamine-acetic acid (7 mmol). The mixture was
heated to reflux for 3 h or irradiated in an Emrys Optimizer™ for 5 min
at 180 °C. After cooling, the mixture was partitioned between 1 N HCl and
EtOAc. After exhaustive extraction of the aqueous layer, the combined
extracts were washed with brine, dried (Na2SO4), and evaporated. The
crude product was recrystallized from, or triturated with, EtOAc.
4-(2-Furan-2-yl-1-methyl-5-pyridin-4-yl-1H-pyrrol-3-yl)benzoic acid (1h),
yield 96%. mp = 228°C. 1H NMR (400 MHz, DMSO-d6): δ (ppm) = 8.62 (dd, 2H,
J = 6.2 Hz, 1.6 Hz); 7.83 (dd, 1H, J = 1.9 Hz, 0.8 Hz); 7.81 (d,2H, J =
8.5 Hz); 7.57 (d, 2H, J = 6.2 Hz); 7.28 (dd, 2H, J = 8.5 Hz); 6.88 (s,
1H); 6.69-6.65 (m, 2H); 3.57 (s, 3H). MS (ESI): m/z = 345 [MH + ].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scope and applicability of an expedient synthesis leading to
polysubstituted 3-(carboxyphenyl)pyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ullrich, Thomas; Ghobrial, Michael; Weigand, Klaus; Marzinzik, Andreas L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2007), 37(7), 1109-1119

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-N-[(1E)-1-(methylthio)-2-nitroethenyl]benzeneethanamine
C13H18N2O2S
949143-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 C 5.3348 3.8500 0.0 0
M  V30 4 C 6.6684 6.1601 0.0 0
M  V30 5 C 8.0022 2.3100 0.0 0
M  V30 6 S 9.3359 4.6201 0.0 0
M  V30 7 C 4.0011 4.6201 0.0 0
M  V30 8 C 8.0022 6.9301 0.0 0
M  V30 9 N 6.6684 1.5400 0.0 0 VAL=5
M  V30 10 C 10.6695 3.8500 0.0 0
M  V30 11 O 6.6684 0.0000 0.0 0
M  V30 12 O 5.3348 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 13
M  V30 11 2 9 11
M  V30 12 2 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1E)-N-Ethyl-N′-methyl-2-nitro-N-(2-phenylethyl)-1,1-ethenediamine
C13H19N3O2
949143-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 C 5.3348 3.0801 0.0 0
M  V30 4 C 6.6685 0.7700 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 N 8.0022 4.6201 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 8.0022 0.0000 0.0 0
M  V30 9 N 10.6697 3.0801 0.0 0 VAL=5
M  V30 10 C 6.6685 5.3901 0.0 0
M  V30 11 O 10.6697 4.6201 0.0 0
M  V30 12 O 12.0033 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 1.3337 5.3901 0.0 0
M  V30 18 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 13
M  V30 11 2 9 11
M  V30 12 2 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 949143-25-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 949143-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-13995662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3.6
1-[N-(benzyl)ethylamino]-1-(methylamino)-2-nitroethene (1a). - Typical
procedure 1-[N-(benzyl)ethylamino]-1-(methylthio)-2-nitroethene 6a (756
mg, 3 mmol) and the aqueous solution of methylamine (5.2 mL, 6 mmol) were
heated together in refluxing 95% ethanol (25 mL) under nitrogen. The
reaction was monitored by thin-layer chromatography (CH2Cl2/MeOH: 20/1).
After disappearance of the starting compound 6a (2 h) and cooling, the
mixture was concentrated under reduced pressure and the resulting oily
product was purified by flash chromatography (eluent CH2Cl2/MeOH (20 : 1)
to afford compound 1a 3.7
1-(N-ethyl-2-phenylethylamino)-1-(methylamino)-2-nitroethene (1b) From
1-(N-ethyl-2-phenylethylamino)-1-(Methylthio)-2-nitroethene 6b (798 mg, 3
mmol) and the aqueous solution of methylamine (5.2 mL, 6 mmol) was
obtained the expected nitroethene derivative 1b (714 mg, 96%) as yellow
oil. - Rf = 0.54 (CH2Cl2/MeOH (20 : 1)) - 1H NMR (CDCl3): δ H = 1.15 (t,
3H, J = 7.1 Hz, -CH2-CH3), 2.88 (t, 2H, J = 7.31 Hz, CH2), 2.89 (d, 3H, J
= 5.3 Hz, -HN-CH3), 3.44 (dd, 2H, J = 7.2 Hz, J = 6.1 Hz, CH2), 6.57 (s,
1H, vinylic H), 7.14-7.18 (m, 2H, ar. H), 7.2-7.35 (m, 3H, ar. H), 9.9
(broad s, NH). - 13C NMR (CDCl3): δ C = 13.1 (CH3), 32.6 (CH3N), 34.2
(CH2-Ph), 45.8 (CH2-Me), 49.3 (CH2), 50.9 (CH2-N), 103.9 (=CH-NO2), 127.3
(ar. CH), 129.0 (ar CH), 127.3 (ar. CH), 138.1 (ipso-C), 163.2 (-NEt-C=).
- HRMS for C13H19N2O [M-NO]+: calcd. 219.1497, found 219.1494.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New amidines from intramolecular cyclization in triflic acid of
nitroketene aminals with a tethered phenyl ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yaya, Soro; Fante, Bamba; Sorho, Siaka; Jean-Marie, Coustard; Augustin,
Adima A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Sciences (Bangalore, India) (2007), 119(3), 259-265

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Pentanediol, 1-(4-methylbenzenesulfonate)
C12H18O4S
95769-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 5.3347 0.0 0 VAL=6
M  V30 2 O 6.1049 4.0011 0.0 0
M  V30 3 O 4.5649 6.6685 0.0 0
M  V30 4 O 6.6685 6.1047 0.0 0
M  V30 5 C 7.6449 4.0011 0.0 0
M  V30 6 C 8.4149 2.6674 0.0 0
M  V30 7 C 9.9549 2.6674 0.0 0
M  V30 8 C 10.7249 1.3338 0.0 0
M  V30 9 C 12.2649 1.3338 0.0 0
M  V30 10 O 13.0349 0.0000 0.0 0
M  V30 11 C 0.0000 2.2547 0.0 0
M  V30 12 C 4.0011 4.5647 0.0 0
M  V30 13 C 4.0011 3.0247 0.0 0
M  V30 14 C 2.6674 5.3347 0.0 0
M  V30 15 C 2.6674 2.2547 0.0 0
M  V30 16 C 1.3338 4.5647 0.0 0
M  V30 17 C 1.3338 3.0247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Methylamino)-1-pentanol
C6H15NO
2751-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 N 8.0023 0.7700 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 8 C 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 95769-37-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2751-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24507053
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional molecules useful as TEAD modulators for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Villemure, Elisia; Rudolph, Joachim; Beroza, Paul
Powell; Crawford, James John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178339 A1 2021-09-10

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-N-(1R,2R,4S)-Bicyclo[2.2.1]hept-2-yl-2-(methylsulfonyl)-5-[4-(trifluorome...
C19H20F3N3O2S
960004-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.8910 0.0 0
M  V30 2 S 1.5400 7.5583 0.0 0 VAL=6
M  V30 3 C 0.0000 7.5583 0.0 0
M  V30 4 O 1.5400 6.0183 0.0 0
M  V30 5 O 1.5400 9.0983 0.0 0
M  V30 6 C 12.3200 7.5583 0.0 0
M  V30 7 F 12.3200 6.0183 0.0 0
M  V30 8 F 13.8600 7.5583 0.0 0
M  V30 9 F 12.3200 9.0983 0.0 0
M  V30 10 C 6.1600 7.5583 0.0 0
M  V30 11 C 5.3900 6.2247 0.0 0
M  V30 12 C 5.3900 8.8920 0.0 0
M  V30 13 N 3.8500 6.2247 0.0 0
M  V30 14 N 3.8500 8.8920 0.0 0
M  V30 15 C 3.0800 7.5583 0.0 0
M  V30 16 C 7.7000 7.5583 0.0 0
M  V30 17 C 8.4700 6.2247 0.0 0
M  V30 18 C 8.4700 8.8920 0.0 0
M  V30 19 C 10.0100 6.2247 0.0 0
M  V30 20 C 10.0100 8.8920 0.0 0
M  V30 21 C 10.7800 7.5583 0.0 0
M  V30 22 C 5.3900 3.5572 0.0 0 CFG=2
M  V30 23 C 5.0603 2.1100 0.0 0 CFG=2
M  V30 24 C 4.4437 2.6801 0.0 0
M  V30 25 C 2.5402 1.3638 0.0 0
M  V30 26 C 5.9746 1.0495 0.0 0
M  V30 27 C 3.9592 1.4327 0.0 0 CFG=1
M  V30 28 C 5.0577 0.3031 0.0 0
M  V30 29 H 6.5549 2.4817 0.0 0
M  V30 30 H 3.3945 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 22 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 16
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 23 26
M  V30 28 1 23 29 CFG=1
M  V30 29 1 24 27
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 1 27 30 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 22 23 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-N4-(1R,2R,4S)-Bicyclo[2.2.1]hept-2-yl-N2-methyl-5-[4-(trifluoromethyl)phe...
C19H21F3N4
960004-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 4.8911 0.0 0
M  V30 2 N 0.7700 7.5585 0.0 0
M  V30 3 C 0.0000 8.8922 0.0 0
M  V30 4 C 11.5503 7.5585 0.0 0
M  V30 5 F 11.5503 6.0185 0.0 0
M  V30 6 F 13.0903 7.5585 0.0 0
M  V30 7 F 11.5503 9.0985 0.0 0
M  V30 8 C 5.3901 7.5585 0.0 0
M  V30 9 C 4.6201 6.2248 0.0 0
M  V30 10 C 4.6201 8.8922 0.0 0
M  V30 11 N 3.0801 6.2248 0.0 0
M  V30 12 N 3.0801 8.8922 0.0 0
M  V30 13 C 2.3101 7.5585 0.0 0
M  V30 14 C 6.9302 7.5585 0.0 0
M  V30 15 C 7.7002 6.2248 0.0 0
M  V30 16 C 7.7002 8.8922 0.0 0
M  V30 17 C 9.2402 6.2248 0.0 0
M  V30 18 C 9.2402 8.8922 0.0 0
M  V30 19 C 10.0102 7.5585 0.0 0
M  V30 20 C 4.6201 3.5573 0.0 0 CFG=2
M  V30 21 C 4.2904 2.1100 0.0 0 CFG=2
M  V30 22 C 3.6738 2.6801 0.0 0
M  V30 23 C 1.7703 1.3639 0.0 0
M  V30 24 C 5.2047 1.0495 0.0 0
M  V30 25 C 3.1893 1.4327 0.0 0 CFG=1
M  V30 26 C 4.2878 0.3031 0.0 0
M  V30 27 H 5.7850 2.4818 0.0 0
M  V30 28 H 2.6245 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 20 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 14
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 21 27 CFG=1
M  V30 27 1 22 25
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 25 28 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 20 21 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960004-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960004-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9774835
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses and optimization of new GS39783 analogues as positive
allosteric modulators of GABAB receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guery, Sebastien; Floersheim, Philipp; Kaupmann, Klemens; Froestl,
Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(22), 6206-6211

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethylphenyl)-3-oxobutanamide
C12H15NO2
97-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 O 6.1600 5.3347 0.0 0
M  V30 5 C 9.2400 5.3347 0.0 0
M  V30 6 C 10.7800 5.3347 0.0 0
M  V30 7 O 8.4700 6.6685 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 0.0000 2.6674 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.8500 1.3338 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 11
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethylphenyl)-3-(methylamino)-2-butenamide
C13H18N2O
2754314-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0021 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 N 10.6695 1.5400 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0
M  V30 8 C 12.0032 2.3100 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 0.0000 4.6201 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 4.0011 3.8500 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 9 12
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-36-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754314-00-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24906861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1643-19-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Tandem Hofmann-Type Rearrangement and Cyclization Reaction
of α-Acyl-β-aminoacrylamides: Access to Polysubstituted Oxazol-2(3H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Baibin; Yuan, Jingwen; Ye, Xuebei; Zhang, Rui; Li, Jiacheng; Wang,
Yu; Hu, Jiana; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2021), 86(24), 17944-17954

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Nitrophenyl)methylene]methanamine
C8H8N2O2
1637328-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1637328-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12643158
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of the
Alkyl Imines The imines were prepared by a modified protocol of Hachiya
and coworkers. In an oven-dried flask equipped with a magnetic stirring
bar and molecular sieve (4 Å, 1 g) a solution of the aldehyde (3 mmol) in
5 mL DCM was added. Then an amine solution e.g. methylamine solution (2 M
in MeOH, 6 mmol, 2.0 equiv.) was added slowly and the stirring continued
for additional 18 hours. The mixture was filtered and the clear filtrate
was washed with saturated NaHCO3 solution and dried over magnesium
sulfate. By concentration under reduced pressure and drying in vacuo the
product were obtained without further purification. Alkyl Imine: 3j,
yield:96%.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Synthesis of Tetrahydropyridines via an Organocatalytic
One-Pot Multicomponent Michael/Aza-Henry/Cyclization Triple Domino
Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bluemel, Marcus; Chauhan, Pankaj; Hahn, Robert; Raabe, Gerhard; Enders,
Dieter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2014), 16(22), 6012-6015

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzenemethanamine
C8H10N2O2
19499-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19499-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9110201
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 142-82-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Non-fouling conducting polymers and modified surface comprising them
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Shaoyi; Bai, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150133609 A1 2015-05-14

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acetoacetate
C5H8O3
105-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylaminobut-2-enoic acid methyl ester
C6H11NO2
13412-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 N 6.6686 2.3100 0.0 0
M  V30 5 C 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13412-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3703104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bexarotene prodrugs: Targeting through cleavage by NQO1 (DT-diaphorase)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schafer, Anja; Burstein, Ethan S.; Olsson, Roger
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(8), 1944-1947

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methylene]methanamine
C9H11NO
13114-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15024127
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 85-95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gamma-lactams-A novel scaffold for highly potent and selective α7
nicotinic acetylcholine receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Enz, Albert; Feuerbach, Dominik; Frederiksen, Mathias U.; Gentsch,
Conrad; Hurth, Konstanze; Muller, Werner; Nozulak, Joachim; Roy, Bernard
L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(5), 1287-1291

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-methoxybenzylamine
C9H13NO
702-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 702-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13763616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxidation of secondary amines by molecular oxygen and cyclohexanone
monooxygenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Colonna, Stefano; Pironti, Vincenza; Carrea, Giacomo; Pasta, Piero;
Zambianchi, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(3), 569-575

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzaldehyde
C8H8O2
135-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Methoxyphenyl)methylene]methanamine
C9H11NO
1125-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 O 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 135-02-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1125-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12894169
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 85-95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gamma-lactams-A novel scaffold for highly potent and selective α7
nicotinic acetylcholine receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Enz, Albert; Feuerbach, Dominik; Frederiksen, Mathias U.; Gentsch,
Conrad; Hurth, Konstanze; Muller, Werner; Nozulak, Joachim; Roy, Bernard
L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(5), 1287-1291

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24184469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as potent and isoform selective
tumor-associated carbonic anhydrase IX/XII inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Uslu, Azize Gizem; Maz, Tugce Gur; Nocentini, Alessio; Banoglu, Erden;
Supuran, Claudiu T.; Caliskan, Burcu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 95103544

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7024093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl
propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine
reuptake inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Puwen; Terefenko, Eugene A.; McComas, Casey C.; Mahaney, Paige E.;
Vu, An; Trybulski, Eugene; Koury, Elizabeth; Johnston, Grace; Bray,
Jenifer; Deecher, Darlene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(23), 6067-6070

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzoyl chloride
C8H7ClO2
1711-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzamide
C9H11NO2
35129-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 O 8.0023 3.0801 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35129-32-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chlorophenyl)methylene]methanamine
C8H8ClN
13114-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13114-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3759209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 85-95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gamma-lactams-A novel scaffold for highly potent and selective α7
nicotinic acetylcholine receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Enz, Albert; Feuerbach, Dominik; Frederiksen, Mathias U.; Gentsch,
Conrad; Hurth, Konstanze; Muller, Werner; Nozulak, Joachim; Roy, Bernard
L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(5), 1287-1291

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-fluoro-3-methyl-2-nitrobenzene
C7H5BrFNO2
1224629-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 F 2.3100 5.3349 0.0 0
M  V30 6 Br 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,3-dimethyl-2-nitrobenzenamine
C8H9BrN2O2
1639116-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 C 2.3101 6.6687 0.0 0
M  V30 7 Br 6.9302 4.0012 0.0 0
M  V30 8 C 3.0801 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1224629-03-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1639116-33-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31611358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM closed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-Benzo[d]imidazole derivatives as TLR9 inhibitors for the treatment of
fibrosis and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoon, David S.; Regueiro-Ren, Alicia; Mandler, Michael; Posy, Shoshana L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022040260 A1 2022-02-24

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-penten-2-one
C6H11NO
14092-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14092-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12351916
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Procatalyst for polymerization of olefins comprising a monoester and an
amidobenzoate internal donor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zuideveld, Martin Alexander; Batinas-Geurts, Aurora Alexandra; Meppelder,
Anika
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015185490 A1 2015-12-10

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-penten-2-one
C6H11NO
14092-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14092-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3009719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst composition for polymerization of olefins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taftaf, Mansour; Sainani, Jaiprakash Brijlal; Zakharov, Vladimir
Aleksandrovich; Bukatov, Gennadii Dimitrievich; Vimalkumar, Mahendrabhai
Patel; Sergeev, Sergei Andreevich; Zuideveld, Martin Alexander;
Batinas-Geurts, Aurora Alexandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014118164 A1 2014-08-07

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-penten-2-one
C6H11NO
14092-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14092-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6239187
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst compositions having internal electron donors for polymerization
of olefins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Taftaf, Mansour; Zuideveld, Martin Alexander; Batinas-Geurts, Aurora
Alexandra; Sainani, Jaiprakash Brijlal; Vimalkumar, Mahendrabhai Patel;
Zakharov, Vladimir Aleksandrovich; Bukatov, Gennadii Dimitrievich;
Sergeev, Sergei Andreevich; Ghalit, Nourdin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014001257 A1 2014-01-03

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Naphthoquinone
C10H6O2
130-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 O 6.1600 4.0011 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 1.5400 1.3338 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-1,4-naphthoquinone
C11H9NO2
14423-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 1.3336 4.6200 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 130-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14423-00-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-12636397
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, ultrasound, catalyst prepared
and used, no solvent, silica support used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antibacterial and antifungal activity of
2-amino-1,4-naphthoquinones using silica-supported perchloric acid
(HClO4-SiO2) as a mild, recyclable and highly efficient heterogeneous
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Upendra; Katoch, Deepali; Sood, Swati; Kumar, Neeraj; Singh,
Bikram; Thakur, Archana; Gulati, Arvind
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry, Section B: Organic Chemistry Including
Medicinal Chemistry (2013), 52B(11), 1431-1440

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-, 1,1-dimet...
C15H22N2O3
109522-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 N 5.3900 1.3336 0.0 0
M  V30 7 O 3.0800 2.6674 0.0 0
M  V30 8 O 9.2400 5.3347 0.0 0
M  V30 9 O 6.9300 6.6685 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 C 10.0100 6.6685 0.0 0
M  V30 12 C 8.6764 7.4385 0.0 0
M  V30 13 C 10.7800 8.0021 0.0 0
M  V30 14 C 11.3436 5.8985 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 109522-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7763687
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Chiral Zwitterionic Phosphorus Heterocycles: Synthesis, Structure,
Properties and Application as Chiral Solvating Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheshenev, Andrey E.; Boltukhina, Ekaterina V.; Grishina, Anastasiya A.;
Cisarova, Ivana; Lyapkalo, Ilya M.; Hii, King Kuok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(25), 8136-8143

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-, 1,1-dimet...
C15H22N2O3
109522-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 N 6.9300 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 N 5.3900 1.3336 0.0 0
M  V30 7 O 3.0800 2.6674 0.0 0
M  V30 8 O 9.2400 5.3347 0.0 0
M  V30 9 O 6.9300 6.6685 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 C 10.0100 6.6685 0.0 0
M  V30 12 C 8.6764 7.4385 0.0 0
M  V30 13 C 10.7800 8.0021 0.0 0
M  V30 14 C 11.3436 5.8985 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 109522-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8260993
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methylene-Bridged Bis(imidazoline)-Derived 2-Oxopyrimidinium Salts as
Catalysts for Asymmetric Michael Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheshenev, Andrey E.; Boltukhina, Ekaterina V.; White, Andrew J. P.; Hii,
King Kuok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2013), 52(27), 6988-6991

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acrylate
C5H8O2
140-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Ethoxy-3-oxopropyl)-N-methyl-β-alanine ethyl ester
C11H21NO4
6315-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 1.5400 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 C 8.0023 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 10.6698 1.5400 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 12.0035 2.3101 0.0 0
M  V30 9 O 2.6675 1.5400 0.0 0
M  V30 10 O 4.0012 3.8501 0.0 0
M  V30 11 O 13.3372 1.5400 0.0 0
M  V30 12 O 12.0035 3.8501 0.0 0
M  V30 13 C 1.3338 2.3101 0.0 0
M  V30 14 C 14.6708 2.3101 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 16 C 16.0046 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 140-88-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6315-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24541218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and sequencing of informational poly(amino phosphodiester)s
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roszak, Ian; Oswald, Laurence; Al Ouahabi, Abdelaziz; Bertin, Annabelle;
Laurent, Eline; Felix, Olivier; Carvin-Sergent, Isaure; Charles,
Laurence; Lutz, Jean-Francois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Chemistry (2021), 12(37), 5279-5282

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acrylate
C5H8O2
140-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Ethoxy-3-oxopropyl)-N-methyl-β-alanine ethyl ester
C11H21NO4
6315-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 1.5400 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 C 8.0023 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 10.6698 1.5400 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 12.0035 2.3101 0.0 0
M  V30 9 O 2.6675 1.5400 0.0 0
M  V30 10 O 4.0012 3.8501 0.0 0
M  V30 11 O 13.3372 1.5400 0.0 0
M  V30 12 O 12.0035 3.8501 0.0 0
M  V30 13 C 1.3338 2.3101 0.0 0
M  V30 14 C 14.6708 2.3101 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 16 C 16.0046 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 140-88-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6315-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9808156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antiproliferative activity of cyclic arylidene ketones: a
direct comparison of monobenzylidene and dibenzylidene derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huber, Imre; Zupko, Istvan; Kovacs, Ida J.; Minorics, Renata;
Gulyas-Fekete, Gergely; Maasz, Gabor; Perjesi, Pal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2015), 146(6), 973-981

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzoyl chloride
C8H7ClO2
100-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzamide
C9H11NO2
3400-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzoyl chloride
C8H7ClO2
100-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzamide
C9H11NO2
3400-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20585784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhenium-Catalyzed Phthalide Synthesis from Benzamides and Aldehydes via
C-H Bond Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Bing; Yang, Yunhui; Jin, Xiqing; Mao, Guoliang; Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(16), 6259-6263

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzoyl chloride
C8H7ClO2
100-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzamide
C9H11NO2
3400-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9835465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 4-methoxy-N-methylbenzamide 1d. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzoyl chloride
C7H4Cl2O
122-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzamide
C8H8ClNO
6873-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6873-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292365
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzoyl chloride
C7H4Cl2O
122-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzamide
C8H8ClNO
6873-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6873-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20585789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhenium-Catalyzed Phthalide Synthesis from Benzamides and Aldehydes via
C-H Bond Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Bing; Yang, Yunhui; Jin, Xiqing; Mao, Guoliang; Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(16), 6259-6263

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzoyl chloride
C7H4Cl2O
122-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzamide
C8H8ClNO
6873-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6873-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2841954
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 4-chloro-N-methylbenzamide 1h. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10953819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination therapy for resistant hypertension
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kowala, Mark Charles
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015130568 A1 2015-09-03

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2851386
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of tadalafil (Cialis) from L-tryptophan
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Sen; Shi, Xiao-Xin; Xing, Jing; Yan, Jing-Jing; Liu, Shi-Ling; Lu,
Wei-Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2009), 20(18), 2090-2096

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7556801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly stereoselective Pictet-Spengler reaction of D-tryptophan methyl
ester with piperonal: convenient syntheses of Cialis (Tadalafil),
12a-epi-Cialis, and their deuterated analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shi, Xiao-Xin; Liu, Shi-Ling; Xu, Wei; Xu, Yu-Lan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2008), 19(4), 435-442

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11585280
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4 The chloroacetyl carboline (86.0 kg, 201 mol) was added to THF
(430 L) , and the resulting mixture was heated to 30°C to 55°C under an
N2 atmosphere and stirred. The resulting solution then was filtered at a
temperature of 45°C to 50°C to remove undissolved particles. Methylamine
(78.2 kg, 1000 mol) then was added to the solution at a temperature of
5°C to 25°C. The resulting mixture was stirred at a temperature of 30°C
to 55°C for about 1 hour, or until HPLC analysis indicated a complete
reaction, i.e., less than 1% of the chloroacetyl carboline remained. The
mixture was cooled to 0°C to 30°C, isopropyl alcohol (344 L) and water
(175 L) then were added, followed by 12M hydrochloric acid (67 L) to
neutralize the excess methylamine, i.e., to pH 2 to 9.4. Upon essentially
complete removal of THF by distillation, the solution was treated with
isopropyl alcohol (260 L) and water (75 L) and cooled to -5°C to 30°C,
followed by stirring for two hours to crystallize the product. The
product was filtered and washed with cold (0°C to 5°C) 50% aqueous
isopropyl alcohol. The wash solvent was filtered at -5°C to 30°C, and the
product was dried under vacuum at 80°C or less (e.g., 70°C to 80°C) to
yield 75 kg (94.6%) of Compound (I) . For increased purity, Compound (I)
optionally can be recrystallized from acetic acid.
$DTYPE RXN:VAR(1):NOTES
$DATUM nitrogen atm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydro-β-carboline diastereomers by modified
Pictet-Spengler reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Orme, Mark W.; Martinelli, Michael John; Doecke, Christopher William;
Pawlak, Joseph Matthew; Chelius, Erik Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004011463 A1 2004-02-05

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αS,3aS,5Z,10aS)-α-[[4-[(2,6-dichlorophenyl)methoxy]phenyl]methyl]-1-[...
C32H38Cl2N2O6
1000049-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6223 3.6219 0.0 0
M  V30 2 O 4.6761 2.0829 0.0 0
M  V30 3 O 5.9282 4.4380 0.0 0
M  V30 4 C 6.0357 1.3598 0.0 0
M  V30 5 C 5.3127 0.0000 0.0 0
M  V30 6 C 7.3955 0.6368 0.0 0
M  V30 7 C 6.7588 2.7195 0.0 0
M  V30 8 O 5.5616 5.6500 0.0 0
M  V30 9 C 6.4486 8.0870 0.0 0 CFG=2
M  V30 10 C 7.2186 6.7534 0.0 0
M  V30 11 C 7.2186 9.4206 0.0 0
M  V30 12 O 6.4486 10.7543 0.0 0
M  V30 13 O 8.7586 9.4206 0.0 0
M  V30 14 C 7.2186 12.0881 0.0 0
M  V30 15 O 13.3786 6.7534 0.0 0
M  V30 16 C 14.1486 8.0870 0.0 0
M  V30 17 Cl 15.6886 10.7543 0.0 0
M  V30 18 Cl 15.6886 5.4196 0.0 0
M  V30 19 C 3.0481 5.8699 0.0 0 CFG=2
M  V30 20 N 3.2625 4.3448 0.0 0
M  V30 21 C 1.5315 6.1372 0.0 0 CFG=1
M  V30 22 C 4.3819 6.6399 0.0 0
M  V30 23 C 1.8783 3.6698 0.0 0
M  V30 24 C 0.8087 4.7775 0.0 0
M  V30 25 C 0.5416 7.3170 0.0 0
M  V30 26 N 4.9086 8.0870 0.0 0
M  V30 27 C 0.5416 8.8570 0.0 0
M  V30 28 C 4.3819 9.5341 0.0 0
M  V30 29 C 1.5315 10.0366 0.0 0
M  V30 30 C 3.0481 10.3041 0.0 0
M  V30 31 C 8.7586 6.7534 0.0 0
M  V30 32 C 9.5286 8.0870 0.0 0
M  V30 33 C 9.5286 5.4196 0.0 0
M  V30 34 C 11.0686 8.0870 0.0 0
M  V30 35 C 11.0686 5.4196 0.0 0
M  V30 36 C 11.8386 6.7534 0.0 0
M  V30 37 C 15.6886 8.0870 0.0 0
M  V30 38 C 16.4586 9.4206 0.0 0
M  V30 39 C 16.4586 6.7534 0.0 0
M  V30 40 C 17.9986 9.4206 0.0 0
M  V30 41 C 17.9986 6.7534 0.0 0
M  V30 42 C 18.7686 8.0870 0.0 0
M  V30 43 H 4.4323 5.1947 0.0 0
M  V30 44 H 0.0000 5.9763 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 22
M  V30 9 1 9 10 CFG=3
M  V30 10 1 9 11
M  V30 11 1 9 26
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 36
M  V30 18 1 16 37
M  V30 19 1 17 38
M  V30 20 1 18 39
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 19 43 CFG=3
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 21 25
M  V30 28 1 21 44 CFG=1
M  V30 29 1 22 26
M  V30 30 1 23 24
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 19 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3aS,5Z,10aS)-9-[(1S)-1-[[4-[(2,6-dichlorophenyl)methoxy]ph...
C32H39Cl2N3O5
1000049-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6223 3.6219 0.0 0
M  V30 2 O 4.6761 2.0829 0.0 0
M  V30 3 O 5.9282 4.4380 0.0 0
M  V30 4 C 6.0357 1.3598 0.0 0
M  V30 5 C 5.3127 0.0000 0.0 0
M  V30 6 C 7.3955 0.6368 0.0 0
M  V30 7 C 6.7588 2.7195 0.0 0
M  V30 8 O 5.5616 5.6500 0.0 0
M  V30 9 C 6.4486 8.0870 0.0 0 CFG=2
M  V30 10 C 7.2186 6.7534 0.0 0
M  V30 11 C 7.2186 9.4206 0.0 0
M  V30 12 N 6.4486 10.7543 0.0 0
M  V30 13 O 8.7586 9.4206 0.0 0
M  V30 14 C 7.2186 12.0881 0.0 0
M  V30 15 O 13.3786 6.7534 0.0 0
M  V30 16 C 14.1486 8.0870 0.0 0
M  V30 17 Cl 15.6886 10.7543 0.0 0
M  V30 18 Cl 15.6886 5.4196 0.0 0
M  V30 19 C 3.0481 5.8699 0.0 0 CFG=2
M  V30 20 N 3.2625 4.3448 0.0 0
M  V30 21 C 1.5315 6.1372 0.0 0 CFG=1
M  V30 22 C 4.3819 6.6399 0.0 0
M  V30 23 C 1.8783 3.6698 0.0 0
M  V30 24 C 0.8087 4.7775 0.0 0
M  V30 25 C 0.5416 7.3170 0.0 0
M  V30 26 N 4.9086 8.0870 0.0 0
M  V30 27 C 0.5416 8.8570 0.0 0
M  V30 28 C 4.3819 9.5341 0.0 0
M  V30 29 C 1.5315 10.0366 0.0 0
M  V30 30 C 3.0481 10.3041 0.0 0
M  V30 31 C 8.7586 6.7534 0.0 0
M  V30 32 C 9.5286 8.0870 0.0 0
M  V30 33 C 9.5286 5.4196 0.0 0
M  V30 34 C 11.0686 8.0870 0.0 0
M  V30 35 C 11.0686 5.4196 0.0 0
M  V30 36 C 11.8386 6.7534 0.0 0
M  V30 37 C 15.6886 8.0870 0.0 0
M  V30 38 C 16.4586 9.4206 0.0 0
M  V30 39 C 16.4586 6.7534 0.0 0
M  V30 40 C 17.9986 9.4206 0.0 0
M  V30 41 C 17.9986 6.7534 0.0 0
M  V30 42 C 18.7686 8.0870 0.0 0
M  V30 43 H 4.4323 5.1947 0.0 0
M  V30 44 H 0.0000 5.9763 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 22
M  V30 9 1 9 10 CFG=3
M  V30 10 1 9 11
M  V30 11 1 9 26
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 15 16
M  V30 17 1 15 36
M  V30 18 1 16 37
M  V30 19 1 17 38
M  V30 20 1 18 39
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 22
M  V30 24 1 19 43 CFG=3
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 21 25
M  V30 28 1 21 44 CFG=1
M  V30 29 1 22 26
M  V30 30 1 23 24
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 19 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000049-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000049-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10289323
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method 2: 16 (2.0 mg, 0.0032 mmol) was dissolved in methyl amine in EtOH
(0.5 ml, 8.03 M) After 36h of stirring at room temperature, the solvent
was evaporated and the residue was cleaned by flash chromatography
(gradient petrol ether - EtOAc, 4:1 -> 3:1 -> 2:1) to afford 18 (1.9 mg,
95%) as a colorless oil. A small portion of the crude material was
retained for HPLC investigations (see below). Epi18: IR (film) 3350,
1691, 1666, 1653 cm-1; EIMS: Anal. Calcd for C32H39 35Cl2N3O5: 615,
Found: 615. 18: IR (film) 3352, 1691, 1666, 1653 cm-1 EIMS: Anal. Calcd
for C32H39 35Cl2N3O5: 615, Found: 615. 1H NMR and EI-mass spectra of
epi18 (by method 1) and 18 (by method 1 and method 2):
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective (epimers not formed)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular Building Kit of Fused-Proline-Derived Peptide Mimetics Allowing
Specific Adjustment of the Dihedral Ψ Angle
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Einsiedel, Juergen; Lanig, Harald; Waibel, Reiner; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(24), 9102-9113

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzyl bromide
C7H6BrNO2
100-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 Br 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenemethanamine
C8H10N2O2
19499-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-11-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19499-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18818782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Characteristics of new bioreductive fluorescent probes based on the
xanthene fluorophore: Detection of nitroreductase and imaging of hypoxic
cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM More, Kunal N.; Lim, Tae-Hwan; Kim, So-Young; Kang, Julie; Inn,
Kyung-Soo; Chang, Dong-Jo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dyes and Pigments (2018), 151245-253

$RFMT $RIREG SCHEME244 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pentanone
C5H10O
107-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethyl-1-methyl-2,6-diphenyl-4-piperidinone
C20H23NO
64292-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 C 5.3348 6.1601 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 5.3348 4.6201 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 6.6684 3.8500 0.0 0
M  V30 10 C 6.6684 2.3100 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 3.8500 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 8.0022 6.1601 0.0 0
M  V30 19 C 9.3359 3.8500 0.0 0
M  V30 20 C 9.3359 6.9301 0.0 0
M  V30 21 C 10.6695 4.6201 0.0 0
M  V30 22 C 10.6695 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 2 4 8
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 9 17
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 107-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64292-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-22381347
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antitumor activities of some novel
thiazinones and thiosemicarbazones derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anand, Selvam Athavan Alias; George, Kiran; Thomas, Nisha Susan; Kabilan,
Senthamaraikannan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2020), 195(10),
821-829

$RFMT $RIREG SCHEME245 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl ethyl ketone
C4H8O
78-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dimethyl-2,6-diphenyl-4-piperidone
C19H21NO
5554-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 4.0012 3.8501 0.0 0
M  V30 5 N 5.3348 4.6201 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 6.6685 3.8501 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 0.0000 6.1601 0.0 0
M  V30 16 C 8.0023 4.6201 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 C 8.0023 6.1601 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 9.3360 6.9302 0.0 0
M  V30 21 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 78-93-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5554-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-22381346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and antitumor activities of some novel
thiazinones and thiosemicarbazones derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anand, Selvam Athavan Alias; George, Kiran; Thomas, Nisha Susan; Kabilan,
Senthamaraikannan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2020), 195(10),
821-829

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Vinylpyridine
C7H7N
100-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Betahistine
C8H12N2
5638-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 N 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5638-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-9307213
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1309-38-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM supported on diatomite
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 914770-47-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, ionic liquid used,
ionic liquid incorporated polytungstate anion immobilized on magnetic
diatomaceous earth nanocatalyst prepared and used, Aza-Michael-type
addition, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aza-Michael-type addition reaction catalysed by a supported ionic liquid
phase incorporating an anionic heteropoly acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghasemi, Mohammad Hadi; Kowsari, Elaheh; Shafiee, Abbas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(10), 1150-1153

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-8-methyl-4H-3,1-...
C17H9Br2ClN4O2
1007099-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.8369 0.0 0
M  V30 2 Br 2.0424 0.0000 0.0 0
M  V30 3 O 7.0036 7.8788 0.0 0
M  V30 4 C 9.6711 1.7187 0.0 0
M  V30 5 Br 12.3384 6.3388 0.0 0
M  V30 6 N 2.9293 3.8850 0.0 0
M  V30 7 C 4.3363 3.2587 0.0 0
M  V30 8 N 1.8989 2.7406 0.0 0
M  V30 9 C 4.1752 1.7271 0.0 0
M  V30 10 C 2.6689 1.4070 0.0 0
M  V30 11 C 2.6091 5.3915 0.0 0
M  V30 12 C 1.1444 5.8674 0.0 0
M  V30 13 N 3.7535 6.4219 0.0 0
M  V30 14 C 0.8242 7.3737 0.0 0
M  V30 15 C 3.4334 7.9284 0.0 0
M  V30 16 C 1.9688 8.4043 0.0 0
M  V30 17 C 5.6699 4.0287 0.0 0
M  V30 18 N 7.0036 3.2587 0.0 0
M  V30 19 O 5.6699 5.5688 0.0 0
M  V30 20 C 8.3373 4.0287 0.0 0
M  V30 21 C 7.0036 6.3388 0.0 0
M  V30 22 C 8.3373 5.5688 0.0 0
M  V30 23 C 9.6711 3.2587 0.0 0
M  V30 24 C 9.6711 6.3388 0.0 0
M  V30 25 C 11.0048 4.0287 0.0 0
M  V30 26 C 11.0048 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 10
M  V30 3 2 3 21
M  V30 4 1 4 23
M  V30 5 1 5 26
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 21 22
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bromoantraniliprole
C18H14Br2ClN5O2
500008-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8690 5.3027 0.0 0
M  V30 2 N 7.4090 5.3027 0.0 0
M  V30 3 O 5.0990 6.6364 0.0 0
M  V30 4 Cl 0.5546 3.1677 0.0 0
M  V30 5 Br 4.7419 0.0000 0.0 0
M  V30 6 C 10.4891 5.3027 0.0 0
M  V30 7 N 12.0291 5.3027 0.0 0
M  V30 8 O 9.7190 3.9689 0.0 0
M  V30 9 C 12.7991 3.9689 0.0 0
M  V30 10 C 5.8690 7.9701 0.0 0
M  V30 11 Br 10.4891 10.6375 0.0 0
M  V30 12 N 3.5673 3.8080 0.0 0
M  V30 13 C 5.0990 3.9689 0.0 0
M  V30 14 N 3.2471 2.3017 0.0 0
M  V30 15 C 5.7253 2.5621 0.0 0
M  V30 16 C 4.5809 1.5317 0.0 0
M  V30 17 C 2.5369 4.9525 0.0 0
M  V30 18 C 1.0306 4.6322 0.0 0
M  V30 19 N 3.0127 6.4171 0.0 0
M  V30 20 C 0.0000 5.7768 0.0 0
M  V30 21 C 1.9823 7.5616 0.0 0
M  V30 22 C 0.4760 7.2413 0.0 0
M  V30 23 C 8.1790 6.6364 0.0 0
M  V30 24 C 9.7190 6.6364 0.0 0
M  V30 25 C 7.4090 7.9701 0.0 0
M  V30 26 C 10.4891 7.9701 0.0 0
M  V30 27 C 8.1790 9.3037 0.0 0
M  V30 28 C 9.7190 9.3037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 23
M  V30 5 1 4 18
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 1 10 25
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1007099-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500008-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4963212
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rynaxypyr: A new insecticidal anthranilic diamide that acts as a potent
and selective ryanodine receptor activator
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lahm, George P.; Stevenson, Thomas M.; Selby, Thomas P.; Freudenberger,
John H.; Cordova, Daniel; Flexner, Lindsey; Bellin, Cheryl A.; Dubas,
Christine M.; Smith, Ben K.; Hughes, Kenneth A.; Hollingshaus, J. Gary;
Clark, Christopher E.; Benner, Eric A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(22), 6274-6279

$RFMT $RIREG SCHEME248 STEP1
$RXN



  5  1
$MOL
3-Hydroxybenzaldehyde
C7H6O2
100-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-1-propanol
C3H7BrO
627-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 C 4.0010 0.0000 0.0 0
M  V30 4 Br 0.0000 0.7700 0.0 0
M  V30 5 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-[4-(difluoromethoxy)phenyl]ethanone
C9H7BrF2O2
141134-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4702 2.6673 0.0 0
M  V30 2 C 9.2402 1.3337 0.0 0
M  V30 3 F 8.4702 0.0000 0.0 0
M  V30 4 F 10.7802 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 1.5400 4.0010 0.0 0
M  V30 7 O 1.5400 1.3337 0.0 0
M  V30 8 Br 0.0000 4.0010 0.0 0
M  V30 9 C 6.9302 2.6673 0.0 0
M  V30 10 C 6.1601 4.0010 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 C 4.6201 4.0010 0.0 0
M  V30 13 C 4.6201 1.3337 0.0 0
M  V30 14 C 3.8501 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Morpholine
C4H9NO
110-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(Difluoromethoxy)phenyl]-1,2,3,4-tetrahydro-2-methyl-7-[3-(4-morpholinyl...
C24H30F2N2O3
892408-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 0.0000 0.0 0
M  V30 2 O 13.3372 6.9302 0.0 0
M  V30 3 C 14.6708 6.1601 0.0 0
M  V30 4 C 16.0045 6.9302 0.0 0
M  V30 5 C 17.3382 6.1601 0.0 0
M  V30 6 O 2.6673 6.9302 0.0 0
M  V30 7 C 1.3337 6.1601 0.0 0
M  V30 8 F 0.0000 6.9302 0.0 0
M  V30 9 F 1.3337 4.6201 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 10.6697 3.8501 0.0 0
M  V30 14 C 9.3360 6.1601 0.0 0
M  V30 15 N 9.3360 1.5400 0.0 0
M  V30 16 C 12.0033 4.6201 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 10.6697 6.9302 0.0 0
M  V30 19 C 12.0033 6.1601 0.0 0
M  V30 20 C 6.6685 4.6201 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 6.6685 6.1601 0.0 0
M  V30 23 C 4.0012 4.6201 0.0 0
M  V30 24 C 5.3348 6.9302 0.0 0
M  V30 25 C 4.0012 6.1601 0.0 0
M  V30 26 N 18.6720 6.9302 0.0 0
M  V30 27 C 20.0057 6.1601 0.0 0
M  V30 28 C 18.6720 8.4702 0.0 0
M  V30 29 C 21.3393 6.9302 0.0 0
M  V30 30 C 20.0057 9.2402 0.0 0
M  V30 31 O 21.3393 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 26
M  V30 7 1 6 7
M  V30 8 1 6 25
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 20
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 13 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 17
M  V30 21 1 16 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-83-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 627-18-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 141134-24-9
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 110-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 892408-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-008-CAS-13457845
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 10
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 75-75-2
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(7):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(8):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(9):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):RGT(10):CAS_RN
$DATUM 403-29-2
$DTYPE RXN:VAR(1):RGT(11):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(12):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-60-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1;3-(3-Hydroxy-propoxy)-benzaldehyde. To
a mixture of 3-hydroxybenzaldehyde (40.0 g, 328 mmol) and K2CO3 (68.0 g,
491 mmol) in acetonitrile (650 mL) was added 3-bromo-propan-1-ol (54.6 g,
393 mmol) and the mixture was heated at reflux for 2 d. The mixture was
allowed to cool to room temperature (rt), a white solid was removed by
filtration, and the filtrate was concentrated. The crude material was
purified by FCC to give 3-(3-Hydroxy-propoxy)-benzaldehyde, as a clear
oil. Step 2; 3-(3-Methylaminomethyl-phenoxy)-propan-1 -ol. To a solution
of 3-(3-hydroxy-propoxy benzaldehyde (30.0 g, 167 mmol) and aqueous MeNH2
(40% wt, 27.2 mL, 350 mmol) in MeOH (330 mL) at 0°C was added NaBH4 (12.0
g, ,316 mmol) portion-wise. The reaction mixture was stirred at 0°C for
30 min. The ice-water bath was. then removed and the reaction was stirred
at rt overnight; The mixture was concentrated and the residue was stirred
in 1 N NaOH (300 mL) for 2 h. The product wag extracted with DCM and the
combined organic layers were washed with brine, dried over Na2 SO4 and
concentrated to give the product, as a clear oil. Step 3;
2-{[3-(3-Hydroxy-propoxy)-benzyl]methyl-amino-1-(4-methoxy-phenyl)-ethanone.
To a solution of 3-(3-methylaminomethyl-phenoxy)-propan-1-ol(43.5 g, 166
mmol) and DlPEA (32.5 g, 250 mmol) in THF (415 mL) was added
2-bromo-4-methoxy-acetophenone (40.0 g, 175 mmol). The mixture was
stirred for 45 min at rt and then most of the THF was removed in vacuo.
The mixture was diluted with water (200 mL) and extracted with DCM. The
combined organic layers were washed with brine, dried over Na2SO4, and
concentrated to give a light yellow oil. Step 4:
7-(3-Hydroxy-propoxy)-4-(4-methoxy-phenyl)-2-methyl-isoquinolinium salt.
2-{[3-(3-Hydroxy-propoxy)-benzyl]-methyl-amino}-1-(4-methoxy-phenyl)-ethanone
(62 g, 181 mmol) was stirred in methanesulfonic acid (MSA, 60 mL) at 60°C
overnight. The mixture was poured into cold 1 NNaOH (500 mL), made basic
with 6 N NaOH, and extracted with DCM (3x). The combined organic layers
were washed with brine, dried over Na2CO3, and concentrated to give the
desired product. To a solution of
7-(3-hydroxy-propoxy)-4-(4-methoxy-pheny1)-2-5 methyl-isoquinolinium
salt(2.5 g, 7.7 mmol) in MeOH (1 00 mL) was added NaCNBH3 (1.5 g,23.1
mmol) in. one portion. Bromocresol green (3 mg, 0.004 mmol)was added
followed by 1.25 M methanolic HCI until a color change from ,
orange-brown or green to yellow was obtained,. The mixture was stirred an
additional 30 min with periodic additidn of methanolic HCI to maintain a
yellow color. The mixture was concentrated and the residue was diluted
with water, made basic with 1 N NaOH, and extractdd with DCM (3x). The
combined organic layers were washed with brine, dried over Na2CO3, and
concentrated. The crude product was purified by FCC to give the desired
product as an orange semi-solid. Step 6; Methanesulfonic acid
3-[4-(4-methoxy-phenyl)-2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-yloxyl-propyl
ester. Methanesulfonyl chloride (0.20 g, 1.75 mmol) was added dropwise to
a solution of 3-[4-(4- ethoxy-phenyl)-2-
methyl-1,2,3,4-tetrahydro-isoquinolin-7-yloxy]-propan-1-ol (0.52 g, 1.59
mmol) and TEA (0.24 g, 2.38 mmol) in DCM (8 mL) at 0°C.The mixture was
brought to rt and stirred for.20 min. The mixture was then diluted with
DCM (30 mL), washed with a satd. aq. NaHCO3 (15 mL), water (15 mL), and
brine (1 5 mL), dried over MgSO4, and concentrated to give the crude
product. Step 7. A mixture of 4-fluoropiperidine hydrochloride (128 mg,
0.92 mmol) and sodiumt-butoxide (60 mg,0.62 mmol) in n-BuOH (1 mL) was
added to a mixture of methanesulfonic acid 3-[4-(4-methoxy-phenyl)-
2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yloxy]-propyl ester (250 mg,
0.62 mmbl), Na2CO3 (98 mg, 0.92 mmol), and KI (5 mg, 0.031 mmol) in
n-BuOH (1.2 mL) and the mixture was heated overnight at 50-80 °C. The
mixture was cooled to rt, filtered, and the filtrate was concentrated.
The crude product waspurified by FCC and then reverse phase
chromatography to give the desired product, as a TFA salt. Example 172;
2,8-Dimethyl-4-(4-methylsulfanyl-phenyl)-7-(3-morpholin-4-yl-propoxy)-1,2,3,4-tetrahydro-isoquinoline.
The title compound was prepared using methods similar to those described
in Example 1. Yield: 27.6 mg, 17% over 3 steps Example 214;
4-(4-Difluoromethoxy-phenyl)-2-methyl-7-(3-morpholin-4-yl-propoxy)-1,2,3,4-tetrahydro-isoquinoline,
yield 1.63 g, 95%. MS (ESI): mass calcd for C20H30F2N2O2, 432.22; m/z
found, 433.4 [M+H]+.1H NMR (acetone-d6): 7.28 (d, J = 8.6, 2H), 7.09 (d,
J = 8.6, 2H), 6.75 (d, J = 8.3, 1 H), 6.70-6.66 (m, 2H), 4.17 (t, J =
5.8, 1 H), 4.03 (t, J = 6.4, 2H), 3.66-3.57 (m, 4H), 3.55-3.51 (m, 2H),
2.88-2.82 (m, 1 H), 2.75-2.72 (m, 2H), 2.61 - 2.56 (m, 1 H),2.48 (t, J =
7.0, 2H), 2.42-2.36 (m, 3H), 2.34 (s, 3H), 1.95-1.89 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinolines as histamine H3 receptor and
serotonin transporter modulators for treatment of central nervous system
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carruthers, Nicholas I.; Gomez, Leslie A.; Jablonowski, Jill A.; Keith,
John M.; Letavic, Michael A.; Ly, Kiev S.; Miller, Jennifer M. B.;
Stocking, Emily M.; Wolin, Ronald L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006066197 A1 2006-06-22

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazole-2-carboxaldehyde
C4H4N2O
10111-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 N 2.2765 0.3202 0.0 0
M  V30 5 N 1.0306 2.4782 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-imidazole-2-methanamine
C5H9N3
473927-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 N 2.2765 0.3202 0.0 0
M  V30 6 N 1.0306 2.4782 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10111-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 473927-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11950517
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, exothermic (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazolylphenylpyrazolopyridinones as factor Xa
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quan, Mimi L.; Wexler, Ruth R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003047520 A2 2003-06-12

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
N-[5-[1,4-Dihydro-1-methyl-7-(methylthio)-2-oxopyrimido[4,5-d]pyrimidin-3(2H)...
C23H26FN7O3S
1011464-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 1.5400 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 N 13.3370 3.8501 0.0 0
M  V30 5 C 14.6708 4.6201 0.0 0
M  V30 6 N 16.0045 3.8501 0.0 0
M  V30 7 O 14.6708 6.1601 0.0 0
M  V30 8 F 13.3370 6.9302 0.0 0
M  V30 9 S 1.3337 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 21.3071 4.9772 0.0 0
M  V30 12 C 21.1462 3.4457 0.0 0
M  V30 13 C 22.8387 4.8163 0.0 0
M  V30 14 C 21.4681 6.5088 0.0 0
M  V30 15 N 8.0022 3.8501 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 N 6.6685 1.5400 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 N 4.0012 1.5400 0.0 0
M  V30 23 N 2.6673 3.8501 0.0 0
M  V30 24 C 2.6673 2.3101 0.0 0
M  V30 25 C 9.3360 4.6201 0.0 0
M  V30 26 C 10.6697 3.8501 0.0 0
M  V30 27 C 9.3360 6.1601 0.0 0
M  V30 28 C 12.0033 4.6201 0.0 0
M  V30 29 C 10.6697 6.9302 0.0 0
M  V30 30 C 12.0033 6.1601 0.0 0
M  V30 31 C 17.3382 4.6201 0.0 0
M  V30 32 C 18.7451 3.9938 0.0 0
M  V30 33 O 17.4991 6.1517 0.0 0
M  V30 34 C 19.7756 5.1382 0.0 0
M  V30 35 N 19.0056 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 27
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 31
M  V30 9 1 8 30
M  V30 10 1 9 10
M  V30 11 1 9 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[1,4-Dihydro-1-methyl-7-(methylamino)-2-oxopyrimido[4,5-d]pyrimidin-3(2H...
C23H27FN8O3
1011462-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 1.5400 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 N 13.3370 3.8501 0.0 0
M  V30 5 C 14.6708 4.6201 0.0 0
M  V30 6 N 16.0045 3.8501 0.0 0
M  V30 7 O 14.6708 6.1601 0.0 0
M  V30 8 F 13.3370 6.9302 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 21.3071 4.9772 0.0 0
M  V30 12 C 21.1462 3.4457 0.0 0
M  V30 13 C 22.8387 4.8163 0.0 0
M  V30 14 C 21.4681 6.5088 0.0 0
M  V30 15 N 8.0022 3.8501 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 N 6.6685 1.5400 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 N 4.0012 1.5400 0.0 0
M  V30 23 N 2.6673 3.8501 0.0 0
M  V30 24 C 2.6673 2.3101 0.0 0
M  V30 25 C 9.3360 4.6201 0.0 0
M  V30 26 C 10.6697 3.8501 0.0 0
M  V30 27 C 9.3360 6.1601 0.0 0
M  V30 28 C 12.0033 4.6201 0.0 0
M  V30 29 C 10.6697 6.9302 0.0 0
M  V30 30 C 12.0033 6.1601 0.0 0
M  V30 31 C 17.3382 4.6201 0.0 0
M  V30 32 C 18.7451 3.9938 0.0 0
M  V30 33 O 17.4991 6.1517 0.0 0
M  V30 34 C 19.7756 5.1382 0.0 0
M  V30 35 N 19.0056 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 27
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 31
M  V30 9 1 8 30
M  V30 10 1 9 10
M  V30 11 1 9 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1011464-62-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1011462-25-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-262633
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 937-14-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7631-90-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: To a solution of
Example A1 (400 mg, 1.3 mmol) in CH2Cl2 (5 mL) was added
3-chloroperoxybenzoic acid (mCPBA) (430 mg, 2.5 mmol) in one portion.
After stirring for 2h, the reaction mixture was quenched with aq NaHCO3
and aq NaHSO3. The organic layer was separated and was washed with brine,
dried (Na2SO4) and concentrated in vacuo. The crude product was dissolved
in DMSO (2 mL) and was treated with a solution of ammonia in dioxane (2
M, 30 ml, 60 mmol). The mixture stirred overnight at RT. The reaction was
concentrated under reduced pressure and the residue was purified by
silica gel chromatography to provide
7-amino-3-(3-amina-4-fluorophenyl)-1-methyl-3,4-dihydropyrimida[4,5-d]pyrimidin-2(1H)-one
(276 mg, 77% yield) as a yellow solid.Using a procedure analogous to
Example A2,
1-(3-tert-butylisoxazol-5-yl)-3-(5-(1-ethyl-7-(methylthio)-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)-2-fluorophenyl)urea.
(0.080 g, 0.16 mmol) was treated with mCPBA (70% wt, 0.10 g, 0.41 mmol)
and then N-methylamine (2.0M in THF, 0.68 mL, 1.4 mmol) to afford
3-(3-amino-4-fluorophenyl)-1-ethyl-7-(methylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one
(0.14 g, 85% yield). Using a procedure analogous to Example A2,
1-(3-tert-butylisoxazol-5-yl)-3-(2-fluoro-4-methyl-5-(1-methyl-7-(methylthio)-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)phenyl)urea
(0.58g, 1.2 mmol) and methylamine (1ml, 3 mmol, 3.0M in THF) were
combined to provide
1-(3-tert-butylisoxazol-5-yl)-3-(2-fluoro-4-methyl-5-(1-methyl-7-(methylamino)-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)phenyl)urea
(0.995 g, 95% yield). 1H NMR (400 MHz, DMSO-d6): δ 10.31(brs, 1H), 8.73
(s, 1H), 8.00 (d,J= 9Hz, 1H), 7.94 (brs, 1H), 7.23 (d,J= 12Hz, 1H), 7.02
(m, 1H), 6.04(s, 1H), 4.55 (d,J= 14Hz, 1H), 4.35 (d,J= 14Hz, 1H), 3.24
(brs, 3H), 2.79 (d,J= 5 Hz, 3H), 2.08 (s, 3H), 1.22 (s, 9H); MS(ESI) m/z
: 483.3(M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic ureas as kinase inhibitors useful for the
treatment of proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Petillo, Peter A.; Kaufman, Michael D.; Patt, William
C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033999 A2 2008-03-20

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
5-Bromo-1,2-dihydro-2-oxo-1-(phenylmethyl)-3-pyridinecarboxylic acid
C13H10BrNO3
101384-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 6.6684 6.1600 0.0 0
M  V30 3 C 9.3358 4.6200 0.0 0
M  V30 4 O 9.3358 6.1600 0.0 0
M  V30 5 O 10.6694 3.8500 0.0 0
M  V30 6 Br 6.6684 0.0000 0.0 0
M  V30 7 N 5.3347 3.8500 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 1.3336 1.5400 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 8
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 6 11
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1,2-dihydro-N-methyl-2-oxo-1-(phenylmethyl)-3-pyridinecarboxamide
C14H13BrN2O2
2088414-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 O 6.6685 6.1601 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 N 10.6697 3.8501 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 Br 6.6685 0.0000 0.0 0
M  V30 8 N 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 2 2 9
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 7 12
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 101384-63-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2088414-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22838585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET)
Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain
(BD2) Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seal, Jonathan T.; Atkinson, Stephen J.; Aylott, Helen; Bamborough, Paul;
Chung, Chun-wa; Copley, Royston C. B.; Gordon, Laurie; Grandi, Paola;
Gray, James R. J.; Harrison, Lee A.; Hayhow, Thomas G.; Lindon, Matthew;
Messenger, Cassie; Michon, Anne-Marie; Mitchell, Darren; Preston, Alex;
Prinjha, Rab K.; Rioja, Inmaculada; Taylor, Simon; Wall, Ian D.; Watson,
Robert J.; Woolven, James M.; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(17), 9093-9126

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
5-Bromo-1,2-dihydro-2-oxo-1-(phenylmethyl)-3-pyridinecarboxylic acid
C13H10BrNO3
101384-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 6.6684 6.1600 0.0 0
M  V30 3 C 9.3358 4.6200 0.0 0
M  V30 4 O 9.3358 6.1600 0.0 0
M  V30 5 O 10.6694 3.8500 0.0 0
M  V30 6 Br 6.6684 0.0000 0.0 0
M  V30 7 N 5.3347 3.8500 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 1.3336 1.5400 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 8
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 6 11
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1,2-dihydro-N-methyl-2-oxo-1-(phenylmethyl)-3-pyridinecarboxamide
C14H13BrN2O2
2088414-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 O 6.6685 6.1601 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 N 10.6697 3.8501 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 Br 6.6685 0.0000 0.0 0
M  V30 8 N 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 2 2 9
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 7 12
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 101384-63-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2088414-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17408645
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Oxo-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain
inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Demont, Emmanuel Hubert; Harrison, Lee Andrew;
Hayhow, Thomas George Christopher; Lindon, Matthew J.; Preston, Alexander
G.; Seal, Jonathan Thomas; Wall, Ian David; Watson, Robert J.; Woolven,
James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017060180 A1 2017-04-13

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
5-Bromo-1,2-dihydro-2-oxo-1-(phenylmethyl)-3-pyridinecarboxylic acid
C13H10BrNO3
101384-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 6.6684 6.1600 0.0 0
M  V30 3 C 9.3358 4.6200 0.0 0
M  V30 4 O 9.3358 6.1600 0.0 0
M  V30 5 O 10.6694 3.8500 0.0 0
M  V30 6 Br 6.6684 0.0000 0.0 0
M  V30 7 N 5.3347 3.8500 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 1.3336 1.5400 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 8
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 6 11
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1,2-dihydro-N-methyl-2-oxo-1-(phenylmethyl)-3-pyridinecarboxamide
C14H13BrN2O2
2088414-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 O 6.6685 6.1601 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 N 10.6697 3.8501 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 Br 6.6685 0.0000 0.0 0
M  V30 8 N 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 2 2 9
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 7 12
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 101384-63-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2088414-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17455059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinone-dicarboxamide for use as bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Demont, Emmanuel Hubert; Harrison, Lee Andrew;
Hayhow, Thomas George Christopher; House, David; Lindon, Matthew J.;
Preston, Alexander G.; Seal, Jonathan Thomas; Wall, Ian David; Watson,
Robert J.; Woolven, James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017050714 A1 2017-03-30

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
5-Bromo-1,2-dihydro-2-oxo-1-(phenylmethyl)-3-pyridinecarboxylic acid
C13H10BrNO3
101384-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 6.6684 6.1600 0.0 0
M  V30 3 C 9.3358 4.6200 0.0 0
M  V30 4 O 9.3358 6.1600 0.0 0
M  V30 5 O 10.6694 3.8500 0.0 0
M  V30 6 Br 6.6684 0.0000 0.0 0
M  V30 7 N 5.3347 3.8500 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 1.3336 1.5400 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 8
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 6 11
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1,2-dihydro-N-methyl-2-oxo-1-(phenylmethyl)-3-pyridinecarboxamide
C14H13BrN2O2
2088414-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 O 6.6685 6.1601 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 N 10.6697 3.8501 0.0 0
M  V30 5 O 9.3360 6.1601 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 Br 6.6685 0.0000 0.0 0
M  V30 8 N 5.3348 3.8501 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 8.0022 3.8501 0.0 0
M  V30 12 C 6.6685 1.5400 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 2 2 9
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 7 12
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 101384-63-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2088414-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17538128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinone dicarboxamide derivatives for use as
bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Aylott, Helen Elizabeth; Cooper, Anthony William
James; Demont, Emmanuel Hubert; Harrison, Lee Andrew; Hayhow, Thomas
George Christopher; Lindon, Matthew J.; Preston, Alexander G.; Seal,
Jonathan Thomas; Wall, Ian David; Watson, Robert J.; Woolven, James
Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017037116 A1 2017-03-09

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-thiophenecarboxylic acid
C10H13NO4S
101537-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.7221 3.4208 0.0 0
M  V30 2 O 8.2461 4.8855 0.0 0
M  V30 3 O 10.2284 3.1006 0.0 0
M  V30 4 N 5.3900 3.7710 0.0 0
M  V30 5 C 3.8500 3.7710 0.0 0
M  V30 6 O 3.0800 5.1048 0.0 0
M  V30 7 O 3.0800 2.4374 0.0 0
M  V30 8 C 1.5400 5.1048 0.0 0
M  V30 9 C 1.5400 6.6448 0.0 0
M  V30 10 C 0.0000 5.1048 0.0 0
M  V30 11 C 1.5400 3.5648 0.0 0
M  V30 12 C 7.6915 2.2764 0.0 0
M  V30 13 C 6.1600 2.4374 0.0 0
M  V30 14 S 8.0117 0.7700 0.0 0
M  V30 15 C 5.5337 1.0306 0.0 0
M  V30 16 C 6.6781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[(methylamino)carbonyl]-3-thienyl]carbamate
C11H16N2O3S
2288709-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.7221 3.4208 0.0 0
M  V30 2 N 10.2284 3.1006 0.0 0
M  V30 3 O 8.2462 4.8855 0.0 0
M  V30 4 C 11.2589 4.2452 0.0 0
M  V30 5 N 5.3900 3.7710 0.0 0
M  V30 6 C 3.8500 3.7710 0.0 0
M  V30 7 O 3.0800 5.1048 0.0 0
M  V30 8 O 3.0800 2.4374 0.0 0
M  V30 9 C 1.5400 5.1048 0.0 0
M  V30 10 C 1.5400 3.5648 0.0 0
M  V30 11 C 0.0000 5.1048 0.0 0
M  V30 12 C 1.5400 6.6448 0.0 0
M  V30 13 C 7.6917 2.2764 0.0 0
M  V30 14 C 6.1600 2.4374 0.0 0
M  V30 15 S 8.0118 0.7700 0.0 0
M  V30 16 C 5.5337 1.0306 0.0 0
M  V30 17 C 6.6781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101537-64-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2288709-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34686495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, DFT calculation and biological activity of
3-((4-chloro-6-((4-morpholinophenyl)amino)-1,3,5-triazin-2-yl)amino)-N-methylthiophene-2-carboxamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rao, Nian; Ding, Yuyu; Yang, Lan; Zhou, Yue; Le, Yi; Yan, Longjia; Liu,
Li
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Crystals and Liquid Crystals (2023), 757(1), 95-106

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5,7-Trichloro-8-quinolinol
C9H4Cl3NO
101870-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 6.1600 0.0 0
M  V30 2 Cl 2.6674 0.0000 0.0 0
M  V30 3 Cl 0.0000 4.6200 0.0 0
M  V30 4 Cl 8.0021 4.6200 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 5.3347 4.6200 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 5.3347 1.5400 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 14 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,7-Dichloro-2-(methylamino)-8-quinolinol
C10H8Cl2N2O
648896-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 6.1601 0.0 0
M  V30 2 Cl 2.6675 0.0000 0.0 0
M  V30 3 Cl 0.0000 4.6201 0.0 0
M  V30 4 N 8.0022 4.6201 0.0 0
M  V30 5 C 9.3359 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101870-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 648896-67-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14728055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5,7-Dichloro-2-methylamino-8-hydroxyquinoline (PBT 1047) [0336]
2,5,7-Trichloro-8-hydroxyquinoline 10 (200 mg, 0.805 mmol) and a solution
of methylamine in ethanol (12 mL of a 33% solution) were heated in a
sealed vessel at 90° C. for 26 h, and cooled. The precipitate was then
isolated via filtration and washed with diethyl ether. This provided pure
5,7-dichloro-2-methylamino-8-hydroxyquinoline (PBT 1047) as a pale yellow
solid (186 mg, 95%). 1H NMR (DMSO-d6, 400 MHz): δ 8.80 (br, 1H), 7.98 (d,
J=9.1, 1H), 7.48 (br, 1H), 7.25 (s, 1H), 6.90 (d, J=9.1, 1H), 2.98 (d,
J=4.8, 3H); mass spectrum: m/z 243, 245 (M++1, 100 and 66%,
respectively).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 8-hydroxyquinolines for treatment of neurological
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barnham, Kevin Jeffrey; Gautier, Elisabeth Colette Louise; Kok, Gaik
Beng; Krippner, Guy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080161353 A1 2008-07-03

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5,7-Trichloro-8-quinolinol
C9H4Cl3NO
101870-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 6.1600 0.0 0
M  V30 2 Cl 2.6674 0.0000 0.0 0
M  V30 3 Cl 0.0000 4.6200 0.0 0
M  V30 4 Cl 8.0021 4.6200 0.0 0
M  V30 5 C 4.0011 3.8500 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 5.3347 4.6200 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 5.3347 1.5400 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 14 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,7-Dichloro-2-(methylamino)-8-quinolinol
C10H8Cl2N2O
648896-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 6.1601 0.0 0
M  V30 2 Cl 2.6675 0.0000 0.0 0
M  V30 3 Cl 0.0000 4.6201 0.0 0
M  V30 4 N 8.0022 4.6201 0.0 0
M  V30 5 C 9.3359 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 13 C 6.6684 3.8500 0.0 0
M  V30 14 C 1.3337 2.3100 0.0 0
M  V30 15 C 6.6684 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101870-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 648896-67-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12120376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 8-hydroxyquinolines for treatment of neurological
conditions.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barnham, Kevin Jeffrey; Gautier, Elisabeth Colette Louise; Kok, Gaik
Beng; Krippner, Guy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004007461 A1 2004-01-22

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-Indolium, 2-[2-[2-chloro-3-[2-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylid...
C32H36ClN2.ClO4
102185-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.4337 10.2621 0.0 0
M  V30 2 C 18.0700 6.1683 0.0 0
M  V30 3 C 16.0539 5.7399 0.0 0
M  V30 4 C 14.0835 6.9301 0.0 0
M  V30 5 C 12.7496 7.7001 0.0 0
M  V30 6 Cl 10.0823 9.2401 0.0 0
M  V30 7 C 7.4148 7.7001 0.0 0
M  V30 8 C 6.0811 6.9301 0.0 0
M  V30 9 C 4.1107 5.7399 0.0 0
M  V30 10 C 2.0946 6.1683 0.0 0
M  V30 11 C 5.7309 10.2621 0.0 0
M  V30 12 C 17.0845 9.5518 0.0 0
M  V30 13 C 17.8545 8.2181 0.0 0
M  V30 14 N 15.5781 9.2316 0.0 0
M  V30 15 C 17.8545 10.8855 0.0 0
M  V30 16 C 16.8239 7.0736 0.0 0
M  V30 17 C 19.3946 8.2181 0.0 0
M  V30 18 C 15.4171 7.7001 0.0 0
M  V30 19 C 19.3946 10.8855 0.0 0
M  V30 20 C 20.1646 9.5518 0.0 0
M  V30 21 C 11.4160 6.9301 0.0 0
M  V30 22 C 10.0823 7.7001 0.0 0
M  V30 23 C 11.4160 5.3900 0.0 0
M  V30 24 C 8.7486 6.9301 0.0 0
M  V30 25 C 10.0823 4.6200 0.0 0
M  V30 26 C 8.7486 5.3900 0.0 0
M  V30 27 C 4.7475 7.7001 0.0 0
M  V30 28 C 3.3406 7.0736 0.0 0
M  V30 29 N 4.5865 9.2316 0.0 0 CHG=1 VAL=4
M  V30 30 C 2.3101 8.2181 0.0 0
M  V30 31 C 3.0801 9.5518 0.0 0
M  V30 32 C 0.7700 8.2181 0.0 0
M  V30 33 C 2.3101 10.8855 0.0 0
M  V30 34 C 0.0000 9.5518 0.0 0
M  V30 35 C 0.7700 10.8855 0.0 0
M  V30 36 Cl 10.0823 1.5400 0.0 0 VAL=7
M  V30 37 O 8.5423 1.5400 0.0 0
M  V30 38 O 11.6223 1.5400 0.0 0
M  V30 39 O 10.0823 0.0000 0.0 0
M  V30 40 O 10.0823 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 16
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 2 4 18 CFG=2
M  V30 6 2 5 21 CFG=2
M  V30 7 1 6 22
M  V30 8 2 7 8 CFG=2
M  V30 9 1 7 24
M  V30 10 1 8 27
M  V30 11 1 9 28
M  V30 12 1 10 28
M  V30 13 1 11 29
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 18
M  V30 22 1 17 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 2 36 38
M  V30 42 2 36 39
M  V30 43 1 36 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[3-[2-(1,3-Dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethylidene]-2-(met...
C33H40N3
1191398-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 5.6421 0.0 0
M  V30 2 C 2.0946 1.5483 0.0 0
M  V30 3 C 4.1107 1.1199 0.0 0
M  V30 4 C 6.0811 2.3101 0.0 0
M  V30 5 C 7.4148 3.0801 0.0 0
M  V30 6 N 10.0823 4.6201 0.0 0
M  V30 7 C 8.7486 5.3901 0.0 0
M  V30 8 C 12.7498 3.0801 0.0 0
M  V30 9 C 14.0835 2.3101 0.0 0
M  V30 10 C 16.0539 1.1199 0.0 0
M  V30 11 C 18.0700 1.5483 0.0 0
M  V30 12 C 14.4337 5.6421 0.0 0
M  V30 13 C 3.0801 4.9318 0.0 0
M  V30 14 C 2.3101 3.5981 0.0 0
M  V30 15 N 4.5865 4.6116 0.0 0
M  V30 16 C 2.3101 6.2655 0.0 0
M  V30 17 C 3.3406 2.4536 0.0 0
M  V30 18 C 0.7700 3.5981 0.0 0
M  V30 19 C 4.7475 3.0801 0.0 0
M  V30 20 C 0.7700 6.2655 0.0 0
M  V30 21 C 0.0000 4.9318 0.0 0
M  V30 22 C 8.7486 2.3101 0.0 0
M  V30 23 C 10.0823 3.0801 0.0 0
M  V30 24 C 8.7486 0.7700 0.0 0
M  V30 25 C 11.4160 2.3101 0.0 0
M  V30 26 C 10.0823 0.0000 0.0 0
M  V30 27 C 11.4160 0.7700 0.0 0
M  V30 28 C 15.4171 3.0801 0.0 0
M  V30 29 C 16.8239 2.4536 0.0 0
M  V30 30 N 15.5781 4.6116 0.0 0 CHG=1 VAL=4
M  V30 31 C 17.8545 3.5981 0.0 0
M  V30 32 C 17.0845 4.9318 0.0 0
M  V30 33 C 19.3946 3.5981 0.0 0
M  V30 34 C 17.8545 6.2655 0.0 0
M  V30 35 C 20.1646 4.9318 0.0 0
M  V30 36 C 19.3946 6.2655 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 17
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 2 4 19 CFG=2
M  V30 6 2 5 22 CFG=2
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 2 8 9 CFG=2
M  V30 10 1 8 25
M  V30 11 1 9 28
M  V30 12 1 10 29
M  V30 13 1 11 29
M  V30 14 1 12 30
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 23 1 18 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 102185-03-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1191398-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1698697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular Design Strategies for Near-Infrared Ratiometric Fluorescent
Probes Based on the Unique Spectral Properties of Aminocyanines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kiyose, Kazuki; Aizawa, Sakiko; Sasaki, Eita; Kojima, Hirotatsu; Hanaoka,
Kenjiro; Terai, Takuya; Urano, Yasuteru; Nagano, Tetsuo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2009), 15(36), 9191-9200, S9191/1-S9191/7

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,6R,6aS)-4-(6-Chloro-9H-purin-9-yl)-3a,5,6,6a-tetrahydro-3-phenyl-...
C18H16ClN5O2
1023322-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1788 9.1158 0.0 0
M  V30 2 O 10.5126 8.3458 0.0 0
M  V30 3 Cl 4.7365 0.0000 0.0 0
M  V30 4 C 5.4078 7.8278 0.0 0 CFG=1
M  V30 5 C 6.1778 6.4941 0.0 0 CFG=2
M  V30 6 C 6.4384 8.9721 0.0 0 CFG=1
M  V30 7 C 4.0010 8.4541 0.0 0
M  V30 8 C 7.6842 6.8143 0.0 0
M  V30 9 C 7.8452 8.3458 0.0 0 CFG=2
M  V30 10 O 5.6684 10.3059 0.0 0
M  V30 11 N 4.1620 9.9856 0.0 0
M  V30 12 N 5.5515 5.0872 0.0 0
M  V30 13 C 6.3215 3.7536 0.0 0
M  V30 14 C 4.0452 4.7670 0.0 0
M  V30 15 C 5.2911 2.6091 0.0 0
M  V30 16 N 7.8279 3.4334 0.0 0
M  V30 17 N 3.8842 3.2355 0.0 0
M  V30 18 C 5.7670 1.1445 0.0 0
M  V30 19 C 8.3038 1.9687 0.0 0
M  V30 20 N 7.2732 0.8244 0.0 0
M  V30 21 C 2.6674 7.6841 0.0 0
M  V30 22 C 2.6674 6.1441 0.0 0
M  V30 23 C 1.3338 8.4541 0.0 0
M  V30 24 C 1.3338 5.3741 0.0 0
M  V30 25 C 0.0000 7.6841 0.0 0
M  V30 26 C 0.0000 6.1441 0.0 0
M  V30 27 H 4.3774 6.6832 0.0 0
M  V30 28 H 7.4688 10.1167 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=3
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 27 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 12 CFG=1
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 28 CFG=3
M  V30 13 2 7 11
M  V30 14 1 7 21
M  V30 15 1 8 9
M  V30 16 1 10 11
M  V30 17 1 12 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 2 13 16
M  V30 21 2 14 17
M  V30 22 1 15 17
M  V30 23 2 15 18
M  V30 24 1 16 19
M  V30 25 1 18 20
M  V30 26 2 19 20
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 4 5 6 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,6R,6aS)-3a,5,6,6a-Tetrahydro-4-[6-(methylamino)-9H-purin-9-yl]-3-...
C19H20N6O2
1023322-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.1901 1.3338 0.0 0
M  V30 2 O 1.9601 0.0000 0.0 0
M  V30 3 N 10.3060 5.7762 0.0 0
M  V30 4 C 11.7707 5.3003 0.0 0
M  V30 5 C 2.4782 5.1049 0.0 0 CFG=1
M  V30 6 C 3.8119 4.3349 0.0 0 CFG=2
M  V30 7 C 1.3337 4.0743 0.0 0 CFG=1
M  V30 8 C 1.8517 6.5117 0.0 0
M  V30 9 C 3.4917 2.8284 0.0 0
M  V30 10 C 1.9601 2.6675 0.0 0 CFG=2
M  V30 11 O 0.0000 4.8443 0.0 0
M  V30 12 N 0.3202 6.3508 0.0 0
M  V30 13 N 5.2188 4.9612 0.0 0
M  V30 14 C 6.5525 4.1912 0.0 0
M  V30 15 C 5.5390 6.4675 0.0 0
M  V30 16 C 7.6969 5.2216 0.0 0
M  V30 17 N 6.8727 2.6847 0.0 0
M  V30 18 N 7.0706 6.6286 0.0 0
M  V30 19 C 9.1616 4.7457 0.0 0
M  V30 20 C 8.3372 2.2089 0.0 0
M  V30 21 N 9.4818 3.2394 0.0 0
M  V30 22 C 2.6217 7.8453 0.0 0
M  V30 23 C 1.8517 9.1790 0.0 0
M  V30 24 C 4.1618 7.8453 0.0 0
M  V30 25 C 2.6217 10.5128 0.0 0
M  V30 26 C 4.9318 9.1790 0.0 0
M  V30 27 C 4.1618 10.5128 0.0 0
M  V30 28 H 3.6226 6.1353 0.0 0
M  V30 29 H 0.1893 3.0439 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 28 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 13 CFG=3
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 29 CFG=1
M  V30 14 2 8 12
M  V30 15 1 8 22
M  V30 16 1 9 10
M  V30 17 1 11 12
M  V30 18 1 13 14
M  V30 19 1 13 15
M  V30 20 1 14 16
M  V30 21 2 14 17
M  V30 22 2 15 18
M  V30 23 1 16 18
M  V30 24 2 16 19
M  V30 25 1 17 20
M  V30 26 1 19 21
M  V30 27 2 20 21
M  V30 28 2 22 23
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 2 24 26
M  V30 32 2 25 27
M  V30 33 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 5 6 7 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1023322-78-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1023322-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14833533
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From cyclopentadiene to isoxazoline-carbocyclic nucleosides: a rapid
access to biological molecules through aza-Diels-Alder reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quadrelli, Paolo; Piccanello, Andrea; Mella, Mariella; Corsaro, Antonino;
Pistara, Venerando
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2008), 64(16), 3541-3547

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (αS)-5-bromo-α-hydroxy-1-(phenylmethyl)-1H-indole-3-acetate
C19H18BrNO3
1027346-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7470 4.3159 0.0 0 CFG=2
M  V30 2 C 4.3402 3.6896 0.0 0
M  V30 3 O 6.9931 3.4107 0.0 0
M  V30 4 O 4.1793 2.1580 0.0 0
M  V30 5 O 3.0944 4.5948 0.0 0
M  V30 6 C 2.7723 1.5315 0.0 0
M  V30 7 C 2.6114 0.0000 0.0 0
M  V30 8 C 4.6200 9.6186 0.0 0
M  V30 9 Br 11.3154 6.6963 0.0 0
M  V30 10 C 7.2418 6.6176 0.0 0
M  V30 11 C 6.9216 8.1239 0.0 0
M  V30 12 C 5.9081 5.8476 0.0 0
M  V30 13 C 8.7063 6.1416 0.0 0
M  V30 14 N 5.3901 8.2848 0.0 0
M  V30 15 C 8.0660 9.1543 0.0 0
M  V30 16 C 4.7636 6.8780 0.0 0
M  V30 17 C 9.8509 7.1722 0.0 0
M  V30 18 C 9.5307 8.6785 0.0 0
M  V30 19 C 3.0800 9.6186 0.0 0
M  V30 20 C 2.3100 10.9523 0.0 0
M  V30 21 C 2.3100 8.2848 0.0 0
M  V30 22 C 0.7700 10.9523 0.0 0
M  V30 23 C 0.7700 8.2848 0.0 0
M  V30 24 C 0.0000 9.6186 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 1 8 19
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-5-Bromo-α-hydroxy-N-methyl-1-(phenylmethyl)-1H-indole-3-acetamide
C18H17BrN2O2
1021299-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 8.0870 0.0 0
M  V30 2 C 5.7471 2.7844 0.0 0 CFG=2
M  V30 3 C 4.3402 2.1579 0.0 0
M  V30 4 O 6.9931 1.8791 0.0 0
M  V30 5 N 4.1793 0.6263 0.0 0
M  V30 6 O 3.0944 3.0631 0.0 0
M  V30 7 C 2.7723 0.0000 0.0 0
M  V30 8 Br 11.3155 5.1646 0.0 0
M  V30 9 C 6.9216 6.5922 0.0 0
M  V30 10 C 7.2418 5.0859 0.0 0
M  V30 11 N 5.3901 6.7533 0.0 0
M  V30 12 C 8.0660 7.6228 0.0 0
M  V30 13 C 5.9081 4.3159 0.0 0
M  V30 14 C 8.7064 4.6101 0.0 0
M  V30 15 C 4.7636 5.3463 0.0 0
M  V30 16 C 9.5307 7.1469 0.0 0
M  V30 17 C 9.8509 5.6405 0.0 0
M  V30 18 C 3.0800 8.0870 0.0 0
M  V30 19 C 2.3100 6.7533 0.0 0
M  V30 20 C 2.3100 9.4206 0.0 0
M  V30 21 C 0.7700 6.7533 0.0 0
M  V30 22 C 0.7700 9.4206 0.0 0
M  V30 23 C 0.0000 8.0870 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 13
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 5 7
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 15
M  V30 18 1 14 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1027346-36-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021299-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2678454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 99% ee, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Friedel-Crafts alkylations of indoles with ethyl glyoxylate
catalyzed by (S)-BINOL-Titanium(IV) complex: direct access to
enantiomerically enriched indolyl(hydroxy)acetates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dong, Hong-Ming; Lu, Hai-Hua; Lu, Liang-Qiu; Chen, Cai-Bao; Xiao,
Wen-Jing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2007), 349(10), 1597-1603

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(2-Benzofuranyl)-N,2-dimethyl-N-phenylpyrazolo[1,5-a]-1,3,5-triazin-4-amine
C21H17N5O
1029531-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6201 0.0 0
M  V30 2 C 4.0011 6.1601 0.0 0
M  V30 3 C 6.6684 0.0000 0.0 0
M  V30 4 N 6.6684 4.6201 0.0 0
M  V30 5 C 8.0021 3.8501 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 N 6.9886 6.1264 0.0 0
M  V30 8 C 9.1467 4.8805 0.0 0
M  V30 9 N 8.0021 2.3100 0.0 0
M  V30 10 N 5.3348 2.3100 0.0 0
M  V30 11 C 8.5203 6.2873 0.0 0
M  V30 12 C 6.6684 1.5400 0.0 0
M  V30 13 C 10.6529 4.5603 0.0 0
M  V30 14 C 11.2794 3.1533 0.0 0
M  V30 15 O 11.7975 5.5907 0.0 0
M  V30 16 C 12.8110 3.3144 0.0 0
M  V30 17 C 13.1311 4.8207 0.0 0
M  V30 18 C 13.9554 2.2839 0.0 0
M  V30 19 C 14.5959 5.2966 0.0 0
M  V30 20 C 15.4201 2.7597 0.0 0
M  V30 21 C 15.7403 4.2662 0.0 0
M  V30 22 C 2.6673 3.8501 0.0 0
M  V30 23 C 1.3337 4.6201 0.0 0
M  V30 24 C 2.6673 2.3100 0.0 0
M  V30 25 C 0.0000 3.8501 0.0 0
M  V30 26 C 1.3337 1.5400 0.0 0
M  V30 27 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 22
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 1 8 11
M  V30 13 1 8 13
M  V30 14 2 9 12
M  V30 15 1 10 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 2 16 18
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(2-Benzofuranyl)-N,2-dimethylpyrazolo[1,5-a]-1,3,5-triazin-4-amine
C15H13N5O
1029531-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.7393 4.6201 0.0 0
M  V30 2 C 13.0730 3.8501 0.0 0
M  V30 3 C 9.0718 0.0000 0.0 0
M  V30 4 C 7.7382 3.8501 0.0 0
M  V30 5 C 6.5936 4.8805 0.0 0
M  V30 6 N 9.0718 4.6201 0.0 0
M  V30 7 N 7.7382 2.3100 0.0 0
M  V30 8 C 7.2201 6.2873 0.0 0
M  V30 9 C 10.4055 3.8501 0.0 0
M  V30 10 N 8.7517 6.1264 0.0 0
M  V30 11 C 9.0718 1.5400 0.0 0
M  V30 12 N 10.4055 2.3100 0.0 0
M  V30 13 C 5.0873 4.5603 0.0 0
M  V30 14 C 4.4610 3.1534 0.0 0
M  V30 15 O 3.9428 5.5908 0.0 0
M  V30 16 C 2.9293 3.3145 0.0 0
M  V30 17 C 2.6091 4.8208 0.0 0
M  V30 18 C 1.7849 2.2839 0.0 0
M  V30 19 C 1.1445 5.2966 0.0 0
M  V30 20 C 0.3202 2.7599 0.0 0
M  V30 21 C 0.0000 4.2662 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 10
M  V30 13 2 9 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1029531-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1029531-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-13490197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclic nucleotide phosphodiesterase type 4 inhibitors: Evaluation of
pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raboisson, Pierre; Schultz, Dominique; Muller, Christian; Reimund,
Jean-Marie; Pinna, Guillaume; Mathieu, Romain; Bernard, Philippe; Do,
Quoc-Tuan; DesJarlais, Renee L.; Justiano, Helene; Lugnier, Claire;
Bourguignon, Jean-Jacques
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2008), 43(4), 816-829

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[2-(Trifluoromethyl)-5-pyrimidinyl]oxy]benzaldehyde
C12H7F3N2O2
1030379-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.4137 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 F 2.1037 0.0000 0.0 0
M  V30 4 F 0.0000 0.5637 0.0 0
M  V30 5 F 0.5637 2.6673 0.0 0
M  V30 6 C 12.0033 1.3337 0.0 0
M  V30 7 O 13.3370 2.1037 0.0 0
M  V30 8 C 5.3348 3.6437 0.0 0
M  V30 9 C 4.0010 4.4137 0.0 0
M  V30 10 C 5.3348 2.1037 0.0 0
M  V30 11 N 2.6673 3.6437 0.0 0
M  V30 12 N 4.0010 1.3337 0.0 0
M  V30 13 C 2.6673 2.1037 0.0 0
M  V30 14 C 8.0022 3.6437 0.0 0
M  V30 15 C 8.0022 2.1037 0.0 0
M  V30 16 C 9.3360 4.4137 0.0 0
M  V30 17 C 9.3360 1.3337 0.0 0
M  V30 18 C 10.6697 3.6437 0.0 0
M  V30 19 C 10.6697 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 13
M  V30 7 2 6 7
M  V30 8 1 6 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[[2-(trifluoromethyl)-5-pyrimidinyl]oxy]benzenemethanamine
C13H12F3N3O
1030379-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.4137 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 F 2.1037 0.0000 0.0 0
M  V30 4 F 0.0000 0.5637 0.0 0
M  V30 5 F 0.5637 2.6673 0.0 0
M  V30 6 C 12.0033 1.3337 0.0 0
M  V30 7 N 13.3370 2.1037 0.0 0
M  V30 8 C 14.6707 1.3337 0.0 0
M  V30 9 C 5.3348 3.6437 0.0 0
M  V30 10 C 5.3348 2.1037 0.0 0
M  V30 11 C 4.0010 4.4137 0.0 0
M  V30 12 N 4.0010 1.3337 0.0 0
M  V30 13 N 2.6673 3.6437 0.0 0
M  V30 14 C 2.6673 2.1037 0.0 0
M  V30 15 C 8.0022 3.6437 0.0 0
M  V30 16 C 8.0022 2.1037 0.0 0
M  V30 17 C 9.3358 4.4137 0.0 0
M  V30 18 C 9.3358 1.3337 0.0 0
M  V30 19 C 10.6697 3.6437 0.0 0
M  V30 20 C 10.6697 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 14
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1030379-88-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1030379-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8377726
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d)
N-Methyl-N-[(4-{[2-(trifluoromethyl)pyrimidin-5-yl]oxy}phenyl)methyl]amine>
4-{[2-(Trifluoromethyl)pyrimidin-5-yl]oxy} benzaldehyde was stirred with
33% methylamine in 95% ethanol (30 mL) at reflux for 1 hour and then
concentrated. The residue was re-dissolved in 95% ethanol, 10%
palladium/carbon was added, and the mixture was hydrogenated at room
temperature under atmospheric pressure for 30 minutes. The reaction was
performed on a 5.0 mmol scale with a yield of 95%. APCI-MS m/z 284 (M+1).
1H NMR (CDCl3): δ 2.49 (s, 3H), 3.80 (s, 2H), 5.30 (s, 1H), 7.08 (dd,
2H), 7.43 (dd, 2H), 8.53 (s, 2H) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydantoin derivatives for use as MMP inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chapman, David; Gabos, Balint; Munck af Rosenschold, Magnus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008065393 A1 2008-06-05

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-[(4-Methoxyphenyl)methylene]bis[4-hydroxy-6-methyl-2H-1-benzopyran-2-one]
C28H22O7
103162-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 5.3348 0.0 0
M  V30 2 O 9.1080 7.5127 0.0 0
M  V30 3 O 7.7272 2.3596 0.0 0
M  V30 4 O 3.8500 5.3348 0.0 0
M  V30 5 O 8.4701 8.0022 0.0 0
M  V30 6 O 3.8500 0.0000 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 14.6594 7.4059 0.0 0
M  V30 9 C 0.0000 9.3359 0.0 0
M  V30 10 C 8.4176 4.9362 0.0 0
M  V30 11 C 9.5065 6.0252 0.0 0
M  V30 12 C 8.8161 3.4487 0.0 0
M  V30 13 C 10.9940 5.6266 0.0 0
M  V30 14 O 10.3036 3.0500 0.0 0
M  V30 15 C 11.3926 4.1389 0.0 0
M  V30 16 C 12.0830 6.7155 0.0 0
M  V30 17 C 12.8802 3.7404 0.0 0
M  V30 18 C 13.5705 6.3170 0.0 0
M  V30 19 C 13.9692 4.8293 0.0 0
M  V30 20 C 6.1601 6.6684 0.0 0
M  V30 21 C 4.6200 6.6684 0.0 0
M  V30 22 C 6.9301 8.0022 0.0 0
M  V30 23 C 3.8500 8.0022 0.0 0
M  V30 24 O 6.1601 9.3359 0.0 0
M  V30 25 C 4.6200 9.3359 0.0 0
M  V30 26 C 2.3100 8.0022 0.0 0
M  V30 27 C 3.8500 10.6695 0.0 0
M  V30 28 C 1.5400 9.3359 0.0 0
M  V30 29 C 2.3100 10.6695 0.0 0
M  V30 30 C 6.1601 4.0011 0.0 0
M  V30 31 C 6.9301 2.6673 0.0 0
M  V30 32 C 4.6200 4.0011 0.0 0
M  V30 33 C 6.1601 1.3337 0.0 0
M  V30 34 C 3.8500 2.6673 0.0 0
M  V30 35 C 4.6200 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 1 30
M  V30 4 1 2 11
M  V30 5 2 3 12
M  V30 6 1 4 21
M  V30 7 2 5 22
M  V30 8 1 6 7
M  V30 9 1 6 35
M  V30 10 1 8 18
M  V30 11 1 9 28
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 15
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 25
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,14-Dihydro-7-(4-methoxyphenyl)-2,12,14-trimethyl-6H,8H-bis[1]benzopyrano[4,...
C29H23NO5
2408511-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 10.0102 0.0 0
M  V30 2 O 10.6697 5.3901 0.0 0
M  V30 3 C 4.0010 4.6201 0.0 0
M  V30 4 O 13.3370 10.0102 0.0 0
M  V30 5 C 14.6707 9.2402 0.0 0
M  V30 6 C 0.0000 6.9302 0.0 0
M  V30 7 C 4.0010 0.0000 0.0 0
M  V30 8 C 8.0022 6.9302 0.0 0
M  V30 9 C 6.6685 7.7002 0.0 0
M  V30 10 C 8.0022 5.3901 0.0 0
M  V30 11 C 5.3348 6.9302 0.0 0
M  V30 12 C 6.6685 9.2402 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 9.3358 4.6201 0.0 0
M  V30 15 C 4.0010 7.7002 0.0 0
M  V30 16 N 5.3348 5.3901 0.0 0
M  V30 17 O 5.3348 10.0102 0.0 0
M  V30 18 C 6.6685 3.0801 0.0 0
M  V30 19 O 9.3358 3.0801 0.0 0
M  V30 20 C 4.0010 9.2402 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 8.0022 2.3101 0.0 0
M  V30 23 C 5.3348 2.3101 0.0 0
M  V30 24 C 2.6673 10.0102 0.0 0
M  V30 25 C 1.3337 7.7002 0.0 0
M  V30 26 C 8.0022 0.7700 0.0 0
M  V30 27 C 5.3348 0.7700 0.0 0
M  V30 28 C 1.3337 9.2402 0.0 0
M  V30 29 C 6.6685 0.0000 0.0 0
M  V30 30 C 9.3358 7.7002 0.0 0
M  V30 31 C 9.3358 9.2402 0.0 0
M  V30 32 C 10.6697 6.9302 0.0 0
M  V30 33 C 10.6697 10.0102 0.0 0
M  V30 34 C 12.0033 7.7002 0.0 0
M  V30 35 C 12.0033 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 14
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 35
M  V30 6 1 6 25
M  V30 7 1 7 27
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 30
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 2 15 21
M  V30 23 1 17 20
M  V30 24 1 18 22
M  V30 25 2 18 23
M  V30 26 1 19 22
M  V30 27 2 20 24
M  V30 28 1 21 25
M  V30 29 2 22 26
M  V30 30 1 23 27
M  V30 31 1 24 28
M  V30 32 2 25 28
M  V30 33 1 26 29
M  V30 34 2 27 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103162-77-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2408511-66-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-22564312
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antimicrobial Activity of Some New Coumarin and Dicoumarol
Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Regal, M. K. A.; Shaban, S. S.; El-Metwally, S. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Bioorganic Chemistry (2020), 46(3), 438-447

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-[(4-Methoxyphenyl)methylene]bis[4-hydroxy-6-methyl-2H-1-benzopyran-2-one]
C28H22O7
103162-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 5.3348 0.0 0
M  V30 2 O 9.1080 7.5127 0.0 0
M  V30 3 O 7.7272 2.3596 0.0 0
M  V30 4 O 3.8500 5.3348 0.0 0
M  V30 5 O 8.4701 8.0022 0.0 0
M  V30 6 O 3.8500 0.0000 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 14.6594 7.4059 0.0 0
M  V30 9 C 0.0000 9.3359 0.0 0
M  V30 10 C 8.4176 4.9362 0.0 0
M  V30 11 C 9.5065 6.0252 0.0 0
M  V30 12 C 8.8161 3.4487 0.0 0
M  V30 13 C 10.9940 5.6266 0.0 0
M  V30 14 O 10.3036 3.0500 0.0 0
M  V30 15 C 11.3926 4.1389 0.0 0
M  V30 16 C 12.0830 6.7155 0.0 0
M  V30 17 C 12.8802 3.7404 0.0 0
M  V30 18 C 13.5705 6.3170 0.0 0
M  V30 19 C 13.9692 4.8293 0.0 0
M  V30 20 C 6.1601 6.6684 0.0 0
M  V30 21 C 4.6200 6.6684 0.0 0
M  V30 22 C 6.9301 8.0022 0.0 0
M  V30 23 C 3.8500 8.0022 0.0 0
M  V30 24 O 6.1601 9.3359 0.0 0
M  V30 25 C 4.6200 9.3359 0.0 0
M  V30 26 C 2.3100 8.0022 0.0 0
M  V30 27 C 3.8500 10.6695 0.0 0
M  V30 28 C 1.5400 9.3359 0.0 0
M  V30 29 C 2.3100 10.6695 0.0 0
M  V30 30 C 6.1601 4.0011 0.0 0
M  V30 31 C 6.9301 2.6673 0.0 0
M  V30 32 C 4.6200 4.0011 0.0 0
M  V30 33 C 6.1601 1.3337 0.0 0
M  V30 34 C 3.8500 2.6673 0.0 0
M  V30 35 C 4.6200 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 1 30
M  V30 4 1 2 11
M  V30 5 2 3 12
M  V30 6 1 4 21
M  V30 7 2 5 22
M  V30 8 1 6 7
M  V30 9 1 6 35
M  V30 10 1 8 18
M  V30 11 1 9 28
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 15
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 25
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,14-Dihydro-7-(4-methoxyphenyl)-2,12,14-trimethyl-6H,8H-bis[1]benzopyrano[4,...
C29H23NO5
2408511-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 10.0102 0.0 0
M  V30 2 O 10.6697 5.3901 0.0 0
M  V30 3 C 4.0010 4.6201 0.0 0
M  V30 4 O 13.3370 10.0102 0.0 0
M  V30 5 C 14.6707 9.2402 0.0 0
M  V30 6 C 0.0000 6.9302 0.0 0
M  V30 7 C 4.0010 0.0000 0.0 0
M  V30 8 C 8.0022 6.9302 0.0 0
M  V30 9 C 6.6685 7.7002 0.0 0
M  V30 10 C 8.0022 5.3901 0.0 0
M  V30 11 C 5.3348 6.9302 0.0 0
M  V30 12 C 6.6685 9.2402 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 9.3358 4.6201 0.0 0
M  V30 15 C 4.0010 7.7002 0.0 0
M  V30 16 N 5.3348 5.3901 0.0 0
M  V30 17 O 5.3348 10.0102 0.0 0
M  V30 18 C 6.6685 3.0801 0.0 0
M  V30 19 O 9.3358 3.0801 0.0 0
M  V30 20 C 4.0010 9.2402 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 8.0022 2.3101 0.0 0
M  V30 23 C 5.3348 2.3101 0.0 0
M  V30 24 C 2.6673 10.0102 0.0 0
M  V30 25 C 1.3337 7.7002 0.0 0
M  V30 26 C 8.0022 0.7700 0.0 0
M  V30 27 C 5.3348 0.7700 0.0 0
M  V30 28 C 1.3337 9.2402 0.0 0
M  V30 29 C 6.6685 0.0000 0.0 0
M  V30 30 C 9.3358 7.7002 0.0 0
M  V30 31 C 9.3358 9.2402 0.0 0
M  V30 32 C 10.6697 6.9302 0.0 0
M  V30 33 C 10.6697 10.0102 0.0 0
M  V30 34 C 12.0033 7.7002 0.0 0
M  V30 35 C 12.0033 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 14
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 35
M  V30 6 1 6 25
M  V30 7 1 7 27
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 30
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 2 15 21
M  V30 23 1 17 20
M  V30 24 1 18 22
M  V30 25 2 18 23
M  V30 26 1 19 22
M  V30 27 2 20 24
M  V30 28 1 21 25
M  V30 29 2 22 26
M  V30 30 1 23 27
M  V30 31 1 24 28
M  V30 32 2 25 28
M  V30 33 1 26 29
M  V30 34 2 27 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103162-77-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2408511-66-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-21569578
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 19479-87-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimicrobial activity of some new coumarin and dicoumarol
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Regal, Mohsen K. A.; Shaban, Safa S.; El-Metwally, Souad A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2020), 57(3), 1368-1378

$RFMT $RIREG SCHEME260 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1R,3R)-3-[[(2S,3S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-methyl...
C24H41N3O6S
1032072-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0035 6.9302 0.0 0 CFG=2
M  V30 2 C 10.6697 6.1601 0.0 0
M  V30 3 O 12.0035 8.4702 0.0 0
M  V30 4 C 9.3360 6.9302 0.0 0 CFG=2
M  V30 5 N 8.0023 6.1601 0.0 0
M  V30 6 C 9.3360 8.4702 0.0 0
M  V30 7 C 8.0023 4.6201 0.0 0
M  V30 8 C 6.6687 6.9302 0.0 0
M  V30 9 C 10.6697 9.2402 0.0 0
M  V30 10 C 8.0023 9.2402 0.0 0
M  V30 11 C 6.6687 3.8501 0.0 0 CFG=2
M  V30 12 O 9.3360 3.8501 0.0 0
M  V30 13 N 5.3348 4.6201 0.0 0
M  V30 14 C 6.6687 2.3101 0.0 0 CFG=1
M  V30 15 C 4.0012 3.8501 0.0 0
M  V30 16 C 8.0023 1.5400 0.0 0
M  V30 17 C 5.3348 1.5400 0.0 0
M  V30 18 O 2.6675 4.6201 0.0 0
M  V30 19 O 4.0012 2.3101 0.0 0
M  V30 20 C 8.0023 0.0000 0.0 0
M  V30 21 C 1.3338 3.8501 0.0 0
M  V30 22 C 0.5638 5.1838 0.0 0
M  V30 23 C 0.0000 3.0801 0.0 0
M  V30 24 C 2.1038 2.5164 0.0 0
M  V30 25 C 17.3061 5.8030 0.0 0
M  V30 26 O 18.2114 4.5571 0.0 0
M  V30 27 O 17.9325 7.2100 0.0 0
M  V30 28 C 19.7429 4.7180 0.0 0
M  V30 29 C 20.6482 3.4722 0.0 0
M  V30 30 C 13.3372 6.1601 0.0 0
M  V30 31 N 14.7440 6.7865 0.0 0
M  V30 32 S 13.4981 4.6286 0.0 0
M  V30 33 C 15.7746 5.6421 0.0 0
M  V30 34 C 15.0045 4.3084 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 30
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 11 13 CFG=3
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17 CFG=3
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 18 21
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 25 26
M  V30 26 2 25 27
M  V30 27 1 25 33
M  V30 28 1 26 28
M  V30 29 1 28 29
M  V30 30 2 30 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 2 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 4 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S,6R,8R)-8-[4-(ethoxycarbonyl)-2-thiazolyl]-5-methyl-6-(1...
C26H44N4O7S
2124254-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.3170 4.6201 0.0 0 CFG=2
M  V30 2 C 8.6507 5.3901 0.0 0
M  V30 3 O 7.3170 3.0801 0.0 0
M  V30 4 C 9.9843 4.6201 0.0 0 CFG=2
M  V30 5 C 5.9833 2.3101 0.0 0
M  V30 6 N 11.3182 5.3901 0.0 0
M  V30 7 C 9.9843 3.0801 0.0 0
M  V30 8 N 5.9833 0.7700 0.0 0
M  V30 9 O 4.6495 3.0801 0.0 0
M  V30 10 C 11.3182 6.9302 0.0 0
M  V30 11 C 12.6518 4.6201 0.0 0
M  V30 12 C 11.3182 2.3101 0.0 0
M  V30 13 C 8.6507 2.3101 0.0 0
M  V30 14 C 4.6495 0.0000 0.0 0
M  V30 15 C 12.6518 7.7002 0.0 0 CFG=2
M  V30 16 O 9.9843 7.7002 0.0 0
M  V30 17 N 13.9855 6.9302 0.0 0
M  V30 18 C 12.6518 9.2402 0.0 0 CFG=1
M  V30 19 C 15.3192 7.7002 0.0 0
M  V30 20 C 11.3182 10.0102 0.0 0
M  V30 21 C 13.9855 10.0102 0.0 0
M  V30 22 O 16.6530 6.9302 0.0 0
M  V30 23 O 15.3192 9.2402 0.0 0
M  V30 24 C 11.3182 11.5503 0.0 0
M  V30 25 C 17.9867 7.7002 0.0 0
M  V30 26 C 18.7567 6.3665 0.0 0
M  V30 27 C 19.3203 8.4702 0.0 0
M  V30 28 C 17.2167 9.0338 0.0 0
M  V30 29 C 3.6896 8.6488 0.0 0
M  V30 30 O 2.1579 8.8098 0.0 0
M  V30 31 O 4.5947 9.8947 0.0 0
M  V30 32 C 1.5316 10.2167 0.0 0
M  V30 33 C 0.0000 10.3777 0.0 0
M  V30 34 C 5.9833 5.3901 0.0 0
M  V30 35 N 5.8223 6.9217 0.0 0
M  V30 36 S 4.5764 4.7638 0.0 0
M  V30 37 C 4.3159 7.2419 0.0 0
M  V30 38 C 3.5459 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 34
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 8 14
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 1 15 17 CFG=3
M  V30 18 1 15 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 21 CFG=3
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 22 25
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 25 28
M  V30 29 1 29 30
M  V30 30 2 29 31
M  V30 31 1 29 37
M  V30 32 1 30 32
M  V30 33 1 32 33
M  V30 34 2 34 35
M  V30 35 1 34 36
M  V30 36 1 35 37
M  V30 37 1 36 38
M  V30 38 2 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 4 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1032072-47-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2124254-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27256502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tubulysin analogs and their engineered antibody conjugates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Subramanyam, Chakrapani; Tumey, Lawrence N.; Xie, Longfei; Leverett,
Carolyn A.; Vetelino, Beth C.; Sukuru, Sai Chetan K.; Hudson, Sarah;
Doppalapudi, Venkata Ramana; Bhat, Abhijit S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017134547 A1 2017-08-10

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,1,3-Benzothiadiazole, 1-[2-(2-bromoethoxy)ethyl]-3-(2-fluorophenyl)-1,3-dih...
C16H16BrFN2O3S
1033225-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1517 6.4354 0.0 0
M  V30 2 O 4.1916 5.7986 0.0 0
M  V30 3 F 3.0800 1.1153 0.0 0
M  V30 4 C 8.2358 5.4579 0.0 0
M  V30 5 C 9.6426 4.8315 0.0 0
M  V30 6 O 10.8886 5.7367 0.0 0
M  V30 7 C 12.2954 5.1103 0.0 0
M  V30 8 C 13.5413 6.0154 0.0 0
M  V30 9 Br 14.9482 5.3891 0.0 0
M  V30 10 N 4.6200 3.7827 0.0 0
M  V30 11 C 5.5252 2.5367 0.0 0
M  V30 12 S 5.5252 5.0286 0.0 0 VAL=6
M  V30 13 C 6.9899 3.0127 0.0 0
M  V30 14 C 5.2051 1.0304 0.0 0
M  V30 15 N 6.9899 4.5527 0.0 0
M  V30 16 C 8.1343 1.9821 0.0 0
M  V30 17 C 6.3496 0.0000 0.0 0
M  V30 18 C 7.8141 0.4759 0.0 0
M  V30 19 C 3.0800 3.7827 0.0 0
M  V30 20 C 2.3100 2.4489 0.0 0
M  V30 21 C 2.3100 5.1164 0.0 0
M  V30 22 C 0.7700 2.4489 0.0 0
M  V30 23 C 0.7700 5.1164 0.0 0
M  V30 24 C 0.0000 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 19
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[3-(2-Fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]ethoxy]-N...
C17H20FN3O3S
1033214-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1516 6.4354 0.0 0
M  V30 2 O 4.1916 5.7986 0.0 0
M  V30 3 F 3.0800 1.1153 0.0 0
M  V30 4 C 8.2358 5.4579 0.0 0
M  V30 5 C 9.6426 4.8315 0.0 0
M  V30 6 O 10.8885 5.7367 0.0 0
M  V30 7 C 12.2954 5.1104 0.0 0
M  V30 8 C 13.5413 6.0154 0.0 0
M  V30 9 N 14.9482 5.3891 0.0 0
M  V30 10 C 16.1941 6.2943 0.0 0
M  V30 11 N 4.6200 3.7827 0.0 0
M  V30 12 C 5.5252 2.5367 0.0 0
M  V30 13 S 5.5252 5.0286 0.0 0 VAL=6
M  V30 14 C 6.9899 3.0127 0.0 0
M  V30 15 C 5.2051 1.0304 0.0 0
M  V30 16 N 6.9899 4.5527 0.0 0
M  V30 17 C 8.1343 1.9821 0.0 0
M  V30 18 C 6.3495 0.0000 0.0 0
M  V30 19 C 7.8142 0.4759 0.0 0
M  V30 20 C 3.0800 3.7827 0.0 0
M  V30 21 C 2.3100 2.4489 0.0 0
M  V30 22 C 2.3100 5.1164 0.0 0
M  V30 23 C 0.7700 2.4489 0.0 0
M  V30 24 C 0.7700 5.1164 0.0 0
M  V30 25 C 0.0000 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 13
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033225-94-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033214-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-4201311
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 3:
1-(3-Bromo-propyl)-3-(4-chloro-phenyl)-1,3-dihydro
benzo[1,2,5]thiadiazole 2,2-dioxide (0.12 g, 0.29 mmol) was dissolved in
8N methylamine in methanol (20 mL) and stirred for 16 hours in a sealed
flask. The mixture was concentrated in vacuo to give the crude product.
The crude product was purified via chromatography (silica, 5% methanol
saturated with ammonia in chloroform) to give 70 mg of
3-[3-(4-chlorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-N-methylpropan-1-amine
Example 84: Preparation of
2-{2-[3-(2-fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]ethoxy}-N-methylethanamine
In an analogous manner to general procedure A, step 3,
1-[2-(2-bromoethoxy)ethyl]-3-(2-fluorophenyl)-1,3-dihydro-2,1,3-benzothiadiazole
2,2-dioxide (0.07 g, 0.16 mmol) was treated with methylamine (10 mL) to
provide 0.05 g (95%) of
2-{2-[3-(2-fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]ethoxy}-N-methylethanamine.
MS (ES) m/z 366.0; HRMS: calculated for C17H20FN3O3S + H+, 366.12822;
found (ESI, [M+H]+), 366.1285; HPLC purity 100.0% at 210-370 nm, 8.4
minutes; Xterra RP18, 3.5u, 150 x 4.6 mm column, 1.2 mL/minutes
85/15-5/95 (Ammon. Bicarb Buff. pH=9.5/ACN+MeOH) for 10 minutes hold 4
minutes
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl sulfamide derivatives as monoamine reuptake inhibitors and their
preparation and methods of their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McComas, Casey Cameron; Cohn, Stephen Todd; Crawley, Matthew L.; Fensome,
Andrew; Goldberg, Joel Adam; Jenkins, Douglas John; Kim, Callain
Younghee; Mahaney, Paige Erin; Mann, Charles William; Marella, Michael
Anthony; O'Neill, David John; Sabatucci, Joseph P.; Terefenko, Eugene
Anthony; Trybulski, Eugene John; Vu, An Thien; Woodworth, Richard Page,
Jr.; Zhang, Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008073459 A1 2008-06-19

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,1,3-Benzothiadiazole, 1-(2-fluorophenyl)-1,3-dihydro-3-[2-(2S)-2-oxiranylet...
C16H15FN2O3S
1033226-01-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1517 6.4354 0.0 0
M  V30 2 O 4.1916 5.7986 0.0 0
M  V30 3 F 3.0800 1.1153 0.0 0
M  V30 4 C 8.2358 5.4578 0.0 0
M  V30 5 C 9.6426 4.8315 0.0 0
M  V30 6 N 4.6200 3.7827 0.0 0
M  V30 7 C 5.5252 2.5367 0.0 0
M  V30 8 S 5.5252 5.0286 0.0 0 VAL=6
M  V30 9 C 6.9899 3.0127 0.0 0
M  V30 10 C 5.2051 1.0304 0.0 0
M  V30 11 N 6.9899 4.5527 0.0 0
M  V30 12 C 8.1343 1.9821 0.0 0
M  V30 13 C 6.3495 0.0000 0.0 0
M  V30 14 C 7.8142 0.4759 0.0 0
M  V30 15 C 3.0800 3.7827 0.0 0
M  V30 16 C 2.3100 2.4489 0.0 0
M  V30 17 C 2.3100 5.1164 0.0 0
M  V30 18 C 0.7700 2.4489 0.0 0
M  V30 19 C 0.7700 5.1164 0.0 0
M  V30 20 C 0.0000 3.7827 0.0 0
M  V30 21 C 10.8885 5.7367 0.0 0 CFG=2
M  V30 22 C 12.4202 5.8976 0.0 0
M  V30 23 O 11.5149 7.1435 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 8
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 21 5 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 11
M  V30 14 2 9 12
M  V30 15 1 10 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,1,3-Benzothiadiazole-1(3H)-propanol, 3-(2-fluorophenyl)-α-[(methylamino)met...
C17H20FN3O3S
1033214-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1517 6.4354 0.0 0
M  V30 2 O 4.1916 5.7986 0.0 0
M  V30 3 F 3.0800 1.1153 0.0 0
M  V30 4 C 8.2358 5.4579 0.0 0
M  V30 5 C 9.6426 4.8315 0.0 0
M  V30 6 C 10.8886 5.7367 0.0 0 CFG=2
M  V30 7 C 12.2954 5.1104 0.0 0
M  V30 8 O 10.7275 7.2682 0.0 0
M  V30 9 N 13.5413 6.0156 0.0 0
M  V30 10 C 14.9482 5.3891 0.0 0
M  V30 11 N 4.6200 3.7827 0.0 0
M  V30 12 C 5.5252 2.5369 0.0 0
M  V30 13 S 5.5252 5.0286 0.0 0 VAL=6
M  V30 14 C 6.9899 3.0127 0.0 0
M  V30 15 C 5.2051 1.0304 0.0 0
M  V30 16 N 6.9899 4.5527 0.0 0
M  V30 17 C 8.1343 1.9821 0.0 0
M  V30 18 C 6.3496 0.0000 0.0 0
M  V30 19 C 7.8142 0.4759 0.0 0
M  V30 20 C 3.0800 3.7827 0.0 0
M  V30 21 C 2.3100 2.4489 0.0 0
M  V30 22 C 2.3100 5.1164 0.0 0
M  V30 23 C 0.7700 2.4489 0.0 0
M  V30 24 C 0.7700 5.1164 0.0 0
M  V30 25 C 0.0000 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 13
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033226-01-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033214-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-3624383
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 7: 7 (0.08 g, 0.23 mmol) was dissolved in MeNH2 solution (8M in
EtOH, 10 mL). The solution was heated to 60°C for 1 hour. The reaction
mixture was cooled and concentrated then loaded directly onto silica gel
and purified via Isco chromatography (Redisep, silica, gradient 0-100% of
10% 7M ammonia in MeOH/dichloromethane) to afford 0.08 g (95%) of 8 as a
foamy oil. This was dissolved in CH2Cl2 (5 mL) and HCl added (4N in
dioxane, 0.11 mL). After stirring for 30 minutes at 23°C the mixture was
concentrated then redissolved in CH2Cl2 (2 mL) and tert-butyl methyl
ether added until the solution was almost cloudy. The solution was
allowed to sit for several hours at 23°C until crystals had formed. These
were collected by filtration and dried under vacuo.
(S)-4-[3-(2-fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ol,
yield 0.08 g (95%) HRMS: calcd for C16H15FN2O3S + H+, 366.1282; found
(ESI, [M+H]+), 366.1287. HPLC purity 100% at 210-370 nm, 6.8 min.; Xterra
RP18, 3.5u, 150 x 4.6 mm column, 1.2 mL/min, 85/15-5/95 (Ammon. Form.
Buff. Ph=3.5/ACN+MeOH) for 10 min, hold 4min.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, product isolated as HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl sulfamide derivatives as monoamine reuptake inhibitors and their
preparation and methods of their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McComas, Casey Cameron; Cohn, Stephen Todd; Crawley, Matthew L.; Fensome,
Andrew; Goldberg, Joel Adam; Jenkins, Douglas John; Kim, Callain
Younghee; Mahaney, Paige Erin; Mann, Charles William; Marella, Michael
Anthony; O'Neill, David John; Sabatucci, Joseph P.; Terefenko, Eugene
Anthony; Trybulski, Eugene John; Vu, An Thien; Woodworth, Richard Page,
Jr.; Zhang, Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008073459 A1 2008-06-19

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H,3H-4,2,1-Benzoxathiazine, 3-(2-bromoethyl)-6-fluoro-1-phenyl-, 2,2-dioxide
C15H13BrFNO3S
1033629-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 C 8.0023 6.9302 0.0 0
M  V30 4 C 9.3360 6.1601 0.0 0
M  V30 5 Br 10.6697 6.9302 0.0 0
M  V30 6 F 4.0012 0.0000 0.0 0
M  V30 7 N 4.0012 6.1601 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 6.6685 6.1601 0.0 0
M  V30 13 O 6.6685 4.6201 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 4.0012 1.5400 0.0 0
M  V30 17 C 2.6673 6.9302 0.0 0
M  V30 18 C 2.6673 8.4702 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 20 C 1.3337 9.2402 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 22 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H,3H-4,2,1-Benzoxathiazine-3-ethanamine, 6-fluoro-N-methyl-1-phenyl-, 2,2-di...
C16H17FN2O3S
1033628-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 8.1098 0.0 0
M  V30 2 O 4.3449 8.1098 0.0 0
M  V30 3 C 8.0022 6.9302 0.0 0
M  V30 4 C 9.3360 6.1601 0.0 0
M  V30 5 N 10.6697 6.9302 0.0 0
M  V30 6 C 12.0033 6.1601 0.0 0
M  V30 7 F 4.0012 0.0000 0.0 0
M  V30 8 N 4.0012 6.1601 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 S 5.3348 6.9302 0.0 0 VAL=6
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 6.6685 6.1601 0.0 0
M  V30 14 O 6.6685 4.6201 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 4.0012 1.5400 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 20 C 2.6673 8.4702 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 22 C 1.3337 9.2402 0.0 0
M  V30 23 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033629-76-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033628-58-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14540381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM This intermediate bromide (0.25g, 0.8 mmol) was treated with solution of
methylamine (8 M in THF, mL, 80 mmol) and stirred overnight. The reaction
mixture was evaporated and the crude reaction product was purified by
flash chromatography (SiO2, 0-5 % 7 M NH3-methanol/dichloromethane) to
provide the racemic
2-[(3)-6-fluoro-2,2-dioxido-1-phenyl-1H-4,2,1-benzoxathiazin-3-yl]-N-methylethanamine
(0.24,95%) as a brown amorphous solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclic sulfonamide derivatives as monoamine reuptake inhibitors, their
preparation, pharmaceutical compositions, and use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel Adam; McComas, Casey Cameron; Mann,
Charles William; Melenski, Edward George; Sabatucci, Joseph P.;
Woodworth, Richard Page, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008073956 A2 2008-06-19

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-chlorobenzeneethanesulfonyl chloride
C8H7BrCl2O2S
1033629-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6673 0.0 0
M  V30 2 C 5.3900 4.0009 0.0 0
M  V30 3 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 4 Cl 8.4700 4.0009 0.0 0
M  V30 5 O 6.9300 5.5409 0.0 0
M  V30 6 O 6.9300 2.4609 0.0 0
M  V30 7 Br 3.0800 0.0000 0.0 0
M  V30 8 Cl 0.0000 5.3347 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3336 0.0 0
M  V30 11 C 2.3100 4.0009 0.0 0
M  V30 12 C 0.7700 1.3336 0.0 0
M  V30 13 C 0.7700 4.0009 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 10
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-chloro-N-methylbenzeneethanesulfonamide
C9H11BrClNO2S
1611444-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 4 N 8.0023 5.3901 0.0 0
M  V30 5 O 5.8985 5.9538 0.0 0
M  V30 6 O 7.4385 3.2864 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 Br 1.3337 6.1601 0.0 0
M  V30 9 Cl 1.3337 0.0000 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 8 11
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033629-82-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1611444-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-9260815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-substituted triazolamines as inhibitors of indoleamine
2,3-dioxygenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boyall, Dean; Davis, Christopher; Dodd, James; Everitt, Simon; Miller,
Andrew; Weber, Peter; Westcott, James; Young, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014081689 A1 2014-05-30

$RFMT $RIREG SCHEME265 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-2-(1-methylethoxy)-5-nitrobenzaldehyde
C10H10FNO4
1037092-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 2.3101 0.0 0
M  V30 2 C 8.0023 3.0801 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 C 8.0023 4.6201 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 F 6.6685 5.3901 0.0 0
M  V30 8 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 9 O 1.3337 6.9302 0.0 0
M  V30 10 O 0.0000 4.6201 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[3-fluoro-2-(1-methylethoxy)-5-nitrophenyl]methyl]-N-met...
C16H23FN2O5
1037093-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3347 0.0 0
M  V30 2 N 6.9300 6.6685 0.0 0
M  V30 3 C 8.4700 6.6685 0.0 0
M  V30 4 C 6.1600 8.0021 0.0 0
M  V30 5 O 9.2400 8.0021 0.0 0
M  V30 6 O 9.2400 5.3347 0.0 0
M  V30 7 C 10.7800 8.0021 0.0 0
M  V30 8 C 10.7800 6.4621 0.0 0
M  V30 9 C 12.3200 8.0021 0.0 0
M  V30 10 C 10.7800 9.5421 0.0 0
M  V30 11 O 4.6200 2.6674 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 C 2.3100 1.3336 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 F 1.5400 2.6674 0.0 0
M  V30 16 N 1.5400 8.0021 0.0 0 VAL=5
M  V30 17 O 0.0000 8.0021 0.0 0
M  V30 18 O 2.3100 9.3358 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 3.8500 4.0011 0.0 0
M  V30 21 C 3.8500 6.6685 0.0 0
M  V30 22 C 2.3100 4.0011 0.0 0
M  V30 23 C 2.3100 6.6685 0.0 0
M  V30 24 C 1.5400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 20
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 15 22
M  V30 16 2 16 17
M  V30 17 2 16 18
M  V30 18 1 16 23
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1037092-99-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037093-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1567724
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 167D: To a solution of 167C (210 mg, 0.924 mmol) in MeOH (6 mL), was
added methylamine (2M, EtOH) (0.92 mL, 1.85 mmol). The mixture was
stirred at rt for 1 h, then was cooled to 0 °C and sodium borohydride
(105 mg, 2.77 mmol) was added. The mixture was stirred at rt for lh, then
was concentrated. The residue was mixed with sodium bicarbonate (123 mg,
1.459 mmol) in water (5 mL) and THF (5 mL). (Boc)2O (127 mg, 0.583 mmol)
was added. The mixture was stirred rt for 1 h. The reaction mixture was
extracted with EtOAc (3×). The combined organic phase was washed with
water and brine, dried (Na2SO4), and concentrated. The crude material was
purified by flash chromatography (0-50% EtOAc in hexanes) to afford 167D
(322 mg, 0.875 mmol, 95 % yield). MS (ESI) m/z 343.4 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic amino acid derivatives as factor VIIa
inhibitors useful as anticoagulants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wurtz, Nicholas Ronald; Priestley, Eldon Scott; Cheney, Daniel L.; Glunz,
Peter W.; Zhang, Xiaojun; Ladziata, Vladimir; Parkhurst, Brandon;
Mueller, Luciano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008079836 A2 2008-07-03

$RFMT $RIREG SCHEME266 STEP1
$RXN



  3  1
$MOL
Ethyl bromopyruvate
C5H7BrO3
70-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 Br 0.0000 2.3100 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-3-methyl-1-phenyl-2-thioxo-4,5-pyrimidinedione
C11H10N2O2S
1872193-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 5.3349 0.0 0
M  V30 2 C 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 N 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 N 2.3100 4.0011 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 1.5400 2.6674 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 6.9300 1.3338 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 8.4700 1.3338 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 8
M  V30 3 2 3 9
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 70-23-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1872193-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-579948
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM ultrasound (irradiation (100 W))
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasound-assisted efficient synthesis of new dihydropyrimidinone and
tetrahydro-2-thioxopyrimidinone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mehrabi, Hossein; Alizadeh-bami, Farzaneh; Zadeh, Ashrafosadat Beheshti
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2015), 39(6), 360-362

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylthiourea
C2H6N2S
598-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 2.6673 2.3101 0.0 0
M  V30 3 N 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 598-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29593227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM generic reaction discussion using alternate solvents also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for the preparation of aminothiazoles that are inducing browning
of white adipose tissue
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Baishan; Nie, Tao; Zhao, Wenling; Zou, Yali; Ding, Qiang; Ding,
Sheng; Wu, Donghai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016131192 A1 2016-08-25

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
S-Ethyl N-[3-(methylsulfonyl)-5-[[5,6,7,8-tetrahydro-5-methyl-8-(1-methylethy...
C20H26N6O4S2
1044272-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 C 2.3101 4.0012 0.0 0
M  V30 3 C 0.0000 5.3348 0.0 0
M  V30 4 C 4.6201 10.6697 0.0 0
M  V30 5 N 6.9302 4.0012 0.0 0
M  V30 6 O 1.5400 10.6697 0.0 0
M  V30 7 N 11.5503 6.6685 0.0 0
M  V30 8 C 13.0903 6.6685 0.0 0
M  V30 9 S 13.8603 8.0023 0.0 0
M  V30 10 O 13.8603 5.3348 0.0 0
M  V30 11 C 15.4003 8.0023 0.0 0
M  V30 12 C 16.1704 9.3360 0.0 0
M  V30 13 S 11.5503 1.3337 0.0 0 VAL=6
M  V30 14 C 12.3203 0.0000 0.0 0
M  V30 15 O 12.8839 2.1037 0.0 0
M  V30 16 O 10.2166 0.5637 0.0 0
M  V30 17 C 3.8501 6.6685 0.0 0
M  V30 18 C 4.6201 8.0023 0.0 0
M  V30 19 N 2.3101 6.6685 0.0 0
M  V30 20 N 4.6201 5.3348 0.0 0
M  V30 21 C 6.1601 8.0023 0.0 0
M  V30 22 N 3.8501 9.3360 0.0 0
M  V30 23 C 1.5400 8.0022 0.0 0
M  V30 24 C 6.1601 5.3348 0.0 0
M  V30 25 N 6.9302 6.6685 0.0 0
M  V30 26 C 2.3101 9.3360 0.0 0
M  V30 27 C 8.4702 4.0012 0.0 0
M  V30 28 C 9.2402 5.3348 0.0 0
M  V30 29 C 9.2402 2.6673 0.0 0
M  V30 30 C 10.7802 5.3348 0.0 0
M  V30 31 C 10.7802 2.6673 0.0 0
M  V30 32 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 4 22
M  V30 5 1 5 24
M  V30 6 1 5 27
M  V30 7 2 6 26
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 13 16
M  V30 17 1 13 31
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 2 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 26
M  V30 28 2 24 25
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-[3-(methylsulfonyl)-5-[[5,6,7,8-tetrahydro-5-methyl-8-(1-methylet...
C19H25N7O4S
1044271-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 C 2.3101 4.0012 0.0 0
M  V30 3 C 0.0000 5.3348 0.0 0
M  V30 4 C 4.6201 10.6697 0.0 0
M  V30 5 N 6.9302 4.0012 0.0 0
M  V30 6 O 1.5400 10.6697 0.0 0
M  V30 7 N 11.5503 6.6685 0.0 0
M  V30 8 C 13.0903 6.6685 0.0 0
M  V30 9 N 13.8603 8.0023 0.0 0
M  V30 10 O 13.8603 5.3348 0.0 0
M  V30 11 C 15.4003 8.0023 0.0 0
M  V30 12 S 11.5503 1.3337 0.0 0 VAL=6
M  V30 13 C 12.3203 0.0000 0.0 0
M  V30 14 O 10.2166 0.5637 0.0 0
M  V30 15 O 12.8839 2.1037 0.0 0
M  V30 16 C 3.8501 6.6685 0.0 0
M  V30 17 C 4.6201 8.0023 0.0 0
M  V30 18 N 2.3101 6.6685 0.0 0
M  V30 19 N 4.6201 5.3348 0.0 0
M  V30 20 N 3.8501 9.3360 0.0 0
M  V30 21 C 6.1601 8.0023 0.0 0
M  V30 22 C 1.5400 8.0023 0.0 0
M  V30 23 C 6.1601 5.3348 0.0 0
M  V30 24 C 2.3101 9.3360 0.0 0
M  V30 25 N 6.9302 6.6685 0.0 0
M  V30 26 C 8.4702 4.0012 0.0 0
M  V30 27 C 9.2402 5.3348 0.0 0
M  V30 28 C 9.2402 2.6673 0.0 0
M  V30 29 C 10.7802 5.3348 0.0 0
M  V30 30 C 10.7802 2.6673 0.0 0
M  V30 31 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 4 20
M  V30 5 1 5 23
M  V30 6 1 5 26
M  V30 7 2 6 24
M  V30 8 1 7 8
M  V30 9 1 7 29
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 12 15
M  V30 16 1 12 30
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1044272-61-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1044271-15-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7291945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [3-(8-Isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydro-pteridin-2-ylamino)-5-(methylsulfonyl)-phenyl]-thiocarbamic
acid ethyl ester (50 mg; 0.104 mmol) was dissolved in 1 ml of dry DMF. A
solution of methylamine (2M in THF; 0.104 ml; 0.209 mmol) was added. The
reaction mixture was stirred at 70 °C overnight, then it was diluted with
dichloromethane and washed with water. The organic phase was filtered on
a phase separator and concentrated. The crude was treated with isopropyl
ether/ethanol. The precipitated formed was filtered and dried in vacuo.
12 mg (0.017mmol; 95% yield) of the desired compound were obtained.
Example 97, yield 12 mg, 0.017mmol, 95%. LC-MS method: G Retention time:
3.57 min [M+H]=448
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pteridinones as phosphatidylinositol-3-kinase (PI3 kinase)
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Giovannini, Riccardo; Frattini, Sara; Brandl, Trixi; Breitfelder,
Steffen; Cereda, Enzo; Grauert, Matthias; Hoffmann, Matthias; Joergensen,
Anne T.; Maier, Udo; Pautsch, Alexander; Quai, Monica; Scheuerer, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008092831 A1 2008-08-07

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromoanisole
C7H7BrO
104-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenamine
C8H11NO
5961-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-92-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5961-59-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15192712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-4-methoxyaniline (Table 2-2). The reaction of
4-bromoanisole (1.870 g, 10 mmol), aqueous methylamine (5.4 mL, 5 eq),
copper powder (0.032 g, 5 mol%) produced 1.307 g (95.3 %) of
N-methyl-4-methoxyaniline as a white to a pale grey solid. 1H NMR (300
MHz, d 6-DMSO) δ (ppm): 2.62(s, 3H), 3.64(s, 3H), 5.16(s, 1H), 6.49(s,
2H), 6.72(s, 2H); 13C NMR (75 MHz, d 6-DMSO) δ (ppm): 31.0, 55.8, 113.1,
115.1, 144.8, 151.2.
$DTYPE RXN:VAR(1):NOTES
$DATUM Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME270 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichlorobenzaldehyde
C7H4Cl2O
83-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 O 5.3901 4.0011 0.0 0
M  V30 3 Cl 3.0800 5.3349 0.0 0
M  V30 4 Cl 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6675 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl chloroacetate
C4H7ClO2
105-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-5-[(2,6-Dichlorophenyl)methylene]-3-methyl-2-thioxo-4-thiazolidinone
C11H7Cl2NOS2
1646147-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 O 7.0618 0.1773 0.0 0
M  V30 3 C 9.3037 2.6672 0.0 0
M  V30 4 S 7.6286 5.5688 0.0 0
M  V30 5 Cl 4.0010 4.6201 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 6.7417 1.6837 0.0 0
M  V30 9 S 5.4958 3.8416 0.0 0
M  V30 10 N 7.7721 2.8281 0.0 0
M  V30 11 C 7.0021 4.1618 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 1 12
M  V30 3 2 2 8
M  V30 4 1 3 10
M  V30 5 2 4 11
M  V30 6 1 5 13
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 83-38-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 105-39-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1646147-42-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-10061786
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 284049-75-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, stereoselective, no solvent, Knoevenagel condensation,
ionic liquid used as catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Butyl-3-methylimidazolium acetate catalyzed synthesis of
N-substituted-5-arylidene-rhodanines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Sarangthem Joychandra; Ahmad, Sohail; Chauhan, S. M. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2014), 51(S1), E129-E139

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Bromomethyl)-3-fluorobenzonitrile
C8H5BrFN
105942-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 N 8.4702 2.6673 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 C 0.7700 2.6673 0.0 0
M  V30 5 Br 0.0000 4.0010 0.0 0
M  V30 6 C 5.3901 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-[(methylamino)methyl]benzonitrile
C9H9FN2
633698-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 C 0.0000 4.0010 0.0 0
M  V30 4 F 3.8500 0.0000 0.0 0
M  V30 5 C 8.4701 2.6673 0.0 0
M  V30 6 N 10.0101 2.6673 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9301 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105942-09-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 633698-43-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13756800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 3-fluoro-4-[(methylamino)methyl]benzonitrile A solution of
4-cyano-2-fluoro-benzylbromide (15 g, 0.07 mol) in dry THF (50 mL) was
added to the 40% aqueous solution of methyl amine (400 mL) at 5-10°C and
allowed to stir for 5 min. The mixture was extracted with DCM and the
organic layer was dried over Na2SO4 and concentrated under vacuum. The
title compound as a brown liquid (10 g, 89 %). 1H NMR (DMSO-d6, 400 MHz)
δ 7.77 (m, 1 H), 7.68-7.61 (m, 2H), 3.71 (s, 2H), 2.24 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives
as ligands on the sphingosine 1-phosphate (S1P) receptors for treating
multiple sclerosis and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bombrun, Agnes; Quattropani, Anna; Gonzalez, Jerome; Dorbais, Jerome;
Knight, Chris; Baker-Glenn, Charles
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012004287 A1 2012-01-12

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylate
C10H11NO2S
106200-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3777 5.1291 0.0 0
M  V30 2 C 5.4385 3.7663 0.0 0
M  V30 3 O 6.7721 2.9963 0.0 0
M  V30 4 O 5.4385 5.3063 0.0 0
M  V30 5 C 8.1058 3.7663 0.0 0
M  V30 6 C 9.4395 2.9963 0.0 0
M  V30 7 C 1.6672 2.4782 0.0 0
M  V30 8 C 2.4373 1.1446 0.0 0
M  V30 9 N 2.6978 3.6226 0.0 0
M  V30 10 C 0.1609 2.1580 0.0 0
M  V30 11 C 3.9437 1.4647 0.0 0
M  V30 12 S 1.4068 0.0000 0.0 0
M  V30 13 C 4.1047 2.9963 0.0 0
M  V30 14 C 0.0000 0.6263 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-4H-thieno[3,2-b]pyrrole-5-carboxamide
C9H10N2OS
335031-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3104 0.0000 0.0 0
M  V30 2 C 6.2796 2.7104 0.0 0
M  V30 3 N 7.0496 4.0441 0.0 0
M  V30 4 O 7.0496 1.3768 0.0 0
M  V30 5 C 8.5896 4.0441 0.0 0
M  V30 6 C 2.3698 1.9404 0.0 0
M  V30 7 C 2.3698 3.4804 0.0 0
M  V30 8 N 3.8345 1.4646 0.0 0
M  V30 9 C 0.9051 1.4646 0.0 0
M  V30 10 C 3.8345 3.9563 0.0 0
M  V30 11 S 0.9051 3.9563 0.0 0
M  V30 12 C 4.7396 2.7104 0.0 0
M  V30 13 C 0.0000 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106200-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335031-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-970846
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: b) N,1-DimethylH-indole-2-carboxamide. A
suspension of ethyl 1-methylH-indole-2-carboxylate (27.10 g, 133.34
mmole) in 40% aqueous CH3NH2 (300 mL) and MeOH (30 mL) was stirred at RT.
A solid tended to gradually creep up the walls of the flask, and was
washed down periodically with MeOH. The flask was tightly stoppered to
keep the material inside the flask. As the reaction proceeded, the solid
dissolved, but eventually the product began to precipitate. The reaction
was stirred at RT for 5 days, then was concentrated to remove
approximately 200 mL of the solvent. The remaining residue was diluted
with H2O (300 mL), and the solid was collected by suction filtration and
washed with H2O. Drying at 50 - 60°C in high vacuum left the title
compound. b) N,4-Dimethy4H-theino[3,2-b]pyrrole-5-carboxamide. According
to the procedure of Preparation 1 (b), except substituting ethyl
4-methy4H-theino[3,2-b]pyrrole-5-carboxylate (1.35 g, 6.5 mmole) for
ethyl-methylindole-2-carboxylate, the title compound. Yellow solid, yield
95% (1.19 g). MS (ES) m/e 195 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Drug screening for effectors of enoyl ACP reductase encoded by fabK and
fabI genes of Streptococcus pneumoniae for treatment of bacterial
infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dewolf, Walter E., Jr.; Payne, David J.; Seefeld, Mark A.; Wallis, Nicola
G.; West, Joshua M.; Brandt, Martin; Keller, Paul M.; Patel, Arunbhai H.;
Reed, Shannon L.; Tew, David G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002031128 A1 2002-04-18

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylate
C10H11NO2S
106200-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3777 5.1291 0.0 0
M  V30 2 C 5.4385 3.7663 0.0 0
M  V30 3 O 6.7721 2.9963 0.0 0
M  V30 4 O 5.4385 5.3063 0.0 0
M  V30 5 C 8.1058 3.7663 0.0 0
M  V30 6 C 9.4395 2.9963 0.0 0
M  V30 7 C 1.6672 2.4782 0.0 0
M  V30 8 C 2.4373 1.1446 0.0 0
M  V30 9 N 2.6978 3.6226 0.0 0
M  V30 10 C 0.1609 2.1580 0.0 0
M  V30 11 C 3.9437 1.4647 0.0 0
M  V30 12 S 1.4068 0.0000 0.0 0
M  V30 13 C 4.1047 2.9963 0.0 0
M  V30 14 C 0.0000 0.6263 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethyl-4H-thieno[3,2-b]pyrrole-5-carboxamide
C9H10N2OS
335031-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3104 0.0000 0.0 0
M  V30 2 C 6.2796 2.7104 0.0 0
M  V30 3 N 7.0496 4.0441 0.0 0
M  V30 4 O 7.0496 1.3768 0.0 0
M  V30 5 C 8.5896 4.0441 0.0 0
M  V30 6 C 2.3698 1.9404 0.0 0
M  V30 7 C 2.3698 3.4804 0.0 0
M  V30 8 N 3.8345 1.4646 0.0 0
M  V30 9 C 0.9051 1.4646 0.0 0
M  V30 10 C 3.8345 3.9563 0.0 0
M  V30 11 S 0.9051 3.9563 0.0 0
M  V30 12 C 4.7396 2.7104 0.0 0
M  V30 13 C 0.0000 2.7104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106200-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335031-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11865372
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: b) N,1-Dimethyl-1 H-indole-2-carboxamide. A
suspension of ethyl 1-methyl-1H-indole-2-carboxylate (27.10 g, 133.34
mmole) in 40% aqueous CH3NH2 (300 mL) and MeOH (30 mL) was stirred at RT.
A solid tended to gradually creep up the walls of the flask, and was
washed down periodically with MeOH. The flask was tightly stoppered to
keep the material inside the flask. As the reaction proceeded, the solid
dissolved, but eventually the product began to precipitate. The reaction
was stirred at RT for 5 days, then was concentrated to remove
approximately 200 25 mL of the solvent. The remaining residue was diluted
with H2O (300 mL), and the solid was collected by suction filtration and
washed with H2O. Drying at 50-60°C in high vacuum left the title
compound. b) N,4-Dimethyl-4H-theino[3,2-b]pyrrole-5-carboxamide According
to the procedure of Preparation 1 (b), except substituting ethyl
4-methyl-4H-theino[3,2-b]pyrrole-5-carboxylate (1.35 g, 6.5 mmole) for
ethyl-1-methylindole-2-carboxylate, the title compound (1.19 g, 95%) was
prepared as a yellow solid. MS (ES) m/e 195 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME273 STEP1
$RXN



  3  1
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Chlorophenyl)amino]-1-methyl-1H-pyrrole-2,5-dione
C11H9ClN2O2
921447-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3028 1.3628 0.0 0
M  V30 2 O 2.2420 0.0000 0.0 0
M  V30 3 C 0.0000 2.4898 0.0 0
M  V30 4 O 1.6752 5.3914 0.0 0
M  V30 5 Cl 10.6376 4.4428 0.0 0
M  V30 6 C 3.9690 2.1328 0.0 0
M  V30 7 C 2.5622 1.5063 0.0 0
M  V30 8 C 3.8080 3.6644 0.0 0
M  V30 9 N 1.5317 2.6509 0.0 0
M  V30 10 C 2.3017 3.9845 0.0 0
M  V30 11 C 6.6365 2.1328 0.0 0
M  V30 12 C 7.9701 1.3628 0.0 0
M  V30 13 C 6.6365 3.6728 0.0 0
M  V30 14 C 9.3038 2.1328 0.0 0
M  V30 15 C 7.9701 4.4428 0.0 0
M  V30 16 C 9.3038 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 2 4 10
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 921447-59-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4004756
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused pyrrolo[3,4-d]tetrahydropyrimidine derivatives by
proline-catalyzed multicomponent reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhi-Peng; Wang, Hai-Bo; Wang, Yu-Qin; Zhu, Qiu-Hua; Xie, Yang; Liu,
Shu-Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(29), 4379-4385

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-2,4-bis(trifluoromethyl)-1,8-naphthyridine
C10H3ClF6N2
106582-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 F 5.5411 1.5400 0.0 0
M  V30 3 F 4.0011 0.0000 0.0 0
M  V30 4 F 2.4611 1.5400 0.0 0
M  V30 5 C 1.3337 6.1601 0.0 0
M  V30 6 F 0.5636 4.8264 0.0 0
M  V30 7 F 0.0000 6.9301 0.0 0
M  V30 8 F 2.1037 7.4937 0.0 0
M  V30 9 Cl 9.3359 6.1601 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 4.0011 3.0800 0.0 0
M  V30 13 C 6.6684 3.0800 0.0 0
M  V30 14 N 4.0011 6.1601 0.0 0
M  V30 15 N 6.6684 6.1601 0.0 0
M  V30 16 C 2.6675 3.8500 0.0 0
M  V30 17 C 8.0022 3.8500 0.0 0
M  V30 18 C 2.6675 5.3901 0.0 0
M  V30 19 C 8.0022 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 18
M  V30 9 1 9 19
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5,7-bis(trifluoromethyl)-1,8-naphthyridin-2-amine
C11H7F6N3
1416050-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 F 2.4611 1.5400 0.0 0
M  V30 3 F 4.0011 0.0000 0.0 0
M  V30 4 F 5.5411 1.5400 0.0 0
M  V30 5 C 1.3336 6.1600 0.0 0
M  V30 6 F 2.1036 7.4936 0.0 0
M  V30 7 F 0.0000 6.9300 0.0 0
M  V30 8 F 0.5636 4.8264 0.0 0
M  V30 9 N 9.3358 6.1600 0.0 0
M  V30 10 C 10.6694 5.3900 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 5.3347 5.3900 0.0 0
M  V30 13 C 4.0011 3.0800 0.0 0
M  V30 14 C 6.6684 3.0800 0.0 0
M  V30 15 N 4.0011 6.1600 0.0 0
M  V30 16 N 6.6684 6.1600 0.0 0
M  V30 17 C 2.6673 3.8500 0.0 0
M  V30 18 C 8.0021 3.8500 0.0 0
M  V30 19 C 2.6673 5.3900 0.0 0
M  V30 20 C 8.0021 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 19
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106582-41-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1416050-19-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8410115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-methylamino-5,7-bis(trifluoromethyl)-1,8-naphthyridine,2: 1,8N-Cl(0.3
g, 1.0 mmol), 40% methylamine aqueous solution (0.54 ml, 5.0 mmol),
copper powder (0.003 g, 0.05 mmol), and water (3 ml) were placed in a
sealed tube and heated at 70 °C for 5 hr. The reaction mixture was cooled
to r. t. and was extracted by ethyl acetate for three times. The ethyl
acetate solution was washed with water and dried on sodium sulfate. After
filtration, the filtrate was evaporated. Crude 2 was purified by
recrystallization from methylenechloride and n-hexane. 2 was obtained.
Yellowish plates , yield (0.3 g, 1.0 mmol 95%). m.p. 227 - 229 °C. IR
(KBr disk) 3204 cm-1 (ν NH ). 1H NMR (500 MHz, CD3OD) δ 8.10 (d, J= 8.5
Hz, 1H), 7.89 (s, 1H), 7.76 (s, 1H), 7.07 (d, J= 9.2 Hz, 1H), 3.08 (s,
3H). 13C NMR (500 MHz, CD3OD) δ 162.33, 158.83, 150.05 (q, JC-F = 33.3
Hz), 137.90 (q, JC-F = 32.4 Hz), 132.87, 124.19 (q, JC-F = 274.9 Hz ),
122.44 (q, JC-F 274.9 Hz) 119.17, 115.81, 110.42, 28.34. ESI-MS(MeOH),
Calcd for [C11H7N3F6Na] + : 318.0442, Found: 318.0336. Anal. Calcd. for
C11H7N3F6: C 44.76, H 2.39, N 14.24%; Found: C 44.76, H 2.34, N 14.42%.
CCDC-888094, and 888095.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymorphic Equilibrium Responsive Thermal and Mechanical Stimuli in
Light-emitting Crystals of N-Methylaminonaphthyridine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harada, Naomi; Abe, Yuichiro; Karasawa, Satoru; Koga, Noboru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(24), 6282-6285

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acrylonitrile
C3H3N
107-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-(Methylimino)bis[propanenitrile]
C7H11N3
1555-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 N 0.0000 3.0801 0.0 0
M  V30 10 N 10.6697 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 3 7 9
M  V30 9 3 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-13-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1555-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16974571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient synthesis of N,N,N',N',N'-pentamethylldipropylenetriamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gui, Sizhe; Mu, Manman; Luo, Hao; Liu, Na; Shen, Huawei; Chen, Ligong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2016), 40(8), 486-488

$RFMT $RIREG SCHEME276 STEP1
$RXN



  3  1
$MOL
Chloromethyl methyl ether
C2H5ClO
107-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 O 2.6673 0.7700 0.0 0
M  V30 3 Cl 0.0000 0.7700 0.0 0
M  V30 4 C 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydroxybenzaldehyde
C7H6O3
139-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Bis(methoxymethoxy)-N-methylbenzenemethanamine
C12H19NO4
494225-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 2.6674 0.0 0
M  V30 3 O 4.6200 1.3336 0.0 0
M  V30 4 C 5.3900 0.0000 0.0 0
M  V30 5 O 3.0800 6.6684 0.0 0
M  V30 6 C 2.3100 8.0021 0.0 0
M  V30 7 O 0.7700 8.0021 0.0 0
M  V30 8 C 0.0000 9.3358 0.0 0
M  V30 9 C 9.2400 6.6684 0.0 0
M  V30 10 N 10.0100 8.0021 0.0 0
M  V30 11 C 11.5500 8.0021 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 4.6200 6.6684 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 5.3900 8.0021 0.0 0
M  V30 16 C 7.7000 6.6684 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 107-30-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 139-85-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 494225-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-008-CAS-2016034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catechol pendant polystyrene for solid-phase synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Wenqian; Gao, Xingming; Springsteen, Greg; Wang, Binghe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(36), 6339-6342

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Maleic anhydride
C4H2O3
108-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 O 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylmaleimide
C5H5NO2
930-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 O 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 C 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 930-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38072964
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Visible-Light-Induced Hydrogen Atom Transfer En Route to Exocylic
Alkenylation of Cyclic Ethers Enabled by Electron Donor-Acceptor Complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mandal, Tanumoy; Das, Sanju; Maji, Rohan; De Sarkar, Suman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2023), 25(42), 7727-7732

$RFMT $RIREG SCHEME278 STEP1
$RXN



  3  1
$MOL
Diethyl squarate
C8H10O4
5231-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.9014 2.2960 0.0 0
M  V30 2 C 7.2351 3.0661 0.0 0
M  V30 3 C 8.5687 2.2960 0.0 0
M  V30 4 O 2.3101 1.3337 0.0 0
M  V30 5 C 0.7700 1.3337 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 O 4.9390 5.8872 0.0 0
M  V30 8 O 1.3478 4.9250 0.0 0
M  V30 9 C 4.5676 3.0661 0.0 0
M  V30 10 C 3.0801 2.6673 0.0 0
M  V30 11 C 4.1690 4.5536 0.0 0
M  V30 12 C 2.6815 4.1550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 2 7 11
M  V30 8 2 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[3-(aminomethyl)phenyl]methyl]carbamate
C13H20N2O2
108467-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0010 3.0801 0.0 0
M  V30 4 O 2.6673 2.3101 0.0 0
M  V30 5 O 4.0010 4.6201 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 C 0.5637 1.7464 0.0 0
M  V30 10 C 12.0033 3.0801 0.0 0
M  V30 11 N 13.3370 2.3101 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 8.0022 0.7700 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 0.0000 0.0 0
M  V30 17 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[3-[[[2-(methylamino)-3,4-dioxo-1-cyclobuten-1-yl]amino]...
C18H23N3O4
943845-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1312 3.5914 0.0 0
M  V30 2 C 6.4651 2.8213 0.0 0
M  V30 3 N 1.5400 4.5536 0.0 0
M  V30 4 C 0.0000 4.5536 0.0 0
M  V30 5 O 4.1690 0.0000 0.0 0
M  V30 6 O 0.5778 0.9624 0.0 0
M  V30 7 C 11.7999 2.8213 0.0 0
M  V30 8 N 13.1336 3.5914 0.0 0
M  V30 9 C 14.4672 2.8213 0.0 0
M  V30 10 O 15.8011 3.5914 0.0 0
M  V30 11 O 14.4672 1.2813 0.0 0
M  V30 12 C 17.1347 2.8213 0.0 0
M  V30 13 C 17.9047 4.1550 0.0 0
M  V30 14 C 18.4684 2.0513 0.0 0
M  V30 15 C 16.3647 1.4877 0.0 0
M  V30 16 C 3.7976 2.8213 0.0 0
M  V30 17 C 2.3101 3.2199 0.0 0
M  V30 18 C 3.3990 1.3337 0.0 0
M  V30 19 C 1.9115 1.7324 0.0 0
M  V30 20 C 7.7987 3.5914 0.0 0
M  V30 21 C 9.1324 2.8213 0.0 0
M  V30 22 C 7.7987 5.1314 0.0 0
M  V30 23 C 10.4661 3.5914 0.0 0
M  V30 24 C 9.1324 5.9014 0.0 0
M  V30 25 C 10.4661 5.1314 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 2 5 18
M  V30 7 2 6 19
M  V30 8 1 7 8
M  V30 9 1 7 23
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5231-87-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108467-99-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943845-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2664439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparative Example 908 Step A To a solution of
3,4-diethoxy-3-cyclobutene-1,2-dione (790 μL) in MeOH (20 mL) was added
commercially available (3-aminomethyl-benzyl)-carbamic acid tert-butyl
ester (840 mg). The mixture was stirred for 2 h, 30% aqueous solution of
methylamine (30 mL) was added and stirring was continued for 2 h. The
formed precipitate was collected by filtration. The title compound as a
white solid (1.17 g, 95%). [MNa]+=368.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amide containing heterobicyclic metalloprotease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Steeneck, Christoph; Gege, Christian; Richter, Frank; Kroth, Heiko;
Hochguertel, Matthias; Essers, Michael; Van Veldhuizen, Joshua; Nolte,
Bert; Gallagher, Brian; Feuerstein, Tim; Schneider, Matthias; Arndt,
Torsten; Deng, Hongbo; Biesinger, Ralf; Wu, Xinyuan; Bluhm, Harald;
Sucholeiki, Irving; Taveras, Arthur G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070155738 A1 2007-07-05

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Cyanuric chloride
C3Cl3N3
108-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 Cl 2.6674 0.0000 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, compd. with trinitromethane (1:1)
CH5N.CHN3O6
14147-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0
M  V30 2 N 1.3338 4.6200 0.0 0 VAL=5
M  V30 3 N 4.0011 4.6200 0.0 0 VAL=5
M  V30 4 N 2.6674 2.3100 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3338 6.1600 0.0 0
M  V30 7 O 4.0011 6.1600 0.0 0
M  V30 8 O 5.3349 3.8500 0.0 0
M  V30 9 O 4.0011 1.5400 0.0 0
M  V30 10 O 1.3338 1.5400 0.0 0
M  V30 11 C 1.8974 0.0000 0.0 0
M  V30 12 N 3.4374 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 2 3 8
M  V30 8 2 4 9
M  V30 9 2 4 10
M  V30 10 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,5-Triazin-2(1H)-one, 4,6-bis(trinitromethyl)-, compd. with methanamine (1:1)
C5HN9O13.CH5N
1246616-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 6.1601 0.0 0
M  V30 2 N 9.3360 6.9301 0.0 0 VAL=5
M  V30 3 N 8.7723 4.8263 0.0 0 VAL=5
M  V30 4 N 7.2323 7.4938 0.0 0 VAL=5
M  V30 5 O 10.6697 6.1601 0.0 0
M  V30 6 O 9.3360 8.4702 0.0 0
M  V30 7 O 10.3124 4.8263 0.0 0
M  V30 8 O 8.0023 3.4926 0.0 0
M  V30 9 O 8.0023 8.8274 0.0 0
M  V30 10 O 5.6923 7.4938 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 N 1.3337 6.9301 0.0 0 VAL=5
M  V30 13 N 3.4374 7.4938 0.0 0 VAL=5
M  V30 14 N 1.8973 4.8263 0.0 0 VAL=5
M  V30 15 O 0.0000 6.1601 0.0 0
M  V30 16 O 1.3337 8.4702 0.0 0
M  V30 17 O 2.6673 8.8274 0.0 0
M  V30 18 O 4.9774 7.4938 0.0 0
M  V30 19 O 2.6673 3.4926 0.0 0
M  V30 20 O 0.3573 4.8263 0.0 0
M  V30 21 O 5.3348 1.5400 0.0 0
M  V30 22 C 6.6685 5.3901 0.0 0
M  V30 23 N 5.3348 6.1601 0.0 0
M  V30 24 N 6.6685 3.8501 0.0 0
M  V30 25 C 4.0012 5.3901 0.0 0
M  V30 26 C 5.3348 3.0800 0.0 0
M  V30 27 N 4.0012 3.8501 0.0 0
M  V30 28 C 4.5648 0.0000 0.0 0
M  V30 29 N 6.1048 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 22
M  V30 5 2 2 5
M  V30 6 2 2 6
M  V30 7 2 3 7
M  V30 8 2 3 8
M  V30 9 2 4 9
M  V30 10 2 4 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 25
M  V30 15 2 12 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 13 18
M  V30 19 2 14 19
M  V30 20 2 14 20
M  V30 21 2 21 26
M  V30 22 1 22 23
M  V30 23 2 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 28 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14147-71-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246616-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-168-CAS-4807515
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of tetraalkylammonium salts of
2-hydroxy-4,6-bis(trinitromethyl)-1,3,5-triazine 4b,f,g (general
procedure). A solution of salt 1a,b,j,k (0.04 mol) in acetone
(acetonitrile) (15 mL) was treated with CC (1.84 g, 0.01 mol) with
stirring and then with water (0.18 mL, 0.01 mol) at 20-25°C. The reaction
mixture was held at 20-25°C until CC was completely reacted (which took
3-4 h in acetone and 20-22 h in acetonitrile). Then the mixture was
poured with stirring into water (150 mL). In the case of salts 1f-h,
salts 4b,f,g precipitated immediately. When using salts 1a,b,j,k, the
obtained solution was treated drop- wise with a solution of appropriate
tetraalkylammonium chlo- ride (0.011 mol) in water (15 mL) over 10-15
min. The resulting precipitate of salts 4b,f,g was filtered off, washed
with water (3×20 mL), and allowed to air dry. Tetramethylammonium salt of
2-hydroxy-4,6-bis(trinitromethyl)-1,3,5-triazine (4b).
$DTYPE RXN:VAR(1):NOTES
$DATUM safety, polynitro compounds are shock-, friction- and
temperature-sensitive, acetonitrile as solvent required longer time,
product depends on presence/absence of water
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Trinitromethylation reactions of chloro-1,3,5-triazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gidaspov, A. A.; Bakharev, V. V.; Kukushkin, I. K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2009), 58(10), 2154-2163

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Cyanuric chloride
C3Cl3N3
108-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 Cl 2.6674 0.0000 0.0 0
M  V30 4 N 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2,N4-dimethyl-1,3,5-triazine-2,4-diamine
C5H8ClN5
2911-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 N 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 Cl 4.0012 0.0000 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 N 4.0012 4.6201 0.0 0
M  V30 8 N 2.6675 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2911-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5829747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Methylmelamines: Synthesis, Characterization, and Physical Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM List, Manuela; Puchinger, Helmut; Gabriel, Herbert; Monkowius, Uwe;
Schwarzinger, Clemens
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2016), 81(10), 4066-4075

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenyl-7-(trichloromethyl)[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-amine
C11H7Cl3N6
1095050-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 Cl 1.1274 1.5400 0.0 0
M  V30 3 Cl 2.6674 0.0000 0.0 0
M  V30 4 Cl 4.2074 1.5400 0.0 0
M  V30 5 N 0.0000 6.1600 0.0 0
M  V30 6 N 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 5.3900 0.0 0
M  V30 9 N 5.4658 3.3741 0.0 0
M  V30 10 N 1.3338 3.8500 0.0 0
M  V30 11 N 5.4658 5.8659 0.0 0
M  V30 12 N 2.6674 6.1600 0.0 0
M  V30 13 C 6.3710 4.6200 0.0 0
M  V30 14 C 1.3338 5.3900 0.0 0
M  V30 15 C 7.9110 4.6200 0.0 0
M  V30 16 C 8.6810 5.9536 0.0 0
M  V30 17 C 8.6810 3.2864 0.0 0
M  V30 18 C 10.2210 5.9536 0.0 0
M  V30 19 C 10.2210 3.2864 0.0 0
M  V30 20 C 10.9910 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N7-Methyl-2-phenyl[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine
C11H11N7
1095050-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 N 0.0000 5.3900 0.0 0
M  V30 4 N 4.0011 3.0800 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 N 5.4658 2.6042 0.0 0
M  V30 8 N 5.4658 5.0959 0.0 0
M  V30 9 N 2.6674 5.3900 0.0 0
M  V30 10 N 1.3338 3.0800 0.0 0
M  V30 11 C 6.3710 3.8500 0.0 0
M  V30 12 C 1.3338 4.6200 0.0 0
M  V30 13 C 7.9110 3.8500 0.0 0
M  V30 14 C 8.6810 2.5164 0.0 0
M  V30 15 C 8.6810 5.1837 0.0 0
M  V30 16 C 10.2210 2.5164 0.0 0
M  V30 17 C 10.2210 5.1837 0.0 0
M  V30 18 C 10.9910 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1095050-82-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1095050-86-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11329319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused heterocyclic systems with s-triazine ring. Part 12. A convenient
method for the synthesis of 7-amino-substituted
1,2,4-triazolo[1,5-a][1,3,5]triazin-5-amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolzhenko, Anton V.; Pastorin, Giorgia; Dolzhenko, Anna V.; Chui, Wai
Keung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2008), 49(50), 7180-7183

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-fluoro-4-nitropyridine
C5H2ClFN2O2
109613-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 N 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-nitro-3-pyridinamine
C6H6ClN3O2
2733348-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Cl 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 N 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109613-90-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2733348-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37767687
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; De Savi, Chris; Weiss, Matthew M.; Zhu, Xiao; Zheng,
Xiaozhang; Follows, Bruce C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023147594 A2 2023-08-03

$RFMT $RIREG SCHEME283 STEP1
$RXN



  6  1
$MOL
Acetyl chloride
C2H3ClO
75-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylamine
C2H7N
124-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Ethylidene-2,2-dimethyl-1,3-dioxane-4,6-dione
C8H10O4
18921-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 1.5400 0.0 0
M  V30 2 C 6.8516 2.3101 0.0 0
M  V30 3 O 5.5178 4.6201 0.0 0
M  V30 4 O 2.8504 0.0000 0.0 0
M  V30 5 C 0.0000 3.5826 0.0 0
M  V30 6 C 0.9899 5.2971 0.0 0
M  V30 7 C 4.1841 2.3101 0.0 0
M  V30 8 C 4.1841 3.8501 0.0 0
M  V30 9 C 2.8504 1.5400 0.0 0
M  V30 10 O 2.8504 4.6201 0.0 0
M  V30 11 O 1.5168 2.3101 0.0 0
M  V30 12 C 1.5168 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 12
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[pyrido[1,2-a]indole-10(6H),2′-pyrrolidine]-3′-carboxamide, 8-amino-9-cy...
C20H21N5O2
2851041-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4421 4.5079 0.0 0
M  V30 2 N 9.4524 5.6701 0.0 0
M  V30 3 O 8.9434 3.0518 0.0 0
M  V30 4 C 10.9642 5.3763 0.0 0
M  V30 5 C 3.0206 5.5717 0.0 0
M  V30 6 C 2.6674 6.1600 0.0 0
M  V30 7 N 2.6674 7.7000 0.0 0
M  V30 8 C 8.1763 7.2469 0.0 0
M  V30 9 O 2.6674 0.0000 0.0 0
M  V30 10 N 0.0000 4.6200 0.0 0
M  V30 11 C 5.4658 4.3259 0.0 0
M  V30 12 C 4.0011 3.8500 0.0 0
M  V30 13 C 6.3710 3.0800 0.0 0
M  V30 14 C 6.9303 4.8017 0.0 0
M  V30 15 N 4.5606 5.5717 0.0 0
M  V30 16 N 4.0011 2.3100 0.0 0
M  V30 17 C 2.6674 4.6200 0.0 0
M  V30 18 C 5.4658 1.8341 0.0 0
M  V30 19 C 7.9025 2.9191 0.0 0
M  V30 20 C 6.9303 6.3417 0.0 0
M  V30 21 C 5.4658 6.8177 0.0 0
M  V30 22 C 2.6674 1.5400 0.0 0
M  V30 23 C 1.3338 3.8500 0.0 0
M  V30 24 C 6.0921 0.4272 0.0 0
M  V30 25 C 8.5288 1.5121 0.0 0
M  V30 26 C 1.3338 2.3100 0.0 0
M  V30 27 C 7.6236 0.2663 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 3 6 7
M  V30 7 1 6 17
M  V30 8 1 8 20
M  V30 9 2 9 22
M  V30 10 1 10 23
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 2 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 16 18
M  V30 22 1 16 22
M  V30 23 1 17 23
M  V30 24 2 18 24
M  V30 25 1 19 25
M  V30 26 1 20 21
M  V30 27 1 22 26
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 2 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 124-40-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 18921-82-9
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2851041-72-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34484638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM iron oxide and cadmium oxide nanoparticles on multi-walled carbon
nanotubes
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, catalyst prepared and used,
recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Six-component synthesis and biological activity of novel
spiropyridoindolepyrrolidine derivatives: a combined experimental and
theoretical investigation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hossaini, Zinatossadat; Mohammadi, Marziyeh; Sheikholeslami-Farahani,
Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Frontiers in Chemistry (Lausanne, Switzerland) (2022), 10949205

$RFMT $RIREG SCHEME284 STEP1
$RXN



  6  1
$MOL
Acetyl chloride
C2H3ClO
75-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylamine
C2H7N
124-40-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-5-(1-methylethylidene)-1,3-dioxane-4,6-dione
C9H12O4
2231-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 1.5400 0.0 0
M  V30 2 C 6.8516 2.3101 0.0 0
M  V30 3 C 5.5178 0.0000 0.0 0
M  V30 4 O 2.8504 0.0000 0.0 0
M  V30 5 O 5.5178 4.6201 0.0 0
M  V30 6 C 0.9899 5.2971 0.0 0
M  V30 7 C 0.0000 3.5826 0.0 0
M  V30 8 C 4.1841 2.3101 0.0 0
M  V30 9 C 2.8504 1.5400 0.0 0
M  V30 10 C 4.1841 3.8501 0.0 0
M  V30 11 O 1.5168 2.3101 0.0 0
M  V30 12 O 2.8504 4.6201 0.0 0
M  V30 13 C 1.5168 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 8
M  V30 4 2 4 9
M  V30 5 2 5 10
M  V30 6 1 6 13
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Malononitrile
C3H2N2
109-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.0000 0.0 0
M  V30 2 C 1.3338 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[pyrido[1,2-a]indole-10(6H),2′-pyrrolidine]-3′-carboxamide, 8-amino-9-cy...
C21H23N5O2
2851041-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4421 4.5079 0.0 0
M  V30 2 N 9.4524 5.6701 0.0 0
M  V30 3 O 8.9434 3.0518 0.0 0
M  V30 4 C 10.9642 5.3763 0.0 0
M  V30 5 C 3.0206 5.5717 0.0 0
M  V30 6 C 2.6674 6.1600 0.0 0
M  V30 7 N 2.6674 7.7000 0.0 0
M  V30 8 C 8.4620 6.1808 0.0 0
M  V30 9 C 7.2505 7.8481 0.0 0
M  V30 10 O 2.6674 0.0000 0.0 0
M  V30 11 N 0.0000 4.6200 0.0 0
M  V30 12 C 5.4658 4.3259 0.0 0
M  V30 13 C 4.0011 3.8500 0.0 0
M  V30 14 C 6.3710 3.0800 0.0 0
M  V30 15 C 6.9303 4.8017 0.0 0
M  V30 16 N 4.5606 5.5717 0.0 0
M  V30 17 N 4.0011 2.3100 0.0 0
M  V30 18 C 2.6674 4.6200 0.0 0
M  V30 19 C 5.4658 1.8341 0.0 0
M  V30 20 C 7.9025 2.9191 0.0 0
M  V30 21 C 6.9303 6.3417 0.0 0
M  V30 22 C 5.4658 6.8177 0.0 0
M  V30 23 C 2.6674 1.5400 0.0 0
M  V30 24 C 1.3338 3.8500 0.0 0
M  V30 25 C 6.0921 0.4272 0.0 0
M  V30 26 C 8.5288 1.5121 0.0 0
M  V30 27 C 1.3338 2.3100 0.0 0
M  V30 28 C 7.6236 0.2663 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 16
M  V30 6 3 6 7
M  V30 7 1 6 18
M  V30 8 1 8 21
M  V30 9 1 9 21
M  V30 10 2 10 23
M  V30 11 1 11 24
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 2 14 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 17 19
M  V30 23 1 17 23
M  V30 24 1 18 24
M  V30 25 2 19 25
M  V30 26 1 20 26
M  V30 27 1 21 22
M  V30 28 1 23 27
M  V30 29 2 24 27
M  V30 30 1 25 28
M  V30 31 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 124-40-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 2231-66-5
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 109-77-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2851041-67-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34484620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM iron oxide and cadmium oxide nanoparticles on multi-walled carbon
nanotubes
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, green chemistry-catalyst, catalyst prepared and used,
recyclable catalyst upto 5 cycles without loss its activity, optimization
study, optimized on catalyst, optimized on solvent, optimized on
temperature, optimized on time, optimized on stoichiometry of catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Six-component synthesis and biological activity of novel
spiropyridoindolepyrrolidine derivatives: a combined experimental and
theoretical investigation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hossaini, Zinatossadat; Mohammadi, Marziyeh; Sheikholeslami-Farahani,
Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Frontiers in Chemistry (Lausanne, Switzerland) (2022), 10949205

$RFMT $RIREG SCHEME285 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 4-chloro-2-[3-(chloromethyl)-4-fluorophenoxy]-
C14H8Cl2FNO
508204-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.8501 4.0012 0.0 0
M  V30 2 C 0.7700 4.0012 0.0 0
M  V30 3 N 0.0000 2.6675 0.0 0
M  V30 4 Cl 3.8501 9.3360 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 Cl 7.7002 0.0000 0.0 0
M  V30 7 F 10.0102 4.0012 0.0 0
M  V30 8 C 3.0801 5.3348 0.0 0
M  V30 9 C 1.5400 5.3348 0.0 0
M  V30 10 C 3.8501 6.6685 0.0 0
M  V30 11 C 0.7700 6.6685 0.0 0
M  V30 12 C 3.0801 8.0023 0.0 0
M  V30 13 C 1.5400 8.0023 0.0 0
M  V30 14 C 5.3901 4.0012 0.0 0
M  V30 15 C 6.1601 2.6675 0.0 0
M  V30 16 C 6.1601 5.3348 0.0 0
M  V30 17 C 7.7002 2.6675 0.0 0
M  V30 18 C 7.7002 5.3348 0.0 0
M  V30 19 C 8.4702 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 3 2 3
M  V30 4 1 2 9
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fumaric acid
C4H4O4
110-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 O 6.6685 1.5400 0.0 0
M  V30 8 O 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 4-chloro-2-[4-fluoro-3-[(methylamino)methyl]phenoxy]-, (2E)-2-b...
C15H12ClFN2O.C4H4O4
508204-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 9.3912 0.0 0
M  V30 2 C 3.0801 6.7237 0.0 0
M  V30 3 N 3.8501 5.3900 0.0 0
M  V30 4 Cl 0.0000 12.0585 0.0 0
M  V30 5 C 9.2402 12.0585 0.0 0
M  V30 6 N 10.0102 10.7248 0.0 0
M  V30 7 C 11.5503 10.7248 0.0 0
M  V30 8 F 7.7002 14.7260 0.0 0
M  V30 9 C 3.0801 9.3912 0.0 0
M  V30 10 C 2.3101 8.0575 0.0 0
M  V30 11 C 2.3101 10.7248 0.0 0
M  V30 12 C 0.7700 8.0575 0.0 0
M  V30 13 C 0.7700 10.7248 0.0 0
M  V30 14 C 0.0000 9.3912 0.0 0
M  V30 15 C 5.3901 10.7248 0.0 0
M  V30 16 C 6.9302 10.7248 0.0 0
M  V30 17 C 4.6201 12.0585 0.0 0
M  V30 18 C 7.7002 12.0585 0.0 0
M  V30 19 C 5.3901 13.3923 0.0 0
M  V30 20 C 6.9302 13.3923 0.0 0
M  V30 21 C 5.1083 2.3100 0.0 0
M  V30 22 C 6.4419 1.5400 0.0 0
M  V30 23 C 3.7747 1.5400 0.0 0
M  V30 24 C 7.7756 2.3100 0.0 0
M  V30 25 O 2.4409 2.3100 0.0 0
M  V30 26 O 3.7747 0.0000 0.0 0
M  V30 27 O 9.1094 1.5400 0.0 0
M  V30 28 O 7.7756 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 3 2 3
M  V30 4 1 2 10
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 1 6 7
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 23 26
M  V30 27 1 24 27
M  V30 28 2 24 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 508204-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 110-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 508204-31-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9962532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) 4-Chloro-2-(4-fluoro-3-methylaminomethyl-phenoxy)-benzonitrile
fumarate To a solution of
4-chloro-2-(3-chloromethyl-4-fluorophenoxy)-benzonitrile (0.14 g, 0.47
mmol) in ethanol (15 mL) was added methylamine (33% in ethanol, 4.0 mL,
32 mmol), and the reaction mixture stirred for 10 days at ambient
temperature. The solvent was removed in vacuo. The residue was treated
with 10% sodium carbonate solution and extracted with ethyl acetate. The
ethyl acetate layer was separated and a solution of fumaric acid (50 mg,
0.43 mmol) in methanol (3 mL) was added. After the solvent was removed in
vacuo, the residue was triturated with diethyl ether overnight, collected
by filtration, and dried to give
4-chloro-2-(4-fluoro-3-methylaminomethyl-phenoxy)-benzonitrile fumarate.
White solid, yield 183 mg, 95%. MS (APCI+) 291/293 [M+1]+. 1H-NMR (300
MHz, d6-DMSO): δ 7.95 (1H, d), 7.38 (1H, dd), 7.33-7.27 (2H, m), 7.23-
7.15 (1H, m), 6.93 (1H, m), 6.45 (1H, s), 3.74 (2H, s), 2.29 (3H, s).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of [(hetero)aryloxy]phenylalkylamines as inhibitors of nitric
oxide synthase for treatment of inflammatory diseases, pain, and CNS
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Connolly, Stephen; Ernst, Glen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003029185 A1 2003-04-10

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Fumaric acid
C4H4O4
110-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 O 6.6685 1.5400 0.0 0
M  V30 8 O 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-L-aspartic acid
C5H9NO4
4226-18-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0 CFG=2
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 N 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 C 1.3338 4.6200 0.0 0
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 110-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4226-18-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9672358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methylaspartic acid 2.36: To a solution of methylamine (40 % in water,
4.20 mL, 50.0 mmol) in 5 mM phosphate buffer 6 N aq. HCl was added until
pH 8.0 was reached. 10 mL of a 500 mM stock solution of fumarate (5.00
mmol) at pH 8.0 were added, and the Greiner tube was filled up to 50 mL
with 5 mM phosphate buffer (pH 8.0). After addition of AspB (400 microL,
0.072 mmol) from a frozen stock, the tube was shaken at 100 rpm at 37
degC for 7 days. The reaction was followed to completion, as confirmed
spectrophotometrically until no absorption at 240-270 nm was observed.
The solvent was evaporated and the white residue purified by flash
chromatography on silica gel (HOAc:EtOAc:MeOH:H2O = 3:3:3:2). After
evaporation of the solvent and lyophilization, the product (95 %) was
obtained as white gum. [alpha 20 D] = +24.6 deg (c = 0.256 in 1 N aq.
HCl).
$DTYPE RXN:VAR(1):NOTES
$DATUM AspB enzyme used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Methods towards the Synthesis of beta-Amino Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiner, Barbara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2009), (20140701), No pp.

$RFMT $RIREG SCHEME287 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-hydroxy-2-(hydroxymethyl)-1-methyl-6-(3-pyridinyl)-1H-indole-3-carbox...
C18H18N2O4
1106670-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3510 4.8721 0.0 0
M  V30 2 O 11.8158 4.3962 0.0 0
M  V30 3 O 10.0309 6.3785 0.0 0
M  V30 4 C 12.9602 5.4266 0.0 0
M  V30 5 C 14.4249 4.9507 0.0 0
M  V30 6 C 10.7012 1.5400 0.0 0
M  V30 7 O 10.7012 0.0000 0.0 0
M  V30 8 C 7.6404 0.1773 0.0 0
M  V30 9 O 4.6201 6.8291 0.0 0
M  V30 10 C 9.2066 3.8416 0.0 0
M  V30 11 C 7.7002 4.1618 0.0 0
M  V30 12 C 9.3676 2.3101 0.0 0
M  V30 13 C 6.9302 2.8281 0.0 0
M  V30 14 C 6.9302 5.4955 0.0 0
M  V30 15 N 7.9607 1.6836 0.0 0
M  V30 16 C 5.3901 2.8281 0.0 0
M  V30 17 C 5.3901 5.4955 0.0 0
M  V30 18 C 4.6201 4.1618 0.0 0
M  V30 19 C 3.0801 4.1618 0.0 0
M  V30 20 C 2.3101 2.8281 0.0 0
M  V30 21 C 2.3101 5.4955 0.0 0
M  V30 22 C 0.7700 2.8281 0.0 0
M  V30 23 N 0.7700 5.4955 0.0 0
M  V30 24 C 0.0000 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 15
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2,3,7-tetrahydro-8-(hydroxymethyl)-2,7-dimethyl-5-(3-pyridinyl)pyrrol...
C21H23N3O4
958451-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3508 4.6245 0.0 0
M  V30 2 O 11.8155 5.1003 0.0 0
M  V30 3 O 10.0306 3.1182 0.0 0
M  V30 4 C 12.9599 4.0699 0.0 0
M  V30 5 C 14.4246 4.5458 0.0 0
M  V30 6 C 7.6402 9.3193 0.0 0
M  V30 7 C 10.7010 7.9566 0.0 0
M  V30 8 O 10.7010 9.4966 0.0 0
M  V30 9 C 7.7000 0.0000 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.9300 6.6685 0.0 0
M  V30 13 C 9.2064 5.6549 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 5.3900 6.6685 0.0 0
M  V30 17 N 7.9606 7.8129 0.0 0
M  V30 18 C 9.3674 7.1866 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 O 4.6200 2.6674 0.0 0
M  V30 21 N 6.9300 1.3338 0.0 0
M  V30 22 C 5.3900 1.3338 0.0 0
M  V30 23 C 3.0800 5.3347 0.0 0
M  V30 24 C 2.3100 4.0011 0.0 0
M  V30 25 C 2.3100 6.6685 0.0 0
M  V30 26 C 0.7700 4.0011 0.0 0
M  V30 27 N 0.7700 6.6685 0.0 0
M  V30 28 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 2 16 19
M  V30 22 1 17 18
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1106670-99-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958451-03-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-12383821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Ethyl
2,7-dimethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylates
(11a-i), general preparation method. The appropriate ethyl
5-hydroxy-1-methyl-1H-indole-3-carboxylate 5 - 8 (0.5 mmol) and MeNH2 (2
mL, 2 M) in THF and formaldehyde as formalin (8 mmol) in THF (10 mL) were
refluxed for 12 h. The course of the reaction was monitored using LC-MS.
When the reaction was finished, the mixture was diluted with ice water
(1.5 L). The precipitate was filtered off, washed with H2O, suspended in
cold (5 - 7°C) isopropanol, and stirred at 5 - 7°C for 1 h. The
precipitate was filtered off, washed with isopropanol, and dried in
vacuo. The resulting product was dissolved in dioxane, treated with HCl
(3 M) in dioxane, and diluted with Et2O. The resulting precipitate was
filtered off and dried in vacuo. Ethyl
8-hydroxymethyl-2,7-dimethyl-6-pyridin-3-yl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylate
(11f), Yield: 75-95%. LC-MS: found m/z 382 (M + H), calculated 382 (M + 1
for C21H23N3O4). PMR spectrum (DMSO-d6), δ, ppm: 9.12 (s, 1H), 8.85 (d, J
5.2 Hz, 1H), 8.65 (d, J 8 Hz, 1H), 8.02 (m, 1H), 7.88 (s, 1H), 5.25 (s,
2H), 4.98 (s, 2H), 4.34 (q, J 7.2 Hz, 2H), 3.91 (s, 3H), 2.35 (s, 7H),
1.38 (t, J 7.6 Hz, 3H. Compound Against Influenza A/New Caledonia/20/99
Virus (H N1) in MDCK Cell Culture: EC50: 8.9 ± 0.9μM.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Ethyl
1,2-dimethyl-5-Hydroxy-1H-Indole-3-carboxylates and Their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil, V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun, I. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 47(12), 636-650

$RFMT $RIREG SCHEME288 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-cyano-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylate
C20H18N2O3S
1106671-44-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2754 3.7535 0.0 0
M  V30 2 O 6.2449 2.6091 0.0 0
M  V30 3 O 8.7818 3.4333 0.0 0
M  V30 4 C 6.7208 1.1444 0.0 0
M  V30 5 C 5.6904 0.0000 0.0 0
M  V30 6 C 9.2447 6.4641 0.0 0
M  V30 7 S 10.0148 7.7977 0.0 0
M  V30 8 C 7.2754 9.1745 0.0 0
M  V30 9 O 1.3338 4.9241 0.0 0
M  V30 10 C 1.3338 8.0041 0.0 0
M  V30 11 N 0.0000 8.7741 0.0 0
M  V30 12 C 5.3348 5.6941 0.0 0
M  V30 13 C 6.7995 5.2182 0.0 0
M  V30 14 C 5.3348 7.2341 0.0 0
M  V30 15 C 4.0011 4.9241 0.0 0
M  V30 16 C 7.7047 6.4641 0.0 0
M  V30 17 N 6.7995 7.7100 0.0 0
M  V30 18 C 4.0011 8.0041 0.0 0
M  V30 19 C 2.6675 5.6941 0.0 0
M  V30 20 C 2.6675 7.2341 0.0 0
M  V30 21 C 11.5548 7.7977 0.0 0
M  V30 22 C 12.3248 9.1314 0.0 0
M  V30 23 C 12.3248 6.4641 0.0 0
M  V30 24 C 13.8648 9.1314 0.0 0
M  V30 25 C 13.8648 6.4641 0.0 0
M  V30 26 C 14.6348 7.7977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 21
M  V30 9 1 8 17
M  V30 10 1 9 19
M  V30 11 3 10 11
M  V30 12 1 10 20
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-cyano-1,2,3,7-tetrahydro-2,7-dimethyl-8-[(phenylthio)methyl]pyrrolo[3...
C23H23N3O3S
958450-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2753 2.6795 0.0 0
M  V30 2 O 8.7817 2.3593 0.0 0
M  V30 3 O 6.2449 1.5349 0.0 0
M  V30 4 C 9.2576 0.8946 0.0 0
M  V30 5 C 10.7639 0.5744 0.0 0
M  V30 6 C 9.2447 5.3900 0.0 0
M  V30 7 S 10.0147 6.7237 0.0 0
M  V30 8 C 7.2753 8.1004 0.0 0
M  V30 9 C 1.3338 6.9300 0.0 0
M  V30 10 N 0.0000 7.7000 0.0 0
M  V30 11 C 2.6674 0.0000 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 4.0011 3.8500 0.0 0
M  V30 14 C 6.7994 4.1440 0.0 0
M  V30 15 C 5.3347 6.1600 0.0 0
M  V30 16 C 2.6674 4.6200 0.0 0
M  V30 17 C 4.0011 2.3100 0.0 0
M  V30 18 C 7.7047 5.3900 0.0 0
M  V30 19 N 6.7994 6.6359 0.0 0
M  V30 20 C 4.0011 6.9300 0.0 0
M  V30 21 C 2.6674 6.1600 0.0 0
M  V30 22 O 1.3338 3.8500 0.0 0
M  V30 23 N 2.6674 1.5400 0.0 0
M  V30 24 C 1.3338 2.3100 0.0 0
M  V30 25 C 11.5547 6.7237 0.0 0
M  V30 26 C 12.3247 5.3900 0.0 0
M  V30 27 C 12.3247 8.0573 0.0 0
M  V30 28 C 13.8647 5.3900 0.0 0
M  V30 29 C 13.8647 8.0573 0.0 0
M  V30 30 C 14.6347 6.7237 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 25
M  V30 9 1 8 19
M  V30 10 3 9 10
M  V30 11 1 9 21
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 1 16 22
M  V30 23 1 17 23
M  V30 24 1 18 19
M  V30 25 2 20 21
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1106671-44-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958450-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-8129358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Ethyl
2,7-dimethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylates
(11a-i), general preparation method. The appropriate ethyl
5-hydroxy-1-methyl-1H-indole-3-carboxylate 5 - 8 (0.5 mmol) and MeNH2 (2
mL, 2 M) in THF and formaldehyde as formalin (8 mmol) in THF (10 mL) were
refluxed for 12 h. The course of the reaction was monitored using LC-MS.
When the reaction was finished, the mixture was diluted with ice water
(1.5 L). The precipitate was filtered off, washed with H2O, suspended in
cold (5 - 7°C) isopropanol, and stirred at 5 - 7°C for 1 h. The
precipitate was filtered off, washed with isopropanol, and dried in
vacuo. The resulting product was dissolved in dioxane, treated with HCl
(3 M) in dioxane, and diluted with Et2O. The resulting precipitate was
filtered off and dried in vacuo. Ethyl
2,7-dimethyl-8-phenylthiomethyl-6-cyano-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylate
(11e), Yield: 75-95%. LC-MS: found m/z 422 (M + H), calculated 422 (M + 1
for C23H23N3O3S). Compounds Against BVDV in MDBK Cell Culture: EC50:
>19.9 μM, CC50: 19.9 ± 1.3 μM, SI50: <1. Compound Against HCV in Human
Hepatoma Cell Line Huh7 Containing HCV Subgenomic RNA-Replicon (Genotype
1a, Clone Con1): EC50: 11.9 ± 1.5 μM, CC50: 12.0 ± 1.9 μM, SI50: 1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Ethyl
1,2-dimethyl-5-Hydroxy-1H-Indole-3-carboxylates and Their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil, V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun, I. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 47(12), 636-650

$RFMT $RIREG SCHEME289 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-hydroxy-1-methyl-2-[(phenylthio)methyl]-6-(3-pyridinyl)-1H-indole-3-c...
C24H22N2O3S
1106671-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6089 3.7534 0.0 0
M  V30 2 O 7.5785 2.6091 0.0 0
M  V30 3 O 10.1153 3.4333 0.0 0
M  V30 4 C 8.0544 1.1444 0.0 0
M  V30 5 C 7.0239 0.0000 0.0 0
M  V30 6 C 10.5783 6.4640 0.0 0
M  V30 7 S 11.3483 7.7976 0.0 0
M  V30 8 C 8.6089 9.1745 0.0 0
M  V30 9 O 2.6674 4.9240 0.0 0
M  V30 10 C 6.6684 5.6940 0.0 0
M  V30 11 C 8.1330 5.2181 0.0 0
M  V30 12 C 6.6684 7.2340 0.0 0
M  V30 13 C 5.3347 4.9240 0.0 0
M  V30 14 C 9.0383 6.4640 0.0 0
M  V30 15 N 8.1330 7.7099 0.0 0
M  V30 16 C 5.3347 8.0040 0.0 0
M  V30 17 C 4.0011 5.6940 0.0 0
M  V30 18 C 4.0011 7.2340 0.0 0
M  V30 19 C 2.6674 8.0040 0.0 0
M  V30 20 C 2.6674 9.5440 0.0 0
M  V30 21 C 1.3336 7.2340 0.0 0
M  V30 22 C 1.3336 10.3140 0.0 0
M  V30 23 N 0.0000 8.0040 0.0 0
M  V30 24 C 0.0000 9.5440 0.0 0
M  V30 25 C 12.8883 7.7976 0.0 0
M  V30 26 C 13.6583 6.4640 0.0 0
M  V30 27 C 13.6583 9.1314 0.0 0
M  V30 28 C 15.1983 6.4640 0.0 0
M  V30 29 C 15.1983 9.1314 0.0 0
M  V30 30 C 15.9683 7.7976 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 25
M  V30 9 1 8 15
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2,3,7-tetrahydro-2,7-dimethyl-8-[(phenylthio)methyl]-5-(3-pyridinyl)p...
C27H27N3O3S
958488-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6089 2.6794 0.0 0
M  V30 2 O 10.1153 2.3593 0.0 0
M  V30 3 O 7.5785 1.5351 0.0 0
M  V30 4 C 10.5912 0.8947 0.0 0
M  V30 5 C 12.0975 0.5744 0.0 0
M  V30 6 C 8.6089 8.1006 0.0 0
M  V30 7 C 10.5783 5.3900 0.0 0
M  V30 8 S 11.3483 6.7236 0.0 0
M  V30 9 C 4.0011 0.0000 0.0 0
M  V30 10 C 6.6684 4.6200 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 6.6684 6.1600 0.0 0
M  V30 13 C 8.1330 4.1441 0.0 0
M  V30 14 C 4.0011 4.6200 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 16 C 5.3347 6.9300 0.0 0
M  V30 17 N 8.1330 6.6359 0.0 0
M  V30 18 C 9.0383 5.3900 0.0 0
M  V30 19 C 4.0011 6.1600 0.0 0
M  V30 20 O 2.6674 3.8500 0.0 0
M  V30 21 N 4.0011 1.5400 0.0 0
M  V30 22 C 2.6674 2.3100 0.0 0
M  V30 23 C 2.6674 6.9300 0.0 0
M  V30 24 C 1.3336 6.1600 0.0 0
M  V30 25 C 2.6674 8.4700 0.0 0
M  V30 26 C 0.0000 6.9300 0.0 0
M  V30 27 N 1.3336 9.2400 0.0 0
M  V30 28 C 0.0000 8.4700 0.0 0
M  V30 29 C 12.8883 6.7236 0.0 0
M  V30 30 C 13.6583 5.3900 0.0 0
M  V30 31 C 13.6583 8.0574 0.0 0
M  V30 32 C 15.1983 5.3900 0.0 0
M  V30 33 C 15.1983 8.0574 0.0 0
M  V30 34 C 15.9683 6.7236 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 17
M  V30 7 1 7 8
M  V30 8 1 7 18
M  V30 9 1 8 29
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 2 13 18
M  V30 19 1 14 19
M  V30 20 1 14 20
M  V30 21 1 15 21
M  V30 22 2 16 19
M  V30 23 1 17 18
M  V30 24 1 19 23
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1106671-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958488-27-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-3248608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Ethyl
2,7-dimethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylates
(11a-i), general preparation method. The appropriate ethyl
5-hydroxy-1-methyl-1H-indole-3-carboxylate 5 - 8 (0.5 mmol) and MeNH2 (2
mL, 2 M) in THF and formaldehyde as formalin (8 mmol) in THF (10 mL) were
refluxed for 12 h. The course of the reaction was monitored using LC-MS.
When the reaction was finished, the mixture was diluted with ice water
(1.5 L). The precipitate was filtered off, washed with H2O, suspended in
cold (5 - 7°C) isopropanol, and stirred at 5 - 7°C for 1 h. The
precipitate was filtered off, washed with isopropanol, and dried in
vacuo. The resulting product was dissolved in dioxane, treated with HCl
(3 M) in dioxane, and diluted with Et2O. The resulting precipitate was
filtered off and dried in vacuo. Ethyl
2,7-dimethyl-6-pyridin-3-yl-8-phenylthiomethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylate
(11g), Yield: 75-95%. LC-MS: found m/z 474 (M + H), calculated 474 (M + 1
for C27H27N3O3S). Compound Against Influenza A/New Caledonia/20/99 Virus
(H N1) in MDCK Cell Culture: EC50: 4.9 ± 0.4μM. Compound Against BVDV in
MDBK Cell Culture: EC50: >52.2 μM, CC50: 52.2 ± 7.9 μM, SI50: <1.
Compound Against HCV in Human Hepatoma Cell Line Huh7 Containing HCV
Subgenomic RNA-Replicon (Genotype 1a, Clone Con1): EC50: 20.2 ± 3.3 μM,
CC50: 29.8 ± 5.7 μM, SI50: 1.4.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Ethyl
1,2-dimethyl-5-Hydroxy-1H-Indole-3-carboxylates and Their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil, V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun, I. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 47(12), 636-650

$RFMT $RIREG SCHEME290 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(dimethylamino)methyl]-6-fluoro-5-hydroxy-1-methyl-1H-indole-3-carbo...
C15H19FN2O3
1106671-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5602 2.4581 0.0 0
M  V30 2 O 3.0957 1.9823 0.0 0
M  V30 3 O 5.7048 1.4277 0.0 0
M  V30 4 C 2.7755 0.4759 0.0 0
M  V30 5 C 1.3108 0.0000 0.0 0
M  V30 6 C 7.6210 3.8209 0.0 0
M  V30 7 N 8.9548 4.5909 0.0 0
M  V30 8 C 8.9548 6.1309 0.0 0
M  V30 9 C 10.2884 3.8209 0.0 0
M  V30 10 C 7.2708 7.1528 0.0 0
M  V30 11 O 0.0000 6.4426 0.0 0
M  V30 12 F 1.5400 9.1100 0.0 0
M  V30 13 C 4.8806 3.9646 0.0 0
M  V30 14 C 3.8500 5.1089 0.0 0
M  V30 15 C 6.2874 4.5909 0.0 0
M  V30 16 C 4.6200 6.4426 0.0 0
M  V30 17 C 2.3100 5.1089 0.0 0
M  V30 18 N 6.1264 6.1224 0.0 0
M  V30 19 C 3.8500 7.7762 0.0 0
M  V30 20 C 1.5400 6.4426 0.0 0
M  V30 21 C 2.3100 7.7764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 18
M  V30 11 1 11 20
M  V30 12 1 12 21
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 8-[(dimethylamino)methyl]-5-fluoro-1,2,3,7-tetrahydro-2,7-dimethylpyrro...
C18H24FN3O3
1641586-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 4.6245 0.0 0
M  V30 2 O 8.7355 5.1003 0.0 0
M  V30 3 O 6.9506 3.1182 0.0 0
M  V30 4 C 9.8799 4.0699 0.0 0
M  V30 5 C 11.3446 4.5458 0.0 0
M  V30 6 C 7.6210 7.9566 0.0 0
M  V30 7 N 7.6210 9.4966 0.0 0
M  V30 8 C 8.9548 10.2666 0.0 0
M  V30 9 C 6.2874 10.2666 0.0 0
M  V30 10 C 4.5602 9.3193 0.0 0
M  V30 11 F 0.0000 5.3347 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 6.1264 5.6549 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 3.8500 6.6685 0.0 0
M  V30 17 C 6.2874 7.1866 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 N 4.8806 7.8129 0.0 0
M  V30 21 C 2.3100 6.6685 0.0 0
M  V30 22 C 1.5400 5.3347 0.0 0
M  V30 23 O 1.5400 2.6674 0.0 0
M  V30 24 N 3.8500 1.3338 0.0 0
M  V30 25 C 2.3100 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 20
M  V30 11 1 11 22
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 21
M  V30 21 1 17 20
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 2 21 22
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1106671-57-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1641586-10-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-9517750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME291 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-hydroxy-1-methyl-6-(3-pyridinyl)-2-(1-pyrrolidinylmethyl)-1H-indole-3...
C22H25N3O3
1106671-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5911 3.7535 0.0 0
M  V30 2 O 5.6215 2.6091 0.0 0
M  V30 3 O 3.0848 3.4333 0.0 0
M  V30 4 C 5.1456 1.1444 0.0 0
M  V30 5 C 6.1760 0.0000 0.0 0
M  V30 6 C 2.6217 6.4640 0.0 0
M  V30 7 C 4.5911 9.1746 0.0 0
M  V30 8 O 10.5327 4.9240 0.0 0
M  V30 9 C 5.0669 5.2182 0.0 0
M  V30 10 C 6.5316 5.6940 0.0 0
M  V30 11 C 4.1617 6.4640 0.0 0
M  V30 12 C 6.5316 7.2340 0.0 0
M  V30 13 C 7.8653 4.9240 0.0 0
M  V30 14 N 5.0669 7.7099 0.0 0
M  V30 15 C 7.8653 8.0040 0.0 0
M  V30 16 C 9.1989 5.6940 0.0 0
M  V30 17 C 9.1989 7.2340 0.0 0
M  V30 18 N 1.8517 7.7977 0.0 0
M  V30 19 C 2.4782 9.2046 0.0 0
M  V30 20 C 0.3202 7.9588 0.0 0
M  V30 21 C 1.3336 10.2350 0.0 0
M  V30 22 C 0.0000 9.4650 0.0 0
M  V30 23 C 10.5327 8.0040 0.0 0
M  V30 24 C 10.5327 9.5440 0.0 0
M  V30 25 C 11.8664 7.2340 0.0 0
M  V30 26 C 11.8664 10.3140 0.0 0
M  V30 27 N 13.2000 8.0040 0.0 0
M  V30 28 C 13.2000 9.5440 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 6 18
M  V30 8 1 7 14
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 17 23
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2,3,7-tetrahydro-2,7-dimethyl-5-(3-pyridinyl)-8-(1-pyrrolidinylmethyl...
C25H30N4O3
958451-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0738 7.2419 0.0 0
M  V30 2 O 2.6091 6.7660 0.0 0
M  V30 3 O 4.3940 8.7483 0.0 0
M  V30 4 C 1.4647 7.7964 0.0 0
M  V30 5 C 0.0000 7.3206 0.0 0
M  V30 6 C 3.7236 3.9099 0.0 0
M  V30 7 C 6.7844 2.5472 0.0 0
M  V30 8 C 6.7246 11.8664 0.0 0
M  V30 9 C 6.7246 6.5316 0.0 0
M  V30 10 C 5.2182 6.2115 0.0 0
M  V30 11 C 7.4946 7.8653 0.0 0
M  V30 12 C 7.4946 5.1980 0.0 0
M  V30 13 C 5.0572 4.6799 0.0 0
M  V30 14 C 9.0346 7.8653 0.0 0
M  V30 15 C 6.7246 9.1989 0.0 0
M  V30 16 N 6.4640 4.0535 0.0 0
M  V30 17 C 9.0346 5.1980 0.0 0
M  V30 18 C 9.8046 6.5316 0.0 0
M  V30 19 O 9.8046 9.1989 0.0 0
M  V30 20 N 7.4946 10.5327 0.0 0
M  V30 21 C 9.0346 10.5327 0.0 0
M  V30 22 N 3.7236 2.3699 0.0 0
M  V30 23 C 2.4777 1.4647 0.0 0
M  V30 24 C 4.9695 1.4647 0.0 0
M  V30 25 C 2.9536 0.0000 0.0 0
M  V30 26 C 4.4936 0.0000 0.0 0
M  V30 27 C 11.3446 6.5316 0.0 0
M  V30 28 C 12.1146 7.8653 0.0 0
M  V30 29 C 12.1146 5.1980 0.0 0
M  V30 30 C 13.6546 7.8653 0.0 0
M  V30 31 N 13.6546 5.1980 0.0 0
M  V30 32 C 14.4246 6.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 6 22
M  V30 8 1 7 16
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 2 17 18
M  V30 23 1 18 27
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1106671-66-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958451-33-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-13059993
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME292 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-hydroxy-1-methyl-2-(4-morpholinylmethyl)-6-(3-pyridinyl)-1H-indole-3-...
C22H25N3O4
1106671-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 3.7535 0.0 0
M  V30 2 O 6.0798 2.6091 0.0 0
M  V30 3 O 3.5430 3.4333 0.0 0
M  V30 4 C 5.6040 1.1444 0.0 0
M  V30 5 C 6.6344 0.0000 0.0 0
M  V30 6 C 3.0800 6.4641 0.0 0
M  V30 7 C 5.0494 9.1745 0.0 0
M  V30 8 O 10.9910 4.9241 0.0 0
M  V30 9 C 5.5253 5.2182 0.0 0
M  V30 10 C 6.9900 5.6941 0.0 0
M  V30 11 C 4.6201 6.4641 0.0 0
M  V30 12 C 6.9900 7.2341 0.0 0
M  V30 13 C 8.3237 4.9241 0.0 0
M  V30 14 N 5.5253 7.7100 0.0 0
M  V30 15 C 8.3237 8.0041 0.0 0
M  V30 16 C 9.6573 5.6941 0.0 0
M  V30 17 C 9.6573 7.2341 0.0 0
M  V30 18 N 2.3100 7.7977 0.0 0
M  V30 19 C 3.0800 9.1314 0.0 0
M  V30 20 C 0.7700 7.7977 0.0 0
M  V30 21 C 2.3100 10.4651 0.0 0
M  V30 22 C 0.0000 9.1314 0.0 0
M  V30 23 O 0.7700 10.4651 0.0 0
M  V30 24 C 10.9910 8.0041 0.0 0
M  V30 25 C 10.9910 9.5441 0.0 0
M  V30 26 C 12.3248 7.2341 0.0 0
M  V30 27 C 12.3248 10.3141 0.0 0
M  V30 28 N 13.6584 8.0041 0.0 0
M  V30 29 C 13.6584 9.5441 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 6 18
M  V30 8 1 7 14
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 17 24
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2,3,7-tetrahydro-2,7-dimethyl-8-(4-morpholinylmethyl)-5-(3-pyridinyl)...
C25H30N4O4
958451-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0738 7.9521 0.0 0
M  V30 2 O 2.6091 7.4762 0.0 0
M  V30 3 O 4.3939 9.4584 0.0 0
M  V30 4 C 1.4647 8.5067 0.0 0
M  V30 5 C 0.0000 8.0308 0.0 0
M  V30 6 C 3.7236 4.6200 0.0 0
M  V30 7 C 6.7843 3.2573 0.0 0
M  V30 8 C 6.7246 12.5766 0.0 0
M  V30 9 C 6.7246 7.2419 0.0 0
M  V30 10 C 5.2181 6.9217 0.0 0
M  V30 11 C 7.4946 8.5755 0.0 0
M  V30 12 C 7.4946 5.9081 0.0 0
M  V30 13 C 5.0572 5.3900 0.0 0
M  V30 14 C 9.0346 8.5755 0.0 0
M  V30 15 C 6.7246 9.9091 0.0 0
M  V30 16 N 6.4640 4.7637 0.0 0
M  V30 17 C 9.0346 5.9081 0.0 0
M  V30 18 C 9.8046 7.2419 0.0 0
M  V30 19 O 9.8046 9.9091 0.0 0
M  V30 20 N 7.4946 11.2428 0.0 0
M  V30 21 C 9.0346 11.2428 0.0 0
M  V30 22 N 3.7236 3.0800 0.0 0
M  V30 23 C 2.3898 2.3100 0.0 0
M  V30 24 C 5.0572 2.3100 0.0 0
M  V30 25 C 2.3898 0.7700 0.0 0
M  V30 26 C 5.0572 0.7700 0.0 0
M  V30 27 O 3.7236 0.0000 0.0 0
M  V30 28 C 11.3446 7.2419 0.0 0
M  V30 29 C 12.1146 8.5755 0.0 0
M  V30 30 C 12.1146 5.9081 0.0 0
M  V30 31 C 13.6546 8.5755 0.0 0
M  V30 32 N 13.6546 5.9081 0.0 0
M  V30 33 C 14.4246 7.2419 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 6 22
M  V30 8 1 7 16
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 2 17 18
M  V30 23 1 18 28
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1106671-71-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958451-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-11216272
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME293 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(dimethylamino)methyl]-5-hydroxy-1-methyl-6-(3-pyridinyl)-1H-indole-...
C20H23N3O3
1106671-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3510 5.6421 0.0 0
M  V30 2 O 11.8158 5.1662 0.0 0
M  V30 3 O 10.0309 7.1485 0.0 0
M  V30 4 C 12.9602 6.1966 0.0 0
M  V30 5 C 14.4249 5.7208 0.0 0
M  V30 6 C 10.7012 2.3101 0.0 0
M  V30 7 N 10.7012 0.7700 0.0 0
M  V30 8 C 12.0351 0.0000 0.0 0
M  V30 9 C 9.3676 0.0000 0.0 0
M  V30 10 C 7.6404 0.9473 0.0 0
M  V30 11 O 4.6201 7.5991 0.0 0
M  V30 12 C 9.2066 4.6116 0.0 0
M  V30 13 C 7.7002 4.9318 0.0 0
M  V30 14 C 9.3676 3.0801 0.0 0
M  V30 15 C 6.9302 3.5981 0.0 0
M  V30 16 C 6.9302 6.2655 0.0 0
M  V30 17 N 7.9607 2.4536 0.0 0
M  V30 18 C 5.3901 3.5981 0.0 0
M  V30 19 C 5.3901 6.2655 0.0 0
M  V30 20 C 4.6201 4.9318 0.0 0
M  V30 21 C 3.0801 4.9318 0.0 0
M  V30 22 C 2.3101 3.5981 0.0 0
M  V30 23 C 2.3101 6.2655 0.0 0
M  V30 24 C 0.7700 3.5981 0.0 0
M  V30 25 N 0.7700 6.2655 0.0 0
M  V30 26 C 0.0000 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 17
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 8-[(dimethylamino)methyl]-1,2,3,7-tetrahydro-2,7-dimethyl-5-(3-pyridiny...
C23H28N4O3
958451-52-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3508 4.6245 0.0 0
M  V30 2 O 11.8155 5.1003 0.0 0
M  V30 3 O 10.0306 3.1182 0.0 0
M  V30 4 C 12.9599 4.0699 0.0 0
M  V30 5 C 14.4246 4.5458 0.0 0
M  V30 6 C 7.6402 9.3193 0.0 0
M  V30 7 C 10.7010 7.9566 0.0 0
M  V30 8 N 10.7010 9.4966 0.0 0
M  V30 9 C 9.3674 10.2666 0.0 0
M  V30 10 C 12.0348 10.2666 0.0 0
M  V30 11 C 7.7000 0.0000 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 6.6685 0.0 0
M  V30 15 C 9.2064 5.6549 0.0 0
M  V30 16 C 5.3900 4.0011 0.0 0
M  V30 17 C 7.7000 2.6674 0.0 0
M  V30 18 C 5.3900 6.6685 0.0 0
M  V30 19 N 7.9606 7.8129 0.0 0
M  V30 20 C 9.3674 7.1866 0.0 0
M  V30 21 C 4.6200 5.3347 0.0 0
M  V30 22 O 4.6200 2.6674 0.0 0
M  V30 23 N 6.9300 1.3338 0.0 0
M  V30 24 C 5.3900 1.3338 0.0 0
M  V30 25 C 3.0800 5.3347 0.0 0
M  V30 26 C 2.3100 6.6685 0.0 0
M  V30 27 C 2.3100 4.0011 0.0 0
M  V30 28 C 0.7700 6.6685 0.0 0
M  V30 29 N 0.7700 4.0011 0.0 0
M  V30 30 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 19
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 23
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 2 15 20
M  V30 20 1 16 21
M  V30 21 1 16 22
M  V30 22 1 17 23
M  V30 23 2 18 21
M  V30 24 1 19 20
M  V30 25 1 21 25
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1106671-85-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958451-52-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-8805781
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME294 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-cyano-2-[(dimethylamino)methyl]-5-hydroxy-1-methyl-1H-indole-3-carbox...
C16H19N3O3
1107174-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0738 5.6420 0.0 0
M  V30 2 O 2.6091 5.1662 0.0 0
M  V30 3 O 4.3940 7.1485 0.0 0
M  V30 4 C 1.4647 6.1966 0.0 0
M  V30 5 C 0.0000 5.7207 0.0 0
M  V30 6 C 3.7236 2.3100 0.0 0
M  V30 7 N 3.7236 0.7700 0.0 0
M  V30 8 C 5.0573 0.0000 0.0 0
M  V30 9 C 2.3898 0.0000 0.0 0
M  V30 10 C 6.7844 0.9473 0.0 0
M  V30 11 O 9.8047 7.5991 0.0 0
M  V30 12 C 11.3447 4.9318 0.0 0
M  V30 13 N 12.8848 4.9318 0.0 0
M  V30 14 C 6.7247 4.9318 0.0 0
M  V30 15 C 5.2182 4.6116 0.0 0
M  V30 16 C 7.4947 3.5981 0.0 0
M  V30 17 C 7.4947 6.2654 0.0 0
M  V30 18 C 5.0573 3.0800 0.0 0
M  V30 19 N 6.4641 2.4536 0.0 0
M  V30 20 C 9.0347 3.5981 0.0 0
M  V30 21 C 9.0347 6.2654 0.0 0
M  V30 22 C 9.8047 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 19
M  V30 11 1 11 21
M  V30 12 3 12 13
M  V30 13 1 12 22
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-cyano-8-[(dimethylamino)methyl]-1,2,3,7-tetrahydro-2,7-dimethylpyrrol...
C19H24N4O3
958488-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0738 4.6245 0.0 0
M  V30 2 O 2.6091 5.1003 0.0 0
M  V30 3 O 4.3939 3.1182 0.0 0
M  V30 4 C 1.4647 4.0699 0.0 0
M  V30 5 C 0.0000 4.5458 0.0 0
M  V30 6 C 3.7236 7.9566 0.0 0
M  V30 7 N 3.7236 9.4966 0.0 0
M  V30 8 C 2.3898 10.2666 0.0 0
M  V30 9 C 5.0572 10.2666 0.0 0
M  V30 10 C 6.7843 9.3193 0.0 0
M  V30 11 C 11.3446 5.3347 0.0 0
M  V30 12 N 12.8846 5.3347 0.0 0
M  V30 13 C 6.7246 0.0000 0.0 0
M  V30 14 C 6.7246 5.3347 0.0 0
M  V30 15 C 5.2181 5.6549 0.0 0
M  V30 16 C 7.4946 4.0011 0.0 0
M  V30 17 C 7.4946 6.6685 0.0 0
M  V30 18 C 5.0572 7.1866 0.0 0
M  V30 19 C 9.0346 4.0011 0.0 0
M  V30 20 C 6.7246 2.6674 0.0 0
M  V30 21 N 6.4640 7.8129 0.0 0
M  V30 22 C 9.0346 6.6685 0.0 0
M  V30 23 C 9.8046 5.3347 0.0 0
M  V30 24 O 9.8046 2.6674 0.0 0
M  V30 25 N 7.4946 1.3338 0.0 0
M  V30 26 C 9.0346 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 21
M  V30 11 3 11 12
M  V30 12 1 11 23
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 2 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 17 22
M  V30 22 1 18 21
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 2 22 23
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1107174-26-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958488-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-244021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME295 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromophenyl)-1-methyl-4,5-diphenyl-1H-imidazole
C22H17BrN2
36750-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0157 3.5103 0.0 0
M  V30 2 Br 12.3670 9.1524 0.0 0
M  V30 3 C 5.3648 4.2206 0.0 0
M  V30 4 C 4.5948 5.5542 0.0 0
M  V30 5 N 6.8711 4.5408 0.0 0
M  V30 6 N 5.6252 6.6988 0.0 0
M  V30 7 C 7.0322 6.0723 0.0 0
M  V30 8 C 4.7385 2.8138 0.0 0
M  V30 9 C 5.6436 1.5677 0.0 0
M  V30 10 C 3.2068 2.6527 0.0 0
M  V30 11 C 5.0172 0.1609 0.0 0
M  V30 12 C 2.5805 1.2459 0.0 0
M  V30 13 C 3.4857 0.0000 0.0 0
M  V30 14 C 3.0633 5.7153 0.0 0
M  V30 15 C 2.1580 4.4693 0.0 0
M  V30 16 C 2.4368 7.1221 0.0 0
M  V30 17 C 0.6265 4.6304 0.0 0
M  V30 18 C 0.9052 7.2831 0.0 0
M  V30 19 C 0.0000 6.0372 0.0 0
M  V30 20 C 8.3659 6.8423 0.0 0
M  V30 21 C 8.3659 8.3823 0.0 0
M  V30 22 C 9.6995 6.0723 0.0 0
M  V30 23 C 9.6995 9.1524 0.0 0
M  V30 24 C 11.0332 6.8423 0.0 0
M  V30 25 C 11.0332 8.3823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 25
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 4 14
M  V30 8 1 5 7
M  V30 9 2 6 7
M  V30 10 1 7 20
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36750-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-37226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 439937-65-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Preparation of
1,2,4,5-Tetrasubstituted Imidazoles Benzil or benzoin (1 mmol), aldehyde
(1 mmol), amine (1 mmol) and ammonium acetate (1 mmol) were added to
triphenyl(propyl-3-sulphonyl)phosphonium toluenesulfonate (0.09 g, 0.2
mmol) at 100 °C for the appropriate time reported in Table 2. After
completion of the reaction which was monitored by TLC, the mixture washed
with water, the solid product purified by recrystallization from ethanol.
All of the desired product(s) were characterized by comparison of their
physical data with those of known compounds. Some characterization data
for selected known products are given below.
1,4,5-Triphenyl-2-P-tolyl-1H-imidazole (Table 2, Entry 6). Table 2.
Synthesis of 1,2,4,5-Tetrasubstituted Imidazoles via a One-Pot Four
Component Condensation Reaction in the Presence of
Triphenyl(propyl-3-sulphonyl)phosphonium toluenesulfonate as Brønsted
Acidic Ionic Liquid (0.09 g, 0.2 mmol) under Solvent-Free Conditions at
100 °C. Entry 8 Yield 95%. M.P. : Found 197-198 °C, Reported 201-202 °C.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, ionic liquid used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of highly substituted imidazoles using Bronsted acidic ionic
liquid, triphenyl(propyl-3-sulfonyl)phosphonium toluenesulfonate, as
reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shaterian, H. R.; Ranjbar, M.; Azizi, K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2011), 8(4), 1120-1134

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Oleic acid
C18H34O2
112-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 5.3347 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 10.0100 6.6685 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 C 11.5500 6.6685 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 12.3200 5.3347 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 13.8600 5.3347 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 14.6300 4.0011 0.0 0
M  V30 13 C 0.7700 1.3338 0.0 0
M  V30 14 C 16.1700 4.0011 0.0 0
M  V30 15 O 0.0000 0.0000 0.0 0
M  V30 16 O 0.0000 2.6674 0.0 0
M  V30 17 C 16.9400 2.6674 0.0 0
M  V30 18 C 18.4800 2.6674 0.0 0
M  V30 19 C 19.2500 1.3338 0.0 0
M  V30 20 C 20.7900 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(9Z)-N-Methyl-9-octadecenamide
C19H37NO
70858-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 1.3338 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 10.7800 1.3338 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 C 11.5500 0.0000 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 13.0900 0.0000 0.0 0
M  V30 9 C 3.8500 5.3347 0.0 0
M  V30 10 C 13.8600 1.3338 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 15.4000 1.3338 0.0 0
M  V30 13 N 1.5400 6.6685 0.0 0
M  V30 14 O 1.5400 4.0011 0.0 0
M  V30 15 C 16.1700 2.6674 0.0 0
M  V30 16 C 0.0000 6.6685 0.0 0
M  V30 17 C 17.7100 2.6674 0.0 0
M  V30 18 C 18.4800 4.0011 0.0 0
M  V30 19 C 20.0200 4.0011 0.0 0
M  V30 20 C 20.7900 5.3347 0.0 0
M  V30 21 C 22.3300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 112-80-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70858-46-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19450252
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and methods for delivery of therapeutic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Besin, Gilles; Hoge, Stephen; Senn, Joseph; Benenato, Kerry; Sabnis,
Staci
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017099823 A1 2017-06-15

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(3-fluoro-2-m...
C18H15ClFN3O2S
1138037-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3751 8.6446 0.0 0
M  V30 2 C 2.0608 6.5096 0.0 0
M  V30 3 C 6.2481 3.3420 0.0 0
M  V30 4 O 5.0021 2.4369 0.0 0
M  V30 5 O 7.6549 2.7156 0.0 0
M  V30 6 C 5.1632 0.9052 0.0 0
M  V30 7 C 3.9173 0.0000 0.0 0
M  V30 8 F 0.0000 8.7985 0.0 0
M  V30 9 Cl 13.5351 8.6446 0.0 0
M  V30 10 N 5.0735 7.1499 0.0 0
M  V30 11 C 6.6051 7.3108 0.0 0
M  V30 12 N 4.7534 5.6436 0.0 0
M  V30 13 C 7.2315 5.9041 0.0 0
M  V30 14 C 6.0870 4.8736 0.0 0
M  V30 15 C 4.0431 8.2944 0.0 0
M  V30 16 C 2.5367 7.9741 0.0 0
M  V30 17 C 4.5190 9.7590 0.0 0
M  V30 18 C 1.5063 9.1186 0.0 0
M  V30 19 C 3.4886 10.9035 0.0 0
M  V30 20 C 1.9821 10.5832 0.0 0
M  V30 21 C 8.9151 8.6446 0.0 0
M  V30 22 C 9.6851 9.9783 0.0 0
M  V30 23 C 9.6851 7.3108 0.0 0
M  V30 24 C 11.2251 9.9783 0.0 0
M  V30 25 N 11.2251 7.3108 0.0 0
M  V30 26 C 11.9951 8.6446 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 18
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(3-fluoro-2-methy...
C17H14ClFN4OS
1138037-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3751 7.7394 0.0 0
M  V30 2 C 2.0608 5.6044 0.0 0
M  V30 3 C 6.2481 2.4367 0.0 0
M  V30 4 N 5.0021 1.5317 0.0 0
M  V30 5 O 7.6549 1.8104 0.0 0
M  V30 6 C 5.1632 0.0000 0.0 0
M  V30 7 F 0.0000 7.8933 0.0 0
M  V30 8 Cl 13.5351 7.7394 0.0 0
M  V30 9 N 5.0735 6.2447 0.0 0
M  V30 10 C 6.6051 6.4056 0.0 0
M  V30 11 N 4.7534 4.7384 0.0 0
M  V30 12 C 7.2315 4.9988 0.0 0
M  V30 13 C 6.0870 3.9684 0.0 0
M  V30 14 C 4.0431 7.3892 0.0 0
M  V30 15 C 2.5367 7.0689 0.0 0
M  V30 16 C 4.5190 8.8538 0.0 0
M  V30 17 C 1.5063 8.2134 0.0 0
M  V30 18 C 3.4886 9.9983 0.0 0
M  V30 19 C 1.9821 9.6780 0.0 0
M  V30 20 C 8.9151 7.7394 0.0 0
M  V30 21 C 9.6851 9.0731 0.0 0
M  V30 22 C 9.6851 6.4056 0.0 0
M  V30 23 C 11.2251 9.0731 0.0 0
M  V30 24 N 11.2251 6.4056 0.0 0
M  V30 25 C 11.9951 7.7394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 17
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10064546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 285
5-[(6-chloropyridin-3-yl)thio]-1-(3-fluoro-2-methylphenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(3-fluoro-2-methylphenyl)-1H-pyrazole-3-carboxylate
(2.9 g) in methanol (10 mL) was added 40% methylamine-methanol solution
(10 mL) at room temperature. The mixture was stirred for 2 hr, and
concentrated under reduced pressure, and the residue was purified by
silica gel column chromatography (eluent: hexane-ethyl
acetate=2:1&#x2192;1:2) to give the title compound as colorless crystals
(2.7 g, yield 95%). 1H-NMR (CDCl3) &#x03B4; : 1.87 (3H, s), 2.97 (3H, d,
J=5.1 Hz), 6.81-6.85 (2H, m), 7.10-7.29 (4H, m), 7.37-7.41 (1H, m),
8.03-8.04 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Benzyloxycarbonylglycine
C10H11NO4
1138-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 N 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 O 12.0033 1.5400 0.0 0
M  V30 9 O 10.6697 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[2-(methylamino)-2-oxoethyl]carbamate
C11H14N2O3
21855-72-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 N 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 N 12.0033 1.5400 0.0 0
M  V30 9 O 10.6697 3.8501 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1138-80-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21855-72-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14629272
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure. To a cold (-78 °C) THF
solution (~0.1-0.2 mmol N-(benzyloxycarbonyl) amino acid/mL of solvent)
containing the N-(benzyloxycarbonyl)amino acid, the 4-methylmorpholine
(1.1 equiv) was slowly added. After stirring (2 min), isobutyl
chloroformate (1.1 equiv) was added. The reaction was stirred (2 min) and
then the amine (1.1 equiv) was added dropwise. The reaction was stirred
at -78 °C (15 min) and allowed to warm to room temperature (1 h). The
reaction mixture was filtered and the filtrate evaporated in vacuo. The
residue was purified by chromatography on SiO2 gel to obtain the desired
product. Synthesis of N-(Benzyloxycarbonyl)glycine-N-methylamide (25) as
a white solid, yield 5.03 g, 95%. mp 105-106 °C (lit.29 mp 105-107 °C);
Rf 0.31 (1:19, MeOH:CHCl3); 1H NMR (CDCl3) δ 2.76 (d, J = 4.5 Hz, NCH3),
3.81 (d, J = 5.7 Hz, CH2C(O)), 5.10 (s, OCH2), 5.86 (br t, J = 5.7 Hz,
NH), 6.48 (br s, NH), 7.27-7.33 (m, PhH); 13C NMR (CDCl3) 26.0 (NCH3),
44.5 (CH2C(O)), 67.0 (OCH2), 127.9 (C4'), 128.1 (2C2'?or 2C3'), 128.4
(2C2'?or 2C3'), 136.1 (C1'), 156.6 (OC(O)NH), 169.7 (C(O)NH) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of Predictive QSAR Models to Database Mining: Identification
and Experimental Validation of Novel Anticonvulsant Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shen, Min; Beguin, Cecile; Golbraikh, Alexander; Stables, James P.; Kohn,
Harold; Tropsha, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(9), 2356-2364

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-3-iodopyridine
C5H3FIN
113975-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 2.6673 0.0 0
M  V30 2 F 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 N 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-N-methyl-2-pyridinamine
C6H7IN2
113975-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 I 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 N 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 113975-22-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 113975-23-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-748411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0201] Synthesis of 3-iodo-N-methylpyridin-2-amine. A 1 L round bottom
flask was charged with 2-fluoro-3-iodopyridine (27.0 g, 121 mmol) and 500
mL of 40% aqueous solution of methylamine. This was stirred at reflux for
4 h before being cooled to ambient temperature. The product was extracted
with dichloromethane. Evaporation of the dichloromethane gave
3-iodo-N-methylpyridin-2-amine. 26.8 g, 95% yield.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridyl carbene phosphorescent emitters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Yonggang; Xia, Chuanjun; Fiordeliso, James; Layek, Suman; Alleyne,
Bert; Dyatkin, Alexey Borisovich; Ansari, Scott; Beers, Scott; Barron,
Ed; Brooks, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012121936 A2 2012-09-13

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8-Dichloro-2,3-quinoxalinedicarbonitrile
C10H2Cl2N4
1140899-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6674 0.0 0
M  V30 2 Cl 3.0800 8.0021 0.0 0
M  V30 3 C 5.3900 1.3336 0.0 0
M  V30 4 N 6.1600 0.0000 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 8.4700 4.0011 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.0800 5.3347 0.0 0
M  V30 9 N 3.0800 2.6674 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 N 4.6200 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 0.0000 5.3347 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 12
M  V30 3 3 3 4
M  V30 4 1 3 13
M  V30 5 3 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8-Dichloro-N-methyl-3-(methylamino)-2-quinoxalinecarboximidamide
C11H11Cl2N5
1311965-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3348 7.7002 0.0 0
M  V30 2 Cl 0.0000 4.6201 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 N 8.0023 3.0801 0.0 0
M  V30 5 N 6.6685 0.7700 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 N 4.0012 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 4.0012 5.3901 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 N 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 6.9302 0.0 0
M  V30 13 N 2.6675 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 2.6675 7.7002 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1140899-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311965-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-4058140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactions of 5,8-dichloro-2,3-dicyanoquinoxaline with amines and
hydrazines. A new and efficient synthetic approach to
3-amino-5,8-dichloroflavazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guirado, Antonio; Lopez Sanchez, Jose I.; Bautista, Delia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(22), 4123-4129

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3S,5S,7R,8S,9S,10R)-2-acetyl-8,9,10-trihydroxy-3,7-bis(hydroxymeth...
C14H23NO9
1148055-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 O 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4032 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 0.7700 7.2697 0.0 0
M  V30 8 O 3.2068 8.3547 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 O 9.9301 3.8501 0.0 0
M  V30 13 O 5.9290 0.0000 0.0 0
M  V30 14 O 8.5965 1.5400 0.0 0
M  V30 15 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 16 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 17 C 3.1885 3.2238 0.0 0
M  V30 18 O 5.9290 4.6201 0.0 0
M  V30 19 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 20 N 2.9279 5.7020 0.0 0
M  V30 21 C 2.1579 4.3682 0.0 0 CFG=1
M  V30 22 C 7.2628 3.8501 0.0 0 CFG=2
M  V30 23 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 24 C 7.2628 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 19 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 9 10
M  V30 10 1 21 9 CFG=1
M  V30 11 1 11 12
M  V30 12 1 22 11 CFG=3
M  V30 13 1 23 13 CFG=3
M  V30 14 1 24 14 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17 CFG=1
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 21
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 15 16 19 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S,5S,7R,8S,9S,10R)-2-Acetyl-8,9,10-trihydroxy-3,7-bis(hydroxymethyl)-N-m...
C14H24N2O8
1148055-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 N 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4032 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 0.7700 7.2697 0.0 0
M  V30 8 O 3.2068 8.3547 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 O 9.9301 3.8501 0.0 0
M  V30 13 O 5.9290 0.0000 0.0 0
M  V30 14 O 8.5965 1.5400 0.0 0
M  V30 15 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 16 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 17 C 3.1885 3.2238 0.0 0
M  V30 18 O 5.9290 4.6201 0.0 0
M  V30 19 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 20 N 2.9279 5.7020 0.0 0
M  V30 21 C 2.1579 4.3682 0.0 0 CFG=1
M  V30 22 C 7.2628 3.8501 0.0 0 CFG=2
M  V30 23 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 24 C 7.2628 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 19 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 9 10
M  V30 10 1 21 9 CFG=1
M  V30 11 1 11 12
M  V30 12 1 22 11 CFG=3
M  V30 13 1 23 13 CFG=3
M  V30 14 1 24 14 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17 CFG=1
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 21
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 15 16 19 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148055-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1148055-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2188474
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (1S)-2,3,4,6-Tetrahydroxy-1'-N-acetyl-5′(S)-hydroxymethylenespiro[1,5-anhydro-D-glucitol-1,3′-L-proline
methylamide] (7). Compound 3 (25 mg, 0.07 mmol) was dissolved in a
solution of methylamine in absolute ethanol (4 mL, 33% wt) and stirred
for 18 hours at room temperature. The mixture was concentrated and
purified by the flash column chromatography (dichloromethane/ methanol:
2/1) to get compound 7 as a colorless oil (23 mg, 95%) [α]D = 46 (c 0.8,
MeOH); 1H NMR (500 MHz, D2O) δ = 1.79 (s, cis, 1.15H), 2.06 (s, trans,
1.85H), 2.11-2.30 (m, both rotamers, 2H), 2.56 (s, trans, 1.83H), 2.61
(s, cis, 1.17H), 3.25-3.50 (m, 4.4H), 3.54-3.70 (m, 2.6H), 3.74 (dd,
trans, 0.64H, J = 5.1 Hz, J = 11.2 Hz), 3.74 (dd, cis, 0.36H, J = 4.7 Hz,
J = 10.7 Hz), 4.12-4.25 (m, 2H); 13C NMR (75 MHz, CD3OD) cis rotamer, δ =
22.6, 26.7, 26.8, 61.6, 62.9, 64.7, 71.4 (2 carbons), 74.3, 75.6, 77.3,
88.5, 171.7, 173.6; trans rotamer, δ = 22.3, 25.7, 26.7, 61.5, 62.7,
63.9, 71.4 (2 carbons), 73.4, 75.5, 77.2, 87.2, 171.5, 173.2; HRMS calcd
for C14H25N2O8 [M + H]+ 349.1611, found 349.1626.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular Hydrogen Bond-Controlled Prolyl Amide Isomerization in
Glucosyl 3'(S)-Hydroxy-5'-hydroxymethylproline Hybrids: Influence of a
C-5'-Hydroxymethyl Substituent on the Thermodynamics and Kinetics of
Prolyl Amide Cis/Trans Isomerization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Kaidong; Teklebrhan, Robel B.; Schreckenbach, G.; Wetmore, Stacey;
Schweizer, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(10), 3735-3743

$RFMT $RIREG SCHEME302 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Triethyl orthopropionate
C9H20O3
115-80-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0012 0.0 0
M  V30 2 O 5.3348 3.2311 0.0 0
M  V30 3 O 2.6675 4.7712 0.0 0
M  V30 4 O 3.2311 2.6675 0.0 0
M  V30 5 C 4.7712 5.3348 0.0 0
M  V30 6 C 6.6687 4.0012 0.0 0
M  V30 7 C 1.3337 4.0012 0.0 0
M  V30 8 C 4.0012 1.3338 0.0 0
M  V30 9 C 4.0012 6.6687 0.0 0
M  V30 10 C 8.0023 3.2311 0.0 0
M  V30 11 C 0.0000 4.7712 0.0 0
M  V30 12 C 3.2311 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-5-methylpyrazole
C4H7N3
31230-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6218 0.0 0
M  V30 2 N 5.3026 1.4946 0.0 0
M  V30 3 C 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 N 1.4946 0.3202 0.0 0
M  V30 7 N 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanimidamide, N′-methyl-N-(5-methyl-1H-pyrazol-3-yl)-
C8H14N4
2935592-89-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1557 4.0010 0.0 0
M  V30 2 C 5.9257 2.6673 0.0 0
M  V30 3 C 7.4657 2.6673 0.0 0
M  V30 4 N 5.1557 1.3337 0.0 0
M  V30 5 C 8.2357 4.0010 0.0 0
M  V30 6 C 5.9257 0.0000 0.0 0
M  V30 7 C 0.0000 5.6762 0.0 0
M  V30 8 C 3.6157 4.0010 0.0 0
M  V30 9 C 2.7104 5.2470 0.0 0
M  V30 10 N 2.7104 2.7551 0.0 0
M  V30 11 C 1.2459 4.7710 0.0 0
M  V30 12 N 1.2459 3.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4 CFG=2
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115-80-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 31230-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2935592-89-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36691496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Characterization of New N-Pyrazol-5-yl amidine Derivatives:
X-Ray Structure Hirshfeld Surface, and DFT Analyses together with
Antibacterial and Antifungal Activity Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Louiz, Sonia; Lahbib, Karima; Abderrahim, Raoudha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(13), e202300315

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[4-(2,2-difluoroethenyl)phenoxy]methyl]-α-(methoxyimino)benzen...
C19H17F2NO4
1159341-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 5.3900 0.0 0
M  V30 3 N 2.6674 5.3900 0.0 0
M  V30 4 O 5.3347 6.9300 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 O 1.3338 4.6200 0.0 0
M  V30 7 C 6.6685 7.7000 0.0 0
M  V30 8 C 0.0000 5.3900 0.0 0
M  V30 9 C 6.6685 3.0800 0.0 0
M  V30 10 O 8.0021 2.3100 0.0 0
M  V30 11 C 13.3369 5.3900 0.0 0
M  V30 12 C 14.6705 4.6200 0.0 0
M  V30 13 F 16.0043 5.3900 0.0 0
M  V30 14 F 14.6705 3.0800 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 17 C 2.6674 2.3100 0.0 0
M  V30 18 C 5.3347 0.7700 0.0 0
M  V30 19 C 2.6674 0.7700 0.0 0
M  V30 20 C 4.0011 0.0000 0.0 0
M  V30 21 C 9.3358 3.0800 0.0 0
M  V30 22 C 10.6696 2.3100 0.0 0
M  V30 23 C 9.3358 4.6200 0.0 0
M  V30 24 C 12.0032 3.0800 0.0 0
M  V30 25 C 10.6696 5.3900 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 10 21
M  V30 12 2 11 12
M  V30 13 1 11 26
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[4-(2,2-Difluoroethenyl)phenoxy]methyl]-α-(methoxyimino)-N-methylbenz...
C19H18F2N2O3
1159341-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 5.3900 0.0 0
M  V30 3 N 2.6674 5.3900 0.0 0
M  V30 4 N 5.3347 6.9300 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 O 1.3338 4.6200 0.0 0
M  V30 7 C 6.6685 7.7000 0.0 0
M  V30 8 C 0.0000 5.3900 0.0 0
M  V30 9 C 6.6685 3.0800 0.0 0
M  V30 10 O 8.0021 2.3100 0.0 0
M  V30 11 C 13.3369 5.3900 0.0 0
M  V30 12 C 14.6705 4.6200 0.0 0
M  V30 13 F 14.6705 3.0800 0.0 0
M  V30 14 F 16.0043 5.3900 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 17 C 2.6674 2.3100 0.0 0
M  V30 18 C 5.3347 0.7700 0.0 0
M  V30 19 C 2.6674 0.7700 0.0 0
M  V30 20 C 4.0011 0.0000 0.0 0
M  V30 21 C 9.3358 3.0800 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 2.3100 0.0 0
M  V30 24 C 10.6696 5.3900 0.0 0
M  V30 25 C 12.0032 3.0800 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 10 21
M  V30 12 2 11 12
M  V30 13 1 11 26
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159341-98-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159341-99-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6739852
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 2: Preparation of
(E)-2-(2-((3-(2,2-dichlorovinyl)phenoxy)methylphenyl)-2-methoxyimino-N-methylacetamide
Example 10: Preparation of
(E)-2-(2-((4-(2,2-difluorovinyl)phenoxy)methylphenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 2 was repeated except for using
methyl-(E)-2-(2-((4-(2,2-difluorovinyl)phenoxy)methylphenyl)-2-methoxyiminoacetate(0.36g,
1mmol) obtained in Example 9 instead of
methyl-(E)-2-(2-((3-(2,2-dichlorovinyl)phenoxy)methylphenyl)-2-methoxyiminoacetate
to obtain the title compound (0.343g, 95%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.82(d, 3H), 3.93(s, 3H), 4.97(s, 2H), 5.21(d, 1H), 6.68-7.54(m, 8H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-(2,2-dichloroethenyl)-4-methylphenoxy]methyl]-α-(methoxyimi...
C20H19Cl2NO4
1159342-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 11.5501 5.3348 0.0 0
M  V30 4 O 10.0101 2.6675 0.0 0
M  V30 5 O 7.7001 4.0011 0.0 0
M  V30 6 O 12.3201 6.6684 0.0 0
M  V30 7 C 9.2401 1.3337 0.0 0
M  V30 8 C 13.8602 6.6684 0.0 0
M  V30 9 C 6.9301 5.3348 0.0 0
M  V30 10 O 5.3901 5.3348 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 Cl 0.0000 4.0011 0.0 0
M  V30 14 Cl 0.0000 6.6684 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 6.9301 8.0022 0.0 0
M  V30 20 C 9.2401 9.3359 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 4.6201 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3901 2.6675 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.0800 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-(2,2-Dichloroethenyl)-4-methylphenoxy]methyl]-α-(methoxyimino)-N-m...
C20H20Cl2N2O3
1159342-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 11.5501 5.3348 0.0 0
M  V30 4 N 10.0101 2.6675 0.0 0
M  V30 5 O 7.7001 4.0011 0.0 0
M  V30 6 O 12.3201 6.6684 0.0 0
M  V30 7 C 9.2401 1.3337 0.0 0
M  V30 8 C 13.8602 6.6684 0.0 0
M  V30 9 C 6.9301 5.3348 0.0 0
M  V30 10 O 5.3901 5.3348 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 Cl 0.0000 4.0011 0.0 0
M  V30 14 Cl 0.0000 6.6684 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 6.9301 8.0022 0.0 0
M  V30 20 C 9.2401 9.3359 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 4.6201 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3901 2.6675 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.0800 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2326684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and SAR of methoxyiminoacetate and methoxyiminoacetamide
derivatives as strobilurin analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hwang, In-Cheon; Kim, Joo-Kyung; Kim, Hyung-Ho; Kyung, Suk-Hun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2009), 30(7), 1475-1480

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-(2,2-dichloroethenyl)-4-methylphenoxy]methyl]-α-(methoxyimi...
C20H19Cl2NO4
1159342-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 11.5501 5.3348 0.0 0
M  V30 4 O 10.0101 2.6675 0.0 0
M  V30 5 O 7.7001 4.0011 0.0 0
M  V30 6 O 12.3201 6.6684 0.0 0
M  V30 7 C 9.2401 1.3337 0.0 0
M  V30 8 C 13.8602 6.6684 0.0 0
M  V30 9 C 6.9301 5.3348 0.0 0
M  V30 10 O 5.3901 5.3348 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 Cl 0.0000 4.0011 0.0 0
M  V30 14 Cl 0.0000 6.6684 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 6.9301 8.0022 0.0 0
M  V30 20 C 9.2401 9.3359 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 4.6201 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3901 2.6675 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.0800 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-(2,2-Dichloroethenyl)-4-methylphenoxy]methyl]-α-(methoxyimino)-N-m...
C20H20Cl2N2O3
1159342-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0101 5.3348 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 11.5501 5.3348 0.0 0
M  V30 4 N 10.0101 2.6675 0.0 0
M  V30 5 O 7.7001 4.0011 0.0 0
M  V30 6 O 12.3201 6.6684 0.0 0
M  V30 7 C 9.2401 1.3337 0.0 0
M  V30 8 C 13.8602 6.6684 0.0 0
M  V30 9 C 6.9301 5.3348 0.0 0
M  V30 10 O 5.3901 5.3348 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 Cl 0.0000 4.0011 0.0 0
M  V30 14 Cl 0.0000 6.6684 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 9.2401 6.6684 0.0 0
M  V30 17 C 7.7001 6.6684 0.0 0
M  V30 18 C 10.0101 8.0022 0.0 0
M  V30 19 C 6.9301 8.0022 0.0 0
M  V30 20 C 9.2401 9.3359 0.0 0
M  V30 21 C 7.7001 9.3359 0.0 0
M  V30 22 C 4.6201 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3901 2.6675 0.0 0
M  V30 25 C 2.3100 2.6675 0.0 0
M  V30 26 C 4.6201 1.3337 0.0 0
M  V30 27 C 3.0800 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 2 11 12
M  V30 13 1 11 23
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10573697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 46: Preparation of
(E)-2-(2-((2-(2,2-dichlorovinyl)-4-methylphenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((2-(2,2-dichlorovinyl)-4-methylphenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.48g,
1mmol) obtained in Example 45 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.388g, 95%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.28(s, 3H), 2.87(d, 3H), 3.92(s, 3H), 4.97(s, 2H), 6.71-6.74(m, 2H),
7.07(s, 1H), 7.00-7.56(m, 6H) MS : 406.1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[1-[3-(Trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-piperidinyl...
C18H16F3N5O3
1166820-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 4.2506 0.0 0
M  V30 2 F 0.0000 3.7747 0.0 0
M  V30 3 F 0.9887 5.7151 0.0 0
M  V30 4 F 2.9292 4.7264 0.0 0
M  V30 5 O 11.4073 5.3900 0.0 0
M  V30 6 C 16.7420 5.3900 0.0 0
M  V30 7 O 16.7420 6.9300 0.0 0
M  V30 8 O 18.0757 4.6200 0.0 0
M  V30 9 N 3.4051 2.3100 0.0 0
M  V30 10 C 3.4051 0.7700 0.0 0
M  V30 11 C 1.9406 2.7859 0.0 0
M  V30 12 N 4.7389 3.0800 0.0 0
M  V30 13 N 1.9406 0.2941 0.0 0
M  V30 14 C 4.7389 0.0000 0.0 0
M  V30 15 N 1.0353 1.5400 0.0 0
M  V30 16 C 6.0726 2.3100 0.0 0
M  V30 17 C 6.0726 0.7700 0.0 0
M  V30 18 N 7.4062 3.0800 0.0 0
M  V30 19 C 8.7399 2.3100 0.0 0
M  V30 20 C 7.4062 4.6200 0.0 0
M  V30 21 C 10.0737 3.0800 0.0 0
M  V30 22 C 8.7399 5.3900 0.0 0
M  V30 23 C 10.0737 4.6200 0.0 0
M  V30 24 C 12.7409 4.6200 0.0 0
M  V30 25 C 14.0746 5.3900 0.0 0
M  V30 26 C 12.7409 3.0800 0.0 0
M  V30 27 C 15.4084 4.6200 0.0 0
M  V30 28 C 14.0746 2.3100 0.0 0
M  V30 29 C 15.4084 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 23
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 27
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 2 14 17
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-[[1-[3-(trifluoromethyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-4-pi...
C19H19F3N6O2
1166817-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4646 4.2506 0.0 0
M  V30 2 F 0.0000 3.7748 0.0 0
M  V30 3 F 0.9887 5.7152 0.0 0
M  V30 4 F 2.9293 4.7265 0.0 0
M  V30 5 O 11.4075 5.3901 0.0 0
M  V30 6 C 16.7423 5.3901 0.0 0
M  V30 7 N 18.0760 4.6201 0.0 0
M  V30 8 O 16.7423 6.9302 0.0 0
M  V30 9 C 19.4097 5.3901 0.0 0
M  V30 10 N 3.4052 2.3101 0.0 0
M  V30 11 C 3.4052 0.7700 0.0 0
M  V30 12 C 1.9406 2.7859 0.0 0
M  V30 13 N 4.7388 3.0801 0.0 0
M  V30 14 N 1.9406 0.2941 0.0 0
M  V30 15 C 4.7388 0.0000 0.0 0
M  V30 16 N 1.0354 1.5400 0.0 0
M  V30 17 C 6.0727 2.3101 0.0 0
M  V30 18 C 6.0727 0.7700 0.0 0
M  V30 19 N 7.4063 3.0801 0.0 0
M  V30 20 C 7.4063 4.6201 0.0 0
M  V30 21 C 8.7400 2.3101 0.0 0
M  V30 22 C 8.7400 5.3901 0.0 0
M  V30 23 C 10.0737 3.0801 0.0 0
M  V30 24 C 10.0737 4.6201 0.0 0
M  V30 25 C 12.7412 4.6201 0.0 0
M  V30 26 C 14.0748 5.3901 0.0 0
M  V30 27 C 12.7412 3.0801 0.0 0
M  V30 28 C 15.4085 4.6201 0.0 0
M  V30 29 C 14.0748 2.3101 0.0 0
M  V30 30 C 15.4085 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 12
M  V30 5 1 5 24
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 28
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 2 15 18
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1166820-22-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1166817-80-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5301493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
N-(2-methoxyethyl)-N-methyl-4-[1-[3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]
benzamide A mixture of
4-[1-[3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-
yl]benzoic acid (79 mg, 0.20 mmol), N-(2-methoxyethyl)methylamine (21 mg,
0.24 mmol), DIPEA (0.105 mL, 0.61 mmol) and HATU (92 mg, 0.24 mmol) in
DMA (3 mL) was stirred at ambient temperature for 16 hours. The reaction
mixture was purified by preparative HPLC (Waters XBridge Prep C18 OBD
column, 5μ silica, 19 mm diameter, 100 mm length), using decreasingly
polar mixtures of water (containing 1% ammonia) and MeCN as eluents.
Fractions containing the desired compound were evaporated to dryness.
Example: 694 1H NMR (399.9 MHz, DMSO-d6) δ 1.75 (2H, m), 2.10 (2H, m),
2.79 (3H, d), 3.56 (2H, m), 3.97 (2H, m), 4.75 (1H, m), 7.16 (1H, m),
7.36 - 7.44 (3H, m), 7.66 (1H, d), 8.26 (1H, d), 8.39 (1H, q) m/z = 421
[M+H]+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bicyclic derivatives for use in the treatment of androgen receptor
associated conditions and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bradbury, Robert Hugh; Hales, Neil James; Rabow, Alfred Arthur
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009081197 A1 2009-07-02

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorophthalic anhydride
C8H3ClO3
117-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 2.6507 0.0 0
M  V30 2 O 1.9571 0.0000 0.0 0
M  V30 3 O 6.6520 2.7105 0.0 0
M  V30 4 C 2.6675 2.6507 0.0 0
M  V30 5 C 4.0012 3.4207 0.0 0
M  V30 6 C 1.3337 3.4207 0.0 0
M  V30 7 C 2.9877 1.1444 0.0 0
M  V30 8 C 5.1456 2.3903 0.0 0
M  V30 9 C 4.0012 4.9608 0.0 0
M  V30 10 C 1.3337 4.9608 0.0 0
M  V30 11 O 4.5192 0.9835 0.0 0
M  V30 12 C 2.6675 5.7308 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-methyl-1H-isoindole-1,3(2H)-dione
C9H6ClNO2
66653-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9570 5.7308 0.0 0
M  V30 2 Cl 0.0000 3.0800 0.0 0
M  V30 3 O 6.6518 3.0204 0.0 0
M  V30 4 C 5.2891 6.0811 0.0 0
M  V30 5 C 2.6674 3.0800 0.0 0
M  V30 6 C 4.0010 2.3100 0.0 0
M  V30 7 C 2.9876 4.5864 0.0 0
M  V30 8 C 1.3336 2.3100 0.0 0
M  V30 9 C 5.1454 3.3405 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 N 4.5191 4.7473 0.0 0
M  V30 12 C 1.3336 0.7700 0.0 0
M  V30 13 C 2.6674 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 2 3 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-21-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 66653-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-19569928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organo-Solubility Carbazole-Containing Polyimides with Tunable Memory
Characteristics Based on Different Dianhydride Moieties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Yanhua; Jin, Pan; Ding, Shijin; Chu, Yueying; Shen, Yingzhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Macromolecular Chemistry and Physics (2018), 219(17), n/a

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-fluorobenzonitrile
C7H3ClFN
117482-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 Cl 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8500 1.3337 0.0 0
M  V30 7 C 3.8500 4.0010 0.0 0
M  V30 8 C 2.3100 1.3337 0.0 0
M  V30 9 C 2.3100 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-(methylamino)benzonitrile
C8H7ClN2
329365-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 N 8.4702 2.6673 0.0 0
M  V30 3 Cl 2.3101 0.0000 0.0 0
M  V30 4 N 0.7700 2.6673 0.0 0
M  V30 5 C 0.0000 4.0010 0.0 0
M  V30 6 C 5.3901 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117482-84-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 329365-26-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7735677
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-chloro-4-(methylamino)benzonitrile A mixture of
3-chloro-4-fluorobenzonitrile (5.2 g, 33 mmol), THF (55 mL), and 40%
methylamine in water (25 mL, 290 mmol) in a sealed tube was heated to
65°C. for 1.5 hours, cooled to room temperature. The organic phase was
washed with brine, dried (Na2SO4), filtered, and concentrated. The
resulting solid was dried for about 16 hours under high vacuum in the
presence of P2O5. 6.3 g (95%) of the desired product. MS (DCI/NH3) m/z
184, 186 (M+H+NH3)+; 1H NMR (DMSO-d6) δ7.72 (d, 1H), 7.55 (dd, 1H), 6.70
(d, 1H), 6.52 (br q, 1H), 2.80 (d, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole and thiazole derivatives of benzonitrile as farnesyltransferase
inhibitors, and their preparation and use for the treatment of cancer.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Claiborne, Akiyo K.; Gwaltney, Stephen L.; Hasvold, Lisa A.; Li, Qun; Li,
Tongmei; Lin, Nan-Horng; Mantei, Robert A.; Rockway, Todd W.; Sham, Hing
L.; Sullivan, Gerard M.; Tong, Yunsong; Wang, Gary; Wang, Le; Wang, Xilu;
Wang, Wei-Bo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030087940 A1 2003-05-08

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-fluorobenzonitrile
C7H3ClFN
117482-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 Cl 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8500 1.3337 0.0 0
M  V30 7 C 3.8500 4.0010 0.0 0
M  V30 8 C 2.3100 1.3337 0.0 0
M  V30 9 C 2.3100 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-(methylamino)benzonitrile
C8H7ClN2
329365-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 2.6673 0.0 0
M  V30 2 N 8.4702 2.6673 0.0 0
M  V30 3 Cl 2.3101 0.0000 0.0 0
M  V30 4 N 0.7700 2.6673 0.0 0
M  V30 5 C 0.0000 4.0010 0.0 0
M  V30 6 C 5.3901 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117482-84-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 329365-26-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14613894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-chloro-4-(methylamino)benzonitrile A mixture of
3-chloro-4-fluorobenzonitrile (5.2 g, 33 mmol), THF (55 mL), and 40%
methylamine in water (25 mL, 290 mmol) in a sealed tube was heated to
65°C. for 1.5 hours, cooled to room temperature. The organic phase was
washed with brine, dried (Na2SO4), filtered, and concentrated. The
resulting solid was dried for about 16 hours under high vacuum in the
presence of P2O5 to provide the desired product. Yield 6.3 g (95%). MS
(DCI/NH3) m/z 184,186 (M+H+ NH3)+; 1H NMR (DMSO-d6) δ 7.72 (d, 1H), 7.55
(dd, 1H), 6.70 (d, 1H), 6.52 (br q, 1H), 2.80 (d, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole and thiazole derivatives of benzonitrile as farnesyltransferase
inhibitors, and their preparation and use for the treatment of cancer.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Claiborne, Akiyo K.; Gwaltney, Stephen L.; Hasvold, Lisa A.; Li, Qun; Li,
Tongmei; Lin, Nan-horng; Mantei, Robert A.; Rockway, Todd W.; Sham, Hing
L.; Sullivan, Gerard M.; Tong, Yunsong; Wang, Gary; Wang, Le; Wang, Xilu;
Wang, Wei-bo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020115640 A1 2002-08-22

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purin-...
C24H19ClFN5O5
118373-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 7.9887 11.9713 0.0 0
M  V30 2 O 10.4787 9.7293 0.0 0
M  V30 3 C 10.9545 11.1940 0.0 0
M  V30 4 O 9.9241 12.3384 0.0 0
M  V30 5 C 9.1159 6.6686 0.0 0
M  V30 6 O 8.3459 5.3348 0.0 0
M  V30 7 C 9.1159 4.0011 0.0 0
M  V30 8 O 10.6559 4.0011 0.0 0
M  V30 9 Cl 0.0000 11.1110 0.0 0
M  V30 10 N 1.6484 6.0374 0.0 0
M  V30 11 N 5.0872 10.2960 0.0 0
M  V30 12 C 3.7535 9.5260 0.0 0
M  V30 13 C 4.7670 11.8023 0.0 0
M  V30 14 C 2.6091 10.5564 0.0 0
M  V30 15 N 3.4333 8.0195 0.0 0
M  V30 16 N 3.2354 11.9634 0.0 0
M  V30 17 C 1.1444 10.0806 0.0 0
M  V30 18 C 1.9686 7.5437 0.0 0
M  V30 19 N 0.8242 8.5743 0.0 0
M  V30 20 C 6.4941 9.6697 0.0 0 CFG=2
M  V30 21 C 7.8278 10.4397 0.0 0 CFG=1
M  V30 22 O 6.8143 8.1632 0.0 0
M  V30 23 C 8.9722 9.4091 0.0 0 CFG=2
M  V30 24 C 8.3459 8.0023 0.0 0 CFG=2
M  V30 25 C 12.4610 11.5142 0.0 0
M  V30 26 C 13.4914 10.3698 0.0 0
M  V30 27 C 12.9369 12.9789 0.0 0
M  V30 28 C 14.9977 10.6900 0.0 0
M  V30 29 C 14.4432 13.2991 0.0 0
M  V30 30 C 15.4736 12.1545 0.0 0
M  V30 31 C 8.3459 2.6675 0.0 0
M  V30 32 C 9.1159 1.3338 0.0 0
M  V30 33 C 6.8058 2.6675 0.0 0
M  V30 34 C 8.3459 0.0000 0.0 0
M  V30 35 C 6.0358 1.3338 0.0 0
M  V30 36 C 6.8058 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 21 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 23 2 CFG=3
M  V30 4 2 3 4
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 1 24 5 CFG=1
M  V30 8 1 6 7
M  V30 9 2 7 8
M  V30 10 1 7 31
M  V30 11 1 9 17
M  V30 12 1 10 18
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 20 11 CFG=1
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 19 1 14 16
M  V30 20 2 14 17
M  V30 21 1 15 18
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 20 21 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-N6-methyl-9H-purine-2,6-diamine
C11H15FN6O3
2171104-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 2.9016 7.1223 0.0 0
M  V30 2 N 10.5371 4.6201 0.0 0
M  V30 3 C 11.8709 3.8501 0.0 0
M  V30 4 N 7.8697 0.0000 0.0 0
M  V30 5 C 0.6967 2.1699 0.0 0
M  V30 6 O 1.1726 0.7053 0.0 0
M  V30 7 O 0.0000 5.4473 0.0 0
M  V30 8 N 5.3915 4.8805 0.0 0
M  V30 9 C 6.5361 3.8501 0.0 0
M  V30 10 C 6.0178 6.2873 0.0 0
M  V30 11 C 7.8697 4.6201 0.0 0
M  V30 12 N 6.5361 2.3101 0.0 0
M  V30 13 N 7.5496 6.1264 0.0 0
M  V30 14 C 9.2034 3.8501 0.0 0
M  V30 15 C 7.8697 1.5400 0.0 0
M  V30 16 N 9.2034 2.3101 0.0 0
M  V30 17 C 3.8852 4.5603 0.0 0 CFG=1
M  V30 18 O 3.2587 3.1534 0.0 0
M  V30 19 C 2.7406 5.5908 0.0 0 CFG=1
M  V30 20 C 1.7271 3.3145 0.0 0 CFG=2
M  V30 21 C 1.4070 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=3
M  V30 7 1 21 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=3
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118373-61-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2171104-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18786935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed container used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 6-aminopurine nucleotides for the treatment of
paramyxovirus and orthomyxovirus infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sommadossi, Jean-Pierre; Moussa, Adel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018009623 A1 2018-01-11

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorophthalic anhydride
C8H3ClO3
118-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 Cl 7.2706 3.9844 0.0 0
M  V30 4 C 3.4206 2.6508 0.0 0
M  V30 5 C 2.6506 3.9844 0.0 0
M  V30 6 C 2.3902 1.5064 0.0 0
M  V30 7 C 4.9606 2.6508 0.0 0
M  V30 8 C 1.1444 3.6643 0.0 0
M  V30 9 C 3.4206 5.3182 0.0 0
M  V30 10 O 0.9834 2.1327 0.0 0
M  V30 11 C 5.7306 3.9844 0.0 0
M  V30 12 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-methyl-1H-isoindole-1,3(2H)-dione
C9H6ClNO2
63197-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4211 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 C 0.0000 2.7106 0.0 0
M  V30 4 Cl 7.9110 4.2506 0.0 0
M  V30 5 C 3.9099 3.4806 0.0 0
M  V30 6 C 3.9099 1.9406 0.0 0
M  V30 7 C 2.4452 3.9564 0.0 0
M  V30 8 C 5.2435 4.2506 0.0 0
M  V30 9 C 2.4452 1.4647 0.0 0
M  V30 10 C 5.2435 1.1706 0.0 0
M  V30 11 N 1.5400 2.7106 0.0 0
M  V30 12 C 6.5772 3.4806 0.0 0
M  V30 13 C 6.5772 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63197-17-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-10348518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 1. Synthesis of N-methyl-4-chlorophthalimide (VIII). An
appropriately equipped glass reaction vessel was charged with 186.5 grams
(1 mole) of 4-chlorotetrahydrophthalic anhydride and heated to 150°C
under nitrogen. Methylamine gas (32 grams, 1.03 mole) was then introduced
to the reaction vessel subsurface over 30 minutes. The reaction mixture
was then heated for 3 hours at 180°C. The product was then distilled to
give N-methyl-4-chlorophthalimide. Yield 95% .
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted phthalic anhydrides especially
4-chlorophthalic anhydride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Odle, Roy Ray; Guggenheim, Thomas Link
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004072012 A1 2004-08-26

$RFMT $RIREG SCHEME310 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3,4-Dimethoxyphenyl)-2,3-dihydro-3-methyl-4(1H)-quinazolinone
C17H18N2O3
1354322-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 6.6687 0.0 0
M  V30 2 O 2.3101 6.6687 0.0 0
M  V30 3 O 10.0102 1.3338 0.0 0
M  V30 4 C 9.2402 0.0000 0.0 0
M  V30 5 O 11.5503 4.0012 0.0 0
M  V30 6 C 12.3203 5.3348 0.0 0
M  V30 7 C 5.3901 4.0012 0.0 0
M  V30 8 N 4.6201 2.6675 0.0 0
M  V30 9 N 4.6201 5.3348 0.0 0
M  V30 10 C 3.0801 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 C 2.3101 1.3338 0.0 0
M  V30 14 C 0.7700 4.0012 0.0 0
M  V30 15 C 0.7700 1.3338 0.0 0
M  V30 16 C 0.0000 2.6675 0.0 0
M  V30 17 C 6.9302 4.0012 0.0 0
M  V30 18 C 7.7002 2.6675 0.0 0
M  V30 19 C 7.7002 5.3348 0.0 0
M  V30 20 C 9.2402 2.6675 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 12
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1354322-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21403894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of TiO2 nanoparticles in the synthesis of some
2,3-disubstituted dihydroquinazolin-4(1H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bharathi, A.; Roopan, Selvaraj Mohana; Kajbafvala, Amir; Padmaja, R. D.;
Darsana, M. S.; Nandhini Kumari, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2014), 25(2), 324-326

$RFMT $RIREG SCHEME311 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Formylchromone
C10H6O3
17422-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 C 6.6686 1.5400 0.0 0
M  V30 3 O 8.0022 2.3100 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 4.0011 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
13a,14-Dihydro-6-methyl-5H-[1]benzopyrano[2,3-b][1,5]benzodiazocine-5,8(6H)-d...
C18H14N2O3
1428148-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 2.4507 0.0 0
M  V30 2 C 6.1514 0.0000 0.0 0
M  V30 3 O 8.7774 0.7036 0.0 0
M  V30 4 C 5.3901 5.1181 0.0 0
M  V30 5 C 4.6201 3.7843 0.0 0
M  V30 6 O 4.6201 6.4518 0.0 0
M  V30 7 N 6.8776 5.5167 0.0 0
M  V30 8 C 3.0801 3.7843 0.0 0
M  V30 9 C 5.0187 2.2968 0.0 0
M  V30 10 C 3.0801 6.4518 0.0 0
M  V30 11 C 8.2113 4.7467 0.0 0
M  V30 12 C 2.3101 5.1181 0.0 0
M  V30 13 N 6.3523 1.5268 0.0 0
M  V30 14 C 2.3101 7.7855 0.0 0
M  V30 15 C 8.6100 3.2592 0.0 0
M  V30 16 C 9.3004 5.8357 0.0 0
M  V30 17 C 0.7700 5.1181 0.0 0
M  V30 18 C 7.8400 1.9254 0.0 0
M  V30 19 C 0.7700 7.7855 0.0 0
M  V30 20 C 10.0975 2.8605 0.0 0
M  V30 21 C 10.7879 5.4371 0.0 0
M  V30 22 C 0.0000 6.4518 0.0 0
M  V30 23 C 11.1865 3.9496 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 13
M  V30 3 2 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 11 16
M  V30 17 2 12 17
M  V30 18 1 13 18
M  V30 19 1 14 19
M  V30 20 1 15 18
M  V30 21 2 15 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 2 19 22
M  V30 25 1 20 23
M  V30 26 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 17422-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1428148-62-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9813330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A three-component synthesis of benzochromenodiazocines and
chromenopyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolatkhah, Zahra; Nasiri-Aghdam, Mahnaz; Bazgir, Ayoob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(15), 1960-1962

$RFMT $RIREG SCHEME312 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Hydroxyacetophenone
C8H8O2
118-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-α-methyl-α-(methylamino)benzeneacetonitrile
C10H12N2O
2447578-04-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6673 0.0 0
M  V30 2 C 6.1600 2.6673 0.0 0
M  V30 3 N 4.6200 4.2073 0.0 0
M  V30 4 C 4.6200 1.1273 0.0 0
M  V30 5 N 7.7000 2.6673 0.0 0
M  V30 6 C 5.9536 4.9773 0.0 0
M  V30 7 O 3.0800 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 2.3100 1.3336 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3336 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 3 2 5
M  V30 6 1 3 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2447578-04-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-22564614
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, catalyst prepared and used, reusable
catalyst used, recyclable catalyst used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnO-nanorods Promoted Synthesis of α-amino Nitrile Benzofuran Derivatives
using One-pot Multicomponent Reaction of Isocyanides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Najar, Asef H.; Hossaini, Zinatossadat; Abdolmohammadi, Shahrzad;
Zareyee, Daryoush
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2020), 23(4),
345-355

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dioxolane-4-ethanol, 2,2-di(9Z,12Z)-9,12-octadecadien-1-yl-, 4-methanesul...
C42H76O5S
1190203-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.8601 12.0031 0.0 0
M  V30 2 C 12.3201 12.0031 0.0 0
M  V30 3 C 11.5501 10.6695 0.0 0
M  V30 4 C 10.0101 10.6695 0.0 0
M  V30 5 C 9.2400 9.3358 0.0 0
M  V30 6 C 7.7000 9.3358 0.0 0
M  V30 7 C 6.9300 8.0020 0.0 0
M  V30 8 C 5.3900 8.0020 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 C 3.0800 9.3358 0.0 0
M  V30 11 C 2.3100 8.0020 0.0 0
M  V30 12 C 0.7700 8.0020 0.0 0
M  V30 13 C 0.0000 6.6684 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.0000 1.3336 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 19 C 15.8759 12.4317 0.0 0
M  V30 20 C 17.2827 13.0580 0.0 0
M  V30 21 C 18.5286 12.1528 0.0 0
M  V30 22 C 19.9356 12.7791 0.0 0
M  V30 23 C 21.1814 11.8741 0.0 0
M  V30 24 C 22.5882 12.5004 0.0 0
M  V30 25 C 23.8342 11.5952 0.0 0
M  V30 26 C 25.2410 12.2217 0.0 0
M  V30 27 C 25.4020 13.7532 0.0 0
M  V30 28 C 26.8089 14.3795 0.0 0
M  V30 29 C 28.0548 13.4743 0.0 0
M  V30 30 C 29.4616 14.1008 0.0 0
M  V30 31 C 30.7076 13.1956 0.0 0
M  V30 32 C 30.5465 11.6640 0.0 0
M  V30 33 C 31.7925 10.7588 0.0 0
M  V30 34 C 31.6315 9.2273 0.0 0
M  V30 35 C 32.8773 8.3220 0.0 0
M  V30 36 C 32.7164 6.7904 0.0 0
M  V30 37 C 12.2397 16.5252 0.0 0
M  V30 38 C 12.5598 18.0316 0.0 0
M  V30 39 O 11.4155 19.0621 0.0 0
M  V30 40 S 11.7356 20.5685 0.0 0 VAL=6
M  V30 41 C 10.2292 20.8887 0.0 0
M  V30 42 O 12.0558 22.0748 0.0 0
M  V30 43 O 13.2419 20.2482 0.0 0
M  V30 44 C 14.6301 13.3368 0.0 0
M  V30 45 O 13.2231 13.9633 0.0 0
M  V30 46 O 15.6605 14.4813 0.0 0
M  V30 47 C 13.3841 15.4948 0.0 0 CFG=3
M  V30 48 C 14.8905 15.8150 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 44
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 44
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 2 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 2 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 1 37 38
M  V30 38 1 37 47
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 2 40 42
M  V30 43 2 40 43
M  V30 44 1 44 45
M  V30 45 1 44 46
M  V30 46 1 45 47
M  V30 47 1 46 48
M  V30 48 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,2-di(9Z,12Z)-9,12-octadecadien-1-yl-1,3-dioxolane-4-ethanamine
C42H77NO2
1190203-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.8601 12.0033 0.0 0
M  V30 2 C 12.3201 12.0033 0.0 0
M  V30 3 C 11.5501 10.6695 0.0 0
M  V30 4 C 10.0101 10.6695 0.0 0
M  V30 5 C 9.2400 9.3358 0.0 0
M  V30 6 C 7.7000 9.3358 0.0 0
M  V30 7 C 6.9300 8.0022 0.0 0
M  V30 8 C 5.3900 8.0022 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 C 3.0800 9.3358 0.0 0
M  V30 11 C 2.3100 8.0022 0.0 0
M  V30 12 C 0.7700 8.0022 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.0000 1.3336 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 19 C 15.8759 12.4317 0.0 0
M  V30 20 C 17.2827 13.0580 0.0 0
M  V30 21 C 18.5286 12.1528 0.0 0
M  V30 22 C 19.9356 12.7793 0.0 0
M  V30 23 C 21.1814 11.8741 0.0 0
M  V30 24 C 22.5882 12.5004 0.0 0
M  V30 25 C 23.8342 11.5952 0.0 0
M  V30 26 C 25.2410 12.2217 0.0 0
M  V30 27 C 25.4020 13.7532 0.0 0
M  V30 28 C 26.8089 14.3795 0.0 0
M  V30 29 C 28.0548 13.4745 0.0 0
M  V30 30 C 29.4616 14.1008 0.0 0
M  V30 31 C 30.7076 13.1956 0.0 0
M  V30 32 C 30.5465 11.6640 0.0 0
M  V30 33 C 31.7925 10.7588 0.0 0
M  V30 34 C 31.6315 9.2273 0.0 0
M  V30 35 C 32.8773 8.3220 0.0 0
M  V30 36 C 32.7164 6.7905 0.0 0
M  V30 37 C 15.5168 17.2219 0.0 0
M  V30 38 C 14.6116 18.4678 0.0 0
M  V30 39 N 15.2381 19.8747 0.0 0
M  V30 40 C 14.3329 21.1206 0.0 0
M  V30 41 C 14.6301 13.3369 0.0 0
M  V30 42 O 15.6605 14.4813 0.0 0
M  V30 43 O 13.2231 13.9633 0.0 0
M  V30 44 C 14.8905 15.8150 0.0 0 CFG=3
M  V30 45 C 13.3841 15.4948 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 41
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 41
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 2 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 2 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 1 37 38
M  V30 38 1 37 44
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 41 42
M  V30 42 1 41 43
M  V30 43 1 42 44
M  V30 44 1 43 45
M  V30 45 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190203-56-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190203-57-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13124016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of compound 11: To a solution of methanesulfonyl derivative of
compound 10 (12.0 g, 17.31 mmol, 1.0 eq) in ethanol (20.0 ml) was added
excess amount of 33% methylamine in ethanol (200 ml) in the Parr reactor
and continued the reaction at 70 °C for 4h hours, after complete
consumption of the starting material, cooled the reaction, transferred
into a round bottom flask, concentrated. Dissolved the reaction product
in the ethylacetate and washed with water, dried on Na2SO4 evaporated and
further dried on vacuum gave 10.3 g (95%) of the pure product 11, this
was used for the next step without further purification. Compound 11,
yield 10.3 g 95%. 1H NMR (400 MHz, CDCl3) δ 5.47 - 5.21 (m, 8H), 4.14 -
4.04 (m, 2H), 3.49 (t, J = 7.6, 1H), 3.00 - 2.83 (m, 1H), 2.80 - 2.74 (m,
5H), 2.60 (s, 3H), 2.04 (q, J = 6.8, 8H), 1.94 - 1.81 (m, 2H), 1.60 -
1.52 (m, 4H), 1.41 - 1.15 (m, 37H), 0.88 (t, J = 6.8, 6H); Calc. mass for
C42H77NO2: 627.6, abs. mass: 628.5 (MH)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Site-specific delivery of nucleic acids by combining targeting ligands
with endosomolytic components
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manoharan, Muthiah; Rajeev, Kallanthottathil G.; Butler, David;
Jayaraman, Muthusamy; Narayanannair, Jayaprakash K.; Matsuda, Shigeo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009126933 A2 2009-10-15

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αS,3S)-1,4-dihydro-α-methyl-2′-oxospiro[isoquinoline-3(2H),3′-pyrroli...
C16H20N2O3
1191929-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.8194 0.4963 0.0 0
M  V30 2 C 9.0058 1.5315 0.0 0 CFG=1
M  V30 3 C 10.4126 2.1580 0.0 0
M  V30 4 C 8.8447 0.0000 0.0 0
M  V30 5 O 11.6585 1.2528 0.0 0
M  V30 6 O 10.5735 3.6896 0.0 0
M  V30 7 C 13.0654 1.8791 0.0 0
M  V30 8 C 5.3900 3.2068 0.0 0 CFG=1
M  V30 9 C 6.2952 1.9609 0.0 0
M  V30 10 C 4.6200 4.5406 0.0 0
M  V30 11 C 6.2952 4.4526 0.0 0
M  V30 12 N 4.6200 1.8731 0.0 0
M  V30 13 N 7.7599 2.4368 0.0 0
M  V30 14 C 3.0800 4.5406 0.0 0
M  V30 15 C 7.7599 3.9768 0.0 0
M  V30 16 C 3.0800 1.8731 0.0 0
M  V30 17 C 2.3100 3.2068 0.0 0
M  V30 18 C 2.3100 5.8742 0.0 0
M  V30 19 C 0.7700 3.2068 0.0 0
M  V30 20 C 0.7700 5.8742 0.0 0
M  V30 21 C 0.0000 4.5406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11 CFG=1
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 16 17
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS,3S)-1,4-Dihydro-N,α-dimethyl-2′-oxospiro[isoquinoline-3(2H),3′-pyrrolidin...
C16H21N3O2
1191929-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.8194 0.4963 0.0 0
M  V30 2 C 9.0058 1.5315 0.0 0 CFG=1
M  V30 3 C 10.4126 2.1580 0.0 0
M  V30 4 C 8.8447 0.0000 0.0 0
M  V30 5 N 11.6585 1.2528 0.0 0
M  V30 6 O 10.5735 3.6896 0.0 0
M  V30 7 C 13.0654 1.8791 0.0 0
M  V30 8 C 5.3900 3.2068 0.0 0 CFG=1
M  V30 9 C 6.2952 1.9609 0.0 0
M  V30 10 C 4.6200 4.5406 0.0 0
M  V30 11 C 6.2952 4.4526 0.0 0
M  V30 12 N 4.6200 1.8731 0.0 0
M  V30 13 N 7.7599 2.4368 0.0 0
M  V30 14 C 3.0800 4.5406 0.0 0
M  V30 15 C 7.7599 3.9768 0.0 0
M  V30 16 C 3.0800 1.8731 0.0 0
M  V30 17 C 2.3100 3.2068 0.0 0
M  V30 18 C 2.3100 5.8742 0.0 0
M  V30 19 C 0.7700 3.2068 0.0 0
M  V30 20 C 0.7700 5.8742 0.0 0
M  V30 21 C 0.0000 4.5406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9 CFG=3
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 16 17
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1191929-76-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1191929-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1092953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-N-Methyl-2-((S)-20-oxo-2,4-dihydro-1H-spiro[isoquinoline-
3,30-pyrrolidine]-10-yl)propanamide, 13. Compound 8 (22mg, 0.08mmol) was
dissolved at room temperature in a solution of methyl amine in EtOH(5 mL,
8.03 M). The reaction mixture was stirred for 12 h and evaporated to give
13 (21mg, 95%) as a foam. Rf 0.63 (EtOAc/MeOH 4:1). [α]25 D -26.9 (c 0.4,
CHCl3). 1H NMR(400 MHz,CDCl3, δ) 7.28-7.06 (m, 4H), 6.45 (br, s, 1H),
4.73 (q, J = 7.2 Hz, 1H), 4.14 (d, AB system, J = 17.5 Hz, 1H), 4.06 (d,
AB system, J =17.5Hz, 1H), 3.47-3.37 (m,2H), 3.06 (d,ABsystem, J =16.3
Hz, 1H), 2.80 (d, J =4.7 Hz, 3H), 2.64 (d, AB system, J =16.3Hz, 1H),
2.19-2.10 (m, 1H), 2.10-1.96 (m, 2H), 1.45 (d, 7.2Hz, 3H). 13C
NMR(100MHz,CDC13, δ) 176.9, 171.3, 135.1, 133.1, 130.4, 127.0 (2C),
126.4, 60.0, 51.3, 44.8, 41.1, 34.6, 30.6, 26.9, 14.3. HRMS (EI) calcd
for C16H21N3O2 287.1634, found 287.1628.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydroisoquinoline-based spirocyclic lactam as a type II' β-turn
inducing peptide mimetic
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Landoni, Nicola; Pilati, Tullio; Sacchetti, Alessandro;
Silvani, Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(21), 8098-8105

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2S)-1-[(2S)-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]propyl]-2-azetidi...
C16H20N2O5
1192501-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9013 2.3100 0.0 0
M  V30 2 C 7.2350 1.5400 0.0 0 CFG=2
M  V30 3 O 5.9013 3.8500 0.0 0
M  V30 4 N 8.5687 2.3100 0.0 0
M  V30 5 C 7.2350 0.0000 0.0 0
M  V30 6 C 9.9023 1.5400 0.0 0
M  V30 7 O 11.2361 2.3100 0.0 0
M  V30 8 O 9.9023 0.0000 0.0 0
M  V30 9 C 12.5698 1.5400 0.0 0
M  V30 10 C 2.3100 3.2722 0.0 0
M  V30 11 O 0.7700 3.2722 0.0 0
M  V30 12 O 3.0800 4.6060 0.0 0
M  V30 13 C 0.0000 4.6060 0.0 0
M  V30 14 N 4.5675 1.5400 0.0 0
M  V30 15 C 3.0800 1.9386 0.0 0 CFG=2
M  V30 16 C 4.1690 0.0525 0.0 0
M  V30 17 C 2.6815 0.4511 0.0 0
M  V30 18 C 13.9034 2.3100 0.0 0
M  V30 19 C 15.2372 1.5400 0.0 0
M  V30 20 C 13.9034 3.8500 0.0 0
M  V30 21 C 16.5709 2.3100 0.0 0
M  V30 22 C 15.2372 4.6201 0.0 0
M  V30 23 C 16.5709 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 15 10 CFG=1
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-methyl-2-[(2S)-2-[(methylamino)carbonyl]-1-azetidinyl]...
C16H21N3O4
1192501-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9013 2.3100 0.0 0
M  V30 2 C 7.2350 1.5400 0.0 0 CFG=2
M  V30 3 O 5.9013 3.8500 0.0 0
M  V30 4 N 8.5687 2.3100 0.0 0
M  V30 5 C 7.2350 0.0000 0.0 0
M  V30 6 C 9.9025 1.5400 0.0 0
M  V30 7 O 11.2361 2.3100 0.0 0
M  V30 8 O 9.9025 0.0000 0.0 0
M  V30 9 C 12.5698 1.5400 0.0 0
M  V30 10 C 2.3100 3.2722 0.0 0
M  V30 11 N 0.7700 3.2722 0.0 0
M  V30 12 O 3.0800 4.6060 0.0 0
M  V30 13 C 0.0000 4.6060 0.0 0
M  V30 14 N 4.5675 1.5400 0.0 0
M  V30 15 C 3.0800 1.9386 0.0 0 CFG=2
M  V30 16 C 4.1690 0.0525 0.0 0
M  V30 17 C 2.6815 0.4511 0.0 0
M  V30 18 C 13.9034 2.3100 0.0 0
M  V30 19 C 13.9034 3.8500 0.0 0
M  V30 20 C 15.2372 1.5400 0.0 0
M  V30 21 C 15.2372 4.6201 0.0 0
M  V30 22 C 16.5709 2.3100 0.0 0
M  V30 23 C 16.5709 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 15 10 CFG=1
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1192501-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1192501-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4379707
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of
Dipeptide Derivatives with C-Terminal Amide Groups. Method A. The
corresponding dipeptide methyl ester (4.22 mmol) was dissolved in MeNH2 •
EtOH (10 mL, 8 M). After 2 h of reaction the solvent was evaporated to
dryness, and when necessary, the residue waspurified by flash
chromatography or centrifugal circular thinlayer chromatography, using
the system of eluents indicated in each case Z-Ala-Aze-NHMe (8a): Solid
95% yield (From 4a, Method A). (mp 125-127 ºC). Eluent: MeOH:CH2Cl2
(1:30). HPLC: tR= 2.37 min (Novapak, A:B=30:70). [α]D= -131.8 (c=0.42,
CHCl3). 1H NMR (CDCl3): Trans/cis isomers ratio 6.7:1. Trans isomer: δ
7.32 (m, 6H, Ph, NH-CH3), 5.41 (d, 1H, J=7.1, NH-Ala), 5.09 (s, 2H,
CH2-Z), 4.87 (dd, 1H, J=9.3, 6.5, H-2), 4.33-4.21 (m, 2H, H-4, α-H, Ala),
4.06 (m, 1H, H-4), 2.81 (d, 3H, J=4.8, CH3-NH), 2.72 (m, 1H, H-3), 2.51
(m, 1H, H-3), 1.31 (d, 3H, J=7.1, β-H, Ala). cis isomer: δ 7.32 (m, 6H,
Ph, NH-CH3), 5.41 (m, 1H, NH-Ala), 5.09 (s, 2H, CH2-Z), 4.84 (m, 1H,
H-2), 4.33-4.21 (m, 2H, H-4, α-H, Ala), 4.06 (m, 1H, H-4), 2.87 (d, 3H,
J=4.8, CH3-NH), 2.72 (m, 1H, H-3), 2.51 (m, 1H, H-3), 1.31 (m, 3H, β-H,
Ala). 1H NMR (400 MHz, DMSO-d6): Trans/cis isomers ratio 4:1. Trans
isomer: δ 7.81 (m, 1H, NH-CH3), 7.57 (d, 1H, J=7.0, NH-Ala), 7.35 (m, 5H,
Ph), 5.02 (s, 2H, CH2-Z), 4.51 (dd, 1H, J=9.0, 6.1, H-2), 4.21-4.01 (m,
3H, H-4, α-H, Ala), 2.60 (d, 3H, J=4.4, CH3-NH), 2.36 (m, 1H, H-3), 2.07
(m, 1H, H-3), 1.17 (d, 3H, J=7.0, β-H, Ala). cis isomer: δ 8.11 (m, 1H,
NH-CH3), 7.35 (m, 6H, Ph, NH-Ala), 5.02 (s, 2H, CH2-Z), 4.76 (m, 1H,
H-2), 4.21-3.81 (m, 3H, H-4, α-H, Ala), 2.60 (m, 3H, CH3-NH), 2.36 (m,
1H, H-3), 2.07 (m, 1H, H-3), 1.17 (m, 3H, β-H, Ala). 13C NMR (CDCl3):
Trans isomer: δ 174.5 (COAla), 170.9 (2-CO), 155.7 (CO-Z), 136.1 (C-Ph),
128.5, 128.2, 128.0 (CH-Ph), 67.0 (CH2-Z), 62.0 (2-C), 48.8 (4-C), 46.2
(α-C, Ala), 26.2 (CH3-NH), 18.8 (3-C), 18.2 (β-C, Ala). cis isomer: δ
174.5 (CO-Ala), 170.9 (2-CO), 156.0 (CO-Z), 136.1 (C-Ph), 128.5, 128.2,
128.0 (CH-Ph), 67.0 (CH2-Z), 63.1 (2-C), 48.8 (4-C), 46.3 (α-C, Ala),
26.2 (CH3-NH), 18.8 (3-C), 18.5 (β-C, Ala). ES-MS: 342.0 [M+Na]+. Anal.
Calcd. for C16H21N3O4: C, 60.17; H, 6.63; N, 13.16. Found: C, 60.10; H,
6.70; N, 13.08.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Further Evidence for 2-Alkyl-2-carboxyazetidines as γ-Turn Inducers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baeza, Jose Luis; Gerona-Navarro, Guillermo; Thompson, Kevin; Perez de
Vega, M. Jesus; Infantes, Lourdes; Garcia-Lopez, M. Teresa;
Gonzalez-Muniz, Rosario; Martin-Martinez, Mercedes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(21), 8203-8211

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N-[2-(4,4-difluoro-1-piperidinyl)-2-[2-(trifluoromethyl)-5-pyrim...
C22H18Cl2F5N5O
1192564-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 6.5698 0.0 0
M  V30 2 N 9.3360 5.7998 0.0 0
M  V30 3 O 10.6697 8.1098 0.0 0
M  V30 4 C 8.0023 6.5698 0.0 0
M  V30 5 C 6.6687 5.7998 0.0 0
M  V30 6 Cl 10.6697 3.4897 0.0 0
M  V30 7 Cl 17.3383 8.8798 0.0 0
M  V30 8 C 1.3338 8.8798 0.0 0
M  V30 9 F 2.1038 10.2135 0.0 0
M  V30 10 F 0.0000 9.6499 0.0 0
M  V30 11 F 0.5638 7.5462 0.0 0
M  V30 12 F 7.6586 0.0000 0.0 0
M  V30 13 F 5.6787 0.0000 0.0 0
M  V30 14 C 13.3372 6.5698 0.0 0
M  V30 15 C 12.0035 5.7998 0.0 0
M  V30 16 C 14.6708 5.7998 0.0 0
M  V30 17 C 13.3372 8.1098 0.0 0
M  V30 18 C 12.0035 4.2597 0.0 0
M  V30 19 C 14.6708 4.2597 0.0 0
M  V30 20 N 16.0045 6.5698 0.0 0
M  V30 21 C 14.6708 8.8798 0.0 0
M  V30 22 C 13.3372 3.4897 0.0 0
M  V30 23 C 16.0045 8.1098 0.0 0
M  V30 24 C 5.3348 6.5698 0.0 0
M  V30 25 C 5.3348 8.1098 0.0 0
M  V30 26 C 4.0012 5.7998 0.0 0
M  V30 27 N 4.0012 8.8798 0.0 0
M  V30 28 N 2.6675 6.5698 0.0 0
M  V30 29 C 2.6675 8.1098 0.0 0
M  V30 30 N 6.6687 4.2597 0.0 0
M  V30 31 C 5.3348 3.4897 0.0 0
M  V30 32 C 8.0023 3.4897 0.0 0
M  V30 33 C 5.3348 1.9497 0.0 0
M  V30 34 C 8.0023 1.9497 0.0 0
M  V30 35 C 6.6687 1.1797 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 24
M  V30 7 1 5 30
M  V30 8 1 6 18
M  V30 9 1 7 23
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 29
M  V30 14 1 12 35
M  V30 15 1 13 35
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 2 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-[2-(4,4-difluoro-1-piperidinyl)-2-[2-(trifluoromethyl)-5-pyrimidin...
C23H22ClF5N6O
1192566-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 6.5698 0.0 0
M  V30 2 N 8.0023 5.7998 0.0 0
M  V30 3 O 6.6687 8.1098 0.0 0
M  V30 4 C 9.3360 6.5698 0.0 0
M  V30 5 C 10.6697 5.7998 0.0 0
M  V30 6 Cl 6.6687 3.4897 0.0 0
M  V30 7 N 0.0000 8.8798 0.0 0
M  V30 8 C 0.0000 10.4199 0.0 0
M  V30 9 C 16.0045 8.8798 0.0 0
M  V30 10 F 15.2345 10.2135 0.0 0
M  V30 11 F 17.3383 9.6499 0.0 0
M  V30 12 F 16.7745 7.5462 0.0 0
M  V30 13 F 11.6596 0.0000 0.0 0
M  V30 14 F 9.6799 0.0000 0.0 0
M  V30 15 C 4.0012 6.5698 0.0 0
M  V30 16 C 5.3348 5.7998 0.0 0
M  V30 17 C 2.6675 5.7998 0.0 0
M  V30 18 C 4.0012 8.1098 0.0 0
M  V30 19 C 5.3348 4.2597 0.0 0
M  V30 20 N 1.3338 6.5698 0.0 0
M  V30 21 C 2.6675 4.2597 0.0 0
M  V30 22 C 2.6675 8.8798 0.0 0
M  V30 23 C 4.0012 3.4897 0.0 0
M  V30 24 C 1.3338 8.1098 0.0 0
M  V30 25 C 12.0035 6.5698 0.0 0
M  V30 26 C 12.0035 8.1098 0.0 0
M  V30 27 C 13.3372 5.7998 0.0 0
M  V30 28 N 13.3372 8.8798 0.0 0
M  V30 29 N 14.6708 6.5698 0.0 0
M  V30 30 C 14.6708 8.1098 0.0 0
M  V30 31 N 10.6697 4.2597 0.0 0
M  V30 32 C 9.3360 3.4897 0.0 0
M  V30 33 C 12.0035 3.4897 0.0 0
M  V30 34 C 9.3360 1.9497 0.0 0
M  V30 35 C 12.0035 1.9497 0.0 0
M  V30 36 C 10.6697 1.1797 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 25
M  V30 7 1 5 31
M  V30 8 1 6 19
M  V30 9 1 7 8
M  V30 10 1 7 24
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 30
M  V30 15 1 13 36
M  V30 16 1 14 36
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 2 20 24
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1192564-53-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1192566-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16247439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery and preclinical characterization of
6-chloro-N-(2-(4,4-difluoropiperidin-1-yl)-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethyl)quinoline-5-carboxamide
based P2X7 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rech, Jason C.; Bhattacharya, Anindya; Branstetter, Bryan J.; Love,
Christopher J.; Leenaerts, Joseph E.; Cooymans, Ludwig P.; Eckert,
William A. III; Ao, Hong; Wang, Qi; Chaplan, Sandra R.; Wickenden, Alan
D.; Lebsack, Alec D.; Breitenbucher, J. Guy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(19), 4781-4784

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Difluorobenzenesulfonamide
C6H5F2NO2S
120022-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 2 N 0.0000 0.5637 0.0 0
M  V30 3 O 0.5638 2.6673 0.0 0
M  V30 4 O 2.1038 0.0000 0.0 0
M  V30 5 F 1.3338 4.4137 0.0 0
M  V30 6 F 6.6687 1.3337 0.0 0
M  V30 7 C 2.6675 2.1037 0.0 0
M  V30 8 C 2.6675 3.6437 0.0 0
M  V30 9 C 4.0012 1.3337 0.0 0
M  V30 10 C 4.0012 4.4137 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 5.3348 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonamide, 5-fluoro-2-(methylamino)-
C7H9FN2O2S
2917551-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.3338 0.0 0 VAL=6
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 3 O 0.9764 2.1038 0.0 0
M  V30 4 O 3.6436 0.5638 0.0 0
M  V30 5 N 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 F 6.9300 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120022-63-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2917551-45-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35895413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New insights in the development of positive allosteric modulators of
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors
belonging to 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides:
Introduction of (mono/difluoro)methyl groups at the 2-position of the
thiadiazine ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goffin, Eric; Fraikin, Pierre; Abboud, Dayana; de Tullio, Pascal;
Beaufour, Caroline; Botez, Iuliana; Hanson, Julien; Danober, Laurence;
Francotte, Pierre; Pirotte, Bernard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 250115221

$RFMT $RIREG SCHEME318 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diphenylphosphine oxide
C12H11OP
4559-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0011 1.5400 0.0 0 VAL=5
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(Diphenylphosphinyl)-3,4-dimethoxy-N-methylbenzenemethanamine
C22H24NO3P
362057-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0010 4.0012 0.0 0 VAL=5
M  V30 2 C 4.7710 5.3348 0.0 0
M  V30 3 O 5.3348 3.2311 0.0 0
M  V30 4 N 4.0010 6.6685 0.0 0
M  V30 5 C 4.7710 8.0023 0.0 0
M  V30 6 O 9.3911 8.0023 0.0 0
M  V30 7 C 8.6211 9.3360 0.0 0
M  V30 8 O 10.9312 5.3348 0.0 0
M  V30 9 C 11.7012 4.0012 0.0 0
M  V30 10 C 3.2310 2.6675 0.0 0
M  V30 11 C 4.0010 1.3337 0.0 0
M  V30 12 C 1.6910 2.6675 0.0 0
M  V30 13 C 3.2310 0.0000 0.0 0
M  V30 14 C 0.9209 1.3337 0.0 0
M  V30 15 C 1.6910 0.0000 0.0 0
M  V30 16 C 2.6673 4.7712 0.0 0
M  V30 17 C 2.6673 6.3112 0.0 0
M  V30 18 C 1.3337 4.0012 0.0 0
M  V30 19 C 1.3337 7.0812 0.0 0
M  V30 20 C 0.0000 4.7712 0.0 0
M  V30 21 C 0.0000 6.3112 0.0 0
M  V30 22 C 6.3111 5.3348 0.0 0
M  V30 23 C 7.0811 6.6685 0.0 0
M  V30 24 C 7.0811 4.0012 0.0 0
M  V30 25 C 8.6211 6.6685 0.0 0
M  V30 26 C 8.6211 4.0012 0.0 0
M  V30 27 C 9.3911 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 16
M  V30 5 1 2 4
M  V30 6 1 2 22
M  V30 7 1 4 5
M  V30 8 1 6 7
M  V30 9 1 6 25
M  V30 10 1 8 9
M  V30 11 1 8 27
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 4559-70-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 362057-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-14819681
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new synthetic approach to dioxoaporphines - application to the
synthesis of N-methylouregidione
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoarau, Christophe; Couture, Axel; Deniau, Eric; Grandclaudon, Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2001), (13), 2559-2567

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-8-methyl-1H-benzo[d][1,3]oxazine-2,4-dione
C9H6ClNO3
120374-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6685 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 Cl 8.4700 2.6674 0.0 0
M  V30 4 O 0.0000 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 N 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 O 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 6.1600 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chloro-N,3-dimethylbenzamide
C9H11ClN2O
890707-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 N 2.6674 6.1600 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120374-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890707-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-10363071
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 2-amino-5-chloro-N,3-dimethylbenzamide (a compound of
Formula 2) A 300-mL flask equipped with a thermometer and nitrogen
bubbler was charged with ethyl acetate (100 mL) and acetic acid (12.6 g,
0.21 mol). Anhydrous methylamine (6.3 g, 0.20 mol) was added below the
surface of the liquid mixture, which was cooled to maintain the
temperature below 35 °C, and then
6-chloro-8-methyl-2H-3,1-benzoxazine-2,4(1H)-dione (21 g, 0.10 mol) (see
Scheme 4 for a method of preparation) was added in portions while
maintaining the reaction mixture at 35-40 °C. After completion of the
addition of the 6-chloro-8-methyl-2H-3,1-benzoxazine-2,4(1H)-dione the
temperature was maintained at 40-45 °C, and the progress of the reaction
was monitored by HPLC analysis. When analysis of the reaction mixture
indicated no more than 0.5% of the
6-chloro-8-methyl-2H-3,1-benzoxazine-2,4(1H)-dione remained (about 20
minutes), water (50 mL) was added to the reaction mixture. A distillation
head was attached, moderate vacuum was applied, and ethyl acetate was
distilled out at an internal temperature of about 46-60 °C and pressure
of about 30 to 50 kPa. To replace the ethyl acetate removed by
distillation, water was added to maintain the original liquid volume in
the reactor. When a significant amount of water began to distill, the
aqueous slurry was cooled to 10 °C. The solid was collected by filtration
and dried at 60 °C and 13.3 kPa to afford the title compound as a white
crystalline solid (19 g, ca. 95% yield, above 98%) purity by peak area in
HPLC analysis). 2-amino-5-chloro-N,3-dimethylbenzamide. Yield 19 g, ca.
95%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing 2-amino-5-cyanobenzoic acid derivatives using
nickel-catalyzed cyanation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annis, Gary David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009006061 A2 2009-01-08

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-8-methyl-1H-benzo[d][1,3]oxazine-2,4-dione
C9H6ClNO3
120374-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6685 0.0 0
M  V30 2 C 3.8500 0.0000 0.0 0
M  V30 3 Cl 8.4700 2.6674 0.0 0
M  V30 4 O 0.0000 4.0011 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 6.1600 4.0011 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 N 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 O 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 C 6.1600 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chloro-N,3-dimethylbenzamide
C9H11ClN2O
890707-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 N 2.6674 6.1600 0.0 0
M  V30 6 C 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 1.5400 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120374-68-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890707-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-10173655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 2-Amino-5-chloro-N, 3-dimethylbenzamide (a compound of
Formula 1) A 300-mL flask equipped with a thermometer and nitrogen
bubbler was charged with ethyl acetate (100 mL) and 12.6 g (0.21 mol) of
acetic acid. Anhydrous methylamine (6.3 g, 0.20 mol) was added below the
surface of the liquid mixture, which was cooled to maintain the
temperature below 35 °C. Then
6-chloro-8-methyl-2H-3,1-benzoxazine-2,4(1H)-dione (21 g, 0.10 mol) (i.e.
the product of Example 1) was added in portions while maintaining the
reaction mixture at 35-40 °C. After completion of the addition of the
6-chloro-8-methyl- 2H-3,1-benzoxazine-2,4(1H)-dione the temperature was
maintained at 40-45 °C, and the progress of the reaction was monitored by
HPLC analysis. After about 20 minutes, when no more than 0.5%
6-chloro-8-methyl-2H-3,1-benzoxazine-2,4(1H)-dione remained, water (50
mL) was added. A distillation head was attached, moderate vacuum was
applied, and ethyl acetate was distilled out at an internal temperature
of about 46-60 °C and pressure of about 30 to 50 kPa. To replace the
ethyl acetate removed by distillation, water was added to 15 maintain the
original liquid volume in the reactor. When a significant amount of water
began to distill, the aqueous slurry was cooled to 10 °C. The solid was
collected by filtration and dried at 60 °C and 13.3 kPa to afford the
title compound as a white crystalline solid (19 g, ca. 95% yield, >98%
purity by peak area in HPLC analysis). 2-Amino-5-chloro-N,
3-dimethylbenzamide, 95% yield,19 g, ca. melting at 143-145 °C. 1H NMR
(DMSO-d6) δ 2.08 (s, 3H), 2.72 (d, 3H, J= 4.5 Hz), 6.36 (s, 2H), 7.13 (d,
1H, J= 2.1 Hz), 7.40 (d, 1H, J= 2.1 Hz), 8.33 (q, 1H, J = 4.5 hz).
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for making 3-substituted 2-amino-5-halobenzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Davis, Richard Frank; Shapiro, Rafael; Taylor, Eric Deguyon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008010897 A2 2008-01-24

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Morpholinobenzaldehyde
C11H13NO2
1204-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 1.3337 0.0 0
M  V30 2 O 10.0102 2.6673 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 6.9302 2.6673 0.0 0
M  V30 8 C 7.7002 1.3337 0.0 0
M  V30 9 N 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(4-morpholinyl)benzenemethanamine
C12H18N2O
179328-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 1.3337 0.0 0
M  V30 2 N 10.0102 2.6673 0.0 0
M  V30 3 C 11.5503 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 C 6.9302 2.6673 0.0 0
M  V30 8 C 6.9302 0.0000 0.0 0
M  V30 9 C 7.7002 1.3337 0.0 0
M  V30 10 N 3.0801 1.3337 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1204-86-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 179328-22-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1938814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development and in Vitro Evaluation of a Microbicide Gel Formulation for
a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the
N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tintori, Cristina; Brai, Annalaura; Dasso Lang, Maria Chiara; Deodato,
Davide; Greco, Antonia Michela; Bizzarri, Bruno Mattia; Cascone, Lorena;
Casian, Alexandru; Zamperini, Claudio; Dreassi, Elena; Crespan,
Emmanuele; Maga, Giovanni; Vanham, Guido; Ceresola, Elisa; Canducci,
Filippo; Arien, Kevin K.; Botta, Maurizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(6), 2747-2759

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-Cyano-3-(dimethylamino)-2-butenamide
C7H11N3O
120651-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 C 4.0011 3.8500 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 N 1.3338 2.3100 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 N 5.3348 4.6201 0.0 0
M  V30 8 O 2.6675 4.6201 0.0 0
M  V30 9 N 6.6686 0.7700 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 3 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-Cyano-3-(methylamino)-2-butenamide
C6H9N3O
360062-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 1.3338 3.0801 0.0 0
M  V30 5 N 5.3348 2.3101 0.0 0
M  V30 6 C 4.0012 4.6201 0.0 0
M  V30 7 N 4.0012 0.0000 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 9 N 0.0000 3.8501 0.0 0
M  V30 10 C 6.6687 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 3 4 9
M  V30 9 1 5 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120651-05-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 360062-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11988166
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and chemical conversions of
2-chloro-3-cyano-4-methylamino-5-nitropyridine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krichevsky, E. S.; Alekseeva, L. M.; Granik, V. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United
States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii) (2003),
39(3), 328-334

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(2-Chlorophenyl)-2-propenoyl chloride
C9H6Cl2O
120681-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 Cl 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 Cl 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, 3-(2-chlorophenyl)-N-methyl-, (E)-
C10H10ClNO
141544-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 N 8.0021 2.3100 0.0 0
M  V30 5 O 6.6684 4.6200 0.0 0
M  V30 6 C 9.3358 3.0800 0.0 0
M  V30 7 Cl 1.3336 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120681-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 141544-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-13673778
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sequential Rhodium/Palladium Catalysis: Enantioselective Formation of
Dihydroquinolinones in the Presence of Achiral and Chiral Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Lei; Qureshi, Zafar; Sonaglia, Lorenzo; Lautens, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2014), 53(50), 13850-13853

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-N-2-propyn-1-yl-1,3,5-triazin-2-amine
C6H4Cl2N4
1206849-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 C 9.3359 5.3901 0.0 0
M  V30 5 Cl 0.0000 4.6201 0.0 0
M  V30 6 Cl 2.6675 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 N 2.6675 4.6201 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 1.3337 3.8500 0.0 0
M  V30 11 C 2.6675 1.5400 0.0 0
M  V30 12 N 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-methyl-N4-2-propyn-1-yl-1,3,5-triazine-2,4-diamine
C7H8ClN5
1610535-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 5.3901 0.0 0
M  V30 5 N 1.3337 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 Cl 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 N 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1206849-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1610535-19-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11159690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazinamine derivatives as oral bioavailable breathing
control modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mannion, James C.; Dax, Scott L.; Golder, Francis John; Macintyre, Duncan
Euan; McLeod, James; Ozola, Vita; Suna, Edgars; Shubin, Kirill; Mencel,
James Joseph; Peng, Sean X.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014078575 A2 2014-05-22

$RFMT $RIREG SCHEME324 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole
C8H7N
120-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 4.1321 2.7859 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 N 4.1321 0.2941 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 5.0371 1.5400 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 7
M  V30 9 1 6 9
M  V30 10 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glyoxylic acid
C2H2O3
298-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 O 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(Methylamino)-1H-indole-3-acetic acid
C11H12N2O2
1185731-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 2.3100 0.0 0
M  V30 2 C 7.0870 3.0800 0.0 0
M  V30 3 N 5.7533 0.7700 0.0 0
M  V30 4 O 7.0870 4.6201 0.0 0
M  V30 5 O 8.4208 2.3100 0.0 0
M  V30 6 C 7.0870 0.0000 0.0 0
M  V30 7 C 3.0127 2.4536 0.0 0
M  V30 8 C 4.4197 3.0800 0.0 0
M  V30 9 C 1.9823 3.5981 0.0 0
M  V30 10 C 2.5369 0.9890 0.0 0
M  V30 11 C 4.2588 4.6116 0.0 0
M  V30 12 N 2.7523 4.9318 0.0 0
M  V30 13 C 0.4760 3.2779 0.0 0
M  V30 14 C 1.0306 0.6688 0.0 0
M  V30 15 C 0.0000 1.8132 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-72-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 298-12-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1185731-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-6718246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, uncatalyzed Friedel-Crafts reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient one-pot synthesis of indol-3-yl-glycines via uncatalyzed
Friedel-Crafts reaction in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghandi, Mehdi; Taheri, Abuzar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2009), 14(3), 1056-1061

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-5-nitrobenzoyl chloride
C7H3ClFNO3
1214331-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 Cl 0.0000 3.8500 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 5 O 6.6685 6.1600 0.0 0
M  V30 6 O 8.0021 3.8500 0.0 0
M  V30 7 F 4.0011 0.0000 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methyl-5-nitrobenzamide
C8H7FN2O3
1239596-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 F 4.0011 0.0000 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1214331-58-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1239596-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14749110
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of acid chloride 17 (11.0 g, 54.04 mmol, 1 equiv) in
dichloromethane (100 mL) under argon gas was cooled to -20 °C, and
diisopropylethylamine (47 mL, 270 mmol, 5 equiv) was added dropwise. A
solution of methylamine (2M THF, 81 mL, 162 mmol, 3 equiv) was added
slowly dropwise. Completion of the reaction was immediately confirmed by
LCMS. The reaction mixture was diluted with ethyl acetate and water. The
layers were separated, and the organic layer was washed with water 2x,
dried over Na2SO4, filtered, and concentrated to provide amide 18 (10.2
g, 95%) as a solid which was used in the next step without further
purification. 18, yield (10.2 g, 95%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of derivatives of N2-(3-pyridyl or
phenyl)-N4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of
inflammatory, autoimmune or proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Rajinder; Li, Hui; Zhao, Haoran; Kolluri, Rao; Tso, Kin; Ramphal,
John; Gu, Shihai; Valdez, Carlos; Zhang, Jing; Stauffer, Emily; Duncton,
Matthew; Alvarez, Salvador
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010090875 A1 2010-08-12

$RFMT $RIREG SCHEME326 STEP1
$RXN



  3  1
$MOL
Triethylamine
C6H15N
121-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6676 0.7700 0.0 0
M  V30 2 C 1.3340 0.0000 0.0 0
M  V30 3 C 4.0013 0.0000 0.0 0
M  V30 4 C 2.6676 2.3101 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3350 0.7700 0.0 0
M  V30 7 C 4.0013 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[1H-indene-1,5′-oxazolidine]-3′-acetamide, 6-amino-N-[(4-fluorophenyl)me...
C23H21F4N3O4
2143467-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.1294 10.7125 0.0 0
M  V30 2 C 6.1600 8.0021 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 N 3.8500 6.6684 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 3.0800 8.0021 0.0 0 CFG=1
M  V30 8 C 1.5400 8.0021 0.0 0
M  V30 9 C 3.8500 9.3358 0.0 0
M  V30 10 F 0.0000 8.0021 0.0 0
M  V30 11 F 1.5400 6.4621 0.0 0
M  V30 12 F 1.5400 9.5421 0.0 0
M  V30 13 O 8.1294 5.2916 0.0 0
M  V30 14 N 14.3188 5.3215 0.0 0
M  V30 15 F 6.1600 0.0000 0.0 0
M  V30 16 C 10.0699 8.7721 0.0 0 CFG=1
M  V30 17 C 11.5344 8.2963 0.0 0
M  V30 18 C 8.6052 9.2480 0.0 0
M  V30 19 O 10.0699 7.2321 0.0 0
M  V30 20 C 10.0699 10.3121 0.0 0
M  V30 21 C 12.4397 9.5421 0.0 0
M  V30 22 C 12.1609 6.8893 0.0 0
M  V30 23 N 7.7000 8.0021 0.0 0
M  V30 24 C 8.6052 6.7563 0.0 0
M  V30 25 C 11.5344 10.7880 0.0 0
M  V30 26 C 13.9712 9.3811 0.0 0
M  V30 27 C 13.6924 6.7284 0.0 0
M  V30 28 C 14.5977 7.9743 0.0 0
M  V30 29 C 3.8500 4.0011 0.0 0
M  V30 30 C 5.3900 4.0011 0.0 0
M  V30 31 C 3.0800 2.6674 0.0 0
M  V30 32 C 6.1600 2.6674 0.0 0
M  V30 33 C 3.8500 1.3336 0.0 0
M  V30 34 C 5.3900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 29
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 2 13 24
M  V30 15 1 14 27
M  V30 16 1 15 34
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20 CFG=3
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 1 21 25
M  V30 27 2 21 26
M  V30 28 1 22 27
M  V30 29 1 23 24
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R)-N-[(4-Fluorophenyl)methyl]-2,3-dihydro-6-[[(methylamino)carbonyl]amino]-...
C25H24F4N4O5
2143464-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.1292 10.7125 0.0 0
M  V30 2 C 6.1600 8.0021 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 N 3.8500 6.6684 0.0 0
M  V30 5 O 6.1600 5.3347 0.0 0
M  V30 6 C 3.0800 5.3347 0.0 0
M  V30 7 C 3.0800 8.0021 0.0 0 CFG=1
M  V30 8 C 1.5400 8.0021 0.0 0
M  V30 9 C 3.8500 9.3358 0.0 0
M  V30 10 F 0.0000 8.0021 0.0 0
M  V30 11 F 1.5400 6.4621 0.0 0
M  V30 12 F 1.5400 9.5421 0.0 0
M  V30 13 O 8.1292 5.2916 0.0 0
M  V30 14 N 14.3188 5.3215 0.0 0
M  V30 15 C 15.8503 5.1605 0.0 0
M  V30 16 N 16.4766 3.7538 0.0 0
M  V30 17 O 16.7555 6.4064 0.0 0
M  V30 18 C 18.0081 3.5927 0.0 0
M  V30 19 F 6.1600 0.0000 0.0 0
M  V30 20 C 10.0698 8.7721 0.0 0 CFG=2
M  V30 21 C 11.5344 8.2963 0.0 0
M  V30 22 C 8.6051 9.2480 0.0 0
M  V30 23 C 10.0698 10.3121 0.0 0
M  V30 24 O 10.0698 7.2321 0.0 0
M  V30 25 C 12.4395 9.5421 0.0 0
M  V30 26 C 12.1608 6.8893 0.0 0
M  V30 27 N 7.7000 8.0021 0.0 0
M  V30 28 C 11.5344 10.7880 0.0 0
M  V30 29 C 8.6051 6.7563 0.0 0
M  V30 30 C 13.9712 9.3811 0.0 0
M  V30 31 C 13.6923 6.7284 0.0 0
M  V30 32 C 14.5975 7.9743 0.0 0
M  V30 33 C 3.8500 4.0011 0.0 0
M  V30 34 C 5.3900 4.0011 0.0 0
M  V30 35 C 3.0800 2.6674 0.0 0
M  V30 36 C 6.1600 2.6674 0.0 0
M  V30 37 C 3.8500 1.3336 0.0 0
M  V30 38 C 5.3900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 2 3
M  V30 3 1 2 27
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 33
M  V30 9 1 7 8
M  V30 10 1 7 9 CFG=3
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 2 13 29
M  V30 15 1 14 15
M  V30 16 1 14 31
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 19 38
M  V30 21 1 20 21 CFG=1
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 27 1 22 27
M  V30 28 1 23 28
M  V30 29 1 24 29
M  V30 30 1 25 28
M  V30 31 2 25 30
M  V30 32 1 26 31
M  V30 33 1 27 29
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2143467-59-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2143464-15-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25802853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a selective catalytic p300/CBP inhibitor that targets
lineage-specific tumours
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lasko, Loren M.; Jakob, Clarissa G.; Edalji, Rohinton P.; Qiu, Wei;
Montgomery, Debra; Digiammarino, Enrico L.; Hansen, T. Matt; Risi,
Roberto M.; Frey, Robin; Manaves, Vlasios; Shaw, Bailin; Algire, Mikkel;
Hessler, Paul; Lam, Lloyd T.; Uziel, Tamar; Faivre, Emily; Ferguson,
Debra; Buchanan, Fritz G.; Martin, Ruth L.; Torrent, Maricel; Chiang,
Gary G.; Karukurichi, Kannan; Langston, J. William; Weinert, Brian T.;
Choudhary, Chunaram; de Vries, Peter; Van Drie, John H.; McElligott,
David; Kesicki, Ed; Marmorstein, Ronen; Sun, Chaohong; Cole, Philip A.;
Rosenberg, Saul H.; Michaelides, Michael R.; Lai, Albert; Bromberg,
Kenneth D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature (London, United Kingdom) (2017), 550(7674), 128-132

$RFMT $RIREG SCHEME327 STEP1
$RXN



  3  1
$MOL
Triethylamine
C6H15N
121-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6676 0.7700 0.0 0
M  V30 2 C 1.3340 0.0000 0.0 0
M  V30 3 C 4.0013 0.0000 0.0 0
M  V30 4 C 2.6676 2.3101 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3350 0.7700 0.0 0
M  V30 7 C 4.0013 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-iodoaniline
C6H5FIN
29632-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 I 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Fluoro-4-iodophenyl)-N′-methylurea
C8H8FIN2O
871700-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0021 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 C 9.3358 2.3100 0.0 0
M  V30 6 F 2.6674 0.0000 0.0 0
M  V30 7 I 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29632-74-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871700-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-550-CAS-3748939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-{3-[5-(2-fluoro-4-iodophenylamino)-3,6,8-trimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}methanesulfonamide.
Synthesis of 1-(2-fluoro-4-iodophenyl)-3-methylurea. Under a nitrogen
atmosphere, to N,N-carbonyldiimidazole (61.4 g) were added
N,N-dimethylformamide (300 ml) and triethylamine (52.8 ml) and a solution
of 2-fluoro-4-iodoaniline 47 (74.8 g) in N,N-dimethylformamide (75 ml)
was added dropwise with stirring under ice-cooling. After the completion
of the dropwise addition, the mixture was stirred at room temperature for
5 hrs. The reaction mixture was ice-cooled, and a solution (60 ml) of 40%
methylamine in methanol was added dropwise. The mixture was stirred at
room temperature for 1 hr, and the reaction mixture was added dropwise to
water-toluene [2:1 (volume ratio), 1125 ml] under stirring. The
precipitated crystals were collected by filtration and dried to give
1-(2-fluoro-4-iodophenyl)-3-methylurea 63 (87.9 g, yield 94.8%) as
colorless crystals.
$DTYPE RXN:VAR(1):NOTES
$DATUM analogs prepared similarly
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidines and
related compounds as MEK inhibitors and p15 and p27 protein inducers for
the treatment of cancer and rheumatic diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sakai, Toshiyuki; Kawasaki, Hisashi; Abe, Hiroyuki; Hayakawa, Kazuhide;
Iida, Tetsuya; Kikuchi, Shinichi; Yamaguchi, Takayuki; Nanayama,
Toyomichi; Kurachi, Hironori; Tamaru, Masahiro; Hori, Yoshikazu;
Takahashi, Mitsuru; Yoshida, Takayuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005121142 A1 2005-12-22

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenyl N-[2-[[4-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]...
C24H23F3N8O5S
1215264-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8702 2.6673 0.0 0
M  V30 2 C 7.6403 1.3337 0.0 0
M  V30 3 C 6.8702 0.0000 0.0 0
M  V30 4 O 12.1595 8.7485 0.0 0
M  V30 5 C 13.4932 7.9785 0.0 0
M  V30 6 C 14.8268 8.7485 0.0 0
M  V30 7 N 16.1605 7.9785 0.0 0
M  V30 8 C 17.4943 8.7485 0.0 0
M  V30 9 O 18.8280 7.9785 0.0 0
M  V30 10 O 17.4943 10.2885 0.0 0
M  V30 11 C 1.5063 10.9989 0.0 0
M  V30 12 F 1.1861 12.5052 0.0 0
M  V30 13 F 0.0000 10.6786 0.0 0
M  V30 14 F 1.8265 9.4925 0.0 0
M  V30 15 N 24.1628 11.0585 0.0 0 VAL=5
M  V30 16 O 24.1628 12.5986 0.0 0
M  V30 17 O 25.4965 10.2885 0.0 0
M  V30 18 C 8.1583 6.4384 0.0 0
M  V30 19 C 8.1583 7.9785 0.0 0
M  V30 20 C 9.4920 5.6684 0.0 0
M  V30 21 C 7.0138 5.4080 0.0 0
M  V30 22 N 9.4920 8.7485 0.0 0
M  V30 23 N 10.8257 6.4384 0.0 0
M  V30 24 S 9.1718 4.1621 0.0 0
M  V30 25 C 7.6403 4.0012 0.0 0
M  V30 26 C 10.8257 7.9785 0.0 0
M  V30 27 N 6.8247 8.7485 0.0 0
M  V30 28 C 6.8247 10.2885 0.0 0
M  V30 29 C 5.4908 7.9785 0.0 0
M  V30 30 C 5.4908 11.0585 0.0 0
M  V30 31 C 4.1572 8.7485 0.0 0
M  V30 32 N 4.1572 10.2885 0.0 0
M  V30 33 N 5.1707 12.5650 0.0 0
M  V30 34 C 3.0128 11.3191 0.0 0
M  V30 35 N 3.6391 12.7259 0.0 0
M  V30 36 C 20.1617 8.7485 0.0 0
M  V30 37 C 21.4953 7.9785 0.0 0
M  V30 38 C 20.1617 10.2885 0.0 0
M  V30 39 C 22.8292 8.7485 0.0 0
M  V30 40 C 21.4953 11.0585 0.0 0
M  V30 41 C 22.8292 10.2885 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 36
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 41
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 27
M  V30 24 2 20 23
M  V30 25 1 20 24
M  V30 26 2 21 25
M  V30 27 2 22 26
M  V30 28 1 23 26
M  V30 29 1 24 25
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 30 33
M  V30 36 1 31 32
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[[4-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-...
C19H23F3N8O2S
1215264-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.1595 8.7485 0.0 0
M  V30 2 C 13.4932 7.9785 0.0 0
M  V30 3 C 14.8270 8.7485 0.0 0
M  V30 4 N 16.1607 7.9785 0.0 0
M  V30 5 C 17.4943 8.7485 0.0 0
M  V30 6 N 18.8280 7.9785 0.0 0
M  V30 7 O 17.4943 10.2885 0.0 0
M  V30 8 C 20.1618 8.7485 0.0 0
M  V30 9 C 6.8702 2.6673 0.0 0
M  V30 10 C 7.6403 1.3337 0.0 0
M  V30 11 C 6.8702 0.0000 0.0 0
M  V30 12 C 1.5065 10.9989 0.0 0
M  V30 13 F 1.1863 12.5052 0.0 0
M  V30 14 F 0.0000 10.6786 0.0 0
M  V30 15 F 1.8266 9.4925 0.0 0
M  V30 16 C 8.1583 7.9785 0.0 0
M  V30 17 C 8.1583 6.4384 0.0 0
M  V30 18 N 9.4922 8.7485 0.0 0
M  V30 19 C 9.4922 5.6684 0.0 0
M  V30 20 C 7.0139 5.4080 0.0 0
M  V30 21 C 10.8258 7.9785 0.0 0
M  V30 22 N 10.8258 6.4384 0.0 0
M  V30 23 S 9.1720 4.1621 0.0 0
M  V30 24 C 7.6403 4.0012 0.0 0
M  V30 25 N 6.8247 8.7485 0.0 0
M  V30 26 C 6.8247 10.2885 0.0 0
M  V30 27 C 5.4910 7.9785 0.0 0
M  V30 28 C 5.4910 11.0585 0.0 0
M  V30 29 C 4.1573 8.7485 0.0 0
M  V30 30 N 4.1573 10.2885 0.0 0
M  V30 31 N 5.1708 12.5650 0.0 0
M  V30 32 C 3.0128 11.3191 0.0 0
M  V30 33 N 3.6393 12.7259 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 24
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 32
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 25
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 18 21
M  V30 22 2 19 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 28 31
M  V30 33 1 29 30
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1215264-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215264-42-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9306867
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-Methyl-3-{2-[6-propyl-4-(3-trifluoromethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-thieno[2,3-d]pyrimidin-2-yloxy]-ethyl}-urea
The compound (70 mg, 0.130 mmol) obtained from Preparation Example 9-25-1
was dissolved in dichloromethane 30 mL and cooled to 0°C. Triethylamine
(0.06 mL, 0.390 mmol) and 2M methylamine tetrahydrofuran solution (0.06
mL, 0.130 mmol) were added thereto and stirred for 3 hours at room
temperature. The reaction solution was distilled under reduced pressure,
diluted with dichloromethane and washed with water and brine. After the
organic layer was dried with anhydrous magnesium sulfate and distilled
under reduced pressure, the title compound (60 mg, 95.0 %) was obtained
by column-chromatography using 20:1 mixture of dichloromethane and
methanol.
1-Methyl-3-{2-[6-propyl-4-(3-trifluoromethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-thieno[2,3-d]pyrimidin-2-yloxy]-ethyl}-urea,
yield (60 mg, 95.0 %) 1H NMR (400MHz, CDCl3) ; δ 6.94 (1H, s), 5.31 (2H,
s), 4.85 (1H, br), 4.44 (2H, t), 4.36 (2H, t), 4.32 (2H, t), 3.61 (2H,
q), 2.82 (2H, t), 2.78 (3H, d), 1.72 (2H, m), 1.00 (3H, t)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused heterocycles, especially thienopyrimidines and
thiazolopyrimidines, as platelet aggregation inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Chang Seok; Lee, Tae Hee; Yoon, Sook Kyung; Choi, Jeung Soon; Jang,
Yong Jin; Kim, Sung Wook; Chang, Hye Kyung; Park, Mi Jeong; Kim, Tae Hun;
Ahn, Young Ha; Park, Hee Dong; Park, Hyun Jung; Lim, Dong Chul; Lee, Joo
Youn; Lee, Sung Hack; Park, Wan Su; Oh, Yeong Soo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010027236 A2 2010-03-11

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetamidobenzenesulfonyl chloride
C8H8ClNO3S
121-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 1.5400 1.1273 0.0 0
M  V30 4 O 1.5400 4.2073 0.0 0
M  V30 5 N 7.7000 2.6673 0.0 0
M  V30 6 C 8.4700 1.3336 0.0 0
M  V30 7 C 7.7000 0.0000 0.0 0
M  V30 8 O 10.0100 1.3336 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[(Methylamino)sulfonyl]phenyl]acetamide
C9H12N2O3S
6884-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 2.6673 0.0 0 VAL=6
M  V30 2 N 0.7700 2.6673 0.0 0
M  V30 3 O 2.3100 1.1273 0.0 0
M  V30 4 O 2.3100 4.2073 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 N 8.4700 2.6673 0.0 0
M  V30 7 C 9.2400 1.3336 0.0 0
M  V30 8 C 10.7800 1.3336 0.0 0
M  V30 9 O 8.4700 0.0000 0.0 0
M  V30 10 C 3.8500 2.6673 0.0 0
M  V30 11 C 4.6200 1.3336 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-60-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6884-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-16575212
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of branched azo dyes based on benzene sulfonamide intermediates
and their spectral properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Feng; Wang, Limin; Cai, Xiaofei; Sun, Yinglei; Su, Lan; Zhang,
Liang; Han, Zhaogang; Zhang, Guanjun; Wang, Guifeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Coloration Technology (2012), 128(6), 425-433

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-[3-[[(1-methyl-1-phenylethyl)amino]carbonyl]phenyl]-4-ni...
C31H23FN2O6
1217340-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.6902 2.0605 0.0 0
M  V30 2 O 14.6596 0.9160 0.0 0
M  V30 3 O 17.1965 1.7404 0.0 0
M  V30 4 N 12.4160 1.6909 0.0 0 VAL=5
M  V30 5 O 11.0821 0.9209 0.0 0
M  V30 6 O 13.7496 0.9209 0.0 0
M  V30 7 C 5.7474 4.0010 0.0 0
M  V30 8 N 4.4137 3.2310 0.0 0
M  V30 9 O 5.7474 5.5410 0.0 0
M  V30 10 C 3.0800 4.0010 0.0 0
M  V30 11 C 3.8501 5.3348 0.0 0
M  V30 12 C 1.7464 4.7710 0.0 0
M  V30 13 F 22.2795 4.7710 0.0 0
M  V30 14 C 13.7496 4.0010 0.0 0
M  V30 15 C 15.2142 3.5251 0.0 0
M  V30 16 C 12.4160 3.2310 0.0 0
M  V30 17 C 13.7496 5.5410 0.0 0
M  V30 18 C 16.1194 4.7710 0.0 0
M  V30 19 C 11.0821 4.0010 0.0 0
M  V30 20 O 15.2142 6.0170 0.0 0
M  V30 21 C 12.4160 6.3110 0.0 0
M  V30 22 C 11.0821 5.5410 0.0 0
M  V30 23 C 17.6594 4.7710 0.0 0
M  V30 24 C 18.4294 6.1048 0.0 0
M  V30 25 C 18.4294 3.4373 0.0 0
M  V30 26 C 19.9694 6.1048 0.0 0
M  V30 27 C 19.9694 3.4373 0.0 0
M  V30 28 C 20.7395 4.7710 0.0 0
M  V30 29 C 9.7485 3.2310 0.0 0
M  V30 30 C 8.4148 4.0010 0.0 0
M  V30 31 C 9.7485 1.6909 0.0 0
M  V30 32 C 7.0812 3.2310 0.0 0
M  V30 33 C 8.4148 0.9209 0.0 0
M  V30 34 C 7.0812 1.6909 0.0 0
M  V30 35 C 2.3100 2.6673 0.0 0
M  V30 36 C 0.7700 2.6673 0.0 0
M  V30 37 C 3.0800 1.3337 0.0 0
M  V30 38 C 0.0000 1.3337 0.0 0
M  V30 39 C 2.3100 0.0000 0.0 0
M  V30 40 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 32
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 35
M  V30 14 1 13 28
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 20
M  V30 23 1 18 23
M  V30 24 2 19 22
M  V30 25 1 19 29
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-N-methyl-5-[3-[[(1-methyl-1-phenylethyl)amino]carbonyl]phe...
C32H26FN3O5
1217333-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.6900 2.0605 0.0 0
M  V30 2 N 17.1963 1.7404 0.0 0
M  V30 3 O 14.6594 0.9160 0.0 0
M  V30 4 C 17.6721 0.2757 0.0 0
M  V30 5 N 12.4158 1.6909 0.0 0 VAL=5
M  V30 6 O 13.7494 0.9209 0.0 0
M  V30 7 O 11.0820 0.9209 0.0 0
M  V30 8 C 5.7473 4.0009 0.0 0
M  V30 9 N 4.4136 3.2309 0.0 0
M  V30 10 O 5.7473 5.5409 0.0 0
M  V30 11 C 3.0800 4.0009 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 1.7462 4.7709 0.0 0
M  V30 14 F 22.2792 4.7709 0.0 0
M  V30 15 C 13.7494 4.0009 0.0 0
M  V30 16 C 15.2140 3.5251 0.0 0
M  V30 17 C 12.4158 3.2309 0.0 0
M  V30 18 C 13.7494 5.5409 0.0 0
M  V30 19 C 16.1192 4.7709 0.0 0
M  V30 20 C 11.0820 4.0009 0.0 0
M  V30 21 O 15.2140 6.0169 0.0 0
M  V30 22 C 12.4158 6.3109 0.0 0
M  V30 23 C 11.0820 5.5409 0.0 0
M  V30 24 C 17.6592 4.7709 0.0 0
M  V30 25 C 18.4292 3.4373 0.0 0
M  V30 26 C 18.4292 6.1047 0.0 0
M  V30 27 C 19.9692 3.4373 0.0 0
M  V30 28 C 19.9692 6.1047 0.0 0
M  V30 29 C 20.7392 4.7709 0.0 0
M  V30 30 C 9.7484 3.2309 0.0 0
M  V30 31 C 8.4147 4.0009 0.0 0
M  V30 32 C 9.7484 1.6909 0.0 0
M  V30 33 C 7.0811 3.2309 0.0 0
M  V30 34 C 8.4147 0.9209 0.0 0
M  V30 35 C 7.0811 1.6909 0.0 0
M  V30 36 C 2.3100 2.6673 0.0 0
M  V30 37 C 0.7700 2.6673 0.0 0
M  V30 38 C 3.0800 1.3336 0.0 0
M  V30 39 C 0.0000 1.3336 0.0 0
M  V30 40 C 2.3100 0.0000 0.0 0
M  V30 41 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 33
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 36
M  V30 15 1 14 29
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 21
M  V30 24 1 19 24
M  V30 25 2 20 23
M  V30 26 1 20 30
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1217340-55-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1217333-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9311619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: EDC (128 mg, 0.668 mmol) was added to a stirring solution of the
crude
2-(4-fluorophenyl)-4-nitro-5-(3-(2-phenylpropan-2-ylcarbamoyl)phenyl)benzofuran-3-carboxylic
acid (300 mg, 0.557 mmol), methanamine (306 μL, 0.613 mmol),
1-hydroxy-7-azabenzotriazole (83 mg, 0.613 mmol), DIEA (204 μL, 1.170
mmol)in DCM (5.5 mL) at rt. It was allowed to stir for 3 days. The slurry
had gone into solution over that period of time. The mixture was
concentrated and purified on silica gel (Biotage, EtOAc/hexanes gradient,
fraction collection at λ = 254 nm) to give the titled compound.
2-(4-fluorophenyl)-N-methyl-4-nitro-5-(3-(2-phenylpropan-2-ylcarbamoyl)phenyl)benzofuran-3-carboxamide,
yield 220 mg, 95%. 1H NMR (500 MHz, CD3OD) δ ppm 7.90 - 7.99 (3 H, m),
7.85 - 7.90 (1 H, m), 7.82 - 7.84 (1 H, m), 7.49 - 7.56 (3 H, m), 7.45 (2
H, d, J=7.32 Hz), 7.27 - 7.34 (4 H, m), 7.19 (1 H, t, J=7.32 Hz), 2.87 (3
H, s), 1.76 (6 H, s). LC-MS retention time: 1.62 min; m/z (MH+): 552. LC
data was recorded on a Shimadzu LC-10AS liquid chromatograph equipped
with a Waters XBridge 5u C18 4.6x50mm column using a SPD-10AV UV-Vis
detector at a detector wave length of 220nM. The elution conditions
employed a flow rate of 5 ml/min, a gradient of 100% solvent A / 0%
solvent B to 0% solvent A / 100% solvent B, a gradient time of 2 min, a
hold time of 1 min, and an analysis time of 3 min where solvent A was 5%
acetonitrile / 95% H2O / 10 mM ammonium acetate and solvent B was 5% H2O
/ 95% acetonitrile / 10 mM ammonium acetate. MS data was determined using
a Micromass Platform for LC in electrospray mode. Additional HPLC method:
Solvent A = 5% CH3CN/95% H2O/0.1% TFA, Solvent B = 95% CH3CN/5% H2O/0.1%
TFA, Start %B = 10, Final %B = 100, Gradient time = 15 min, Stop time =
18 min, Flow Rate = 1 ml/min. Column: Waters Sunfire C-18, 4.6 x 150 mm,
3.5 μm, Rt = 13.60 min, purity = 94%; Column: Waters Xbridge Phenyl
column 4.6 x 150 mm, 3.5 μm, Rt = 12.66 min, purity = 96%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofurancarboxamide derivatives and their preparation
and use for the treatment of hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yeung, Kap-Sun; Parcella, Kyle E.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Kadow, John
F.; Nickel, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011112191 A1 2011-09-15

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-[3-[[(1-methyl-1-phenylethyl)amino]carbonyl]phenyl]-4-ni...
C31H23FN2O6
1217340-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.6902 2.0605 0.0 0
M  V30 2 O 14.6596 0.9160 0.0 0
M  V30 3 O 17.1965 1.7404 0.0 0
M  V30 4 N 12.4160 1.6909 0.0 0 VAL=5
M  V30 5 O 11.0821 0.9209 0.0 0
M  V30 6 O 13.7496 0.9209 0.0 0
M  V30 7 C 5.7474 4.0010 0.0 0
M  V30 8 N 4.4137 3.2310 0.0 0
M  V30 9 O 5.7474 5.5410 0.0 0
M  V30 10 C 3.0800 4.0010 0.0 0
M  V30 11 C 3.8501 5.3348 0.0 0
M  V30 12 C 1.7464 4.7710 0.0 0
M  V30 13 F 22.2795 4.7710 0.0 0
M  V30 14 C 13.7496 4.0010 0.0 0
M  V30 15 C 15.2142 3.5251 0.0 0
M  V30 16 C 12.4160 3.2310 0.0 0
M  V30 17 C 13.7496 5.5410 0.0 0
M  V30 18 C 16.1194 4.7710 0.0 0
M  V30 19 C 11.0821 4.0010 0.0 0
M  V30 20 O 15.2142 6.0170 0.0 0
M  V30 21 C 12.4160 6.3110 0.0 0
M  V30 22 C 11.0821 5.5410 0.0 0
M  V30 23 C 17.6594 4.7710 0.0 0
M  V30 24 C 18.4294 6.1048 0.0 0
M  V30 25 C 18.4294 3.4373 0.0 0
M  V30 26 C 19.9694 6.1048 0.0 0
M  V30 27 C 19.9694 3.4373 0.0 0
M  V30 28 C 20.7395 4.7710 0.0 0
M  V30 29 C 9.7485 3.2310 0.0 0
M  V30 30 C 8.4148 4.0010 0.0 0
M  V30 31 C 9.7485 1.6909 0.0 0
M  V30 32 C 7.0812 3.2310 0.0 0
M  V30 33 C 8.4148 0.9209 0.0 0
M  V30 34 C 7.0812 1.6909 0.0 0
M  V30 35 C 2.3100 2.6673 0.0 0
M  V30 36 C 0.7700 2.6673 0.0 0
M  V30 37 C 3.0800 1.3337 0.0 0
M  V30 38 C 0.0000 1.3337 0.0 0
M  V30 39 C 2.3100 0.0000 0.0 0
M  V30 40 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 32
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 35
M  V30 14 1 13 28
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 20
M  V30 23 1 18 23
M  V30 24 2 19 22
M  V30 25 1 19 29
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-N-methyl-5-[3-[[(1-methyl-1-phenylethyl)amino]carbonyl]phe...
C32H26FN3O5
1217333-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.6900 2.0605 0.0 0
M  V30 2 N 17.1963 1.7404 0.0 0
M  V30 3 O 14.6594 0.9160 0.0 0
M  V30 4 C 17.6721 0.2757 0.0 0
M  V30 5 N 12.4158 1.6909 0.0 0 VAL=5
M  V30 6 O 13.7494 0.9209 0.0 0
M  V30 7 O 11.0820 0.9209 0.0 0
M  V30 8 C 5.7473 4.0009 0.0 0
M  V30 9 N 4.4136 3.2309 0.0 0
M  V30 10 O 5.7473 5.5409 0.0 0
M  V30 11 C 3.0800 4.0009 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 1.7462 4.7709 0.0 0
M  V30 14 F 22.2792 4.7709 0.0 0
M  V30 15 C 13.7494 4.0009 0.0 0
M  V30 16 C 15.2140 3.5251 0.0 0
M  V30 17 C 12.4158 3.2309 0.0 0
M  V30 18 C 13.7494 5.5409 0.0 0
M  V30 19 C 16.1192 4.7709 0.0 0
M  V30 20 C 11.0820 4.0009 0.0 0
M  V30 21 O 15.2140 6.0169 0.0 0
M  V30 22 C 12.4158 6.3109 0.0 0
M  V30 23 C 11.0820 5.5409 0.0 0
M  V30 24 C 17.6592 4.7709 0.0 0
M  V30 25 C 18.4292 3.4373 0.0 0
M  V30 26 C 18.4292 6.1047 0.0 0
M  V30 27 C 19.9692 3.4373 0.0 0
M  V30 28 C 19.9692 6.1047 0.0 0
M  V30 29 C 20.7392 4.7709 0.0 0
M  V30 30 C 9.7484 3.2309 0.0 0
M  V30 31 C 8.4147 4.0009 0.0 0
M  V30 32 C 9.7484 1.6909 0.0 0
M  V30 33 C 7.0811 3.2309 0.0 0
M  V30 34 C 8.4147 0.9209 0.0 0
M  V30 35 C 7.0811 1.6909 0.0 0
M  V30 36 C 2.3100 2.6673 0.0 0
M  V30 37 C 0.7700 2.6673 0.0 0
M  V30 38 C 3.0800 1.3336 0.0 0
M  V30 39 C 0.0000 1.3336 0.0 0
M  V30 40 C 2.3100 0.0000 0.0 0
M  V30 41 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 33
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 36
M  V30 15 1 14 29
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 21
M  V30 24 1 19 24
M  V30 25 2 20 23
M  V30 26 1 20 30
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1217340-55-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1217333-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6928194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: EDC (128 mg, 0.668 mmol) was added to a stirring solution of the
crude
2-(4-fluorophenyl)-4-nitro-5-(3-(2-phenylpropan-2-ylcarbamoyl)phenyl)benzofuran-3-carboxylic
acid (300 mg, 0.557 mmol), methanamine (306 μL, 0.613 mmol),
1-hydroxy-7-azabenzotriazole (83 mg, 0.613 mmol), DIEA (204 μL, 1.170
mmol) in DCM (5.5 mL) at rt. It was allowed to stir for 3 days. The
slurry had gone into solution over that period of time. The mixture was
concentrated and purified on silica gel (Biotage, EtOAc/hexanes gradient,
fraction collection at λ=254 nm) to give the titled compound (220 mg,
95%).
2-(4-fluorophenyl)-N-methyl-4-nitro-5-(3-(2-phenylpropan-2-ylcarbamoyl)phenyl)benzofuran-3-carboxamide.
1H NMR (500 MHz, CD3OD) δ ppm 7.90-7.99 (3H, m), 7.85-7.90 (1H, m),
7.82-7.84 (1H, m), 7.49-7.56 (3H, m), 7.45 (2H, d, J=7.32 Hz), 7.27-7.34
(4H, m), 7.19 (1H, t, J=7.32 Hz), 2.87 (3H, s), 1.76 (6H, s). LC-MS
retention time: 1.62 min; m/z (MH+): 552. LC data was recorded on a
Shimadzu LC-10AS liquid chromatograph equipped with a Waters XBridge 5u
C18 4.6×50 mm column using a SPD-10AV UV-Vis detector at a detector wave
length of 220 nM. The elution conditions employed a flow rate of 5
ml/min, a gradient of 100% solvent A/0% solvent B to 0% solvent A/100%
solvent B, a gradient time of 2 min, a hold time of 1 min, and an
analysis time of 3 min where solvent A was 5% acetonitrile/95% H2O/10 mM
ammonium acetate and solvent B was 5% H2O/95% acetonitrile/10 mM ammonium
acetate. MS data was determined using a Micromass Platform for LC in
electrospray mode. Additional HPLC method: Solvent A=5% CH3CN/95%
H2O/0.1% TFA, Solvent B=95% CH3CN/5% H2O/0.1% TFA, Start % B=10, Final %
B=100, Gradient time=15 min, Stop time=18 min, Flow Rate=1 ml/min.
Column: Waters Sunfire C-18, 4.6×150 mm, 3.5 μm, R t =13.60 min,
purity=94%; Column: Waters Xbridge Phenyl column 4.6×150 mm, 3.5 μm, R t
=12.66 min, purity=96%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofurancarboxamide derivatives for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yeung, Kap-Sun; Parcella, Kyle E.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Kadow, John
F.; Nickel, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100249094 A1 2010-09-30

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-[3-[[(1-methyl-1-phenylethyl)amino]carbonyl]phenyl]-4-ni...
C31H23FN2O6
1217340-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.6902 2.0605 0.0 0
M  V30 2 O 14.6596 0.9160 0.0 0
M  V30 3 O 17.1965 1.7404 0.0 0
M  V30 4 N 12.4160 1.6909 0.0 0 VAL=5
M  V30 5 O 11.0821 0.9209 0.0 0
M  V30 6 O 13.7496 0.9209 0.0 0
M  V30 7 C 5.7474 4.0010 0.0 0
M  V30 8 N 4.4137 3.2310 0.0 0
M  V30 9 O 5.7474 5.5410 0.0 0
M  V30 10 C 3.0800 4.0010 0.0 0
M  V30 11 C 3.8501 5.3348 0.0 0
M  V30 12 C 1.7464 4.7710 0.0 0
M  V30 13 F 22.2795 4.7710 0.0 0
M  V30 14 C 13.7496 4.0010 0.0 0
M  V30 15 C 15.2142 3.5251 0.0 0
M  V30 16 C 12.4160 3.2310 0.0 0
M  V30 17 C 13.7496 5.5410 0.0 0
M  V30 18 C 16.1194 4.7710 0.0 0
M  V30 19 C 11.0821 4.0010 0.0 0
M  V30 20 O 15.2142 6.0170 0.0 0
M  V30 21 C 12.4160 6.3110 0.0 0
M  V30 22 C 11.0821 5.5410 0.0 0
M  V30 23 C 17.6594 4.7710 0.0 0
M  V30 24 C 18.4294 6.1048 0.0 0
M  V30 25 C 18.4294 3.4373 0.0 0
M  V30 26 C 19.9694 6.1048 0.0 0
M  V30 27 C 19.9694 3.4373 0.0 0
M  V30 28 C 20.7395 4.7710 0.0 0
M  V30 29 C 9.7485 3.2310 0.0 0
M  V30 30 C 8.4148 4.0010 0.0 0
M  V30 31 C 9.7485 1.6909 0.0 0
M  V30 32 C 7.0812 3.2310 0.0 0
M  V30 33 C 8.4148 0.9209 0.0 0
M  V30 34 C 7.0812 1.6909 0.0 0
M  V30 35 C 2.3100 2.6673 0.0 0
M  V30 36 C 0.7700 2.6673 0.0 0
M  V30 37 C 3.0800 1.3337 0.0 0
M  V30 38 C 0.0000 1.3337 0.0 0
M  V30 39 C 2.3100 0.0000 0.0 0
M  V30 40 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 32
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 35
M  V30 14 1 13 28
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 20
M  V30 23 1 18 23
M  V30 24 2 19 22
M  V30 25 1 19 29
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-N-methyl-5-[3-[[(1-methyl-1-phenylethyl)amino]carbonyl]phe...
C32H26FN3O5
1217333-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 15.6900 2.0605 0.0 0
M  V30 2 N 17.1963 1.7404 0.0 0
M  V30 3 O 14.6594 0.9160 0.0 0
M  V30 4 C 17.6721 0.2757 0.0 0
M  V30 5 N 12.4158 1.6909 0.0 0 VAL=5
M  V30 6 O 13.7494 0.9209 0.0 0
M  V30 7 O 11.0820 0.9209 0.0 0
M  V30 8 C 5.7473 4.0009 0.0 0
M  V30 9 N 4.4136 3.2309 0.0 0
M  V30 10 O 5.7473 5.5409 0.0 0
M  V30 11 C 3.0800 4.0009 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 1.7462 4.7709 0.0 0
M  V30 14 F 22.2792 4.7709 0.0 0
M  V30 15 C 13.7494 4.0009 0.0 0
M  V30 16 C 15.2140 3.5251 0.0 0
M  V30 17 C 12.4158 3.2309 0.0 0
M  V30 18 C 13.7494 5.5409 0.0 0
M  V30 19 C 16.1192 4.7709 0.0 0
M  V30 20 C 11.0820 4.0009 0.0 0
M  V30 21 O 15.2140 6.0169 0.0 0
M  V30 22 C 12.4158 6.3109 0.0 0
M  V30 23 C 11.0820 5.5409 0.0 0
M  V30 24 C 17.6592 4.7709 0.0 0
M  V30 25 C 18.4292 3.4373 0.0 0
M  V30 26 C 18.4292 6.1047 0.0 0
M  V30 27 C 19.9692 3.4373 0.0 0
M  V30 28 C 19.9692 6.1047 0.0 0
M  V30 29 C 20.7392 4.7709 0.0 0
M  V30 30 C 9.7484 3.2309 0.0 0
M  V30 31 C 8.4147 4.0009 0.0 0
M  V30 32 C 9.7484 1.6909 0.0 0
M  V30 33 C 7.0811 3.2309 0.0 0
M  V30 34 C 8.4147 0.9209 0.0 0
M  V30 35 C 7.0811 1.6909 0.0 0
M  V30 36 C 2.3100 2.6673 0.0 0
M  V30 37 C 0.7700 2.6673 0.0 0
M  V30 38 C 3.0800 1.3336 0.0 0
M  V30 39 C 0.0000 1.3336 0.0 0
M  V30 40 C 2.3100 0.0000 0.0 0
M  V30 41 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 33
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 36
M  V30 15 1 14 29
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 21
M  V30 24 1 19 24
M  V30 25 2 20 23
M  V30 26 1 20 30
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1217340-55-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1217333-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14186937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [00133] Step 2: EDC (128 mg, 0.668 mmol) was added to a stirring solution
of the crude
2-(4-fluorophenyl)-4-nitro-5-(3-(2-phenylpropan-2-ylcarbamoyl)phenyl)benzofuran-3-carboxylic
acid (300 mg, 0.557 mmol), methanamine (306 μL, 0.613 mmol),
1-hydroxy-7-azabenzotriazole (83 mg, 0.613 mmol), DIEA (204 μL, 1.170
mmol) in DCM (5.5 mL) at rt. It was allowed to stir for 3 days. The
slurry had gone into solution over that period of time. The mixture was
concentrated and purified on silica gel (Biotage, EtOAc/hexanes gradient,
fraction collection at λ=254 nm) to give the titled compound (220 mg,
95%). 1H NMR (500 MHz, CD3OD) δ ppm 7.90-7.99 (3H, m), 7.85-7.90 (1H, m),
7.82-7.84 (1H, m), 7.49-7.56 (3H, m), 7.45 (2H, d, J=7.32 Hz), 7.27-7.34
(4H, m), 7.19 (1H, t, J=7.32 Hz), 2.87 (3H, s), 1.76 (6H, s). LC-MS
retention time: 1.62 min; m/z (MH+): 552. LC data was recorded on a
Shimadzu LC-10AS liquid chromatograph equipped with a Waters XBridge 5u
C18 4.6×50 mm column using a SPD-10AV UV-Vis detector at a detector wave
length of 220 nM. The elution conditions employed a flow rate of 5
ml/min, a gradient of 100% solvent A/0% solvent B to 0% solvent A/100%
solvent B, a gradient time of 2 min, a hold time of 1 min, and an
analysis time of 3 min where solvent A was 5% acetonitrile/95% H2O/10 mM
ammonium acetate and solvent B was 5% H2O/95% acetonitrile/10 mM ammonium
acetate. MS data was determined using a Micromass Platform for LC in
electrospray mode. Additional HPLC method: Solvent A=5% CH3CN/95%
H2O/0.1% TFA, Solvent B=95% CH3CN/5% H2O/0.1% TFA, Start % B=10, Final %
B=100, Gradient time=15 min, Stop time=18 min, Flow Rate=1 ml/min.
Column: Waters Sunfire C-18, 4.6×150 mm, 3.5 μm, Rt=13.60 min,
purity=94%; Column: Waters Xbridge Phenyl column 4.6×150 mm, 3.5 μm,
Rt=12.66 min, purity=96%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofurancarboxamide derivatives for the treatment of
hepatitis C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yeung, Kap-Sun; Parcella, Kyle E.; Bender, John A.; Beno, Brett R.;
Grant-Young, Katharine A.; Han, Ying; Hewawasam, Piyasena; Kadow, John
F.; Nickel, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010030592 A1 2010-03-18

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
9H-Xanthene-9-acetic acid
C15H12O3
1217-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 5.3900 0.0 0
M  V30 2 C 6.6685 4.6200 0.0 0
M  V30 3 O 8.0021 5.3900 0.0 0
M  V30 4 O 6.6685 3.0800 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 2.6674 5.3900 0.0 0
M  V30 10 O 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 5.3347 0.7700 0.0 0
M  V30 13 C 1.3336 4.6200 0.0 0
M  V30 14 C 2.6674 6.9300 0.0 0
M  V30 15 C 4.0011 0.0000 0.0 0
M  V30 16 C 0.0000 5.3900 0.0 0
M  V30 17 C 1.3336 7.7000 0.0 0
M  V30 18 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 13
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-9H-xanthene-9-acetamide
C16H15NO2
524743-89-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 5.3900 0.0 0
M  V30 2 C 6.6684 4.6200 0.0 0
M  V30 3 N 8.0021 5.3900 0.0 0
M  V30 4 O 6.6684 3.0800 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 2.6674 5.3900 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 6.9300 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 O 1.3336 3.0800 0.0 0
M  V30 14 C 0.0000 5.3900 0.0 0
M  V30 15 C 1.3336 7.7000 0.0 0
M  V30 16 C 2.6674 0.7700 0.0 0
M  V30 17 C 5.3347 0.7700 0.0 0
M  V30 18 C 0.0000 6.9300 0.0 0
M  V30 19 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 13
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1217-58-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 524743-89-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17610496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazine derivatives having SST1 antagonistic activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Troxler, Thomas J.; Hoyer, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003040125 A1 2003-05-15

$RFMT $RIREG SCHEME332 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzoyl chloride
C7H4ClNO3
122-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 Cl 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ammonium thiocyanate
CHNS.H3N
1762-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 0.0000 1.5400 0.0 0
M  V30 3 S 3.0800 1.5400 0.0 0
M  V30 4 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indene-1,2,3-trione
C9H4O3
938-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,3a,8a-Tetrahydro-3a,8a-dihydroxy-2-(methylimino)-3-(4-nitrobenzoyl)-8H-in...
C18H13N3O6S
2172698-75-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.5830 4.5371 0.0 0
M  V30 2 O 3.6225 0.0180 0.0 0
M  V30 3 C 6.5644 4.5254 0.0 0
M  V30 4 O 5.7944 5.8591 0.0 0
M  V30 5 O 1.6412 0.0297 0.0 0
M  V30 6 N 7.9271 1.4647 0.0 0
M  V30 7 C 8.4030 0.0000 0.0 0
M  V30 8 N 12.7244 4.5254 0.0 0 VAL=5
M  V30 9 O 13.4944 3.1917 0.0 0
M  V30 10 O 13.4944 5.8591 0.0 0
M  V30 11 C 4.2629 3.0307 0.0 0
M  V30 12 C 3.9427 1.5244 0.0 0
M  V30 13 N 5.7944 3.1917 0.0 0
M  V30 14 C 2.9292 3.8007 0.0 0
M  V30 15 C 2.4112 1.3634 0.0 0
M  V30 16 S 5.2763 0.7544 0.0 0
M  V30 17 C 6.4209 1.7849 0.0 0
M  V30 18 C 1.7847 2.7703 0.0 0
M  V30 19 C 2.6091 5.3071 0.0 0
M  V30 20 C 0.3202 3.2462 0.0 0
M  V30 21 C 1.1444 5.7830 0.0 0
M  V30 22 C 0.0000 4.7524 0.0 0
M  V30 23 C 8.1044 4.5254 0.0 0
M  V30 24 C 8.8744 5.8591 0.0 0
M  V30 25 C 8.8744 3.1917 0.0 0
M  V30 26 C 10.4144 5.8591 0.0 0
M  V30 27 C 10.4144 3.1917 0.0 0
M  V30 28 C 11.1844 4.5254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 2 3 4
M  V30 4 1 3 13
M  V30 5 1 3 23
M  V30 6 2 5 15
M  V30 7 1 6 7
M  V30 8 2 6 17 CFG=2
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 28
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 18
M  V30 21 1 16 17
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122-04-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1762-95-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 938-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2172698-75-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-18341311
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free synthesis of functionalized indenothiazoles using
four-component reactions of ninhydrin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moradi, Ali Varasteh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2017), 41(7), 403-405

$RFMT $RIREG SCHEME333 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanesulfonyl chloride
CH3ClO2S
124-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 Cl 3.0800 1.5400 0.0 0
M  V30 4 O 1.5400 3.0800 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methyl]-N-methylmethanesulfonamide
C10H15NO3S
34825-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0
M  V30 3 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 4 C 3.8500 0.2062 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 O 1.5400 0.0000 0.0 0
M  V30 7 O 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 12 C 6.1600 4.2073 0.0 0
M  V30 13 C 7.7000 1.5400 0.0 0
M  V30 14 C 7.7000 4.2073 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 3 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 34825-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-18526966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Next Generation Synthesis of BACE1 Inhibitor Verubecestat (MK-8931)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thaisrivongs, David A.; Morris, William J.; Tan, Lushi; Song, Zhiguo J.;
Lyons, Thomas W.; Waldman, Jacob H.; Naber, John R.; Chen, Wenyong; Chen,
Lu; Zhang, Baoyun; Yang, Jun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(6), 1568-1571

$RFMT $RIREG SCHEME333 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanesulfonyl chloride
CH3ClO2S
124-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 Cl 3.0800 1.5400 0.0 0
M  V30 4 O 1.5400 3.0800 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methyl]-N-methylmethanesulfonamide
C10H15NO3S
34825-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0
M  V30 3 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 4 C 3.8500 0.2062 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 O 1.5400 0.0000 0.0 0
M  V30 7 O 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 12 C 6.1600 4.2073 0.0 0
M  V30 13 C 7.7000 1.5400 0.0 0
M  V30 14 C 7.7000 4.2073 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 3 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 34825-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16293705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 7
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM reactor used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Verubecestat, a BACE1 Inhibitor for the Treatment of
Alzheimer's Disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thaisrivongs, David A.; Miller, Steven P.; Molinaro, Carmela; Chen,
Qinghao; Song, Zhiguo J.; Tan, Lushi; Chen, Lu; Chen, Wenyong; Lekhal,
Azzeddine; Pulicare, Sarah K.; Xu, Yanke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2016), 18(22), 5780-5783

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(2-Isothiocyanatophenyl)-N,N-dimethyl-2-propenamide
C12H12N2OS
1232682-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 2.3100 5.3347 0.0 0
M  V30 4 N 0.7700 5.3347 0.0 0
M  V30 5 O 3.0800 6.6685 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 N 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 S 10.7800 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 7.7000 1.3338 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 C 6.9300 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 12
M  V30 10 2 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,4-Tetrahydro-N,N,3-trimethyl-2-thioxo-4-quinazolineacetamide
C13H17N3OS
1232682-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 C 6.6684 3.8500 0.0 0
M  V30 3 N 8.0021 4.6200 0.0 0
M  V30 4 O 6.6684 2.3100 0.0 0
M  V30 5 C 8.0021 6.1600 0.0 0
M  V30 6 C 9.3358 3.8500 0.0 0
M  V30 7 C 5.3347 1.5400 0.0 0
M  V30 8 S 2.6674 0.0000 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.6674 6.1600 0.0 0
M  V30 13 N 4.0011 2.3100 0.0 0
M  V30 14 N 1.3336 2.3100 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 2.6674 1.5400 0.0 0
M  V30 18 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 13
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1232682-74-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1232682-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2859778
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Methyl
2-[2-(Pyrrolidin-1-yl)-4H-3,1-benzothiazin-4-yl]acetate (6a); Typical
Procedure A mixture of 4a (0.10 g, 0.46 mmol) and pyrrolidine (32 mg,
0.46 mmol) in MeOH (3 mL) was stirred at r.t. for 5 min. The mixture was
then heated at reflux temperature for 10 min. The completion of each step
of the sequence could be confirmed by TLC (silica gel) analyses. After
cooling to r.t., the resulting mixture was concentrated by evaporation.
The residue was purified by column chromatography on silica gel.
N,N-Dimethyl-2-(3-methyl-2-thioxo-1,2,3,4-tetrahydroquinazolin-4-yl)acetamide
(8b) Pale-yellow solid. Mp 172-173 °C (hexane-CH2Cl2). IR (KBr): 3233,
1616, 1485, 1125 cm-1. 1H NMR: δ = 2.68 (dd, J = 15.1, 8.2 Hz, 1 H), 2.75
(s, 3 H), 2.77 (dd, J = 15.1, 5.5 Hz, 1 H), 2.91 (s, 3 H), 3.51 (s, 3 H),
5.18 (dd, J = 8.2, 5.5 Hz, 1 H), 6.86 (d, J = 7.8 Hz, 1 H), 7.03 (t, J =
7.8 Hz, 1 H), 7.20 (d, J = 7.8 Hz, 1 H), 7.23 (t, J = 7.8 Hz, 1 H), 8.87
(s, 1 H). 13C NMR: δ = 35.59, 37.27, 37.34, 40.86, 59.55, 113.27, 121.32,
123.66, 126.02, 128.85, 134.25, 168.99, 176.91. MS: m/z (%) = 263 (49,
[M+]), 177 (100). Anal. Calcd for C13H17N3OS: C, 59.29; H, 6.51; N,
15.96. Found: C, 59.28; H, 6.57; N, 15.90.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2-(2-dialkylamino-4H-3,1-benzothiazin-4-yl)acetic acid
derivatives and 2-(2-thioxo-1,2,3,4-tetrahydroquinazolin-4-yl)acetic acid
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fukamachi, Shuhei; Konishi, Hisatoshi; Kobayashi, Kazuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (10), 1593-1598

$RFMT $RIREG SCHEME335 STEP1
$RXN



  3  1
$MOL
4-Aminophenol
C6H7NO
123-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Hydroxyphenyl)amino]-1-methyl-1H-pyrrole-2,5-dione
C11H10N2O3
920874-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3028 1.3628 0.0 0
M  V30 2 O 2.2420 0.0000 0.0 0
M  V30 3 C 0.0000 2.4898 0.0 0
M  V30 4 O 1.6752 5.3914 0.0 0
M  V30 5 O 10.6376 4.4428 0.0 0
M  V30 6 C 3.9690 2.1328 0.0 0
M  V30 7 C 2.5622 1.5063 0.0 0
M  V30 8 C 3.8080 3.6644 0.0 0
M  V30 9 N 1.5317 2.6509 0.0 0
M  V30 10 C 2.3017 3.9845 0.0 0
M  V30 11 C 6.6365 2.1328 0.0 0
M  V30 12 C 7.9701 1.3628 0.0 0
M  V30 13 C 6.6365 3.6728 0.0 0
M  V30 14 C 9.3038 2.1328 0.0 0
M  V30 15 C 7.9701 4.4428 0.0 0
M  V30 16 C 9.3038 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 2 4 10
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-30-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 920874-42-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10406596
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused pyrrolo[3,4-d]tetrahydropyrimidine derivatives by
proline-catalyzed multicomponent reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhi-Peng; Wang, Hai-Bo; Wang, Yu-Qin; Zhu, Qiu-Hua; Xie, Yang; Liu,
Shu-Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(29), 4379-4385

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9(10H)-Acridinone, 1-chloro-10-methyl-2-nitro-
C14H9ClN2O3
1237443-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 Cl 6.6684 6.1600 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 N 9.3358 4.6200 0.0 0 VAL=5
M  V30 5 O 9.3358 6.1600 0.0 0
M  V30 6 O 10.6694 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 6.6684 4.6200 0.0 0
M  V30 11 N 4.0011 1.5400 0.0 0
M  V30 12 C 6.6684 1.5400 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 1.3336 4.6200 0.0 0
M  V30 18 C 1.3336 1.5400 0.0 0
M  V30 19 C 0.0000 3.8500 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 2 14 16
M  V30 19 2 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9(10H)-Acridinone, 10-methyl-1-(methylamino)-2-nitro-
C15H13N3O3
1237443-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 6.1600 0.0 0
M  V30 2 C 8.0021 6.9300 0.0 0
M  V30 3 O 4.0011 6.1600 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 N 9.3358 4.6200 0.0 0 VAL=5
M  V30 6 O 9.3358 6.1600 0.0 0
M  V30 7 O 10.6694 3.8500 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6684 4.6200 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 N 4.0011 1.5400 0.0 0
M  V30 13 C 6.6684 1.5400 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 1.3336 1.5400 0.0 0
M  V30 20 C 0.0000 3.8500 0.0 0
M  V30 21 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 1 15 16
M  V30 19 2 15 18
M  V30 20 2 16 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1237443-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1237443-31-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7257011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acridone-Benzimidazole Ring-Fused Ligands: A New Class of Sensitizers of
Lanthanide Luminescence via Low-Energy Excitation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deiters, Emmanuel; Gumy, Frederic; Bunzli, Jean-Claude G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Inorganic Chemistry (2010), (18), 2723-2734

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[[5-formyl-3′-[(methylamino)sulfonyl][1,1′-biphenyl]-2-yl...
C20H23NO6S
1242846-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 6.6684 0.0 0
M  V30 2 C 10.7800 6.6684 0.0 0
M  V30 3 C 11.5500 8.0021 0.0 0
M  V30 4 O 13.0900 8.0021 0.0 0
M  V30 5 O 10.7800 9.3358 0.0 0
M  V30 6 C 13.8600 9.3358 0.0 0
M  V30 7 C 12.5264 10.1058 0.0 0
M  V30 8 C 14.6300 10.6694 0.0 0
M  V30 9 C 15.1936 8.5658 0.0 0
M  V30 10 C 6.1600 1.3336 0.0 0
M  V30 11 O 6.9300 0.0000 0.0 0
M  V30 12 S 2.3100 8.0020 0.0 0 VAL=6
M  V30 13 N 0.7700 8.0020 0.0 0
M  V30 14 O 2.3100 9.5421 0.0 0
M  V30 15 O 2.3100 6.4621 0.0 0
M  V30 16 C 0.0000 9.3358 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 6.1600 4.0011 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 8.4700 2.6673 0.0 0
M  V30 23 C 6.1600 6.6684 0.0 0
M  V30 24 C 4.6200 6.6684 0.0 0
M  V30 25 C 6.9300 8.0021 0.0 0
M  V30 26 C 3.8500 8.0020 0.0 0
M  V30 27 C 6.1600 9.3358 0.0 0
M  V30 28 C 4.6200 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 21
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 12 15
M  V30 15 1 12 26
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[[5-[(methylamino)methyl]-3′-[(methylamino)sulfonyl][1,1′...
C21H28N2O5S
1242846-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2402 8.0022 0.0 0
M  V30 2 C 10.7802 8.0022 0.0 0
M  V30 3 C 11.5503 9.3360 0.0 0
M  V30 4 O 13.0903 9.3360 0.0 0
M  V30 5 O 10.7802 10.6697 0.0 0
M  V30 6 C 13.8603 10.6697 0.0 0
M  V30 7 C 15.1940 9.8996 0.0 0
M  V30 8 C 14.6303 12.0033 0.0 0
M  V30 9 C 12.5266 11.4397 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 N 6.9302 1.3337 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 S 2.3101 9.3360 0.0 0 VAL=6
M  V30 14 N 0.7700 9.3360 0.0 0
M  V30 15 O 2.3101 10.8760 0.0 0
M  V30 16 O 2.3101 7.7960 0.0 0
M  V30 17 C 0.0000 10.6697 0.0 0
M  V30 18 C 6.9302 6.6685 0.0 0
M  V30 19 C 8.4702 6.6685 0.0 0
M  V30 20 C 6.1601 5.3348 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 6.9302 4.0012 0.0 0
M  V30 23 C 8.4702 4.0012 0.0 0
M  V30 24 C 6.1601 8.0022 0.0 0
M  V30 25 C 4.6201 8.0022 0.0 0
M  V30 26 C 6.9302 9.3360 0.0 0
M  V30 27 C 3.8501 9.3360 0.0 0
M  V30 28 C 6.1601 10.6697 0.0 0
M  V30 29 C 4.6201 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 13 16
M  V30 16 1 13 27
M  V30 17 1 14 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 24
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1242846-60-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1242846-61-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4678373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 13. t-butyl
2-(2-(3-N-methylsulfamoylphenyl)-4-((methylamino)methyl)phenoxy)acetate
(13): A solution of t-butyl
2-(2-(3-N-methylsulfamoylphenyl)-4-formylphenoxy)acetate (12) (291 mg,
0.72 mmol, 1 eq) and methylamine (0.53 mL of a 2M solution in THF; 1.08
mmol, 1.5 eq.) in methanol (20 mL) was stirred at room temperature for
2h. Sodium borohydride (22 mg, 0.58 mmol, 0.5 eq.) was added, and the
resulting mixture was stirred at room temperature for additional 2h.
Water (3 mL) was added and the MeOH was removed in vacuo. The resulting
solution was extracted with EtOAc, and the combined organic layers were
dried (Na2SO4), filtered, and concentrated in vacuo to afford 289 mg
(95%) of t-butyl
2-(2-(3-N-methylsulfamoylphenyl)-4-((methylamino)methyl)phenoxy)acetate
(13 ) as oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation biaryl oxyacetic acid compounds as inhibitors of CRTH2
receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McGuinness, Brian F.; Ho, Koc-Kan; Babu, Suresh; Dong, Guizhen; Duo,
Jingqi; Le, Thuy X.H.; Saionz, Kurt W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010102154 A2 2010-09-10

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon dioxide
CO2
124-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-methyl-, compd. with methanamine (1:1)
C2H5NO2.CH5N
65398-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 N 2.6673 3.8501 0.0 0
M  V30 3 O 1.3337 1.5400 0.0 0
M  V30 4 O 0.0000 3.8501 0.0 0
M  V30 5 C 4.0010 3.0800 0.0 0
M  V30 6 C 1.2305 0.0000 0.0 0
M  V30 7 N 2.7705 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124-38-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65398-48-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22949850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stainless steel autoclave reactor used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable carbamate pathway towards organic-inorganic hybrid perovskites and
aromatic imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Kyu Hyung; Kim, Sun Joo; Park, Hee Sun; Lim, Byung Wook; Lee,
Byeongno; Park, Young Jun; Nam, Wonwoo; Hur, Nam Hwi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2020), 10(62), 38055-38062

$RFMT $RIREG SCHEME339 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[5-(2-Chloro-4-pyrimidinyl)-2-cyclopropyl-1-[[2-(trimethylsilyl)ethoxy]meth...
C22H27ClFN5OSi
1269233-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 5.5025 0.0 0
M  V30 2 O 10.2090 6.7484 0.0 0
M  V30 3 C 11.7406 6.5875 0.0 0
M  V30 4 C 12.6458 7.8334 0.0 0
M  V30 5 Si 14.1774 7.6724 0.0 0
M  V30 6 C 15.7090 7.5115 0.0 0
M  V30 7 C 14.0165 6.1409 0.0 0
M  V30 8 C 14.3383 9.2040 0.0 0
M  V30 9 F 2.6673 6.6854 0.0 0
M  V30 10 Cl 10.3115 0.5546 0.0 0
M  V30 11 N 0.0000 5.1454 0.0 0
M  V30 12 C 6.7417 4.5191 0.0 0
M  V30 13 C 5.3348 5.1454 0.0 0
M  V30 14 N 7.7722 5.6635 0.0 0
M  V30 15 N 5.4958 6.6771 0.0 0
M  V30 16 C 7.0022 6.9973 0.0 0
M  V30 17 C 7.0618 3.0128 0.0 0
M  V30 18 N 8.5266 2.5367 0.0 0
M  V30 19 C 5.9174 1.9822 0.0 0
M  V30 20 C 8.8467 1.0304 0.0 0
M  V30 21 C 6.2376 0.4759 0.0 0
M  V30 22 N 7.7023 0.0000 0.0 0
M  V30 23 C 4.0012 4.3754 0.0 0
M  V30 24 C 2.6673 5.1454 0.0 0
M  V30 25 C 4.0012 2.8354 0.0 0
M  V30 26 C 1.3337 4.3754 0.0 0
M  V30 27 C 2.6673 2.0653 0.0 0
M  V30 28 C 1.3337 2.8354 0.0 0
M  V30 29 C 7.6286 8.4041 0.0 0
M  V30 30 C 8.8744 9.3094 0.0 0
M  V30 31 C 7.4676 9.9357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 24
M  V30 10 1 10 20
M  V30 11 1 11 26
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 17
M  V30 15 1 13 15
M  V30 16 1 13 23
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 16 29
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanesulfonyl chloride
CH3ClO2S
124-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 Cl 3.0800 1.5400 0.0 0
M  V30 4 O 1.5400 3.0800 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[2-Cyclopropyl-5-[2-(methylamino)-4-pyrimidinyl]-1-[[2-(trimethylsilyl)e...
C24H33FN6O3SSi
1269233-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4051 6.4544 0.0 0
M  V30 2 O 5.4999 7.7004 0.0 0
M  V30 3 C 3.9683 7.5393 0.0 0
M  V30 4 C 3.0631 8.7852 0.0 0
M  V30 5 Si 1.5316 8.6243 0.0 0
M  V30 6 C 0.0000 8.4633 0.0 0
M  V30 7 C 1.3705 10.1558 0.0 0
M  V30 8 C 1.6925 7.0927 0.0 0
M  V30 9 F 13.0414 7.6374 0.0 0
M  V30 10 N 5.3975 1.5064 0.0 0
M  V30 11 C 5.0773 0.0000 0.0 0
M  V30 12 N 15.7088 6.0974 0.0 0
M  V30 13 S 17.0425 5.3274 0.0 0 VAL=6
M  V30 14 C 18.3762 4.5574 0.0 0
M  V30 15 O 16.2725 3.9936 0.0 0
M  V30 16 O 17.8125 6.6611 0.0 0
M  V30 17 C 8.9671 5.4709 0.0 0
M  V30 18 C 10.3741 6.0974 0.0 0
M  V30 19 N 7.9367 6.6155 0.0 0
M  V30 20 N 10.2131 7.6290 0.0 0
M  V30 21 C 8.7067 7.9491 0.0 0
M  V30 22 C 8.6469 3.9646 0.0 0
M  V30 23 N 7.1824 3.4888 0.0 0
M  V30 24 C 9.7915 2.9341 0.0 0
M  V30 25 C 6.8622 1.9823 0.0 0
M  V30 26 C 9.4713 1.4278 0.0 0
M  V30 27 N 8.0066 0.9519 0.0 0
M  V30 28 C 11.7077 5.3274 0.0 0
M  V30 29 C 13.0414 6.0974 0.0 0
M  V30 30 C 11.7077 3.7874 0.0 0
M  V30 31 C 14.3752 5.3274 0.0 0
M  V30 32 C 13.0414 3.0174 0.0 0
M  V30 33 C 14.3752 3.7874 0.0 0
M  V30 34 C 8.0803 9.3559 0.0 0
M  V30 35 C 6.8345 10.2612 0.0 0
M  V30 36 C 8.2413 10.8876 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 29
M  V30 10 1 10 11
M  V30 11 1 10 25
M  V30 12 1 12 13
M  V30 13 1 12 31
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 22
M  V30 20 1 18 20
M  V30 21 1 18 28
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 21 34
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1269233-33-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1269233-57-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-811639
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 3 Preparation of
N-(3-(2-cyclopropyl-5-(2-(methylamino)pyrimidin-4-yl)-1H-imidazol-4-yl)-2-fluorophenyl)methanesulfonamide,
free base (3A-1)and hydrogen chloride salt (3A-2) To a solution of
3-(5-(2-chloropyrimidin-4-yl)-2-cyclopropyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-4-yl)-2-fluoroaniline
(I-1i, 81 mg, 0.15 mmol) in dry NMP (2 mL) was added methylamine solution
(2.0 M in THF, 0.38 ml, 0.76 mmol). The reaction was then sealed and
heated to and maintained at 80° C. for 3 hours. LCMS indicated no
conversion. After allowing to cool to room temperature, another solution
of methylamine was added (2.0 M in MeOH) and the resulting reaction was
heated to and maintained at 80° C. for 2 hours. LCMS indicated complete
conversion. The reaction was allowed to cool to room temperature and was
diluted with saturated aqueous NH4Cl solution and extracted with EtOAc
(2×). The combined extracts were washed with brine, dried (Na2SO4), and
concentrated to give
N-(3-(2-cyclopropyl-5-(2-(methylamino)pyrimidin-4-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-4-yl)-2-fluorophenyl)methanesulfonamide
(78 mg, 0.143 mmol, 95%) as a yellow residue which was carried forward
without further purification. LCMS(m/z) 533.2 (MH+), tR=0.83 minute.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed, incremental addition MeNH2 in stage 2, last stage reactant
assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sulfonamidophenylimidazolylpyrimidine derivatives for use
as protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Costales, Abran Q.; Huang, Shenlin; Jin, Jeff; Liu, Zuosheng; Pecchi,
Sabina; Poon, Daniel; Tellew, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011023773 A1 2011-03-03

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-(2,3,4,5,6-pentafluorophenyl)-1,2,4-oxadiazole-3-carboxylate
C11H5F5N2O3
1251535-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.6200 5.3347 0.0 0
M  V30 2 F 4.6200 0.0000 0.0 0
M  V30 3 C 9.7758 4.3427 0.0 0
M  V30 4 O 11.1826 3.7162 0.0 0
M  V30 5 O 9.6147 5.8742 0.0 0
M  V30 6 C 12.4285 4.6214 0.0 0
M  V30 7 C 13.8354 3.9951 0.0 0
M  V30 8 F 1.5400 5.3347 0.0 0
M  V30 9 F 1.5400 0.0000 0.0 0
M  V30 10 F 0.0000 2.6674 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 N 7.0652 3.9133 0.0 0
M  V30 13 O 7.0652 1.4216 0.0 0
M  V30 14 C 8.5299 3.4375 0.0 0
M  V30 15 N 8.5299 1.8974 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 3.8500 1.3336 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 1.3336 0.0 0
M  V30 21 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 18
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 19
M  V30 9 1 9 20
M  V30 10 1 10 21
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 16
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-[2,3,5,6-tetrafluoro-4-(methylamino)phenyl]-1,2,4-oxadiazole-3-carbox...
C12H9F4N3O3
1251535-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 5.3900 5.3347 0.0 0
M  V30 2 F 5.3900 0.0000 0.0 0
M  V30 3 F 2.3100 5.3347 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 C 10.5458 4.3427 0.0 0
M  V30 6 O 11.9526 3.7162 0.0 0
M  V30 7 O 10.3847 5.8742 0.0 0
M  V30 8 C 13.1985 4.6214 0.0 0
M  V30 9 C 14.6054 3.9951 0.0 0
M  V30 10 N 0.7700 2.6674 0.0 0
M  V30 11 C 0.0000 1.3336 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 4.6200 1.3336 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 3.0800 1.3336 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 6.9300 2.6674 0.0 0
M  V30 19 N 7.8353 3.9133 0.0 0
M  V30 20 O 7.8353 1.4216 0.0 0
M  V30 21 C 9.3000 3.4375 0.0 0
M  V30 22 N 9.3000 1.8974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 21
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1251535-87-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1251535-94-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8029452
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorescent Hg2+ Sensors: Synthesis and Evaluation of a Tren-Based
Starburst Molecule Containing Fluorinated 1,2,4-Oxadiazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pibiri, Ivana; Palumbo Piccionello, Antonio; Calabrese, Alessandro;
Buscemi, Silvestre; Vivona, Nicolo; Pace, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2010), (24), 4549-4553,
S4549/1-S4549/7

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 8′-methyl-2-(methylthio)-2′,4-dioxospiro[2-cyclopentene-1,3′(2′H)-imida...
C16H16N2O4S
1256269-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1291 0.9052 0.0 0
M  V30 2 C 7.3749 0.0000 0.0 0
M  V30 3 O 5.2892 0.7267 0.0 0
M  V30 4 C 9.0306 2.5804 0.0 0
M  V30 5 O 10.2765 3.4857 0.0 0
M  V30 6 O 9.1915 1.0489 0.0 0
M  V30 7 C 11.6833 2.8592 0.0 0
M  V30 8 C 12.9293 3.7644 0.0 0
M  V30 9 O 8.3341 5.8576 0.0 0
M  V30 10 C 0.0000 3.7277 0.0 0
M  V30 11 C 5.1456 3.4673 0.0 0
M  V30 12 N 4.0011 4.4977 0.0 0
M  V30 13 C 6.2900 2.4368 0.0 0
M  V30 14 C 5.7720 4.8741 0.0 0
M  V30 15 C 4.5192 2.0604 0.0 0
M  V30 16 C 2.6674 3.7277 0.0 0
M  V30 17 C 4.0011 6.0378 0.0 0
M  V30 18 C 7.6237 3.2068 0.0 0
M  V30 19 C 7.3035 4.7132 0.0 0
M  V30 20 N 2.9876 2.2213 0.0 0
M  V30 21 C 1.3338 4.4977 0.0 0
M  V30 22 C 2.6674 6.8078 0.0 0
M  V30 23 C 1.3338 6.0378 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 3 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 18
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 19
M  V30 10 1 10 21
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 2 16 20
M  V30 21 1 16 21
M  V30 22 2 17 22
M  V30 23 1 18 19
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 8′-methyl-2-(methylamino)-2′,4-dioxospiro[2-cyclopentene-1,3′(2′H)-imid...
C16H17N3O4
1256269-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1291 0.9052 0.0 0
M  V30 2 C 7.3749 0.0000 0.0 0
M  V30 3 O 5.2892 0.7267 0.0 0
M  V30 4 C 9.0306 2.5804 0.0 0
M  V30 5 O 10.2765 3.4857 0.0 0
M  V30 6 O 9.1915 1.0489 0.0 0
M  V30 7 C 11.6833 2.8592 0.0 0
M  V30 8 C 12.9293 3.7644 0.0 0
M  V30 9 O 8.3341 5.8576 0.0 0
M  V30 10 C 0.0000 3.7277 0.0 0
M  V30 11 C 5.1456 3.4673 0.0 0
M  V30 12 N 4.0011 4.4977 0.0 0
M  V30 13 C 6.2900 2.4368 0.0 0
M  V30 14 C 5.7720 4.8741 0.0 0
M  V30 15 C 4.5192 2.0604 0.0 0
M  V30 16 C 2.6674 3.7277 0.0 0
M  V30 17 C 4.0011 6.0378 0.0 0
M  V30 18 C 7.6237 3.2068 0.0 0
M  V30 19 C 7.3035 4.7132 0.0 0
M  V30 20 N 2.9876 2.2213 0.0 0
M  V30 21 C 1.3338 4.4977 0.0 0
M  V30 22 C 2.6674 6.8078 0.0 0
M  V30 23 C 1.3338 6.0378 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 3 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 18
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 19
M  V30 10 1 10 21
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 2 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 2 16 20
M  V30 21 1 16 21
M  V30 22 2 17 22
M  V30 23 1 18 19
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1256269-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256269-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-7212454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new nitrogen-bridged heterocycles. 70. Synthesis of
spiro[2-cyclopentene-1,3'-imidazo[1,2-a]-pyridine] derivatives and their
interesting behavior in 1H-NMR spectra in deuteriochloroform
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abe, Takashi; Kakehi, Akikazu; Suga, Hiroyuki; Okumura, Yukihisa; Itoh,
Kennosuke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2010), 81(9), 2075-2086

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylthio)-3-nitro-4H-1-benzopyran-4-one
C10H7NO4S
1264701-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 S 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 5 O 1.3336 6.1600 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 O 4.0011 1.5400 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 6.6685 4.6200 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 C 8.0021 2.3100 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-3-nitro-4H-1-benzopyran-4-one
C10H8N2O4
1264701-74-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 5 O 1.3336 6.1600 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 O 4.0011 1.5400 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 6.6685 4.6200 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 C 8.0021 2.3100 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1264701-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1264701-74-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10802053
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A concise synthetic strategy to functionalized chromenones via [5+1]
heteroannulation and facile C-N/C-S/C-O bond formation with various
nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savant, Mahesh M.; Gowda, Neetha S.; Pansuriya, Akshay M.; Bhuva, Chirag
V.; Kapuriya, Naval; Anandalwar, Sridhar M.; Prasad, Shashidhara J.;
Shah, Anamik; Naliapara, Yogesh T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(2), 254-257

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-[[(1E,4E)-3-Oxo-1,4-pentadiene-1,5-diyl]di-4,1-phenylene]bis[acetamide]
C21H20N2O3
1275576-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3372 1.5400 0.0 0
M  V30 2 C 12.0033 2.3101 0.0 0
M  V30 3 C 10.6697 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 10.6697 0.0000 0.0 0
M  V30 6 C 8.0022 1.5400 0.0 0
M  V30 7 N 18.6720 4.6201 0.0 0
M  V30 8 C 20.0057 3.8501 0.0 0
M  V30 9 C 20.0057 2.3101 0.0 0
M  V30 10 O 21.3393 4.6201 0.0 0
M  V30 11 N 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 O 0.0000 4.6201 0.0 0
M  V30 15 C 14.6708 2.3101 0.0 0
M  V30 16 C 14.6708 3.8501 0.0 0
M  V30 17 C 16.0045 1.5400 0.0 0
M  V30 18 C 16.0045 4.6201 0.0 0
M  V30 19 C 17.3382 2.3101 0.0 0
M  V30 20 C 17.3382 3.8501 0.0 0
M  V30 21 C 6.6685 2.3101 0.0 0
M  V30 22 C 5.3348 1.5400 0.0 0
M  V30 23 C 6.6685 3.8501 0.0 0
M  V30 24 C 4.0012 2.3101 0.0 0
M  V30 25 C 5.3348 4.6201 0.0 0
M  V30 26 C 4.0012 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 1 11 26
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-N,N′-[[(2R,6S)-1-Methyl-4-oxo-2,6-piperidinediyl]di-4,1-phenylene]bis[ace...
C22H25N3O3
1275577-07-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 6.1601 0.0 0
M  V30 2 O 9.3360 0.0000 0.0 0
M  V30 3 N 2.6675 6.9302 0.0 0
M  V30 4 C 1.3337 6.1601 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 O 0.0000 6.9302 0.0 0
M  V30 7 N 16.0045 6.9302 0.0 0
M  V30 8 C 17.3383 6.1601 0.0 0
M  V30 9 C 17.3383 4.6201 0.0 0
M  V30 10 O 18.6720 6.9302 0.0 0
M  V30 11 C 8.0023 3.8501 0.0 0 CFG=1
M  V30 12 N 9.3360 4.6201 0.0 0
M  V30 13 C 8.0023 2.3101 0.0 0
M  V30 14 C 10.6697 3.8501 0.0 0 CFG=2
M  V30 15 C 9.3360 1.5400 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 18 C 6.6685 6.1601 0.0 0
M  V30 19 C 5.3348 3.8501 0.0 0
M  V30 20 C 5.3348 6.9302 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 C 4.0012 6.1601 0.0 0
M  V30 23 C 12.0035 4.6201 0.0 0
M  V30 24 C 13.3372 3.8501 0.0 0
M  V30 25 C 12.0035 6.1601 0.0 0
M  V30 26 C 14.6708 4.6201 0.0 0
M  V30 27 C 13.3372 6.9302 0.0 0
M  V30 28 C 14.6708 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 15
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17 CFG=3
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 23 CFG=3
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1275576-87-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1275577-07-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-3870388
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM meso-2,6-Bis(4-acetamido-phenyl)-1-methyl-piperidin-4-one (NW-B577). A
yellow suspension of
N-{4-[(1E,4E)-5-(4-acetylamino-phenyl)-3-oxo-penta-1,4-dienyl]-phenyl}-acetamide
(800 mg, 2.3 mmol) in EtOH (9 mL) was treated with N-methylamine (40 % in
H2O, 803 μL, 9.2 mmol). The reaction mixture was stirred for overnight at
room temperature in the dark. The reaction mixture was diluted with water
(12 mL) and the resulting precipitate was filtered, recrystallized from
EtOH and dried in vacuo to obtain NW- B577 as a pale yellow solid (831
mg, 95%). mp: 234-237 °C. 1H NMR (300 MHz, DMSO- d6) δ (ppm): 9.94 (s,
2H, NH), 7.57 (d, 3J= 8.4 Hz, 4H, HAr), 7.36 (d, 3J= 8.4 Hz, 4H, HAr),
3.43-3.34 (m, 2H, CH2), 2.87 (t, ABX system, 3J= 13.0 Hz, 2H, CH), 2.25
(d, 3J= 14.1 Hz, 2H, CH2), 2.03 (s, 6H, COCH3), 1.67 (s, 3H, NCH3). 13C
NMR (75 MHz, DMSO-d6) δ (ppm): 206.6 (C), 168.6 (C), 138.9 (C), 138.2
(C), 127.7 (CH2), 119.7 (CH2), 68.7 (CH), 50.1, 24.3. MS (FAB) m/z: 380.3
(M+). Anal. calcd for C22H25N3O3 C · 0.2H2O: 68.98, H 6.68, N 10.97,
found: C 68.85, H 6.92, N 11.26%.
$DTYPE RXN:VAR(1):NOTES
$DATUM in the dark, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dibenzylidene- and heteroarylideneacetone derivatives as kinetoplastideae
parasiticides and their preparation, pharmaceutical compositions and use
in the treatment of trypanosomiasis and leishmaniasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Davioud-Charvet, Elisabeth; Wenzel, Ingrid Nicole; Mueller, Thomas J.J.;
Hanquet, Gilles; Lanfranchi, Don Antoine; Leroux, Frederic; Gendron,
Thibault
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011033115 A2 2011-03-24

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-[(2R)-3,5-Bis-O-(4-chlorobenzoyl)-2-deoxy-2-fluoro-2-methyl-β-D-erythro-pen...
C25H19Cl3FN5O5
1294481-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6549 12.6561 0.0 0
M  V30 2 F 8.6391 13.0845 0.0 0
M  V30 3 O 6.6684 11.8945 0.0 0
M  V30 4 C 5.3348 11.1245 0.0 0
M  V30 5 O 5.3348 9.5845 0.0 0
M  V30 6 C 7.0187 8.5624 0.0 0
M  V30 7 O 7.3390 7.0561 0.0 0
M  V30 8 C 6.1944 6.0255 0.0 0
M  V30 9 O 4.7299 6.5014 0.0 0
M  V30 10 Cl 17.0613 9.9704 0.0 0
M  V30 11 N 13.9255 5.6545 0.0 0
M  V30 12 Cl 0.0000 14.2045 0.0 0
M  V30 13 Cl 7.4753 0.0000 0.0 0
M  V30 14 N 11.9712 10.7674 0.0 0
M  V30 15 C 13.0016 9.6228 0.0 0
M  V30 16 C 12.7412 12.1010 0.0 0
M  V30 17 C 14.4084 10.2493 0.0 0
M  V30 18 N 12.8407 8.0913 0.0 0
M  V30 19 N 14.2475 11.7809 0.0 0
M  V30 20 C 15.6543 9.3441 0.0 0
M  V30 21 C 14.0866 7.1861 0.0 0
M  V30 22 N 15.4934 7.8125 0.0 0
M  V30 23 C 10.4395 10.6064 0.0 0 CFG=2
M  V30 24 C 9.4091 11.7508 0.0 0 CFG=1
M  V30 25 O 9.6695 9.2726 0.0 0
M  V30 26 C 8.0023 11.1245 0.0 0 CFG=2
M  V30 27 C 8.1632 9.5928 0.0 0 CFG=2
M  V30 28 C 4.0011 11.8945 0.0 0
M  V30 29 C 2.6675 11.1245 0.0 0
M  V30 30 C 4.0011 13.4345 0.0 0
M  V30 31 C 1.3337 11.8945 0.0 0
M  V30 32 C 2.6675 14.2045 0.0 0
M  V30 33 C 1.3337 13.4345 0.0 0
M  V30 34 C 6.5146 4.5192 0.0 0
M  V30 35 C 5.3702 3.4888 0.0 0
M  V30 36 C 7.9793 4.0433 0.0 0
M  V30 37 C 5.6904 1.9823 0.0 0
M  V30 38 C 8.2995 2.5369 0.0 0
M  V30 39 C 7.1549 1.5064 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 24 1 CFG=3
M  V30 2 1 24 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 26 3 CFG=1
M  V30 5 2 4 5
M  V30 6 1 4 28
M  V30 7 1 6 7
M  V30 8 1 27 6 CFG=3
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 8 34
M  V30 12 1 10 20
M  V30 13 1 11 21
M  V30 14 1 12 33
M  V30 15 1 13 39
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 23 14 CFG=3
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 17 19
M  V30 23 2 17 20
M  V30 24 1 18 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 23 24 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2′R)-2-Amino-2′-deoxy-2′-fluoro-N,2′-dimethyladenosine
C12H17FN6O3
1998705-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8851 6.6212 0.0 0
M  V30 2 F 1.8354 6.8367 0.0 0
M  V30 3 N 10.5368 4.6200 0.0 0
M  V30 4 C 11.8706 3.8500 0.0 0
M  V30 5 N 7.8696 0.0000 0.0 0
M  V30 6 C 0.6967 2.1700 0.0 0
M  V30 7 O 1.1726 0.7053 0.0 0
M  V30 8 O 0.0000 5.4471 0.0 0
M  V30 9 N 5.3914 4.8804 0.0 0
M  V30 10 C 6.5359 3.8500 0.0 0
M  V30 11 C 6.0177 6.2874 0.0 0
M  V30 12 C 7.8696 4.6200 0.0 0
M  V30 13 N 6.5359 2.3100 0.0 0
M  V30 14 N 7.5494 6.1264 0.0 0
M  V30 15 C 9.2032 3.8500 0.0 0
M  V30 16 C 7.8696 1.5400 0.0 0
M  V30 17 N 9.2032 2.3100 0.0 0
M  V30 18 C 3.8851 4.5602 0.0 0 CFG=1
M  V30 19 O 3.2586 3.1535 0.0 0
M  V30 20 C 2.7406 5.5908 0.0 0 CFG=1
M  V30 21 C 1.7271 3.3144 0.0 0 CFG=2
M  V30 22 C 1.4069 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=3
M  V30 2 1 20 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 21 6 CFG=3
M  V30 8 1 22 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1294481-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1998705-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22657495
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly active drug combination for treatment of hepatitis C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sommadossi, Jean-Pierre; Moussa, Adel; Pietropaolo, Keith M.; Zhou,
Xia-Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020117966 A1 2020-06-11

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-[(2R)-3,5-Bis-O-(4-chlorobenzoyl)-2-deoxy-2-fluoro-2-methyl-β-D-erythro-pen...
C25H19Cl3FN5O5
1294481-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6549 12.6561 0.0 0
M  V30 2 F 8.6391 13.0845 0.0 0
M  V30 3 O 6.6684 11.8945 0.0 0
M  V30 4 C 5.3348 11.1245 0.0 0
M  V30 5 O 5.3348 9.5845 0.0 0
M  V30 6 C 7.0187 8.5624 0.0 0
M  V30 7 O 7.3390 7.0561 0.0 0
M  V30 8 C 6.1944 6.0255 0.0 0
M  V30 9 O 4.7299 6.5014 0.0 0
M  V30 10 Cl 17.0613 9.9704 0.0 0
M  V30 11 N 13.9255 5.6545 0.0 0
M  V30 12 Cl 0.0000 14.2045 0.0 0
M  V30 13 Cl 7.4753 0.0000 0.0 0
M  V30 14 N 11.9712 10.7674 0.0 0
M  V30 15 C 13.0016 9.6228 0.0 0
M  V30 16 C 12.7412 12.1010 0.0 0
M  V30 17 C 14.4084 10.2493 0.0 0
M  V30 18 N 12.8407 8.0913 0.0 0
M  V30 19 N 14.2475 11.7809 0.0 0
M  V30 20 C 15.6543 9.3441 0.0 0
M  V30 21 C 14.0866 7.1861 0.0 0
M  V30 22 N 15.4934 7.8125 0.0 0
M  V30 23 C 10.4395 10.6064 0.0 0 CFG=2
M  V30 24 C 9.4091 11.7508 0.0 0 CFG=1
M  V30 25 O 9.6695 9.2726 0.0 0
M  V30 26 C 8.0023 11.1245 0.0 0 CFG=2
M  V30 27 C 8.1632 9.5928 0.0 0 CFG=2
M  V30 28 C 4.0011 11.8945 0.0 0
M  V30 29 C 2.6675 11.1245 0.0 0
M  V30 30 C 4.0011 13.4345 0.0 0
M  V30 31 C 1.3337 11.8945 0.0 0
M  V30 32 C 2.6675 14.2045 0.0 0
M  V30 33 C 1.3337 13.4345 0.0 0
M  V30 34 C 6.5146 4.5192 0.0 0
M  V30 35 C 5.3702 3.4888 0.0 0
M  V30 36 C 7.9793 4.0433 0.0 0
M  V30 37 C 5.6904 1.9823 0.0 0
M  V30 38 C 8.2995 2.5369 0.0 0
M  V30 39 C 7.1549 1.5064 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 24 1 CFG=3
M  V30 2 1 24 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 26 3 CFG=1
M  V30 5 2 4 5
M  V30 6 1 4 28
M  V30 7 1 6 7
M  V30 8 1 27 6 CFG=3
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 8 34
M  V30 12 1 10 20
M  V30 13 1 11 21
M  V30 14 1 12 33
M  V30 15 1 13 39
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 23 14 CFG=3
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 17 19
M  V30 23 2 17 20
M  V30 24 1 18 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 23 24 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2′R)-2-Amino-2′-deoxy-2′-fluoro-N,2′-dimethyladenosine
C12H17FN6O3
1998705-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8851 6.6212 0.0 0
M  V30 2 F 1.8354 6.8367 0.0 0
M  V30 3 N 10.5368 4.6200 0.0 0
M  V30 4 C 11.8706 3.8500 0.0 0
M  V30 5 N 7.8696 0.0000 0.0 0
M  V30 6 C 0.6967 2.1700 0.0 0
M  V30 7 O 1.1726 0.7053 0.0 0
M  V30 8 O 0.0000 5.4471 0.0 0
M  V30 9 N 5.3914 4.8804 0.0 0
M  V30 10 C 6.5359 3.8500 0.0 0
M  V30 11 C 6.0177 6.2874 0.0 0
M  V30 12 C 7.8696 4.6200 0.0 0
M  V30 13 N 6.5359 2.3100 0.0 0
M  V30 14 N 7.5494 6.1264 0.0 0
M  V30 15 C 9.2032 3.8500 0.0 0
M  V30 16 C 7.8696 1.5400 0.0 0
M  V30 17 N 9.2032 2.3100 0.0 0
M  V30 18 C 3.8851 4.5602 0.0 0 CFG=1
M  V30 19 O 3.2586 3.1535 0.0 0
M  V30 20 C 2.7406 5.5908 0.0 0 CFG=1
M  V30 21 C 1.7271 3.3144 0.0 0 CFG=2
M  V30 22 C 1.4069 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 20 1 CFG=3
M  V30 2 1 20 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 16
M  V30 6 1 6 7
M  V30 7 1 21 6 CFG=3
M  V30 8 1 22 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1294481-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1998705-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19343011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nucleotide hemi-sulfate salt for the treatment of Hepatitis C virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moussa, Adel; Sommadossi, Jean-Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180215776 A1 2018-08-02

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[4-[1-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclobutyl]phenyl]-2-(methylthio...
C29H28F3N3O6S2
1301611-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 6.6685 0.0 0
M  V30 2 S 1.5400 6.6685 0.0 0 VAL=6
M  V30 3 C 1.5400 8.2085 0.0 0
M  V30 4 O 0.0000 6.6685 0.0 0
M  V30 5 O 1.5400 5.1285 0.0 0
M  V30 6 F 0.2064 8.9785 0.0 0
M  V30 7 F 1.5400 9.7485 0.0 0
M  V30 8 F 2.8736 8.9785 0.0 0
M  V30 9 S 3.0800 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 N 13.9321 7.5991 0.0 0
M  V30 12 C 15.4721 7.5991 0.0 0
M  V30 13 O 16.2421 6.2655 0.0 0
M  V30 14 O 16.2421 8.9328 0.0 0
M  V30 15 C 17.7821 6.2655 0.0 0
M  V30 16 C 17.7821 7.8055 0.0 0
M  V30 17 C 19.3221 6.2655 0.0 0
M  V30 18 C 17.7821 4.7255 0.0 0
M  V30 19 C 5.3900 5.3347 0.0 0
M  V30 20 C 6.4204 6.4792 0.0 0
M  V30 21 C 6.1600 4.0011 0.0 0
M  V30 22 C 3.8500 5.3347 0.0 0
M  V30 23 C 7.8274 5.8528 0.0 0
M  V30 24 O 7.6664 4.3212 0.0 0
M  V30 25 N 5.3900 2.6674 0.0 0
M  V30 26 N 3.0800 4.0011 0.0 0
M  V30 27 C 3.8500 2.6674 0.0 0
M  V30 28 C 6.1002 7.9855 0.0 0
M  V30 29 C 7.2448 9.0161 0.0 0
M  V30 30 C 4.6357 8.4614 0.0 0
M  V30 31 C 6.9246 10.5224 0.0 0
M  V30 32 C 4.3155 9.9678 0.0 0
M  V30 33 C 5.4599 10.9982 0.0 0
M  V30 34 C 9.1610 6.6228 0.0 0
M  V30 35 C 9.1610 8.1628 0.0 0
M  V30 36 C 10.4946 5.8528 0.0 0
M  V30 37 C 10.4946 8.9328 0.0 0
M  V30 38 C 11.8284 6.6228 0.0 0
M  V30 39 C 11.8284 8.1628 0.0 0
M  V30 40 C 13.1621 8.9328 0.0 0
M  V30 41 C 12.3921 10.2666 0.0 0
M  V30 42 C 14.4957 9.7028 0.0 0
M  V30 43 C 13.7257 11.0366 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 9 27
M  V30 11 1 11 12
M  V30 12 1 11 40
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 2 20 23
M  V30 23 1 20 28
M  V30 24 1 21 24
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 1 23 24
M  V30 28 1 23 34
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 1 39 40
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-[4-[4-(methylamino)-2-(methylthio)-5-phenylfuro[2,3-d]...
C29H32N4O3S
1301611-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 6.6685 0.0 0
M  V30 2 C 0.0000 6.6685 0.0 0
M  V30 3 S 1.5400 1.3338 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 N 12.3921 7.5991 0.0 0
M  V30 6 C 13.9321 7.5991 0.0 0
M  V30 7 O 14.7021 6.2655 0.0 0
M  V30 8 O 14.7021 8.9328 0.0 0
M  V30 9 C 16.2421 6.2655 0.0 0
M  V30 10 C 16.2421 7.8055 0.0 0
M  V30 11 C 17.7821 6.2655 0.0 0
M  V30 12 C 16.2421 4.7255 0.0 0
M  V30 13 C 4.8804 6.4792 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 6.2874 5.8528 0.0 0
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 O 6.1264 4.3212 0.0 0
M  V30 19 N 3.8500 2.6674 0.0 0
M  V30 20 N 1.5400 4.0011 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 4.5602 7.9855 0.0 0
M  V30 23 C 5.7048 9.0161 0.0 0
M  V30 24 C 3.0957 8.4614 0.0 0
M  V30 25 C 5.3846 10.5224 0.0 0
M  V30 26 C 2.7755 9.9678 0.0 0
M  V30 27 C 3.9199 10.9982 0.0 0
M  V30 28 C 7.6210 6.6228 0.0 0
M  V30 29 C 8.9546 5.8528 0.0 0
M  V30 30 C 7.6210 8.1628 0.0 0
M  V30 31 C 10.2884 6.6228 0.0 0
M  V30 32 C 8.9546 8.9328 0.0 0
M  V30 33 C 10.2884 8.1628 0.0 0
M  V30 34 C 11.6221 8.9328 0.0 0
M  V30 35 C 10.8521 10.2666 0.0 0
M  V30 36 C 12.9557 9.7028 0.0 0
M  V30 37 C 12.1857 11.0366 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 1 5 6
M  V30 6 1 5 34
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 15 28
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 33 34
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1301611-75-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1301611-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8676525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: tert-Butyl
1-(4-(4-(methylamino)-2-(methylthio)-5-phenylfuro[2,3-d]pyrimidin-6-yl)phenyl)cyclobutylcarbamate:
To a solution of
6-(4-(1-(tert-butoxycarbonylamino)cyclobutyl)phenyl)-2-(methylthio)-5-phenylfuro[2,3-d]pyrimidin-4-yl
trifluoromethanesulfonate (0.09 g, 0.142 mmol) in THF (2 ml) was added
methanamine (2.0M in THF) (3 ml, 6.00 mmol). The reaction mixture was
stirred at room temperature for 2 h and concentrated in vacuo affording
tert-butyl
1-(4-(4-(methylamino)-2-(methylthio)-5-phenylfuro[2,3-d]pyrimidin-6-yl)phenyl)cyclobutylcarbamate.
Oil, yield (0.07 g, 0.135 mmol, 95%). LCMS (Method A) RT= 8.62 min, M+H+=
517.16.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furopyrimidine and furopyridine derivatives as AKT/PKB
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bell, Mark Peter; O'Dowd, Colin Roderick; Rountree, James Samuel Shane;
Trevitt, Graham Peter; Harrison, Timothy; McFarland, Mary Melissa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011055115 A1 2011-05-12

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[trans-4-[[[4-[(1S)-1-(4-Chlorophenyl)-3,4-dihydro-6-methoxy-7-(1-methyleth...
C36H44ClN3O5
1313365-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6697 1.5400 0.0 0
M  V30 2 O 2.6675 4.6201 0.0 0
M  V30 3 C 1.3338 3.8501 0.0 0
M  V30 4 C 1.3338 2.3101 0.0 0
M  V30 5 C 0.0000 4.6201 0.0 0
M  V30 6 O 2.6675 1.5400 0.0 0
M  V30 7 C 2.6675 0.0000 0.0 0
M  V30 8 Cl 8.0023 10.7802 0.0 0
M  V30 9 N 14.6708 6.9302 0.0 0
M  V30 10 C 16.0046 6.1601 0.0 0
M  V30 11 C 14.6708 8.4702 0.0 0
M  V30 12 N 21.3395 9.2402 0.0 0
M  V30 13 C 22.6731 8.4702 0.0 0
M  V30 14 C 24.0068 9.2402 0.0 0
M  V30 15 O 25.3405 8.4702 0.0 0
M  V30 16 O 24.0068 10.7802 0.0 0
M  V30 17 C 26.6743 9.2402 0.0 0
M  V30 18 C 8.0023 4.6201 0.0 0 CFG=2
M  V30 19 C 6.6687 3.8501 0.0 0
M  V30 20 N 9.3360 3.8501 0.0 0
M  V30 21 C 6.6687 2.3101 0.0 0
M  V30 22 C 5.3348 4.6201 0.0 0
M  V30 23 C 9.3360 2.3101 0.0 0
M  V30 24 C 5.3348 1.5400 0.0 0
M  V30 25 C 8.0023 1.5400 0.0 0
M  V30 26 C 4.0012 3.8501 0.0 0
M  V30 27 C 4.0012 2.3101 0.0 0
M  V30 28 C 8.0023 6.1601 0.0 0
M  V30 29 C 6.6687 6.9302 0.0 0
M  V30 30 C 9.3360 6.9302 0.0 0
M  V30 31 C 6.6687 8.4702 0.0 0
M  V30 32 C 9.3360 8.4702 0.0 0
M  V30 33 C 8.0023 9.2402 0.0 0
M  V30 34 C 10.6697 4.6201 0.0 0
M  V30 35 C 12.0035 3.8501 0.0 0
M  V30 36 C 10.6697 6.1601 0.0 0
M  V30 37 C 13.3372 4.6201 0.0 0
M  V30 38 C 12.0035 6.9302 0.0 0
M  V30 39 C 13.3372 6.1601 0.0 0
M  V30 40 C 17.3383 6.9302 0.0 0 CFG=1
M  V30 41 C 18.6720 6.1601 0.0 0
M  V30 42 C 17.3383 8.4702 0.0 0
M  V30 43 C 20.0057 6.9302 0.0 0
M  V30 44 C 18.6720 9.2402 0.0 0
M  V30 45 C 20.0057 8.4702 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 23
M  V30 2 1 2 3
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 27
M  V30 8 1 8 33
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 39
M  V30 12 1 40 10 CFG=1
M  V30 13 1 12 13
M  V30 14 1 45 12 CFG=3
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 28 CFG=3
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 20 34
M  V30 26 2 21 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 25
M  V30 30 1 24 27
M  V30 31 2 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 18 40 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[trans-4-[[[4-[(1S)-1-(4-Chlorophenyl)-3,4-dihydro-6-methoxy-7-(1-methylet...
C36H45ClN4O4
1313363-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6697 1.5400 0.0 0
M  V30 2 O 2.6675 4.6201 0.0 0
M  V30 3 C 1.3338 3.8501 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 1.3338 2.3101 0.0 0
M  V30 6 O 2.6675 1.5400 0.0 0
M  V30 7 C 2.6675 0.0000 0.0 0
M  V30 8 Cl 8.0023 10.7802 0.0 0
M  V30 9 N 14.6708 6.9302 0.0 0
M  V30 10 C 16.0046 6.1601 0.0 0
M  V30 11 C 14.6708 8.4702 0.0 0
M  V30 12 N 21.3395 9.2402 0.0 0
M  V30 13 C 22.6731 8.4702 0.0 0
M  V30 14 C 24.0068 9.2402 0.0 0
M  V30 15 N 25.3405 8.4702 0.0 0
M  V30 16 O 24.0068 10.7802 0.0 0
M  V30 17 C 26.6743 9.2402 0.0 0
M  V30 18 C 8.0023 4.6201 0.0 0 CFG=2
M  V30 19 C 6.6687 3.8501 0.0 0
M  V30 20 N 9.3360 3.8501 0.0 0
M  V30 21 C 6.6687 2.3101 0.0 0
M  V30 22 C 5.3348 4.6201 0.0 0
M  V30 23 C 9.3360 2.3101 0.0 0
M  V30 24 C 5.3348 1.5400 0.0 0
M  V30 25 C 8.0023 1.5400 0.0 0
M  V30 26 C 4.0012 3.8501 0.0 0
M  V30 27 C 4.0012 2.3101 0.0 0
M  V30 28 C 8.0023 6.1601 0.0 0
M  V30 29 C 9.3360 6.9302 0.0 0
M  V30 30 C 6.6687 6.9302 0.0 0
M  V30 31 C 9.3360 8.4702 0.0 0
M  V30 32 C 6.6687 8.4702 0.0 0
M  V30 33 C 8.0023 9.2402 0.0 0
M  V30 34 C 10.6697 4.6201 0.0 0
M  V30 35 C 10.6697 6.1601 0.0 0
M  V30 36 C 12.0035 3.8501 0.0 0
M  V30 37 C 12.0035 6.9302 0.0 0
M  V30 38 C 13.3372 4.6201 0.0 0
M  V30 39 C 13.3372 6.1601 0.0 0
M  V30 40 C 17.3383 6.9302 0.0 0 CFG=2
M  V30 41 C 18.6720 6.1601 0.0 0
M  V30 42 C 17.3383 8.4702 0.0 0
M  V30 43 C 20.0057 6.9302 0.0 0
M  V30 44 C 18.6720 9.2402 0.0 0
M  V30 45 C 20.0057 8.4702 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 23
M  V30 2 1 2 3
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 27
M  V30 8 1 8 33
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 39
M  V30 12 1 40 10 CFG=3
M  V30 13 1 12 13
M  V30 14 1 45 12 CFG=1
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 28 CFG=3
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 20 34
M  V30 26 2 21 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 25
M  V30 30 1 24 27
M  V30 31 2 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 18 40 45)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313365-64-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313363-64-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3796278
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 105.2:
2-(4-{[(4-Iodo-phenyl)-methyl-amino]-methyl}-trans-cyclohexylamino)-N-methyl-acetamide.
A mixture of Intermediate 105.3 (700 mg, 1.68 mmol) and 33% EtOH solution
of MeNH2 (2.1 mL, 168 mmol) was sealed and heated at 80° C. for 24 h. The
reaction mixture was concentrated in vacuo, then the resulting yellow oil
was directly purified by column chromatography. Example 116:
2-{4-[({4-[(S)-1-(4-Chloro-phenyl)-7-isopropoxy-6-methoxy-3-oxo-3,4-dihydro-1H-isoquinolin-2-yl]-phenyl}-methyl-amino)-methyl]-trans-cyclohexylamino}-N-methyl-acetamide.
The title compound (94.9 mg, 0.15 mmol, 95%) was obtained as a yellow
solid from Intermediate 79.1 (100 mg, 0.158 mmol) analogously to
Intermediate 105.2. HPLC: At Ret =1.86 min; LC-MS: m/z 633.2 [M+H]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in sealed flask, alternate reaction method also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isoquinolinone and quinazolinone derivatives as MDM2 and MDM4 inhibitors
and their preparation and use for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berghausen, Joerg; Buschmann, Nicole; Furet, Pascal; Gessier, Francois;
Hergovich Lisztwan, Joanna; Holzer, Philipp; Jacoby, Edgar; Kallen,
Joerg; Masuya, Keiichi; Pissot Soldermann, Carole; Ren, Haixia; Stutz,
Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011076786 A1 2011-06-30

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
(13aS)-5,8,13,13a-Tetrahydro-1,2,3-trimethoxy-6H-dibenzo[a,g]quinolizin-9-ol
C20H23NO4
1316259-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 1.3338 0.0 0
M  V30 2 C 7.7002 0.0000 0.0 0
M  V30 3 O 10.0102 1.3338 0.0 0
M  V30 4 C 11.5503 1.3338 0.0 0
M  V30 5 O 11.5503 4.0012 0.0 0
M  V30 6 C 12.3203 5.3348 0.0 0
M  V30 7 O 0.0000 5.3348 0.0 0
M  V30 8 C 6.9302 4.0012 0.0 0
M  V30 9 C 5.3901 4.0012 0.0 0 CFG=2
M  V30 10 C 7.7002 5.3348 0.0 0
M  V30 11 C 7.7002 2.6675 0.0 0
M  V30 12 N 4.6201 5.3348 0.0 0
M  V30 13 C 4.6201 2.6675 0.0 0
M  V30 14 C 9.2402 5.3348 0.0 0
M  V30 15 C 6.9302 6.6687 0.0 0
M  V30 16 C 9.2402 2.6675 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0
M  V30 18 C 5.3901 6.6687 0.0 0
M  V30 19 C 3.0801 2.6675 0.0 0
M  V30 20 C 10.0102 4.0012 0.0 0
M  V30 21 C 2.3101 4.0012 0.0 0
M  V30 22 C 2.3101 1.3338 0.0 0
M  V30 23 C 0.7700 4.0012 0.0 0
M  V30 24 C 0.7700 1.3338 0.0 0
M  V30 25 C 0.0000 2.6675 0.0 0
M  V30 26 H 6.1601 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 26 CFG=1
M  V30 14 2 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 15 18
M  V30 22 2 16 20
M  V30 23 1 17 21
M  V30 24 1 19 21
M  V30 25 2 19 22
M  V30 26 2 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzeneacetamide
C10H13NO2
53102-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1316259-14-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53102-68-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-111-CAS-8125224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of Amides 7b-d. A literature procedure32 was adapted for our
purpose: A solution of phenylacetic acid derivative 6b-d (20.0 mmol),
oxalyl chloride (2.89 g, 22.8 mmol) and one drop of DMF in dry toluene
(50 mL) was stirred at room temperature for 1 h. The solvent was
evaporated under reduced pressure to give the acyl chloride (quant),
which was used without further purification. A solution of the crude acyl
chloride (20.0 mmol) in CH2Cl2 (40 mL) was cooled to 0 °C on an ice bath.
A solution of amino methane (40% in H2O; 4.11 g, 52.9 mmol) in 2 M
aqueous NaOH (20 mL) was added dropwise over 1 h. The ice bath was
removed and stirring was continued overnight. The phases were separated
and the aqueous phase was extracted with CH2Cl2 (2 x 20 mL). The combined
organic phases were washed with 2 N HCl solution (100 mL), saturated
NaHCO3 solution (100 mL), and water (100 mL) and dried over Na2SO4.
Evaporation of the solvent under reduced pressure yielded the amides
7b-d, which were used in the following transformation without further
purification. 3-Methoxyphenyl-N-methylacetamide (7b). Yield: 3.40 g (95%)
as a pale yellowish solid. Mp: 41-44 °C. TLC (petroleum ether/EtOAc =
1/1): Rf = 0.22. The 1H and 13C NMR as well as MS data are in accordance
with literature.19,33
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biocatalytic Organic Synthesis of Optically Pure (S)-Scoulerine and
Berbine and Benzylisoquinoline Alkaloids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schrittwieser, Joerg H.; Resch, Verena; Wallner, Silvia; Lienhart,
Wolf-Dieter; Sattler, Johann H.; Resch, Jasmin; Macheroux, Peter;
Kroutil, Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(16), 6703-6714

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
(13aS)-5,8,13,13a-Tetrahydro-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizin-9-ol
C18H17NO3
1316259-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0800 0.0 0
M  V30 2 C 5.3347 4.6200 0.0 0 CFG=2
M  V30 3 C 6.6684 5.3900 0.0 0
M  V30 4 N 4.0011 5.3900 0.0 0
M  V30 5 C 5.3347 3.0800 0.0 0
M  V30 6 C 6.6684 6.9300 0.0 0
M  V30 7 C 8.0020 4.6200 0.0 0
M  V30 8 C 2.6673 4.6200 0.0 0
M  V30 9 C 4.0011 6.9300 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 8.0020 7.7000 0.0 0
M  V30 12 C 5.3347 7.7000 0.0 0
M  V30 13 C 9.3358 5.3900 0.0 0
M  V30 14 C 2.6673 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 9.3358 6.9300 0.0 0
M  V30 17 O 10.8004 4.9142 0.0 0
M  V30 18 C 1.3336 2.3100 0.0 0
M  V30 19 C 2.6673 0.0000 0.0 0
M  V30 20 O 10.8004 7.4059 0.0 0
M  V30 21 C 11.7056 6.1600 0.0 0
M  V30 22 C 1.3336 0.7700 0.0 0
M  V30 23 H 6.6684 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 23 CFG=1
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 5 10
M  V30 11 2 6 11
M  V30 12 1 6 12
M  V30 13 1 7 13
M  V30 14 1 8 14
M  V30 15 1 9 12
M  V30 16 1 10 14
M  V30 17 2 10 15
M  V30 18 1 11 16
M  V30 19 2 13 16
M  V30 20 1 13 17
M  V30 21 2 14 18
M  V30 22 1 15 19
M  V30 23 1 16 20
M  V30 24 1 17 21
M  V30 25 1 18 22
M  V30 26 2 19 22
M  V30 27 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,3-benzodioxole-5-acetamide
C10H11NO3
127901-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 N 9.0383 3.0800 0.0 0
M  V30 4 O 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 O 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1316259-17-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 127901-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-544-CAS-12388559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of Amides 7b-d. A literature
procedure32 was adapted for our purpose: A solution of phenylacetic acid
derivative 6b-d (20.0 mmol), oxalyl chloride (2.89 g, 22.8 mmol) and one
drop of DMF in dry toluene (50 mL) was stirred at room temperature for 1
h. The solvent was evaporated under reduced pressure to give the acyl
chloride (quant), which was used without further purification. A solution
of the crude acyl chloride (20.0 mmol) in CH2Cl2 (40 mL) was cooled to 0
°C on an ice bath. A solution of amino methane (40% in H2O; 4.11 g, 52.9
mmol) in 2 M aqueous NaOH (20 mL) was added dropwise over 1 h. The ice
bath was removed and stirring was continued overnight. The phases were
separated and the aqueous phase was extracted with CH2Cl2 (2 x 20 mL).
The combined organic phases were washed with 2 N HCl solution (100 mL),
saturated NaHCO3 solution (100 mL), and water (100 mL) and dried over
Na2SO4. Evaporation of the solvent under reduced pressure yielded the
amides 7b-d, which were used in the following transformation without
further purification. (3,4-Methylenedioxy)phenyl-N-methylacetamide (7d).
Yield: 3.68 g (95%) as a pale yellowish solid. Mp: 100-101 °C (lit.35 99-
101 °C). TLC (petroleum ether/EtOAc = 1/1): Rf = 0.20. The 1H and 13C NMR
as well as MS data are in accordance with literature.19,32
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biocatalytic Organic Synthesis of Optically Pure (S)-Scoulerine and
Berbine and Benzylisoquinoline Alkaloids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schrittwieser, Joerg H.; Resch, Verena; Wallner, Silvia; Lienhart,
Wolf-Dieter; Sattler, Johann H.; Resch, Jasmin; Macheroux, Peter;
Kroutil, Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(16), 6703-6714

$RFMT $RIREG SCHEME349 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylate
C19H18BrNO3S
131707-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9417 3.7535 0.0 0
M  V30 2 O 4.9112 2.6091 0.0 0
M  V30 3 O 7.4479 3.4333 0.0 0
M  V30 4 C 5.3871 1.1444 0.0 0
M  V30 5 C 4.3565 0.0000 0.0 0
M  V30 6 C 7.9110 6.4640 0.0 0
M  V30 7 S 8.6810 7.7977 0.0 0
M  V30 8 C 5.9417 9.1744 0.0 0
M  V30 9 O 0.0000 4.9240 0.0 0
M  V30 10 Br 0.0000 8.0040 0.0 0
M  V30 11 C 4.0011 5.6940 0.0 0
M  V30 12 C 5.4658 5.2182 0.0 0
M  V30 13 C 4.0011 7.2340 0.0 0
M  V30 14 C 2.6674 4.9240 0.0 0
M  V30 15 C 6.3710 6.4640 0.0 0
M  V30 16 N 5.4658 7.7099 0.0 0
M  V30 17 C 2.6674 8.0040 0.0 0
M  V30 18 C 1.3338 5.6940 0.0 0
M  V30 19 C 1.3338 7.2340 0.0 0
M  V30 20 C 10.2210 7.7977 0.0 0
M  V30 21 C 10.9910 9.1313 0.0 0
M  V30 22 C 10.9910 6.4640 0.0 0
M  V30 23 C 12.5310 9.1313 0.0 0
M  V30 24 C 12.5310 6.4640 0.0 0
M  V30 25 C 13.3010 7.7977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 20
M  V30 9 1 8 16
M  V30 10 1 9 18
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-1,2,3,7-tetrahydro-2,7-dimethyl-8-[(phenylthio)methyl]pyrrolo[3...
C22H23BrN2O3S
958450-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3303 3.5673 0.0 0
M  V30 2 O 6.4749 2.5369 0.0 0
M  V30 3 O 3.8658 3.0915 0.0 0
M  V30 4 C 6.1546 1.0304 0.0 0
M  V30 5 C 7.2991 0.0000 0.0 0
M  V30 6 C 8.3911 4.9301 0.0 0
M  V30 7 S 9.7248 5.7001 0.0 0
M  V30 8 C 8.0409 8.2622 0.0 0
M  V30 9 Br 2.3100 10.2193 0.0 0
M  V30 10 C 0.0000 3.5508 0.0 0
M  V30 11 C 4.6201 6.2182 0.0 0
M  V30 12 C 5.6505 5.0738 0.0 0
M  V30 13 C 3.0801 6.2182 0.0 0
M  V30 14 C 5.3901 7.5518 0.0 0
M  V30 15 C 7.0575 5.7001 0.0 0
M  V30 16 C 2.3100 7.5518 0.0 0
M  V30 17 C 2.3100 4.8845 0.0 0
M  V30 18 N 6.8964 7.2317 0.0 0
M  V30 19 C 4.6201 8.8857 0.0 0
M  V30 20 C 3.0801 8.8857 0.0 0
M  V30 21 O 0.7700 7.5518 0.0 0
M  V30 22 N 0.7700 4.8845 0.0 0
M  V30 23 C 0.0000 6.2182 0.0 0
M  V30 24 C 11.0585 4.9301 0.0 0
M  V30 25 C 11.0586 3.3901 0.0 0
M  V30 26 C 12.3923 5.7001 0.0 0
M  V30 27 C 12.3923 2.6200 0.0 0
M  V30 28 C 13.7260 4.9301 0.0 0
M  V30 29 C 13.7260 3.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 24
M  V30 9 1 8 18
M  V30 10 1 9 20
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 18
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 2 19 20
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 131707-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958450-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-3569832
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Ethyl
2,7-dimethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylates
(11a-i), general preparation method. The appropriate ethyl
5-hydroxy-1-methyl-1H-indole-3-carboxylate 5 - 8 (0.5 mmol) and MeNH2 (2
mL, 2 M) in THF and formaldehyde as formalin (8 mmol) in THF (10 mL) were
refluxed for 12 h. The course of the reaction was monitored using LC-MS.
When the reaction was finished, the mixture was diluted with ice water
(1.5 L). The precipitate was filtered off, washed with H2O, suspended in
cold (5 - 7°C) isopropanol, and stirred at 5 - 7°C for 1 h. The
precipitate was filtered off, washed with isopropanol, and dried in
vacuo. The resulting product was dissolved in dioxane, treated with HCl
(3 M) in dioxane, and diluted with Et2O. The resulting precipitate was
filtered off and dried in vacuo. Ethyl
6-bromo-2,7-dimethyl-8-phenylthiomethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylate
(11b), Yield: 75-95%. LC-MS: found m/z 475, 477 (M + H), calculated 475,
477 (M + 1 for C22H23BrN2O3S). Compound Against Influenza A/New
Caledonia/20/99 Virus (H N1) in MDCK Cell Culture: EC50: 4.8 ± 0.5μM.
Compounds Against BVDV in MDBK Cell Culture: EC50: >17.5 μM, CC50: 17.5 ±
2.6μM, SI50: <1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Ethyl
1,2-dimethyl-5-Hydroxy-1H-Indole-3-carboxylates and Their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil, V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun, I. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 47(12), 636-650

$RFMT $RIREG SCHEME350 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-5-hydroxy-1-methyl-2-[(phenylamino)methyl]-1H-indole-3-carboxylate
C19H19BrN2O3
132629-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9417 3.7535 0.0 0
M  V30 2 O 4.9112 2.6091 0.0 0
M  V30 3 O 7.4479 3.4333 0.0 0
M  V30 4 C 5.3871 1.1444 0.0 0
M  V30 5 C 4.3565 0.0000 0.0 0
M  V30 6 C 7.9110 6.4640 0.0 0
M  V30 7 N 8.6810 7.7977 0.0 0
M  V30 8 C 5.9417 9.1744 0.0 0
M  V30 9 O 0.0000 4.9240 0.0 0
M  V30 10 Br 0.0000 8.0040 0.0 0
M  V30 11 C 4.0011 5.6940 0.0 0
M  V30 12 C 5.4658 5.2182 0.0 0
M  V30 13 C 4.0011 7.2340 0.0 0
M  V30 14 C 2.6674 4.9240 0.0 0
M  V30 15 C 6.3710 6.4640 0.0 0
M  V30 16 N 5.4658 7.7099 0.0 0
M  V30 17 C 2.6674 8.0040 0.0 0
M  V30 18 C 1.3338 5.6940 0.0 0
M  V30 19 C 1.3338 7.2340 0.0 0
M  V30 20 C 10.2210 7.7977 0.0 0
M  V30 21 C 10.9910 6.4640 0.0 0
M  V30 22 C 10.9910 9.1313 0.0 0
M  V30 23 C 12.5310 6.4640 0.0 0
M  V30 24 C 12.5310 9.1313 0.0 0
M  V30 25 C 13.3010 7.7977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 20
M  V30 9 1 8 16
M  V30 10 1 9 18
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-1,2,3,7-tetrahydro-2,7-dimethyl-8-[(phenylamino)methyl]pyrrolo[...
C22H24BrN3O3
958450-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3304 3.5673 0.0 0
M  V30 2 O 6.4749 2.5369 0.0 0
M  V30 3 O 3.8658 3.0915 0.0 0
M  V30 4 C 6.1547 1.0304 0.0 0
M  V30 5 C 7.2991 0.0000 0.0 0
M  V30 6 C 8.3912 4.9301 0.0 0
M  V30 7 N 9.7249 5.7001 0.0 0
M  V30 8 C 8.0410 8.2623 0.0 0
M  V30 9 Br 2.3101 10.2194 0.0 0
M  V30 10 C 0.0000 3.5509 0.0 0
M  V30 11 C 4.6201 6.2182 0.0 0
M  V30 12 C 5.6505 5.0738 0.0 0
M  V30 13 C 3.0801 6.2182 0.0 0
M  V30 14 C 5.3901 7.5519 0.0 0
M  V30 15 C 7.0575 5.7001 0.0 0
M  V30 16 C 2.3101 7.5519 0.0 0
M  V30 17 C 2.3101 4.8845 0.0 0
M  V30 18 N 6.8964 7.2317 0.0 0
M  V30 19 C 4.6201 8.8857 0.0 0
M  V30 20 C 3.0801 8.8857 0.0 0
M  V30 21 O 0.7700 7.5519 0.0 0
M  V30 22 N 0.7700 4.8845 0.0 0
M  V30 23 C 0.0000 6.2182 0.0 0
M  V30 24 C 11.0587 4.9301 0.0 0
M  V30 25 C 11.0587 3.3901 0.0 0
M  V30 26 C 12.3923 5.7001 0.0 0
M  V30 27 C 12.3923 2.6201 0.0 0
M  V30 28 C 13.7260 4.9301 0.0 0
M  V30 29 C 13.7260 3.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 24
M  V30 9 1 8 18
M  V30 10 1 9 20
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 18
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 2 19 20
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 132629-06-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958450-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-11926880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) hydrogen N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-aspartate
C23H25NO6
134098-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 6.6684 0.0 0
M  V30 2 O 6.7708 6.6684 0.0 0
M  V30 3 C 7.5408 5.3348 0.0 0
M  V30 4 N 9.0808 5.3348 0.0 0
M  V30 5 O 6.7708 4.0011 0.0 0
M  V30 6 C 9.8508 4.0011 0.0 0 CFG=2
M  V30 7 C 11.3909 4.0011 0.0 0
M  V30 8 C 9.0808 2.6675 0.0 0
M  V30 9 O 12.1609 5.3348 0.0 0
M  V30 10 O 12.1609 2.6675 0.0 0
M  V30 11 C 9.8508 1.3337 0.0 0
M  V30 12 C 13.7009 5.3348 0.0 0
M  V30 13 O 11.3909 1.3337 0.0 0
M  V30 14 O 9.0808 0.0000 0.0 0
M  V30 15 C 13.7009 6.8748 0.0 0
M  V30 16 C 15.2409 5.3348 0.0 0
M  V30 17 C 13.7009 3.7947 0.0 0
M  V30 18 C 4.4608 8.0022 0.0 0
M  V30 19 C 5.0873 9.4090 0.0 0
M  V30 20 C 2.9293 8.1631 0.0 0
M  V30 21 C 3.9427 10.4394 0.0 0
M  V30 22 C 6.5518 9.8849 0.0 0
M  V30 23 C 2.6091 9.6694 0.0 0
M  V30 24 C 1.7849 7.1327 0.0 0
M  V30 25 C 4.2629 11.9459 0.0 0
M  V30 26 C 6.8720 11.3913 0.0 0
M  V30 27 C 1.1444 10.1453 0.0 0
M  V30 28 C 0.3202 7.6086 0.0 0
M  V30 29 C 5.7276 12.4217 0.0 0
M  V30 30 C 0.0000 9.1149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 23
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-D-asparagine 1,1-dimethylethyl...
C24H28N2O5
1641530-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 8.0020 0.0 0
M  V30 2 O 6.7708 8.0020 0.0 0
M  V30 3 C 7.5408 6.6684 0.0 0
M  V30 4 N 9.0808 6.6684 0.0 0
M  V30 5 O 6.7708 5.3347 0.0 0
M  V30 6 C 9.8508 5.3347 0.0 0 CFG=2
M  V30 7 C 11.3908 5.3347 0.0 0
M  V30 8 C 9.0808 4.0011 0.0 0
M  V30 9 O 12.1608 6.6684 0.0 0
M  V30 10 O 12.1608 4.0011 0.0 0
M  V30 11 C 9.8508 2.6673 0.0 0
M  V30 12 C 13.7008 6.6684 0.0 0
M  V30 13 N 9.0808 1.3336 0.0 0
M  V30 14 O 11.3908 2.6673 0.0 0
M  V30 15 C 13.7008 5.1284 0.0 0
M  V30 16 C 15.2408 6.6684 0.0 0
M  V30 17 C 13.7008 8.2084 0.0 0
M  V30 18 C 9.8508 0.0000 0.0 0
M  V30 19 C 4.4608 9.3358 0.0 0
M  V30 20 C 5.0872 10.7426 0.0 0
M  V30 21 C 2.9292 9.4967 0.0 0
M  V30 22 C 3.9427 11.7730 0.0 0
M  V30 23 C 6.5518 11.2184 0.0 0
M  V30 24 C 2.6091 11.0030 0.0 0
M  V30 25 C 1.7849 8.4663 0.0 0
M  V30 26 C 4.2629 13.2794 0.0 0
M  V30 27 C 6.8719 12.7249 0.0 0
M  V30 28 C 1.1444 11.4790 0.0 0
M  V30 29 C 0.3202 8.9422 0.0 0
M  V30 30 C 5.7276 13.7553 0.0 0
M  V30 31 C 0.0000 10.4484 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 2 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 134098-70-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1641530-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16603384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Amino-3-(heteroaryl-phenyl)propanoic acid derivatives as GLP-1 receptor
modulators and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boehm, Marcus F.; Martinborough, Esther; Moorjani, Manisha; Tamiya,
Junko; Huang, Liming; Yeager, Adam R.; Brahmachary, Enugurthi; Fowler,
Thomas; Novak, Andrew; Meghani, Premji; Knaggs, Michael; Glynn, Daniel;
Mills, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016094729 A1 2016-06-16

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) hydrogen N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-aspartate
C23H25NO6
134098-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 6.6684 0.0 0
M  V30 2 O 6.7708 6.6684 0.0 0
M  V30 3 C 7.5408 5.3348 0.0 0
M  V30 4 N 9.0808 5.3348 0.0 0
M  V30 5 O 6.7708 4.0011 0.0 0
M  V30 6 C 9.8508 4.0011 0.0 0 CFG=2
M  V30 7 C 11.3909 4.0011 0.0 0
M  V30 8 C 9.0808 2.6675 0.0 0
M  V30 9 O 12.1609 5.3348 0.0 0
M  V30 10 O 12.1609 2.6675 0.0 0
M  V30 11 C 9.8508 1.3337 0.0 0
M  V30 12 C 13.7009 5.3348 0.0 0
M  V30 13 O 11.3909 1.3337 0.0 0
M  V30 14 O 9.0808 0.0000 0.0 0
M  V30 15 C 13.7009 6.8748 0.0 0
M  V30 16 C 15.2409 5.3348 0.0 0
M  V30 17 C 13.7009 3.7947 0.0 0
M  V30 18 C 4.4608 8.0022 0.0 0
M  V30 19 C 5.0873 9.4090 0.0 0
M  V30 20 C 2.9293 8.1631 0.0 0
M  V30 21 C 3.9427 10.4394 0.0 0
M  V30 22 C 6.5518 9.8849 0.0 0
M  V30 23 C 2.6091 9.6694 0.0 0
M  V30 24 C 1.7849 7.1327 0.0 0
M  V30 25 C 4.2629 11.9459 0.0 0
M  V30 26 C 6.8720 11.3913 0.0 0
M  V30 27 C 1.1444 10.1453 0.0 0
M  V30 28 C 0.3202 7.6086 0.0 0
M  V30 29 C 5.7276 12.4217 0.0 0
M  V30 30 C 0.0000 9.1149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 23
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 2 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 2 26 29
M  V30 31 1 27 30
M  V30 32 2 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-D-asparagine 1,1-dimethylethyl...
C24H28N2O5
1641530-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 8.0020 0.0 0
M  V30 2 O 6.7708 8.0020 0.0 0
M  V30 3 C 7.5408 6.6684 0.0 0
M  V30 4 N 9.0808 6.6684 0.0 0
M  V30 5 O 6.7708 5.3347 0.0 0
M  V30 6 C 9.8508 5.3347 0.0 0 CFG=2
M  V30 7 C 11.3908 5.3347 0.0 0
M  V30 8 C 9.0808 4.0011 0.0 0
M  V30 9 O 12.1608 6.6684 0.0 0
M  V30 10 O 12.1608 4.0011 0.0 0
M  V30 11 C 9.8508 2.6673 0.0 0
M  V30 12 C 13.7008 6.6684 0.0 0
M  V30 13 N 9.0808 1.3336 0.0 0
M  V30 14 O 11.3908 2.6673 0.0 0
M  V30 15 C 13.7008 5.1284 0.0 0
M  V30 16 C 15.2408 6.6684 0.0 0
M  V30 17 C 13.7008 8.2084 0.0 0
M  V30 18 C 9.8508 0.0000 0.0 0
M  V30 19 C 4.4608 9.3358 0.0 0
M  V30 20 C 5.0872 10.7426 0.0 0
M  V30 21 C 2.9292 9.4967 0.0 0
M  V30 22 C 3.9427 11.7730 0.0 0
M  V30 23 C 6.5518 11.2184 0.0 0
M  V30 24 C 2.6091 11.0030 0.0 0
M  V30 25 C 1.7849 8.4663 0.0 0
M  V30 26 C 4.2629 13.2794 0.0 0
M  V30 27 C 6.8719 12.7249 0.0 0
M  V30 28 C 1.1444 11.4790 0.0 0
M  V30 29 C 0.3202 8.9422 0.0 0
M  V30 30 C 5.7276 13.7553 0.0 0
M  V30 31 C 0.0000 10.4484 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 2 27 30
M  V30 32 1 28 31
M  V30 33 2 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 134098-70-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1641530-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13449504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amido-carboxylic acids as novel GLP-1 receptor modulators and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boehm, Marcus F.; Martinborough, Esther; Moorjani, Manisha; Tamiya,
Junko; Huang, Liming; Yeager, Adam R.; Brahmachary, Enugurthi; Fowler,
Thomas; Novak, Andrew; Meghani, Premji; Knaggs, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014201172 A1 2014-12-18

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2-deoxy-2-fluoro-β-D-ribofuranosyl)-9H-purin-2-amine
C10H11ClFN5O3
134444-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 10.5369 4.6201 0.0 0
M  V30 2 N 7.8695 0.0000 0.0 0
M  V30 3 F 2.9016 7.1223 0.0 0
M  V30 4 C 0.6966 2.1699 0.0 0
M  V30 5 O 1.1724 0.7053 0.0 0
M  V30 6 O 0.0000 5.4472 0.0 0
M  V30 7 C 6.5359 3.8501 0.0 0
M  V30 8 N 5.3913 4.8805 0.0 0
M  V30 9 C 7.8695 4.6201 0.0 0
M  V30 10 N 6.5359 2.3100 0.0 0
M  V30 11 C 6.0178 6.2873 0.0 0
M  V30 12 N 7.5494 6.1264 0.0 0
M  V30 13 C 9.2032 3.8501 0.0 0
M  V30 14 C 7.8695 1.5400 0.0 0
M  V30 15 N 9.2032 2.3100 0.0 0
M  V30 16 C 3.8850 4.5603 0.0 0 CFG=1
M  V30 17 O 3.2585 3.1534 0.0 0
M  V30 18 C 2.7405 5.5908 0.0 0 CFG=2
M  V30 19 C 1.7270 3.3145 0.0 0 CFG=2
M  V30 20 C 1.4068 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 18 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 16 8 CFG=3
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 2-amino-2′-deoxy-2′-fluoro-N-methyl-
C11H15FN6O3
134444-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 2.9016 7.1223 0.0 0
M  V30 2 N 10.5371 4.6201 0.0 0
M  V30 3 C 11.8709 3.8501 0.0 0
M  V30 4 N 7.8697 0.0000 0.0 0
M  V30 5 C 0.6967 2.1699 0.0 0
M  V30 6 O 1.1726 0.7053 0.0 0
M  V30 7 O 0.0000 5.4473 0.0 0
M  V30 8 N 5.3915 4.8805 0.0 0
M  V30 9 C 6.5361 3.8501 0.0 0
M  V30 10 C 6.0178 6.2873 0.0 0
M  V30 11 C 7.8697 4.6201 0.0 0
M  V30 12 N 6.5361 2.3101 0.0 0
M  V30 13 N 7.5496 6.1264 0.0 0
M  V30 14 C 9.2034 3.8501 0.0 0
M  V30 15 C 7.8697 1.5400 0.0 0
M  V30 16 N 9.2034 2.3101 0.0 0
M  V30 17 C 3.8852 4.5603 0.0 0 CFG=1
M  V30 18 O 3.2587 3.1534 0.0 0
M  V30 19 C 2.7406 5.5908 0.0 0 CFG=2
M  V30 20 C 1.7271 3.3145 0.0 0 CFG=2
M  V30 21 C 1.4070 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=3
M  V30 7 1 21 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=3
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134444-54-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 134444-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19080646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed container used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2'-substituted-N6-substituted purine nucleotides for RNA
virus treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sommadossi, Jean-Pierre; Moussa, Adel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018048937 A1 2018-03-15

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2-deoxy-2-fluoro-β-D-ribofuranosyl)-9H-purin-2-amine
C10H11ClFN5O3
134444-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 10.5369 4.6201 0.0 0
M  V30 2 N 7.8695 0.0000 0.0 0
M  V30 3 F 2.9016 7.1223 0.0 0
M  V30 4 C 0.6966 2.1699 0.0 0
M  V30 5 O 1.1724 0.7053 0.0 0
M  V30 6 O 0.0000 5.4472 0.0 0
M  V30 7 C 6.5359 3.8501 0.0 0
M  V30 8 N 5.3913 4.8805 0.0 0
M  V30 9 C 7.8695 4.6201 0.0 0
M  V30 10 N 6.5359 2.3100 0.0 0
M  V30 11 C 6.0178 6.2873 0.0 0
M  V30 12 N 7.5494 6.1264 0.0 0
M  V30 13 C 9.2032 3.8501 0.0 0
M  V30 14 C 7.8695 1.5400 0.0 0
M  V30 15 N 9.2032 2.3100 0.0 0
M  V30 16 C 3.8850 4.5603 0.0 0 CFG=1
M  V30 17 O 3.2585 3.1534 0.0 0
M  V30 18 C 2.7405 5.5908 0.0 0 CFG=2
M  V30 19 C 1.7270 3.3145 0.0 0 CFG=2
M  V30 20 C 1.4068 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 18 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 16 8 CFG=3
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 2-amino-2′-deoxy-2′-fluoro-N-methyl-
C11H15FN6O3
134444-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 2.9016 7.1223 0.0 0
M  V30 2 N 10.5371 4.6201 0.0 0
M  V30 3 C 11.8709 3.8501 0.0 0
M  V30 4 N 7.8697 0.0000 0.0 0
M  V30 5 C 0.6967 2.1699 0.0 0
M  V30 6 O 1.1726 0.7053 0.0 0
M  V30 7 O 0.0000 5.4473 0.0 0
M  V30 8 N 5.3915 4.8805 0.0 0
M  V30 9 C 6.5361 3.8501 0.0 0
M  V30 10 C 6.0178 6.2873 0.0 0
M  V30 11 C 7.8697 4.6201 0.0 0
M  V30 12 N 6.5361 2.3101 0.0 0
M  V30 13 N 7.5496 6.1264 0.0 0
M  V30 14 C 9.2034 3.8501 0.0 0
M  V30 15 C 7.8697 1.5400 0.0 0
M  V30 16 N 9.2034 2.3101 0.0 0
M  V30 17 C 3.8852 4.5603 0.0 0 CFG=1
M  V30 18 O 3.2587 3.1534 0.0 0
M  V30 19 C 2.7406 5.5908 0.0 0 CFG=2
M  V30 20 C 1.7271 3.3145 0.0 0 CFG=2
M  V30 21 C 1.4070 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=3
M  V30 7 1 21 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=3
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134444-54-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 134444-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18786866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed container used,alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 6-aminopurine nucleotides for the treatment of
paramyxovirus and orthomyxovirus infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sommadossi, Jean-Pierre; Moussa, Adel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018009623 A1 2018-01-11

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl β-oxo-2-thiophenepropanoate
C8H8O3S
134568-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 C 5.1047 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4385 2.6217 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4385 4.1618 0.0 0
M  V30 7 C 9.1059 2.6217 0.0 0
M  V30 8 C 2.4374 1.8517 0.0 0
M  V30 9 C 1.0304 2.4782 0.0 0
M  V30 10 S 2.2763 0.3202 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(methylamino)-3-(2-thienyl)-2-propenoate
C9H11NO2S
2304416-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 C 5.1048 3.0801 0.0 0
M  V30 3 N 3.7711 0.7700 0.0 0
M  V30 4 C 6.4386 2.3101 0.0 0
M  V30 5 C 2.4374 0.0000 0.0 0
M  V30 6 O 7.7722 3.0801 0.0 0
M  V30 7 O 6.4386 0.7700 0.0 0
M  V30 8 C 9.1059 2.3101 0.0 0
M  V30 9 C 2.4374 3.0801 0.0 0
M  V30 10 C 2.2763 4.6116 0.0 0
M  V30 11 S 1.0304 2.4536 0.0 0
M  V30 12 C 0.7700 4.9318 0.0 0
M  V30 13 C 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134568-16-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME354 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4,5-dihydro-4,5-dihydroxy-1,2-dimethyl-4,5-diphenyl-1H-pyrrole-3-carbox...
C21H23NO4
1357480-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 3.5046 0.0 0
M  V30 2 O 3.0959 4.3197 0.0 0
M  V30 3 C 7.8861 4.6787 0.0 0
M  V30 4 O 9.1319 5.5839 0.0 0
M  V30 5 O 8.0470 3.1472 0.0 0
M  V30 6 C 10.5389 4.9576 0.0 0
M  V30 7 C 11.7848 5.8628 0.0 0
M  V30 8 C 3.8574 8.3062 0.0 0
M  V30 9 C 7.1895 7.9560 0.0 0
M  V30 10 C 5.1455 4.5352 0.0 0
M  V30 11 C 4.0011 5.5656 0.0 0
M  V30 12 C 6.4793 5.3052 0.0 0
M  V30 13 N 4.6274 6.9725 0.0 0
M  V30 14 C 6.1590 6.8115 0.0 0
M  V30 15 C 5.4393 3.0233 0.0 0
M  V30 16 C 4.2771 2.0131 0.0 0
M  V30 17 C 6.8955 2.5221 0.0 0
M  V30 18 C 4.5709 0.5014 0.0 0
M  V30 19 C 7.1894 1.0104 0.0 0
M  V30 20 C 6.0271 0.0000 0.0 0
M  V30 21 C 2.6674 6.3356 0.0 0
M  V30 22 C 1.3336 5.5656 0.0 0
M  V30 23 C 2.6674 7.8756 0.0 0
M  V30 24 C 0.0000 6.3356 0.0 0
M  V30 25 C 1.3336 8.6456 0.0 0
M  V30 26 C 0.0000 7.8756 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 11 21
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1357480-51-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-40817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free synthesis of pyrrole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rostami-Charati, Faramarz; Hossaini, Zinatossadat; Khalilzadeh, Mohammad
A.; Jafaryan, Hojatollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2012), 49(1), 217-220

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-methyl-1-(3-nitrophenyl)-2-oxoethyl]carbamate
C14H18N2O5
1350523-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.6673 0.0 0
M  V30 2 N 5.3348 1.8973 0.0 0
M  V30 3 C 7.4385 1.3337 0.0 0
M  V30 4 C 5.8985 4.0012 0.0 0
M  V30 5 C 4.0010 2.6673 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 2.6673 1.8973 0.0 0
M  V30 8 O 4.0010 4.2074 0.0 0
M  V30 9 C 1.3337 2.6673 0.0 0
M  V30 10 C 2.1037 4.0012 0.0 0
M  V30 11 C 0.0000 3.4374 0.0 0
M  V30 12 C 0.5637 1.3337 0.0 0
M  V30 13 N 12.0033 2.6673 0.0 0 VAL=5
M  V30 14 O 12.0033 1.1273 0.0 0
M  V30 15 O 13.3370 3.4374 0.0 0
M  V30 16 C 8.0022 3.4374 0.0 0
M  V30 17 C 9.3360 2.6673 0.0 0
M  V30 18 C 8.0022 4.9774 0.0 0
M  V30 19 C 10.6697 3.4374 0.0 0
M  V30 20 C 9.3360 5.7474 0.0 0
M  V30 21 C 10.6697 4.9774 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 2 13 15
M  V30 15 1 13 19
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-methyl-2-(methylamino)-1-(3-nitrophenyl)ethyl]carbamate
C15H23N3O4
1350523-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.0010 0.0 0
M  V30 2 N 8.0022 3.2310 0.0 0
M  V30 3 C 5.8985 2.6673 0.0 0
M  V30 4 C 7.4385 5.3348 0.0 0
M  V30 5 C 9.3360 4.0010 0.0 0
M  V30 6 N 6.6685 1.3337 0.0 0
M  V30 7 O 10.6697 3.2310 0.0 0
M  V30 8 O 9.3360 5.5410 0.0 0
M  V30 9 C 5.8985 0.0000 0.0 0
M  V30 10 C 12.0033 4.0010 0.0 0
M  V30 11 C 12.7733 2.6673 0.0 0
M  V30 12 C 13.3370 4.7710 0.0 0
M  V30 13 C 11.2333 5.3348 0.0 0
M  V30 14 N 1.3337 4.0010 0.0 0 VAL=5
M  V30 15 O 1.3337 2.4610 0.0 0
M  V30 16 O 0.0000 4.7710 0.0 0
M  V30 17 C 5.3348 4.7710 0.0 0
M  V30 18 C 4.0010 4.0010 0.0 0
M  V30 19 C 5.3348 6.3111 0.0 0
M  V30 20 C 2.6673 4.7710 0.0 0
M  V30 21 C 4.0010 7.0811 0.0 0
M  V30 22 C 2.6673 6.3111 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1350523-44-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350523-45-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2149152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
rac-[1-methyl-2-methylamino-1-(3-nitro-phenyl)-ethyl]-carbamic acid
tert-butyl ester Methylamine 2 M in THF (5.78 mL, 11.55 mmol) was added
to a solution of rac-[1-methyl- 1-(3-nitro-phenyl)-2-oxo-ethyl]-carbamic
acid tert-butyl ester (1.7 g, 5.78 mmol) in a mixture of DCM (100 mL) and
AcOH (1.98 mL). The mixture was stirred at room temperature for 1 hour.
Then sodium triacetoxyborohydride (3.43 g, 16.17 mmol) was added and the
mixture was stirred at room temperature for 2 hours. The mixture was
diluted with DCM and poured into NaHCO3 (aqueous sat. soltn.). The
organic layer was separated and the aqueous layer was further extracted
with DCM. The combined organic layers were separated, dried (MgSO4),
filtered and the solvents evaporated in vacuo to yield
rac-[1-methyl-2-methylamino- 1-(3-nitro-phenyl)-ethyl]-carbamic acid
tert-butyl ester that was used in the next step without further
purification. Colourless oil, yield 1.7 g, 95%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-amino-5,6-dihydro-1H-pyrazin-2-one derivatives as
β-secretase inhibitors useful for the treatment of Alzheimer's disease
and other forms of dementia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trabanco-Suarez, Andres Avelino; Delgado-Jimenez, Francisca; Tresadern,
Gary John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012000933 A1 2012-01-05

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-methyl-1-(3-nitrophenyl)-2-oxoethyl]carbamate
C14H18N2O5
1350523-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.6673 0.0 0
M  V30 2 N 5.3348 1.8973 0.0 0
M  V30 3 C 7.4385 1.3337 0.0 0
M  V30 4 C 5.8985 4.0012 0.0 0
M  V30 5 C 4.0010 2.6673 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 2.6673 1.8973 0.0 0
M  V30 8 O 4.0010 4.2074 0.0 0
M  V30 9 C 1.3337 2.6673 0.0 0
M  V30 10 C 2.1037 4.0012 0.0 0
M  V30 11 C 0.0000 3.4374 0.0 0
M  V30 12 C 0.5637 1.3337 0.0 0
M  V30 13 N 12.0033 2.6673 0.0 0 VAL=5
M  V30 14 O 12.0033 1.1273 0.0 0
M  V30 15 O 13.3370 3.4374 0.0 0
M  V30 16 C 8.0022 3.4374 0.0 0
M  V30 17 C 9.3360 2.6673 0.0 0
M  V30 18 C 8.0022 4.9774 0.0 0
M  V30 19 C 10.6697 3.4374 0.0 0
M  V30 20 C 9.3360 5.7474 0.0 0
M  V30 21 C 10.6697 4.9774 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 13 14
M  V30 14 2 13 15
M  V30 15 1 13 19
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-methyl-2-(methylamino)-1-(3-nitrophenyl)ethyl]carbamate
C15H23N3O4
1350523-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.0010 0.0 0
M  V30 2 N 8.0022 3.2310 0.0 0
M  V30 3 C 5.8985 2.6673 0.0 0
M  V30 4 C 7.4385 5.3348 0.0 0
M  V30 5 C 9.3360 4.0010 0.0 0
M  V30 6 N 6.6685 1.3337 0.0 0
M  V30 7 O 10.6697 3.2310 0.0 0
M  V30 8 O 9.3360 5.5410 0.0 0
M  V30 9 C 5.8985 0.0000 0.0 0
M  V30 10 C 12.0033 4.0010 0.0 0
M  V30 11 C 12.7733 2.6673 0.0 0
M  V30 12 C 13.3370 4.7710 0.0 0
M  V30 13 C 11.2333 5.3348 0.0 0
M  V30 14 N 1.3337 4.0010 0.0 0 VAL=5
M  V30 15 O 1.3337 2.4610 0.0 0
M  V30 16 O 0.0000 4.7710 0.0 0
M  V30 17 C 5.3348 4.7710 0.0 0
M  V30 18 C 4.0010 4.0010 0.0 0
M  V30 19 C 5.3348 6.3111 0.0 0
M  V30 20 C 2.6673 4.7710 0.0 0
M  V30 21 C 4.0010 7.0811 0.0 0
M  V30 22 C 2.6673 6.3111 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1350523-44-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1350523-45-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1120913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design and synthesis of aminopiperazinones as β-secretase (BACE)
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tresadern, Gary; Delgado, Francisca; Delgado, Oscar; Gijsen, Harrie;
Macdonald, Gregor J.; Moechars, Dieder; Rombouts, Frederik; Alexander,
Richard; Spurlino, John; Van Gool, Michiel; Vega, Juan Antonio; Trabanco,
Andres A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(24), 7255-7260

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Glucopyranosiduronic acid, 2-nitro-4-[[[(4-nitrophenoxy)carbonyl]oxy]meth...
C35H34N2O20
1353003-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 59 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6687 6.9302 0.0 0
M  V30 2 C 6.6687 5.3901 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 O 8.0023 4.6201 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 O 9.3360 5.3901 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0
M  V30 10 O 10.6697 3.0801 0.0 0
M  V30 11 O 12.0035 5.3901 0.0 0
M  V30 12 C 12.0035 2.3101 0.0 0
M  V30 13 C 12.0035 0.7700 0.0 0
M  V30 14 C 13.3372 0.0000 0.0 0
M  V30 15 O 6.6687 10.0102 0.0 0
M  V30 16 C 5.3348 9.2402 0.0 0
M  V30 17 O 4.0012 10.0102 0.0 0
M  V30 18 O 5.3348 7.7002 0.0 0
M  V30 19 C 2.6675 9.2402 0.0 0
M  V30 20 C 1.3338 10.0102 0.0 0
M  V30 21 C 0.0000 9.2402 0.0 0
M  V30 22 O 12.0035 6.9302 0.0 0
M  V30 23 C 9.3360 11.5503 0.0 0
M  V30 24 O 8.0023 12.3203 0.0 0
M  V30 25 O 10.6697 12.3203 0.0 0
M  V30 26 C 8.0023 13.8603 0.0 0
M  V30 27 C 6.6687 14.6303 0.0 0
M  V30 28 C 6.6687 16.1704 0.0 0
M  V30 29 N 14.6708 5.3901 0.0 0 VAL=5
M  V30 30 O 13.3372 4.6201 0.0 0
M  V30 31 O 16.0045 4.6201 0.0 0
M  V30 32 C 17.3383 10.0102 0.0 0
M  V30 33 O 18.6720 9.2402 0.0 0
M  V30 34 C 20.0057 10.0102 0.0 0
M  V30 35 O 21.3393 9.2402 0.0 0
M  V30 36 O 20.0057 11.5503 0.0 0
M  V30 37 N 26.6742 12.3203 0.0 0 VAL=5
M  V30 38 O 26.6742 13.8603 0.0 0
M  V30 39 O 28.0080 11.5503 0.0 0
M  V30 40 C 8.0023 7.7002 0.0 0 CFG=1
M  V30 41 C 9.3360 6.9302 0.0 0 CFG=1
M  V30 42 C 8.0023 9.2402 0.0 0 CFG=2
M  V30 43 C 10.6697 7.7002 0.0 0 CFG=2
M  V30 44 C 9.3360 10.0102 0.0 0 CFG=1
M  V30 45 O 10.6697 9.2402 0.0 0
M  V30 46 C 13.3372 7.7002 0.0 0
M  V30 47 C 14.6708 6.9302 0.0 0
M  V30 48 C 13.3372 9.2402 0.0 0
M  V30 49 C 16.0045 7.7002 0.0 0
M  V30 50 C 14.6708 10.0102 0.0 0
M  V30 51 C 16.0045 9.2402 0.0 0
M  V30 52 C 22.6731 10.0102 0.0 0
M  V30 53 C 24.0068 9.2402 0.0 0
M  V30 54 C 22.6731 11.5503 0.0 0
M  V30 55 C 25.3405 10.0102 0.0 0
M  V30 56 C 24.0068 12.3203 0.0 0
M  V30 57 C 25.3405 11.5503 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 40 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 41 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 2 13 14
M  V30 15 1 15 16
M  V30 16 1 42 15 CFG=3
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 2 20 21
M  V30 22 1 43 22 CFG=1
M  V30 23 1 22 46
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 1 44 23 CFG=1
M  V30 27 1 24 26
M  V30 28 1 26 27
M  V30 29 2 27 28
M  V30 30 2 29 30
M  V30 31 2 29 31
M  V30 32 1 29 47
M  V30 33 1 32 33
M  V30 34 1 32 51
M  V30 35 1 33 34
M  V30 36 1 34 35
M  V30 37 2 34 36
M  V30 38 1 35 52
M  V30 39 2 37 38
M  V30 40 2 37 39
M  V30 41 1 37 57
M  V30 42 1 40 41
M  V30 43 1 40 42
M  V30 44 1 41 43
M  V30 45 1 42 44
M  V30 46 1 43 45
M  V30 47 1 44 45
M  V30 48 2 46 47
M  V30 49 1 46 48
M  V30 50 1 47 49
M  V30 51 2 48 50
M  V30 52 2 49 51
M  V30 53 1 50 51
M  V30 54 2 52 53
M  V30 55 1 52 54
M  V30 56 1 53 55
M  V30 57 2 54 56
M  V30 58 2 55 57
M  V30 59 1 56 57
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 40 41 42 43 44)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C30H34N2O17
2919192-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 9.2402 0.0 0
M  V30 2 C 6.6685 10.7802 0.0 0
M  V30 3 O 5.3348 11.5503 0.0 0
M  V30 4 O 8.0022 11.5503 0.0 0
M  V30 5 C 5.3348 13.0903 0.0 0
M  V30 6 C 4.0012 13.8603 0.0 0
M  V30 7 C 4.0012 15.4003 0.0 0
M  V30 8 O 9.3360 10.7802 0.0 0
M  V30 9 C 10.6697 11.5503 0.0 0
M  V30 10 O 10.6697 13.0903 0.0 0
M  V30 11 O 12.0033 10.7802 0.0 0
M  V30 12 C 12.0033 13.8603 0.0 0
M  V30 13 C 12.0033 15.4003 0.0 0
M  V30 14 C 13.3370 16.1704 0.0 0
M  V30 15 O 6.6685 6.1601 0.0 0
M  V30 16 C 5.3348 6.9302 0.0 0
M  V30 17 O 4.0012 6.1601 0.0 0
M  V30 18 O 5.3348 8.4702 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 21 C 0.0000 6.9302 0.0 0
M  V30 22 O 12.0033 9.2402 0.0 0
M  V30 23 C 9.3360 4.6201 0.0 0
M  V30 24 O 8.0022 3.8501 0.0 0
M  V30 25 O 10.6697 3.8501 0.0 0
M  V30 26 C 8.0022 2.3101 0.0 0
M  V30 27 C 6.6685 1.5400 0.0 0
M  V30 28 C 6.6685 0.0000 0.0 0
M  V30 29 N 14.6708 10.7802 0.0 0 VAL=5
M  V30 30 O 16.0045 11.5503 0.0 0
M  V30 31 O 13.3370 11.5503 0.0 0
M  V30 32 C 17.3382 6.1601 0.0 0
M  V30 33 O 18.6718 6.9302 0.0 0
M  V30 34 C 20.0057 6.1601 0.0 0
M  V30 35 N 21.3393 6.9302 0.0 0
M  V30 36 O 20.0057 4.6201 0.0 0
M  V30 37 C 22.6730 6.1601 0.0 0
M  V30 38 C 8.0022 8.4702 0.0 0 CFG=1
M  V30 39 C 9.3360 9.2402 0.0 0 CFG=1
M  V30 40 C 8.0022 6.9302 0.0 0 CFG=2
M  V30 41 C 10.6697 8.4702 0.0 0 CFG=2
M  V30 42 C 9.3360 6.1601 0.0 0 CFG=1
M  V30 43 O 10.6697 6.9302 0.0 0
M  V30 44 C 13.3370 8.4702 0.0 0
M  V30 45 C 14.6708 9.2402 0.0 0
M  V30 46 C 13.3370 6.9302 0.0 0
M  V30 47 C 16.0045 8.4702 0.0 0
M  V30 48 C 14.6708 6.1601 0.0 0
M  V30 49 C 16.0045 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 38 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 39 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 2 13 14
M  V30 15 1 15 16
M  V30 16 1 40 15 CFG=1
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 2 20 21
M  V30 22 1 41 22 CFG=3
M  V30 23 1 22 44
M  V30 24 1 23 24
M  V30 25 2 23 25
M  V30 26 1 42 23 CFG=3
M  V30 27 1 24 26
M  V30 28 1 26 27
M  V30 29 2 27 28
M  V30 30 2 29 30
M  V30 31 2 29 31
M  V30 32 1 29 45
M  V30 33 1 32 33
M  V30 34 1 32 49
M  V30 35 1 33 34
M  V30 36 1 34 35
M  V30 37 2 34 36
M  V30 38 1 35 37
M  V30 39 1 38 39
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 1 40 42
M  V30 43 1 41 43
M  V30 44 1 42 43
M  V30 45 2 44 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 2 46 48
M  V30 49 2 47 49
M  V30 50 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 38 39 40 41 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353003-36-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919192-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36236886
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Linkers for use in antibody drug conjugates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fishkin, Nathan; Bai, Chen; Takrouri, Khuloud; Park, Peter U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023037268 A1 2023-03-16

$RFMT $RIREG SCHEME357 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenoxymethyl)-1H-indole-3-carboxylate
C19H18BrNO4
135980-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9417 3.7535 0.0 0
M  V30 2 O 4.9112 2.6091 0.0 0
M  V30 3 O 7.4479 3.4333 0.0 0
M  V30 4 C 5.3871 1.1444 0.0 0
M  V30 5 C 4.3565 0.0000 0.0 0
M  V30 6 C 7.9110 6.4640 0.0 0
M  V30 7 O 8.6810 7.7977 0.0 0
M  V30 8 C 5.9417 9.1744 0.0 0
M  V30 9 O 0.0000 4.9240 0.0 0
M  V30 10 Br 0.0000 8.0040 0.0 0
M  V30 11 C 4.0011 5.6940 0.0 0
M  V30 12 C 5.4658 5.2182 0.0 0
M  V30 13 C 4.0011 7.2340 0.0 0
M  V30 14 C 2.6674 4.9240 0.0 0
M  V30 15 C 6.3710 6.4640 0.0 0
M  V30 16 N 5.4658 7.7099 0.0 0
M  V30 17 C 2.6674 8.0040 0.0 0
M  V30 18 C 1.3338 5.6940 0.0 0
M  V30 19 C 1.3338 7.2340 0.0 0
M  V30 20 C 10.2210 7.7977 0.0 0
M  V30 21 C 10.9910 9.1313 0.0 0
M  V30 22 C 10.9910 6.4640 0.0 0
M  V30 23 C 12.5310 9.1313 0.0 0
M  V30 24 C 12.5310 6.4640 0.0 0
M  V30 25 C 13.3010 7.7977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 20
M  V30 9 1 8 16
M  V30 10 1 9 18
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-1,2,3,7-tetrahydro-2,7-dimethyl-8-(phenoxymethyl)pyrrolo[3,2-f]...
C22H23BrN2O4
958449-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3304 3.5673 0.0 0
M  V30 2 O 6.4749 2.5369 0.0 0
M  V30 3 O 3.8658 3.0915 0.0 0
M  V30 4 C 6.1547 1.0304 0.0 0
M  V30 5 C 7.2991 0.0000 0.0 0
M  V30 6 C 8.3912 4.9301 0.0 0
M  V30 7 O 9.7249 5.7001 0.0 0
M  V30 8 C 8.0410 8.2623 0.0 0
M  V30 9 Br 2.3101 10.2194 0.0 0
M  V30 10 C 0.0000 3.5509 0.0 0
M  V30 11 C 4.6201 6.2182 0.0 0
M  V30 12 C 5.6505 5.0738 0.0 0
M  V30 13 C 3.0801 6.2182 0.0 0
M  V30 14 C 5.3901 7.5519 0.0 0
M  V30 15 C 7.0575 5.7001 0.0 0
M  V30 16 C 2.3101 7.5519 0.0 0
M  V30 17 C 2.3101 4.8845 0.0 0
M  V30 18 N 6.8964 7.2317 0.0 0
M  V30 19 C 4.6201 8.8857 0.0 0
M  V30 20 C 3.0801 8.8857 0.0 0
M  V30 21 O 0.7700 7.5519 0.0 0
M  V30 22 N 0.7700 4.8845 0.0 0
M  V30 23 C 0.0000 6.2182 0.0 0
M  V30 24 C 11.0587 4.9301 0.0 0
M  V30 25 C 11.0587 3.3901 0.0 0
M  V30 26 C 12.3923 5.7001 0.0 0
M  V30 27 C 12.3923 2.6201 0.0 0
M  V30 28 C 13.7260 4.9301 0.0 0
M  V30 29 C 13.7260 3.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 24
M  V30 9 1 8 18
M  V30 10 1 9 20
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 18
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 2 19 20
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 135980-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958449-88-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-1444522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Ethyl
2,7-dimethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylates
(11a-i), general preparation method. The appropriate ethyl
5-hydroxy-1-methyl-1H-indole-3-carboxylate 5 - 8 (0.5 mmol) and MeNH2 (2
mL, 2 M) in THF and formaldehyde as formalin (8 mmol) in THF (10 mL) were
refluxed for 12 h. The course of the reaction was monitored using LC-MS.
When the reaction was finished, the mixture was diluted with ice water
(1.5 L). The precipitate was filtered off, washed with H2O, suspended in
cold (5 - 7°C) isopropanol, and stirred at 5 - 7°C for 1 h. The
precipitate was filtered off, washed with isopropanol, and dried in
vacuo. The resulting product was dissolved in dioxane, treated with HCl
(3 M) in dioxane, and diluted with Et2O. The resulting precipitate was
filtered off and dried in vacuo. Ethyl
6-bromo-2,7-dimethyl-8-phenoxymethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylate
(11a), Yield: 75-95%. LC-MS: found m/z 459, 461 (M + H), calculated 459,
461 (M + 1 for C22H23BrN2O4). Compounds Against BVDV in MDBK Cell
Culture: EC50: >71.1 μM, CC50: 71.1 ± 8.2μM, SI50: <1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Ethyl
1,2-dimethyl-5-Hydroxy-1H-Indole-3-carboxylates and Their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil, V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun, I. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 47(12), 636-650

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitro-4-[(tribromomethyl)sulfonyl]benzene
C7H3Br3ClNO4S
1374125-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 2.3101 0.0 0 VAL=6
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 3.4375 0.9764 0.0 0
M  V30 4 O 1.8975 3.6437 0.0 0
M  V30 5 Br 0.0000 2.3101 0.0 0
M  V30 6 Br 0.0000 0.7700 0.0 0
M  V30 7 Br 1.3337 0.0000 0.0 0
M  V30 8 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 9 O 8.0023 0.7700 0.0 0
M  V30 10 O 9.3360 3.0801 0.0 0
M  V30 11 Cl 8.0023 5.3901 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 5.3901 0.0 0
M  V30 17 C 6.6685 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-4-[(tribromomethyl)sulfonyl]benzenamine
C8H7Br3N2O4S
1374125-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 C 8.4700 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 Br 9.2400 5.3347 0.0 0
M  V30 6 Br 10.0100 4.0009 0.0 0
M  V30 7 Br 9.2400 2.6673 0.0 0
M  V30 8 N 2.3100 1.3336 0.0 0 VAL=5
M  V30 9 O 0.7700 1.3336 0.0 0
M  V30 10 O 3.0800 0.0000 0.0 0
M  V30 11 N 0.7700 4.0009 0.0 0
M  V30 12 C 0.0000 5.3347 0.0 0
M  V30 13 C 5.3900 4.0009 0.0 0
M  V30 14 C 4.6200 2.6673 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 3.0800 2.6673 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 C 2.3100 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1374125-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374125-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12138847
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Derivatives of phenyl tribromomethyl sulfone as novel compounds with
potential pesticidal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Borys, Krzysztof M.; Korzynski, Maciej D.; Ochal, Zbigniew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2012), 8259-265

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Chlorophenyl)sulfonyl]-L-proline ethyl ester
C13H16ClNO4S
1375313-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.3103 2.6218 0.0 0 VAL=6
M  V30 2 O 5.5403 3.9554 0.0 0
M  V30 3 O 7.0803 1.2881 0.0 0
M  V30 4 C 3.2495 3.9845 0.0 0
M  V30 5 O 1.7849 4.4604 0.0 0
M  V30 6 O 4.3940 5.0150 0.0 0
M  V30 7 C 1.4647 5.9667 0.0 0
M  V30 8 C 0.0000 6.4426 0.0 0
M  V30 9 Cl 11.6451 5.7018 0.0 0
M  V30 10 N 4.9766 1.8517 0.0 0
M  V30 11 C 3.5696 2.4781 0.0 0 CFG=2
M  V30 12 C 4.8155 0.3202 0.0 0
M  V30 13 C 2.5392 1.3337 0.0 0
M  V30 14 C 3.3092 0.0000 0.0 0
M  V30 15 C 7.6440 3.3918 0.0 0
M  V30 16 C 8.9778 2.6218 0.0 0
M  V30 17 C 7.6440 4.9318 0.0 0
M  V30 18 C 10.3115 3.3918 0.0 0
M  V30 19 C 8.9778 5.7018 0.0 0
M  V30 20 C 10.3115 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 11 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-1-[(4-Chlorophenyl)sulfonyl]-N-methyl-2-pyrrolidinecarboxamide
C12H15ClN2O3S
1375313-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.8457 2.6218 0.0 0 VAL=6
M  V30 2 O 5.6157 1.2881 0.0 0
M  V30 3 O 4.0757 3.9554 0.0 0
M  V30 4 C 1.7849 3.9845 0.0 0
M  V30 5 N 0.3202 4.4604 0.0 0
M  V30 6 O 2.9293 5.0150 0.0 0
M  V30 7 C 0.0000 5.9667 0.0 0
M  V30 8 Cl 10.1805 5.7018 0.0 0
M  V30 9 N 3.5119 1.8517 0.0 0
M  V30 10 C 2.1051 2.4781 0.0 0 CFG=2
M  V30 11 C 3.3510 0.3202 0.0 0
M  V30 12 C 1.0746 1.3337 0.0 0
M  V30 13 C 1.8447 0.0000 0.0 0
M  V30 14 C 6.1794 3.3918 0.0 0
M  V30 15 C 7.5131 2.6218 0.0 0
M  V30 16 C 6.1794 4.9318 0.0 0
M  V30 17 C 8.8469 3.3918 0.0 0
M  V30 18 C 7.5131 5.7018 0.0 0
M  V30 19 C 8.8469 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 14
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 10 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1375313-82-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1375313-86-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9471069
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N'-(Arylsulfonyl)-N-methylprolinamides 1a-f
(General Method). A mixture of N-arylsulfonyl-proline ethyl ester 8a-f
(30 mmol) and 40% aqueous MeNH2 (30 ml) was stirred at room temperature
for seven days. The precipitate formed was filtered off and dried in the
air. N'-(4-Chlorophenylsulfonyl)-N-methyl-(S)-prolinamide ((S)-1d). Yield
8.7 g (95%). mp 176-177°C (EtOH), [α]D 25 -157.4° (c 4.4, CHCl3). IR
spectrum (KBr), ν, cm-1: 1651 and 1568 (NCO), 1360 and 1160 (SO2). 1H NMR
spectrum (CDCl3), δ, ppm (J, Hz): 1.45-1.75 and 2.10-2.22 (4H, m, 3,
4-CH2); 2.81 (3H, d, 3 J = 4.9, CH3N); 3.09-3.18 and 3.45-3.57 (2H, m,
5-CH2); 3.95-4.08 (1H, m, 2-CH); 6.80 (1H, br. s, NH); 7.48 (2H, d, 3 J =
8.8, H Ar); 7.72 (2H, d, 3 J = 8.8, H Ar). 13C NMR spectrum (CDCl3), δ,
ppm: 19.1 (C-4); 21.4 (CH3N); 24.9 (C-3); 44.7 (C-5); 57.4 (C-2); 127.1
(C-3, 5 Ar); 128.3 (C-2, 6 Ar); 142.1 (C-1 Ar); 154.8 (C-4 Ar); 174.6
(C=O). Found, %: C 47.50; H 4.98; N 9.30. C12H15ClN2O3S. Calculated, %: C
47.60; H 4.99; N 9.25.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pentacoordinated chlorosilanes with C,O-chelate ligands derived from
N-methyl-N'-organosulfonyl-prolinamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nikolin, A. A.; Arkhipov, D. E.; Shipov, A. G.; Kramarova, E. P.;
Koval'chuk, N. A.; Korlyukov, A. A.; Negrebetsky, V. V.; Baukov, Yu. I.;
Bassindale, A. R.; Taylor, P. G.; Bowden, A.; Bylikin, S. Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2012),
47(12), 1565-1583

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Bromophenyl)sulfonyl]-L-proline ethyl ester
C13H16BrNO4S
1375313-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.3103 2.6218 0.0 0 VAL=6
M  V30 2 O 5.5403 3.9554 0.0 0
M  V30 3 O 7.0803 1.2881 0.0 0
M  V30 4 C 3.2495 3.9845 0.0 0
M  V30 5 O 1.7849 4.4604 0.0 0
M  V30 6 O 4.3940 5.0150 0.0 0
M  V30 7 C 1.4647 5.9667 0.0 0
M  V30 8 C 0.0000 6.4426 0.0 0
M  V30 9 Br 11.6451 5.7018 0.0 0
M  V30 10 N 4.9766 1.8517 0.0 0
M  V30 11 C 3.5696 2.4781 0.0 0 CFG=2
M  V30 12 C 4.8155 0.3202 0.0 0
M  V30 13 C 2.5392 1.3337 0.0 0
M  V30 14 C 3.3092 0.0000 0.0 0
M  V30 15 C 7.6440 3.3918 0.0 0
M  V30 16 C 8.9778 2.6218 0.0 0
M  V30 17 C 7.6440 4.9318 0.0 0
M  V30 18 C 10.3115 3.3918 0.0 0
M  V30 19 C 8.9778 5.7018 0.0 0
M  V30 20 C 10.3115 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 1 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 11 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-1-[(4-Bromophenyl)sulfonyl]-N-methyl-2-pyrrolidinecarboxamide
C12H15BrN2O3S
1375313-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.8457 2.6218 0.0 0 VAL=6
M  V30 2 O 5.6157 1.2881 0.0 0
M  V30 3 O 4.0757 3.9554 0.0 0
M  V30 4 C 1.7849 3.9845 0.0 0
M  V30 5 N 0.3202 4.4604 0.0 0
M  V30 6 O 2.9293 5.0150 0.0 0
M  V30 7 C 0.0000 5.9667 0.0 0
M  V30 8 Br 10.1805 5.7018 0.0 0
M  V30 9 N 3.5119 1.8517 0.0 0
M  V30 10 C 2.1051 2.4781 0.0 0 CFG=2
M  V30 11 C 3.3510 0.3202 0.0 0
M  V30 12 C 1.0746 1.3337 0.0 0
M  V30 13 C 1.8447 0.0000 0.0 0
M  V30 14 C 6.1794 3.3918 0.0 0
M  V30 15 C 7.5131 2.6218 0.0 0
M  V30 16 C 6.1794 4.9318 0.0 0
M  V30 17 C 8.8469 3.3918 0.0 0
M  V30 18 C 7.5131 5.7018 0.0 0
M  V30 19 C 8.8469 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 14
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 10 4 CFG=1
M  V30 8 1 5 7
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1375313-83-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1375313-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3360692
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N'-(Arylsulfonyl)-N-methylprolinamides 1a-f
(General Method). A mixture of N-arylsulfonyl-proline ethyl ester 8a-f
(30 mmol) and 40% aqueous MeNH2 (30 ml) was stirred at room temperature
for seven days. The precipitate formed was filtered off and dried in the
air. N'-(4-Bromophenylsulfonyl)-N-methyl-(S)-prolinamide ((S)-1e). Yield
9.9 g (95%). mp 151-153°C (EtOH), [α]D 25 -146.3° (c 4.3, CHCl3). IR
spectrum (KBr), ν, cm-1: 1650 (S) and 1534 (m, NCO), 1600 (m, Ar), 1360
(s) and 1160 (s, SO2). 1H NMR spectrum (CDCl3), δ, ppm (J, Hz): 1.45-1.80
and 2.10-2.25 (4H, m, 3, 4-CH2); 2.81 (3H, d, 3 J = 4.9, CH3N); 3.05-3.21
and 3.45-3.61 (2H, m, 5-CH2); 3.95-4.08 (1H, m, 2-CH); 6.87 (1H, br. s,
NH); 7.69 (4H, m, H Ar). 13C NMR spectrum (CDCl3), δ, ppm: 24.4 (C-4);
26.4 (CH3N); 30.2 (C-3); 50.1 (C-5); 62.8 (C-2); 128.8 (C-4 Ar); 129.3
(C-3, 5 Ar); 132.8 (C-2, 6 Ar); 134.8 (C-1 Ar); 171.4 (C=O). Found, %: C
41.60; H 4.39; N 8.15. C12H15BrN2O3S. Calculated, %: C 41.51; H 4.35; N
8.07.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pentacoordinated chlorosilanes with C,O-chelate ligands derived from
N-methyl-N'-organosulfonyl-prolinamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nikolin, A. A.; Arkhipov, D. E.; Shipov, A. G.; Kramarova, E. P.;
Koval'chuk, N. A.; Korlyukov, A. A.; Negrebetsky, V. V.; Baukov, Yu. I.;
Bassindale, A. R.; Taylor, P. G.; Bowden, A.; Bylikin, S. Yu.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2012),
47(12), 1565-1583

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
6-[[(4-Bromo-3-fluorophenyl)methyl](methylsulfonyl)amino]-2-(4-chlorophenyl)-...
C25H20BrClFN3O4S
1378868-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 5.3950 0.0 0
M  V30 2 C 5.3347 4.6250 0.0 0
M  V30 3 S 6.6684 6.9350 0.0 0 VAL=6
M  V30 4 C 6.6684 8.4750 0.0 0
M  V30 5 O 5.1284 6.9350 0.0 0
M  V30 6 O 8.2084 6.9350 0.0 0
M  V30 7 C 12.6100 1.1444 0.0 0
M  V30 8 O 14.1163 0.8242 0.0 0
M  V30 9 O 11.5795 0.0000 0.0 0
M  V30 10 F 0.0000 4.6250 0.0 0
M  V30 11 Br 0.0000 7.7050 0.0 0
M  V30 12 Cl 19.1993 3.8549 0.0 0
M  V30 13 C 8.0020 4.6250 0.0 0
M  V30 14 C 8.0020 3.0849 0.0 0
M  V30 15 C 9.3358 5.3950 0.0 0
M  V30 16 C 9.3358 2.3149 0.0 0
M  V30 17 N 10.6695 4.6250 0.0 0
M  V30 18 C 10.6695 3.0849 0.0 0
M  V30 19 N 12.1340 5.1008 0.0 0
M  V30 20 C 12.1340 2.6091 0.0 0
M  V30 21 C 13.0392 3.8549 0.0 0
M  V30 22 C 6.6684 2.3149 0.0 0
M  V30 23 C 5.1284 2.3149 0.0 0
M  V30 24 C 5.8984 0.9813 0.0 0
M  V30 25 C 4.0011 5.3950 0.0 0
M  V30 26 C 2.6673 4.6250 0.0 0
M  V30 27 C 4.0011 6.9350 0.0 0
M  V30 28 C 1.3336 5.3950 0.0 0
M  V30 29 C 2.6673 7.7050 0.0 0
M  V30 30 C 1.3336 6.9350 0.0 0
M  V30 31 C 14.5793 3.8549 0.0 0
M  V30 32 C 15.3493 5.1886 0.0 0
M  V30 33 C 15.3493 2.5213 0.0 0
M  V30 34 C 16.8893 5.1886 0.0 0
M  V30 35 C 16.8893 2.5213 0.0 0
M  V30 36 C 17.6593 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 25
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 3 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 20
M  V30 11 1 10 28
M  V30 12 1 11 30
M  V30 13 1 12 36
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 14 22
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 21 31
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[[(4-Bromo-3-fluorophenyl)methyl](methylsulfonyl)amino]-2-(4-chlorophenyl)-...
C26H23BrClFN4O3S
1378868-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.6100 2.6091 0.0 0
M  V30 2 N 11.5794 1.4645 0.0 0
M  V30 3 O 14.1163 2.2889 0.0 0
M  V30 4 C 12.0553 0.0000 0.0 0
M  V30 5 N 6.6684 6.8595 0.0 0
M  V30 6 C 5.3347 6.0895 0.0 0
M  V30 7 S 6.6684 8.3995 0.0 0 VAL=6
M  V30 8 C 6.6684 9.9395 0.0 0
M  V30 9 O 8.2084 8.3995 0.0 0
M  V30 10 O 5.1284 8.3995 0.0 0
M  V30 11 Cl 19.1992 5.3195 0.0 0
M  V30 12 F 0.0000 6.0895 0.0 0
M  V30 13 Br 0.0000 9.1695 0.0 0
M  V30 14 C 10.6694 4.5495 0.0 0
M  V30 15 N 10.6694 6.0895 0.0 0
M  V30 16 C 12.1340 4.0736 0.0 0
M  V30 17 C 9.3358 3.7795 0.0 0
M  V30 18 C 9.3358 6.8595 0.0 0
M  V30 19 N 12.1340 6.5655 0.0 0
M  V30 20 C 13.0392 5.3195 0.0 0
M  V30 21 C 8.0020 4.5495 0.0 0
M  V30 22 C 8.0020 6.0895 0.0 0
M  V30 23 C 14.5792 5.3195 0.0 0
M  V30 24 C 15.3492 3.9858 0.0 0
M  V30 25 C 15.3492 6.6533 0.0 0
M  V30 26 C 16.8892 3.9858 0.0 0
M  V30 27 C 16.8892 6.6533 0.0 0
M  V30 28 C 17.6592 5.3195 0.0 0
M  V30 29 C 6.6684 3.7795 0.0 0
M  V30 30 C 5.1284 3.7795 0.0 0
M  V30 31 C 5.8984 2.4458 0.0 0
M  V30 32 C 4.0011 6.8595 0.0 0
M  V30 33 C 2.6673 6.0895 0.0 0
M  V30 34 C 4.0011 8.3995 0.0 0
M  V30 35 C 1.3336 6.8595 0.0 0
M  V30 36 C 2.6673 9.1695 0.0 0
M  V30 37 C 1.3336 8.3995 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 22
M  V30 8 1 6 32
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 28
M  V30 13 1 12 35
M  V30 14 1 13 37
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 2 19 20
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 1 21 29
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1378868-90-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1378868-91-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6940993
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5:
6-(N-(4-bromo-3-fluorobenzyl)methylsulfonamido)-2-(4-chlorophenyl)-5-cyclopropyl-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide
To a solution of
6-(N-(4-bromo-3-fluorobenzyl)methylsulfonamido)-2-(4-chlorophenyl)-5-cyclopropylpyrazolo[1,5-a]pyridine-3-carboxylic
acid (0.4 g, 0.6745 mmol) and TEA (0.15 g, 1.484 mmol) in dry DMF (8 mL)
was added HATU (0.309 g, 0.8094 mmol) at 21°C under nitrogen atmosphere.
After the mixture was stirred for 15 min, MeNH2 in THF (1.35 mL, 2.7
mmol) was added and the mixture was stirred at rt for 1 h. The reaction
was quenched with water (30 mL) and filtered. The crude solid was
dissolved in EtOAc (100 mL) and dried over anhydrous Na2SO4. After the
removal of solvent, the residue was purified by column chromatography to
afford
6-(N-(4-bromo-3-fluorobenzyl)methylsulfonamido)-2-(4-chlorophenyl)-5-cyclopropyl-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide.
Yield 0.39 g, 95%, brown solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (Pyrazolopyridinyl)aminomethylboronic acid derivatives and their
preparation and use for the treatment of viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johns, Brian Alvin; Shotwell, John Brad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012067664 A1 2012-05-24

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3,5-dinitro-4-pyridinamine
C5H3ClN4O4
1378875-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 3.0800 0.0 0 VAL=5
M  V30 2 O 1.3336 4.6200 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 N 4.0011 4.6200 0.0 0
M  V30 5 Cl 1.3336 0.0000 0.0 0
M  V30 6 N 6.6685 3.0800 0.0 0 VAL=5
M  V30 7 O 6.6685 4.6200 0.0 0
M  V30 8 O 8.0021 2.3100 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 N 4.0011 0.0000 0.0 0
M  V30 14 C 5.3347 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-Methyl-3,5-dinitro-2,4-pyridinediamine
C6H7N5O4
1493770-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 2.6675 6.9302 0.0 0
M  V30 3 O 5.3348 6.9302 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 N 6.6687 4.6201 0.0 0
M  V30 6 C 8.0023 3.8501 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 N 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1378875-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1493770-73-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-607694
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM safety
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of New Substituted 4-Amino-3,5-dinitropyridine Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Congming; Wang, Yongbin; Hou, Kehui; Liu, Zuliang; Yao, Qizheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2013), 31(10), 1299-1304

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-(Dinitromethyl)-2-oxidodiazenyl]-4-nitro-1,2,5-oxadiazole
C3HN7O8
1379606-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.4646 3.9845 0.0 0 VAL=5
M  V30 2 O 0.0000 4.4604 0.0 0
M  V30 3 O 2.6091 5.0149 0.0 0
M  V30 4 N 4.5253 2.6217 0.0 0
M  V30 5 N 5.8590 1.8517 0.0 0 VAL=5
M  V30 6 C 7.1928 2.6217 0.0 0
M  V30 7 O 5.8590 0.3117 0.0 0
M  V30 8 N 7.1928 4.1617 0.0 0 VAL=5
M  V30 9 N 8.5265 1.8517 0.0 0 VAL=5
M  V30 10 O 8.5265 4.9318 0.0 0
M  V30 11 O 5.8590 4.9318 0.0 0
M  V30 12 O 9.8601 2.6217 0.0 0
M  V30 13 O 8.5265 0.3117 0.0 0
M  V30 14 C 1.7847 2.4780 0.0 0
M  V30 15 C 3.1917 1.8517 0.0 0
M  V30 16 N 0.7543 1.3337 0.0 0
M  V30 17 N 3.0308 0.3202 0.0 0
M  V30 18 O 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 2 9 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-(Dinitromethyl)-2-oxidodiazenyl]-N-methyl-1,2,5-oxadiazol-3-amine
C4H5N7O6
1415932-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.5254 2.3101 0.0 0
M  V30 2 N 5.8591 3.0801 0.0 0 VAL=5
M  V30 3 C 7.1929 2.3101 0.0 0
M  V30 4 O 5.8591 4.6201 0.0 0
M  V30 5 N 7.1929 0.7700 0.0 0 VAL=5
M  V30 6 N 8.5266 3.0801 0.0 0 VAL=5
M  V30 7 O 5.8591 0.0000 0.0 0
M  V30 8 O 8.5266 0.0000 0.0 0
M  V30 9 O 9.8602 2.3101 0.0 0
M  V30 10 O 8.5266 4.6201 0.0 0
M  V30 11 N 1.4646 0.9473 0.0 0
M  V30 12 C 0.0000 0.4714 0.0 0
M  V30 13 C 3.1917 3.0801 0.0 0
M  V30 14 C 1.7847 2.4536 0.0 0
M  V30 15 N 3.0308 4.6116 0.0 0
M  V30 16 N 0.7543 3.5981 0.0 0
M  V30 17 O 1.5243 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 2 6 10
M  V30 11 1 11 12
M  V30 12 1 11 14
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1379606-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1415932-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-196-CAS-3242462
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a 0 °C solution of MeNH2 (0.143 g, 4.61 mmol) in water (7.0 mL), a
solution of 11 (0.100 g, 0.380 mmol) in CH2Cl2 (4.0 mL) was added with
vigorous stirring. The emulsion was stirred at 20 °C for 20 min, diluted
with water (10 mL), washed with CH2Cl2 (3×5 mL), 33% HCl (0.45 mL, 4.74
mmol) was added to the aqueous layer, the product was extracted with
CH2Cl2 (4×10 mL), the organic phase was dired with MgSO4. Removal of the
solvent in vacuo afforded compound 14. compound 14 (0.089 g, 95%), orange
oil 1H NMR (CDCl3), δ: 3.56 (s, 3 H, Me); 4.41 (s, 1 H, NH); 7.71 (s, 1
H, CH).
$DTYPE RXN:VAR(1):NOTES
$DATUM further converted to potassium salt with 78% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Amino-4-(α-nitroalkyl-ONN-azoxy)furazans and some of their derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luk'yanov, O. A.; Parakhin, V. V.; Pokhvisneva, G. V.; Ternikova, T. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2012), 61(2), 355-359

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoethoxy)-3-nitrobenzene
C8H8BrNO3
13831-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 Br 10.6697 2.3101 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(3-nitrophenoxy)ethanamine
C9H12N2O3
68157-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13831-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68157-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2056787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McDonnell, Mark E.; Bian, Haiyan; Wrobel, Jay; Smith, Garry R.; Liang,
Shuguang; Ma, Haiching; Reitz, Allen B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(4), 1116-1121

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E,7E)-3,7-Decadiene-2,9-dione
C10H14O2
138879-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 8.0022 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 O 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 8 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1′-[(2R,5S)-1-Methyl-2,5-pyrrolidinediyl]bis[2-propanone]
C11H19NO2
1395875-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.3627 0.0 0
M  V30 2 C 1.3336 2.1328 0.0 0
M  V30 3 C 0.0000 1.3627 0.0 0
M  V30 4 O 1.3336 3.6728 0.0 0
M  V30 5 C 5.7280 0.0000 0.0 0
M  V30 6 C 7.9700 2.4899 0.0 0
M  V30 7 C 8.8752 3.7357 0.0 0
M  V30 8 C 8.2487 5.1427 0.0 0
M  V30 9 O 10.4067 3.5748 0.0 0
M  V30 10 C 4.0011 2.1328 0.0 0 CFG=2
M  V30 11 N 5.4079 1.5064 0.0 0
M  V30 12 C 4.1620 3.6643 0.0 0
M  V30 13 C 6.4384 2.6508 0.0 0 CFG=1
M  V30 14 C 5.6684 3.9846 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 13 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 138879-01-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1395875-47-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4387958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, stereoselective, ultrasound, key step, aza-Michael
addition, scalable, de >95%, solution-phase synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free double aza-Michael under ultrasound irradiation:
diastereoselective sequential one-pot synthesis of pyrrolidine Lobelia
alkaloids analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amara, Zacharias; Drege, Emmanuelle; Troufflard, Claire; Retailleau,
Pascal; Joseph, Delphine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2012), 10(35), 7148-7157

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
3-(1,1-Dimethyl-2-propen-1-yl)-2,3-dihydro-5-methoxy-1-methyl-2-oxo-1H-indole...
C17H21NO4
1396316-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.2896 0.0 0
M  V30 2 C 1.3337 4.0597 0.0 0
M  V30 3 C 1.3337 2.5196 0.0 0
M  V30 4 C 2.6673 1.7496 0.0 0
M  V30 5 C 0.0000 3.2896 0.0 0
M  V30 6 C 4.6275 2.6528 0.0 0
M  V30 7 C 3.7222 1.4068 0.0 0
M  V30 8 O 2.1907 1.5679 0.0 0
M  V30 9 O 4.3486 0.0000 0.0 0
M  V30 10 O 1.5559 5.3055 0.0 0
M  V30 11 C 3.5251 8.0161 0.0 0
M  V30 12 O 9.4668 3.7655 0.0 0
M  V30 13 C 10.8005 4.5355 0.0 0
M  V30 14 C 4.0011 4.0597 0.0 0
M  V30 15 C 5.4657 4.5355 0.0 0
M  V30 16 C 3.0959 5.3055 0.0 0
M  V30 17 C 5.4657 6.0755 0.0 0
M  V30 18 C 6.7994 3.7655 0.0 0
M  V30 19 N 4.0011 6.5514 0.0 0
M  V30 20 C 6.7994 6.8456 0.0 0
M  V30 21 C 8.1332 4.5355 0.0 0
M  V30 22 C 8.1332 6.0755 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 14
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 16
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 21
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1-Dimethyl-2-propen-1-yl)-2,3-dihydro-5-methoxy-N,1-dimethyl-2-oxo-1H-in...
C18H24N2O3
1396316-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6275 3.8987 0.0 0
M  V30 2 C 3.7223 2.6529 0.0 0
M  V30 3 N 4.3486 1.2459 0.0 0
M  V30 4 O 2.1907 2.8138 0.0 0
M  V30 5 C 3.4435 0.0000 0.0 0
M  V30 6 C 2.6673 4.5356 0.0 0
M  V30 7 C 1.3337 5.3056 0.0 0
M  V30 8 C 1.3337 3.7655 0.0 0
M  V30 9 C 2.6673 2.9955 0.0 0
M  V30 10 C 0.0000 4.5356 0.0 0
M  V30 11 O 1.5559 6.5515 0.0 0
M  V30 12 C 3.5251 9.2621 0.0 0
M  V30 13 O 9.4669 5.0114 0.0 0
M  V30 14 C 10.8006 5.7814 0.0 0
M  V30 15 C 4.0012 5.3056 0.0 0
M  V30 16 C 5.4657 5.7814 0.0 0
M  V30 17 C 3.0959 6.5515 0.0 0
M  V30 18 C 5.4657 7.3215 0.0 0
M  V30 19 C 6.7994 5.0114 0.0 0
M  V30 20 N 4.0012 7.7975 0.0 0
M  V30 21 C 6.7994 8.0915 0.0 0
M  V30 22 C 8.1332 5.7814 0.0 0
M  V30 23 C 8.1332 7.3215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 7 10
M  V30 11 2 11 17
M  V30 12 1 12 20
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1396316-70-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1396316-71-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9148149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 771-61-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 42% overall yield over six steps from author
1-acetyl-5-methoxyindolin-3-one
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of phenserine analogues and evaluation of their cholinesterase
inhibitory activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shinada, Masashi; Narumi, Fuminori; Osada, Yuji; Matsumoto, Koji;
Yoshida, Takayasu; Higuchi, Kazuhiro; Kawasaki, Tomomi; Tanaka, Hiroyuki;
Satoh, Mitsutoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2012), 20(16), 4901-4914

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2-(Acetylamino)phenyl]sulfonyl]-L-valine methyl ester
C14H20N2O5S
1401065-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 2.3101 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 S 5.3348 3.8501 0.0 0 VAL=6
M  V30 6 N 6.6685 3.0801 0.0 0
M  V30 7 O 6.1048 5.1838 0.0 0
M  V30 8 O 4.5648 2.5164 0.0 0
M  V30 9 C 8.0023 3.8501 0.0 0 CFG=1
M  V30 10 C 9.3360 3.0801 0.0 0
M  V30 11 C 8.0023 5.3901 0.0 0
M  V30 12 O 9.3360 1.5400 0.0 0
M  V30 13 O 10.6697 3.8501 0.0 0
M  V30 14 C 6.6685 6.1601 0.0 0
M  V30 15 C 9.3360 6.1601 0.0 0
M  V30 16 C 10.6697 0.7700 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 4.0012 4.6201 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 4.0012 6.1601 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 2.6673 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 18
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-2-[[[2-(Acetylamino)phenyl]sulfonyl]amino]-N,3-dimethylbutanamide
C14H21N3O4S
1401065-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 2.3101 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 S 5.3348 3.8501 0.0 0 VAL=6
M  V30 6 N 6.6685 3.0801 0.0 0
M  V30 7 O 6.1048 5.1838 0.0 0
M  V30 8 O 4.5648 2.5164 0.0 0
M  V30 9 C 8.0023 3.8501 0.0 0 CFG=1
M  V30 10 C 9.3360 3.0801 0.0 0
M  V30 11 C 8.0023 5.3901 0.0 0
M  V30 12 N 9.3360 1.5400 0.0 0
M  V30 13 O 10.6697 3.8501 0.0 0
M  V30 14 C 6.6685 6.1601 0.0 0
M  V30 15 C 9.3360 6.1601 0.0 0
M  V30 16 C 10.6697 0.7700 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 4.0012 4.6201 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 4.0012 6.1601 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 2.6673 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 18
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401065-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401065-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1992549
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereo-retention
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An unusual conformational similarity of two peptide folds featuring
sulfonamide and carboxamide on the backbone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vijayadas, Kuruppanthara N.; Davis, Hilda C.; Kotmale, Amol S.; Gawade,
Rupesh L.; Puranik, Vedavadi G.; Rajamohanan, Pattuparambil R.; Sanjayan,
Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2012), 48(78),
9747-9749

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[C(Z)]-N′-[(2-Chloroacetyl)oxy]-4-methylbenzenecarboximidamide
C10H11ClN2O2
1401223-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 N 5.3348 0.0000 0.0 0
M  V30 4 O 8.0022 1.5400 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 O 9.3360 3.8501 0.0 0
M  V30 8 Cl 12.0033 2.3101 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(4-methylphenyl)-1,2,4-oxadiazole-5-methanamine
C11H13N3O
890324-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7757 3.0089 0.0 0
M  V30 2 N 11.1826 2.3824 0.0 0
M  V30 3 C 12.4285 3.2876 0.0 0
M  V30 4 C 0.0000 1.3336 0.0 0
M  V30 5 C 6.1600 1.3336 0.0 0
M  V30 6 N 7.0652 2.5795 0.0 0
M  V30 7 N 7.0652 0.0878 0.0 0
M  V30 8 C 8.5298 2.1037 0.0 0
M  V30 9 O 8.5298 0.5636 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401223-67-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890324-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8143427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: SO1-142 (10a).
Isopropyl-(3-p-tolyl-[1,2,4]oxadiazol-5-ylmethyl)-amine (SO1-142) (10a):
To a solution of 5-chloromethyl-3-p-tolyl-[1,2,4]oxadiazole (9a) (300 mg,
1.44 mmol) in 20 mL acetonitrile was added diisopropyl amine (0.17 g,
2.88 mmol) and potassium carbonate (994 mg, 7.2 mmol) and the mixture was
refluxed for 30min. Acetonitrile was evaporated and the residue was
dissolved in ethyl acetate and washed with water. Organic solvent was
dried (MgSO4) and evaporated. SO1-183 (10k).
Methyl-(3-p-tolyl-[1,2,4]oxadiazol-5-ylmethyl)-amine (SO1-183) (10k):
This compound was synthesized using the same protocol for SO1-142 10a
except using 5-chloromethyl-3-p-tolyl-[1,2,4]oxadiazole (8a) (85 mg, 0.41
mmol) and methyl amine (1ml from 40% solution in water) and potassium
carbonate (282 mg, 2.04 mmol). The compound SO1-183 10k was obtained as a
yellow viscous liquid (90 mg, 95%). 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J
= 8.2 Hz, 2H), 7.29 (d, J = 7.9 Hz, 2H), 4.07 (s, 2H), 2.55 (s, 3H), 2.41
(s, 3H). LC-MS (ESI+) m/z 204.12 (M+H)+; HRMS (ESI+ve) m/z calculated for
C11H14N3O (M+H)+ 204.1131, found 204.1141. Chemical Formula: C11H13N3O,
Exact Mass: 203.1059, Molecular Weight: 203.2404.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(oxadiazolylmethyl) phenoxy acetamide derivatives as
proteasome inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lawrence, Harshani R.; Sebti, Said M.; Ozcan, Sevil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012129564 A2 2012-09-27

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[4-(4-chlorophenyl)-3-cyano-7-methoxy-4H-1-benzopyran-2-yl]methanimidate
C20H17ClN2O3
1403826-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 9.2401 0.0 0
M  V30 2 N 6.6684 10.7801 0.0 0
M  V30 3 N 9.3357 7.7001 0.0 0
M  V30 4 C 10.6695 6.9301 0.0 0
M  V30 5 O 12.0032 7.7001 0.0 0
M  V30 6 C 13.3369 6.9301 0.0 0
M  V30 7 C 14.6705 7.7001 0.0 0
M  V30 8 O 5.3348 0.7700 0.0 0
M  V30 9 C 4.0010 0.0000 0.0 0
M  V30 10 Cl 0.0000 10.0101 0.0 0
M  V30 11 C 5.3348 6.9301 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 6.6684 7.7001 0.0 0
M  V30 14 C 6.6684 4.6201 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 8.0021 6.9301 0.0 0
M  V30 17 O 8.0021 5.3901 0.0 0
M  V30 18 C 6.6684 3.0800 0.0 0
M  V30 19 C 4.0010 3.0800 0.0 0
M  V30 20 C 5.3348 2.3100 0.0 0
M  V30 21 C 4.0010 7.7001 0.0 0
M  V30 22 C 2.6673 6.9301 0.0 0
M  V30 23 C 4.0010 9.2401 0.0 0
M  V30 24 C 1.3337 7.7001 0.0 0
M  V30 25 C 2.6673 10.0101 0.0 0
M  V30 26 C 1.3337 9.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 13
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 26
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 21
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)-3,5-dihydro-8-methoxy-3-methyl-4H-[1]benzopyrano[2,3-d]pyr...
C19H16ClN3O2
1422739-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 4.6201 0.0 0
M  V30 2 C 0.0000 6.1601 0.0 0
M  V30 3 O 10.6697 9.2402 0.0 0
M  V30 4 C 12.0033 8.4702 0.0 0
M  V30 5 Cl 5.3348 0.0000 0.0 0
M  V30 6 C 5.3348 6.1601 0.0 0
M  V30 7 C 4.0012 6.9302 0.0 0
M  V30 8 C 6.6685 6.9302 0.0 0
M  V30 9 C 4.0012 8.4702 0.0 0
M  V30 10 C 2.6673 6.1601 0.0 0
M  V30 11 C 6.6685 8.4702 0.0 0
M  V30 12 C 8.0022 6.1601 0.0 0
M  V30 13 O 5.3348 9.2402 0.0 0
M  V30 14 N 2.6673 9.2402 0.0 0
M  V30 15 N 1.3337 6.9302 0.0 0
M  V30 16 C 8.0022 9.2402 0.0 0
M  V30 17 C 9.3360 6.9302 0.0 0
M  V30 18 C 1.3337 8.4702 0.0 0
M  V30 19 C 9.3360 8.4702 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 6.6685 3.8501 0.0 0
M  V30 22 C 4.0012 3.8501 0.0 0
M  V30 23 C 6.6685 2.3101 0.0 0
M  V30 24 C 4.0012 2.3101 0.0 0
M  V30 25 C 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 20
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 13
M  V30 17 2 11 16
M  V30 18 1 12 17
M  V30 19 2 14 18
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 17 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1403826-32-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1422739-83-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-18152932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel chromene derivatives of expected antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kandeel, Manal M.; Kamal, Aliaa M.; Abdelall, Eman K. A.; Elshemy, Heba
A. H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 59183-193

$RFMT $RIREG SCHEME370 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Formylphenoxy)acetic acid
C9H8O4
6280-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 2.6674 0.0 0
M  V30 2 C 6.1600 2.6674 0.0 0
M  V30 3 C 6.9300 1.3338 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 O 8.4700 1.3338 0.0 0
M  V30 6 C 1.5400 2.6674 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 1.5400 5.3347 0.0 0
M  V30 12 C 3.8500 6.6685 0.0 0
M  V30 13 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxybenzo[f]quinoxaline-2,3-dicarbonitrile
C14H6N4O
1407160-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 1.3336 0.0 0
M  V30 2 N 8.4700 0.0000 0.0 0
M  V30 3 O 2.3100 8.0021 0.0 0
M  V30 4 C 9.2400 4.0011 0.0 0
M  V30 5 N 10.7800 4.0011 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 5.3900 5.3347 0.0 0
M  V30 9 N 5.3900 2.6674 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 N 6.9300 5.3347 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 3.0800 6.6685 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 7.7000 4.0011 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 14
M  V30 3 1 3 15
M  V30 4 3 4 5
M  V30 5 1 4 18
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 2 10 15
M  V30 15 1 10 16
M  V30 16 2 11 17
M  V30 17 2 12 18
M  V30 18 1 13 15
M  V30 19 1 14 18
M  V30 20 2 16 19
M  V30 21 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Hydroxy-5-(2,3,4,5-tetrahydro-4-methyl-3-oxo-1,4-benzoxazepin-5-yl)benzo[f]...
C24H15N5O3
1643336-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.9984 4.0011 0.0 0
M  V30 2 C 6.9288 7.7114 0.0 0
M  V30 3 C 9.9284 8.0021 0.0 0
M  V30 4 N 10.6984 9.3358 0.0 0
M  V30 5 O 6.0808 10.4600 0.0 0
M  V30 6 C 11.4684 5.3347 0.0 0
M  V30 7 N 13.0084 5.3347 0.0 0
M  V30 8 C 5.3084 5.3347 0.0 0
M  V30 9 C 6.8484 5.3347 0.0 0
M  V30 10 C 4.5384 4.0011 0.0 0
M  V30 11 C 7.6184 4.0011 0.0 0
M  V30 12 N 7.6184 6.6685 0.0 0
M  V30 13 C 5.3084 2.6674 0.0 0
M  V30 14 C 6.8484 2.6674 0.0 0
M  V30 15 N 9.1584 4.0011 0.0 0
M  V30 16 C 9.1584 6.6685 0.0 0
M  V30 17 C 4.5384 1.3338 0.0 0
M  V30 18 C 7.6184 1.3338 0.0 0
M  V30 19 C 9.9284 5.3347 0.0 0
M  V30 20 C 5.3084 0.0000 0.0 0
M  V30 21 C 6.8484 0.0000 0.0 0
M  V30 22 C 4.5384 6.6685 0.0 0
M  V30 23 C 3.0027 6.5533 0.0 0
M  V30 24 N 5.4060 7.9409 0.0 0
M  V30 25 C 1.9553 7.6823 0.0 0
M  V30 26 C 2.5489 5.0818 0.0 0
M  V30 27 C 4.9520 9.4125 0.0 0
M  V30 28 O 2.1848 9.2050 0.0 0
M  V30 29 C 0.4538 7.3396 0.0 0
M  V30 30 C 1.0474 4.7390 0.0 0
M  V30 31 C 3.5184 9.9750 0.0 0
M  V30 32 C 0.0000 5.8680 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 24
M  V30 3 3 3 4
M  V30 4 1 3 16
M  V30 5 2 5 27
M  V30 6 3 6 7
M  V30 7 1 6 19
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 22
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 14
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 2 18 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 27
M  V30 30 1 25 28
M  V30 31 2 25 29
M  V30 32 1 26 30
M  V30 33 1 27 31
M  V30 34 1 28 31
M  V30 35 1 29 32
M  V30 36 2 30 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6280-80-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1407160-45-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1643336-56-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-3795546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of oxazepin-quinoxaline bis-heterocyclic scaffolds via an
efficient three component synthetic protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hajishaabanha, Fatemeh; Shaabani, Ahmad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(87), 46844-46850

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,6′-[1,2-Ethanediylbis(methylimino)]bis[2-pyridinecarboxaldehyde]
C16H18N4O2
1407535-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 2.3101 0.0 0
M  V30 2 C 8.0023 3.0801 0.0 0
M  V30 3 C 6.6687 0.7700 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 N 10.6697 3.0801 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 O 0.0000 3.0801 0.0 0
M  V30 9 C 16.0045 3.0801 0.0 0
M  V30 10 O 17.3383 2.3101 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 N 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 12.0035 2.3101 0.0 0
M  V30 18 N 13.3372 3.0801 0.0 0
M  V30 19 C 12.0035 0.7700 0.0 0
M  V30 20 C 14.6708 2.3101 0.0 0
M  V30 21 C 13.3372 0.0000 0.0 0
M  V30 22 C 14.6708 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 2 7 8
M  V30 9 1 7 14
M  V30 10 2 9 10
M  V30 11 1 9 20
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1,N2-Dimethyl-N1,N2-bis[6-[(E)-(methylimino)methyl]-2-pyridinyl]-1,2-ethaned...
C18H24N6
1407535-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 8.0023 4.6201 0.0 0
M  V30 4 C 10.6697 3.0801 0.0 0
M  V30 5 N 12.0033 2.3101 0.0 0
M  V30 6 C 12.0033 0.7700 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 N 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 17.3382 2.3101 0.0 0
M  V30 11 N 18.6720 3.0801 0.0 0
M  V30 12 C 20.0057 2.3101 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 N 5.3348 3.0801 0.0 0
M  V30 15 C 6.6685 0.7700 0.0 0
M  V30 16 C 4.0012 2.3101 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 4.0012 0.7700 0.0 0
M  V30 19 C 13.3372 3.0801 0.0 0
M  V30 20 N 14.6708 2.3101 0.0 0
M  V30 21 C 13.3372 4.6201 0.0 0
M  V30 22 C 16.0045 3.0801 0.0 0
M  V30 23 C 14.6708 5.3901 0.0 0
M  V30 24 C 16.0045 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 19
M  V30 8 2 7 8
M  V30 9 1 7 16
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 22
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1407535-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1407535-73-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6154101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of
N1,N2-dimethyl-N1,N2-bis(6-((E)-(methylimino)methyl)pyridin-2-yl)ethane-
1,2-diamine (4) To a solution of 2 (388 mg, 1.30 mmol, 1.00 equiv.) in
THF (30 mL) was added methylamine (8M in EtOH, 650 SL, 5.20 mmol, 4.0
equiv.) and molecular sieves (4 Å ). The mixture was stirred for 90 min
at room temperature before filtration and removal of the solvent under
reduced pressure. The product was obtained. Yellow crystalline solid.
Yield 400 mg, 1.23 mmol, 95%. 1H NMR (300 MHz, CDCl3): δ = 8.18 (d, J =
1.5 Hz, 1H, CHNMe), 7.50 - 7.41 (m, 1H, CHar), 7.18 (d, J = 7.3 Hz, 1H,
CHar), 6.53 (d, J = 8.4 Hz, 1H, CHar), 3.81 (s, 2H, NCH2), 3.54 (d, J =
1.6 Hz, 3H, CHNCH3), 3.06 (s, 3H, NCH3). 13C NMR (101 MHz, CDCl3): δ =
164.8 (CHNMe), 158.2 (Cq), 152.6 (Cq), 137.6 (CHar), 108.6 (CHar), 106.6
(CHar), 48.2 (NCH2), 47.4 (NCH3), 36.9 (NCH3). ESIMS: m/z: calc.:
325.2135 [(C18H25N6)+], found: 325.2135 [(M+H)+]; calc.: 163.1104
[(C18H26N6)2+], found: 163.1134 [(M+2H)2+]. ATR-FTIR (cm-1): ν = 2940,
2869, 2777, 2359, 1650, 1590, 1561, 1493, 1428, 1381, 1269, 1234, 1205,
1160, 1117, 996, 971, 951, 892, 793, 738, 647. -
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Iron(II) Complex of a Diamine-Bridged Bis-N-Heterocyclic Carbene
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grohmann, Christoph; Hashimoto, Takayoshi; Froehlich, Roland; Ohki,
Yasuhiro; Tatsumi, Kazuyuki; Glorius, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organometallics (2012), 31(23), 8047-8050

$RFMT $RIREG SCHEME372 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-5-hydroxy-1-methyl-2-[(2-pyridinylthio)methyl]-1H-indole-3-carb...
C18H17BrN2O3S
141599-36-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9417 3.7535 0.0 0
M  V30 2 O 4.9112 2.6091 0.0 0
M  V30 3 O 7.4479 3.4333 0.0 0
M  V30 4 C 5.3871 1.1444 0.0 0
M  V30 5 C 4.3565 0.0000 0.0 0
M  V30 6 C 7.9110 6.4640 0.0 0
M  V30 7 S 8.6810 7.7977 0.0 0
M  V30 8 C 5.9417 9.1744 0.0 0
M  V30 9 O 0.0000 4.9240 0.0 0
M  V30 10 Br 0.0000 8.0040 0.0 0
M  V30 11 C 4.0011 5.6940 0.0 0
M  V30 12 C 5.4658 5.2182 0.0 0
M  V30 13 C 4.0011 7.2340 0.0 0
M  V30 14 C 2.6674 4.9240 0.0 0
M  V30 15 C 6.3710 6.4640 0.0 0
M  V30 16 N 5.4658 7.7099 0.0 0
M  V30 17 C 2.6674 8.0040 0.0 0
M  V30 18 C 1.3338 5.6940 0.0 0
M  V30 19 C 1.3338 7.2340 0.0 0
M  V30 20 C 10.2210 7.7977 0.0 0
M  V30 21 C 10.9910 9.1313 0.0 0
M  V30 22 N 10.9910 6.4640 0.0 0
M  V30 23 C 12.5310 9.1313 0.0 0
M  V30 24 C 12.5310 6.4640 0.0 0
M  V30 25 C 13.3010 7.7977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 20
M  V30 9 1 8 16
M  V30 10 1 9 18
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-1,2,3,7-tetrahydro-2,7-dimethyl-8-[(2-pyridinylthio)methyl]pyrr...
C21H22BrN3O3S
1606174-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3304 3.5673 0.0 0
M  V30 2 O 6.4749 2.5369 0.0 0
M  V30 3 O 3.8658 3.0915 0.0 0
M  V30 4 C 6.1547 1.0304 0.0 0
M  V30 5 C 7.2991 0.0000 0.0 0
M  V30 6 C 8.3912 4.9301 0.0 0
M  V30 7 S 9.7249 5.7001 0.0 0
M  V30 8 C 8.0410 8.2623 0.0 0
M  V30 9 Br 2.3101 10.2194 0.0 0
M  V30 10 C 0.0000 3.5509 0.0 0
M  V30 11 C 4.6201 6.2182 0.0 0
M  V30 12 C 5.6505 5.0738 0.0 0
M  V30 13 C 3.0801 6.2182 0.0 0
M  V30 14 C 5.3901 7.5519 0.0 0
M  V30 15 C 7.0575 5.7001 0.0 0
M  V30 16 C 2.3101 7.5519 0.0 0
M  V30 17 C 2.3101 4.8845 0.0 0
M  V30 18 N 6.8964 7.2317 0.0 0
M  V30 19 C 4.6201 8.8857 0.0 0
M  V30 20 C 3.0801 8.8857 0.0 0
M  V30 21 O 0.7700 7.5519 0.0 0
M  V30 22 N 0.7700 4.8845 0.0 0
M  V30 23 C 0.0000 6.2182 0.0 0
M  V30 24 C 11.0587 4.9301 0.0 0
M  V30 25 C 11.0587 3.3901 0.0 0
M  V30 26 N 12.3923 5.7001 0.0 0
M  V30 27 C 12.3923 2.6201 0.0 0
M  V30 28 C 13.7260 4.9301 0.0 0
M  V30 29 C 13.7260 3.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 24
M  V30 9 1 8 18
M  V30 10 1 9 20
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 18
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 2 19 20
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 141599-36-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1606174-48-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-3848823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Ethyl
2,7-dimethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylates
(11a-i), general preparation method. The appropriate ethyl
5-hydroxy-1-methyl-1H-indole-3-carboxylate 5 - 8 (0.5 mmol) and MeNH2 (2
mL, 2 M) in THF and formaldehyde as formalin (8 mmol) in THF (10 mL) were
refluxed for 12 h. The course of the reaction was monitored using LC-MS.
When the reaction was finished, the mixture was diluted with ice water
(1.5 L). The precipitate was filtered off, washed with H2O, suspended in
cold (5 - 7°C) isopropanol, and stirred at 5 - 7°C for 1 h. The
precipitate was filtered off, washed with isopropanol, and dried in
vacuo. The resulting product was dissolved in dioxane, treated with HCl
(3 M) in dioxane, and diluted with Et2O. The resulting precipitate was
filtered off and dried in vacuo. Ethyl
6-bromo-2,7-dimethyl-8-(pyridin-2-yloxymethyl)-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylate
(11d), Yield: 75-95%. LC-MS: found m/z 476, 478 (M + H), calculated 476,
478 (M + 1 for C21H22BrN3O3S2). Compound Against Influenza A/New
Caledonia/20/99 Virus (H N1) in MDCK Cell Culture: EC50: 15.0 ± 2.1μM.
Compounds Against BVDV in MDBK Cell Culture: EC50: >43.9 μM, CC50: 43.9 ±
4.1 μM, SI50: <1. Compound Against HCV in Human Hepatoma Cell Line Huh7
Containing HCV Subgenomic RNA-Replicon (Genotype 1a, Clone Con1): EC50:
12.5 ± 1.3 μM, CC50: 15.2 ± 1.8 μM, SI50: 1.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Ethyl
1,2-dimethyl-5-Hydroxy-1H-Indole-3-carboxylates and Their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil, V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun, I. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 47(12), 636-650

$RFMT $RIREG SCHEME373 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-5-hydroxy-1-methyl-2-[(2-thienylthio)methyl]-1H-indole-3-carbox...
C17H16BrNO3S2
141599-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5603 6.6520 0.0 0
M  V30 2 O 3.0956 7.1279 0.0 0
M  V30 3 O 5.7049 7.6824 0.0 0
M  V30 4 C 2.7754 8.6343 0.0 0
M  V30 5 C 1.3109 9.1102 0.0 0
M  V30 6 C 7.6211 5.2892 0.0 0
M  V30 7 S 8.9548 4.5192 0.0 0
M  V30 8 C 7.2709 1.9572 0.0 0
M  V30 9 O 0.0000 2.6675 0.0 0
M  V30 10 Br 1.5400 0.0000 0.0 0
M  V30 11 C 3.8501 4.0011 0.0 0
M  V30 12 C 4.8805 5.1455 0.0 0
M  V30 13 C 4.6201 2.6675 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 6.2875 4.5192 0.0 0
M  V30 16 N 6.1264 2.9877 0.0 0
M  V30 17 C 3.8501 1.3338 0.0 0
M  V30 18 C 1.5400 2.6675 0.0 0
M  V30 19 C 2.3100 1.3337 0.0 0
M  V30 20 C 10.2885 5.2892 0.0 0
M  V30 21 C 11.6954 4.6629 0.0 0
M  V30 22 S 10.4496 6.8208 0.0 0
M  V30 23 C 12.7259 5.8073 0.0 0
M  V30 24 C 11.9559 7.1410 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 20
M  V30 9 1 8 16
M  V30 10 1 9 18
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-1,2,3,7-tetrahydro-2,7-dimethyl-8-[(2-thienylthio)methyl]pyrrol...
C20H21BrN2O3S2
958450-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3304 3.5673 0.0 0
M  V30 2 O 6.4748 2.5369 0.0 0
M  V30 3 O 3.8656 3.0915 0.0 0
M  V30 4 C 6.1546 1.0304 0.0 0
M  V30 5 C 7.2991 0.0000 0.0 0
M  V30 6 C 8.3912 4.9301 0.0 0
M  V30 7 S 9.7249 5.7001 0.0 0
M  V30 8 C 8.0410 8.2623 0.0 0
M  V30 9 Br 2.3101 10.2194 0.0 0
M  V30 10 C 0.0000 3.5509 0.0 0
M  V30 11 C 4.6201 6.2182 0.0 0
M  V30 12 C 5.6505 5.0738 0.0 0
M  V30 13 C 3.0801 6.2182 0.0 0
M  V30 14 C 5.3901 7.5519 0.0 0
M  V30 15 C 7.0575 5.7001 0.0 0
M  V30 16 C 2.3101 7.5519 0.0 0
M  V30 17 C 2.3101 4.8845 0.0 0
M  V30 18 N 6.8964 7.2317 0.0 0
M  V30 19 C 4.6201 8.8857 0.0 0
M  V30 20 C 3.0801 8.8857 0.0 0
M  V30 21 O 0.7700 7.5519 0.0 0
M  V30 22 N 0.7700 4.8845 0.0 0
M  V30 23 C 0.0000 6.2182 0.0 0
M  V30 24 C 11.0585 4.9301 0.0 0
M  V30 25 C 11.2196 3.3985 0.0 0
M  V30 26 S 12.4655 5.5564 0.0 0
M  V30 27 C 12.7259 3.0784 0.0 0
M  V30 28 C 13.4959 4.4120 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 24
M  V30 9 1 8 18
M  V30 10 1 9 20
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 18
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 2 19 20
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 141599-38-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958450-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-5725593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Ethyl
2,7-dimethyl-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylates
(11a-i), general preparation method. The appropriate ethyl
5-hydroxy-1-methyl-1H-indole-3-carboxylate 5 - 8 (0.5 mmol) and MeNH2 (2
mL, 2 M) in THF and formaldehyde as formalin (8 mmol) in THF (10 mL) were
refluxed for 12 h. The course of the reaction was monitored using LC-MS.
When the reaction was finished, the mixture was diluted with ice water
(1.5 L). The precipitate was filtered off, washed with H2O, suspended in
cold (5 - 7°C) isopropanol, and stirred at 5 - 7°C for 1 h. The
precipitate was filtered off, washed with isopropanol, and dried in
vacuo. The resulting product was dissolved in dioxane, treated with HCl
(3 M) in dioxane, and diluted with Et2O. The resulting precipitate was
filtered off and dried in vacuo. Ethyl
6-bromo-2,7-dimethyl-8-(2-thiophen-2-yloxymethyl)-1,2,3,7-tetrahydro[1,3]oxazino[5,6-e]indole-9-carboxylate
(11c), Yield: 75-95%. LC-MS: found m/z 481, 483 (M + H), calculated 481,
483 (M + 1 for C20H21BrN2O3S2). Compound Against Influenza A/New
Caledonia/20/99 Virus (H N1) in MDCK Cell Culture: EC50: 4.9 ± 0.3μM.
Compounds Against BVDV in MDBK Cell Culture: EC50: >17.8 μM, CC50: 17.8 ±
1.9 μM, SI50: <1. Compound Against HCV in Human Hepatoma Cell Line Huh7
Containing HCV Subgenomic RNA-Replicon (Genotype 1a, Clone Con1): EC50:
12.8 ± 1.8 μM, CC50: 20.1 ± 2.8 μM, SI50: 1.6.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Ethyl
1,2-dimethyl-5-Hydroxy-1H-Indole-3-carboxylates and Their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil, V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun, I. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 47(12), 636-650

$RFMT $RIREG SCHEME374 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indene-1,2,3-trione
C9H4O3
938-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 O 6.5770 2.7106 0.0 0
M  V30 4 C 2.6673 1.9406 0.0 0
M  V30 5 C 2.6673 3.4806 0.0 0
M  V30 6 C 4.1320 1.4647 0.0 0
M  V30 7 C 1.3336 1.1706 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2506 0.0 0
M  V30 10 C 5.0370 2.7106 0.0 0
M  V30 11 C 0.0000 1.9406 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,3a,4,8b-tetrahydro-3a,8b-dihydroxy-1,2-dimethyl-4-oxoindeno[1,2-b]pyr...
C16H17NO5
1357480-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1205 5.0294 0.0 0
M  V30 2 O 3.0291 1.5961 0.0 0
M  V30 3 C 7.8307 4.0285 0.0 0
M  V30 4 O 9.1644 3.2585 0.0 0
M  V30 5 O 7.8307 5.5686 0.0 0
M  V30 6 C 10.4980 4.0285 0.0 0
M  V30 7 C 11.8317 3.2585 0.0 0
M  V30 8 O 4.9464 6.6255 0.0 0
M  V30 9 C 4.2032 0.0000 0.0 0
M  V30 10 C 7.4805 0.6966 0.0 0
M  V30 11 C 5.0901 3.8850 0.0 0
M  V30 12 C 4.0597 2.7405 0.0 0
M  V30 13 C 6.4969 3.2585 0.0 0
M  V30 14 C 4.3201 5.2187 0.0 0
M  V30 15 C 2.6527 3.3670 0.0 0
M  V30 16 N 4.8297 1.4068 0.0 0
M  V30 17 C 6.3360 1.7270 0.0 0
M  V30 18 C 2.8136 4.8985 0.0 0
M  V30 19 C 1.2459 2.7405 0.0 0
M  V30 20 C 1.5677 5.8037 0.0 0
M  V30 21 C 0.0000 3.6457 0.0 0
M  V30 22 C 0.1609 5.1773 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 8 14
M  V30 9 1 9 16
M  V30 10 1 10 17
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 17
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 938-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1357480-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25370992
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free synthesis of pyrrole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rostami-Charati, Faramarz; Hossaini, Zinatossadat; Khalilzadeh, Mohammad
A.; Jafaryan, Hojatollah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2012), 49(1), 217-220

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(methylimino)butanoate
C7H13NO2
65578-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 O 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 2.3101 0.0 0
M  V30 7 C 2.6675 0.0000 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6 CFG=2
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65578-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19904405
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolobenzodiazepine prodrugs and antibody conjugates
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dragovich, Peter; Pei, Zhonghua; Pillow, Thomas; Sadowsky, Jack; Verma,
Vishal; Zhang, Donglu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018031662 A1 2018-02-15

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylium, tris(2,6-dimethoxyphenyl)-, tetrafluoroborate(1-) (1:1)
C25H27O6.BF4
142467-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7750 10.6215 0.0 0
M  V30 2 O 1.9250 11.9552 0.0 0
M  V30 3 C 0.3850 11.9552 0.0 0
M  V30 4 O 6.5450 14.6226 0.0 0
M  V30 5 C 7.3150 15.9562 0.0 0
M  V30 6 O 1.5400 8.6211 0.0 0
M  V30 7 C 0.0000 8.6211 0.0 0
M  V30 8 O 6.1600 5.9536 0.0 0
M  V30 9 C 6.9300 4.6200 0.0 0
M  V30 10 O 9.6250 7.9543 0.0 0 CHG=1 VAL=3
M  V30 11 C 8.8550 6.6205 0.0 0
M  V30 12 O 9.6250 13.2890 0.0 0
M  V30 13 C 10.3950 14.6226 0.0 0
M  V30 14 C 4.2350 13.2890 0.0 0
M  V30 15 C 2.6950 13.2890 0.0 0
M  V30 16 C 5.0050 14.6226 0.0 0
M  V30 17 C 1.9250 14.6226 0.0 0
M  V30 18 C 4.2350 15.9562 0.0 0
M  V30 19 C 2.6950 15.9562 0.0 0
M  V30 20 C 3.8500 7.2873 0.0 0
M  V30 21 C 2.3100 7.2873 0.0 0
M  V30 22 C 4.6200 5.9536 0.0 0
M  V30 23 C 1.5400 5.9536 0.0 0
M  V30 24 C 3.8500 4.6200 0.0 0
M  V30 25 C 2.3100 4.6200 0.0 0
M  V30 26 C 9.6250 10.6215 0.0 0
M  V30 27 C 10.3950 9.2879 0.0 0
M  V30 28 C 10.3950 11.9552 0.0 0
M  V30 29 C 11.9350 9.2879 0.0 0
M  V30 30 C 11.9350 11.9552 0.0 0
M  V30 31 C 12.7050 10.6215 0.0 0
M  V30 32 B 6.3525 1.5400 0.0 0 CHG=3 VAL=4
M  V30 33 F 4.8125 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 34 F 7.8925 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 35 F 6.3525 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 36 F 6.3525 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 2 1 26
M  V30 4 1 2 3
M  V30 5 1 2 15
M  V30 6 1 4 5
M  V30 7 1 4 16
M  V30 8 1 6 7
M  V30 9 1 6 21
M  V30 10 1 8 9
M  V30 11 1 8 22
M  V30 12 1 10 11
M  V30 13 2 10 27 CFG=2
M  V30 14 1 12 13
M  V30 15 1 12 28
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 1 32 33
M  V30 35 1 32 34
M  V30 36 1 32 35
M  V30 37 1 32 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acridinium, 9-(2,6-dimethoxyphenyl)-1,8-dimethoxy-10-methyl-, tetrafluorobora...
C24H24NO4.BF4
1354558-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 5.9537 0.0 0
M  V30 2 C 6.9301 4.6200 0.0 0
M  V30 3 O 6.1601 11.2886 0.0 0
M  V30 4 C 6.9301 12.6222 0.0 0
M  V30 5 O 8.4701 5.9537 0.0 0
M  V30 6 C 9.2401 4.6200 0.0 0
M  V30 7 O 8.4701 11.2886 0.0 0
M  V30 8 C 9.2401 12.6222 0.0 0
M  V30 9 C 0.0000 8.6211 0.0 0
M  V30 10 C 4.6201 8.6211 0.0 0
M  V30 11 C 3.8500 7.2875 0.0 0
M  V30 12 C 3.8500 9.9548 0.0 0
M  V30 13 C 2.3100 7.2875 0.0 0
M  V30 14 C 4.6201 5.9537 0.0 0
M  V30 15 C 2.3100 9.9548 0.0 0
M  V30 16 C 4.6201 11.2886 0.0 0
M  V30 17 N 1.5400 8.6211 0.0 0 CHG=1 VAL=4
M  V30 18 C 1.5400 5.9537 0.0 0
M  V30 19 C 3.8500 4.6200 0.0 0
M  V30 20 C 1.5400 11.2886 0.0 0
M  V30 21 C 3.8500 12.6222 0.0 0
M  V30 22 C 2.3100 4.6200 0.0 0
M  V30 23 C 2.3100 12.6222 0.0 0
M  V30 24 C 8.4701 8.6211 0.0 0
M  V30 25 C 9.2401 7.2875 0.0 0
M  V30 26 C 9.2401 9.9548 0.0 0
M  V30 27 C 10.7801 7.2875 0.0 0
M  V30 28 C 10.7801 9.9548 0.0 0
M  V30 29 C 11.5501 8.6211 0.0 0
M  V30 30 B 5.7751 1.5400 0.0 0 CHG=3 VAL=4
M  V30 31 F 4.2351 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 32 F 7.3151 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 33 F 5.7751 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 34 F 5.7751 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 7 8
M  V30 8 1 7 26
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 24
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 2 14 19
M  V30 20 2 15 17
M  V30 21 1 15 20
M  V30 22 2 16 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 30 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 142467-18-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1354558-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16671063
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16872-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Synthesis of pH-Sensitive Fluorescent Diaza[4]helicenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wallabregue, Antoine; Sherin, Petr; Guin, Joyram; Besnard, Celine;
Vauthey, Eric; Lacour, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2014), 2014(29), 6431-6438

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-2-(4-methyl-1-piperazinyl)-4-[[(trifluor...
C19H28F3N5O5S
1443153-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.4373 0.0 0
M  V30 2 S 5.3348 2.6673 0.0 0 VAL=6
M  V30 3 C 6.1048 1.3337 0.0 0
M  V30 4 O 4.0011 1.8973 0.0 0
M  V30 5 O 4.5648 4.0011 0.0 0
M  V30 6 F 7.6449 1.3337 0.0 0
M  V30 7 F 6.8748 0.0000 0.0 0
M  V30 8 F 5.3348 0.0000 0.0 0
M  V30 9 C 12.9159 6.5174 0.0 0
M  V30 10 O 13.6859 7.8511 0.0 0
M  V30 11 O 13.6859 5.1837 0.0 0
M  V30 12 C 15.2259 7.8512 0.0 0
M  V30 13 C 15.2259 9.3911 0.0 0
M  V30 14 C 16.7660 7.8512 0.0 0
M  V30 15 C 15.2259 6.3112 0.0 0
M  V30 16 C 0.0000 10.3675 0.0 0
M  V30 17 C 8.0023 5.7474 0.0 0
M  V30 18 C 6.6685 4.9774 0.0 0
M  V30 19 C 8.0023 7.2874 0.0 0
M  V30 20 C 9.2063 4.7872 0.0 0
M  V30 21 N 5.3348 5.7474 0.0 0
M  V30 22 N 6.6685 8.0574 0.0 0
M  V30 23 C 9.2063 8.2476 0.0 0
M  V30 24 C 10.7077 5.1300 0.0 0
M  V30 25 C 5.3348 7.2874 0.0 0
M  V30 26 C 10.7077 7.9050 0.0 0
M  V30 27 N 11.3759 6.5174 0.0 0
M  V30 28 N 4.0011 8.0574 0.0 0
M  V30 29 C 4.0011 9.5975 0.0 0
M  V30 30 C 2.6675 7.2874 0.0 0
M  V30 31 C 2.6675 10.3675 0.0 0
M  V30 32 C 1.3337 8.0574 0.0 0
M  V30 33 N 1.3337 9.5975 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 27
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 16 33
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 25
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 1 24 27
M  V30 28 1 25 28
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5,6,8,9-tetrahydro-4-(methylamino)-2-(4-methyl-1-piperaziny...
C19H32N6O2
1443153-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 0.7700 0.0 0
M  V30 2 C 5.3347 0.0000 0.0 0
M  V30 3 C 12.9157 3.8500 0.0 0
M  V30 4 O 13.6857 5.1836 0.0 0
M  V30 5 O 13.6857 2.5164 0.0 0
M  V30 6 C 15.2257 5.1836 0.0 0
M  V30 7 C 15.2257 6.7236 0.0 0
M  V30 8 C 16.7657 5.1836 0.0 0
M  V30 9 C 15.2257 3.6436 0.0 0
M  V30 10 C 0.0000 7.7000 0.0 0
M  V30 11 C 8.0021 3.0800 0.0 0
M  V30 12 C 8.0021 4.6200 0.0 0
M  V30 13 C 6.6684 2.3100 0.0 0
M  V30 14 C 9.2061 2.1198 0.0 0
M  V30 15 N 6.6684 5.3900 0.0 0
M  V30 16 C 9.2061 5.5802 0.0 0
M  V30 17 N 5.3347 3.0800 0.0 0
M  V30 18 C 10.7075 2.4625 0.0 0
M  V30 19 C 5.3347 4.6200 0.0 0
M  V30 20 C 10.7075 5.2375 0.0 0
M  V30 21 N 11.3757 3.8500 0.0 0
M  V30 22 N 4.0011 5.3900 0.0 0
M  V30 23 C 4.0011 6.9300 0.0 0
M  V30 24 C 2.6674 4.6200 0.0 0
M  V30 25 C 2.6674 7.7000 0.0 0
M  V30 26 C 1.3336 5.3900 0.0 0
M  V30 27 N 1.3336 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 27
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 19
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443153-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443153-31-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-303598
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel pyrimidoazepine analogs as serotonin 5-HT2A and 5-HT2C receptor
ligands for the treatment of obesity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Ha Yun; Tae, Jinsung; Seo, Yong Wan; Kim, Yoon Jung; Im, Hye Yeon;
Choi, Gil Don; Cho, Heeyeong; Park, Woo-Kyu; Kwon, Oh Seung; Cho, Yong
Seo; Ko, Minkyung; Jang, HyunSeo; Lee, Jaeick; Choi, Kihang; Kim,
Chan-Hwa; Lee, Jiyoun; Pae, Ae Nim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 63558-569

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(4-methoxyphenyl)-4-(methylsulfonyl)-2-oxo-2H-pyran-3-carboxylate
C15H14O7S
144361-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.8501 1.3338 0.0 0 VAL=6
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 2.5164 2.1038 0.0 0
M  V30 4 O 5.1838 0.5638 0.0 0
M  V30 5 O 3.8501 6.6687 0.0 0
M  V30 6 C 2.3101 4.0012 0.0 0
M  V30 7 O 1.5400 5.3348 0.0 0
M  V30 8 O 1.5400 2.6675 0.0 0
M  V30 9 C 0.0000 5.3348 0.0 0
M  V30 10 O 13.0903 4.0012 0.0 0
M  V30 11 C 13.8603 5.3348 0.0 0
M  V30 12 C 6.9302 4.0012 0.0 0
M  V30 13 C 6.1601 2.6675 0.0 0
M  V30 14 O 6.1601 5.3348 0.0 0
M  V30 15 C 4.6201 2.6675 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 17 C 3.8501 4.0012 0.0 0
M  V30 18 C 8.4702 4.0012 0.0 0
M  V30 19 C 9.2402 2.6675 0.0 0
M  V30 20 C 9.2402 5.3348 0.0 0
M  V30 21 C 10.7802 2.6675 0.0 0
M  V30 22 C 10.7802 5.3348 0.0 0
M  V30 23 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 2 5 16
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 23
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-(4-methoxyphenyl)-4-(methylamino)-2-oxo-2H-pyran-3-carboxylate
C15H15NO5
905578-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 4.0012 0.0 0
M  V30 2 O 1.5400 5.3348 0.0 0
M  V30 3 O 1.5400 2.6675 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 N 3.8501 1.3338 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 O 3.8501 6.6687 0.0 0
M  V30 8 O 13.0903 4.0012 0.0 0
M  V30 9 C 13.8603 5.3348 0.0 0
M  V30 10 C 3.8501 4.0012 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 6.1601 2.6675 0.0 0
M  V30 14 O 6.1601 5.3348 0.0 0
M  V30 15 C 6.9302 4.0012 0.0 0
M  V30 16 C 8.4702 4.0012 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.7802 5.3348 0.0 0
M  V30 20 C 10.7802 2.6675 0.0 0
M  V30 21 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 12
M  V30 8 1 8 9
M  V30 9 1 8 21
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144361-17-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 905578-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25309345
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and fluorescence of 2H-pyrone derivatives for organic
light-emitting diodes (OLED)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizuyama, Naoko; Murakami, Yuka; Kohra, Shinya; Ueda, Kazuo; Hiraoka,
Kyoko; Nagaoka, Junko; Takahashi, Kojiro; Shigemitsu, Yasuhiro; Tominaga,
Yoshinori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2007), 44(1), 115-132

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6,7,8-trifluoro-4-oxo-2-phenyl-4H-1-benzopyran-3-carboxylate
C18H11F3O4
1443627-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 O 2.3100 6.6684 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 0.7700 6.6684 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 O 4.6200 8.0021 0.0 0
M  V30 7 F 10.0100 4.0011 0.0 0
M  V30 8 F 11.5500 6.6684 0.0 0
M  V30 9 F 10.0100 9.3358 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 O 6.9300 4.0011 0.0 0
M  V30 13 C 5.3900 6.6684 0.0 0
M  V30 14 C 7.7000 5.3347 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 7.7000 8.0021 0.0 0
M  V30 18 C 10.0100 6.6684 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 5.3900 1.3336 0.0 0
M  V30 22 C 3.0800 2.6674 0.0 0
M  V30 23 C 4.6200 0.0000 0.0 0
M  V30 24 C 2.3100 1.3336 0.0 0
M  V30 25 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 13
M  V30 7 1 7 16
M  V30 8 1 8 18
M  V30 9 1 9 19
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 20
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7,8-Trifluoro-3-[(methylamino)phenylmethylene]-2H-1-benzopyran-2,4(3H)-dione
C17H10F3NO3
1443627-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.7700 0.0 0
M  V30 2 F 9.3360 6.9302 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 N 4.0012 0.7700 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 F 12.0033 2.3101 0.0 0
M  V30 7 O 4.0012 5.3901 0.0 0
M  V30 8 F 12.0033 5.3901 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 O 6.6685 5.3901 0.0 0
M  V30 14 C 9.3360 5.3901 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 2.6673 3.0801 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 1.3337 2.3101 0.0 0
M  V30 22 C 1.3337 5.3901 0.0 0
M  V30 23 C 0.0000 3.0801 0.0 0
M  V30 24 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 15 CFG=2
M  V30 5 1 3 19
M  V30 6 1 4 5
M  V30 7 1 6 16
M  V30 8 2 7 17
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443627-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443627-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28989942
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reaction of flavones IIIа, IIIb and chromone VII with amines. To a
solution of 1 mmol of compound IIIа, IIIb, VII in 15 ml of an appropriate
solvent was added 1 mmol of amine (or 1 mmol of methylamine sulfate at
the preparation of ester Vb, coumarins mixture VIb, VII, 2 mmol for the
synthesis of coumarin X). Ethanol or acetonitrile were used in the
syntheses of compounds Vа-Ve, XII, VIа, VIb, VId, VIe, X, XIII, DMSO, for
preparation of chromones XIа, XIb. The reaction mixture was vigorously
stirred for 24 h at 25°С (at the synthesis of compounds Vа-Ve, XII,
IVа-IVc, VIIIа, VIIIb, XIа, Xb, XIII) or at 50°С (at the synthesis of
coumarins VIа, VIb, VId, VIe, X). The reaction progress was monitored by
TLC. The solvent was distilled off, the solid residue was crystallized
from an appropriate solvent. The mixtures of esters Vd, Ve or coumarins
VId, VIe, and also the mixture of coumarins VIb, X were separated by
column chromatography, eluent chloroform.
3-[(Methylamino)(phenyl)methylidene]-6,7,8-trifluoro-2Н-chromene-2,4(3Н)-dione
(IVb). Colorless powder, yield 0.317 g, 95%. Mp 240°С (from ethanol). IR
spectrum, ν, cm-1: 3418 (NH), 1723 (O- C=O), 1646 (C=O), 1595, 1569,
1522, 1489, 1461, 1415 (C=C, NH), 1063, 1039, 1007 (CF). 1Н NMR spectrum,
δ, ppm: 2.89 s (3Н, СН, 7.32-7.53 m (5Н, СН, 7.71d.d.d (1Н, Н5, JHF 10.4,
8.3, 2.3 Hz), 13.06 s (1Н, NH). 19F NMR spectrum, δ, ppm: 9.13 m, 10.54
m, 21.98 m (1F each). Found, %: C 61.54; H 2.98; F 17.40; N 3.93.
С17Н10F3NO3. Calculated, %: C 61.27; H 3.02; F 17.10; N 4.20.
$DTYPE RXN:VAR(1):NOTES
$DATUM acetonitrile can be used as alternative solvent, chromone-coumarin
rearrangement
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Features of reactions of polyfluorinated ethyl
4-oxo-2-phenyl-4H-chromene-3-carboxylates with N-nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shcherbakov, K. V.; Burgart, Ya. V.; Saloutin, V. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2013), 49(5), 719-729

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6,7,8-trifluoro-2-methyl-4-oxo-4H-1-benzopyran-3-carboxylate
C13H9F3O4
1443627-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 F 2.6673 0.0000 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 O 9.3360 3.8501 0.0 0
M  V30 5 O 8.0022 6.1601 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 C 12.0033 3.8501 0.0 0
M  V30 8 F 0.0000 4.6201 0.0 0
M  V30 9 C 8.0022 1.5400 0.0 0
M  V30 10 F 0.0000 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 O 5.3348 1.5400 0.0 0
M  V30 16 C 2.6673 1.5400 0.0 0
M  V30 17 C 6.6685 3.8501 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 6.6685 2.3101 0.0 0
M  V30 20 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 18
M  V30 9 1 9 19
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7,8-Trifluoro-3-[1-(methylamino)ethylidene]-2H-1-benzopyran-2,4(3H)-dione
C12H8F3NO3
1443627-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 1.3338 0.0 0
M  V30 2 F 1.5400 5.3348 0.0 0
M  V30 3 C 8.4702 4.0012 0.0 0
M  V30 4 N 9.2402 5.3348 0.0 0
M  V30 5 C 9.2402 2.6675 0.0 0
M  V30 6 C 10.7802 5.3348 0.0 0
M  V30 7 F 1.5400 0.0000 0.0 0
M  V30 8 O 6.9302 6.6687 0.0 0
M  V30 9 F 0.0000 2.6675 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 3.8501 4.0012 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 13 C 3.8501 1.3338 0.0 0
M  V30 14 O 4.6201 5.3348 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 6.9302 4.0012 0.0 0
M  V30 17 C 2.3101 1.3338 0.0 0
M  V30 18 C 6.1601 5.3348 0.0 0
M  V30 19 C 1.5400 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 16 CFG=2
M  V30 6 1 4 6
M  V30 7 1 7 17
M  V30 8 2 8 18
M  V30 9 1 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443627-63-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443627-77-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29073225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Reaction of flavones IIIа, IIIb and chromone
VII with amines. To a solution of 1 mmol of compound IIIа, IIIb, VII in
15 ml of an appropriate solvent was added 1 mmol of amine (or 1 mmol of
methylamine sulfate at the preparation of ester Vb, coumarins mixture
VIb, VII, 2 mmol for the synthesis of coumarin X). Ethanol or
acetonitrile were used in the syntheses of compounds Vа-Ve, XII, VIа,
VIb, VId, VIe, X, XIII, DMSO, for preparation of chromones XIа, XIb. The
reaction mixture was vigorously stirred for 24 h at 25°С (at the
synthesis of compounds Vа-Ve, XII, IVа-IVc, VIIIа, VIIIb, XIа, Xb, XIII)
or at 50°С (at the synthesis of coumarins VIа, VIb, VId, VIe, X). The
reaction progress was monitored by TLC. The solvent was distilled off,
the solid residue was crystallized from an appropriate solvent. The
mixtures of esters Vd, Ve or coumarins VId, VIe, and also the mixture of
coumarins VIb, X were separated by column chromatography, eluent
chloroform. 3-[1-(Methylamino)ethylidene]-6,7,8-trifluoro-2Н-
chromene-2,4(3Н)-dione (VIIIb). Yield 0.258 g (95%), colorless powder. Mp
236°С (from ethanol). IR spectrum, ν, cm-1: 3074 (NH), 1736 (O-C=O), 1622
(C=O), 1520, 1493 (C=C, NH), 1068, 1048 (CF). 1Н NMR spectrum, δ, ppm:
2.64 с, 3.24 с (po 3Н, 2СН, 7.69 d.d.d (1Н, Н5, JHF 10.4, 8.3, 2.3 Hz),
13.09 br.s (1H, NH). 19F NMR spectrum, δ, ppm: 8.90 m, 10.21 m, 21.93 m
(1F each). Found, %: C 52.99; H 2.87; F 20.82; N 5.13. С12Н8F3NO3.
Calculated, %: C 53.15; H 2.97; F 21.02; N 5.16.
$DTYPE RXN:VAR(1):NOTES
$DATUM acetonitrile can be used as alternative solvent, chromone-coumarin
rearrangement
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Features of reactions of polyfluorinated ethyl
4-oxo-2-phenyl-4H-chromene-3-carboxylates with N-nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shcherbakov, K. V.; Burgart, Ya. V.; Saloutin, V. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2013), 49(5), 719-729

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2′R,4′S,6′aR,10′aS,11′aR)-Octahydro-2′-hydroxy-4′,10′,10′-trimethylspiro[1,3...
C18H27NO5
1447811-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.7610 5.7998 0.0 0
M  V30 2 C 2.7811 5.7998 0.0 0
M  V30 3 O 6.4384 0.0000 0.0 0
M  V30 4 C 9.1059 0.0000 0.0 0
M  V30 5 O 11.7733 4.6201 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0 CFG=2
M  V30 7 C 5.1048 2.3101 0.0 0 CFG=2
M  V30 8 O 6.4384 3.0801 0.0 0
M  V30 9 C 3.7711 4.6201 0.0 0
M  V30 10 C 6.4384 4.6201 0.0 0
M  V30 11 C 6.4384 1.5400 0.0 0
M  V30 12 C 3.7711 1.5400 0.0 0
M  V30 13 C 2.4373 3.8501 0.0 0
M  V30 14 C 7.7722 3.8501 0.0 0 CFG=1
M  V30 15 N 7.7722 2.3101 0.0 0
M  V30 16 C 2.4373 2.3101 0.0 0
M  V30 17 O 1.0304 3.2236 0.0 0
M  V30 18 O 2.2763 5.3816 0.0 0
M  V30 19 C 9.1059 4.6201 0.0 0
M  V30 20 C 9.1059 1.5400 0.0 0 CFG=1
M  V30 21 C 0.0000 4.3682 0.0 0
M  V30 22 C 0.7700 5.7018 0.0 0
M  V30 23 C 10.4396 3.8501 0.0 0 CFG=2
M  V30 24 C 10.4396 2.3101 0.0 0
M  V30 25 H 7.7722 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 9
M  V30 3 2 3 11
M  V30 4 1 20 4 CFG=3
M  V30 5 1 23 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=3
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 8 CFG=3
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 15
M  V30 21 1 14 19
M  V30 22 1 14 25 CFG=3
M  V30 23 1 15 20
M  V30 24 1 17 21
M  V30 25 1 18 22
M  V30 26 1 19 23
M  V30 27 1 20 24
M  V30 28 1 21 22
M  V30 29 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 7 14 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,4S,6aS,10aS,11aR)-Decahydro-2,10a-dihydroxy-4,10,10-trimethyl-6a-(methyla...
C19H32N2O5
1447811-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.1047 0.7700 0.0 0
M  V30 2 C 3.7711 0.0000 0.0 0
M  V30 3 O 5.1047 5.3901 0.0 0
M  V30 4 O 6.4384 0.0000 0.0 0
M  V30 5 C 2.7811 5.7997 0.0 0
M  V30 6 C 4.7610 5.7997 0.0 0
M  V30 7 C 9.1059 0.0000 0.0 0
M  V30 8 O 11.7732 4.6201 0.0 0
M  V30 9 C 5.1047 2.3100 0.0 0 CFG=2
M  V30 10 C 5.1047 3.8501 0.0 0 CFG=1
M  V30 11 C 6.4384 1.5400 0.0 0
M  V30 12 C 3.7711 1.5400 0.0 0
M  V30 13 C 3.7711 4.6201 0.0 0
M  V30 14 C 6.4384 4.6201 0.0 0
M  V30 15 N 7.7722 2.3100 0.0 0
M  V30 16 C 2.4372 2.3100 0.0 0
M  V30 17 C 2.4372 3.8501 0.0 0
M  V30 18 C 7.7722 3.8501 0.0 0 CFG=1
M  V30 19 C 9.1059 1.5400 0.0 0 CFG=1
M  V30 20 O 1.0304 3.2236 0.0 0
M  V30 21 O 2.2763 5.3816 0.0 0
M  V30 22 C 9.1059 4.6201 0.0 0
M  V30 23 C 10.4395 2.3100 0.0 0
M  V30 24 C 0.0000 4.3681 0.0 0
M  V30 25 C 0.7700 5.7018 0.0 0
M  V30 26 C 10.4395 3.8501 0.0 0 CFG=2
M  V30 27 H 7.7722 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 10 3 CFG=3
M  V30 4 2 4 11
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 19 7 CFG=3
M  V30 8 1 26 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 18 27 CFG=3
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 26
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 10 18 19 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1447811-60-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1447811-61-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-7361096
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2'R,4'S,6a'S,10a'S,11a'R)-2',10a'-Dihydroxy-4',10',10'-trimethyl-6a'-(methylamino)decahydrospiro[[1,3]dioxolane-2,9'-pyrido[1,2-b]isoquinolin]-6'(6a'H)-one
(46). A mixture of epoxyamide 47 (320 mg, 0.95 mmol) and aqueous
methylamine (4 mL, 40% w/w) was heated at 100 °C in a sealed tube for 48
h. The solution was cooled to room temperature, and H2O (20 mL) was
added. The resulting mixture was extracted with CH2Cl2 (3 x 50 mL). The
combined organic layers were dried (Na2SO4) and concentrated under
reduced pressure. The residue was purified by flash chromatography,
eluting with EtOAc. 333 mg (95%) of aminoalcohol 46 as white solid. Mp
278 °C (dec); 1H NMR (500 MHz) δ 4.63 (dquin, J = 6.5, 1.5 Hz, 1 H),
4.23-4.21 (m, 2 H), 4.04-3.90 (m, 5 H), 2.27 (s, 3 H), 2.15-2.11 (m, 1
H), 1.95-1.73 (m, 7 H), 1.53-1.46 (m, 2 H), 1.42 (d, J = 3.0 Hz, 1 H),
1.34-1.33 (comp, 6 H), 0.93 (s, 3 H); 13C NMR (125 MHz) δ 172.5, 113.3,
76.5, 65.5, 65.3, 64.22, 64.21, 45.2, 43.6, 41.5, 40.8, 36.6, 30.9, 30.2,
26.1, 22.0, 21.1, 17.5, 17.1; IR (thin film) 3518, 3302, 1611, 1438,
1319, 730 cm-1; HRMS-ESI m/z calculated for [C19H33N2O5 (M+1)], 369.2384;
found 369.2384.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Total Syntheses of Citrinadins A and B. Stereochemical
Revision of Their Assigned Structures
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bian, Zhiguo; Marvin, Christopher C.; Pettersson, Martin; Martin, Stephen
F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2014), 136(40), 14184-14192

$RFMT $RIREG SCHEME381 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2′R,4′S,6′aR,10′aS,11′aR)-Octahydro-2′-hydroxy-4′,10′,10′-trimethylspiro[1,3...
C18H27NO5
1447811-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.7610 5.7998 0.0 0
M  V30 2 C 2.7811 5.7998 0.0 0
M  V30 3 O 6.4384 0.0000 0.0 0
M  V30 4 C 9.1059 0.0000 0.0 0
M  V30 5 O 11.7733 4.6201 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0 CFG=2
M  V30 7 C 5.1048 2.3101 0.0 0 CFG=2
M  V30 8 O 6.4384 3.0801 0.0 0
M  V30 9 C 3.7711 4.6201 0.0 0
M  V30 10 C 6.4384 4.6201 0.0 0
M  V30 11 C 6.4384 1.5400 0.0 0
M  V30 12 C 3.7711 1.5400 0.0 0
M  V30 13 C 2.4373 3.8501 0.0 0
M  V30 14 C 7.7722 3.8501 0.0 0 CFG=1
M  V30 15 N 7.7722 2.3101 0.0 0
M  V30 16 C 2.4373 2.3101 0.0 0
M  V30 17 O 1.0304 3.2236 0.0 0
M  V30 18 O 2.2763 5.3816 0.0 0
M  V30 19 C 9.1059 4.6201 0.0 0
M  V30 20 C 9.1059 1.5400 0.0 0 CFG=1
M  V30 21 C 0.0000 4.3682 0.0 0
M  V30 22 C 0.7700 5.7018 0.0 0
M  V30 23 C 10.4396 3.8501 0.0 0 CFG=2
M  V30 24 C 10.4396 2.3101 0.0 0
M  V30 25 H 7.7722 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 9
M  V30 3 2 3 11
M  V30 4 1 20 4 CFG=3
M  V30 5 1 23 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=3
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 8 CFG=3
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 15
M  V30 21 1 14 19
M  V30 22 1 14 25 CFG=3
M  V30 23 1 15 20
M  V30 24 1 17 21
M  V30 25 1 18 22
M  V30 26 1 19 23
M  V30 27 1 20 24
M  V30 28 1 21 22
M  V30 29 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 7 14 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,4S,6aS,10aS,11aR)-Decahydro-2,10a-dihydroxy-4,10,10-trimethyl-6a-(methyla...
C19H32N2O5
1447811-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.1047 0.7700 0.0 0
M  V30 2 C 3.7711 0.0000 0.0 0
M  V30 3 O 5.1047 5.3901 0.0 0
M  V30 4 O 6.4384 0.0000 0.0 0
M  V30 5 C 2.7811 5.7997 0.0 0
M  V30 6 C 4.7610 5.7997 0.0 0
M  V30 7 C 9.1059 0.0000 0.0 0
M  V30 8 O 11.7732 4.6201 0.0 0
M  V30 9 C 5.1047 2.3100 0.0 0 CFG=2
M  V30 10 C 5.1047 3.8501 0.0 0 CFG=1
M  V30 11 C 6.4384 1.5400 0.0 0
M  V30 12 C 3.7711 1.5400 0.0 0
M  V30 13 C 3.7711 4.6201 0.0 0
M  V30 14 C 6.4384 4.6201 0.0 0
M  V30 15 N 7.7722 2.3100 0.0 0
M  V30 16 C 2.4372 2.3100 0.0 0
M  V30 17 C 2.4372 3.8501 0.0 0
M  V30 18 C 7.7722 3.8501 0.0 0 CFG=1
M  V30 19 C 9.1059 1.5400 0.0 0 CFG=1
M  V30 20 O 1.0304 3.2236 0.0 0
M  V30 21 O 2.2763 5.3816 0.0 0
M  V30 22 C 9.1059 4.6201 0.0 0
M  V30 23 C 10.4395 2.3100 0.0 0
M  V30 24 C 0.0000 4.3681 0.0 0
M  V30 25 C 0.7700 5.7018 0.0 0
M  V30 26 C 10.4395 3.8501 0.0 0 CFG=2
M  V30 27 H 7.7722 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 10 3 CFG=3
M  V30 4 2 4 11
M  V30 5 1 5 13
M  V30 6 1 6 13
M  V30 7 1 19 7 CFG=3
M  V30 8 1 26 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 18 27 CFG=3
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 23 26
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 10 18 19 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1447811-60-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1447811-61-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-10961135
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2'R,4'S,6a'S,10a'S,11a'R)-2',10a'-Dihydroxy-4',10',10'-trimethyl-6a'-(methylamino)decahydrospiro[[1,3]dioxolane-2,9'-pyrido[1,2-b]isoquinolin]-6'(6a'H)-one
(7). A mixture of epoxyamide 19 (320 mg, 0.95 mmol) and aqueous
methylamine (40%, 4 mL) was heated at 100°C in a sealed tube for 48 h.
The solution was cooled to room temperature, and H2O (20 mL) was added.
The resulting mixture was extracted with CH2Cl2 (3 x 50 mL). The combined
organic layers were dried (Na2SO4) and concentrated under reduced
pressure. The residue was purified by flash chromatography, eluting with
EtOAc. 333 mg (95%) of aminoalcohol 7 as white solid. Mp 278°C (dec); 1H
NMR (500 MHz) δ 4.63 (dquin, J = 6.5, 1.5 Hz, 1 H), 4.23-4.21 (m, 2 H),
4.04-3.90 (m, 5 H), 2.27 (s, 3 H), 2.15-2.11 (m, 1 H), 1.95-1.73 (m, 7
H), 1.53-1.46 (m, 2 H), 1.42 (d, J = 3.0 Hz, 1 H), 1.34-1.33 (comp, 6 H),
0.93 (s, 3 H); 13C NMR (125 MHz) δ 172.5 (C), 113.3 (C), 76.5 (C), 65.5
(CH2), 65.3 (CH), 64.22 (CH2), 64.21 (C), 45.2 (C), 43.6 (CH), 41.5 (CH),
40.8 (CH2), 36.6 (CH2), 30.9 (CH2), 30.2 (CH3), 26.1 (CH2), 22.0 (CH3),
21.1 (CH2), 17.5 (CH3), 17.1 (CH3); IR (thin film) 3518, 3302, 1611,
1438, 1319, 730 cm-1; HRMS-ESI m/z calculated for [C19H33N2O5 (M+1)],
369.2384; found 369.2384.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Total Synthesis of (-)-Citrinadin A and Revision of Its
Stereochemical Structure
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bian, Zhiguo; Marvin, Christopher C.; Martin, Stephen F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(30), 10886-10889

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (1S,3S)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1-(4-methoxyphenyl)-1H-py...
C23H23ClN2O4
1447959-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 8.9401 0.0 0
M  V30 2 C 9.3358 9.7101 0.0 0
M  V30 3 O 6.6684 9.7101 0.0 0
M  V30 4 Cl 9.3358 11.2502 0.0 0
M  V30 5 C 10.6696 7.4001 0.0 0
M  V30 6 O 12.0032 6.6301 0.0 0
M  V30 7 O 10.6696 8.9401 0.0 0
M  V30 8 C 13.3369 7.4001 0.0 0
M  V30 9 C 14.6706 6.6301 0.0 0
M  V30 10 O 1.3337 9.7101 0.0 0
M  V30 11 C 0.0000 8.9401 0.0 0
M  V30 12 C 6.6684 6.6301 0.0 0 CFG=2
M  V30 13 C 6.6684 5.0901 0.0 0
M  V30 14 N 8.0021 7.4001 0.0 0
M  V30 15 C 8.0021 4.3201 0.0 0
M  V30 16 N 5.5239 4.0597 0.0 0
M  V30 17 C 9.3358 6.6301 0.0 0 CFG=2
M  V30 18 C 7.6819 2.8138 0.0 0
M  V30 19 C 9.3358 5.0901 0.0 0
M  V30 20 C 6.1504 2.6527 0.0 0
M  V30 21 C 8.5872 1.5679 0.0 0
M  V30 22 C 5.5239 1.2459 0.0 0
M  V30 23 C 7.9608 0.1609 0.0 0
M  V30 24 C 6.4291 0.0000 0.0 0
M  V30 25 C 5.3348 7.4001 0.0 0
M  V30 26 C 4.0010 6.6301 0.0 0
M  V30 27 C 5.3348 8.9401 0.0 0
M  V30 28 C 2.6673 7.4001 0.0 0
M  V30 29 C 4.0010 9.7101 0.0 0
M  V30 30 C 2.6673 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 17 5 CFG=3
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 30
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 25 CFG=3
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 18 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6S,12aS)-2,3,6,7,12,12a-Hexahydro-6-(4-methoxyphenyl)-2-methylpyrazino[1′,2′...
C22H21N3O3
1447960-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7102 0.0 0
M  V30 2 O 0.0000 6.6302 0.0 0
M  V30 3 C 0.0000 9.7102 0.0 0
M  V30 4 O 10.6697 9.7102 0.0 0
M  V30 5 C 12.0033 8.9402 0.0 0
M  V30 6 C 5.3348 6.6302 0.0 0 CFG=2
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 N 4.0012 7.4002 0.0 0
M  V30 9 C 4.0012 4.3201 0.0 0
M  V30 10 N 6.4792 4.0597 0.0 0
M  V30 11 C 2.6673 6.6302 0.0 0 CFG=2
M  V30 12 C 4.0012 8.9402 0.0 0
M  V30 13 C 4.3213 2.8138 0.0 0
M  V30 14 C 2.6673 5.0901 0.0 0
M  V30 15 C 5.8529 2.6527 0.0 0
M  V30 16 C 1.3337 7.4002 0.0 0
M  V30 17 C 2.6673 9.7102 0.0 0
M  V30 18 C 3.4161 1.5679 0.0 0
M  V30 19 C 6.4792 1.2459 0.0 0
M  V30 20 N 1.3337 8.9402 0.0 0
M  V30 21 C 4.0424 0.1609 0.0 0
M  V30 22 C 5.5740 0.0000 0.0 0
M  V30 23 C 6.6685 7.4002 0.0 0
M  V30 24 C 6.6685 8.9402 0.0 0
M  V30 25 C 8.0022 6.6302 0.0 0
M  V30 26 C 8.0022 9.7102 0.0 0
M  V30 27 C 9.3360 7.4002 0.0 0
M  V30 28 C 9.3360 8.9402 0.0 0
M  V30 29 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 16
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 23 CFG=1
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 11 14
M  V30 17 1 11 16
M  V30 18 1 11 29 CFG=3
M  V30 19 1 12 17
M  V30 20 1 13 15
M  V30 21 2 13 18
M  V30 22 2 15 19
M  V30 23 1 16 20
M  V30 24 1 17 20
M  V30 25 1 18 21
M  V30 26 1 19 22
M  V30 27 2 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1447959-78-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1447960-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8102439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3. General procedure for the synthesis of
compounds 10 and 11. A mixture of 9a (100 mg, 0.25 mmol) and propylamine
(64 mg, 1.25 mmol) in dry EtOH (10 ml) was stirred for 24 h at room
temperature. Then, the mixture was poured in water and extracted with
EtOAc for three times. The combined organic phases were washed, dried
(MgSO4) and evaporated in vacuo. Purification by means of column
chromatography on silicagel (hexane/EtOAc, 1/1) gave pure compound.
cis-6-(4-Methoxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
11e. Reactant:
cis-Ethyl-2-(2-chloroacetyl)-1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylate
9b. Yield 95%. White powder. mp: 250-250.5 °C, [α]D15 = -4.9° (c = 0.41,
CH2Cl2). 1H NMR-270 MHz (CDCl3): δ 3.00 (3H, s, Me), 3.22 (1H, ddd, J =
1.1, 11.6, 16.1 Hz, H-12a), 3.69 (3H, s, OMe), 3.77 (1H, dd, J = 16.1,
4.7 Hz, H-12b), 3.87 (1H, d, J = 17.6 Hz, H-3a), 4.05 (1H, d, J = 17.6
Hz, H-3b), 4.26 (1H, dd, J = 11.6, 4.7 Hz, H-13), 6.20 (1H, br. s, H-6),
6.74 (2H, dd, J = 8.8, 3.0 Hz, H-3', H-5'), 7.20-7.28 (5H, m, overlap,
H-2', H-6', H-8, H-9, H-10), 7.61 (1H, db, J = 9.1 Hz, H-11), 8.15 (1H,
br. s, H-7). 13C NMR-68 MHz (CDCl3): δ 23.17 (C-12), 33.60 (Me), 52.09
(C-3), 55.22 (OMe), 56.20 (C-13, C-6), 106.48 (Cquat), 111.24 (C-8),
113.93 (C-3', C-5'), 118.55 (C-11), 120.08 (C-10), 122.39 (C-9), 126.16
(Cquat), 128.69 (C-2', C-6'), 133.12 (Cquat), 133.34 (Cquat), 136.53
(Cquat), 159.03 (Cquat), 166.53 (C═O), 166.79 (C═O). IR (KBr) ν 3233
(NH), 2930, 1672 (C═O), 1651 (C═O), 1604, 1509, 1324, 1247, 1170, 1031
cm-1. MS m/z (%). 376 (M+H+, 50), 269 (50), 268 (100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of functionalized diketopiperazines as Cyclotryprostatin and
Tryprostatin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van, Tuyen Nguyen; Claes, Pieter; De Kimpe, Norbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(8), 1006-1010

$RFMT $RIREG SCHEME383 STEP1
$RXN



  6  1
$MOL
Glycine ethyl ester
C4H9NO2
459-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 N 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyl isothiocyanate
C8H7NS
622-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 6.9301 2.6673 0.0 0
M  V30 4 S 8.4701 2.6673 0.0 0
M  V30 5 C 3.0800 1.3337 0.0 0
M  V30 6 C 2.3100 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1,2-benzenedicarboxaldehyde
C9H8O2
147119-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 O 6.6687 3.0801 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 O 1.3338 0.0000 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 1.3338 3.0801 0.0 0
M  V30 10 C 2.6675 5.3901 0.0 0
M  V30 11 C 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-buten-3-yne
C5H6
78-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,4′-Dihydroxyacetophenone
C8H8O3
89-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 14-methyl-2-(1-methylethenyl)-5-[1-(methylimino)ethyl]-7-[(phenylmethyl...
C35H33N3O4
2754289-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.2650 6.6685 0.0 0
M  V30 2 C 12.0350 5.3348 0.0 0
M  V30 3 C 11.2650 9.3359 0.0 0
M  V30 4 O 12.0350 10.6696 0.0 0
M  V30 5 O 12.0350 8.0021 0.0 0
M  V30 6 C 13.5750 10.6696 0.0 0
M  V30 7 C 14.3450 12.0033 0.0 0
M  V30 8 C 4.9706 7.8018 0.0 0
M  V30 9 C 7.4149 2.6673 0.0 0
M  V30 10 N 6.6449 1.3337 0.0 0
M  V30 11 C 8.9549 2.6673 0.0 0
M  V30 12 C 7.4149 0.0000 0.0 0
M  V30 13 C 1.3338 7.9565 0.0 0
M  V30 14 C 1.3338 9.4966 0.0 0
M  V30 15 C 0.0000 7.1865 0.0 0
M  V30 16 C 7.4149 8.0021 0.0 0
M  V30 17 C 6.6449 6.6685 0.0 0
M  V30 18 N 8.9549 8.0021 0.0 0
M  V30 19 C 6.6449 9.3359 0.0 0
M  V30 20 C 7.4149 5.3348 0.0 0
M  V30 21 C 5.1049 6.6685 0.0 0
M  V30 22 C 9.7249 6.6685 0.0 0
M  V30 23 C 9.7249 9.3359 0.0 0
M  V30 24 C 7.4149 10.6696 0.0 0
M  V30 25 C 5.1049 9.3359 0.0 0
M  V30 26 C 6.6449 4.0011 0.0 0
M  V30 27 O 8.9549 5.3348 0.0 0
M  V30 28 C 4.3349 5.3348 0.0 0
M  V30 29 O 4.0743 7.8130 0.0 0
M  V30 30 C 8.9549 10.6696 0.0 0
M  V30 31 C 6.6449 12.0033 0.0 0
M  V30 32 C 4.3349 10.6696 0.0 0
M  V30 33 C 5.1049 4.0011 0.0 0
M  V30 34 C 2.8284 5.6550 0.0 0
M  V30 35 C 2.6675 7.1865 0.0 0
M  V30 36 C 5.1049 12.0033 0.0 0
M  V30 37 C 13.5750 5.3348 0.0 0
M  V30 38 C 14.3450 4.0011 0.0 0
M  V30 39 C 14.3450 6.6685 0.0 0
M  V30 40 C 15.8850 4.0011 0.0 0
M  V30 41 C 15.8850 6.6685 0.0 0
M  V30 42 C 16.6551 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 22 CFG=2
M  V30 3 1 2 37
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 23
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 25
M  V30 10 2 9 10 CFG=2
M  V30 11 1 9 11
M  V30 12 1 9 26
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 35
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 2 19 25
M  V30 26 1 20 26
M  V30 27 1 20 27
M  V30 28 2 21 28
M  V30 29 1 21 29
M  V30 30 1 22 27
M  V30 31 2 23 30
M  V30 32 1 24 30
M  V30 33 2 24 31
M  V30 34 1 25 32
M  V30 35 2 26 33
M  V30 36 1 28 33
M  V30 37 1 28 34
M  V30 38 1 29 35
M  V30 39 1 31 36
M  V30 40 2 32 36
M  V30 41 2 34 35
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 459-73-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 622-78-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 147119-69-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 78-80-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 89-84-9
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754289-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24903593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 12173-10-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst can be
recycled and reused, MWCNTs nanocomposite support used, catalyst prepared
and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biosynthesis of Cu/KF/Clinoptilolite@MWCNTs nanocomposite and its
application as a recyclable nanocatalyst for the synthesis of new Schiff
base of benzoxazine derivatives and reduction of organic pollutants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamedani, Naghmeh Faal; Hargalani, Fariba Zamani; Rostami-Charati,
Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2022), 26(4), 2069-2083

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3a,4,7,7a-tetrahydro-1,3-isobenzofurandione
C8H7ClO3
14737-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 Cl 7.2706 3.9844 0.0 0
M  V30 4 C 3.4206 2.6508 0.0 0
M  V30 5 C 2.6506 3.9844 0.0 0
M  V30 6 C 2.3902 1.5064 0.0 0
M  V30 7 C 4.9606 2.6508 0.0 0
M  V30 8 C 1.1444 3.6643 0.0 0
M  V30 9 C 3.4206 5.3182 0.0 0
M  V30 10 O 0.9834 2.1327 0.0 0
M  V30 11 C 5.7306 3.9844 0.0 0
M  V30 12 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-methyl-1H-isoindole-1,3(2H)-dione
C9H6ClNO2
63197-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4211 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 C 0.0000 2.7106 0.0 0
M  V30 4 Cl 7.9110 4.2506 0.0 0
M  V30 5 C 3.9099 3.4806 0.0 0
M  V30 6 C 3.9099 1.9406 0.0 0
M  V30 7 C 2.4452 3.9564 0.0 0
M  V30 8 C 5.2435 4.2506 0.0 0
M  V30 9 C 2.4452 1.4647 0.0 0
M  V30 10 C 5.2435 1.1706 0.0 0
M  V30 11 N 1.5400 2.7106 0.0 0
M  V30 12 C 6.5772 3.4806 0.0 0
M  V30 13 C 6.5772 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14737-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63197-17-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-17618822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for the preparation of 4-chlorophthalic anhydride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Odle, Roy Ray; Guggenheim, Thomas Link
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6528663 B1 2003-03-04

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3a,4,7,7a-tetrahydro-1,3-isobenzofurandione
C8H7ClO3
14737-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 Cl 7.2706 3.9844 0.0 0
M  V30 4 C 3.4206 2.6508 0.0 0
M  V30 5 C 2.6506 3.9844 0.0 0
M  V30 6 C 2.3902 1.5064 0.0 0
M  V30 7 C 4.9606 2.6508 0.0 0
M  V30 8 C 1.1444 3.6643 0.0 0
M  V30 9 C 3.4206 5.3182 0.0 0
M  V30 10 O 0.9834 2.1327 0.0 0
M  V30 11 C 5.7306 3.9844 0.0 0
M  V30 12 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-3a,4,7,7a-tetrahydro-2-methyl-1H-isoindole-1,3(2H)-dione
C9H10ClNO2
99233-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4211 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 C 0.0000 2.7106 0.0 0
M  V30 4 Cl 7.9110 4.2506 0.0 0
M  V30 5 C 3.9099 3.4806 0.0 0
M  V30 6 C 3.9099 1.9406 0.0 0
M  V30 7 C 2.4452 3.9564 0.0 0
M  V30 8 C 5.2435 4.2506 0.0 0
M  V30 9 C 2.4452 1.4647 0.0 0
M  V30 10 C 5.2435 1.1706 0.0 0
M  V30 11 N 1.5400 2.7106 0.0 0
M  V30 12 C 6.5772 3.4806 0.0 0
M  V30 13 C 6.5772 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14737-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99233-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-6095134
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 1. Synthesis of
N-methyl-4-chlorophthalimide (VIII). An appropriately equipped glass
reaction vessel was charged with 186.5 grams (1 mole) of
4-chlorotetrahydrophthalic anhydride and heated to 150°C under nitrogen.
Methylamine gas (32 grams, 1.03 mole) was then introduced to the reaction
vessel subsurface over 30 minutes. The reaction mixture was then heated
for 3 hours at 180°C. The product was then distilled to give
N-methyl-4-chlorophthalimide. N-methyl-4-chlorotetrahydrophthalimide (X).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted phthalic anhydrides especially
4-chlorophthalic anhydride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Odle, Roy Ray; Guggenheim, Thomas Link
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004072012 A1 2004-08-26

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-(2-Phenylethynyl)phenyl]ethanone
C16H12O
147492-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 C 0.0000 1.3338 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 3.8500 5.3349 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 10.0100 5.3349 0.0 0
M  V30 14 C 10.0100 2.6674 0.0 0
M  V30 15 C 11.5500 5.3349 0.0 0
M  V30 16 C 11.5500 2.6674 0.0 0
M  V30 17 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[1-[3-(2-phenylethynyl)phenyl]ethylidene]-
C17H15N
3061733-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 C 4.0010 3.0801 0.0 0
M  V30 3 C 10.6697 3.8501 0.0 0
M  V30 4 N 12.0033 4.6201 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 8.0022 3.8501 0.0 0
M  V30 9 C 6.6685 6.1601 0.0 0
M  V30 10 C 9.3360 4.6201 0.0 0
M  V30 11 C 8.0022 6.9302 0.0 0
M  V30 12 C 9.3360 6.1601 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 0.0000 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 2 3 4 CFG=2
M  V30 5 1 3 5
M  V30 6 1 3 10
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147492-77-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3061733-81-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42450027
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A ligand-assisted proximity effect allows for H2-driven copper hydride
chemistry under mild conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gorai, Mahadeb; Rotering, Philipp; Franzen, Jonas; Dielmann, Fabian;
Teichert, Johannes F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2024), 1-9

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5β,7α,12α)-7,12-dihydroxy-3-oxocholan-24-oate
C25H40O5
14772-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0020 0.7700 0.0 0
M  V30 2 C 8.1631 6.9217 0.0 0
M  V30 3 C 3.3501 4.4759 0.0 0
M  V30 4 C 8.8404 7.2728 0.0 0 CFG=2
M  V30 5 C 9.7455 8.5187 0.0 0
M  V30 6 C 7.3087 7.4338 0.0 0
M  V30 7 C 9.1192 9.9257 0.0 0
M  V30 8 C 10.0244 11.1715 0.0 0
M  V30 9 O 9.3981 12.5783 0.0 0
M  V30 10 O 11.5559 11.0106 0.0 0
M  V30 11 C 10.3031 13.8243 0.0 0
M  V30 12 O 6.6684 7.7000 0.0 0
M  V30 13 O 0.0000 0.7700 0.0 0
M  V30 14 C 6.6684 3.0800 0.0 0 CFG=2
M  V30 15 C 8.0020 3.8500 0.0 0 CFG=2
M  V30 16 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 17 C 6.6684 1.5400 0.0 0 CFG=2
M  V30 18 C 8.0020 5.3900 0.0 0 CFG=1
M  V30 19 C 9.4667 3.3742 0.0 0
M  V30 20 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 21 C 5.3347 5.3900 0.0 0
M  V30 22 C 5.3347 0.7700 0.0 0
M  V30 23 C 9.4667 5.8660 0.0 0 CFG=1
M  V30 24 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 25 C 10.3720 4.6200 0.0 0
M  V30 26 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 27 C 2.6673 3.8500 0.0 0
M  V30 28 C 2.6673 0.7700 0.0 0
M  V30 29 C 1.3336 3.0800 0.0 0
M  V30 30 C 1.3336 1.5400 0.0 0
M  V30 31 H 7.7573 1.9911 0.0 0
M  V30 32 H 8.7953 2.5301 0.0 0
M  V30 33 H 4.2458 4.9391 0.0 0
M  V30 34 H 10.8004 6.6360 0.0 0
M  V30 35 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=3
M  V30 2 1 18 2 CFG=1
M  V30 3 1 20 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 23
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 24 12 CFG=3
M  V30 13 2 13 30
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 31 CFG=1
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 32 CFG=3
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 16 33 CFG=3
M  V30 24 1 17 22
M  V30 25 1 18 23
M  V30 26 1 18 24
M  V30 27 1 19 25
M  V30 28 1 20 26
M  V30 29 1 20 27
M  V30 30 1 21 24
M  V30 31 1 22 26
M  V30 32 1 23 25
M  V30 33 1 23 34 CFG=3
M  V30 34 1 26 28
M  V30 35 1 26 35 CFG=1
M  V30 36 1 27 29
M  V30 37 1 28 30
M  V30 38 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 4 14 15 16 17 18 20 23 24 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cholan-24-oic acid, 7,12-dihydroxy-3-(methylamino)-, methyl ester, (3α,5β,7α,...
C26H45NO4
753013-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 8.4700 0.0 0
M  V30 2 C 9.4090 5.5336 0.0 0
M  V30 3 C 4.8843 2.5884 0.0 0
M  V30 4 C 10.0518 5.9446 0.0 0 CFG=2
M  V30 5 C 11.5833 6.1055 0.0 0
M  V30 6 C 9.4253 4.5376 0.0 0
M  V30 7 C 12.4885 4.8596 0.0 0
M  V30 8 C 14.0201 5.0206 0.0 0
M  V30 9 O 14.9253 3.7747 0.0 0
M  V30 10 O 14.6464 6.4275 0.0 0
M  V30 11 C 16.4568 3.9356 0.0 0
M  V30 12 O 9.3358 3.8500 0.0 0
M  V30 13 N 0.0000 1.5400 0.0 0
M  V30 14 C 0.0000 0.0000 0.0 0
M  V30 15 C 5.3347 6.1600 0.0 0 CFG=2
M  V30 16 C 6.6684 6.9300 0.0 0 CFG=2
M  V30 17 C 5.3347 4.6200 0.0 0 CFG=2
M  V30 18 C 4.0011 6.9300 0.0 0 CFG=2
M  V30 19 C 8.0020 6.1600 0.0 0 CFG=1
M  V30 20 C 6.9886 8.4363 0.0 0
M  V30 21 C 4.0011 3.8500 0.0 0 CFG=2
M  V30 22 C 6.6684 3.8500 0.0 0
M  V30 23 C 2.6673 6.1600 0.0 0
M  V30 24 C 9.1466 7.1905 0.0 0 CFG=1
M  V30 25 C 8.0020 4.6200 0.0 0 CFG=1
M  V30 26 C 8.5202 8.5972 0.0 0
M  V30 27 C 2.6673 4.6200 0.0 0 CFG=1
M  V30 28 C 4.0011 2.3100 0.0 0
M  V30 29 C 1.3336 3.8500 0.0 0
M  V30 30 C 2.6673 1.5400 0.0 0
M  V30 31 C 1.3336 2.3100 0.0 0 CFG=2
M  V30 32 H 4.9362 7.6475 0.0 0
M  V30 33 H 5.6993 8.1268 0.0 0
M  V30 34 H 5.7333 3.1324 0.0 0
M  V30 35 H 10.4802 7.9605 0.0 0
M  V30 36 H 1.3336 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=1
M  V30 2 1 19 2 CFG=3
M  V30 3 1 21 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=1
M  V30 6 1 4 24
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 25 12 CFG=1
M  V30 13 1 13 14
M  V30 14 1 31 13 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 32 CFG=3
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 33 CFG=1
M  V30 22 1 17 21
M  V30 23 1 17 22
M  V30 24 1 17 34 CFG=1
M  V30 25 1 18 23
M  V30 26 1 19 24
M  V30 27 1 19 25
M  V30 28 1 20 26
M  V30 29 1 21 27
M  V30 30 1 21 28
M  V30 31 1 22 25
M  V30 32 1 23 27
M  V30 33 1 24 26
M  V30 34 1 24 35 CFG=1
M  V30 35 1 27 29
M  V30 36 1 27 36 CFG=3
M  V30 37 1 28 30
M  V30 38 1 29 31
M  V30 39 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 4 15 16 17 18 19 21 24 25 27 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14772-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 753013-04-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8850606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method D. Preparation of Amine-Linked Derivatives of Cholic Acid. Method
D1. Preparation of Compound 9a. 3-Oxo-cholic acid methyl ester, prepared
according to the method of Tserng (550 mg, 1.3 mmol), was dissolved in 10
mL of acetonitrile and stirred with 5.0 mL of 2.0 M methanolic
methylamine for 30 min at ambient temperature. 110 mg (1.6 mmol) of
NaCNBH3 was added, and stirring was continued for 2 h at room
temperature. 5 drops of acetic acid was added; stirring was continued for
an additional 1h, until TLC indicated that no starting ketone remained.
10 mL of water was added; the resultant mixture was extracted with ethyl
acetate and dried over Na2SO4. This crude product (540 mg, 95%) was
carried forward without further purification. 300 mg (0.69 mmol) of the
crude amine is combined with 3 equiv of Hunig's base and 130 mg (0.69
mmol) of 4-bromobutyryl chloride in acetonitrile (6.0 mL); the resultant
mixture was stirred overnight in a sealed bottle at ambient temperature.
The resultant solution was carried forward without workup or
purification.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Liver-selective glucocorticoid antagonists: a novel treatment for type 2
diabetes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM von Geldern, Thomas W.; Tu, Noah; Kym, Philip R.; Link, James T.; Jae,
Hwan-Soo; Lai, Chunqiu; Apelqvist, Theresa; Rhonnstad, Patrik; Hagberg,
Lars; Koehler, Konrad; Grynfarb, Marlena; Goos-Nilsson, Annika; Sandberg,
Johnny; Oesterlund, Marie; Barkhem, Tomas; Hoeglund, Marie; Wang,
Jiahong; Fung, Steven; Wilcox, Denise; Nguyen, Phong; Jakob, Clarissa;
Hutchins, Charles; Faernegrdh, Mathias; Kauppi, Bjoern; Oehman, Lars;
Jacobson, Peer B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(17), 4213-4230

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[[[2-[[(2S)-2-[(phenylmethoxy)carbonyl]-1-pyrrolidin...
C29H35N3O6
1496550-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0453 3.5673 0.0 0
M  V30 2 O 8.3654 5.0737 0.0 0
M  V30 3 C 5.3349 5.5366 0.0 0
M  V30 4 O 4.0011 6.3066 0.0 0
M  V30 5 O 6.6685 6.3066 0.0 0
M  V30 6 C 4.0011 7.8466 0.0 0
M  V30 7 N 10.9745 4.5191 0.0 0
M  V30 8 C 12.4392 4.9950 0.0 0
M  V30 9 O 13.5836 3.9644 0.0 0
M  V30 10 C 15.4999 6.3577 0.0 0
M  V30 11 O 16.8336 7.1277 0.0 0
M  V30 12 O 15.4999 4.8177 0.0 0
M  V30 13 C 18.1672 6.3577 0.0 0
M  V30 14 C 18.9372 7.6914 0.0 0
M  V30 15 C 19.5010 5.5877 0.0 0
M  V30 16 C 17.3972 5.0239 0.0 0
M  V30 17 N 6.5807 3.0914 0.0 0
M  V30 18 C 5.3349 3.9966 0.0 0 CFG=2
M  V30 19 C 6.1049 1.6267 0.0 0
M  V30 20 C 4.0889 3.0914 0.0 0
M  V30 21 C 4.5649 1.6267 0.0 0
M  V30 22 C 9.1898 2.5368 0.0 0
M  V30 23 C 10.6543 3.0127 0.0 0
M  V30 24 C 8.8696 1.0304 0.0 0
M  V30 25 C 11.7989 1.9823 0.0 0
M  V30 26 C 10.0140 0.0000 0.0 0
M  V30 27 C 11.4787 0.4759 0.0 0
M  V30 28 C 2.6674 8.6166 0.0 0
M  V30 29 C 1.3338 7.8466 0.0 0
M  V30 30 C 2.6674 10.1566 0.0 0
M  V30 31 C 0.0000 8.6166 0.0 0
M  V30 32 C 1.3338 10.9266 0.0 0
M  V30 33 C 0.0000 10.1566 0.0 0
M  V30 34 C 12.7594 6.5013 0.0 0 CFG=2
M  V30 35 N 14.1663 7.1277 0.0 0
M  V30 36 C 11.7289 7.6458 0.0 0
M  V30 37 C 14.0052 8.6593 0.0 0
M  V30 38 C 12.4989 8.9794 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 22
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 18 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 6 28
M  V30 9 1 7 8
M  V30 10 1 7 23
M  V30 11 2 8 9
M  V30 12 1 34 8 CFG=3
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 10 35
M  V30 16 1 11 13
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 1 13 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 18 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[[[2-[[(2S)-2-[(methylamino)carbonyl]-1-pyrrolidinyl...
C23H32N4O5
1496550-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.8455 3.0800 0.0 0
M  V30 2 O 4.8455 4.6200 0.0 0
M  V30 3 C 1.7847 4.4427 0.0 0
M  V30 4 N 0.3202 4.9186 0.0 0
M  V30 5 O 2.9292 5.4732 0.0 0
M  V30 6 C 0.0000 6.4250 0.0 0
M  V30 7 N 7.5129 4.6200 0.0 0
M  V30 8 C 8.8465 5.3900 0.0 0
M  V30 9 O 10.1802 4.6200 0.0 0
M  V30 10 C 11.5571 7.3594 0.0 0
M  V30 11 O 12.7015 8.3898 0.0 0
M  V30 12 O 11.8773 5.8531 0.0 0
M  V30 13 C 14.1662 7.9139 0.0 0
M  V30 14 C 13.6903 6.4494 0.0 0
M  V30 15 C 15.6307 7.4380 0.0 0
M  V30 16 C 14.6420 9.3786 0.0 0
M  V30 17 N 3.5118 2.3100 0.0 0
M  V30 18 C 2.1049 2.9365 0.0 0 CFG=2
M  V30 19 C 3.3509 0.7785 0.0 0
M  V30 20 C 1.0745 1.7919 0.0 0
M  V30 21 C 1.8445 0.4583 0.0 0
M  V30 22 C 6.1791 2.3100 0.0 0
M  V30 23 C 7.5129 3.0800 0.0 0
M  V30 24 C 6.1791 0.7700 0.0 0
M  V30 25 C 8.8465 2.3100 0.0 0
M  V30 26 C 7.5129 0.0000 0.0 0
M  V30 27 C 8.8465 0.7700 0.0 0
M  V30 28 C 8.8465 6.9300 0.0 0 CFG=2
M  V30 29 N 10.0924 7.8352 0.0 0
M  V30 30 C 7.6007 7.8352 0.0 0
M  V30 31 C 9.6165 9.2999 0.0 0
M  V30 32 C 8.0765 9.2999 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 1 22
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 18 3 CFG=1
M  V30 7 1 4 6
M  V30 8 1 7 8
M  V30 9 1 7 23
M  V30 10 2 8 9
M  V30 11 1 28 8 CFG=3
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 10 29
M  V30 15 1 11 13
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 13 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 18 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1496550-79-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1496550-71-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5997439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ester vs. amide on folding: a case study with a 2-residue synthetic
peptide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vijayadas, Kuruppanthara N.; Nair, Roshna V.; Gawade, Rupesh L.; Kotmale,
Amol S.; Prabhakaran, Panchami; Gonnade, Rajesh G.; Puranik, Vedavadi G.;
Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2013), 11(48), 8348-8356

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
3-(2-Bromophenyl)propionic acid
C9H9BrO2
15115-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 Br 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzenepropanamide
C10H12BrNO
163810-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6684 3.0800 0.0 0
M  V30 4 N 8.0021 2.3100 0.0 0
M  V30 5 O 6.6684 4.6200 0.0 0
M  V30 6 C 9.3358 3.0800 0.0 0
M  V30 7 Br 1.3336 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15115-58-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 163810-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18448349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Catalyzed Carbon-Carbon Bond-Forming Reductive Amination
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heinz, Christoph; Lutz, J. Patrick; Simmons, Eric M.; Miller, Michael M.;
Ewing, William R.; Doyle, Abigail G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2018), 140(6), 2292-2300

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
6-(4-Chlorophenyl)-4-(methylthio)-2-oxo-2H-pyran-3-carboxylic acid
C13H9ClO4S
1512808-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0012 0.0 0
M  V30 2 O 0.0000 2.6675 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 S 2.3101 1.3338 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 O 2.3101 6.6687 0.0 0
M  V30 7 Cl 11.5503 4.0012 0.0 0
M  V30 8 C 2.3101 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 O 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 7.7002 2.6675 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 10
M  V30 7 1 7 19
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenyl)-N-methyl-4-(methylthio)-2-oxo-2H-pyran-3-carboxamide
C14H12ClNO3S
1512808-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 4.0012 0.0 0
M  V30 2 N 1.5400 5.3348 0.0 0
M  V30 3 O 1.5400 2.6675 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 S 3.8501 1.3338 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 O 3.8501 6.6687 0.0 0
M  V30 8 Cl 13.0903 4.0012 0.0 0
M  V30 9 C 3.8501 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 13 O 6.1601 5.3348 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 8.4702 4.0012 0.0 0
M  V30 16 C 9.2402 5.3348 0.0 0
M  V30 17 C 9.2402 2.6675 0.0 0
M  V30 18 C 10.7802 5.3348 0.0 0
M  V30 19 C 10.7802 2.6675 0.0 0
M  V30 20 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 11
M  V30 8 1 8 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1512808-60-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1512808-16-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5982420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General method for the preparation of
substituted 4-(methylthio)-2-oxo-6-phenyl-2H-pyran-3-carboxamides (11) To
a stirring solution of appropriately substituted 10 (0.76 mmoles) in DMF
at rt, HATU (0.83 mmoles) and diisopropylethylamine (2.29 mmoles) was
added. Appropriately substituted amine (0.76 mmoles) was added after 15
min and stirring continued for another 1h at rt. The reaction was
monitored by TLC and then poured into ice water with stirring. The so
formed precipitate was filtered off and recrystallized from a mixture of
ethyl acetate and n-hexane to get pure compound.
6-(4-fluorophenyl)-4-(methylthio)-2-oxo-N-phenyl-2H-pyran-3-carboxamide
6-(4-chlorophenyl)-N-methyl-4-(methylthio)-2-oxo-2H-pyran-3-carboxamide
Yellow powder; Yield 95 %. mp 205-206°C; Mass [M+] = 310.3, [M++2] =
312.3; 1H NMR: (400 MHz, DMSO-d6): δ 2.59 (s, 3H, Me), 2.75-2.76 (d, J =
4.4 Hz, 3H, Me), 7.17 (s, 1H, Pyrone), 7.63-7.65 (d, J = 8.8 Hz, 2H,
ArH), 8.02-8.04 (d, J = 8.4 Hz, 2H, ArH), 8.64-8.65 (q, J = 5.2 Hz, 1H,
NH amide).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide
Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konreddy, Ananda Kumar; Toyama, Massaki; Ito, Wataru; Bal, Chandralata;
Baba, Masanori; Sharon, Ashoke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(3), 259-263

$RFMT $RIREG SCHEME391 STEP1
$RXN



  6  1
$MOL
Aminoacetonitrile
C2H4N2
540-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 N 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenyl isothiocyanate
C8H7NOS
2284-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 C 8.0023 0.7700 0.0 0
M  V30 3 S 9.3360 1.5400 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-1,2-benzenedicarboxaldehyde
C9H8O2
15158-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 C 2.3100 1.3338 0.0 0
M  V30 4 O 3.0800 0.0000 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-buten-3-yne
C5H6
78-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,4′-Dihydroxyacetophenone
C8H8O3
89-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[(4-Methoxyphenyl)imino]-12-methyl-2-(1-methylethenyl)-5-[1-(methylimino)et...
C33H28N4O3
2754289-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0147 7.7002 0.0 0
M  V30 2 C 8.6810 10.0102 0.0 0
M  V30 3 N 10.0147 10.7802 0.0 0
M  V30 4 C 8.6810 2.3101 0.0 0
M  V30 5 N 8.6810 0.7700 0.0 0
M  V30 6 C 10.0147 3.0801 0.0 0
M  V30 7 C 10.0147 0.0000 0.0 0
M  V30 8 C 0.7700 3.8501 0.0 0
M  V30 9 C 0.0000 2.5164 0.0 0
M  V30 10 C 0.0000 5.1838 0.0 0
M  V30 11 C 0.6787 10.0102 0.0 0
M  V30 12 O 15.3495 4.6201 0.0 0
M  V30 13 C 16.6832 5.3901 0.0 0
M  V30 14 C 6.0135 6.9302 0.0 0
M  V30 15 C 6.0135 5.3901 0.0 0
M  V30 16 N 7.3473 7.7002 0.0 0
M  V30 17 C 4.6799 7.7002 0.0 0
M  V30 18 C 7.3473 4.6201 0.0 0
M  V30 19 C 4.6799 4.6201 0.0 0
M  V30 20 C 8.6810 6.9302 0.0 0
M  V30 21 C 7.3473 9.2402 0.0 0
M  V30 22 C 4.6799 9.2402 0.0 0
M  V30 23 C 3.3462 6.9302 0.0 0
M  V30 24 C 7.3473 3.0801 0.0 0
M  V30 25 O 8.6810 5.3901 0.0 0
M  V30 26 C 4.6799 3.0801 0.0 0
M  V30 27 O 3.2153 5.0960 0.0 0
M  V30 28 C 6.0135 10.0102 0.0 0
M  V30 29 C 3.3462 10.0102 0.0 0
M  V30 30 C 2.0125 7.7002 0.0 0
M  V30 31 C 6.0135 2.3101 0.0 0
M  V30 32 C 3.2153 2.6042 0.0 0
M  V30 33 C 2.3101 3.8501 0.0 0
M  V30 34 C 2.0125 9.2402 0.0 0
M  V30 35 C 11.3484 6.9302 0.0 0
M  V30 36 C 11.3484 5.3901 0.0 0
M  V30 37 C 12.6822 7.7002 0.0 0
M  V30 38 C 12.6822 4.6201 0.0 0
M  V30 39 C 14.0158 6.9302 0.0 0
M  V30 40 C 14.0158 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20 CFG=2
M  V30 2 1 1 35
M  V30 3 3 2 3
M  V30 4 1 2 21
M  V30 5 2 4 5 CFG=2
M  V30 6 1 4 6
M  V30 7 1 4 24
M  V30 8 1 5 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 33
M  V30 12 1 11 34
M  V30 13 1 12 13
M  V30 14 1 12 40
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 17 22
M  V30 23 2 17 23
M  V30 24 1 18 24
M  V30 25 1 18 25
M  V30 26 2 19 26
M  V30 27 1 19 27
M  V30 28 1 20 25
M  V30 29 2 21 28
M  V30 30 1 22 28
M  V30 31 2 22 29
M  V30 32 1 23 30
M  V30 33 2 24 31
M  V30 34 1 26 31
M  V30 35 1 26 32
M  V30 36 1 27 33
M  V30 37 1 29 34
M  V30 38 2 30 34
M  V30 39 2 32 33
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 540-61-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2284-20-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15158-36-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 78-80-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 89-84-9
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754289-92-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24903599
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 12173-10-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst prepared and
used, catalyst can be recycled and reused, MWCNTs nanocomposite support
used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biosynthesis of Cu/KF/Clinoptilolite@MWCNTs nanocomposite and its
application as a recyclable nanocatalyst for the synthesis of new Schiff
base of benzoxazine derivatives and reduction of organic pollutants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamedani, Naghmeh Faal; Hargalani, Fariba Zamani; Rostami-Charati,
Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2022), 26(4), 2069-2083

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethenyl-N,N-dimethyl-4-pyridinamine
C9H12N2
151732-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 N 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dimethylamino)-N-[2-[4-(dimethylamino)-2-pyridinyl]ethyl]-N-methyl-2-pyrid...
C19H29N5
494190-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 12.0035 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 N 17.3383 3.0801 0.0 0
M  V30 11 C 18.6720 2.3101 0.0 0
M  V30 12 C 17.3383 4.6201 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 3.0801 0.0 0
M  V30 15 N 5.3348 0.7700 0.0 0
M  V30 16 C 2.6675 2.3101 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 2.6675 0.7700 0.0 0
M  V30 19 C 13.3372 2.3101 0.0 0
M  V30 20 C 14.6708 3.0801 0.0 0
M  V30 21 N 13.3372 0.7700 0.0 0
M  V30 22 C 16.0045 2.3101 0.0 0
M  V30 23 C 14.6708 0.0000 0.0 0
M  V30 24 C 16.0045 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 22
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 151732-33-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 494190-95-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-6176328
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Me2N-MePY2. In a pressure tube (Ace pressure tube, Aldrich Z18,106-111),
13 (1.5 mg, 10 mmol) was dissolved in 2 mL of a 2 M methanol solution of
MeNH2 along with 2 mL of MeOH and a catalytic amount of AcOH. The mixture
was heated at 80 °C for 4 days, cooled to room temperature, and the
volatiles removed by high vacuum rotary evaporation. The resulting brown
oil was dissolved in CH2Cl2, washed with 1 M NaOH (aq), and dried over
Na2SO4. Removal of the solvent, followed by purification by column
chromatography (silica, 95:5 EtOAc/MeOH) produced the title compound as
an off white solid (1.2 g, 95%). Me2N-MePY2, yield 1.2 g, 95%. Rf = 0.13
(silica, 1% MeOH/99% CH2Cl2). 1H-NMR (300 MHz, CDCl3): δ 8.14 (2H, d, J =
6 Hz), 6.38 (2H, d, J = 3 Hz), 6.34 (2H, dd, J = 6 Hz, J= 3 Hz), 2.97
(12H, s), 2.86 (8H, m), 2.41 (8H, m). FAB m/z (M + H+) = 328.4.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tuning Copper-Dioxygen Reactivity and Exogenous Substrate Oxidations via
Alterations in Ligand Electronics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Christiana Xin; Liang, Hong-Chang; Kim, Eun-il; Shearer, Jason;
Helton, Matthew E.; Kim, Eunsuk; Kaderli, Susan; Incarvito, Christopher
D.; Zuberbuehler, Andreas D.; Rheingold, Arnold L.; Karlin, Kenneth D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2003), 125(3), 634-635

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-6-methyl-2-(trifluoromethyl)imidazo[1,2-a]pyridine
C9H6F4N2
1519058-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.5094 0.0000 0.0 0
M  V30 2 C 1.5400 2.7104 0.0 0
M  V30 3 F 1.5400 4.2504 0.0 0
M  V30 4 F 0.0000 2.7104 0.0 0
M  V30 5 F 1.5400 1.1704 0.0 0
M  V30 6 C 9.4510 1.1704 0.0 0
M  V30 7 N 5.4499 1.9404 0.0 0
M  V30 8 C 5.4499 3.4804 0.0 0
M  V30 9 C 3.9852 1.4645 0.0 0
M  V30 10 C 6.7835 1.1704 0.0 0
M  V30 11 N 3.9852 3.9564 0.0 0
M  V30 12 C 6.7835 4.2504 0.0 0
M  V30 13 C 3.0800 2.7104 0.0 0
M  V30 14 C 8.1172 1.9404 0.0 0
M  V30 15 C 8.1172 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 13
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 2 12 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,6-Dimethyl-2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-amine
C10H10F3N3
1620629-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5094 1.1444 0.0 0
M  V30 2 C 4.5398 0.0000 0.0 0
M  V30 3 C 1.5400 3.8549 0.0 0
M  V30 4 F 1.5400 2.3149 0.0 0
M  V30 5 F 0.0000 3.8549 0.0 0
M  V30 6 F 1.5400 5.3949 0.0 0
M  V30 7 C 9.4510 2.3149 0.0 0
M  V30 8 N 5.4499 3.0849 0.0 0
M  V30 9 C 3.9852 2.6091 0.0 0
M  V30 10 C 5.4499 4.6249 0.0 0
M  V30 11 C 6.7835 2.3149 0.0 0
M  V30 12 C 3.0800 3.8549 0.0 0
M  V30 13 N 3.9852 5.1008 0.0 0
M  V30 14 C 6.7835 5.3949 0.0 0
M  V30 15 C 8.1172 3.0849 0.0 0
M  V30 16 C 8.1172 4.6249 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 12
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 13
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1519058-47-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620629-51-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13634192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
Methyl-(6-methyl-2-trifluoromethylimidazo[1,2-a]pyridin-3-yl)amine (4a).
A solution of imidazopyridine 2a (2.2 g, 0.01 mol) and methylamine 3
(0.93 g, 0.03 mol) in CH3CN (20 mL) was heated in a sealed vessel for 6 h
at 80 °C. Then, the reaction mixture was poured into H2O (50 mL), A
precipitate formed was filtered off and recrystallized from 50% aq.
ethanol. The yield was 2.1 g (95%). M.p. 51-53 °C. Found (%): C, 52.64;
H, 4.21; N, 18.52. C10H10F3N3. Calculated (%): C, 52.40; H, 4.40; N,
18.33. 1H NMR (CDCl3), δ: 2.56 (s, 3 H, Me); 2.81 (d, 3 H, MeN, J = 5.8
Hz); 3.46 (q, 1 H, NH, J = 5.8 Hz); 6.77 (t, 1 H, CHAr, J = 6.8 Hz); 7.00
(d, 1 H, CHAr, J = 6.8 Hz); 7.91 (d, 1 H, CHAr, J = 6.8 Hz). 19F NMR
(CDCl3), δ: 16.52 s.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modification of biologically active amides and amines by
fluoro-containing heterocycles 10. γ-Carbolines modified by
2-trifluoromethylimidazo[1,2-a]pyridin-3-ylpropionamide fragments
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bachurin, S. O.; Sokolov, V. B.; Aksinenko, A. Yu.; Epishina, T. A.;
Goreva, T. V.; Grigor'ev, V. V.; Zamoiskii, V. L.; Gabrel'yan, A. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2013), 62(11), 2438-2441

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(imino-1H-pyrazol-1-ylmethyl)carbamate
C9H14N4O2
152120-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 N 5.1048 1.8517 0.0 0
M  V30 3 N 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6218 0.0 0
M  V30 8 C 8.3359 3.9554 0.0 0
M  V30 9 C 10.4396 3.3918 0.0 0
M  V30 10 C 9.8759 1.2881 0.0 0
M  V30 11 N 2.4374 1.8517 0.0 0
M  V30 12 C 2.2763 0.3202 0.0 0
M  V30 13 N 1.0304 2.4782 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[imino(methylamino)methyl]carbamate
C7H15N3O2
935530-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 2.1037 2.6673 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 0.5637 0.0000 0.0 0
M  V30 7 N 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 N 8.0023 0.5637 0.0 0
M  V30 11 N 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 152120-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 935530-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-18242984
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Debromokeramadine from the marine sponge Agelas cf. mauritiana: isolation
and short regioselective and flexible synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schroif-Gregoire, Cosima; Appenzeller, Jerome; Debitus, Cecile;
Zaparucha, Anne; Al-Mourabit, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2015), 71(22), 3609-3613

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(imino-1H-pyrazol-1-ylmethyl)carbamate
C9H14N4O2
152120-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 N 5.1048 1.8517 0.0 0
M  V30 3 N 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6218 0.0 0
M  V30 8 C 8.3359 3.9554 0.0 0
M  V30 9 C 10.4396 3.3918 0.0 0
M  V30 10 C 9.8759 1.2881 0.0 0
M  V30 11 N 2.4374 1.8517 0.0 0
M  V30 12 C 2.2763 0.3202 0.0 0
M  V30 13 N 1.0304 2.4782 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[imino(methylamino)methyl]carbamate
C7H15N3O2
935530-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 2.1037 2.6673 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 0.5637 0.0000 0.0 0
M  V30 7 N 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 N 8.0023 0.5637 0.0 0
M  V30 11 N 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 152120-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 935530-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-8506939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-alkyl-N'-carboalkoxy guanidines: unexpected effective
trans-alkoxylation transforming the 2,2,2-trichloroethoxycarbonyl into
various carbamates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schroif-Gregoire, Cosima; Barale, Karine; Zaparucha, Anne; Al-Mourabit,
Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2007), 48(13), 2357-2359

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C29H44N4O6
1539320-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 O 8.0022 4.6201 0.0 0
M  V30 3 C 11.0630 4.4428 0.0 0
M  V30 4 N 12.5277 4.9187 0.0 0
M  V30 5 O 9.9186 5.4733 0.0 0
M  V30 6 C 12.8479 6.4250 0.0 0 CFG=1
M  V30 7 C 14.3125 6.9010 0.0 0
M  V30 8 C 11.7033 7.4556 0.0 0
M  V30 9 O 15.4570 5.8705 0.0 0
M  V30 10 O 14.6326 8.4074 0.0 0
M  V30 11 C 12.0235 8.9619 0.0 0
M  V30 12 C 16.9216 6.3463 0.0 0
M  V30 13 C 13.4882 9.4378 0.0 0
M  V30 14 C 10.8791 9.9924 0.0 0
M  V30 15 N 5.3348 4.6201 0.0 0
M  V30 16 C 4.0010 5.3901 0.0 0
M  V30 17 C 4.0010 6.9302 0.0 0 CFG=2
M  V30 18 O 2.6673 4.6201 0.0 0
M  V30 19 N 2.6673 7.7002 0.0 0
M  V30 20 C 5.3348 7.7002 0.0 0
M  V30 21 C 2.6673 9.2402 0.0 0
M  V30 22 C 6.6685 6.9302 0.0 0
M  V30 23 C 5.3348 9.2402 0.0 0
M  V30 24 C 1.3337 10.0102 0.0 0
M  V30 25 O 4.0010 10.0102 0.0 0
M  V30 26 C 2.1037 11.3439 0.0 0
M  V30 27 C 0.0000 10.7802 0.0 0
M  V30 28 C 0.5637 8.6765 0.0 0
M  V30 29 N 9.3358 2.3101 0.0 0
M  V30 30 C 10.7428 2.9364 0.0 0 CFG=2
M  V30 31 C 9.4969 0.7785 0.0 0
M  V30 32 C 11.7732 1.7920 0.0 0
M  V30 33 C 11.0032 0.4583 0.0 0
M  V30 34 C 6.6685 2.3101 0.0 0
M  V30 35 C 5.3348 3.0801 0.0 0
M  V30 36 C 6.6685 0.7700 0.0 0
M  V30 37 C 4.0010 2.3101 0.0 0
M  V30 38 C 5.3348 0.0000 0.0 0
M  V30 39 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 29
M  V30 3 1 1 34
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 30 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=1
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 35
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 17 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H45N5O5
1539320-44-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 O 8.0022 4.6201 0.0 0
M  V30 3 C 11.0630 4.4428 0.0 0
M  V30 4 N 12.5277 4.9187 0.0 0
M  V30 5 O 9.9186 5.4733 0.0 0
M  V30 6 C 12.8479 6.4250 0.0 0 CFG=1
M  V30 7 C 14.3125 6.9010 0.0 0
M  V30 8 C 11.7033 7.4556 0.0 0
M  V30 9 N 15.4570 5.8705 0.0 0
M  V30 10 O 14.6326 8.4074 0.0 0
M  V30 11 C 12.0235 8.9619 0.0 0
M  V30 12 C 16.9216 6.3463 0.0 0
M  V30 13 C 13.4882 9.4378 0.0 0
M  V30 14 C 10.8791 9.9924 0.0 0
M  V30 15 N 5.3348 4.6201 0.0 0
M  V30 16 C 4.0010 5.3901 0.0 0
M  V30 17 C 4.0010 6.9302 0.0 0 CFG=2
M  V30 18 O 2.6673 4.6201 0.0 0
M  V30 19 N 2.6673 7.7002 0.0 0
M  V30 20 C 5.3348 7.7002 0.0 0
M  V30 21 C 2.6673 9.2402 0.0 0
M  V30 22 C 5.3348 9.2402 0.0 0
M  V30 23 C 6.6685 6.9302 0.0 0
M  V30 24 C 1.3337 10.0102 0.0 0
M  V30 25 O 4.0010 10.0102 0.0 0
M  V30 26 C 0.5637 8.6765 0.0 0
M  V30 27 C 0.0000 10.7802 0.0 0
M  V30 28 C 2.1037 11.3439 0.0 0
M  V30 29 N 9.3358 2.3101 0.0 0
M  V30 30 C 10.7428 2.9364 0.0 0 CFG=2
M  V30 31 C 9.4969 0.7785 0.0 0
M  V30 32 C 11.7732 1.7920 0.0 0
M  V30 33 C 11.0032 0.4583 0.0 0
M  V30 34 C 6.6685 2.3101 0.0 0
M  V30 35 C 5.3348 3.0801 0.0 0
M  V30 36 C 6.6685 0.7700 0.0 0
M  V30 37 C 4.0010 2.3101 0.0 0
M  V30 38 C 5.3348 0.0000 0.0 0
M  V30 39 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 29
M  V30 3 1 1 34
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 30 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8 CFG=1
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 35
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 21 24
M  V30 26 2 21 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 33
M  V30 35 2 34 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 17 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1539320-73-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1539320-44-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10095091
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formation of a pseudo-β-hairpin motif utilizing the Ant-Pro reverse turn:
consequences of stereochemical reordering
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nair, Roshna V.; Kotmale, Amol S.; Dhokale, Snehal A.; Gawade, Rupesh L.;
Puranik, Vedavadi G.; Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(5), 774-782

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Nitrophenyl)sulfonyl]-L-leucine ethyl ester
C14H20N2O6S
154587-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6685 0.0 0 VAL=6
M  V30 2 N 4.6200 6.6685 0.0 0
M  V30 3 O 6.1600 5.1285 0.0 0
M  V30 4 O 6.1600 8.2085 0.0 0
M  V30 5 C 3.8500 5.3347 0.0 0 CFG=1
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3347 0.0 0
M  V30 8 O 3.8500 2.6674 0.0 0
M  V30 9 O 6.1600 4.0011 0.0 0
M  V30 10 C 1.5400 6.6685 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 2.3100 8.0021 0.0 0
M  V30 14 C 3.8500 0.0000 0.0 0
M  V30 15 N 12.3200 6.6685 0.0 0 VAL=5
M  V30 16 O 13.0900 8.0021 0.0 0
M  V30 17 O 13.0900 5.3347 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 8.4700 8.0021 0.0 0
M  V30 21 C 10.0100 5.3347 0.0 0
M  V30 22 C 10.0100 8.0021 0.0 0
M  V30 23 C 10.7800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 18
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=3
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 15 16
M  V30 16 2 15 17
M  V30 17 1 15 23
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-N,4-Dimethyl-2-[[(4-nitrophenyl)sulfonyl]amino]pentanamide
C13H19N3O5S
1448453-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 4.0011 0.0 0 CFG=1
M  V30 2 N 8.4700 5.3349 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 C 10.7800 4.0011 0.0 0
M  V30 5 S 6.9300 5.3349 0.0 0 VAL=6
M  V30 6 N 9.2400 1.3338 0.0 0
M  V30 7 O 6.9300 2.6674 0.0 0
M  V30 8 C 11.5500 5.3349 0.0 0
M  V30 9 O 6.9300 3.7949 0.0 0
M  V30 10 O 6.9300 6.8749 0.0 0
M  V30 11 C 8.4700 0.0000 0.0 0
M  V30 12 C 10.7800 6.6685 0.0 0
M  V30 13 C 13.0900 5.3349 0.0 0
M  V30 14 N 0.7700 5.3349 0.0 0 VAL=5
M  V30 15 O 0.0000 4.0011 0.0 0
M  V30 16 O 0.0000 6.6685 0.0 0
M  V30 17 C 5.3900 5.3349 0.0 0
M  V30 18 C 4.6200 6.6685 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 C 3.0800 6.6685 0.0 0
M  V30 21 C 3.0800 4.0011 0.0 0
M  V30 22 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 5 10
M  V30 10 1 5 17
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 154587-28-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448453-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8267882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Organosulfonyl-2-sila-5-piperazinones: Synthesis, molecular and crystal
structure, and chemical transformations into 2-aminoacid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shipov, Alexandr G.; Kramarova, Eugenia P.; Fang, Huntse; Arkhipov,
Dmitry E.; Nikolin, Alexey A.; Bylikin, Sergey Yu.; Negrebetsky, Vadim
V.; Korlyukov, Alexandr A.; Voronina, Natalia A.; Bassindale, Alan R.;
Taylor, Peter G.; Baukov, Yuri I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2013), 741-742114-121

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Propanediol, 1-phenyl-, 3-(4-methylbenzenesulfonate), (1S)-
C16H18O4S
156453-52-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 7.7001 6.6686 0.0 0 VAL=6
M  V30 2 O 6.9301 5.3348 0.0 0
M  V30 3 O 8.4701 8.0022 0.0 0
M  V30 4 O 6.3664 7.4386 0.0 0
M  V30 5 C 5.3901 5.3348 0.0 0
M  V30 6 C 4.6201 4.0011 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 8 O 2.3100 5.3348 0.0 0
M  V30 9 C 13.0350 3.5885 0.0 0
M  V30 10 C 9.0339 5.8986 0.0 0
M  V30 11 C 10.3675 6.6686 0.0 0
M  V30 12 C 9.0339 4.3586 0.0 0
M  V30 13 C 11.7012 5.8986 0.0 0
M  V30 14 C 10.3675 3.5885 0.0 0
M  V30 15 C 11.7012 4.3586 0.0 0
M  V30 16 C 2.3100 2.6675 0.0 0
M  V30 17 C 0.7700 2.6675 0.0 0
M  V30 18 C 3.0800 1.3337 0.0 0
M  V30 19 C 0.0000 1.3337 0.0 0
M  V30 20 C 2.3100 0.0000 0.0 0
M  V30 21 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8 CFG=1
M  V30 9 1 7 16
M  V30 10 1 9 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-[2-(Methylamino)ethyl]benzenemethanol
C10H15NO
114133-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 156453-52-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 114133-37-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12478963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pd-Catalyzed kinetic resolution of benzylic alcohols: a practical
synthesis of (R)-tomoxetine and (S)-fluoxetine hydrochlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ali, Iliyas Sayyed; Sudalai, Arumugam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(31), 5435-5436

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3S,4S,21R)-14-ethyl-9-(hydroxymethyl)-21-(methoxycarbonyl)-4,8,13,18-...
C35H38N4O6
157492-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.5587 10.4617 0.0 0
M  V30 2 O 13.3545 11.7801 0.0 0
M  V30 3 O 13.3026 9.1133 0.0 0
M  V30 4 C 14.8942 11.7500 0.0 0
M  V30 5 C 13.2506 7.9123 0.0 0
M  V30 6 C 14.5842 7.1423 0.0 0
M  V30 7 C 15.9179 7.9123 0.0 0
M  V30 8 O 17.2515 7.1423 0.0 0
M  V30 9 O 15.9179 9.4523 0.0 0
M  V30 10 C 18.5851 7.9123 0.0 0
M  V30 11 O 10.6108 13.2190 0.0 0
M  V30 12 C 6.5347 13.1063 0.0 0
M  V30 13 C 12.8944 4.5657 0.0 0
M  V30 14 C 1.4520 9.3736 0.0 0
M  V30 15 C 0.0000 8.8609 0.0 0
M  V30 16 C 8.0290 0.9152 0.0 0
M  V30 17 C 1.1932 6.0137 0.0 0
M  V30 18 C 4.7084 1.4948 0.0 0
M  V30 19 O 5.0785 0.0000 0.0 0
M  V30 20 C 10.0582 9.2448 0.0 0
M  V30 21 C 8.6673 9.7398 0.0 0
M  V30 22 C 10.5004 7.7712 0.0 0
M  V30 23 C 11.0190 10.4917 0.0 0 CFG=1
M  V30 24 C 8.6247 11.2945 0.0 0
M  V30 25 N 7.2985 9.1677 0.0 0
M  V30 26 C 11.9170 7.1423 0.0 0 CFG=1
M  V30 27 N 9.4615 6.6201 0.0 0
M  V30 28 C 10.1183 11.7599 0.0 0
M  V30 29 C 7.1081 11.6770 0.0 0
M  V30 30 C 6.2815 10.3601 0.0 0
M  V30 31 C 11.7531 5.5996 0.0 0 CFG=2
M  V30 32 C 10.2346 5.2850 0.0 0
M  V30 33 C 4.7739 10.1092 0.0 0
M  V30 34 C 9.5581 3.9235 0.0 0
M  V30 35 C 4.1309 8.7294 0.0 0
M  V30 36 C 8.0652 3.6708 0.0 0
M  V30 37 C 2.6221 8.3723 0.0 0
M  V30 38 N 4.9414 7.4112 0.0 0
M  V30 39 N 6.9903 4.7808 0.0 0
M  V30 40 C 7.3475 2.2961 0.0 0
M  V30 41 C 2.5024 6.8246 0.0 0
M  V30 42 C 3.9408 6.2427 0.0 0
M  V30 43 C 5.6101 4.1003 0.0 0
M  V30 44 C 5.8180 2.5628 0.0 0
M  V30 45 C 4.2779 4.7828 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 26 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 28
M  V30 12 1 12 29
M  V30 13 1 31 13 CFG=3
M  V30 14 1 14 15
M  V30 15 1 14 37
M  V30 16 1 16 40
M  V30 17 1 17 41
M  V30 18 1 18 19
M  V30 19 1 18 44
M  V30 20 1 20 21
M  V30 21 2 20 22
M  V30 22 1 20 23
M  V30 23 2 21 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 22 27
M  V30 27 1 23 28
M  V30 28 1 24 28
M  V30 29 1 24 29
M  V30 30 1 25 30
M  V30 31 1 26 31
M  V30 32 2 27 32
M  V30 33 2 29 30
M  V30 34 1 30 33
M  V30 35 1 31 32
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 37
M  V30 40 1 35 38
M  V30 41 1 36 39
M  V30 42 1 36 40
M  V30 43 2 37 41
M  V30 44 2 38 42
M  V30 45 1 39 43
M  V30 46 2 40 44
M  V30 47 1 41 42
M  V30 48 1 42 45
M  V30 49 1 43 44
M  V30 50 2 43 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 23 26 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
21H,23H-Porphine-7-propanoic acid, 18-ethyl-7,8-dihydro-13-(hydroxymethyl)-5-...
C36H43N5O6
507230-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.4123 11.7595 0.0 0
M  V30 2 C 11.9439 11.9205 0.0 0
M  V30 3 O 12.5704 13.3273 0.0 0
M  V30 4 O 12.8491 10.6746 0.0 0
M  V30 5 C 14.1019 13.4884 0.0 0
M  V30 6 C 8.4232 13.4132 0.0 0
M  V30 7 N 7.6532 14.7471 0.0 0
M  V30 8 O 9.9632 13.4132 0.0 0
M  V30 9 C 8.4232 16.0807 0.0 0
M  V30 10 C 5.0910 13.0630 0.0 0
M  V30 11 C 13.3914 9.0757 0.0 0
M  V30 12 C 14.5176 8.0254 0.0 0
M  V30 13 C 15.9903 8.4757 0.0 0
M  V30 14 O 17.1167 7.4254 0.0 0
M  V30 15 O 16.3368 9.9762 0.0 0
M  V30 16 C 18.5894 7.8756 0.0 0
M  V30 17 C 13.4132 6.3238 0.0 0
M  V30 18 C 1.3337 8.4232 0.0 0
M  V30 19 C 0.0000 7.6532 0.0 0
M  V30 20 C 1.6839 5.0910 0.0 0
M  V30 21 C 9.6560 1.6839 0.0 0
M  V30 22 C 6.3238 1.3337 0.0 0
M  V30 23 O 7.0939 0.0000 0.0 0
M  V30 24 C 8.2795 10.6727 0.0 0
M  V30 25 C 9.7860 10.3526 0.0 0
M  V30 26 C 7.6532 12.0796 0.0 0
M  V30 27 N 7.1350 9.6423 0.0 0
M  V30 28 C 10.4123 8.9456 0.0 0
M  V30 29 C 6.1215 11.9186 0.0 0
M  V30 30 C 5.8013 10.4123 0.0 0
M  V30 31 C 11.9186 8.6254 0.0 0 CFG=1
M  V30 32 N 9.6423 7.6119 0.0 0
M  V30 33 C 4.3943 9.7860 0.0 0
M  V30 34 C 12.0796 7.0939 0.0 0 CFG=2
M  V30 35 C 10.6727 6.4675 0.0 0
M  V30 36 C 4.0743 8.2795 0.0 0
M  V30 37 C 10.3526 4.9611 0.0 0
M  V30 38 C 2.6675 7.6532 0.0 0
M  V30 39 N 5.1047 7.1351 0.0 0
M  V30 40 C 8.9456 4.3347 0.0 0
M  V30 41 C 2.8284 6.1215 0.0 0
M  V30 42 C 4.3347 5.8013 0.0 0
M  V30 43 N 7.6119 5.1047 0.0 0
M  V30 44 C 8.6254 2.8284 0.0 0
M  V30 45 C 4.9611 4.3943 0.0 0
M  V30 46 C 6.4675 4.0743 0.0 0
M  V30 47 C 7.0939 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 26
M  V30 9 1 7 9
M  V30 10 1 10 29
M  V30 11 1 11 12
M  V30 12 1 31 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 34 17 CFG=3
M  V30 18 1 18 19
M  V30 19 1 18 38
M  V30 20 1 20 41
M  V30 21 1 21 44
M  V30 22 1 22 23
M  V30 23 1 22 47
M  V30 24 1 24 25
M  V30 25 2 24 26
M  V30 26 1 24 27
M  V30 27 2 25 28
M  V30 28 1 26 29
M  V30 29 1 27 30
M  V30 30 1 28 31
M  V30 31 1 28 32
M  V30 32 2 29 30
M  V30 33 1 30 33
M  V30 34 1 31 34
M  V30 35 2 32 35
M  V30 36 2 33 36
M  V30 37 1 34 35
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 36 39
M  V30 41 2 37 40
M  V30 42 2 38 41
M  V30 43 2 39 42
M  V30 44 1 40 43
M  V30 45 1 40 44
M  V30 46 1 41 42
M  V30 47 1 42 45
M  V30 48 1 43 46
M  V30 49 2 44 47
M  V30 50 2 45 46
M  V30 51 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 31 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 157492-58-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 507230-06-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-160-CAS-3119981
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of chlorin photosensitizing agents for use in photodynamic
therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Robinson, Byron C.; Phadke, Avinash; Small, Ward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003028629 A2 2003-04-10

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Benzyloxy)-2-(hydroxymethyl)-4-pyrone
C13H12O4
15771-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 11.5500 2.6674 0.0 0
M  V30 5 O 12.3200 4.0011 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3338 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 1.3338 0.0 0
M  V30 10 O 9.2400 4.0011 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 2 3 7
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxymethyl)-1-methyl-5-(phenylmethoxy)-4(1H)-pyridinone
C14H15NO3
89539-51-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 10.0100 5.3349 0.0 0
M  V30 5 C 11.5500 2.6674 0.0 0
M  V30 6 O 12.3200 1.3338 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 7.7000 1.3338 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 9.2400 1.3338 0.0 0
M  V30 11 N 9.2400 4.0011 0.0 0
M  V30 12 C 10.0100 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 2 3 8
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15771-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89539-51-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31394996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Propargylamine-hydroxypyridinone hybrids as multitarget agents for the
treatment of Alzheimer disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guo, Jianan; Zhang, Yujia; Zhang, Changjun; Yao, Chuansheng; Zhang,
Jingqi; Jiang, Xiaoying; Zhong, Zhichao; Ge, Jiamin; Zhou, Tao; Bai,
Renren; Xie, Yuanyuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2021), 113105013

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-pentenoic acid
C11H22O3Si
1605348-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 2.6673 2.1037 0.0 0
M  V30 2 O 4.0012 2.8737 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 3.4374 0.7700 0.0 0
M  V30 5 C 1.8973 3.4374 0.0 0
M  V30 6 C 5.3348 2.1037 0.0 0
M  V30 7 C 0.5637 2.6673 0.0 0
M  V30 8 C 0.0000 0.5637 0.0 0
M  V30 9 C 2.1037 0.0000 0.0 0
M  V30 10 C 6.6685 2.8737 0.0 0
M  V30 11 C 8.0022 2.1037 0.0 0
M  V30 12 C 9.3360 2.8737 0.0 0
M  V30 13 C 10.6697 2.1037 0.0 0
M  V30 14 O 10.6697 0.5637 0.0 0
M  V30 15 O 12.0033 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 6 10
M  V30 10 1 10 11
M  V30 11 2 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-N-methyl-2-pentenamide
C12H25NO2Si
2226991-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 2.6673 2.1037 0.0 0
M  V30 2 O 4.0010 2.8737 0.0 0
M  V30 3 C 1.3337 1.3337 0.0 0
M  V30 4 C 1.8973 3.4374 0.0 0
M  V30 5 C 3.4374 0.7700 0.0 0
M  V30 6 C 5.3348 2.1037 0.0 0
M  V30 7 C 2.1037 0.0000 0.0 0
M  V30 8 C 0.0000 0.5637 0.0 0
M  V30 9 C 0.5637 2.6673 0.0 0
M  V30 10 C 6.6685 2.8737 0.0 0
M  V30 11 C 8.0022 2.1037 0.0 0
M  V30 12 C 9.3360 2.8737 0.0 0
M  V30 13 C 10.6697 2.1037 0.0 0
M  V30 14 N 12.0033 2.8737 0.0 0
M  V30 15 O 10.6697 0.5637 0.0 0
M  V30 16 C 13.3370 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 6 10
M  V30 10 1 10 11
M  V30 11 2 11 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1605348-86-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2226991-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20079448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrasubstituted alkene compounds as anticancer agents and
their use in the treatment of breast cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bock, Mark; Hao, Ming-Hong; Korpal, Manav; Nyavanandi, Vijay Kumar;
Puyang, Xiaoling; Samajdar, Susanta; Smith, Peter Gerard; Wang, John;
Zheng, Guo Zhu; Zhu, Ping; Mitchell, Lorna Helen; Larsen, Nicholas;
Rioux, Nathalie; Prajapati, Sudeep; Reynolds, Dominic; O'Shea, Morgan;
Samarakoon, Thiwanka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180141913 A1 2018-05-24

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[(E)-(1-benzo[b]thien-2-ylethylidene)amino]oxy]methyl]-α-(met...
C21H20N2O4S
1607822-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 N 9.3358 4.6200 0.0 0
M  V30 12 C 10.6696 5.3900 0.0 0
M  V30 13 C 10.6696 6.9300 0.0 0
M  V30 14 C 4.0011 4.6200 0.0 0
M  V30 15 C 5.3347 5.3900 0.0 0
M  V30 16 C 2.6674 5.3900 0.0 0
M  V30 17 C 5.3347 6.9300 0.0 0
M  V30 18 C 2.6674 6.9300 0.0 0
M  V30 19 C 4.0011 7.7000 0.0 0
M  V30 20 C 12.0032 4.6200 0.0 0
M  V30 21 C 13.4100 5.2463 0.0 0
M  V30 22 S 12.1642 3.0885 0.0 0
M  V30 23 C 14.4406 4.1019 0.0 0
M  V30 24 C 13.6706 2.7683 0.0 0
M  V30 25 C 15.9806 4.1019 0.0 0
M  V30 26 C 14.4406 1.4345 0.0 0
M  V30 27 C 16.7506 2.7683 0.0 0
M  V30 28 C 15.9806 1.4345 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 20
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[(E)-(1-Benzo[b]thien-2-ylethylidene)amino]oxy]methyl]-α-(methoxyimi...
C21H21N3O3S
1607822-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 N 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 N 9.3358 4.6200 0.0 0
M  V30 12 C 10.6696 5.3900 0.0 0
M  V30 13 C 10.6696 6.9300 0.0 0
M  V30 14 C 4.0011 4.6200 0.0 0
M  V30 15 C 5.3347 5.3900 0.0 0
M  V30 16 C 2.6674 5.3900 0.0 0
M  V30 17 C 5.3347 6.9300 0.0 0
M  V30 18 C 2.6674 6.9300 0.0 0
M  V30 19 C 4.0011 7.7000 0.0 0
M  V30 20 C 12.0032 4.6200 0.0 0
M  V30 21 C 13.4100 5.2463 0.0 0
M  V30 22 S 12.1642 3.0885 0.0 0
M  V30 23 C 14.4406 4.1019 0.0 0
M  V30 24 C 13.6706 2.7683 0.0 0
M  V30 25 C 15.9806 4.1019 0.0 0
M  V30 26 C 14.4406 1.4345 0.0 0
M  V30 27 C 16.7506 2.7683 0.0 0
M  V30 28 C 15.9806 1.4345 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 20
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1607822-56-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1607822-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13647934
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and fungicidal activities of novel benzothiophene-substituted
oxime ether strobilurins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tu, Song; Xie, Ya-Qiang; Gui, Si-Zhe; Ye, Li-Yi; Huang, Zi-Long; Huang,
Yi-Bing; Che, Li-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2014), 24(9), 2173-2176

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N2-propyl-N4-2-propyn-1-yl-1,3,5-triazine-2,4-diamine
C9H12ClN5
1610535-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 4.6201 0.0 0
M  V30 2 C 2.6673 3.8501 0.0 0
M  V30 3 C 1.3337 4.6201 0.0 0
M  V30 4 C 0.0000 3.8501 0.0 0
M  V30 5 N 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0
M  V30 7 C 12.0033 4.6201 0.0 0
M  V30 8 C 13.3370 5.3901 0.0 0
M  V30 9 Cl 6.6685 0.0000 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 N 6.6685 4.6201 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 14 C 6.6685 1.5400 0.0 0
M  V30 15 N 8.0022 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 3 7 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-Methyl-N4-propyl-N6-2-propyn-1-yl-1,3,5-triazine-2,4,6-triamine
C10H16N6
1610533-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 6.6685 0.0 0
M  V30 2 C 2.3100 6.6685 0.0 0
M  V30 3 C 1.5400 8.0021 0.0 0
M  V30 4 C 0.0000 8.0021 0.0 0
M  V30 5 N 8.4700 4.0011 0.0 0
M  V30 6 C 9.2400 5.3347 0.0 0
M  V30 7 C 10.7800 5.3347 0.0 0
M  V30 8 C 12.3200 5.3347 0.0 0
M  V30 9 N 3.8500 1.3336 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 N 6.1600 5.3347 0.0 0
M  V30 13 N 3.8500 4.0011 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 N 6.1600 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 3 7 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1610535-08-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1610533-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13575711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into HCl salt with 100% yield, closed vial
used, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazinamine derivatives as oral bioavailable breathing
control modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mannion, James C.; Dax, Scott L.; Golder, Francis John; Macintyre, Duncan
Euan; McLeod, James; Ozola, Vita; Suna, Edgars; Shubin, Kirill; Mencel,
James Joseph; Peng, Sean X.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014078575 A2 2014-05-22

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5bS)-6H,10H-Pyrrolo[2,1-c]quinazolino[3,2-a][1,4]benzodiazepine-8,10,16(5bH,...
C19H13N3O3
1620751-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 3.1027 0.0 0
M  V30 2 O 9.2605 2.6464 0.0 0
M  V30 3 O 10.7842 5.0548 0.0 0
M  V30 4 C 5.3901 5.7702 0.0 0
M  V30 5 N 4.6201 4.4364 0.0 0
M  V30 6 C 6.9129 5.9996 0.0 0 CFG=2
M  V30 7 N 4.6201 7.1039 0.0 0
M  V30 8 C 5.1827 3.0029 0.0 0
M  V30 9 C 3.0801 4.4364 0.0 0
M  V30 10 N 8.0419 4.9521 0.0 0
M  V30 11 C 7.5603 7.3971 0.0 0
M  V30 12 C 3.0801 7.1039 0.0 0
M  V30 13 C 6.6543 2.5489 0.0 0
M  V30 14 C 4.0538 1.9554 0.0 0
M  V30 15 C 2.3100 5.7702 0.0 0
M  V30 16 C 7.9267 3.4164 0.0 0
M  V30 17 C 9.3869 5.7021 0.0 0
M  V30 18 C 9.0893 7.2132 0.0 0
M  V30 19 C 2.3100 8.4375 0.0 0
M  V30 20 C 6.9970 1.0475 0.0 0
M  V30 21 C 4.3965 0.4540 0.0 0
M  V30 22 C 0.7700 5.7702 0.0 0
M  V30 23 C 0.7700 8.4375 0.0 0
M  V30 24 C 5.8681 0.0000 0.0 0
M  V30 25 C 0.0000 7.1039 0.0 0
M  V30 26 H 5.9892 7.2318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 16
M  V30 3 2 3 17
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 6 26 CFG=1
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 1 11 18
M  V30 19 1 12 15
M  V30 20 2 12 19
M  V30 21 1 13 16
M  V30 22 2 13 20
M  V30 23 1 14 21
M  V30 24 2 15 22
M  V30 25 1 17 18
M  V30 26 1 19 23
M  V30 27 1 20 24
M  V30 28 2 21 24
M  V30 29 1 22 25
M  V30 30 2 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(7S)-5,6,7,13-Tetrahydro-N-methyl-5,13-dioxoquinazolino[3,2-a][1,4]benzodiaze...
C20H18N4O3
1620751-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.2506 4.0011 0.0 0
M  V30 2 C 7.5623 6.1960 0.0 0
M  V30 3 C 8.6097 7.3250 0.0 0
M  V30 4 C 10.1112 6.9824 0.0 0
M  V30 5 N 11.1585 8.1112 0.0 0
M  V30 6 O 10.5650 5.5107 0.0 0
M  V30 7 C 12.6600 7.7685 0.0 0
M  V30 8 O 4.3306 10.2484 0.0 0
M  V30 9 N 3.5606 5.3347 0.0 0
M  V30 10 C 5.1006 5.3347 0.0 0
M  V30 11 C 2.6006 6.5388 0.0 0
M  V30 12 C 2.7906 4.0011 0.0 0
M  V30 13 C 6.0608 6.5388 0.0 0 CFG=2
M  V30 14 N 5.8706 4.0011 0.0 0
M  V30 15 C 2.9432 8.0402 0.0 0
M  V30 16 C 1.1290 6.0848 0.0 0
M  V30 17 C 3.5606 2.6674 0.0 0
M  V30 18 N 5.7182 8.0402 0.0 0
M  V30 19 C 5.1006 2.6674 0.0 0
M  V30 20 C 4.3306 8.7084 0.0 0
M  V30 21 C 1.8143 9.0877 0.0 0
M  V30 22 C 0.0000 7.1324 0.0 0
M  V30 23 C 2.7906 1.3338 0.0 0
M  V30 24 C 5.8706 1.3338 0.0 0
M  V30 25 C 0.3428 8.6337 0.0 0
M  V30 26 C 3.5606 0.0000 0.0 0
M  V30 27 C 5.1006 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 2 15 21
M  V30 21 1 16 22
M  V30 22 1 17 19
M  V30 23 2 17 23
M  V30 24 1 18 20
M  V30 25 2 19 24
M  V30 26 1 21 25
M  V30 27 2 22 25
M  V30 28 1 23 26
M  V30 29 1 24 27
M  V30 30 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1620751-48-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620751-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-1092482
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First total synthesis of (-)-auranomide C and its derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sorra, Kumaraswamy; Mukkanti, K.; Pusuluri, Srinivas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2014), 46(2), 189-194, 6 pp.

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 1-(4-nitrophenyl)-5-(3-phenanthrenyl)-, methyl...
C25H17N3O4
1633806-53-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0571 2.4367 0.0 0
M  V30 2 O 9.3030 1.5315 0.0 0
M  V30 3 O 6.6502 1.8104 0.0 0
M  V30 4 C 9.1421 0.0000 0.0 0
M  V30 5 N 13.3533 10.8225 0.0 0 VAL=5
M  V30 6 O 14.8598 10.5022 0.0 0
M  V30 7 O 12.8775 12.2870 0.0 0
M  V30 8 C 7.7000 6.4056 0.0 0
M  V30 9 N 9.2315 6.2447 0.0 0
M  V30 10 C 7.0737 4.9988 0.0 0
M  V30 11 N 9.5517 4.7383 0.0 0
M  V30 12 C 8.2181 3.9683 0.0 0
M  V30 13 C 6.9300 7.7393 0.0 0
M  V30 14 C 5.3900 7.7393 0.0 0
M  V30 15 C 7.7000 9.0729 0.0 0
M  V30 16 C 4.6200 9.0729 0.0 0
M  V30 17 C 6.9300 10.4067 0.0 0
M  V30 18 C 3.0800 9.0729 0.0 0
M  V30 19 C 5.3900 10.4067 0.0 0
M  V30 20 C 2.3100 10.4067 0.0 0
M  V30 21 C 2.3100 7.7393 0.0 0
M  V30 22 C 4.6200 11.7403 0.0 0
M  V30 23 C 3.0800 11.7403 0.0 0
M  V30 24 C 0.7700 10.4067 0.0 0
M  V30 25 C 0.7700 7.7393 0.0 0
M  V30 26 C 0.0000 9.0729 0.0 0
M  V30 27 C 10.2621 7.3891 0.0 0
M  V30 28 C 11.7684 7.0689 0.0 0
M  V30 29 C 9.7861 8.8538 0.0 0
M  V30 30 C 12.7988 8.2133 0.0 0
M  V30 31 C 10.8167 9.9981 0.0 0
M  V30 32 C 12.3229 9.6780 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 32
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 24 2 19 22
M  V30 25 2 20 23
M  V30 26 1 20 24
M  V30 27 2 21 25
M  V30 28 1 22 23
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-(4-nitrophenyl)-5-(3-phenanthrenyl)-1H-pyrazole-3-carboxamide
C25H18N4O3
1633806-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0571 2.4367 0.0 0
M  V30 2 N 9.3030 1.5315 0.0 0
M  V30 3 O 6.6502 1.8104 0.0 0
M  V30 4 C 9.1421 0.0000 0.0 0
M  V30 5 N 13.3533 10.8225 0.0 0 VAL=5
M  V30 6 O 14.8598 10.5022 0.0 0
M  V30 7 O 12.8775 12.2870 0.0 0
M  V30 8 C 7.7000 6.4056 0.0 0
M  V30 9 N 9.2315 6.2447 0.0 0
M  V30 10 C 7.0737 4.9988 0.0 0
M  V30 11 N 9.5517 4.7383 0.0 0
M  V30 12 C 8.2181 3.9683 0.0 0
M  V30 13 C 6.9300 7.7393 0.0 0
M  V30 14 C 5.3900 7.7393 0.0 0
M  V30 15 C 7.7000 9.0729 0.0 0
M  V30 16 C 4.6200 9.0729 0.0 0
M  V30 17 C 6.9300 10.4067 0.0 0
M  V30 18 C 3.0800 9.0729 0.0 0
M  V30 19 C 5.3900 10.4067 0.0 0
M  V30 20 C 2.3100 10.4067 0.0 0
M  V30 21 C 2.3100 7.7393 0.0 0
M  V30 22 C 4.6200 11.7403 0.0 0
M  V30 23 C 3.0800 11.7403 0.0 0
M  V30 24 C 0.7700 10.4067 0.0 0
M  V30 25 C 0.7700 7.7393 0.0 0
M  V30 26 C 0.0000 9.0729 0.0 0
M  V30 27 C 10.2621 7.3891 0.0 0
M  V30 28 C 11.7684 7.0689 0.0 0
M  V30 29 C 9.7861 8.8538 0.0 0
M  V30 30 C 12.7988 8.2133 0.0 0
M  V30 31 C 10.8167 9.9981 0.0 0
M  V30 32 C 12.3229 9.6780 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 32
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 9 27
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 24 2 19 22
M  V30 25 2 20 23
M  V30 26 1 20 24
M  V30 27 2 21 25
M  V30 28 1 22 23
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1633806-53-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1633806-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19129300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of anti-fungal pesticides from protein kinase inhibitor-based
anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Yihui; Liang, Shen; Zhang, Yongchao; Yang, Dangwei; Wang, Ruofei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 148349-358

$RFMT $RIREG SCHEME405 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-hydroxy-1-methyl-6-(4-pyridinyl)-2-(1-pyrrolidinylmethyl)-1H-indole-3...
C22H25N3O3
1641585-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5911 3.7535 0.0 0
M  V30 2 O 5.6215 2.6091 0.0 0
M  V30 3 O 3.0848 3.4333 0.0 0
M  V30 4 C 5.1456 1.1444 0.0 0
M  V30 5 C 6.1760 0.0000 0.0 0
M  V30 6 C 2.6217 6.4640 0.0 0
M  V30 7 C 4.5911 9.1746 0.0 0
M  V30 8 O 10.5327 4.9240 0.0 0
M  V30 9 C 5.0669 5.2182 0.0 0
M  V30 10 C 6.5316 5.6940 0.0 0
M  V30 11 C 4.1617 6.4640 0.0 0
M  V30 12 C 6.5316 7.2340 0.0 0
M  V30 13 C 7.8653 4.9240 0.0 0
M  V30 14 N 5.0669 7.7099 0.0 0
M  V30 15 C 7.8653 8.0040 0.0 0
M  V30 16 C 9.1989 5.6940 0.0 0
M  V30 17 C 9.1989 7.2340 0.0 0
M  V30 18 N 1.8517 7.7977 0.0 0
M  V30 19 C 2.4782 9.2046 0.0 0
M  V30 20 C 0.3202 7.9588 0.0 0
M  V30 21 C 1.3336 10.2350 0.0 0
M  V30 22 C 0.0000 9.4650 0.0 0
M  V30 23 C 10.5327 8.0040 0.0 0
M  V30 24 C 10.5327 9.5440 0.0 0
M  V30 25 C 11.8664 7.2340 0.0 0
M  V30 26 C 11.8664 10.3140 0.0 0
M  V30 27 C 13.2000 8.0040 0.0 0
M  V30 28 N 13.2000 9.5440 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 6 18
M  V30 8 1 7 14
M  V30 9 1 8 16
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 17 23
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2,3,7-tetrahydro-2,7-dimethyl-5-(4-pyridinyl)-8-(1-pyrrolidinylmethyl...
C25H30N4O3
1446260-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0738 7.2419 0.0 0
M  V30 2 O 2.6091 6.7660 0.0 0
M  V30 3 O 4.3940 8.7483 0.0 0
M  V30 4 C 1.4647 7.7964 0.0 0
M  V30 5 C 0.0000 7.3206 0.0 0
M  V30 6 C 3.7236 3.9099 0.0 0
M  V30 7 C 6.7844 2.5472 0.0 0
M  V30 8 C 6.7246 11.8664 0.0 0
M  V30 9 C 6.7246 6.5316 0.0 0
M  V30 10 C 5.2182 6.2115 0.0 0
M  V30 11 C 7.4946 7.8653 0.0 0
M  V30 12 C 7.4946 5.1980 0.0 0
M  V30 13 C 5.0572 4.6799 0.0 0
M  V30 14 C 9.0346 7.8653 0.0 0
M  V30 15 C 6.7246 9.1989 0.0 0
M  V30 16 N 6.4640 4.0535 0.0 0
M  V30 17 C 9.0346 5.1980 0.0 0
M  V30 18 C 9.8046 6.5316 0.0 0
M  V30 19 O 9.8046 9.1989 0.0 0
M  V30 20 N 7.4946 10.5327 0.0 0
M  V30 21 C 9.0346 10.5327 0.0 0
M  V30 22 N 3.7236 2.3699 0.0 0
M  V30 23 C 2.4777 1.4647 0.0 0
M  V30 24 C 4.9695 1.4647 0.0 0
M  V30 25 C 2.9536 0.0000 0.0 0
M  V30 26 C 4.4936 0.0000 0.0 0
M  V30 27 C 11.3446 6.5316 0.0 0
M  V30 28 C 12.1146 7.8653 0.0 0
M  V30 29 C 12.1146 5.1980 0.0 0
M  V30 30 C 13.6546 7.8653 0.0 0
M  V30 31 C 13.6546 5.1980 0.0 0
M  V30 32 N 14.4246 6.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 6 22
M  V30 8 1 7 16
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 13 16
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 2 17 18
M  V30 23 1 18 27
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1641585-99-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1446260-56-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-13347802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME406 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[6-Bromo-3-(ethoxycarbonyl)-5-hydroxy-1-(phenylmethyl)-1H-indol-2-yl]methy...
C25H30BrN2O3
1641586-00-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.4640 3.6643 0.0 0
M  V30 2 C 3.7534 5.6336 0.0 0
M  V30 3 C 9.1746 5.6336 0.0 0
M  V30 4 O 10.3189 6.6640 0.0 0
M  V30 5 O 9.4947 4.1274 0.0 0
M  V30 6 C 11.7836 6.1882 0.0 0
M  V30 7 C 12.9280 7.2186 0.0 0
M  V30 8 C 4.6037 4.3414 0.0 0
M  V30 9 Br 4.9240 11.5753 0.0 0
M  V30 10 O 8.0040 11.5753 0.0 0
M  V30 11 C 6.4640 5.2043 0.0 0
M  V30 12 N 5.2181 6.1095 0.0 0
M  V30 13 C 7.7099 6.1095 0.0 0
M  V30 14 C 5.6940 7.5742 0.0 0
M  V30 15 C 7.2340 7.5742 0.0 0
M  V30 16 C 4.9240 8.9078 0.0 0
M  V30 17 C 8.0040 8.9078 0.0 0
M  V30 18 C 5.6940 10.2415 0.0 0
M  V30 19 C 7.2340 10.2415 0.0 0
M  V30 20 N 5.1304 2.8943 0.0 0 CHG=1 VAL=4
M  V30 21 C 6.1203 1.7146 0.0 0
M  V30 22 C 3.6138 2.6269 0.0 0
M  V30 23 C 5.5934 0.2675 0.0 0
M  V30 24 C 3.0869 1.1798 0.0 0
M  V30 25 C 4.0768 0.0000 0.0 0
M  V30 26 C 2.6091 6.6640 0.0 0
M  V30 27 C 1.1444 6.1882 0.0 0
M  V30 28 C 2.9292 8.1705 0.0 0
M  V30 29 C 0.0000 7.2186 0.0 0
M  V30 30 C 1.7847 9.2009 0.0 0
M  V30 31 C 0.3202 8.7250 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 20
M  V30 3 1 2 12
M  V30 4 1 2 26
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 3 13
M  V30 8 1 4 6
M  V30 9 1 6 7
M  V30 10 1 8 20
M  V30 11 1 9 18
M  V30 12 1 10 19
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[5-Bromo-9-(ethoxycarbonyl)-1,2,3,7-tetrahydro-2-methyl-7-(phenylmethyl)py...
C28H35BrN3O3
1641586-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3302 3.5673 0.0 0
M  V30 2 O 6.4748 2.5368 0.0 0
M  V30 3 O 3.8657 3.0914 0.0 0
M  V30 4 C 6.1546 1.0304 0.0 0
M  V30 5 C 7.2990 0.0000 0.0 0
M  V30 6 C 8.3910 4.9300 0.0 0
M  V30 7 C 8.0408 8.2621 0.0 0
M  V30 8 Br 2.3100 10.2191 0.0 0
M  V30 9 C 0.0000 3.5508 0.0 0
M  V30 10 C 8.7349 6.8796 0.0 0
M  V30 11 C 4.6200 6.2181 0.0 0
M  V30 12 C 5.6506 5.0737 0.0 0
M  V30 13 C 5.3900 7.5517 0.0 0
M  V30 14 C 3.0800 6.2181 0.0 0
M  V30 15 C 7.0574 5.7000 0.0 0
M  V30 16 N 6.8964 7.2315 0.0 0
M  V30 17 C 4.6200 8.8855 0.0 0
M  V30 18 C 2.3100 7.5517 0.0 0
M  V30 19 C 2.3100 4.8844 0.0 0
M  V30 20 C 3.0800 8.8855 0.0 0
M  V30 21 O 0.7700 7.5517 0.0 0
M  V30 22 N 0.7700 4.8844 0.0 0
M  V30 23 C 0.0000 6.2181 0.0 0
M  V30 24 N 9.7248 5.7000 0.0 0 CHG=1 VAL=4
M  V30 25 C 10.2515 4.2529 0.0 0
M  V30 26 C 10.7145 6.8796 0.0 0
M  V30 27 C 11.7681 3.9855 0.0 0
M  V30 28 C 12.2313 6.6123 0.0 0
M  V30 29 C 12.7580 5.1652 0.0 0
M  V30 30 C 7.7206 9.7684 0.0 0
M  V30 31 C 6.2561 10.2442 0.0 0
M  V30 32 C 8.8652 10.7988 0.0 0
M  V30 33 C 5.9358 11.7507 0.0 0
M  V30 34 C 8.5448 12.3052 0.0 0
M  V30 35 C 7.0803 12.7811 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 15
M  V30 7 1 6 24
M  V30 8 1 7 16
M  V30 9 1 7 30
M  V30 10 1 8 20
M  V30 11 1 9 22
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 14 19
M  V30 21 1 15 16
M  V30 22 2 17 20
M  V30 23 1 18 20
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1641586-00-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1641586-12-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-15517051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-2-methylalanyl-2-aminobenzenesulfonylglycine...
C18H27N3O7S
1642577-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3901 4.0012 0.0 0 VAL=6
M  V30 2 N 4.6201 5.3348 0.0 0
M  V30 3 O 4.0564 3.2311 0.0 0
M  V30 4 O 6.7239 4.7712 0.0 0
M  V30 5 C 3.0801 5.3348 0.0 0
M  V30 6 C 2.3101 6.6687 0.0 0
M  V30 7 O 0.7700 6.6687 0.0 0
M  V30 8 O 3.0801 8.0023 0.0 0
M  V30 9 C 0.0000 8.0023 0.0 0
M  V30 10 N 8.4702 4.0012 0.0 0
M  V30 11 C 10.0102 4.0012 0.0 0
M  V30 12 C 10.7802 5.3348 0.0 0
M  V30 13 O 10.7802 2.6675 0.0 0
M  V30 14 N 12.1141 4.5648 0.0 0
M  V30 15 C 9.4466 6.1048 0.0 0
M  V30 16 C 11.5503 6.6687 0.0 0
M  V30 17 C 13.4477 5.3348 0.0 0
M  V30 18 O 14.7814 4.5648 0.0 0
M  V30 19 O 13.4477 6.8749 0.0 0
M  V30 20 C 16.1151 5.3348 0.0 0
M  V30 21 C 15.3451 6.6685 0.0 0
M  V30 22 C 17.4489 6.1048 0.0 0
M  V30 23 C 16.8851 4.0012 0.0 0
M  V30 24 C 6.1601 2.6675 0.0 0
M  V30 25 C 7.7002 2.6675 0.0 0
M  V30 26 C 5.3901 1.3337 0.0 0
M  V30 27 C 8.4702 1.3337 0.0 0
M  V30 28 C 6.1601 0.0000 0.0 0
M  V30 29 C 7.7002 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 24
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 14 17
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-2-methylalanyl-2-aminobenzenesulfonyl-N-meth...
C18H28N4O6S
1642577-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3901 4.0012 0.0 0 VAL=6
M  V30 2 N 4.6201 5.3348 0.0 0
M  V30 3 O 4.0564 3.2311 0.0 0
M  V30 4 O 6.7239 4.7712 0.0 0
M  V30 5 C 3.0801 5.3348 0.0 0
M  V30 6 C 2.3101 6.6687 0.0 0
M  V30 7 N 0.7700 6.6687 0.0 0
M  V30 8 O 3.0801 8.0023 0.0 0
M  V30 9 C 0.0000 8.0023 0.0 0
M  V30 10 N 8.4702 4.0012 0.0 0
M  V30 11 C 10.0102 4.0012 0.0 0
M  V30 12 C 10.7802 5.3348 0.0 0
M  V30 13 O 10.7802 2.6675 0.0 0
M  V30 14 N 12.1141 4.5648 0.0 0
M  V30 15 C 9.4466 6.1048 0.0 0
M  V30 16 C 11.5503 6.6687 0.0 0
M  V30 17 C 13.4477 5.3348 0.0 0
M  V30 18 O 14.7814 4.5648 0.0 0
M  V30 19 O 13.4477 6.8749 0.0 0
M  V30 20 C 16.1151 5.3348 0.0 0
M  V30 21 C 15.3451 6.6685 0.0 0
M  V30 22 C 17.4489 6.1048 0.0 0
M  V30 23 C 16.8851 4.0012 0.0 0
M  V30 24 C 6.1601 2.6675 0.0 0
M  V30 25 C 7.7002 2.6675 0.0 0
M  V30 26 C 5.3901 1.3337 0.0 0
M  V30 27 C 8.4702 1.3337 0.0 0
M  V30 28 C 6.1601 0.0000 0.0 0
M  V30 29 C 7.7002 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 24
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 25
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 14 17
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1642577-02-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1642577-03-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5265075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformational modulation of peptides using β-amino benzenesulfonic acid
(SAnt)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priya, Gowri; Kotmale, Amol S.; Chakravarty, Debamitra; Puranik, Vedavati
G.; Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(7), 2087-2091

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-2-aminobenzenesulfonylglycine methy...
C19H27N3O7S
1642577-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.1180 4.6200 0.0 0
M  V30 2 C 6.7843 5.3900 0.0 0
M  V30 3 O 5.4505 4.6200 0.0 0
M  V30 4 S 10.7852 3.0800 0.0 0 VAL=6
M  V30 5 N 12.1190 3.8500 0.0 0
M  V30 6 O 10.0152 4.4138 0.0 0
M  V30 7 O 11.5552 1.7464 0.0 0
M  V30 8 C 13.4527 3.0800 0.0 0
M  V30 9 C 14.7863 3.8500 0.0 0
M  V30 10 O 16.1200 3.0800 0.0 0
M  V30 11 O 14.7863 5.3900 0.0 0
M  V30 12 C 17.4537 3.8500 0.0 0
M  V30 13 C 4.0738 7.3594 0.0 0
M  V30 14 O 2.9292 8.3898 0.0 0
M  V30 15 O 3.7536 5.8531 0.0 0
M  V30 16 C 1.4647 7.9139 0.0 0
M  V30 17 C 0.9888 9.3786 0.0 0
M  V30 18 C 0.0000 7.4380 0.0 0
M  V30 19 C 1.9406 6.4494 0.0 0
M  V30 20 C 8.1180 3.0800 0.0 0
M  V30 21 C 9.4516 2.3100 0.0 0
M  V30 22 C 6.7843 2.3100 0.0 0
M  V30 23 C 9.4516 0.7700 0.0 0
M  V30 24 C 6.7843 0.7700 0.0 0
M  V30 25 C 8.1180 0.0000 0.0 0
M  V30 26 C 6.7843 6.9300 0.0 0 CFG=2
M  V30 27 N 5.5383 7.8352 0.0 0
M  V30 28 C 8.0302 7.8352 0.0 0
M  V30 29 C 6.0143 9.2999 0.0 0
M  V30 30 C 7.5543 9.2999 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 2 2 3
M  V30 4 1 26 2 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 21
M  V30 9 1 5 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 27
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-2-aminobenzenesulfonyl-N-methylglyc...
C19H28N4O6S
1642577-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.1180 4.6200 0.0 0
M  V30 2 C 6.7843 5.3900 0.0 0
M  V30 3 O 5.4505 4.6200 0.0 0
M  V30 4 S 10.7852 3.0800 0.0 0 VAL=6
M  V30 5 N 12.1190 3.8500 0.0 0
M  V30 6 O 10.0152 4.4138 0.0 0
M  V30 7 O 11.5552 1.7464 0.0 0
M  V30 8 C 13.4527 3.0800 0.0 0
M  V30 9 C 14.7863 3.8500 0.0 0
M  V30 10 N 16.1200 3.0800 0.0 0
M  V30 11 O 14.7863 5.3900 0.0 0
M  V30 12 C 17.4537 3.8500 0.0 0
M  V30 13 C 4.0738 7.3594 0.0 0
M  V30 14 O 2.9292 8.3898 0.0 0
M  V30 15 O 3.7536 5.8531 0.0 0
M  V30 16 C 1.4647 7.9139 0.0 0
M  V30 17 C 0.9888 9.3786 0.0 0
M  V30 18 C 0.0000 7.4380 0.0 0
M  V30 19 C 1.9406 6.4494 0.0 0
M  V30 20 C 8.1180 3.0800 0.0 0
M  V30 21 C 9.4516 2.3100 0.0 0
M  V30 22 C 6.7843 2.3100 0.0 0
M  V30 23 C 9.4516 0.7700 0.0 0
M  V30 24 C 6.7843 0.7700 0.0 0
M  V30 25 C 8.1180 0.0000 0.0 0
M  V30 26 C 6.7843 6.9300 0.0 0 CFG=2
M  V30 27 N 5.5383 7.8352 0.0 0
M  V30 28 C 8.0302 7.8352 0.0 0
M  V30 29 C 6.0143 9.2999 0.0 0
M  V30 30 C 7.5543 9.2999 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 2 2 3
M  V30 4 1 26 2 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 21
M  V30 9 1 5 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 27
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1642577-16-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1642577-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9546378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformational modulation of peptides using β-amino benzenesulfonic acid
(SAnt)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priya, Gowri; Kotmale, Amol S.; Chakravarty, Debamitra; Puranik, Vedavati
G.; Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2015), 13(7), 2087-2091

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Chloroethyl)pyridine
C7H8ClN
16927-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 Cl 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 N 2.3101 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Betahistine
C8H12N2
5638-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 N 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16927-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5638-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31623767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM other acids also used (hydrochloric acid and sulfuric acid), product
further converted into dihydrochloride salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for preparation of betahistine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patel, Kalpesh, Ravajibhai; Thakrar, Virendra, Haridasbhai; Prajapati,
Nitin Vasantbhai; Sutariya, Nirav Bavanjibhai; Shah, Kinchit,
Jitendrakumar; Patel, Vaishalee Vikas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN201921001039 A 2020-07-17

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
1694-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0009 0.0 0 VAL=6
M  V30 2 Cl 6.1600 4.0009 0.0 0
M  V30 3 O 4.6200 2.4609 0.0 0
M  V30 4 O 4.6200 5.5409 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 C 3.0800 4.0009 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenesulfonamide
C7H8N2O4S
23530-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 5.3900 5.3349 0.0 0
M  V30 3 O 5.9536 3.2311 0.0 0
M  V30 4 O 3.2864 4.7711 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 7 O 2.3100 5.3349 0.0 0
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 1.5400 1.3338 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23530-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-13672006
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolinone derivatives as CB agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brain, Christopher Thomas; Dziadulewicz, Edward Karol; Hart, Terance
William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003066603 A1 2003-08-14

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodobenzoyl chloride
C7H4ClIO
1711-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-N-methylbenzamide
C8H8INO
89976-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 I 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89976-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292377
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodobenzoyl chloride
C7H4ClIO
1711-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-N-methylbenzamide
C8H8INO
89976-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 I 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89976-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20585791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhenium-Catalyzed Phthalide Synthesis from Benzamides and Aldehydes via
C-H Bond Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Bing; Yang, Yunhui; Jin, Xiqing; Mao, Guoliang; Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(16), 6259-6263

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodobenzoyl chloride
C7H4ClIO
1711-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 I 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-N-methylbenzamide
C8H8INO
89976-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 I 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89976-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14376040
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 4-iodo-N-methylbenzamide 1j. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzoyl chloride
C7H4ClFO
1711-07-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 F 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methylbenzamide
C8H8FNO
701-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 F 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-07-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9515256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 3-fluoro-N-methylbenzamide 1o. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzoyl chloride
C7H4BrClO
1711-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Br 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methylbenzamide
C8H8BrNO
49834-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Br 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 49834-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylspiro[3H-indole-3,2′-oxiran]-2(1H)-one
C10H9NO2
172605-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5772 2.7106 0.0 0
M  V30 2 C 4.6079 0.0000 0.0 0
M  V30 3 C 4.1321 3.9565 0.0 0
M  V30 4 C 2.6673 3.4806 0.0 0
M  V30 5 C 5.0371 2.7106 0.0 0
M  V30 6 C 3.8117 5.4628 0.0 0
M  V30 7 O 5.2765 4.9869 0.0 0
M  V30 8 C 2.6673 1.9406 0.0 0
M  V30 9 C 1.3337 4.2506 0.0 0
M  V30 10 N 4.1321 1.4646 0.0 0
M  V30 11 C 1.3337 1.1706 0.0 0
M  V30 12 C 0.0000 3.4806 0.0 0
M  V30 13 C 0.0000 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 7
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-3-hydroxy-1-methyl-3-[(methylamino)methyl]-2H-indol-2-one
C11H14N2O2
1330786-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1264 3.6643 0.0 0
M  V30 2 N 6.8964 4.9981 0.0 0
M  V30 3 C 8.4364 4.9981 0.0 0
M  V30 4 O 4.7474 5.1960 0.0 0
M  V30 5 O 6.0810 1.3627 0.0 0
M  V30 6 C 3.0202 0.0000 0.0 0
M  V30 7 C 3.0800 3.9844 0.0 0
M  V30 8 C 4.5864 3.6643 0.0 0
M  V30 9 C 2.3100 2.6508 0.0 0
M  V30 10 C 2.3100 5.3182 0.0 0
M  V30 11 C 4.7474 2.1327 0.0 0
M  V30 12 N 3.3406 1.5064 0.0 0
M  V30 13 C 0.7700 2.6508 0.0 0
M  V30 14 C 0.7700 5.3182 0.0 0
M  V30 15 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 11
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172605-03-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1330786-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-15500818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regiospecific epoxide opening: a facile approach for the synthesis of
3-hydroxy-3-aminomethylindolin-2-one derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chouhan, Mangilal; Senwar, Kishna Ram; Sharma, Ratnesh; Grover, Vikas;
Nair, Vipin A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2011), 13(9), 2553-2560

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-(1,1-Dimethylethyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetyl chloride
C14H14ClNO3
173208-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.7106 0.0 0 CFG=2
M  V30 2 C 1.5400 4.0442 0.0 0
M  V30 3 C 1.5400 1.3769 0.0 0
M  V30 4 C 2.8736 4.8142 0.0 0
M  V30 5 C 0.7700 5.3780 0.0 0
M  V30 6 C 0.2062 3.2742 0.0 0
M  V30 7 Cl 0.0000 1.3769 0.0 0
M  V30 8 O 2.3100 0.0431 0.0 0
M  V30 9 O 4.2792 5.4211 0.0 0
M  V30 10 O 4.2792 0.0000 0.0 0
M  V30 11 N 3.8500 2.7106 0.0 0
M  V30 12 C 4.7551 3.9564 0.0 0
M  V30 13 C 4.7551 1.4647 0.0 0
M  V30 14 C 6.2198 3.4806 0.0 0
M  V30 15 C 6.2198 1.9406 0.0 0
M  V30 16 C 7.5534 4.2506 0.0 0
M  V30 17 C 7.5534 1.1706 0.0 0
M  V30 18 C 8.8870 3.4806 0.0 0
M  V30 19 C 8.8870 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 3 7
M  V30 8 2 3 8
M  V30 9 2 9 12
M  V30 10 2 10 13
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-(1,1-Dimethylethyl)-1,3-dihydro-N-methyl-1,3-dioxo-2H-isoindole-2-acet...
C15H18N2O3
2749464-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0810 3.0800 0.0 0 CFG=1
M  V30 2 C 7.4146 3.8500 0.0 0
M  V30 3 C 6.0810 1.5400 0.0 0
M  V30 4 N 8.7484 3.0800 0.0 0
M  V30 5 O 7.4146 5.3900 0.0 0
M  V30 6 C 4.5410 1.5400 0.0 0
M  V30 7 C 6.0810 0.0000 0.0 0
M  V30 8 C 7.6210 1.5400 0.0 0
M  V30 9 C 10.0821 3.8500 0.0 0
M  V30 10 O 3.0202 1.7173 0.0 0
M  V30 11 O 5.7308 6.4119 0.0 0
M  V30 12 N 4.7474 3.8500 0.0 0
M  V30 13 C 3.3404 3.2235 0.0 0
M  V30 14 C 4.5864 5.3815 0.0 0
M  V30 15 C 2.3100 4.3681 0.0 0
M  V30 16 C 3.0800 5.7017 0.0 0
M  V30 17 C 0.7700 4.3681 0.0 0
M  V30 18 C 2.3100 7.0353 0.0 0
M  V30 19 C 0.0000 5.7017 0.0 0
M  V30 20 C 0.7700 7.0353 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 4 9
M  V30 10 2 10 13
M  V30 11 2 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 173208-57-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2749464-05-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31136448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric C-H Activation for the Synthesis of P- and Axially Chiral
Biaryl Phosphine Oxides by an Achiral Cp*Ir Catalyst with Chiral
Carboxylic Amide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Chao-Wei; Hu, Xian-Qi; Dai, Yuan-Hao; Yin, Peng; Wang, Chuanyong;
Duan, Wei-Liang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2022), 12(1), 193-199

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
Ethyl 3-[(ethoxymethylene)amino]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxylate
C15H18N2O3S
175847-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0737 7.2708 0.0 0
M  V30 2 C 3.5673 6.9506 0.0 0
M  V30 3 O 2.5368 8.0952 0.0 0
M  V30 4 C 1.0304 7.7748 0.0 0
M  V30 5 C 0.0000 8.9194 0.0 0
M  V30 6 C 3.1165 4.6200 0.0 0
M  V30 7 C 8.4056 7.6210 0.0 0
M  V30 8 O 9.9456 7.6210 0.0 0
M  V30 9 O 7.6356 8.9548 0.0 0
M  V30 10 C 10.7156 8.9548 0.0 0
M  V30 11 C 12.2556 8.9548 0.0 0
M  V30 12 C 5.7839 0.0000 0.0 0
M  V30 13 C 5.7839 4.6200 0.0 0
M  V30 14 C 6.1041 6.1264 0.0 0
M  V30 15 C 7.1176 3.8500 0.0 0
M  V30 16 C 4.4501 3.8500 0.0 0
M  V30 17 C 7.6356 6.2874 0.0 0
M  V30 18 S 8.2619 4.8806 0.0 0
M  V30 19 N 7.1176 2.3100 0.0 0
M  V30 20 C 4.4501 2.3100 0.0 0
M  V30 21 C 5.7839 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 21
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 18
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7,9-Trimethylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-one
C12H11N3OS
67795-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7270 0.0000 0.0 0
M  V30 2 O 2.4917 6.6771 0.0 0
M  V30 3 C 0.0000 4.8667 0.0 0
M  V30 4 C 10.3470 2.6674 0.0 0
M  V30 5 C 4.2205 2.9876 0.0 0
M  V30 6 C 5.7270 2.6674 0.0 0
M  V30 7 C 4.0596 4.5191 0.0 0
M  V30 8 N 2.9747 2.0824 0.0 0
M  V30 9 C 6.4970 4.0011 0.0 0
M  V30 10 C 6.4970 1.3338 0.0 0
M  V30 11 S 5.4665 5.1456 0.0 0
M  V30 12 C 2.6528 5.1454 0.0 0
M  V30 13 C 1.5679 2.7087 0.0 0
M  V30 14 N 8.0370 4.0011 0.0 0
M  V30 15 C 8.0370 1.3338 0.0 0
M  V30 16 N 1.4069 4.2404 0.0 0
M  V30 17 C 8.8070 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 12
M  V30 3 1 3 16
M  V30 4 1 4 17
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 9 11
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 175847-74-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67795-45-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-683286
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of some new pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4(3H)-ones
and pyrido[3',2':4,5]thieno[2,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ho, Yuh-Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Chinese Chemical Society (Taipei, Taiwan) (2001), 48(6B),
1163-1174

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-(trifluoromethyl)benzenesulfonyl chloride
C7H3BrClF3O2S
176225-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 Br 1.3337 0.0000 0.0 0
M  V30 6 C 6.6687 3.0801 0.0 0
M  V30 7 F 5.8986 4.4137 0.0 0
M  V30 8 F 8.0023 3.8501 0.0 0
M  V30 9 F 7.4387 1.7464 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-5-(trifluoromethyl)benzenesulfonamide
C8H7BrF3NO2S
1621415-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.9537 2.6675 0.0 0 VAL=6
M  V30 2 N 7.4937 2.6675 0.0 0
M  V30 3 O 5.9537 1.1274 0.0 0
M  V30 4 O 5.9537 4.2075 0.0 0
M  V30 5 C 8.2637 4.0011 0.0 0
M  V30 6 Br 4.4137 0.0000 0.0 0
M  V30 7 C 1.3337 5.3348 0.0 0
M  V30 8 F 0.0000 4.5648 0.0 0
M  V30 9 F 0.5636 6.6686 0.0 0
M  V30 10 F 2.6673 6.1048 0.0 0
M  V30 11 C 4.4137 2.6675 0.0 0
M  V30 12 C 3.6437 4.0011 0.0 0
M  V30 13 C 3.6437 1.3338 0.0 0
M  V30 14 C 2.1037 4.0011 0.0 0
M  V30 15 C 2.1037 1.3338 0.0 0
M  V30 16 C 1.3337 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 176225-08-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1621415-14-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36049095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted phthalazinylphenols as inhibitors of NLRP3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaoyan; Alam, Rauful; Barraza, Scott J.; Bejcek, Lauren; Gilbert,
Bradley B.; Gong, Hua; Handoko, Handoko; Hosseyni, Seyedmorteza; Huarte,
Eduardo; Jeon, Woohyung; Li, Jing; Liu, Yao; Niederer, Kyle; Parker,
Erica N.; Pillai, Meenu; Rastelli, Ettore; Sydorenko, Nadiya; Turpoff,
Anthony; Woll, Matthew G.; Zhang, Nanjing; Zhang, Yan; Zheng, Tianyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023028534 A1 2023-03-02

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pentafluorobenzyl bromide
C7H2BrF5
1765-40-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 F 4.6200 5.3349 0.0 0
M  V30 4 F 4.6200 0.0000 0.0 0
M  V30 5 F 1.5400 5.3349 0.0 0
M  V30 6 F 1.5400 0.0000 0.0 0
M  V30 7 F 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluoro-N-methylbenzenemethanamine
C8H6F5N
1156113-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 F 4.6200 5.3349 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 F 1.5400 5.3349 0.0 0
M  V30 7 F 1.5400 0.0000 0.0 0
M  V30 8 F 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 3.8500 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1765-40-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1156113-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-78196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Hydrogenation Using Rhodium Complexes Generated from Mixtures
of Monodentate Neutral and Anionic Phosphorus Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Frank, Dominik J.; Franzke, Axel; Pfaltz, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(7), 2405-2415

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2,6-bis[(2-methyl-1-oxopropyl)amino]-4-pyridinecarboxylate
C15H21N3O4
1771744-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 6.9301 0.0 0
M  V30 2 C 2.6673 8.4701 0.0 0
M  V30 3 C 1.3337 9.2401 0.0 0
M  V30 4 O 4.0011 9.2401 0.0 0
M  V30 5 C 0.0000 8.4701 0.0 0
M  V30 6 C 1.3337 10.7801 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 O 4.0011 1.5400 0.0 0
M  V30 9 O 6.6684 1.5400 0.0 0
M  V30 10 C 4.0011 0.0000 0.0 0
M  V30 11 N 8.0021 6.9301 0.0 0
M  V30 12 C 9.3359 6.1601 0.0 0
M  V30 13 C 10.6695 6.9301 0.0 0
M  V30 14 O 9.3359 4.6201 0.0 0
M  V30 15 C 10.6695 8.4701 0.0 0
M  V30 16 C 12.0032 6.1601 0.0 0
M  V30 17 C 4.0011 6.1601 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 N 5.3348 6.9301 0.0 0
M  V30 20 C 5.3348 3.8500 0.0 0
M  V30 21 C 6.6684 6.1601 0.0 0
M  V30 22 C 6.6684 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 21
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,6-bis[(2-methyl-1-oxopropyl)amino]-4-pyridinecarboxamide
C15H22N4O3
1771744-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 6.9301 0.0 0
M  V30 2 C 2.6673 8.4701 0.0 0
M  V30 3 C 1.3337 9.2401 0.0 0
M  V30 4 O 4.0011 9.2401 0.0 0
M  V30 5 C 0.0000 8.4701 0.0 0
M  V30 6 C 1.3337 10.7801 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 N 4.0011 1.5400 0.0 0
M  V30 9 O 6.6684 1.5400 0.0 0
M  V30 10 C 4.0011 0.0000 0.0 0
M  V30 11 N 8.0021 6.9301 0.0 0
M  V30 12 C 9.3359 6.1601 0.0 0
M  V30 13 C 10.6695 6.9301 0.0 0
M  V30 14 O 9.3359 4.6201 0.0 0
M  V30 15 C 10.6695 8.4701 0.0 0
M  V30 16 C 12.0032 6.1601 0.0 0
M  V30 17 C 4.0011 6.1601 0.0 0
M  V30 18 C 4.0011 4.6201 0.0 0
M  V30 19 N 5.3348 6.9301 0.0 0
M  V30 20 C 5.3348 3.8500 0.0 0
M  V30 21 C 6.6684 6.1601 0.0 0
M  V30 22 C 6.6684 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 21
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1771744-93-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1771744-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14779739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rebek Imide Platforms as Model Systems for the Investigation of Weak
Intermolecular Interactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harder, Michael; Carnero Corrales, Marjorie A.; Trapp, Nils; Kuhn, Bernd;
Diederich, Francois
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2015), 21(23), 8455-8463

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-nitrobenzonitrile
C8H6N2O3
177476-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 5.3349 0.0 0
M  V30 5 O 0.0000 2.6674 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 3-(methylamino)-4-nitro-
C8H7N3O2
64910-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 177476-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64910-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11031213
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (b) 3-(Methylamino)-4-nitrobenzonitrile. Following the procedure of
Mackman etal in J. Med. Chem. 2001, 44, 2753-2771,
3-methoxy-4-nitrobenzonitrile (l.0 g, 5.62 mmol) was dissolved in DMSO (7
mL) in a pressure tube and a 40% solution of MeNH2 in water (1 mL) was
added. The tube was sealed and heated to 75 °C for 4 h, then cooled and
poured onto an ice/water mixture. The precipitate was filtered, rinsed
with water, and dried to afford 3-(methylamino)-4-nitrobenzonitrile (0.95
g, 95%) as an orange solid. 1H NMR (CDCl3): δ 8.26 (d, J = 8.8 Hz, 1H),
8.05 (bs, 1H), 7.15 (d, J = 1.2 Hz, 1H), 6.89 (dd, J = 1.6, 8.8 Hz, 1H),
3.06 (d, J = 5.2 Hz, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiazolone compounds for inhibiting hYAK3 proteins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duffy, Kevin J.; Fitch, Duke M.; Goodman, Steven Neal; Hasegawa,
Masaichi; Johnson, Neil W.; Kasparec, Jiri; Shaw, Antony N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005082901 A1 2005-09-09

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-fluorobenzonitrile
C7H3BrFN
179897-89-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 N 0.0000 3.8501 0.0 0
M  V30 3 F 1.3338 0.0000 0.0 0
M  V30 4 Br 6.6687 3.0801 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(methylamino)benzonitrile
C8H7BrN2
106874-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3349 0.0 0
M  V30 3 C 2.3100 1.3338 0.0 0
M  V30 4 N 1.5400 0.0000 0.0 0
M  V30 5 Br 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 3 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 179897-89-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 106874-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35515878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ferroptosis modulators, preparations, and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Jianguang; Zhang, Zhiyuan; Hou, Weijie; Jiang, Yimin; Xu, Yanping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023280296 A1 2023-01-12

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzene, 2-bromo-3-fluoro-1-methoxy-4-nitro-
C7H5BrFNO3
1805556-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 Br 4.0011 6.1600 0.0 0
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-methoxy-N-methyl-6-nitrobenzenamine
C8H9BrN2O3
2713621-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 Br 4.0011 6.1600 0.0 0
M  V30 7 O 6.6685 4.6200 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1805556-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2713621-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33768158
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM yield depends on reaction conditions, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022147465 A1 2022-07-07

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzene, 2-bromo-3-fluoro-1-methoxy-4-nitro-
C7H5BrFNO3
1805556-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 Br 4.0011 6.1600 0.0 0
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-3-methoxy-N-methyl-6-nitrobenzenamine
C8H9BrN2O3
2713621-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 Br 4.0011 6.1600 0.0 0
M  V30 7 O 6.6685 4.6200 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1805556-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2713621-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24567953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as MDM2 degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021188948 A1 2021-09-23

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
1,3-Dioxino[5,4-b]furo[2,3-d]pyrrol-7(4H)-one, hexahydro-2,2-dimethyl-5-penty...
C15H25NO4
1823154-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1132 6.2861 0.0 0
M  V30 2 C 8.4469 5.5161 0.0 0
M  V30 3 C 9.7805 6.2861 0.0 0
M  V30 4 C 11.1142 5.5161 0.0 0
M  V30 5 C 12.4480 6.2861 0.0 0
M  V30 6 C 0.0000 6.0598 0.0 0
M  V30 7 C 0.4116 7.9964 0.0 0
M  V30 8 O 5.6782 0.0000 0.0 0
M  V30 9 C 3.3422 4.9980 0.0 0 CFG=2
M  V30 10 C 4.1122 3.6643 0.0 0 CFG=1
M  V30 11 C 4.3726 6.1425 0.0 0 CFG=1
M  V30 12 O 1.8357 5.3182 0.0 0
M  V30 13 C 5.6185 3.9845 0.0 0 CFG=1
M  V30 14 O 3.9511 2.1328 0.0 0
M  V30 15 N 5.7794 5.5161 0.0 0
M  V30 16 C 3.8967 7.6071 0.0 0
M  V30 17 C 1.3598 6.7829 0.0 0
M  V30 18 C 6.3885 2.6508 0.0 0
M  V30 19 C 5.3580 1.5063 0.0 0
M  V30 20 O 2.3903 7.9273 0.0 0
M  V30 21 H 2.1453 4.0289 0.0 0
M  V30 22 H 2.8822 2.7375 0.0 0
M  V30 23 H 5.5170 7.1730 0.0 0
M  V30 24 H 7.1248 4.3047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 17
M  V30 7 1 7 17
M  V30 8 2 8 19
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 21 CFG=1
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 22 CFG=1
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 11 23 CFG=3
M  V30 19 1 12 17
M  V30 20 1 13 15
M  V30 21 1 13 18
M  V30 22 1 13 24 CFG=1
M  V30 23 1 14 19
M  V30 24 1 16 20
M  V30 25 1 17 20
M  V30 26 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 10 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-N-methyl-1-pentyl-2-pyrrolidine...
C13H26N2O4
1823154-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 3.0800 2.6673 0.0 0
M  V30 3 C 2.3100 1.3337 0.0 0
M  V30 4 C 0.7700 1.3337 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 C 7.9521 3.0175 0.0 0
M  V30 7 C 9.4585 3.3377 0.0 0
M  V30 8 N 10.4889 2.1933 0.0 0
M  V30 9 O 9.9344 4.8024 0.0 0
M  V30 10 C 11.9952 2.5135 0.0 0
M  V30 11 C 3.2573 5.7281 0.0 0
M  V30 12 O 2.7814 7.1928 0.0 0
M  V30 13 O 8.6486 6.2948 0.0 0
M  V30 14 O 5.7471 7.9699 0.0 0
M  V30 15 N 5.3901 4.0010 0.0 0
M  V30 16 C 6.9216 4.1621 0.0 0 CFG=2
M  V30 17 C 4.7636 5.4079 0.0 0 CFG=2
M  V30 18 C 7.2418 5.6684 0.0 0 CFG=2
M  V30 19 C 5.9081 6.4384 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 16 6 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 17 11 CFG=3
M  V30 13 1 18 13 CFG=1
M  V30 14 1 19 14 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1823154-84-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1823154-86-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-006-CAS-13692689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Convenient Approach to Stereoisomeric Iminocyclitols: Generation of
Potent Brain-Permeable OGA Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bergeron-Brlek, Milan; Goodwin-Tindall, Jake; Cekic, Nevena; Roth,
Christian; Zandberg, Wesley F.; Shan, Xiaoyang; Varghese, Vimal; Chan,
Sherry; Davies, Gideon J.; Vocadlo, David J.; Britton, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(51), 15429-15433

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
Methyl (2Z)-2-bromo-3-(4-methoxyphenyl)-2-propenoate
C11H11BrO3
182884-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 Br 8.0022 3.8501 0.0 0
M  V30 5 O 10.6697 2.3101 0.0 0
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 C 12.0033 1.5400 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-Bromo-3-(4-methoxyphenyl)-N-methyl-2-propenamide
C11H12BrNO2
1110652-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 Br 8.0022 3.8501 0.0 0
M  V30 5 N 10.6697 2.3101 0.0 0
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 C 12.0033 1.5400 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 182884-69-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1110652-45-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6382726
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Bromo-3-(4-methoxy-phenyl)-N-methyl-acrylamide (45). Ester (30) (10.95
g, 40.4 mmol) was dissolved in 30 mL of THF, 5 mL of H2O, and 10 mL of
MeOH. LiOH-H2O (3.40 g, 80.8 mmol) was added, and the reaction was
stirred vigorously at room temperature for 2 h. The reaction was then
acidified with 1 M HCl and extracted into EtOAc. The organic layer was
dried over Na2SO4, filtered, and concentrated to dryness. The resulting
solid was redissolved in 70 mL of CH2Cl2. HOBt (8.2 g, 60.6 mmol) and
DMAP (~10 mg) were added, and the solution was cooled to 0 °C. DIPC (9.38
mL, 60.6 mmol) was slowly added, and the solution was stirred for 10 min
at 0 °C. The reaction was warmed to room temperature and stirred for an
additional 1 h. The reaction was then concentrated to dryness. The
residue was then redissolved in THF and treated with MeNH2 (50 mL, 2.0 M
in THF, 100 mmol) for 10 min. The reaction was then extracted into EtOAc
and washed with 2 × 1 M HCl and 2 × saturated NaHCO3. The organic layer
was dried over Na2SO4, filtered, and concentrated. The crude product was
purified by column chromatography (hexanes/EtOAc) to yield 45 (10.3 g,
38.4 mmol, 95%) as a colorless oil that crystallized upon standing.
2-Bromo-3-(4-methoxy-phenyl)-N-methyl-acrylamide (45), yield (10.3 g,
38.4 mmol, 95%) 1H NMR (400 MHz, CDCl3) δ 2.96 (d, J = 4.8 Hz, 3H), 3.85
(s, 3H), 6.83 (s, br, 1H), 6.94 (d, J = 8.7 Hz, 2H), 7.80 (d, J = 8.7 Hz,
2H), 8.27 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 28.4, 56.3, 113.3, 114.8,
127.5, 132.9, 137.9, 161.7, 164.2; ESIMS [M + Na]+ calcd for
C11H12NO279BrNa 291.9949, found 291.9940.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic Approaches to the Microtubule-Stabilizing Sponge Alkaloid
Ceratamine A and Desbromo Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nodwell, Matt; Pereira, Alban; Riffell, Jenna L.; Zimmerman, Carla;
Patrick, Brian O.; Roberge, Michel; Andersen, Raymond J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(3), 995-1006

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-2-bromo-3-(4-methoxyphenyl)-2-propenoate
C11H11BrO3
182884-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 Br 8.0022 3.8501 0.0 0
M  V30 5 O 10.6697 2.3101 0.0 0
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 C 12.0033 1.5400 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-Bromo-3-(4-methoxyphenyl)-N-methyl-2-propenamide
C11H12BrNO2
1110652-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 Br 8.0022 3.8501 0.0 0
M  V30 5 N 10.6697 2.3101 0.0 0
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 C 12.0033 1.5400 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 182884-69-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1110652-45-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11572757
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Biologically Active Marine Natural Product Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nodwell, Matthew B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2009), (20140701), No pp.

$RFMT $RIREG SCHEME425 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,6E)-1,8-Diphenyl-2,6-octadiene-1,8-dione
C20H18O2
182888-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3347 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 6.6685 2.3100 0.0 0
M  V30 5 C 8.0021 3.0800 0.0 0
M  V30 6 C 9.3358 2.3100 0.0 0
M  V30 7 C 10.6694 3.0800 0.0 0
M  V30 8 C 12.0032 2.3100 0.0 0
M  V30 9 C 13.3369 3.0800 0.0 0
M  V30 10 O 13.3369 4.6200 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3338 2.3100 0.0 0
M  V30 14 C 1.3338 5.3900 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 17 C 14.6705 2.3100 0.0 0
M  V30 18 C 14.6705 0.7700 0.0 0
M  V30 19 C 16.0041 3.0800 0.0 0
M  V30 20 C 16.0041 0.0000 0.0 0
M  V30 21 C 17.3379 2.3100 0.0 0
M  V30 22 C 17.3379 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2,2′-[(2R,5S)-1-Methyl-2,5-pyrrolidinediyl]bis[1-phenylethanone]
C21H23NO2
1395349-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0010 3.0801 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 8.3955 0.9473 0.0 0
M  V30 5 C 10.6374 3.4372 0.0 0
M  V30 6 C 11.5427 4.6831 0.0 0
M  V30 7 O 10.9162 6.0899 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0 CFG=2
M  V30 9 N 8.0753 2.4536 0.0 0
M  V30 10 C 6.8294 4.6116 0.0 0
M  V30 11 C 9.1059 3.5981 0.0 0 CFG=1
M  V30 12 C 8.3359 4.9318 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 1.3337 0.0000 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 19 C 13.0742 4.5220 0.0 0
M  V30 20 C 13.9795 5.7680 0.0 0
M  V30 21 C 13.7006 3.1152 0.0 0
M  V30 22 C 15.5110 5.6069 0.0 0
M  V30 23 C 15.2323 2.9542 0.0 0
M  V30 24 C 16.1373 4.2001 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=3
M  V30 8 2 6 7
M  V30 9 1 6 19
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 182888-28-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1395349-05-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2265052
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, stereoselective, ultrasound, key step, aza-Michael
addition, scalable, de >95%, solution-phase synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solvent-free double aza-Michael under ultrasound irradiation:
diastereoselective sequential one-pot synthesis of pyrrolidine Lobelia
alkaloids analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amara, Zacharias; Drege, Emmanuelle; Troufflard, Claire; Retailleau,
Pascal; Joseph, Delphine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2012), 10(35), 7148-7157

$RFMT $RIREG SCHEME426 STEP1
$RXN



  2  1
$MOL
2-Bromophenylacetic acid
C8H7BrO2
18698-97-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzeneacetamide
C9H10BrNO
141438-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 O 5.3347 3.8500 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 Br 1.3336 0.0000 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18698-97-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 141438-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18448348
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Catalyzed Carbon-Carbon Bond-Forming Reductive Amination
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heinz, Christoph; Lutz, J. Patrick; Simmons, Eric M.; Miller, Michael M.;
Ewing, William R.; Doyle, Abigail G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2018), 140(6), 2292-2300

$RFMT $RIREG SCHEME427 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-1-phenyl-1-propanol
C9H11ClO
18776-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 Cl 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-1-phenyl-1-propanol
C10H15NO
42142-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6684 1.5400 0.0 0
M  V30 5 N 8.0022 2.3100 0.0 0
M  V30 6 C 9.3359 1.5400 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18776-12-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 42142-52-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2421961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM see experimental details, flow system used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fluoxetine by multiple flow processing steps
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmed-Omer, Batoul; Sanderson, Adam J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2011), 9(10), 3854-3862

$RFMT $RIREG SCHEME428 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromopropyl)-1,2-dihydro-5-nitro-2-(phenylmethyl)-3H-indazol-3-one
C17H16BrN3O3
1894197-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 3.7535 0.0 0
M  V30 2 C 6.0798 2.6091 0.0 0
M  V30 3 C 5.6040 1.1444 0.0 0
M  V30 4 Br 6.6344 0.0000 0.0 0
M  V30 5 C 3.0800 6.4641 0.0 0
M  V30 6 O 5.0494 9.1745 0.0 0
M  V30 7 N 10.9910 8.0041 0.0 0 VAL=5
M  V30 8 O 10.9910 9.5441 0.0 0
M  V30 9 O 12.3248 7.2341 0.0 0
M  V30 10 C 6.9900 5.6941 0.0 0
M  V30 11 N 5.5253 5.2182 0.0 0
M  V30 12 C 6.9900 7.2341 0.0 0
M  V30 13 C 8.3237 4.9241 0.0 0
M  V30 14 N 4.6201 6.4641 0.0 0
M  V30 15 C 5.5253 7.7100 0.0 0
M  V30 16 C 8.3237 8.0041 0.0 0
M  V30 17 C 9.6573 5.6941 0.0 0
M  V30 18 C 9.6573 7.2341 0.0 0
M  V30 19 C 2.3100 7.7977 0.0 0
M  V30 20 C 3.0800 9.1314 0.0 0
M  V30 21 C 0.7700 7.7977 0.0 0
M  V30 22 C 2.3100 10.4651 0.0 0
M  V30 23 C 0.0000 9.1314 0.0 0
M  V30 24 C 0.7700 10.4651 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 1 5 19
M  V30 7 2 6 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 18
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-1-[3-(methylamino)propyl]-5-nitro-2-(phenylmethyl)-3H-indazol-3-one
C18H20N4O3
2231748-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9519 8.0408 0.0 0
M  V30 2 C 9.4584 7.7206 0.0 0
M  V30 3 C 10.4888 8.8652 0.0 0
M  V30 4 N 11.9952 8.5450 0.0 0
M  V30 5 C 13.0256 9.6894 0.0 0
M  V30 6 C 4.6200 8.3910 0.0 0
M  V30 7 O 3.2573 5.3304 0.0 0
M  V30 8 N 7.2417 0.7700 0.0 0 VAL=5
M  V30 9 O 5.9081 0.0000 0.0 0
M  V30 10 O 8.5755 0.0000 0.0 0
M  V30 11 C 7.2417 5.3900 0.0 0
M  V30 12 N 6.9215 6.8964 0.0 0
M  V30 13 C 5.9081 4.6200 0.0 0
M  V30 14 C 8.5755 4.6200 0.0 0
M  V30 15 N 5.3900 7.0574 0.0 0
M  V30 16 C 4.7637 5.6506 0.0 0
M  V30 17 C 5.9081 3.0800 0.0 0
M  V30 18 C 8.5755 3.0800 0.0 0
M  V30 19 C 7.2417 2.3100 0.0 0
M  V30 20 C 3.0800 8.3910 0.0 0
M  V30 21 C 2.3100 7.0574 0.0 0
M  V30 22 C 2.3100 9.7248 0.0 0
M  V30 23 C 0.7700 7.0574 0.0 0
M  V30 24 C 0.7700 9.7248 0.0 0
M  V30 25 C 0.0000 8.3910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 15
M  V30 7 1 6 20
M  V30 8 2 7 16
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 19
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1894197-18-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2231748-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19285546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antichagasic, Leishmanicidal, and Trichomonacidal Activity of
2-Benzyl-5-nitroindazole-Derived Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fonseca-Berzal, Cristina; Ibanez-Escribano, Alexandra; Vela, Nerea;
Cumella, Jose; Nogal-Ruiz, Juan Jose; Escario, Jose Antonio; Bernardino
da Silva, Patricia; Batista, Marcos Meuser; Soeiro, Maria de Nazare C.;
Sifontes-Rodriguez, Sergio; Meneses-Marcel, Alfredo; Gomez-Barrio,
Alicia; Aran, Vicente J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2018), 13(12), 1246-1259

$RFMT $RIREG SCHEME429 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[3-[[(3-amino-6-bromo-2-pyrazinyl)carbonyl]amino]-2-[(10...
C25H36BrN5O9S
1903809-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 9.0338 0.0 0
M  V30 2 C 8.0022 8.2638 0.0 0
M  V30 3 C 9.3360 9.0338 0.0 0
M  V30 4 O 10.6697 8.2638 0.0 0
M  V30 5 C 12.0033 9.0338 0.0 0
M  V30 6 C 13.3372 8.2638 0.0 0
M  V30 7 O 14.6708 9.0338 0.0 0
M  V30 8 C 16.0045 8.2638 0.0 0
M  V30 9 C 17.3382 9.0338 0.0 0
M  V30 10 O 18.6720 8.2638 0.0 0
M  V30 11 S 20.0057 9.0338 0.0 0 VAL=6
M  V30 12 C 20.7757 7.7002 0.0 0
M  V30 13 O 21.3393 9.8039 0.0 0
M  V30 14 O 19.2356 10.3675 0.0 0
M  V30 15 N 4.0012 10.5739 0.0 0
M  V30 16 C 2.6673 11.3439 0.0 0
M  V30 17 O 1.3337 10.5739 0.0 0
M  V30 18 C 6.6685 5.9538 0.0 0
M  V30 19 N 6.6685 4.4137 0.0 0
M  V30 20 C 8.0022 3.6437 0.0 0
M  V30 21 C 5.3348 3.6437 0.0 0
M  V30 22 O 8.0022 2.1037 0.0 0
M  V30 23 O 9.3360 4.4137 0.0 0
M  V30 24 C 9.3360 1.3337 0.0 0
M  V30 25 C 8.5660 0.0000 0.0 0
M  V30 26 C 10.6697 0.5637 0.0 0
M  V30 27 C 10.1060 2.6673 0.0 0
M  V30 28 N 0.0000 12.8839 0.0 0
M  V30 29 Br 5.3348 15.9640 0.0 0
M  V30 30 C 5.3348 8.2638 0.0 0
M  V30 31 C 4.0012 9.0338 0.0 0
M  V30 32 C 5.3348 6.7238 0.0 0
M  V30 33 C 2.6673 8.2638 0.0 0
M  V30 34 C 4.0012 5.9538 0.0 0
M  V30 35 C 2.6673 6.7238 0.0 0
M  V30 36 C 2.6673 12.8839 0.0 0
M  V30 37 C 1.3337 13.6539 0.0 0
M  V30 38 N 4.0012 13.6539 0.0 0
M  V30 39 N 1.3337 15.1940 0.0 0
M  V30 40 C 4.0012 15.1940 0.0 0
M  V30 41 C 2.6673 15.9640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 15 16
M  V30 16 1 15 31
M  V30 17 2 16 17
M  V30 18 1 16 36
M  V30 19 1 18 19
M  V30 20 1 18 32
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 22 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 28 37
M  V30 30 1 29 40
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 37 1 36 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 2 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[[3-[[(3-amino-6-bromo-2-pyrazinyl)carbonyl]amino]-2-[2-[2-[...
C25H37BrN6O6
1903809-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 9.0338 0.0 0
M  V30 2 C 8.0023 8.2638 0.0 0
M  V30 3 C 9.3360 9.0338 0.0 0
M  V30 4 O 10.6697 8.2638 0.0 0
M  V30 5 C 12.0033 9.0338 0.0 0
M  V30 6 C 13.3372 8.2638 0.0 0
M  V30 7 O 14.6708 9.0338 0.0 0
M  V30 8 C 16.0045 8.2638 0.0 0
M  V30 9 C 17.3382 9.0338 0.0 0
M  V30 10 N 18.6720 8.2638 0.0 0
M  V30 11 C 20.0057 9.0338 0.0 0
M  V30 12 N 4.0012 10.5739 0.0 0
M  V30 13 C 2.6675 11.3439 0.0 0
M  V30 14 O 1.3337 10.5739 0.0 0
M  V30 15 C 6.6685 5.9538 0.0 0
M  V30 16 N 6.6685 4.4137 0.0 0
M  V30 17 C 8.0023 3.6437 0.0 0
M  V30 18 C 5.3348 3.6437 0.0 0
M  V30 19 O 8.0023 2.1037 0.0 0
M  V30 20 O 9.3360 4.4137 0.0 0
M  V30 21 C 9.3360 1.3337 0.0 0
M  V30 22 C 8.5660 0.0000 0.0 0
M  V30 23 C 10.6697 0.5637 0.0 0
M  V30 24 C 10.1060 2.6673 0.0 0
M  V30 25 N 0.0000 12.8839 0.0 0
M  V30 26 Br 5.3348 15.9640 0.0 0
M  V30 27 C 5.3348 8.2638 0.0 0
M  V30 28 C 4.0012 9.0338 0.0 0
M  V30 29 C 5.3348 6.7238 0.0 0
M  V30 30 C 2.6675 8.2638 0.0 0
M  V30 31 C 4.0012 5.9538 0.0 0
M  V30 32 C 2.6675 6.7238 0.0 0
M  V30 33 C 2.6675 12.8839 0.0 0
M  V30 34 C 1.3337 13.6539 0.0 0
M  V30 35 N 4.0012 13.6539 0.0 0
M  V30 36 N 1.3337 15.1940 0.0 0
M  V30 37 C 4.0012 15.1940 0.0 0
M  V30 38 C 2.6675 15.9640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 28
M  V30 14 2 13 14
M  V30 15 1 13 33
M  V30 16 1 15 16
M  V30 17 1 15 29
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 34
M  V30 27 1 26 37
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 1 33 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1903809-48-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1903809-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16102053
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as ataxia telangiectasia and
Rad3-related (ATR) protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breslin, Henry Joseph; Gilad, Oren
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016061097 A1 2016-04-21

$RFMT $RIREG SCHEME429 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[3-[[(3-amino-6-bromo-2-pyrazinyl)carbonyl]amino]-2-[(10...
C25H36BrN5O9S
1903809-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 9.0338 0.0 0
M  V30 2 C 8.0022 8.2638 0.0 0
M  V30 3 C 9.3360 9.0338 0.0 0
M  V30 4 O 10.6697 8.2638 0.0 0
M  V30 5 C 12.0033 9.0338 0.0 0
M  V30 6 C 13.3372 8.2638 0.0 0
M  V30 7 O 14.6708 9.0338 0.0 0
M  V30 8 C 16.0045 8.2638 0.0 0
M  V30 9 C 17.3382 9.0338 0.0 0
M  V30 10 O 18.6720 8.2638 0.0 0
M  V30 11 S 20.0057 9.0338 0.0 0 VAL=6
M  V30 12 C 20.7757 7.7002 0.0 0
M  V30 13 O 21.3393 9.8039 0.0 0
M  V30 14 O 19.2356 10.3675 0.0 0
M  V30 15 N 4.0012 10.5739 0.0 0
M  V30 16 C 2.6673 11.3439 0.0 0
M  V30 17 O 1.3337 10.5739 0.0 0
M  V30 18 C 6.6685 5.9538 0.0 0
M  V30 19 N 6.6685 4.4137 0.0 0
M  V30 20 C 8.0022 3.6437 0.0 0
M  V30 21 C 5.3348 3.6437 0.0 0
M  V30 22 O 8.0022 2.1037 0.0 0
M  V30 23 O 9.3360 4.4137 0.0 0
M  V30 24 C 9.3360 1.3337 0.0 0
M  V30 25 C 8.5660 0.0000 0.0 0
M  V30 26 C 10.6697 0.5637 0.0 0
M  V30 27 C 10.1060 2.6673 0.0 0
M  V30 28 N 0.0000 12.8839 0.0 0
M  V30 29 Br 5.3348 15.9640 0.0 0
M  V30 30 C 5.3348 8.2638 0.0 0
M  V30 31 C 4.0012 9.0338 0.0 0
M  V30 32 C 5.3348 6.7238 0.0 0
M  V30 33 C 2.6673 8.2638 0.0 0
M  V30 34 C 4.0012 5.9538 0.0 0
M  V30 35 C 2.6673 6.7238 0.0 0
M  V30 36 C 2.6673 12.8839 0.0 0
M  V30 37 C 1.3337 13.6539 0.0 0
M  V30 38 N 4.0012 13.6539 0.0 0
M  V30 39 N 1.3337 15.1940 0.0 0
M  V30 40 C 4.0012 15.1940 0.0 0
M  V30 41 C 2.6673 15.9640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 30
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 15 16
M  V30 16 1 15 31
M  V30 17 2 16 17
M  V30 18 1 16 36
M  V30 19 1 18 19
M  V30 20 1 18 32
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 22 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 28 37
M  V30 30 1 29 40
M  V30 31 2 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 2 33 35
M  V30 36 1 34 35
M  V30 37 1 36 37
M  V30 38 2 36 38
M  V30 39 2 37 39
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 2 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[[3-[[(3-amino-6-bromo-2-pyrazinyl)carbonyl]amino]-2-[2-[2-[...
C25H37BrN6O6
1903809-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 9.0338 0.0 0
M  V30 2 C 8.0023 8.2638 0.0 0
M  V30 3 C 9.3360 9.0338 0.0 0
M  V30 4 O 10.6697 8.2638 0.0 0
M  V30 5 C 12.0033 9.0338 0.0 0
M  V30 6 C 13.3372 8.2638 0.0 0
M  V30 7 O 14.6708 9.0338 0.0 0
M  V30 8 C 16.0045 8.2638 0.0 0
M  V30 9 C 17.3382 9.0338 0.0 0
M  V30 10 N 18.6720 8.2638 0.0 0
M  V30 11 C 20.0057 9.0338 0.0 0
M  V30 12 N 4.0012 10.5739 0.0 0
M  V30 13 C 2.6675 11.3439 0.0 0
M  V30 14 O 1.3337 10.5739 0.0 0
M  V30 15 C 6.6685 5.9538 0.0 0
M  V30 16 N 6.6685 4.4137 0.0 0
M  V30 17 C 8.0023 3.6437 0.0 0
M  V30 18 C 5.3348 3.6437 0.0 0
M  V30 19 O 8.0023 2.1037 0.0 0
M  V30 20 O 9.3360 4.4137 0.0 0
M  V30 21 C 9.3360 1.3337 0.0 0
M  V30 22 C 8.5660 0.0000 0.0 0
M  V30 23 C 10.6697 0.5637 0.0 0
M  V30 24 C 10.1060 2.6673 0.0 0
M  V30 25 N 0.0000 12.8839 0.0 0
M  V30 26 Br 5.3348 15.9640 0.0 0
M  V30 27 C 5.3348 8.2638 0.0 0
M  V30 28 C 4.0012 9.0338 0.0 0
M  V30 29 C 5.3348 6.7238 0.0 0
M  V30 30 C 2.6675 8.2638 0.0 0
M  V30 31 C 4.0012 5.9538 0.0 0
M  V30 32 C 2.6675 6.7238 0.0 0
M  V30 33 C 2.6675 12.8839 0.0 0
M  V30 34 C 1.3337 13.6539 0.0 0
M  V30 35 N 4.0012 13.6539 0.0 0
M  V30 36 N 1.3337 15.1940 0.0 0
M  V30 37 C 4.0012 15.1940 0.0 0
M  V30 38 C 2.6675 15.9640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 28
M  V30 14 2 13 14
M  V30 15 1 13 33
M  V30 16 1 15 16
M  V30 17 1 15 29
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 25 34
M  V30 27 1 26 37
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 34 1 33 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1903809-48-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1903809-49-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19774654
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as ataxia telangiectasia and
Rad3-related (ATR) protein kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breslin, Henry Joseph; Gilad, Oren
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160102104 A1 2016-04-14

